Citrus Sinensis ID: 015852

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------40
Protein Sequence
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHccccccccccccccccccccccEEEEcccccEEEEEcccccccccccHHHcccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccHHHHHHHHcccccccEEEEccccEEEEEEEccccEEEEEEEccccccccHHHHHHHHHHHHccccccccccEEEEEcccccEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHcccccccccccccccccccccEEEEcccccEEEEEEccccccccccHHHcccccccEEEcccccccccccHHHHcccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEHHHHHHHHHHHHHHHHHHHHHHHHHHcccccEccccccccccccccccEEEcHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccHHHHHHHHHHcc
Coil and Loop (DISEMBL)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKsklqdpnnslqswdnlpgnlctwfhitcnpegsvtrvdlgnaalsgelapelgqlknlELLRLnnnslsgliptslttitslnildlsnnrlsgpvpdngsfsqftpisfennlnlcgpntkkpcsgsppfsppppfgptsspgrnksnaaiPVGVALGAALLFAVPvigfaywrrtrphefffdvpaeddselqlgqlkRFSLRELQVAtdgfsnknilgrggfgkvykgrladgKLVAVKRLKEertsggelqfqTEVKIISMAVHRNLLRLYGFCTTVTEKLLVypymtngsvASRLRerqsslppldwptrkkiALGSARGlsylhehcdpkiihRDVKAANIlldedadqsskTILRRL
Flexible Loop (DISEMBL)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVAtdgfsnknilgrggfgkvykgrlaDGKLVAVKrlkeertsggelqfqteVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRlrerqsslppldwptrkKIALGSARGLSYLHEHCDPKIIHRDVKAANilldedadqssktilrrl
Low Complexity Region (SEG)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPelgqlknlellrlnnnslsgliptslttitslnildlsNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKpcsgsppfsppppfgptsspgRNKSNaaipvgvalgaallfavpvIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered region (IsUnstruct)
****VLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSN****************TPISFE**L************************************AIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV**************DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL***************
Disordered Region (DISOPRED)
**KRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT******************************IPVGVALGAALLFAVPVIGFAYW************************LKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKR***************EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered Region (DISEMBL)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT************************NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered Region (DISPRO)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPC*GSP*****************KSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Transmembrane Helix (TMHMM)
iiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	399	2.2.26 [Sep-21-2011]
Q94F62	615	BRASSINOSTEROID INSENSITI	yes	no	0.942	0.611	0.595	1e-129
Q94AG2	625	Somatic embryogenesis rec	no	no	0.969	0.619	0.620	1e-127
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.889	0.572	0.601	1e-123
Q9XIC7	628	Somatic embryogenesis rec	no	no	0.914	0.581	0.608	1e-119
Q8LPS5	601	Somatic embryogenesis rec	no	no	0.854	0.567	0.537	1e-100
Q9LFS4	638	Protein NSP-INTERACTING K	no	no	0.889	0.556	0.454	8e-90
Q8RY65	635	Protein NSP-INTERACTING K	no	no	0.879	0.552	0.441	3e-87
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.944	0.596	0.438	2e-84
Q0WVM4	634	Probable LRR receptor-lik	no	no	0.924	0.582	0.437	3e-84
Q8VYT3	648	Probable LRR receptor-lik	no	no	0.932	0.574	0.437	4e-83

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  461 bits (1187), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 261/438 (59%), Positives = 296/438 (67%), Gaps = 62/438 (14%)

Query: 1   MEKRVLV---FYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCT 57
           ME+R+++   F+L+  +VL  +  +S NAE DAL   K+ L DPN  LQSWD      CT
Sbjct: 1   MERRLMIPCFFWLI--LVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCT 58

Query: 58  WFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLE----------------------- 94
           WFH+TCN + SVTRVDLGNA LSG+L  +LGQL NL+                       
Sbjct: 59  WFHVTCNSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTEL 118

Query: 95  -------------------------LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
                                     LRLNNNSLSG IP SLT + +L +LDLSNN L+G
Sbjct: 119 VSLDLYLNNLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTG 178

Query: 130 PVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPV 189
            +P NGSFS FTPISF N          K         PP    P S  G N+   AI  
Sbjct: 179 DIPVNGSFSLFTPISFANT---------KLTPLPASPPPPISPTPPSPAGSNRITGAIAG 229

Query: 190 GVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGF 249
           GVA GAALLFAVP I  A+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D F
Sbjct: 230 GVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNF 289

Query: 250 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           SNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL
Sbjct: 290 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 349

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
            GFC T TE+LLVYPYM NGSVAS LRER  S PPLDWP R++IALGSARGL+YLH+HCD
Sbjct: 350 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 409

Query: 370 PKIIHRDVKAANILLDED 387
           PKIIHRDVKAANILLDE+
Sbjct: 410 PKIIHRDVKAANILLDEE 427

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  455 bits (1171), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 273/440 (62%), Positives = 299/440 (67%), Gaps = 53/440 (12%)

Query: 1   MEKRVLVFYLVSTIVL--VALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTW 58
           ME   +VF L+S I+L   +L + SAN E DAL+  +  L DPNN LQSWD    N CTW
Sbjct: 1   MESSYVVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTW 60

Query: 59  FHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRL--NN---------------- 100
           FH+TCN E SV RVDLGNA LSG L PELG LKNL+ L L  NN                
Sbjct: 61  FHVTCNNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLV 120

Query: 101 ------NSLSGLIPTSLTTITSLNILDLSNNRL------------------------SGP 130
                 NS SG IP SL  ++ L  L L+NN L                        SG 
Sbjct: 121 SLDLYLNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGS 180

Query: 131 VPDNGSFSQFTPISFENNLNLCGPNTKK---PCSGSPPFSPPPPFGPTSSPGRNKSNAAI 187
           VPDNGSFS FTPISF NNL+LCGP T           P  P     P S+P       AI
Sbjct: 181 VPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAI 240

Query: 188 PVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATD 247
             GVA GAALLFA P I FA+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D
Sbjct: 241 AGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASD 300

Query: 248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           GFSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLL
Sbjct: 301 GFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 360

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           RL GFC T TE+LLVYPYM NGSVAS LRER  S PPLDWPTRK+IALGSARGLSYLH+H
Sbjct: 361 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDH 420

Query: 368 CDPKIIHRDVKAANILLDED 387
           CDPKIIHRDVKAANILLDE+
Sbjct: 421 CDPKIIHRDVKAANILLDEE 440

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  441 bits (1133), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 251/417 (60%), Positives = 278/417 (66%), Gaps = 62/417 (14%)

Query: 22  ISANAEVDALYIFKSKLQ--DP-NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAA 78
           ++ NAE DAL   K+ L   DP NN LQSWD      CTWFH+TCNPE  VTRVDLGNA 
Sbjct: 27  VAGNAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAK 86

Query: 79  LSGELAPELGQLKNLE-------------------------------------------- 94
           LSG+L PELGQL NL+                                            
Sbjct: 87  LSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKL 146

Query: 95  ----LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 150
                LRLNNNSLSG IP +LT++  L +LD+SNNRLSG +P NGSFS FTPISF NN  
Sbjct: 147 GKLRFLRLNNNSLSGEIPMTLTSV-QLQVLDISNNRLSGDIPVNGSFSLFTPISFANN-- 203

Query: 151 LCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWR 210
                     +  P   P         P   +  AAI  GVA GAALLFAVP I FA+W 
Sbjct: 204 --------SLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWL 255

Query: 211 RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 270
           R +P + FFDVPAE+D E+ LGQLKRF+LREL VATD FSNKN+LGRGGFGKVYKGRLAD
Sbjct: 256 RRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLAD 315

Query: 271 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 330
           G LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGS
Sbjct: 316 GNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 375

Query: 331 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           VAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIHRDVKAANILLDE+
Sbjct: 376 VASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEE 432

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1

 Score =  427 bits (1098), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 253/416 (60%), Positives = 283/416 (68%), Gaps = 51/416 (12%)

Query: 23  SANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGE 82
           S+N E DAL+  ++ L DPNN LQSWD    N CTWFH+TCN E SV RVDLGNA LSG+
Sbjct: 28  SSNMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNADLSGQ 87

Query: 83  LAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL-------------------- 122
           L P+LGQLKNL+ L L +N+++G +P+ L  +T+L  LDL                    
Sbjct: 88  LVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLR 147

Query: 123 ----SNNRLSGP------------------------VPDNGSFSQFTPISFENNLNLCGP 154
               +NN L+GP                        VPDNGSFS FTPISF NNL+LCGP
Sbjct: 148 FLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGP 207

Query: 155 NTKKPCSGSPPFSPPPPFGPTSSPGRNK--SNAAIPVGVALGAALLFAVPVIGFAYW-RR 211
            T +PC GSPPFSPPPPF P          S      G     A L          W RR
Sbjct: 208 VTSRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGAIAGGVAAGAALLFAAPALAFAWWRR 267

Query: 212 TRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADG 271
            +P EFFFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFGKVYKGRLADG
Sbjct: 268 RKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADG 327

Query: 272 KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV 331
            LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSV
Sbjct: 328 TLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 387

Query: 332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           AS LRER  S  PL W  R++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 388 ASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443

Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2

 Score =  366 bits (940), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 224/417 (53%), Positives = 260/417 (62%), Gaps = 76/417 (18%)

Query: 22  ISANAEVDALYIFKSKL---QDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAA 78
           ++   +VDAL   +S L      NN LQSW+      C+WFH+TCN E SVTR+DLG+A 
Sbjct: 22  VTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCNTENSVTRLDLGSAN 81

Query: 79  LSGELAPELGQLKNLE-------------------------------------------- 94
           LSGEL P+L QL NL+                                            
Sbjct: 82  LSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIPSSLGKL 141

Query: 95  ----LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 150
                LRL NNSLSG IP SLT +  L++LD+SNNRLSG +P NGSFSQFT +SF NN  
Sbjct: 142 GKLRFLRLYNNSLSGEIPRSLTAL-PLDVLDISNNRLSGDIPVNGSFSQFTSMSFANN-- 198

Query: 151 LCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWR 210
                               P   + SP  + ++AAI VGVA GAALLFA+         
Sbjct: 199 -----------------KLRPRPASPSPSPSGTSAAIVVGVAAGAALLFALAWW-----L 236

Query: 211 RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 270
           R +    F DVPAE+D E+ LGQ KRFSLREL VAT+ FS +N+LG+G FG +YKGRLAD
Sbjct: 237 RRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLAD 296

Query: 271 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 330
             LVAVKRL EERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGS
Sbjct: 297 DTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 356

Query: 331 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           VAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIH DVKAANILLDE+
Sbjct: 357 VASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEE 413

Serine/threonine-kinase of unknown function.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1

 Score =  331 bits (848), Expect = 8e-90,   Method: Compositional matrix adjust.
 Identities = 189/416 (45%), Positives = 239/416 (57%), Gaps = 61/416 (14%)

Query: 24  ANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPE----------------- 66
            N EV AL   K+ L DP+  L +WD    + C+W  +TC+ E                 
Sbjct: 38  VNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSENFVIGLGTPSQNLSGTL 97

Query: 67  ----------------------------GSVTR---VDLGNAALSGELAPELGQLKNLEL 95
                                       G +TR   +DL +    GE+   +G L++L+ 
Sbjct: 98  SPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQY 157

Query: 96  LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN 155
           LRLNNNSLSG+ P SL+ +T L  LDLS N LSGPVP    F+  T  S   N  +C   
Sbjct: 158 LRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP---RFAAKT-FSIVGNPLICPTG 213

Query: 156 TKKPCSGSPPFSPPPPFGPTSSP----GRNKSNAAIPVGVALGAALLFAVPVIGFAYWRR 211
           T+  C+G+           T  P    G      AI VG ++G   L  + V  F +WR+
Sbjct: 214 TEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWRQ 273

Query: 212 TRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 270
                 FFDV       E+ LG L+RF  RELQ+AT+ FS+KN+LG+GG+G VYKG L D
Sbjct: 274 RHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGD 333

Query: 271 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 330
             +VAVKRLK+    GGE+QFQTEV++IS+AVHRNLLRLYGFC T TEKLLVYPYM+NGS
Sbjct: 334 STVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGS 393

Query: 331 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           VASR++ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIHRDVKAANILLD+
Sbjct: 394 VASRMKAK----PVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDD 445

Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  322 bits (825), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 185/419 (44%), Positives = 247/419 (58%), Gaps = 68/419 (16%)

Query: 24  ANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGEL 83
            N EV AL   KS L DP+  L +WD+   + C+W  ITC+ +G V R++  +  LSG L
Sbjct: 39  VNFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCS-DGFVIRLEAPSQNLSGTL 97

Query: 84  APELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLS-------------------- 123
           +  +G L NL+ + L NN ++G IP  +  +  L  LDLS                    
Sbjct: 98  SSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQY 157

Query: 124 ----NNRLSGPVPD---NGSFSQFTPISFEN-----------------NLNLCGPNTKKP 159
               NN L+G +P    N +   F  +S+ N                 N  +C   T+K 
Sbjct: 158 LRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPTGTEKD 217

Query: 160 CSGSPPFSPPPPFGPTSSPGRNKSN--------AAIPVGVALGAALLFAVPVIGFAY--- 208
           C+G    + P P   T +  +NKS+         A+  GV+L    L    +IGF +   
Sbjct: 218 CNG----TQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLL---IIGFGFLLW 270

Query: 209 WRRTRPHE-FFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 267
           WRR    +  FFD+  ++  E+ LG L+RF+ +ELQ AT  FS+KN++G+GGFG VYKG 
Sbjct: 271 WRRRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGC 330

Query: 268 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT 327
           L DG ++AVKRLK+    GGE+QFQTE+++IS+AVHRNLLRLYGFCTT +E+LLVYPYM+
Sbjct: 331 LHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMS 390

Query: 328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           NGSVASRL+ +    P LDW TRK+IALG+ RGL YLHE CDPKIIHRDVKAANILLD+
Sbjct: 391 NGSVASRLKAK----PVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDD 445

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  313 bits (802), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 189/431 (43%), Positives = 243/431 (56%), Gaps = 54/431 (12%)

Query: 6   LVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNP 65
           LVF     I    L     N EV AL   K++L DP   L++WD    + C+W  ++C  
Sbjct: 14  LVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCT- 72

Query: 66  EGSVTRVDLGNAALSGELAPELG------------------------QLKNLELLRLNNN 101
           +G V+ +DL + +LSG L+P +G                        +L+ L+ L L+NN
Sbjct: 73  DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNN 132

Query: 102 SLSGLIPT------------------------SLTTITSLNILDLSNNRLSGPVPDNGSF 137
           S +G IP                         SL+ I  L ++D+S N LSG +P   S 
Sbjct: 133 SFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLP-KVSA 191

Query: 138 SQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAAL 197
             F  I    N  +CGP     CS  P     P  GP  S  R   +       A  +A 
Sbjct: 192 RTFKVIG---NALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAA 248

Query: 198 LFAVPVIG-FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILG 256
            F     G F +WR  R  + FFDV  + D E+ LG LKR++ +EL+ AT+ F++KNILG
Sbjct: 249 FFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILG 308

Query: 257 RGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV 316
           RGG+G VYKG L DG LVAVKRLK+   +GGE+QFQTEV+ IS+A+HRNLLRL GFC++ 
Sbjct: 309 RGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSN 368

Query: 317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 376
            E++LVYPYM NGSVASRL++     P LDW  RKKIA+G+ARGL YLHE CDPKIIHRD
Sbjct: 369 QERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRD 428

Query: 377 VKAANILLDED 387
           VKAANILLDED
Sbjct: 429 VKAANILLDED 439

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  312 bits (799), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 188/430 (43%), Positives = 254/430 (59%), Gaps = 61/430 (14%)

Query: 7   VFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPE 66
           V  L+   V  +L     N EV+AL   K++L DP+   ++WD    + C+W  I+C+ +
Sbjct: 14  VLLLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISCSSD 73

Query: 67  ---------------------GSVT---RVDLGNAALSGELAPELGQLKNLELLRLNNNS 102
                                G++T   +V L N  +SG++ PE+  L  L+ L L+NN 
Sbjct: 74  NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNR 133

Query: 103 LSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISF----ENNLN-------- 150
            SG IP S+  +++L  L L+NN LSGP P   S SQ   +SF     NNL         
Sbjct: 134 FSGEIPGSVNQLSNLQYLRLNNNSLSGPFP--ASLSQIPHLSFLDLSYNNLRGPVPKFPA 191

Query: 151 ----------LCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFA 200
                     +C  +  + CSGS   S P      SS GR  +  A+ +GV+LG    FA
Sbjct: 192 RTFNVAGNPLICKNSLPEICSGSISAS-PLSVSLRSSSGRRTNILAVALGVSLG----FA 246

Query: 201 VPVI---GFAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNKNILG 256
           V VI   GF ++R+ +       +   +++  L LG L+ F+ REL VATDGFS+K+ILG
Sbjct: 247 VSVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILG 306

Query: 257 RGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV 316
            GGFG VY+G+  DG +VAVKRLK+   + G  QF+TE+++IS+AVHRNLLRL G+C + 
Sbjct: 307 AGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASS 366

Query: 317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 376
           +E+LLVYPYM+NGSVASRL+ +    P LDW TRKKIA+G+ARGL YLHE CDPKIIHRD
Sbjct: 367 SERLLVYPYMSNGSVASRLKAK----PALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRD 422

Query: 377 VKAANILLDE 386
           VKAANILLDE
Sbjct: 423 VKAANILLDE 432

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1

 Score =  308 bits (790), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 187/427 (43%), Positives = 255/427 (59%), Gaps = 55/427 (12%)

Query: 6   LVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNP 65
            +F   ST+ L + P    N EV+AL   ++ L DP+ +L +WD    + C+W  ITC+P
Sbjct: 19  FLFLCFSTLTLSSEP---RNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSP 75

Query: 66  E---------------------GSVT---RVDLGNAALSGELAPELGQLKNLELLRLNNN 101
           +                     G++T   +V L N  +SG++ PELG L  L+ L L+NN
Sbjct: 76  DNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNN 135

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN--NLNLCGPNTKKP 159
             SG IP S+  ++SL  L L+NN LSGP P   S SQ   +SF +    NL GP  K P
Sbjct: 136 RFSGDIPVSIDQLSSLQYLRLNNNSLSGPFP--ASLSQIPHLSFLDLSYNNLSGPVPKFP 193

Query: 160 C-----SGSPPF--SPPPPFGPTS------------SPGRNKSNAAIPVGVALGAALLFA 200
                 +G+P    S PP     S            S GR  +  AI + V+LG+ ++  
Sbjct: 194 ARTFNVAGNPLICRSNPPEICSGSINASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILV 253

Query: 201 VPVIGFAYWRRTRPHEFFFDVPAEDDSELQ-LGQLKRFSLRELQVATDGFSNKNILGRGG 259
           + +  F ++R+ +      ++  + +  LQ LG L+ F+ REL V TDGFS+KNILG GG
Sbjct: 254 LALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGG 313

Query: 260 FGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK 319
           FG VY+G+L DG +VAVKRLK+   + G+ QF+ E+++IS+AVH+NLLRL G+C T  E+
Sbjct: 314 FGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGER 373

Query: 320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKA 379
           LLVYPYM NGSVAS+L+ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIHRDVKA
Sbjct: 374 LLVYPYMPNGSVASKLKSK----PALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKA 429

Query: 380 ANILLDE 386
           ANILLDE
Sbjct: 430 ANILLDE 436

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	399
418204460	624	somatic embryogenesis receptor-like kina	0.969	0.620	0.656	1e-140
115475023	624	Os08g0174700 [Oryza sativa Japonica Grou	0.962	0.615	0.652	1e-139
218200553	624	hypothetical protein OsI_28003 [Oryza sa	0.962	0.615	0.652	1e-138
400532041	624	somatic embryogenesis receptor-like kina	0.969	0.620	0.649	1e-138
413917200	631	putative leucine-rich repeat receptor-li	0.917	0.580	0.669	1e-137
115458750	628	Os04g0457800 [Oryza sativa Japonica Grou	0.934	0.593	0.647	1e-136
413917199	564	putative leucine-rich repeat receptor-li	0.917	0.648	0.669	1e-136
357163915	630	PREDICTED: somatic embryogenesis recepto	0.932	0.590	0.639	1e-136
242065530	626	hypothetical protein SORBIDRAFT_04g02381	0.914	0.583	0.662	1e-135
357149741	627	PREDICTED: somatic embryogenesis recepto	0.907	0.577	0.660	1e-134

>gi|418204460|gb|AFX61784.1| somatic embryogenesis receptor-like kinase [Camellia nitidissima]

 Score =  505 bits (1301), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 288/439 (65%), Positives = 313/439 (71%), Gaps = 52/439 (11%)

Query: 1   MEKRVLVFYLVS-TIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWF 59
           M++ + V  L+   +V   L MISAN E DAL+  +S L+DPNN LQSWD    N CTWF
Sbjct: 1   MKREIAVCSLLWLVMVFHPLTMISANMEGDALHNLRSNLEDPNNVLQSWDPTLVNPCTWF 60

Query: 60  HITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELL----------------------- 96
           H+TCN E SV RVDLGNAALSG+L P+LGQLKNL+ L                       
Sbjct: 61  HVTCNNENSVIRVDLGNAALSGQLVPQLGQLKNLQYLELYSNNMSGPIPSDLGNLTNLVS 120

Query: 97  -------------------------RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 131
                                    RLNNNSLSG IP SL  IT+L +LDLSNNRLSGPV
Sbjct: 121 LDLYLNGFTGPIPDTLGKLTKLRFFRLNNNSLSGSIPMSLINITALQVLDLSNNRLSGPV 180

Query: 132 PDNGSFSQFTPISFENNLNLCGPNTKKPC---SGSPPFSPPPPFGPTSSPGRNKSNAAIP 188
           PDNGSFS FTPISF NN NLCGP T KPC       P  P  P    SSP  N +  AI 
Sbjct: 181 PDNGSFSLFTPISFANNFNLCGPVTGKPCPGSPPFAPPPPFVPPSTISSPSGNSATGAIA 240

Query: 189 VGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDG 248
            GVA GAALLFA P IGFA+WRR +PHE FFDVPAE+D E+ LGQLKRFSLRELQVATD 
Sbjct: 241 GGVAAGAALLFAAPAIGFAWWRRRKPHEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDT 300

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           FSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLR
Sbjct: 301 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 360

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           L GFC T TE+LLVYPYM NGSVAS LRER  S  PLDWPTRK+IALGSARGLSYLH+HC
Sbjct: 361 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSEQPLDWPTRKRIALGSARGLSYLHDHC 420

Query: 369 DPKIIHRDVKAANILLDED 387
           DPKIIHRDVKAANILLDE+
Sbjct: 421 DPKIIHRDVKAANILLDEE 439

Source: Camellia nitidissima

Species: Camellia nitidissima

Genus: Camellia

Family: Theaceae

Order: Ericales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115475023|ref|NP_001061108.1| Os08g0174700 [Oryza sativa Japonica Group] gi|40253600|dbj|BAD05545.1| putative somatic embryogenesis receptor kinase 1 [Oryza sativa Japonica Group] gi|57753893|dbj|BAD86793.1| SERK-family receptor-like protein kinase [Oryza sativa Japonica Group] gi|113623077|dbj|BAF23022.1| Os08g0174700 [Oryza sativa Japonica Group] gi|215736920|dbj|BAG95849.1| unnamed protein product [Oryza sativa Japonica Group] gi|222639998|gb|EEE68130.1| hypothetical protein OsJ_26221 [Oryza sativa Japonica Group]

 Score =  499 bits (1286), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 284/435 (65%), Positives = 314/435 (72%), Gaps = 51/435 (11%)

Query: 4   RVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITC 63
           R  V+ ++   +LV    + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TC
Sbjct: 5   RWAVWAVLLLRLLVPAARVLANMEGDALHSLRTNLVDPNNVLQSWDPTLVNPCTWFHVTC 64

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLE----------------------------- 94
           N + SV RVDLGNAALSG L P+LGQLKNL+                             
Sbjct: 65  NNDNSVIRVDLGNAALSGTLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLY 124

Query: 95  -------------------LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG 135
                               LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP  G
Sbjct: 125 LNNFTGPIPDSLGNLLKLRFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPSTG 184

Query: 136 SFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAIPVGVA 192
           SFS FTPISF NN +LCGP T KPC G+PPFSPPPP+ P     SPG + S  AI  GVA
Sbjct: 185 SFSLFTPISFANNPSLCGPGTTKPCPGAPPFSPPPPYNPPTPVQSPGSSSSTGAIAGGVA 244

Query: 193 LGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNK 252
            GAALLFA+P IGFA++RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNK
Sbjct: 245 AGAALLFAIPAIGFAWYRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNK 304

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           NILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GF
Sbjct: 305 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 364

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
           C T TE+LLVYPYM NGSVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKI
Sbjct: 365 CMTPTERLLVYPYMANGSVASRLRERPPSEPPLDWRTRRRIALGSARGLSYLHDHCDPKI 424

Query: 373 IHRDVKAANILLDED 387
           IHRDVKAANILLDED
Sbjct: 425 IHRDVKAANILLDED 439

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218200553|gb|EEC82980.1| hypothetical protein OsI_28003 [Oryza sativa Indica Group]

 Score =  499 bits (1285), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 284/435 (65%), Positives = 314/435 (72%), Gaps = 51/435 (11%)

Query: 4   RVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITC 63
           R  V+ ++   +LV    + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TC
Sbjct: 5   RWAVWAVLLLRLLVPAARVLANMEGDALHSLRTNLVDPNNVLQSWDPTLVNPCTWFHVTC 64

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLE----------------------------- 94
           N + SV RVDLGNAALSG L P+LGQLKNL+                             
Sbjct: 65  NNDNSVIRVDLGNAALSGTLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLY 124

Query: 95  -------------------LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG 135
                               LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP  G
Sbjct: 125 LNNFTGPIPDSLGNLLKLRFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPSTG 184

Query: 136 SFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAIPVGVA 192
           SFS FTPISF NN +LCGP T KPC G+PPFSPPPP+ P     SPG + S  AI  GVA
Sbjct: 185 SFSLFTPISFANNPSLCGPGTTKPCPGAPPFSPPPPYNPPTPVQSPGSSSSTGAIAGGVA 244

Query: 193 LGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNK 252
            GAALLFA+P IGFA++RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNK
Sbjct: 245 AGAALLFAIPAIGFAWYRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNK 304

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           NILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GF
Sbjct: 305 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 364

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
           C T TE+LLVYPYM NGSVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKI
Sbjct: 365 CMTPTERLLVYPYMANGSVASRLRERPPSEPPLDWRTRRRIALGSARGLSYLHDHCDPKI 424

Query: 373 IHRDVKAANILLDED 387
           IHRDVKAANILLDED
Sbjct: 425 IHRDVKAANILLDED 439

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|400532041|gb|AFP87140.1| somatic embryogenesis receptor-like kinase [Camellia nitidissima]

 Score =  498 bits (1282), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 285/439 (64%), Positives = 311/439 (70%), Gaps = 52/439 (11%)

Query: 1   MEKRVLVFYLVS-TIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWF 59
           M++ + V  L+   +V   L MISAN E DAL+  +S L+DPNN LQSWD    N CTWF
Sbjct: 1   MKREIAVCSLLWLVMVFHPLTMISANMEGDALHNLRSNLEDPNNVLQSWDPTLVNPCTWF 60

Query: 60  HITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELL----------------------- 96
           H+TCN E SV RVDL NAALSG+L P+LGQLKNL+ L                       
Sbjct: 61  HVTCNNENSVIRVDLENAALSGQLVPQLGQLKNLQYLELYSNNMSGPIPSDLGNLTNLVS 120

Query: 97  -------------------------RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 131
                                    RLNNNSLSG IP SL  IT+L +LDLSNNRLSGPV
Sbjct: 121 LDLYLNGFTGPIPDTLGKLTKLRFFRLNNNSLSGSIPMSLINITALQVLDLSNNRLSGPV 180

Query: 132 PDNGSFSQFTPISFENNLNLCGPNTKKPC---SGSPPFSPPPPFGPTSSPGRNKSNAAIP 188
           PDNGSF+ FTPISF NN NLCGP T KPC       P  P  P    SSP  N +  AI 
Sbjct: 181 PDNGSFTLFTPISFANNFNLCGPVTGKPCPGSPPFAPPPPFVPPSTISSPSGNSATGAIA 240

Query: 189 VGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDG 248
            GVA GAALLFA P IGFA+WRR +PHE FFDVPAE+D E+ LGQLKRFSLRELQVATD 
Sbjct: 241 GGVAAGAALLFAAPAIGFAWWRRRKPHEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDT 300

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           FSNKNILGRGGFGKVYKG LADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLR
Sbjct: 301 FSNKNILGRGGFGKVYKGCLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 360

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           L GFC T TE+LLVYPYM NGSVAS LRER  S  PLDWPTRK+IALGSARGLSYLH+HC
Sbjct: 361 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSEQPLDWPTRKRIALGSARGLSYLHDHC 420

Query: 369 DPKIIHRDVKAANILLDED 387
           DPKIIHRDVKAANILLDE+
Sbjct: 421 DPKIIHRDVKAANILLDEE 439

Source: Camellia nitidissima

Species: Camellia nitidissima

Genus: Camellia

Family: Theaceae

Order: Ericales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|413917200|gb|AFW57132.1| putative leucine-rich repeat receptor-like protein kinase family protein [Zea mays]

 Score =  493 bits (1270), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 280/418 (66%), Positives = 305/418 (72%), Gaps = 52/418 (12%)

Query: 22  ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG 81
           + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TCN + SV RVDLGNAALSG
Sbjct: 29  VLANTEGDALHSLRTNLNDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSG 88

Query: 82  ELAPELGQLKNLELLRL------------------------------------------- 98
            L P+LGQLKNL+ L L                                           
Sbjct: 89  TLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIPDSLGKLLKL 148

Query: 99  -----NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 153
                NNNSLSG IP SLT IT+L +LDLSNN LSG VP  GSFS FTPISF NN NLCG
Sbjct: 149 RFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPSTGSFSLFTPISFGNNPNLCG 208

Query: 154 PNTKKPCSGSPPFSPPPPFGP---TSSPGRNKS-NAAIPVGVALGAALLFAVPVIGFAYW 209
           P T KPC G+PPFSPPPP+ P     SPG + S   AI  GVA GAALLFA+P I FAYW
Sbjct: 209 PGTTKPCPGAPPFSPPPPYNPTTPVQSPGSSSSSTGAIAGGVAAGAALLFAIPAISFAYW 268

Query: 210 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 269
           RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA
Sbjct: 269 RRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 328

Query: 270 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 329
           DG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 329 DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 388

Query: 330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           SVASRLR+R  + PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 389 SVASRLRDRPPAEPPLDWQTRQRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 446

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115458750|ref|NP_001052975.1| Os04g0457800 [Oryza sativa Japonica Group] gi|21740899|emb|CAD40895.1| OSJNBa0036B21.13 [Oryza sativa Japonica Group] gi|113564546|dbj|BAF14889.1| Os04g0457800 [Oryza sativa Japonica Group]

 Score =  491 bits (1264), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 275/425 (64%), Positives = 300/425 (70%), Gaps = 52/425 (12%)

Query: 14  IVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVD 73
           +V VA+  + AN E DALY  +  L+D NN LQSWD    N CTWFH+TCNP+ SV RVD
Sbjct: 21  VVAVAVSRVGANTEGDALYSLRQSLKDANNVLQSWDPTLVNPCTWFHVTCNPDNSVIRVD 80

Query: 74  LGNAALSGELAPELGQLKNLE--------------------------------------- 94
           LGNA LSG L P+LGQLKNL+                                       
Sbjct: 81  LGNAQLSGALVPQLGQLKNLQYLELYSNNISGTIPNELGNLTNLVSLDLYLNNFTGFIPE 140

Query: 95  ---------LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISF 145
                     LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP  GSFS FTPISF
Sbjct: 141 TLGQLYKLRFLRLNNNSLSGSIPKSLTNITTLQVLDLSNNNLSGEVPSTGSFSLFTPISF 200

Query: 146 ENNLNLCGPNTKKPC---SGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVP 202
            NN +LCGP T KPC       P  P  P  PT S G +K+ A     VA  AALLFAVP
Sbjct: 201 ANNKDLCGPGTTKPCPGAPPFSPPPPFNPPTPTVSQGDSKTGAIAGG-VAAAAALLFAVP 259

Query: 203 VIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGK 262
            IGFA+WRR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFGK
Sbjct: 260 AIGFAWWRRRKPEEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNKNILGRGGFGK 319

Query: 263 VYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV 322
           VYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLV
Sbjct: 320 VYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 379

Query: 323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI 382
           YPYM NGSVASRLRERQ + PPL+W TR +IALGSARGLSYLH+HCDPKIIHRDVKAANI
Sbjct: 380 YPYMANGSVASRLRERQPNDPPLEWQTRTRIALGSARGLSYLHDHCDPKIIHRDVKAANI 439

Query: 383 LLDED 387
           LLDED
Sbjct: 440 LLDED 444

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|413917199|gb|AFW57131.1| putative leucine-rich repeat receptor-like protein kinase family protein [Zea mays]

 Score =  491 bits (1264), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 280/418 (66%), Positives = 305/418 (72%), Gaps = 52/418 (12%)

Query: 22  ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG 81
           + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TCN + SV RVDLGNAALSG
Sbjct: 29  VLANTEGDALHSLRTNLNDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSG 88

Query: 82  ELAPELGQLKNLELLRL------------------------------------------- 98
            L P+LGQLKNL+ L L                                           
Sbjct: 89  TLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIPDSLGKLLKL 148

Query: 99  -----NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 153
                NNNSLSG IP SLT IT+L +LDLSNN LSG VP  GSFS FTPISF NN NLCG
Sbjct: 149 RFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPSTGSFSLFTPISFGNNPNLCG 208

Query: 154 PNTKKPCSGSPPFSPPPPFGP---TSSPGRNKS-NAAIPVGVALGAALLFAVPVIGFAYW 209
           P T KPC G+PPFSPPPP+ P     SPG + S   AI  GVA GAALLFA+P I FAYW
Sbjct: 209 PGTTKPCPGAPPFSPPPPYNPTTPVQSPGSSSSSTGAIAGGVAAGAALLFAIPAISFAYW 268

Query: 210 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 269
           RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA
Sbjct: 269 RRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 328

Query: 270 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 329
           DG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 329 DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 388

Query: 330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           SVASRLR+R  + PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 389 SVASRLRDRPPAEPPLDWQTRQRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 446

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357163915|ref|XP_003579889.1| PREDICTED: somatic embryogenesis receptor kinase 1-like [Brachypodium distachyon]

 Score =  491 bits (1263), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 271/424 (63%), Positives = 303/424 (71%), Gaps = 52/424 (12%)

Query: 15  VLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDL 74
           V++ +  ++AN E DALY  +  L+D N+ LQSWD    N CTWFH+TCN + SV RVDL
Sbjct: 24  VVLGVSQVAANTEGDALYSLRQSLKDANSVLQSWDPTLVNPCTWFHVTCNTDNSVIRVDL 83

Query: 75  GNAALSGELAPELGQLKNLE---------------------------------------- 94
           GNA LSG L  +LGQLKNL+                                        
Sbjct: 84  GNAQLSGALVSQLGQLKNLQYLELYSNNISGTIPYELGNLTNLVSLDLYLNNFTGVIPDT 143

Query: 95  --------LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE 146
                    LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP  GSF  FTPISF 
Sbjct: 144 LGQLLKLRFLRLNNNSLSGQIPNSLTKITTLQVLDLSNNNLSGEVPSTGSFQLFTPISFA 203

Query: 147 NNLNLCGPNTKKPCSGSPPFSPPPPFGPTS---SPGRNKSNAAIPVGVALGAALLFAVPV 203
           NNLNLCGP T KPC G+PPFSPPPPF P +   + G +K+ A      A  AAL+FAVP 
Sbjct: 204 NNLNLCGPATTKPCPGAPPFSPPPPFNPPATPVAQGDSKTGAIAGGVAAG-AALIFAVPA 262

Query: 204 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 263
           IGFA WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKV
Sbjct: 263 IGFALWRRRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKV 322

Query: 264 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 323
           YKGRL DG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct: 323 YKGRLTDGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 382

Query: 324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 383
           PYM NGSVASRLRERQ + PPL+WP R +IALGSARGLSYLH+HCDPKIIHRDVKAANIL
Sbjct: 383 PYMANGSVASRLRERQPNEPPLEWPKRTRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 442

Query: 384 LDED 387
           LDED
Sbjct: 443 LDED 446

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242065530|ref|XP_002454054.1| hypothetical protein SORBIDRAFT_04g023810 [Sorghum bicolor] gi|241933885|gb|EES07030.1| hypothetical protein SORBIDRAFT_04g023810 [Sorghum bicolor]

 Score =  489 bits (1259), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 277/418 (66%), Positives = 300/418 (71%), Gaps = 53/418 (12%)

Query: 22  ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG 81
           + AN E DALY  +  L+D NN LQSWD    N CTWFH+TCN + SV RVDLGNA LSG
Sbjct: 26  VVANTEGDALYSLRQSLKDANNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAQLSG 85

Query: 82  ELAPELGQLKNLE----------------------------------------------- 94
            L P+LGQLKNL+                                               
Sbjct: 86  VLVPQLGQLKNLQYLELYSNNISGTIPPELGNLTNLVSLDLYMNNFSGSIPDSLGNLLKL 145

Query: 95  -LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 153
             LRLNNNSL G IP SLT I++L +LDLSNN LSG VP  GSFS FTPISF NN  LCG
Sbjct: 146 RFLRLNNNSLVGQIPVSLTNISTLQVLDLSNNNLSGQVPSTGSFSLFTPISFANNPGLCG 205

Query: 154 PNTKKPCSGSPPFSPPPPFGP----TSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYW 209
           P T KPC G+PPFSPPPPF P    T S G + S  AI  GVA GAAL+FAVP I FA W
Sbjct: 206 PGTTKPCPGAPPFSPPPPFNPPSPPTQSTGAS-STGAIAGGVAAGAALVFAVPAIAFAMW 264

Query: 210 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 269
           RR +P E FFDVPAE+D E+ LGQLK+FSLRELQVATD FSNKNILGRGGFGKVYKGRLA
Sbjct: 265 RRRKPEEHFFDVPAEEDPEVHLGQLKKFSLRELQVATDNFSNKNILGRGGFGKVYKGRLA 324

Query: 270 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 329
           DG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 325 DGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 384

Query: 330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           SVASRLRERQ S PPL W TR++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 385 SVASRLRERQQSEPPLKWETRRRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 442

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357149741|ref|XP_003575217.1| PREDICTED: somatic embryogenesis receptor kinase 1-like [Brachypodium distachyon]

 Score =  483 bits (1243), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 274/415 (66%), Positives = 298/415 (71%), Gaps = 53/415 (12%)

Query: 25  NAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELA 84
           N E DALY  +  L+D NN LQSWD    N CTWFH+TCN + SV RVDLGNA LSG L 
Sbjct: 30  NTEGDALYNLRQSLKDTNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAQLSGVLV 89

Query: 85  PELGQLKNLE------------------------------------------------LL 96
            +LGQLKNL+                                                 L
Sbjct: 90  SQLGQLKNLQYLELYSNNISGPIPAELGNLTSLVSLDLYLNKFTGVIPDSLGNLLKLRFL 149

Query: 97  RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT 156
           RLNNNS+SG IP SLT IT+L +LDLSNN LSG VP  GSFS FTPISF NN  LCGP T
Sbjct: 150 RLNNNSMSGQIPKSLTDITTLQVLDLSNNNLSGAVPSTGSFSLFTPISFANNPLLCGPGT 209

Query: 157 KKPCSGSPPFSPPPPFGP----TSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRT 212
            KPC G PPFSPPPP+ P    T S G + S  AI  GVA GAAL+FAVP I FA WRR 
Sbjct: 210 TKPCPGEPPFSPPPPYIPPTPPTQSAGAS-STGAIAGGVAAGAALVFAVPAIAFAMWRRR 268

Query: 213 RPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK 272
           +P E FFDVPAE+D E+ LGQLK+FSLRELQVA+D F+NKNILGRGGFGKVYKGRLADG 
Sbjct: 269 KPEEHFFDVPAEEDPEVHLGQLKKFSLRELQVASDNFNNKNILGRGGFGKVYKGRLADGT 328

Query: 273 LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA 332
           LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVA
Sbjct: 329 LVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 388

Query: 333 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           SRLRERQ S PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 389 SRLRERQPSEPPLDWDTRRRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 443

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	399
TAIR|locus:2013021	625	SERK1 "somatic embryogenesis r	0.461	0.294	0.847	1.3e-117
TAIR|locus:2026097	628	SERK2 "somatic embryogenesis r	0.461	0.292	0.826	2.8e-113
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.461	0.296	0.798	8.1e-106
TAIR|locus:2040471	601	SERK5 "somatic embryogenesis r	0.453	0.301	0.734	7.8e-92
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.649	0.409	0.503	3e-75
TAIR|locus:2146102	638	NIK1 "NSP-interacting kinase 1	0.443	0.277	0.648	6.8e-72
TAIR|locus:2061466	634	AT2G23950 [Arabidopsis thalian	0.448	0.282	0.597	7.4e-69
TAIR|locus:2118811	648	SARK "SENESCENCE-ASSOCIATED RE	0.631	0.388	0.465	3.2e-68
TAIR|locus:2171973	614	AT5G45780 [Arabidopsis thalian	0.631	0.410	0.480	1.1e-67
TAIR|locus:2160644	614	AT5G63710 [Arabidopsis thalian	0.443	0.288	0.629	7.3e-67

TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 813 (291.2 bits), Expect = 1.3e-117, Sum P(3) = 1.3e-117
 Identities = 156/184 (84%), Positives = 168/184 (91%)

Query:   204 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 263
             I FA+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+DGFSNKNILGRGGFGKV
Sbjct:   257 IAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKV 316

Query:   264 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 323
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   317 YKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 376

Query:   324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 383
             PYM NGSVAS LRER  S PPLDWPTRK+IALGSARGLSYLH+HCDPKIIHRDVKAANIL
Sbjct:   377 PYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 436

Query:   384 LDED 387
             LDE+
Sbjct:   437 LDEE 440

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0043234 "protein complex" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI;IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0007030 "Golgi organization" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IGI

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0009880 "embryonic pattern specification" evidence=RCA

GO:0010072 "primary shoot apical meristem specification" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010431 "seed maturation" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045595 "regulation of cell differentiation" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 784 (281.0 bits), Expect = 2.8e-113, Sum P(3) = 2.8e-113
 Identities = 152/184 (82%), Positives = 164/184 (89%)

Query:   204 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 263
             + FA+WRR +P EFFFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFGKV
Sbjct:   260 LAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKV 319

Query:   264 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 323
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   320 YKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 379

Query:   324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 383
             PYM NGSVAS LRER  S  PL W  R++IALGSARGLSYLH+HCDPKIIHRDVKAANIL
Sbjct:   380 PYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANIL 439

Query:   384 LDED 387
             LDE+
Sbjct:   440 LDEE 443

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 765 (274.4 bits), Expect = 8.1e-106, Sum P(3) = 8.1e-106
 Identities = 147/184 (79%), Positives = 160/184 (86%)

Query:   204 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 263
             I FA+W R +P + FFDVPAE+D E+ LGQLKRF+LREL VATD FSNKN+LGRGGFGKV
Sbjct:   249 IAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKV 308

Query:   264 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 323
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   309 YKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 368

Query:   324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 383
             PYM NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIHRDVKAANIL
Sbjct:   369 PYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANIL 428

Query:   384 LDED 387
             LDE+
Sbjct:   429 LDEE 432

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 676 (243.0 bits), Expect = 7.8e-92, Sum P(3) = 7.8e-92
 Identities = 133/181 (73%), Positives = 148/181 (81%)

Query:   207 AYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG 266
             A+W R +    F DVPAE+D E+ LGQ KRFSLREL VAT+ FS +N+LG+G FG +YKG
Sbjct:   233 AWWLRRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKG 292

Query:   267 RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM 326
             RLAD  LVAVKRL EERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM
Sbjct:   293 RLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 352

Query:   327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIH DVKAANILLDE
Sbjct:   353 ANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDE 412

Query:   387 D 387
             +
Sbjct:   413 E 413

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 621 (223.7 bits), Expect = 3.0e-75, Sum P(3) = 3.0e-75
 Identities = 133/264 (50%), Positives = 162/264 (61%)

Query:   125 NRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXRNKSN 184
             N LSG +P   S   F  I    N  +CGP                         R   +
Sbjct:   180 NNLSGSLP-KVSARTFKVIG---NALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGH 235

Query:   185 XXXXXXXXXXXXXXXXXXXIG-FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQ 243
                                 G F +WR  R  + FFDV  + D E+ LG LKR++ +EL+
Sbjct:   236 HVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELR 295

Query:   244 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 303
              AT+ F++KNILGRGG+G VYKG L DG LVAVKRLK+   +GGE+QFQTEV+ IS+A+H
Sbjct:   296 SATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALH 355

Query:   304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
             RNLLRL GFC++  E++LVYPYM NGSVASRL++     P LDW  RKKIA+G+ARGL Y
Sbjct:   356 RNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVY 415

Query:   364 LHEHCDPKIIHRDVKAANILLDED 387
             LHE CDPKIIHRDVKAANILLDED
Sbjct:   416 LHEQCDPKIIHRDVKAANILLDED 439

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 610 (219.8 bits), Expect = 6.8e-72, Sum P(3) = 6.8e-72
 Identities = 118/182 (64%), Positives = 142/182 (78%)

Query:   206 FAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVY 264
             F +WR+      FFDV       E+ LG L+RF  RELQ+AT+ FS+KN+LG+GG+G VY
Sbjct:   268 FLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVY 327

Query:   265 KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP 324
             KG L D  +VAVKRLK+    GGE+QFQTEV++IS+AVHRNLLRLYGFC T TEKLLVYP
Sbjct:   328 KGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYP 387

Query:   325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
             YM+NGSVASR++ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIHRDVKAANILL
Sbjct:   388 YMSNGSVASRMKAK----PVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILL 443

Query:   385 DE 386
             D+
Sbjct:   444 DD 445

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0051607 "defense response to virus" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009736 "cytokinin mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)]

 Score = 564 (203.6 bits), Expect = 7.4e-69, Sum P(3) = 7.4e-69
 Identities = 110/184 (59%), Positives = 142/184 (77%)

Query:   204 IGFAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGK 262
             +GF ++R+ +       +   +++  L LG L+ F+ REL VATDGFS+K+ILG GGFG 
Sbjct:   253 LGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGN 312

Query:   263 VYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV 322
             VY+G+  DG +VAVKRLK+   + G  QF+TE+++IS+AVHRNLLRL G+C + +E+LLV
Sbjct:   313 VYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLV 372

Query:   323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI 382
             YPYM+NGSVASRL+ +    P LDW TRKKIA+G+ARGL YLHE CDPKIIHRDVKAANI
Sbjct:   373 YPYMSNGSVASRLKAK----PALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANI 428

Query:   383 LLDE 386
             LLDE
Sbjct:   429 LLDE 432

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)]

 Score = 558 (201.5 bits), Expect = 3.2e-68, Sum P(3) = 3.2e-68
 Identities = 123/264 (46%), Positives = 158/264 (59%)

Query:   125 NRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXRNKSN 184
             N LSGPVP    F   T  +   N  +C  N  +                     R  SN
Sbjct:   183 NNLSGPVP---KFPART-FNVAGNPLICRSNPPEICSGSINASPLSVSLSSSSGRR--SN 236

Query:   185 XXXXXXXXXXXXXXXXXXXIG-FAYWRRTRPHEFFFDVPAEDDSELQ-LGQLKRFSLREL 242
                                +G F ++R+ +      ++  + +  LQ LG L+ F+ REL
Sbjct:   237 RLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFREL 296

Query:   243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV 302
              V TDGFS+KNILG GGFG VY+G+L DG +VAVKRLK+   + G+ QF+ E+++IS+AV
Sbjct:   297 HVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAV 356

Query:   303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
             H+NLLRL G+C T  E+LLVYPYM NGSVAS+L+ +    P LDW  RK+IA+G+ARGL 
Sbjct:   357 HKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKSK----PALDWNMRKRIAIGAARGLL 412

Query:   363 YLHEHCDPKIIHRDVKAANILLDE 386
             YLHE CDPKIIHRDVKAANILLDE
Sbjct:   413 YLHEQCDPKIIHRDVKAANILLDE 436

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010150 "leaf senescence" evidence=IMP

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048438 "floral whorl development" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)]

 Score = 564 (203.6 bits), Expect = 1.1e-67, Sum P(3) = 1.1e-67
 Identities = 126/262 (48%), Positives = 154/262 (58%)

Query:   125 NRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXRNKSN 184
             N LSGP P N S   +  +    N  LCGP +++                     ++ S 
Sbjct:   185 NNLSGPTP-NISAKDYRIVG---NAFLCGPASQELCSDATPVRNATGLSEKDNS-KHHSL 239

Query:   185 XXXXXXXXXXXXXXXXXXXIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQV 244
                                  +  W R+R          + D E ++G LKRFS RE+Q 
Sbjct:   240 VLSFAFGIVVAFIISLMFLFFWVLWHRSRLSRSH----VQQDYEFEIGHLKRFSFREIQT 295

Query:   245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 304
             AT  FS KNILG+GGFG VYKG L +G +VAVKRLK+   +G E+QFQTEV++I +AVHR
Sbjct:   296 ATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKDPIYTG-EVQFQTEVEMIGLAVHR 354

Query:   305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
             NLLRL+GFC T  E++LVYPYM NGSVA RLR+     P LDW  R  IALG+ARGL YL
Sbjct:   355 NLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYL 414

Query:   365 HEHCDPKIIHRDVKAANILLDE 386
             HE C+PKIIHRDVKAANILLDE
Sbjct:   415 HEQCNPKIIHRDVKAANILLDE 436

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009560 "embryo sac egg cell differentiation" evidence=RCA

TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)]

 Score = 595 (214.5 bits), Expect = 7.3e-67, Sum P(3) = 7.3e-67
 Identities = 112/178 (62%), Positives = 142/178 (79%)

Query:   210 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 269
             RRT+ ++ FFDV  EDD ++  GQLKRFSLRE+Q+ATD F+  N++G+GGFGKVY+G L 
Sbjct:   251 RRTK-YDIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLP 309

Query:   270 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 329
             D   VAVKRL +  + GGE  FQ E+++IS+AVH+NLLRL GFCTT +E++LVYPYM N 
Sbjct:   310 DKTKVAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENL 369

Query:   330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             SVA RLR+ ++    LDWPTRK++A GSA GL YLHEHC+PKIIHRD+KAANILLD +
Sbjct:   370 SVAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNN 427

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q94F62	BAK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.5958	0.9423	0.6113	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	4336035	BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative, expressed (628 aa)
		(Oryza sativa Japonica)
Predicted Functional Partners:
	4326014	ferredoxin--nitrite reductase, putative, expressed; Catalyzes the six-electron reduction of nit [...] (627 aa)							•		0.831
	4330586	histone-like transcription factor and archaeal histone, putative, expressed (254 aa)							•		0.499

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	399
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-35
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-33
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-31
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-31
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-23
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-20
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-16
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-11
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-09
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-07
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-07
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	4e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-06
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-06
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-05
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	8e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-04
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-04
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-04
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-04
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	0.001
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.001
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.001
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.002
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.002
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.002
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.002
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.002
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.003
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	0.003
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	0.003
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.003
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	0.003
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	0.003
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  127 bits (322), Expect = 7e-35
 Identities = 51/137 (37%), Positives = 69/137 (50%), Gaps = 7/137 (5%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           LG GGFG VY  R    GK VA+K +K+E +S    +   E++I+    H N+++LYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
                  LV  Y   GS+   L+E +     L      +I L    GL YLH +    II
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 374 HRDVKAANILLDEDADQ 390
           HRD+K  NILLD D  +
Sbjct: 115 HRDLKPENILLDSDNGK 131

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (320), Expect = 4e-34
 Identities = 49/143 (34%), Positives = 68/143 (47%), Gaps = 11/143 (7%)

Query: 250 SNKNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHR 304
           +    LG G FG+VYKG+L          VAVK LKE+ +     +F  E +I+    H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L G CT      +V  YM  G + S LR+ +  L           AL  ARG+ YL
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS---LSDLLSFALQIARGMEYL 118

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                   IHRD+ A N L+ E+
Sbjct: 119 ESK---NFIHRDLAARNCLVGEN 138

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (315), Expect = 2e-33
 Identities = 48/143 (33%), Positives = 67/143 (46%), Gaps = 10/143 (6%)

Query: 250 SNKNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHR 304
           +    LG G FG+VYKG L          VAVK LKE+ +     +F  E +I+    H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L G CT     ++V  YM  G +   LR+ +     L        AL  ARG+ YL
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYL 119

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                   IHRD+ A N L+ E+
Sbjct: 120 ESK---NFIHRDLAARNCLVGEN 139

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  120 bits (303), Expect = 1e-31
 Identities = 47/140 (33%), Positives = 65/140 (46%), Gaps = 8/140 (5%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           +     LG G FGKVY  R    GKLVA+K +K+++      +   E+KI+    H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           RLY       +  LV  Y   G +   L++R   L        +         L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSE---DEARFYLRQILSALEYLHSK 116

Query: 368 CDPKIIHRDVKAANILLDED 387
               I+HRD+K  NILLDED
Sbjct: 117 ---GIVHRDLKPENILLDED 133

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 2e-31
 Identities = 49/144 (34%), Positives = 67/144 (46%), Gaps = 12/144 (8%)

Query: 253 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
             LG G FG+VYKG+L         VAVK LKE+ +      F  E +++    H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP-----PLDWPTRKKIALGSARGLSY 363
           L G CT      LV  YM  G +   LR+ +   P      L        A+  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           L      K +HRD+ A N L+ ED
Sbjct: 121 LASK---KFVHRDLAARNCLVGED 141

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  118 bits (299), Expect = 5e-31
 Identities = 47/138 (34%), Positives = 64/138 (46%), Gaps = 11/138 (7%)

Query: 255 LGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG G FG+VYKG L          VAVK LKE  +     +F  E  I+    H N++RL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
            G CT      +V  YM  G +   LR+       L      ++AL  A+G+ YL     
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLESK-- 121

Query: 370 PKIIHRDVKAANILLDED 387
              +HRD+ A N L+ E+
Sbjct: 122 -NFVHRDLAARNCLVTEN 138

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  118 bits (298), Expect = 6e-31
 Identities = 53/136 (38%), Positives = 66/136 (48%), Gaps = 9/136 (6%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
            LG G FG VYK +    GK+VAVK L K    S  +   + E++I+    H N++RL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
                    LV  Y   G +   L        PL     KKIAL   RGL YLH +    
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 372 IIHRDVKAANILLDED 387
           IIHRD+K  NILLDE+
Sbjct: 119 IIHRDLKPENILLDEN 134

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  102 bits (256), Expect = 6e-25
 Identities = 51/139 (36%), Positives = 77/139 (55%), Gaps = 11/139 (7%)

Query: 253 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 310
            +LGRG FG VY     D G+L+AVK ++    S  EL   + E++I+S   H N++R Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 311 GFCTTVTEK-LLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G      +  L ++  Y++ GS++S L ++   LP    P  +K       GL+YLH + 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPE---PVIRKYTRQILEGLAYLHSN- 120

Query: 369 DPKIIHRDVKAANILLDED 387
              I+HRD+K ANIL+D D
Sbjct: 121 --GIVHRDIKGANILVDSD 137

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  101 bits (254), Expect = 3e-23
 Identities = 95/347 (27%), Positives = 145/347 (41%), Gaps = 66/347 (19%)

Query: 72  VDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 131
           + L    LSGE+  EL   K L  L L++N LSG IP S + +  L+ LDLS N+LSG +
Sbjct: 504 LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEI 563

Query: 132 PDN------------------------GSFSQFTPISFENNLNLCGPNTKKPCSGSPPFS 167
           P N                        G+F      +   N++LCG +T    SG P   
Sbjct: 564 PKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTT---SGLP--- 617

Query: 168 PPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDS 227
                 P     +  S     +   LGA L+ A+   GF + R     E    V  ED +
Sbjct: 618 ------PCKRVRKTPSWWFY-ITCTLGAFLVLALVAFGFVFIRGRNNLE-LKRVENEDGT 669

Query: 228 -ELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE---- 281
            ELQ    K      +         +N++ RG  G  YKG+ + +G    VK + +    
Sbjct: 670 WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI 729

Query: 282 ---ERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER 338
              E    G+LQ            H N+++L G C +     L++ Y+   +++  LR  
Sbjct: 730 PSSEIADMGKLQ------------HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN- 776

Query: 339 QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
                 L W  R+KIA+G A+ L +LH  C P ++  ++    I++D
Sbjct: 777 ------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 51/145 (35%), Positives = 74/145 (51%), Gaps = 16/145 (11%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F     +G+GGFG+VYK R    GK VA+K +K E     E     E++I+    H N++
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60

Query: 308 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA---LGSARGLSY 363
           + YG      ++L +V  + + GS+   L+    +L      T  +IA       +GL Y
Sbjct: 61  KYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTL------TESQIAYVCKELLKGLEY 113

Query: 364 LHEHCDPKIIHRDVKAANILLDEDA 388
           LH +    IIHRD+KAANILL  D 
Sbjct: 114 LHSN---GIIHRDIKAANILLTSDG 135

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 9/141 (6%)

Query: 249 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 306
           +   +++GRG FG VYKG  L  G  VA+K++  E+     L+    E+ ++    H N+
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           ++  G   T     ++  Y  NGS+   + ++    P           L   +GL+YLHE
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVL---QGLAYLHE 117

Query: 367 HCDPKIIHRDVKAANILLDED 387
                +IHRD+KAANIL  +D
Sbjct: 118 Q---GVIHRDIKAANILTTKD 135

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.0 bits (218), Expect = 1e-18
 Identities = 47/130 (36%), Positives = 72/130 (55%), Gaps = 4/130 (3%)

Query: 21  MISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALS 80
           M+ A  E++ L  FKS + DP   L +W N   ++C W  ITCN    V  +DL    +S
Sbjct: 25  MLHAE-ELELLLSFKSSINDPLKYLSNW-NSSADVCLWQGITCNNSSRVVSIDLSGKNIS 82

Query: 81  GELAPELGQLKNLELLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLSGPVPDNGSFSQ 139
           G+++  + +L  ++ + L+NN LSG IP  + TT +SL  L+LSNN  +G +P  GS   
Sbjct: 83  GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP-RGSIPN 141

Query: 140 FTPISFENNL 149
              +   NN+
Sbjct: 142 LETLDLSNNM 151

Length = 968

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.9 bits (211), Expect = 1e-18
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 17/146 (11%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNL 306
           +     +G G +G+VYK R    G+LVA+K+++ E    G  +    E+K++    H N+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 307 LRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
           +RL      VT K      +V+ YM +  +   L   +           K        GL
Sbjct: 61  VRLKE---IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTE---SQIKCYMKQLLEGL 113

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YLH +    I+HRD+K +NIL++ D
Sbjct: 114 QYLHSN---GILHRDIKGSNILINND 136

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 5e-18
 Identities = 45/139 (32%), Positives = 65/139 (46%), Gaps = 10/139 (7%)

Query: 253 NILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
            ++G G FG+V +GRL         VA+K LK   +    L F TE  I+    H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           L G  T     +++  YM NGS+   LRE               +  G A G+ YL E  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASGMKYLSEMN 126

Query: 369 DPKIIHRDVKAANILLDED 387
               +HRD+ A NIL++ +
Sbjct: 127 ---YVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 83.3 bits (204), Expect = 1e-17
 Identities = 49/146 (33%), Positives = 68/146 (46%), Gaps = 9/146 (6%)

Query: 248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL--QFQTEVKII-SMAVHR 304
            +     LG G FG+VY  R  D KLVA+K L ++  S  +   +F  E++I+ S+    
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++LY F        LV  Y+  GS+   L++     P L       I       L YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP-LSESEALFILAQILSALEYL 117

Query: 365 HEHCDPKIIHRDVKAANILLDEDADQ 390
           H      IIHRD+K  NILLD D   
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRV 140

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 19/152 (12%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           K  LG G FGKV+ G     +      LVAVK LKE  ++     F+ E ++++   H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------KIAL 355
           +++ YG CT     ++V+ YM +G +   LR        L  P             +IA+
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             A G+ YL        +HRD+   N L+  D
Sbjct: 130 QIASGMVYLASQ---HFVHRDLATRNCLVGYD 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 16/145 (11%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F     LG G +G VYK      G++VA+K +          +   E+ I+       ++
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYL 364
           + YG     T+  +V  Y   GSV+  ++    +L      T ++IA     + +GL YL
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEIAAILYQTLKGLEYL 115

Query: 365 HEHCDPKIIHRDVKAANILLDEDAD 389
           H +   K IHRD+KA NILL+E+  
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQ 137

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 8/136 (5%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
              +G+G FG V  G    G+ VAVK LK++  S     F  E  +++   H NL++L G
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
                    +V  YM  GS+   LR R  ++  L    +   AL    G+ YL E     
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---N 122

Query: 372 IIHRDVKAANILLDED 387
            +HRD+ A N+L+ ED
Sbjct: 123 FVHRDLAARNVLVSED 138

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 7e-17
 Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 10/135 (7%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G+G FG VYKG L     VAVK  +       + +F  E +I+    H N+++L G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLSYLHEHCDPKI 372
                 +V   +  GS+ + LR++++ L       +K  +++L +A G+ YL        
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRL-----TVKKLLQMSLDAAAGMEYLESKN---C 114

Query: 373 IHRDVKAANILLDED 387
           IHRD+ A N L+ E+
Sbjct: 115 IHRDLAARNCLVGEN 129

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 8e-17
 Identities = 57/180 (31%), Positives = 83/180 (46%), Gaps = 39/180 (21%)

Query: 245 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK--RLKEERTSGGELQFQTEVKII-SM 300
            T  F    ++G G +GKVYK R    G+LVA+K   + E+     E + + E  I+   
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKY 59

Query: 301 AVHRNLLRLYGF-----CTTVTEKL-LVYPYMTNGSV---ASRLRERQSSLPPLDWPTRK 351
           + H N+   YG           ++L LV      GSV      LR++   L   +W    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EW---- 114

Query: 352 KIAL---GSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 398
            IA     + RGL+YLHE+   K+IHRD+K  NILL ++A+          Q   T+ RR
Sbjct: 115 -IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 17/146 (11%)

Query: 255 LGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           LG+G FG VY+G LA G +       VA+K + E  +    ++F  E  ++      +++
Sbjct: 14  LGQGSFGMVYEG-LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKI---ALGSARGL 361
           RL G  +T    L+V   M  G + S LR R+    + P L  PT +K    A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
           +YL      K +HRD+ A N ++ ED
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAED 155

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 10/141 (7%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           F+ +  LG G FG+V++G   +   VA+K LK +     +  FQ EV+ +    H++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLR--ERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           L+  C+      ++   M  GS+ + LR  E Q     L   +   +A   A G++YL E
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV----LPVASLIDMACQVAEGMAYLEE 122

Query: 367 HCDPKIIHRDVKAANILLDED 387
                 IHRD+ A NIL+ ED
Sbjct: 123 Q---NSIHRDLAARNILVGED 140

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 77.2 bits (191), Expect = 4e-16
 Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 13/134 (9%)

Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG-F 312
           LG+G  G VYK R    GK+ A+K++  +       Q   E+K +       +++ YG F
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 313 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
                ++   +V  YM  GS+A  L+ +   +P    P    IA    +GL YLH     
Sbjct: 69  YKEGEIS---IVLEYMDGGSLADLLK-KVGKIPE---PVLAYIARQILKGLDYLHT--KR 119

Query: 371 KIIHRDVKAANILL 384
            IIHRD+K +N+L+
Sbjct: 120 HIIHRDIKPSNLLI 133

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 21/143 (14%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYGF 312
           +G+G FGKVY  R  +DGKL  +K +     S  E +    EVKI+    H N+++ Y  
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66

Query: 313 CTTVTEKLL--VYPYMTNGSVASRLRERQSSLPP------LDWPTRKKIALGSARGLSYL 364
            +   +  L  V  Y   G ++ ++++++    P      LDW    ++ L     L YL
Sbjct: 67  -SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYL 119

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H     KI+HRD+K  NI L  +
Sbjct: 120 HSR---KILHRDIKPQNIFLTSN 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 76.7 bits (189), Expect = 8e-16
 Identities = 51/151 (33%), Positives = 67/151 (44%), Gaps = 12/151 (7%)

Query: 243 QVATDGFSNKNILGRGGFGKVYKG--RLADGKL----VAVKRLKEERTSGGELQFQTEVK 296
           +V  D  +    LG G FG+VY+G  R  DG      VAVK L E  +   E  F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 297 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKI 353
           I+S   H+N++RL G       + ++   M  G + S LRE   R      L        
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           A   A+G  YL E+     IHRD+ A N LL
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLL 149

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 14/139 (10%)

Query: 255 LGRGGFGKVYKG-RLADGKLVAVKRLK---EERTSGGEL-QFQTEVKIISMAVHRNLLRL 309
           LG G FG VY+G  L DG   AVK +    + +T    + Q + E+ ++S   H N+++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 310 YGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
            G      + L ++   +  GS+A  L++  S   P+     ++I LG    L YLH   
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH--- 119

Query: 369 DPKIIHRDVKAANILLDED 387
           D   +HRD+K ANIL+D +
Sbjct: 120 DRNTVHRDIKGANILVDTN 138

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 48/162 (29%), Positives = 69/162 (42%), Gaps = 21/162 (12%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F+    +G+G FG+VYK       ++VA+K +  E         Q E++ +S      + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 308 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           + YG       KL ++  Y   GS    L+        LD      I      GL YLHE
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE 116

Query: 367 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 398
                 IHRD+KAANILL E+ D          Q + T+ +R
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 48/137 (35%), Positives = 77/137 (56%), Gaps = 12/137 (8%)

Query: 254 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +LG+G FG+V+KG L D   VAVK  KE+     +++F +E +I+    H N+++L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLSYLH-EHCDP 370
           T      +V   +  G   S LR+++  L      T++  K AL +A G++YL  ++C  
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDEL-----KTKQLVKFALDAAAGMAYLESKNC-- 114

Query: 371 KIIHRDVKAANILLDED 387
             IHRD+ A N L+ E+
Sbjct: 115 --IHRDLAARNCLVGEN 129

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 75.6 bits (187), Expect = 2e-15
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 15/144 (10%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT----EVKIISMAVH 303
           +     LG G +G VYK R    G++VA+K+++ +    G     +    E+ ++    H
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKH 57

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            N+++L     T  +  LV+ Y     +   L +R   L P      K I     RGL+Y
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP---NLIKSIMYQLLRGLAY 113

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
            H H   +I+HRD+K  NIL++ D
Sbjct: 114 CHSH---RILHRDLKPQNILINRD 134

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 26/152 (17%)

Query: 72  VDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 131
           ++L   ++ G + P LG + +LE+L L+ NS +G IP SL  +TSL IL+L+ N LSG V
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506

Query: 132 PD--NGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPV 189
           P    G        +F +N  LCG    + C            GP  S           +
Sbjct: 507 PAALGGRLLHRASFNFTDNAGLCGIPGLRAC------------GPHLS-------VGAKI 547

Query: 190 GVALGAALLFAVPVIGFAYW--RR---TRPHE 216
           G+A G ++ F   VI    W  RR    R   
Sbjct: 548 GIAFGVSVAFLFLVICAMCWWKRRQNILRAQR 579

Length = 623

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 74.1 bits (183), Expect = 4e-15
 Identities = 51/139 (36%), Positives = 67/139 (48%), Gaps = 16/139 (11%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 310
           LG+G FGKV   R    GKL A+K LK+++           TE  I+S   H  +++L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 311 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHC 368
            F T   EKL LV  Y   G + S L  ++      +   R   A +  A  L YLH   
Sbjct: 61  AFQTE--EKLYLVLEYAPGGELFSHLS-KEGRFS--EERARFYAAEIVLA--LEYLHSL- 112

Query: 369 DPKIIHRDVKAANILLDED 387
              II+RD+K  NILLD D
Sbjct: 113 --GIIYRDLKPENILLDAD 129

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 19/146 (13%)

Query: 253 NILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQ---FQTEVKIISMAVHR 304
             LG G FGKV   R        G+ VAVK L     SG E     F+ E++I+    H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN---HSGEEQHRSDFEREIEILRTLDHE 66

Query: 305 NLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           N+++  G C     +   L+  Y+ +GS+   L+  +     ++       +    +G+ 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMD 123

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           YL      + IHRD+ A NIL++ + 
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESED 146

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 13/137 (9%)

Query: 253 NILGRGGFGKVYKG-RLADGKLVAVK--RLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           N +G G FGKVY    L  G+L+AVK  R+++      + +   E+K++ +  H NL++ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLELLKHPNLVKY 64

Query: 310 YGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           YG      EK+ ++  Y + G++   L   +     LD    +   L    GL+YLH H 
Sbjct: 65  YGV-EVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSH- 118

Query: 369 DPKIIHRDVKAANILLD 385
              I+HRD+K ANI LD
Sbjct: 119 --GIVHRDIKPANIFLD 133

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 8/133 (6%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G G FG V+ G   + + VA+K ++E   S  E  F  E +++    H  L++LYG CT
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
             +   LV+ +M +G ++  LR ++         T   + L    G++YL       +IH
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 375 RDVKAANILLDED 387
           RD+ A N L+ E+
Sbjct: 124 RDLAARNCLVGEN 136

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 46/137 (33%), Positives = 64/137 (46%), Gaps = 16/137 (11%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V+ G+      VA+K ++E   S  E  F  E K++    H NL++LYG CT
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA----RGLSYLHEHCDP 370
                 +V  YM NG + + LRER+  L         +  L         + YL  +   
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKL-------GTEWLLDMCSDVCEAMEYLESNG-- 120

Query: 371 KIIHRDVKAANILLDED 387
             IHRD+ A N L+ ED
Sbjct: 121 -FIHRDLAARNCLVGED 136

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 41/139 (29%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 254 ILGRGGFGKVYKGR-LADG---KL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           +LG G FG VYKG  + +G   K+ VA+K L+EE +     +   E  +++   H +++R
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 365
           L G C +     L+   M  G +   +R  + ++     L+W       +  A+G+SYL 
Sbjct: 74  LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE 126

Query: 366 EHCDPKIIHRDVKAANILL 384
           E    +++HRD+ A N+L+
Sbjct: 127 EK---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 46/141 (32%), Positives = 66/141 (46%), Gaps = 6/141 (4%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           D       LG G  G V K      GK++AVK ++ E     + Q   E+ I+       
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           ++  YG      +  +   YM  GS+   L+E Q  +P        KIA+   +GL+YLH
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE---RILGKIAVAVLKGLTYLH 117

Query: 366 EHCDPKIIHRDVKAANILLDE 386
           E    KIIHRDVK +NIL++ 
Sbjct: 118 E--KHKIIHRDVKPSNILVNS 136

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.8 bits (176), Expect = 4e-14
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 27/158 (17%)

Query: 255 LGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           +G+G FG+V++ R           +VAVK LKEE ++  +  FQ E  +++   H N+++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----QSSL--------------PPLDWPTR 350
           L G C       L++ YM  G +   LR R    Q SL               PL    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
             IA   A G++YL E    K +HRD+   N L+ E+ 
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENM 167

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.0 bits (174), Expect = 7e-14
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 13/138 (9%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-----FQTEVKIISMAVHRNLL 307
            LG G F   Y+ R +  G L+AVK++   R +  E +      + E+++++   H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           R+ G     +   L   +M  GSV+  L    S                  RGLSYLHE+
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 368 CDPKIIHRDVKAANILLD 385
              +IIHRDVK AN+L+D
Sbjct: 123 ---QIIHRDVKGANLLID 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 70.4 bits (173), Expect = 8e-14
 Identities = 44/132 (33%), Positives = 61/132 (46%), Gaps = 7/132 (5%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK    S     F  E +I+    H  L++LY  C+
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 +V  YM+ GS+   L+  +     L  P    +A   A G++YL        IH
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR---NYIH 126

Query: 375 RDVKAANILLDE 386
           RD+ A NIL+ E
Sbjct: 127 RDLAARNILVGE 138

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 9/135 (6%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGF 312
           +G G  G V+K +    G+ VA+K++   R  GG   Q   E+K +    H  +++L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
               +  +LV  YM    ++  LR+ +  LP       K       +G++Y+H +    I
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPE---AQVKSYMRMLLKGVAYMHAN---GI 120

Query: 373 IHRDVKAANILLDED 387
           +HRD+K AN+L+  D
Sbjct: 121 MHRDLKPANLLISAD 135

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 49/134 (36%), Positives = 63/134 (47%), Gaps = 10/134 (7%)

Query: 255 LGRGGFGKVYKGRL--ADGKL--VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G FG V +G    + GK+  VAVK LK ++ S     F  E  I+    H NL+RLY
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G   T     +V      GS+  RLR+    L      T    A+  A G+ YL      
Sbjct: 63  GVVLTHPLM-MVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 371 KIIHRDVKAANILL 384
           + IHRD+ A NILL
Sbjct: 117 RFIHRDLAARNILL 130

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 21/150 (14%)

Query: 255 LGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FGKV+           D  LVAVK LKE  +      FQ E +++++  H++++R
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE-----------RQSSLPPLDWPTRKKIALGS 357
            YG CT     L+V+ YM +G +   LR               +   L       IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A G+ YL        +HRD+   N L+ + 
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQG 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 52/158 (32%), Positives = 76/158 (48%), Gaps = 24/158 (15%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G +G VYK R +A G+LVA+K +K E     E   Q E+ ++    H N++  +G  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGSY 69

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYLHEHCDP 370
               +  +V  Y   GS+    +  +  L  L      +IA     + +GL+YLHE    
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL------QIAYVCRETLKGLAYLHET--- 120

Query: 371 KIIHRDVKAANILLDEDAD----------QSSKTILRR 398
             IHRD+K ANILL ED D          Q + TI +R
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 10/137 (7%)

Query: 252 KNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G        VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           G CT      ++  +MT G++   LRE  +  +  +       +A   +  + YL +   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKK-- 123

Query: 370 PKIIHRDVKAANILLDE 386
              IHRD+ A N L+ E
Sbjct: 124 -NFIHRDLAARNCLVGE 139

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 9/140 (6%)

Query: 253 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
            ++G G    VY    L + + VA+KR+  E+      + + EV+ +S   H N+++ Y 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSARGLSYLHEHCD 369
                 E  LV PY++ GS+   ++   SS P   LD      +     +GL YLH +  
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121

Query: 370 PKIIHRDVKAANILLDEDAD 389
              IHRD+KA NILL ED  
Sbjct: 122 -GQIHRDIKAGNILLGEDGS 140

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 16/147 (10%)

Query: 254 ILGRGGFGKVYKGRLA--DGKL--VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLR 308
           ILG G FG V +G+L+  DG    VAVK +K +  +  E++ F +E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 309 LYGFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARG 360
           L G C   +        +++ P+M +G + S L   +    P   P +   K  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDED 387
           + YL        IHRD+ A N +L ED
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLRED 149

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 44/133 (33%), Positives = 64/133 (48%), Gaps = 8/133 (6%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 +V  YM+NG + + LRE      P       ++      G++YL      + IH
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESK---QFIH 123

Query: 375 RDVKAANILLDED 387
           RD+ A N L+D+ 
Sbjct: 124 RDLAARNCLVDDQ 136

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 46/134 (34%), Positives = 67/134 (50%), Gaps = 9/134 (6%)

Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +GRG FG+V+ GRL AD   VAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKI 372
           T      +V   +  G   + LR   +  P L      ++   +A G+ YL  +HC    
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC---- 115

Query: 373 IHRDVKAANILLDE 386
           IHRD+ A N L+ E
Sbjct: 116 IHRDLAARNCLVTE 129

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 10/140 (7%)

Query: 250 SNKNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           + + ++G G FG+V++G L   G+    VA+K LK   T      F +E  I+    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           ++RL G  T     +++  YM NG++   LR+              +   G A G+ YL 
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL- 123

Query: 366 EHCDPKIIHRDVKAANILLD 385
              D   +HRD+ A NIL++
Sbjct: 124 --SDMNYVHRDLAARNILVN 141

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 10/138 (7%)

Query: 254 ILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++G G FG+V +GRL   GK    VA+K LK   T      F +E  I+    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
            G  T     +++  +M NG++ S LR+       +       +  G A G+ YL E   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSEM-- 125

Query: 370 PKIIHRDVKAANILLDED 387
              +HRD+ A NIL++ +
Sbjct: 126 -NYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 27/153 (17%)

Query: 255 LGRGGFGKVYKGRL---ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FGKVYKG L    +      VA+K LKE      + +F+ E +++S   H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 309 LYGFCTTVTEKLLVYPYMTNGSV---------------ASRLRERQSSLPPLDWPTRKKI 353
           L G CT      +++ Y+ +G +                S     +SSL   D+     I
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LHI 129

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           A+  A G+ YL  H     +HRD+ A N L+ E
Sbjct: 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 14/138 (10%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLR 308
           +LG+G FG+VY     D G+ +AVK++  +     T       + E++++    H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 309 LYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            YG C    E L ++  YM  GSV  +L+    +   L     +K       G+ YLH +
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 368 CDPKIIHRDVKAANILLD 385
               I+HRD+K ANIL D
Sbjct: 124 ---MIVHRDIKGANILRD 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 12/137 (8%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKR--LKEERTSGGELQF---QTEVKIISMAVHRNLL 307
            +LG+G +G VY G    G+L+AVK+  L        E ++   Q EV ++    H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           +  G C       +   ++  GS++S L        PL  P   K       G++YLH +
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 368 CDPKIIHRDVKAANILL 384
           C   ++HRD+K  N++L
Sbjct: 122 C---VVHRDIKGNNVML 135

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 42/132 (31%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V++G   +   VAVK LK       +  F  E +I+    H  L++LY  CT
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 +V   M  GS+   L+        L  P    +A   A G++YL        IH
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 375 RDVKAANILLDE 386
           RD+ A N+L+ E
Sbjct: 127 RDLAARNVLVGE 138

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 25/150 (16%)

Query: 249 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           + N   +G G  G+VYK    A GK VA+K+++  + +  +     E+ I+    H N++
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPNIV 78

Query: 308 RLYGFCTTVTEKL-LVYPYMTNGSVA-------SRLRERQSSLPPLDWPTRKKIALGSAR 359
             Y     V ++L +V  YM  GS+         R+ E Q +           +     +
Sbjct: 79  DYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA----------YVCREVLQ 127

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           GL YLH      +IHRD+K+ NILL +D  
Sbjct: 128 GLEYLHSQ---NVIHRDIKSDNILLSKDGS 154

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           LG G FGKVYK +  + G   A K ++ E  S  EL+ F  E+ I+S   H N++ LY  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE- 69

Query: 313 CTTVTE-KLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
                E KL +   +   G++ S + E +     L  P  + +       L++LH H   
Sbjct: 70  -AYFYENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH--- 122

Query: 371 KIIHRDVKAANILLDEDAD 389
           K+IHRD+KA NILL  D D
Sbjct: 123 KVIHRDLKAGNILLTLDGD 141

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 29/159 (18%)

Query: 254 ILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
            LG G FGKV K         A    VAVK LKE  +S       +E  ++    H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------PLDWPTRKKIAL 355
           +LYG C+     LL+  Y   GS+ S LRE +   P             LD P  + + +
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 356 GS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           G         +RG+ YL E    K++HRD+ A N+L+ E
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAE 162

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 13/137 (9%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAVHRNLLRLY 310
           +G G +G V K R  A G++VA+K+ KE      E   +T   EVK++    H N++ L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNLK 66

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
                     LV+ Y+   ++   L      LPP      +       + ++Y H H   
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD---AVRSYIWQLLQAIAYCHSH--- 119

Query: 371 KIIHRDVKAANILLDED 387
            IIHRD+K  NIL+ E 
Sbjct: 120 NIIHRDIKPENILVSES 136

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.9 bits (158), Expect = 7e-12
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 13/153 (8%)

Query: 253 NILGRGGFGKVYKGRLAD------GKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           N LG G FG+VY+G   D      G + VAVK L++  T   + +F  E  ++S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPP--LDWPTRKKIALGSARGLS 362
           +++L G C     + ++   M  G + S LR+ R     P  L       I L  A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 395
           YL        IHRD+ A N L+ E    + + +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVV 150

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 46/156 (29%), Positives = 69/156 (44%), Gaps = 28/156 (17%)

Query: 254 ILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNL 306
            LG G FG+V K              VAVK LK++ T        +E++++ M   H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP-------LDWPTRKKI------ 353
           + L G CT      +V  Y  +G++   LR R+   PP          P  + +      
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARR---PPGEYASPDDPRPPEETLTQKDLV 135

Query: 354 --ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             A   ARG+ +L      K IHRD+ A N+L+ ED
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 50/150 (33%), Positives = 71/150 (47%), Gaps = 35/150 (23%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRL-- 309
           LG G FG+VYK R +  G++VA+K++    E+  G  +    E+KI+    H N++ L  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLID 74

Query: 310 --YGFCTTVTEKL----LVYPYM--------TNGSVASRLRERQSSLPPLDWPTRKKIAL 355
                      K     +V PYM         N SV  +L E Q           K   L
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--KLTESQI----------KCYML 122

Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLD 385
               G++YLHE+    I+HRD+KAANIL+D
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILID 149

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 35/142 (24%), Positives = 64/142 (45%), Gaps = 14/142 (9%)

Query: 254 ILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
            LGRG FG+V+  +           LV VK L++ +    + +F+ E+ +     H+N++
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 308 RLYGFCTTVTEKLLVYPYMTNGS-----VASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           RL G C       ++  Y   G       A++ ++ +   PPL    +  +    A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           +L      + +HRD+ A N L+
Sbjct: 132 HLSNA---RFVHRDLAARNCLV 150

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 40/144 (27%), Positives = 69/144 (47%), Gaps = 17/144 (11%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGG---ELQ------FQTEVKIISMAVH 303
           ++G+G +G+VY       G+++AVK+++   T  G     Q       ++E++ +    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            N+++  GF TT     +   Y+  GS+ S LR         +    +        GL+Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAY 123

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           LH      I+HRD+KA N+L+D D
Sbjct: 124 LHSK---GILHRDLKADNLLVDAD 144

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 25/163 (15%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYG 311
           ++G G +G+VYKGR +  G+L A+K +  + T   E + + E+ ++   + HRN+   YG
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 312 FCTTVT------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
                +      +  LV  +   GSV   ++  + +    DW     I     RGL++LH
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH 138

Query: 366 EHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 398
            H   K+IHRD+K  N+LL E+A+          Q  +T+ RR
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 17/142 (11%)

Query: 253 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
            ++G+G FG VY G L D        AVK L          QF  E  I+    H N+L 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 309 LYGFC-TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 364
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYL 114

Query: 365 HEHCDPKIIHRDVKAANILLDE 386
                 K +HRD+ A N +LDE
Sbjct: 115 ASK---KFVHRDLAARNCMLDE 133

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 62.6 bits (152), Expect = 3e-11
 Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 16/136 (11%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V+ G+      VA+K + E   S  E  F  E K++    H  L++LYG CT
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDP 370
                 +V  +M NG + + LR+RQ  L        K + L   +    G+ YL  +   
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKL-------SKDMLLSMCQDVCEGMEYLERN--- 119

Query: 371 KIIHRDVKAANILLDE 386
             IHRD+ A N L+  
Sbjct: 120 SFIHRDLAARNCLVSS 135

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 46/144 (31%), Positives = 78/144 (54%), Gaps = 15/144 (10%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYG 311
           ++G G +G+VYKGR +  G+L A+K +  + T   E + + E+ ++   + HRN+   YG
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 312 FCTT-----VTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
                    + ++L LV  +   GSV   ++  + +    +W     I     RGLS+LH
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH 128

Query: 366 EHCDPKIIHRDVKAANILLDEDAD 389
           +H   K+IHRD+K  N+LL E+A+
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAE 149

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  +   G+V + + E +    PL  P  + +   +   L+YLHE+   KIIH
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 375 RDVKAANILLDEDAD----------QSSKTILRR 398
           RD+KA NIL   D D          ++++TI RR
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 62.2 bits (152), Expect = 6e-11
 Identities = 42/144 (29%), Positives = 61/144 (42%), Gaps = 23/144 (15%)

Query: 254 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISM--------AVHR 304
           I+G G F  V   +     K  A+K L + +     L  + +VK + +          H 
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-----LIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 305 NLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            +++LY +     E L  V  Y  NG +   +R+  S    LD    +  A      L Y
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEY 117

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           LH      IIHRD+K  NILLD+D
Sbjct: 118 LHSK---GIIHRDLKPENILLDKD 138

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 45/135 (33%), Positives = 71/135 (52%), Gaps = 12/135 (8%)

Query: 254 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           I+G G FG V +G    G+ VAVK +K + T+     F  E  +++   H+NL+RL G  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG-- 66

Query: 314 TTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
             +   L +V   M+ G++ + LR R  +L  +      + +L  A G+ YL      K+
Sbjct: 67  VILHNGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYLESK---KL 121

Query: 373 IHRDVKAANILLDED 387
           +HRD+ A NIL+ ED
Sbjct: 122 VHRDLAARNILVSED 136

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKE-ERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G G +G VYK R    G++VA+K++K    + G       E+K++    H N+++L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 313 CTTVTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
                +  LV+ +M T+  +   +++RQ  LP       K       +GL++ H H    
Sbjct: 67  FRHKGDLYLVFEFMDTD--LYKLIKDRQRGLPE---SLIKSYLYQLLQGLAFCHSH---G 118

Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+K  N+L++ +  
Sbjct: 119 ILHRDLKPENLLINTEGV 136

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 47/135 (34%), Positives = 69/135 (51%), Gaps = 14/135 (10%)

Query: 255 LGRGGFGKVYKG--RLADGKL--VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G FG V KG   +  GK   VAVK LK+E  + G+ +F  E  +++   H  ++RL 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 311 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           G C    E L LV      G +   L++R+  +P  D    K++A   A G++YL     
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYLKKRR-EIPVSDL---KELAHQVAMGMAYLESK-- 114

Query: 370 PKIIHRDVKAANILL 384
              +HRD+ A N+LL
Sbjct: 115 -HFVHRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 44/140 (31%), Positives = 68/140 (48%), Gaps = 7/140 (5%)

Query: 248 GFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRN 305
            F     LG+G +G VYK  RL+D +  A+K +     S  E      E++I++   H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 306 LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           ++  Y        KL +V  Y   G ++  + +R+     +      +I +   RGL  L
Sbjct: 61  IIS-YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 365 HEHCDPKIIHRDVKAANILL 384
           HE    KI+HRD+K+ANILL
Sbjct: 120 HEQ---KILHRDLKSANILL 136

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 15/140 (10%)

Query: 255 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG G FGKV            G++VAVK LK E        ++ E+ I+    H N+++ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            G C+    K   L+  Y+  GS+   L + + +L  L        A     G++YLH  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHSQ 126

Query: 368 CDPKIIHRDVKAANILLDED 387
                IHRD+ A N+LLD D
Sbjct: 127 ---HYIHRDLAARNVLLDND 143

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 18/149 (12%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 304
           +     + LG G  G V K RL +  ++   +         +LQ Q   E++I       
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSP 59

Query: 305 NLLRLYGFCTTVTEKLL--VYPYMTNGSVAS---RLRER--QSSLPPLDWPTRKKIALGS 357
            +++ YG     +   +     Y   GS+ S   ++++R  +     L      KIA   
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESV 114

Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
            +GLSYLH     KIIHRD+K +NILL  
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTR 140

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 14/135 (10%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAVHRNLLRLYGF 312
           LG G FG VY  R    G+LVA+K++K++  S  E     EVK +  +  H N+++L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64

Query: 313 CTTVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
                E      V+ YM  G++   +++R+    P      + I     +GL+++H+H  
Sbjct: 65  -EVFRENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH-- 118

Query: 370 PKIIHRDVKAANILL 384
               HRD+K  N+L+
Sbjct: 119 -GFFHRDLKPENLLV 132

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 13/144 (9%)

Query: 249 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNL 306
           F   N +G+G FG V+K  R AD ++ A+K++   + +  E +    E ++++      +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 307 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLD--WPTRKKIALGSARGLSY 363
           +R Y        KL +V  Y  NG +   L+ ++    P D  W    +  +    GL++
Sbjct: 62  IRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           LH     KI+HRD+K+ N+ LD  
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAY 137

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 35/146 (23%), Positives = 58/146 (39%), Gaps = 16/146 (10%)

Query: 253 NILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLY 310
             +G+G FG V K  R +DGK++  K +     +  E  Q  +EV I+    H N++R Y
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 311 GFCTTVTEKLLVYPYMTN------GSVASRLRERQSSLP-PLDWPTRKKIALGSARGLSY 363
                      +Y  M          +  + ++ +  +     W    +I       L  
Sbjct: 66  DR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYE 120

Query: 364 LH--EHCDPKIIHRDVKAANILLDED 387
            H        ++HRD+K ANI LD +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDAN 146

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 35/121 (28%), Positives = 53/121 (43%), Gaps = 10/121 (8%)

Query: 273 LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA 332
           LVAVK L+ + +      F  EVKI+S     N+ RL G CT      ++  YM NG + 
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 333 SRLRERQ-------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
             L++          +   L + T   +A   A G+ YL        +HRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG 164

Query: 386 E 386
           +
Sbjct: 165 K 165

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 23/161 (14%)

Query: 242 LQVATDGFSNKNILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQ---FQT 293
           + ++ D  +  ++L  G FG+++ G L D K      V VK +K+  +   E+Q      
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTLLLQ 57

Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWP---- 348
           E  ++    H+N+L +   C    E   V YPYM  G++   L+  Q  L   + P    
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ--QCRLGEANNPQALS 115

Query: 349 TRKKIALGS--ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           T++ + +    A G+SYLH+     +IH+D+ A N ++DE+
Sbjct: 116 TQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE 153

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 45/138 (32%), Positives = 66/138 (47%), Gaps = 10/138 (7%)

Query: 254 ILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++G G FG+V  GRL   GK    VA+K LK   T      F +E  I+    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
            G  T     ++V  YM NGS+ + LR+       +       +  G A G+ YL    D
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYL---SD 124

Query: 370 PKIIHRDVKAANILLDED 387
              +HRD+ A NIL++ +
Sbjct: 125 MGYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 24/144 (16%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG----------ELQFQTEVKIISMAVH 303
           LG G +  VYK R    G++VA+K++K                 E++   E+K      H
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            N++ L       +   LV+ +M    +   ++++   L P D    K   L + RGL Y
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPAD---IKSYMLMTLRGLEY 117

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           LH +    I+HRD+K  N+L+  D
Sbjct: 118 LHSN---WILHRDLKPNNLLIASD 138

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 46/137 (33%), Positives = 66/137 (48%), Gaps = 7/137 (5%)

Query: 255 LGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           +G G FGKV  G +  G     V VK L+   +   +++F  E +      H NLL+  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
            CT VT  LLV  +   G +   LR  R++ L   D  T +++A   A GL +LH++   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 371 KIIHRDVKAANILLDED 387
             IH D+   N LL  D
Sbjct: 120 NFIHSDLALRNCLLTAD 136

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 40/138 (28%), Positives = 58/138 (42%), Gaps = 7/138 (5%)

Query: 255 LGRGGFGKVYKGRLADGKLVA---VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           +G G FGKV  G    G   A   VK L+   T   +L F  EV+      H N+L+  G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP-TRKKIALGSARGLSYLHEHCDP 370
            C      LLV  +   G + + LR  +  +  +      +++A   A GL +LH+    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119

Query: 371 KIIHRDVKAANILLDEDA 388
             IH D+   N  L  D 
Sbjct: 120 DFIHSDLALRNCQLTADL 137

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 12/144 (8%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 304
           F++   +G G FG VY  R +   ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHP 75

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N +   G         LV  Y   GS AS + E      PL       I  G+ +GL+YL
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCL-GS-ASDILEVHKK--PLQEVEIAAICHGALQGLAYL 131

Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H     IHRD+KA NILL E  
Sbjct: 132 HSHE---RIHRDIKAGNILLTEPG 152

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 45/142 (31%), Positives = 66/142 (46%), Gaps = 9/142 (6%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F+    +G+G FG+VYKG     K +VA+K +  E         Q E+ ++S      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           R YG     T+  ++  Y+  GS    L+       PL+      I     +GL YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE 120

Query: 368 CDPKIIHRDVKAANILLDEDAD 389
              + IHRD+KAAN+LL E  D
Sbjct: 121 ---RKIHRDIKAANVLLSEQGD 139

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 45/137 (32%), Positives = 65/137 (47%), Gaps = 14/137 (10%)

Query: 254 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
            +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G  
Sbjct: 13  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG-- 66

Query: 314 TTVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
             V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +   
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN--- 121

Query: 371 KIIHRDVKAANILLDED 387
             +HRD+ A N+L+ ED
Sbjct: 122 NFVHRDLAARNVLVSED 138

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 26/146 (17%)

Query: 253 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHR 304
             +G G +G VYK R L  G+ VA+K+++   +  G       E+     +K +    H 
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL---LKQLESFEHP 61

Query: 305 NLLRLYGFCTTVTEK-----LLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGS 357
           N++RL   C            LV+ +     V   L    S  P   L   T K +    
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 358 ARGLSYLHEHCDPKIIHRDVKAANIL 383
            RG+ +LH H    I+HRD+K  NIL
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNIL 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 60.2 bits (146), Expect = 8e-10
 Identities = 35/91 (38%), Positives = 55/91 (60%), Gaps = 2/91 (2%)

Query: 72  VDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 131
           +DL + +LSGE+   + QL+NLE+L L +N+ +G IP +LT++  L +L L +N+ SG +
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348

Query: 132 PDN-GSFSQFTPISFENNLNLCGPNTKKPCS 161
           P N G  +  T +    N NL G   +  CS
Sbjct: 349 PKNLGKHNNLTVLDLSTN-NLTGEIPEGLCS 378

Length = 968

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 58.7 bits (142), Expect = 8e-10
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 12/134 (8%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VA+K LK+   S     F  E  ++    H  L+RLY    
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE--AFLAEANLMKQLQHPRLVRLYA--- 68

Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            VT++   ++  YM NGS+   L+  +     L       +A   A G++++        
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFLKTPEGI--KLTINKLIDMAAQIAEGMAFIERK---NY 123

Query: 373 IHRDVKAANILLDE 386
           IHRD++AANIL+ E
Sbjct: 124 IHRDLRAANILVSE 137

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 10/137 (7%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 310
           LG+GGFG+V   ++   GK+ A K+L ++R     GE     E KI+     R ++ L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
            F  T  +  LV   M  G +  +        P          A     GL +LH+    
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 371 KIIHRDVKAANILLDED 387
           +I++RD+K  N+LLD+ 
Sbjct: 115 RIVYRDLKPENVLLDDH 131

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 15/145 (10%)

Query: 255 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 310
           LG G FG V +G+L        VAVK +K    +  E++ F +E   +    H N++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 311 GFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLS 362
           G C    E       +++ P+M +G + S L   +    P   PT+   K     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YL        IHRD+ A N +L+E+
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNEN 148

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 11/140 (7%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNL 306
           F   N +G G +G VY+ R    G++VA+K+++ +    G  +    E+ ++    H N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 307 LRLYGFCT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           + L        +    LV  Y     +AS L    +   P      K + L   RGL YL
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT---PFSESQVKCLMLQLLRGLQYL 124

Query: 365 HEHCDPKIIHRDVKAANILL 384
           HE+    IIHRD+K +N+LL
Sbjct: 125 HENF---IIHRDLKVSNLLL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)

Query: 252 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 307
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGS-------- 357
            L G C       L   Y  +G++   LR+ +   + P           L S        
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 358 --ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGEN 160

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 28/59 (47%), Positives = 40/59 (67%)

Query: 74  LGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           L +  L G++  ELGQ+K+L+ + L  N+LSG IP  +  +TSLN LDL  N L+GP+P
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253

Length = 968

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLLR 308
           +LG+G FG+VY    AD G+ +AVK+++       TS      + E++++   +H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 309 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
            YG      E+ L     +M  GS+  +L+    S   L     +K       G+SYLH 
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS 124

Query: 367 HCDPKIIHRDVKAANILLD 385
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 15/138 (10%)

Query: 254 ILGRGGFGKVYK-GRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           ++GRG FG V+   R AD KLV +K++  E+ T    L  Q E +++ +  H N++  Y 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARGLSYLHEH 367
                   ++V  Y   G++A  +++R +SL      L +  +  +AL       ++H  
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHVHTK 120

Query: 368 CDPKIIHRDVKAANILLD 385
               I+HRD+K  NILLD
Sbjct: 121 ---LILHRDLKTQNILLD 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM  GS+   L+  +     +  P     +   A G++Y+        IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGG--KVLLPKLIDFSAQIAEGMAYIERK---NYIH 126

Query: 375 RDVKAANILLDE 386
           RD++AAN+L+ E
Sbjct: 127 RDLRAANVLVSE 138

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 6/134 (4%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           LG G +  VYKGR    G++VA+K +  +   G       E+ ++    H N++RL+   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
            T  + +LV+ YM       +  +       LD  T K       +G+++ HE+   +++
Sbjct: 68  HTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122

Query: 374 HRDVKAANILLDED 387
           HRD+K  N+L+++ 
Sbjct: 123 HRDLKPQNLLINKR 136

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 8/139 (5%)

Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRL-Y 310
           LG+GGFG+V   ++ A GKL A K+L ++R     G      E +I++    R ++ L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
            F  T T+  LV   M  G +   +       P    P           GL +LH+    
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 371 KIIHRDVKAANILLDEDAD 389
           +II+RD+K  N+LLD D +
Sbjct: 117 RIIYRDLKPENVLLDNDGN 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 44/139 (31%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRL----KEERTSGGELQFQTEVKIISMAVHRNLLR 308
           +LGRG FG+VY    AD G+ +AVK++      + TS      + E++++    H  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 309 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
            YG      EK L     YM  GS+  +L+    +   L     ++      +G+SYLH 
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS 124

Query: 367 HCDPKIIHRDVKAANILLD 385
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)

Query: 249 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE 120

Query: 368 CDPKIIHRDVKAANILLDEDAD 389
              K IHRD+KAAN+LL E  +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGE 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 13/144 (9%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           F+    +G+G FG+V+KG   D +   +VA+K +  E         Q E+ ++S      
Sbjct: 6   FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           + + YG     T+  ++  Y+  GS    LR       P D      +     +GL YLH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH 118

Query: 366 EHCDPKIIHRDVKAANILLDEDAD 389
                K IHRD+KAAN+LL E  D
Sbjct: 119 SE---KKIHRDIKAANVLLSEQGD 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 6/146 (4%)

Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 299
           E +   D    + +LG+G +G VY  R L+    +A+K +  ER S        E+ + S
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHS 60

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              HRN+++  G  +      +    +  GS+++ LR +   L   +  T          
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIIFYTKQILE 119

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLD 385
           GL YLH++   +I+HRD+K  N+L++
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLVN 142

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 254 ILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+R
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 365
           L G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL 
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126

Query: 366 EHCDPKIIHRDVKAANILL 384
           E    +++HRD+ A N+L+
Sbjct: 127 ER---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 40/146 (27%), Positives = 64/146 (43%), Gaps = 30/146 (20%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYG- 311
           +GRG FG V K      G ++AVKR++       + +   ++ ++  +     +++ YG 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 312 --------FC----TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
                    C        +K   Y Y     + S + E              KIA+ + +
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYE---VLKSVIPEEILG----------KIAVATVK 118

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLD 385
            L+YL E  + KIIHRDVK +NILLD
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLD 142

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 30/66 (45%), Positives = 41/66 (62%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           S+  +DL    L+G +   LG LKNL+ L L  N LSG IP S+ ++  L  LDLS+N L
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296

Query: 128 SGPVPD 133
           SG +P+
Sbjct: 297 SGEIPE 302

Length = 968

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T + L+   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121

Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL E    +++HRD+ A N+L+
Sbjct: 122 MNYLEER---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 12/135 (8%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH---RNLLRL 309
           ++GRG +G VY+G+ +  G++VA+K +  +         Q EV ++S        N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           YG         ++  Y   GSV + ++       P+       I       L Y+H+   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV-- 120

Query: 370 PKIIHRDVKAANILL 384
             +IHRD+KAANIL+
Sbjct: 121 -GVIHRDIKAANILV 134

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEV 295
           +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  E 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 296 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTRKK 352
            ++      +++RL G  +     L++   MT G + S LR  +  +   P    P+ KK
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 353 ---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKR----LKEERTSGGELQFQTEVKIISMA 301
           D +     +G G +GKVYK R    GKLVA+K+    + EE      L+   E+ ++ M 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQML 57

Query: 302 VHRN-LLRLYGFCTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 353
                ++RL        E+        LV+ Y+ +          +    PL   T K  
Sbjct: 58  SESIYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                +G+++ H+H    ++HRD+K  N+L+D+ 
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQ 146

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 7e-09
 Identities = 31/71 (43%), Positives = 44/71 (61%), Gaps = 3/71 (4%)

Query: 65  PEGSVT---RVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILD 121
           P GS+     +DL N  LSGE+  ++G   +L++L L  N L G IP SLT +TSL  L 
Sbjct: 135 PRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLT 194

Query: 122 LSNNRLSGPVP 132
           L++N+L G +P
Sbjct: 195 LASNQLVGQIP 205

Length = 968

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 27/150 (18%)

Query: 253 NILGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
             +G+G FG+V+K R     ++VA+K+ L E    G  +    E+KI+ +  H N++ L 
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 311 GFCTTVTEKLLVYPYMTNGSVAS-------------RLRERQSSLPPLDWPTRKKIALGS 357
             C T            N    S              L    +          KK+    
Sbjct: 78  EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLL--SNKNVKFTLSEIKKVMKML 128

Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             GL Y+H +   KI+HRD+KAANIL+ +D
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKD 155

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 16/154 (10%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
              +  ++  +   G+V + + E    L     P  + I       L YLH     KIIH
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM---KIIH 133

Query: 375 RDVKAANILLDEDAD----------QSSKTILRR 398
           RD+KA N+LL  D D          ++ KT+ RR
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)

Query: 254 ILGRGGFGKVYKG-RLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAV--HRNL 306
           +LG G FG V+KG  + +G      VA+K + ++R+     Q  T+  +++M    H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITD-HMLAMGSLDHAYI 71

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSY 363
           +RL G C   + +L V      GS+   +R+ + SL P   L+W       +  A+G+ Y
Sbjct: 72  VRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYY 124

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           L EH    ++HR++ A NILL  D
Sbjct: 125 LEEHR---MVHRNLAARNILLKSD 145

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 24/154 (15%)

Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRN 305
           LG G FG+V         K R      VAVK LK+  T        +E++++  +  H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------PLDWPTRKKI 353
           ++ L G CT      ++  Y   G++   LR R+   P             L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   ARG+ YL      + IHRD+ A N+L+ ED
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTED 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 28/158 (17%)

Query: 252 KNILGRGGFGKVYKGRLADG----------------KLVAVKRLKEERTSGGELQFQTEV 295
           K  LG G FG+V+    A+G                 LVAVK L+ + T      F  E+
Sbjct: 10  KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 296 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ--------SSLPPLDW 347
           KI+S   + N++RL G C +     ++  YM NG +   L +R+        +++P +  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 348 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
                +A+  A G+ YL        +HRD+   N L+ 
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 21/148 (14%)

Query: 255 LGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E  ++      +++R
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKI---ALGSAR 359
           L G  +     L+V   M +G + S LR      E     PP   PT +++   A   A 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 130

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDED 387
           G++YL+     K +HRD+ A N ++  D
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHD 155

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 48/152 (31%), Positives = 69/152 (45%), Gaps = 10/152 (6%)

Query: 239 LRELQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKI 297
           L  L   TD +     +G+G +GKVYK     DG L AVK L        E++ +  + +
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72

Query: 298 ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 352
            S+  H N+++ YG      + +     LV      GSV   ++        LD      
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132

Query: 353 IALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           I  G+  GL +LH +   +IIHRDVK  NILL
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILL 161

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 44/145 (30%), Positives = 61/145 (42%), Gaps = 14/145 (9%)

Query: 248 GFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL-KEERTSGGELQ-FQTEVKIISMAVHR 304
            F    ++G+G FGKV   +  D K + A+K + K++    G ++    E +I+    H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 305 NLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
            L+ L Y F     E + LV   +  G     LR   S          K         L 
Sbjct: 61  FLVNLWYSFQDE--ENMYLVVDLLLGGD----LRYHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YLH      IIHRD+K  NILLDE 
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQ 136

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 12/142 (8%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 304
           FS+   +G G FG VY  R + + ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N ++  G         LV  Y   GS +  L   +  L  ++      +  G+ +GL+YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYL 131

Query: 365 HEHCDPKIIHRDVKAANILLDE 386
           H H    +IHRDVKA NILL E
Sbjct: 132 HSH---NMIHRDVKAGNILLSE 150

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 17/141 (12%)

Query: 255 LGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMA---VHRNLLR 308
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 309 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
           L+  CT       T+  LV+ ++         +  +  +P     T K +     RGL +
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 125

Query: 364 LHEHCDPKIIHRDVKAANILL 384
           LH H   +++HRD+K  NIL+
Sbjct: 126 LHSH---RVVHRDLKPQNILV 143

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 22/144 (15%)

Query: 254 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ----------FQTEVKIISMAV 302
           ++G G FG VY G  A  G+L+AVK++  E  S                  E+ ++    
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQV--ELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 303 HRNLLRLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
           H N+++  G  +   + L ++  Y+  GSVA+ L    +    L     ++I     +GL
Sbjct: 65  HENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGL 119

Query: 362 SYLHEHCDPKIIHRDVKAANILLD 385
           +YLH      IIHRD+K ANIL+D
Sbjct: 120 NYLHNR---GIIHRDIKGANILVD 140

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 18/139 (12%)

Query: 254 ILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           +LG G FG VYKG    DG+     VA+K L+E  +     +   E  +++      + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLH 365
           L G C T T + LV   M  G +   +RE   R  S   L+W       +  A+G+SYL 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126

Query: 366 EHCDPKIIHRDVKAANILL 384
           E    +++HRD+ A N+L+
Sbjct: 127 E---VRLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 27/153 (17%)

Query: 255 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG   FGK+YKG L        +LVA+K LK+        +FQ E  +++   H N++ L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRER----------------QSSLPPLDWPTRKKI 353
            G  T      +++ Y+  G +   L  R                +SSL   D+     I
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF---LHI 129

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           A+  A G+ YL  H     +H+D+ A NIL+ E
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 28/156 (17%)

Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK++ T        +E++++ M   H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP-----------TRKKI- 353
           ++ L G CT      ++  Y + G++   LR R+   P +D+            T K + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRP--PGMDYSFDTCKLPEEQLTFKDLV 137

Query: 354 --ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTED 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 41/161 (25%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV------------------- 295
           LG+G F K++KG            ++ E    GEL  +TEV                   
Sbjct: 3   LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49

Query: 296 -KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 354
             ++S   H++L+  YG C    E ++V  Y+  GS+ + L++ ++ +    W       
Sbjct: 50  ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W------K 102

Query: 355 LGSARGLSY-LHEHCDPKIIHRDVKAANILLDEDADQSSKT 394
           L  A+ L++ LH   D  + H +V A N+LL  + D+ +  
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGN 143

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 19/151 (12%)

Query: 252 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           K  LG G FGKV+           D  LVAVK LK+  +      F  E ++++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 68

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------PPLDWPTRK--KIALG 356
           +++ YG C      ++V+ YM +G +   LR              P +    +   IA  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            A G+ YL        +HRD+   N L+ E+
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGEN 156

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 31/142 (21%), Positives = 62/142 (43%), Gaps = 6/142 (4%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAV 302
              F  +  +G+G F  VYK   L DG++VA+K+++  E   +        E+ ++    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++         E  +V      G ++  ++  +     +   T  K  +     L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           ++H     +I+HRD+K AN+ +
Sbjct: 121 HMHSK---RIMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.6 bits (128), Expect = 5e-08
 Identities = 52/162 (32%), Positives = 72/162 (44%), Gaps = 15/162 (9%)

Query: 232 GQLKRFSLRELQVATDG---FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG 287
           G LK   + EL    D    F++   +G G FG VY  R     ++VA+K++        
Sbjct: 7   GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66

Query: 288 ELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP 344
           E ++Q    EVK +    H N +   G         LV  Y   GS +  L   +    P
Sbjct: 67  E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK---P 121

Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           L       I  G+ +GL+YLH H    +IHRD+KA NILL E
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTE 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 43/139 (30%), Positives = 67/139 (48%), Gaps = 14/139 (10%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLLR 308
           +LG+G FG+VY     D G+ +A K+++       TS      + E++++    H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 309 LYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
            YG      EK L     YM  GSV  +L+    +   L     +K       G+SYLH 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS 124

Query: 367 HCDPKIIHRDVKAANILLD 385
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 50/155 (32%), Positives = 70/155 (45%), Gaps = 27/155 (17%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK--RLKEERTSGGELQFQTEVKIISMAVH 303
           D F     +G G +G+VYK R  D G+LVA+K  RL  E+  G  +    E+KI+    H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNH 65

Query: 304 RNLLRLYGFCTTVTEK-------------LLVYPYMTNGSVASRLRERQSSLPPLDWPTR 350
           RN++ L      VT+K              LV+ YM +  +   L E  S L        
Sbjct: 66  RNIVNL---KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLE--SGLVHFSEDHI 118

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
           K        GL+Y H       +HRD+K +NILL+
Sbjct: 119 KSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLN 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 14/141 (9%)

Query: 254 ILGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 306
            LG G FGKV +        +D  + VAVK LK    S       +E+KI+S +  H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-H 365
           + L G CT     L++  Y   G + + LR ++ S   L        +   A+G+++L  
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAFLAS 159

Query: 366 EHCDPKIIHRDVKAANILLDE 386
           ++C    IHRD+ A N+LL  
Sbjct: 160 KNC----IHRDLAARNVLLTH 176

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 10/138 (7%)

Query: 254 ILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ILG G FG++ +G L    K    VA+  L+   +      F  E   +    H N++RL
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
            G  T     ++V  YM+NG++ S LR+ +  L          +  G A G+ YL E   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPGLASGMKYLSEM-- 126

Query: 370 PKIIHRDVKAANILLDED 387
              +H+ + A  +L++ D
Sbjct: 127 -GYVHKGLAAHKVLVNSD 143

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.8 bits (127), Expect = 8e-08
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 22/145 (15%)

Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLR 308
           LG+G FG V   R   L D  G++VAVK+L+        L+ F+ E++I+    H N+++
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69

Query: 309 LYGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSY 363
             G C +   +   LV  Y+  GS+   L   RER      LD       A    +G+ Y
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER------LDHRKLLLYASQICKGMEY 123

Query: 364 LHEHCDPKIIHRDVKAANILLDEDA 388
           L      + +HRD+   NIL++ + 
Sbjct: 124 LGSK---RYVHRDLATRNILVESEN 145

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 68

Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 123

Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 124 VHRDLRAANILVGEN 138

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 24/143 (16%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNL 306
           +G G +G VYK R    G++VA+K+++ E    G       E+    E+       H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--PLDWPTRKKIALGSARGLSYL 364
           +RL     +  +  LV+ ++        L++   S P   LD P  K       +G++Y 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLD-----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H H   +++HRD+K  N+L+D +
Sbjct: 116 HSH---RVLHRDLKPQNLLIDRE 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 43/131 (32%), Positives = 58/131 (44%), Gaps = 10/131 (7%)

Query: 257 RGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFC 313
           RG FGKVY GR   + KL AVK +K+       +  Q Q E   ++++    ++ LY   
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
            +     LV  Y+  G V S L          D     K     A  L YLH H    II
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHRH---GII 126

Query: 374 HRDVKAANILL 384
           HRD+K  N+L+
Sbjct: 127 HRDLKPDNMLI 137

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 12/136 (8%)

Query: 255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHRNLLRLY 310
           +G G FG VY    +   ++VAVK++        E ++Q    EVK +    H N +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G         LV  Y   GS +  L   +    PL       I  G+ +GL+YLH H   
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 371 KIIHRDVKAANILLDE 386
            +IHRD+KA NILL E
Sbjct: 142 -MIHRDIKAGNILLTE 156

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.8 bits (126), Expect = 9e-08
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 10/145 (6%)

Query: 247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           D +     LG G +  VYKG+   +GKLVA+K ++ +   G       E  ++    H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYL 364
           ++ L+    T     LV+ Y     V + L +     P    P   K+ L    RGLSY+
Sbjct: 65  IVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 365 HEHCDPKIIHRDVKAANILLDEDAD 389
           H+     I+HRD+K  N+L+ +  +
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGE 141

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 42/136 (30%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G +G VYK R L  G+L AVK +K E      L  Q E+ ++    H N++  +G  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIVAYFGSY 75

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
            +  +  +   Y   GS    L++      PL       +   + +GL+YLH       +
Sbjct: 76  LSREKLWICMEYCGGGS----LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128

Query: 374 HRDVKAANILLDEDAD 389
           HRD+K ANILL ++ D
Sbjct: 129 HRDIKGANILLTDNGD 144

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 28/59 (47%), Positives = 38/59 (64%)

Query: 74  LGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           LG   LSGE+  E+G L +L  L L  N+L+G IP+SL  + +L  L L  N+LSGP+P
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277

Length = 968

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 24/154 (15%)

Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----------SSLP--PLDWPTRKKI 353
           ++ L G CT      ++  Y + G++   LR R+          + +P   + +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTEN 173

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 12/137 (8%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYG 311
           + +G +G+V+  +  + G + A+K +K+          Q  TE  I+S A    +++LY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 312 FCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           +     + L LV  Y+  G +AS L     ++  LD    +         L YLH +   
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN--- 112

Query: 371 KIIHRDVKAANILLDED 387
            IIHRD+K  NIL+D +
Sbjct: 113 GIIHRDLKPDNILIDSN 129

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 8/79 (10%)

Query: 51  LPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTS 110
           +P  LC+         G++ ++ L + +L GE+   LG  ++L  +RL +NS SG +P+ 
Sbjct: 372 IPEGLCS--------SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423

Query: 111 LTTITSLNILDLSNNRLSG 129
            T +  +  LD+SNN L G
Sbjct: 424 FTKLPLVYFLDISNNNLQG 442

Length = 968

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 10/135 (7%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAVHRNLLRLY 310
           LG+G +G VYK      G  +A   +KE R    E +F     E+ I+  AV   ++  Y
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMA---MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G         +   YM  GS+  +L     +   +     ++I     +GL +L E  + 
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122

Query: 371 KIIHRDVKAANILLD 385
            IIHRDVK  N+L++
Sbjct: 123 NIIHRDVKPTNVLVN 137

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 25/125 (20%)

Query: 271 GKLVAVKRL---KEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT 327
           G+ VAVK++   K++R    EL F  EV I+    H N++ +Y       E  +V  ++ 
Sbjct: 44  GRQVAVKKMDLRKQQRR---ELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99

Query: 328 NGSV-----ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI 382
            G++      +R+ E Q +           + L   + LS+LH      +IHRD+K+ +I
Sbjct: 100 GGALTDIVTHTRMNEEQIA----------TVCLAVLKALSFLHAQ---GVIHRDIKSDSI 146

Query: 383 LLDED 387
           LL  D
Sbjct: 147 LLTSD 151

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 9/137 (6%)

Query: 254 ILGRGGFGK--VYKGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLY 310
           +LG+G FG+  +Y+ R  D  LV  K +   R S  E +    E+ I+S+  H N++  Y
Sbjct: 7   VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
                    L+   Y   G++  ++  ++  L   +        + SA  +SY+H+    
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120

Query: 371 KIIHRDVKAANILLDED 387
            I+HRD+K  NI L + 
Sbjct: 121 GILHRDIKTLNIFLTKA 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 23/143 (16%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYG- 311
           LGRG +G V K R +  G ++AVKR++    S  + +   ++ I   +V     +  YG 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 312 --------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
                    C  V +  L   Y        ++ ++  ++P        KIA+   + L Y
Sbjct: 69  LFREGDVWICMEVMDTSLDKFY-------KKVYDKGLTIPE---DILGKIAVSIVKALEY 118

Query: 364 LHEHCDPKIIHRDVKAANILLDE 386
           LH      +IHRDVK +N+L++ 
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINR 139

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 45/149 (30%), Positives = 64/149 (42%), Gaps = 32/149 (21%)

Query: 254 ILGRGGFGKV----YKGRLADGKLVAVKRLKEERTSGGELQFQTEVK----------IIS 299
           +LGRG FGKV    YK     G+L A+K LK+     G++  + EV+            +
Sbjct: 6   VLGRGHFGKVLLAEYKK---TGELYAIKALKK-----GDIIARDEVESLMCEKRIFETAN 57

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI-ALGSA 358
              H  L+ L+    T      V  Y   G +   +     S P      R    A    
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVV 111

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
            GL YLHE+   KI++RD+K  N+LLD +
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTE 137

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 24/152 (15%)

Query: 252 KNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           K  LG G FGKV+           D  LVAVK LK+   +  +  FQ E ++++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEH 68

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-------------RQSSLPPLDWPTRKK 352
           +++ YG C      ++V+ YM +G +   LR              RQ+    L       
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK-GELGLSQMLH 127

Query: 353 IALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           IA   A G+ YL        +HRD+   N L+
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLV 156

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 16/147 (10%)

Query: 255 LGRGGFGKVYKGRL-------ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRN 305
           LG+G F  +YKG L         G    V  + +   S     L F     ++S   H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           L++LYG C    E ++V  Y+  G +   L  R+ +   L W  +  +A   A  L YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 366 EHCDPKIIHRDVKAANILLDEDADQSS 392
           +    K++H +V   NIL+        
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEG 142

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 33/138 (23%), Positives = 68/138 (49%), Gaps = 11/138 (7%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGF 312
           +G G +G V+K +  +  ++VA+KR++ +    G       E+ ++    H+N++RLY  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLP-PLDWPTRKKIALGSARGLSYLHEHCDPK 371
             +  +  LV+ Y         L++   S    +D    K       +GL++ H H    
Sbjct: 68  LHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 372 IIHRDVKAANILLDEDAD 389
           ++HRD+K  N+L++++ +
Sbjct: 120 VLHRDLKPQNLLINKNGE 137

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 35/139 (25%), Positives = 66/139 (47%), Gaps = 11/139 (7%)

Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRN 305
           + N  ++G G +G V K +  + G++VA+K+    E+     ++  + E++++    H N
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           L+ L           LV+ ++ +    + L + +     LD    +K      RG+ + H
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 366 EHCDPKIIHRDVKAANILL 384
            H    IIHRD+K  NIL+
Sbjct: 118 SH---NIIHRDIKPENILV 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 43/132 (32%), Positives = 65/132 (49%), Gaps = 12/132 (9%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK    S     F  E +I+    H  L++LY    
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYA--- 68

Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L++ +     L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERM---NY 123

Query: 373 IHRDVKAANILL 384
           IHRD+++ANIL+
Sbjct: 124 IHRDLRSANILV 135

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 10/137 (7%)

Query: 255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           LG G +  V+KGR      LVA+K ++ E   G       EV ++    H N++ L+   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 372
            T     LV+ Y+      S L++   +   L      KI +    RGLSY H+    KI
Sbjct: 73  HTERCLTLVFEYLD-----SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 373 IHRDVKAANILLDEDAD 389
           +HRD+K  N+L++E  +
Sbjct: 125 LHRDLKPQNLLINEKGE 141

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 40/141 (28%), Positives = 56/141 (39%), Gaps = 19/141 (13%)

Query: 254 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYGF 312
                    + K +     LVAVK++  +  S  +L+  Q E+       H N+L  Y  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVT 66

Query: 313 CTTVTEKL-LVYPYMTNGSVASRLRER-QSSLPPLDWPTRKKIAL---GSARGLSYLH-E 366
              V  +L +V P M  GS    L+      LP L       IA         L Y+H +
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSK 120

Query: 367 HCDPKIIHRDVKAANILLDED 387
                 IHR VKA++ILL  D
Sbjct: 121 GF----IHRSVKASHILLSGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 33/184 (17%)

Query: 227 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVY--------KGRLADGKLVAVKR 278
           SE +L +  R+     +V  D       LG G FG+V         K +      VAVK 
Sbjct: 3   SEYELPEDPRW-----EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM 57

Query: 279 LKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 337
           LK + T        +E++++ M   H+N++ L G CT      ++  Y + G++   LR 
Sbjct: 58  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 117

Query: 338 RQSSLPPLDW---PTRKKIALGS-----------ARGLSYLHEHCDPKIIHRDVKAANIL 383
           R+   P +++   PT+      S           ARG+ YL      K IHRD+ A N+L
Sbjct: 118 RRP--PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVL 172

Query: 384 LDED 387
           + ED
Sbjct: 173 VTED 176

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 37/141 (26%), Positives = 60/141 (42%), Gaps = 21/141 (14%)

Query: 252 KNILGRGGFGKVYKG---RLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
              +G G FG VY+G      + K+ VAVK  K   +     +F  E  I+    H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 308 RLYGFCT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           +L G  T      V E   + P    G + S L+  + SL      +    +   +  L+
Sbjct: 71  KLIGVITENPVWIVME---LAPL---GELRSYLQVNKYSLDLA---SLILYSYQLSTALA 121

Query: 363 YLHEHCDPKIIHRDVKAANIL 383
           YL      + +HRD+ A N+L
Sbjct: 122 YLESK---RFVHRDIAARNVL 139

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 22/155 (14%)

Query: 249 FSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVH 303
           F+   +LG+G FG V + +L       + VAVK LK +  S  ++ +F  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 304 RNLLRLYGFCTTVTEK------LLVYPYMTNGSV-----ASRLRERQSSLPPLDWPTRKK 352
            N+++L G       K      +++ P+M +G +      SR+ E   +LP     T  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLP---LQTLVR 117

Query: 353 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             +  A G+ YL        IHRD+ A N +L+E+
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNEN 149

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 45.8 bits (109), Expect = 4e-07
 Identities = 17/42 (40%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 24 ANAEVDALYIFKSKLQ-DPNNSLQSWDNLPGNLCTWFHITCN 64
           N + DAL  FKS L  DP+ +L SW+    + C+W  +TC+
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 46/171 (26%), Positives = 65/171 (38%), Gaps = 41/171 (23%)

Query: 252 KNILGRGGFGKVY--------------------KGRLADGKLVAVKRLKEERTSGGELQF 291
           K  LG G FG+V+                    KGR     LVAVK L+ +        F
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66

Query: 292 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------ 339
             EVKI+S     N++RL G C       ++  YM NG +   L                
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 340 ---SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                LP + + +   +AL  A G+ YL        +HRD+   N L+ E+
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGEN 174

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 47/142 (33%), Positives = 66/142 (46%), Gaps = 20/142 (14%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEV---KIISMAVHRNLLRL 309
           +G G +G VYK R    G  VA+K ++ +    G  L    EV   K +    H N++RL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 310 YGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALGSARGLS 362
              C T      T+  LV+ +     V   LR     +PP   P  T K +     RGL 
Sbjct: 68  MDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           +LH +C   I+HRD+K  NIL+
Sbjct: 123 FLHANC---IVHRDLKPENILV 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 50.3 bits (120), Expect = 6e-07
 Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 21/143 (14%)

Query: 254 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQ------FQTEVKIISMAV-HRN 305
           +LG+G FGKV   RL   G+L AVK LK++      LQ        TE +I+S+A  H  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPF 57

Query: 306 LLRLYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           L +LY  C    ++L  V  ++  G +   +++ +      D    +  A      L +L
Sbjct: 58  LTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFL 112

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H   D  II+RD+K  N+LLD +
Sbjct: 113 H---DKGIIYRDLKLDNVLLDHE 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 51/147 (34%), Positives = 69/147 (46%), Gaps = 29/147 (19%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL----- 307
           ++G+G FGKV   +  ADGK  AVK L+++      +  + E K I MA  RN+L     
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKK-----AILKKKEQKHI-MA-ERNVLLKNVK 54

Query: 308 ------RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
                   Y F T   +KL  V  Y+  G +   L +R+ S P    P  +  A   A  
Sbjct: 55  HPFLVGLHYSFQTA--DKLYFVLDYVNGGELFFHL-QRERSFPE---PRARFYAAEIASA 108

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDED 387
           L YLH      II+RD+K  NILLD  
Sbjct: 109 LGYLHSL---NIIYRDLKPENILLDSQ 132

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 12/137 (8%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H N+++L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYLHEHCDP 370
             T  +  LV+ ++        L++   + P    P    K       +GL++ H H   
Sbjct: 68  IHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119

Query: 371 KIIHRDVKAANILLDED 387
           +++HRD+K  N+L++ +
Sbjct: 120 RVLHRDLKPQNLLINTE 136

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 24/66 (36%), Positives = 38/66 (57%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           S+ RV L + + SGEL  E  +L  +  L ++NN+L G I +    + SL +L L+ N+ 
Sbjct: 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464

Query: 128 SGPVPD 133
            G +PD
Sbjct: 465 FGGLPD 470

Length = 968

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 31/168 (18%)

Query: 232 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ 290
           GQ     L +L+   +       +G G  G+VYK R    G ++AVK+++  RT   E  
Sbjct: 7   GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKE-- 55

Query: 291 FQTEVKIISMAV------HR--NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 342
              E K I M +      H    +++ YG+  T ++  +    M   +   +L +R    
Sbjct: 56  ---ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGP 110

Query: 343 PPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDAD 389
            P D     K+ +   + L YL E H    +IHRDVK +NILLD   +
Sbjct: 111 IPED--ILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGN 153

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 17/142 (11%)

Query: 255 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLL 307
           LG G FGKV   R        G+ VAVK LK E  SGG      + E++I+    H N++
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIV 69

Query: 308 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           +  G CT        L+  ++ +GS+   L   ++    ++   + K A+   +G+ YL 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126

Query: 366 EHCDPKIIHRDVKAANILLDED 387
                + +HRD+ A N+L++ +
Sbjct: 127 SR---QYVHRDLAARNVLVESE 145

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 12/135 (8%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK          F  E +I+    H  L+ LY    
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYA--- 68

Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  +M  GS+   L+E       L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYIERM---NY 123

Query: 373 IHRDVKAANILLDED 387
           IHRD++AANIL+ ++
Sbjct: 124 IHRDLRAANILVGDN 138

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 43/157 (27%), Positives = 65/157 (41%), Gaps = 27/157 (17%)

Query: 252 KNILGRGGFGKVY------------KGRLADGK-----LVAVKRLKEERTSGGELQFQTE 294
           K  LG G FG+V+            K    D       LVAVK L+E+        F  E
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 295 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV---ASRLRER----QSSLPPLDW 347
           +KI+S     N++RL   C T     ++  YM NG +    SR   +    ++ +  + +
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 348 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
            T   +A   A G+ YL        +HRD+   N L+
Sbjct: 130 STLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 21/143 (14%)

Query: 252 KNILGRGGFGKVY----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           K I G+  FGKV     K      KL   K +K +  +  E      V  + M  + N +
Sbjct: 23  KLIDGK--FGKVSVLKHKP---TQKLFVQKIIKAKNFNAIEPM----VHQL-MKDNPNFI 72

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           +LY   TT+   +L+  Y+ +G +   L++       L     KKI       L+ LH+H
Sbjct: 73  KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH 128

Query: 368 CDPKIIHRDVKAANILLDEDADQ 390
               IIH D+K  N+L D   D+
Sbjct: 129 ---NIIHNDIKLENVLYDRAKDR 148

Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 12/144 (8%)

Query: 256 GRGGFGKVYKGRL---ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA---VHRNLLRL 309
           GRG +G+VYK +     DGK  A+K+ K ++     +  Q+  + I++     H N++ L
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVSL 67

Query: 310 YGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
                   +K   L++ Y  +         RQ+    +     K +      G+ YLH +
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127

Query: 368 CDPKIIHRDVKAANILLDEDADQS 391
               ++HRD+K ANIL+  +  + 
Sbjct: 128 W---VLHRDLKPANILVMGEGPER 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 16/138 (11%)

Query: 255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 311
           LG GGFG+V   ++    +  A+K +K+        Q    +E +I+    H  +++LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 312 FCTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
              T  +K  +Y    Y   G + + LR+R       D  T +           YLH   
Sbjct: 60  --RTFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLHNR- 112

Query: 369 DPKIIHRDVKAANILLDE 386
              II+RD+K  N+LLD 
Sbjct: 113 --GIIYRDLKPENLLLDS 128

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)

Query: 255 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           LG G +  VYKGR  L D  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
             T     LV+ Y+ +  +   L +  +S   ++    K       RGL+Y H     K+
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125

Query: 373 IHRDVKAANILLDEDAD 389
           +HRD+K  N+L++E  +
Sbjct: 126 LHRDLKPQNLLINERGE 142

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 12/138 (8%)

Query: 255 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           LG G +  V+KGR  L +  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA-RGLSYLHEHCDPK 371
             T     LV+ Y+        L++       +      KI L    RGL+Y H     K
Sbjct: 73  VHTDKSLTLVFEYLDKD-----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 372 IIHRDVKAANILLDEDAD 389
           ++HRD+K  N+L++E  +
Sbjct: 125 VLHRDLKPQNLLINERGE 142

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 37/146 (25%), Positives = 71/146 (48%), Gaps = 19/146 (13%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           D +   N +  G +G VY+ R    G++VA+K+LK E+   G  +    E+ I+    H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 305 NLLRL----YGFCTTVTEKLLVYPYMTNG--SVASRLRERQSSLPPLDWPTRKKIALGSA 358
           N++ +     G  + + +  +V  Y+ +   S+   ++       P      K + L   
Sbjct: 65  NIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMK------QPFLQSEVKCLMLQLL 116

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILL 384
            G+++LH++    I+HRD+K +N+LL
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLL 139

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 10/134 (7%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           LG G +  VYKGR    G+LVA+K ++ E   G       E  ++    H N++ L+   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 372
            T     LV+ Y+      + L++              ++ L    RGL+Y H+    ++
Sbjct: 73  HTKKTLTLVFEYLD-----TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RV 124

Query: 373 IHRDVKAANILLDE 386
           +HRD+K  N+L+ E
Sbjct: 125 LHRDLKPQNLLISE 138

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 47.9 bits (115), Expect = 4e-06
 Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 45/163 (27%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 298
           +     +G G +G V        G+ VA+K++           F           E+K++
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53

Query: 299 SMAVHRNLLRLYGFCT-TVTEKL----LVYPYM-TNGSVASRLRERQSSLPPLDWPTRKK 352
               H N++ L         E      +V   M T+  +   ++  Q    PL   T   
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQ----PL---TDDH 104

Query: 353 I------ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           I       L   RGL YLH      +IHRD+K +NIL++ + D
Sbjct: 105 IQYFLYQIL---RGLKYLHS---ANVIHRDLKPSNILVNSNCD 141

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 35/98 (35%), Positives = 50/98 (51%), Gaps = 8/98 (8%)

Query: 255 LGRGGFGKVYK------GRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FGKV +       + A  + VAVK LKE  T+       TE+KI I +  H N++
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 344
            L G CT     L+V   Y   G++++ LR ++    P
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 15/135 (11%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT----EVKIISMAVHRNLLRL 309
           +G G +G V+K R  + G++VA+K+  E   S  +   +     E++++    H NL+ L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVE---SEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
                   +  LV+ Y  + +V + L +    +P       KKI   + + +++ H+H  
Sbjct: 66  IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEH---LIKKIIWQTLQAVNFCHKH-- 119

Query: 370 PKIIHRDVKAANILL 384
              IHRDVK  NIL+
Sbjct: 120 -NCIHRDVKPENILI 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 29/149 (19%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL---QFQTEVKIISMAVHRNLLRL 309
           ++G+GG G+VY        + VA+K+++E+  S   L   +F  E KI +  +H  ++ +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 310 YGFCTTVTEKLLVY---PYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG--LS 362
           Y  C+   +   VY   PY+   ++ S L+   ++ SL        K++A  ++ G  LS
Sbjct: 68  YSICS---DGDPVYYTMPYIEGYTLKSLLKSVWQKESLS-------KELAEKTSVGAFLS 117

Query: 363 YLHEHC-------DPKIIHRDVKAANILL 384
             H+ C          ++HRD+K  NILL
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL 146

Length = 932

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 17/141 (12%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEE---RTSGGELQFQTEVKIISMA-VHRNLLR 308
           +LG+G FGKV    L    +L AVK LK++   +    E    TE +++++A  H  L +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVLALAGKHPFLTQ 60

Query: 309 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           L       T+  L  V  Y+  G +   ++         D P  +  A     GL +LHE
Sbjct: 61  L--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHE 114

Query: 367 HCDPKIIHRDVKAANILLDED 387
                II+RD+K  N+LLD +
Sbjct: 115 R---GIIYRDLKLDNVLLDSE 132

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 37/136 (27%), Positives = 59/136 (43%), Gaps = 6/136 (4%)

Query: 255 LGRGGFGKVYKGRLADGKLVA---VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           +G G FGKV    +     VA   VK LK   +S  + +F  +     +  H N+L+  G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            C      LLV+ Y   G + S L + Q           +++A   A G++++H+H    
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119

Query: 372 IIHRDVKAANILLDED 387
            +H D+   N  L  D
Sbjct: 120 FLHSDLALRNCFLTSD 135

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 26/69 (37%), Positives = 36/69 (52%), Gaps = 1/69 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           S+  + L      G L P+    K LE L L+ N  SG +P  L +++ L  L LS N+L
Sbjct: 453 SLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511

Query: 128 SGPVPDNGS 136
           SG +PD  S
Sbjct: 512 SGEIPDELS 520

Length = 968

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 24/141 (17%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNL 306
           +G G +G VYK R     + +A+K+++ E+   G       E+    E++      H N+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ------HGNI 63

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYL 364
           +RL     +     LV+ Y+        L++   S P      R  K       RG++Y 
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 365 HEHCDPKIIHRDVKAANILLD 385
           H H   +++HRD+K  N+L+D
Sbjct: 119 HSH---RVLHRDLKPQNLLID 136

Length = 294

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 17/141 (12%)

Query: 254 ILGRGGFGKVY--KGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLY 310
            +G G FGK+Y  K + +D +   +K +   +    E +  + EV +++   H N++  +
Sbjct: 7   KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSL----PPLDWPTRKKIALGSARGLSYLHE 366
                     +V  Y   G +  R+  ++  L      L W    +I+LG    L ++H 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG----LKHIH- 118

Query: 367 HCDPKIIHRDVKAANILLDED 387
             D KI+HRD+K+ NI L ++
Sbjct: 119 --DRKILHRDIKSQNIFLSKN 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 12/135 (8%)

Query: 252 KNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           + ILG G  G VYK   L   +++AVK +  + T   + Q  +E++I+       ++  Y
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G         +   +M  GS+     +    +P        +IA+   +GL+YL      
Sbjct: 66  GAFFVENRISICTEFMDGGSL-----DVYRKIPE---HVLGRIAVAVVKGLTYL---WSL 114

Query: 371 KIIHRDVKAANILLD 385
           KI+HRDVK +N+L++
Sbjct: 115 KILHRDVKPSNMLVN 129

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 29/165 (17%)

Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERTSGGELQFQTE 294
           E+ ++T  F  +  LG   FGKVYKG L   A G   + VA+K LK++       +F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 295 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---------------Q 339
             + S   H N++ L G  T      +++ Y ++  +   L  R               +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 340 SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           S+L P D+     I    A G+ +L  H    ++H+D+   N+L+
Sbjct: 119 STLEPADF---VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 31/84 (36%), Positives = 41/84 (48%), Gaps = 2/84 (2%)

Query: 72  VDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 131
           +DLG   L G++   L  L +LE L L +N L G IP  L  + SL  + L  N LSG +
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228

Query: 132 PDN-GSFSQFTPISFENNLNLCGP 154
           P   G  +    +    N NL GP
Sbjct: 229 PYEIGGLTSLNHLDLVYN-NLTGP 251

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 38/116 (32%), Positives = 52/116 (44%), Gaps = 18/116 (15%)

Query: 45  LQSWDN-----LPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLN 99
           LQ W N     +P NL            ++T +DL    L+GE+   L    NL  L L 
Sbjct: 337 LQLWSNKFSGEIPKNL--------GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388

Query: 100 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN 155
           +NSL G IP SL    SL  + L +N  SG +P     S+FT +     L++   N
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP-----SEFTKLPLVYFLDISNNN 439

Length = 968

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 72  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 125

Query: 375 RDVKAANILL 384
           RD++AANIL+
Sbjct: 126 RDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 2e-05
 Identities = 20/61 (32%), Positives = 34/61 (55%), Gaps = 2/61 (3%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
           ++  +DL N  L+  +       L NL++L L+ N+L+ + P + + + SL  LDLS N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 127 L 127
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 45.6 bits (109), Expect = 2e-05
 Identities = 44/139 (31%), Positives = 61/139 (43%), Gaps = 16/139 (11%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYG 311
           LG G FG+V   R    GK  A+K L + +            E +I+    H  L+ LYG
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYLHEHC 368
                +   LV  Y+  G + S LR  +S   P     R    ++ L     L YLH   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-ARFYAAQVVLA----LEYLH-SL 120

Query: 369 DPKIIHRDVKAANILLDED 387
           D  I++RD+K  N+LLD D
Sbjct: 121 D--IVYRDLKPENLLLDSD 137

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 19/151 (12%)

Query: 253 NILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLR 308
           +++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------------RQSSLPPLDWPTRKKIALG 356
           L G C       L   Y  +G++   LR+              S+   L        A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGEN 148

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 8/98 (8%)

Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 344
            L G CT     L+V   +   G++++ LR ++    P
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 23/144 (15%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRN----L 306
           I+GRGGFG+VY  R AD GK+ A+K L ++R     GE     E  ++S+    +    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 307 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 362
              Y F T   +KL  +   M  G +   L +           +  ++   +A    GL 
Sbjct: 61  CMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVF-------SEAEMRFYAAEIILGLE 111

Query: 363 YLHEHCDPKIIHRDVKAANILLDE 386
           ++H      +++RD+K ANILLDE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDE 132

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 33/134 (24%), Positives = 58/134 (43%), Gaps = 12/134 (8%)

Query: 253 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           N +G G  G VYK      G+L A+K +          Q   E++I+    H N+++ + 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
                 E  ++  +M  GS+       +  L          +A     G++YLH      
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFL--------ADVARQILSGIAYLHRR---H 188

Query: 372 IIHRDVKAANILLD 385
           I+HRD+K +N+L++
Sbjct: 189 IVHRDIKPSNLLIN 202

Length = 353

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 19/123 (15%)

Query: 271 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 330
           GK VAVK++   +    EL F  EV I+    H N++ +Y       E  +V  ++  G+
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 331 VA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
           +      +R+ E Q +           + L   R LSYLH      +IHRD+K+ +ILL 
Sbjct: 106 LTDIVTHTRMNEEQIA----------TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 152

Query: 386 EDA 388
            D 
Sbjct: 153 SDG 155

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 9/135 (6%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G +G VYK R +  G+L A+K +K E      +  Q E+ ++    H N++  +G  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
               +  +   +   GS    L++      PL       ++  + +GL YLH       +
Sbjct: 76  LRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---M 128

Query: 374 HRDVKAANILLDEDA 388
           HRD+K ANILL ++ 
Sbjct: 129 HRDIKGANILLTDNG 143

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 48/139 (34%), Positives = 68/139 (48%), Gaps = 17/139 (12%)

Query: 254 ILGRGGFGKVY-KGRLADGKLVAVKRLKEE----RTSGGELQFQTEVKIISMAVHRNLLR 308
           ++G+G FGKV    R  DGK  AVK L+++    R     +  +  V ++    H  L+ 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 309 L-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           L Y F TT  EKL  V  ++  G +   L +R+ S P    P  +  A   A  L YLH 
Sbjct: 61  LHYSFQTT--EKLYFVLDFVNGGELFFHL-QRERSFPE---PRARFYAAEIASALGYLHS 114

Query: 367 HCDPKIIHRDVKAANILLD 385
                I++RD+K  NILLD
Sbjct: 115 ---INIVYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 16/147 (10%)

Query: 249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 305
           F    +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLPPLDWPTRKKIALGSAR---GL 361
           ++ L     T     LV   M  G +   +    ++           +    +A    GL
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE------EGRAVFYAAEICCGL 115

Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDA 388
             LH+    +I++RD+K  NILLD+  
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHG 139

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 12/147 (8%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVH 303
           T+ + +   +G G FG V   R    G+ VA+K++ K   T     +   E+K++    H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 304 RNLLRLYG-FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
            N++ L   F + + +   V   +  G+   RL   +    PL+    +       RGL 
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR----PLEKQFIQYFLYQILRGLK 122

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDAD 389
           Y+H      ++HRD+K +NIL++E+ D
Sbjct: 123 YVHS---AGVVHRDLKPSNILINENCD 146

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 11/138 (7%)

Query: 255 LGRG--GFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 310
           +GRG      VY  R    G LV V+    E  +   L+  Q EV +     H N++  +
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP-LDWPTRKKIALGSARGLSYLHEHCD 369
              TT +   ++ P+M  GS  S L+   +  P  +       I  G+ RGL+YLH++  
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLK---TYFPEGMSEALIGNILFGALRGLNYLHQN-- 120

Query: 370 PKIIHRDVKAANILLDED 387
              IHR++KA++IL+  D
Sbjct: 121 -GYIHRNIKASHILISGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)

Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86

Query: 314 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLKALSVLHAQ- 135

Query: 369 DPKIIHRDVKAANILLDEDAD----------QSSKTILRR 398
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 42/147 (28%), Positives = 61/147 (41%), Gaps = 22/147 (14%)

Query: 253 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-----------LQFQT--EVKII 298
             LG G +GKV K      GK+VA+K++K    S              + F T  E+KI+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 299 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           +   H N++ L           LV   M     AS L++       L     K I L   
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQIL 129

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLD 385
            GL+ LH+      +HRD+  ANI ++
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFIN 153

Length = 335

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 35/136 (25%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +GRG +G VYK +  DGK      LK+   +G  +    E+ ++    H N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 315 TVTEK--LLVYPYMTNG--SVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYLHEHC 368
           + +++   L++ Y  +    +    R  +++  P+  P    K +      G+ YLH + 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 369 DPKIIHRDVKAANILL 384
              ++HRD+K ANIL+
Sbjct: 129 ---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 37/152 (24%), Positives = 67/152 (44%), Gaps = 19/152 (12%)

Query: 252 KNILGRGGFGKVYKGRLA-DGKLV--AVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 307
           ++++G G FG+V +  +  DG  +  A+K LKE  +      F  E++++  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRE------------RQSSLPPLDWPTRKKIAL 355
            L G C       +   Y   G++   LR+               +   L      + A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             A G+ YL    + + IHRD+ A N+L+ E+
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGEN 155

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 35/140 (25%), Positives = 66/140 (47%), Gaps = 17/140 (12%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGF 312
           +G G F +V K +    GK  A+K +K+   S  ++    E++ +  ++ H N+LRL   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL--- 63

Query: 313 CTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
              + ++      LV+  M + ++   ++ R+  LP       K       + L ++H +
Sbjct: 64  IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK---RVKSYMYQLLKSLDHMHRN 119

Query: 368 CDPKIIHRDVKAANILLDED 387
               I HRD+K  NIL+ +D
Sbjct: 120 ---GIFHRDIKPENILIKDD 136

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 39/124 (31%), Positives = 54/124 (43%), Gaps = 20/124 (16%)

Query: 269 ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL---YGFCTTVTEKLLVYPY 325
              K V VK +   +T G E+     +K IS   HR ++ L   Y + +TV   +  Y  
Sbjct: 117 EQRKKVIVKAVTGGKTPGREIDI---LKTIS---HRAIINLIHAYRWKSTVCMVMPKYKC 170

Query: 326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
                V     +R   LP     T ++  L +   L+YLH      IIHRDVK  NI LD
Sbjct: 171 DLFTYV-----DRSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLD 219

Query: 386 EDAD 389
           E  +
Sbjct: 220 EPEN 223

Length = 392

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 23/144 (15%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRN----L 306
           I+GRGGFG+VY  R AD GK+ A+K L ++R     GE     E  ++S+    +    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 307 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 362
              Y F T   +KL  +   M  G +   L +           + K++   +     GL 
Sbjct: 61  CMTYAFHT--PDKLCFILDLMNGGDLHYHLSQHGVF-------SEKEMRFYATEIILGLE 111

Query: 363 YLHEHCDPKIIHRDVKAANILLDE 386
           ++H      +++RD+K ANILLDE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDE 132

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 14/146 (9%)

Query: 249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 305
           F    +LG+GGFG+V   ++ A GK+ A KRL+++R     GE     E +I+     + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 362
           ++ L     T     LV   M  G +   +    +  P  +    ++    +A    GL 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFE---EERALFYAAEILCGLE 116

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
            LH       ++RD+K  NILLD+  
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYG 139

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 43.6 bits (103), Expect = 8e-05
 Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 32/154 (20%)

Query: 255 LGRGGFGKVYKGRLADG--KLVAVKRL-----------KEERTSGGELQFQTEVKIISMA 301
           LG G FG VYK R  +    L+A+K +           +E   S G++   +EV II   
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIV--SEVTIIKEQ 65

Query: 302 V-HRNLLRLYGFCTTVTEKLLVYPYM------TNGSVASRLRERQSSLPPLD-WPTRKKI 353
           + H N++R Y    T  E   +Y  M        G   + L+E++        W    ++
Sbjct: 66  LRHPNIVRYY---KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            L     L YLH+  + +I+HRD+   NI+L ED
Sbjct: 123 VLA----LRYLHK--EKRIVHRDLTPNNIMLGED 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.6 bits (103), Expect = 8e-05
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 17/138 (12%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLY 310
           +G G +G VYKGR    G++VA+K+++ E  S  E    T ++ IS+     H N++ L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEH 367
                 +   L++ +++       L++   SLP    +D    K       +G+ + H  
Sbjct: 66  DVLMQESRLYLIFEFLS-----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 368 CDPKIIHRDVKAANILLD 385
              +++HRD+K  N+L+D
Sbjct: 121 ---RVLHRDLKPQNLLID 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 30/151 (19%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-------ISMAV----- 302
           LGRG   ++Y G L        K   E+     E + +  +K+       IS+A      
Sbjct: 3   LGRGTRTQIYAGILNY------KDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETAS 56

Query: 303 ------HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 356
                 H++++ LYG C    E ++V  ++  G +   +  R+S    L  P + K+A  
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSD--VLTTPWKFKVAKQ 113

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            A  LSYL    D  ++H +V   NILL  +
Sbjct: 114 LASALSYLE---DKDLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 21/143 (14%)

Query: 254 ILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ------FQTEVKIISMAV-HRN 305
           +LG+G FGKV         ++ A+K LK++      LQ        TE +I+++A  H  
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI----LQDDDVDCTMTEKRILALAAKHPF 57

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYL 364
           L  L+    T      V  Y+  G +  ++ R R+      D P  +  A      L +L
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFL 112

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H H    +I+RD+K  NILLD +
Sbjct: 113 HRH---GVIYRDLKLDNILLDAE 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 8/141 (5%)

Query: 245 ATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 303
           A   + N   LG G +  VYKG    +G+LVA+K +  +   G       E  ++    H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            N++ L+    T      V+ YM +  +A  + +    L P +    +       RGL+Y
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN---VRLFMFQLLRGLAY 118

Query: 364 LHEHCDPKIIHRDVKAANILL 384
           +H      I+HRD+K  N+L+
Sbjct: 119 IHGQ---HILHRDLKPQNLLI 136

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 11/139 (7%)

Query: 254 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLY 310
           ++GRG + KV   RL  + ++ A+K +K+E     E     QTE  +   A     L   
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 311 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
             C   T +L LV  Y+  G +   + +RQ  LP       +  A      L++LHE   
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPE---EHARFYAAEICIALNFLHER-- 115

Query: 370 PKIIHRDVKAANILLDEDA 388
             II+RD+K  N+LLD D 
Sbjct: 116 -GIIYRDLKLDNVLLDADG 133

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 45/140 (32%), Positives = 67/140 (47%), Gaps = 15/140 (10%)

Query: 254 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQT--EVKIISMA-VHRNLLRL 309
           +LG+G FGKV+   L    +  A+K LK++     +    T  E +++S+A  H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 310 YGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           Y  CT  T++ L  V  Y+  G +   ++    S    D P     A     GL +LH  
Sbjct: 62  Y--CTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 368 CDPKIIHRDVKAANILLDED 387
               I++RD+K  NILLD D
Sbjct: 116 ---GIVYRDLKLDNILLDTD 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 16/140 (11%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRL- 309
           +LG+G FGKV   R  A GK  A+K LK+E     +      TE +++    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 310 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           Y F T   ++L  V  Y   G +   L RER  S     +   + ++      L YLH  
Sbjct: 62  YSFQTH--DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALGYLHS- 113

Query: 368 CDPKIIHRDVKAANILLDED 387
           CD  +++RD+K  N++LD+D
Sbjct: 114 CD--VVYRDLKLENLMLDKD 131

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 17/140 (12%)

Query: 255 LGRGGFGK--VYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYG 311
           +G G FGK  + K +  DGK   +K +   + S  E +  + EV ++S   H N+++   
Sbjct: 8   IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARGLSYLHEH 367
                    +V  Y   G +  ++  ++  L P    LDW  +  +AL         H H
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--------HVH 118

Query: 368 CDPKIIHRDVKAANILLDED 387
            D KI+HRD+K+ NI L +D
Sbjct: 119 -DRKILHRDIKSQNIFLTKD 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG-FC 313
           +GRG +G VYK +  DGK      LK+   +G  +    E+ ++    H N++ L   F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 314 TTVTEKL-LVYPYMTNG--SVASRLRERQSSLPPLDWP--TRKKIALGSARGLSYLHEHC 368
           +    K+ L++ Y  +    +    R  +++  P+  P    K +      G+ YLH + 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 369 DPKIIHRDVKAANILL 384
              ++HRD+K ANIL+
Sbjct: 129 ---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 22/54 (40%), Positives = 33/54 (61%)

Query: 79  LSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           LSG + P +  L+ L  L L++NSLSG IP  +  + +L IL L +N  +G +P
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325

Length = 968

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 10/136 (7%)

Query: 255 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF- 312
           +G+G +GKV+K     +G   AVK L        E++ +  + + +++ H N+++ YG  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHPNVVKFYGMY 84

Query: 313 ----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
                    +  LV      GSV   ++        ++ P    I   +  GL +LH + 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143

Query: 369 DPKIIHRDVKAANILL 384
             K IHRDVK  NILL
Sbjct: 144 --KTIHRDVKGNNILL 157

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 12/101 (11%)

Query: 254 ILGRGGFGKV--------YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHR 304
           +LG G FGKV         K    +   VAVK LKE  T+       +E+KI I +  H 
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCN--TVAVKMLKEGATASEHKALMSELKILIHIGNHL 71

Query: 305 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 344
           N++ L G CT     L+V   +   G++++ LR ++    P
Sbjct: 72  NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 48/144 (33%), Positives = 66/144 (45%), Gaps = 24/144 (16%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 311
           LG+G  G+V+  RL   GKL A+K L K+E     ++ +  TE +I++   H  L  LY 
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 363
              T T   LV  Y   G +  RL +RQ           K ++   AR         L Y
Sbjct: 69  SFQTETYLCLVMDYCPGGEL-FRLLQRQP---------GKCLSEEVARFYAAEVLLALEY 118

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           LH      I++RD+K  NILL E 
Sbjct: 119 LHLL---GIVYRDLKPENILLHES 139

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 17/142 (11%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 309
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLSYLHE 366
           +    T +    V  Y+  G +   + +RQ  LP       +     SA     L+YLHE
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP------EEHARFYSAEISLALNYLHE 114

Query: 367 HCDPKIIHRDVKAANILLDEDA 388
                II+RD+K  N+LLD + 
Sbjct: 115 R---GIIYRDLKLDNVLLDSEG 133

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 17/32 (53%), Positives = 20/32 (62%), Gaps = 4/32 (12%)

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQ 390
            GL YLH     +IIHRDVK  NI ++ D DQ
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFIN-DVDQ 195

Length = 357

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 8/141 (5%)

Query: 249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 305
           F +  +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           ++ L     T     LV   M  G +   +    +  P  D       A     GL  L 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQ 119

Query: 366 EHCDPKIIHRDVKAANILLDE 386
                +I++RD+K  NILLD+
Sbjct: 120 RE---RIVYRDLKPENILLDD 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 41/136 (30%), Positives = 60/136 (44%), Gaps = 11/136 (8%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLY 310
           ++G+G FGKV   R  A+ K  AVK L+++       E    +E  ++   V    L   
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 311 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
            F     +KL  V  Y+  G +   L+  +  L P      +  A   A  L YLH    
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAEIASALGYLHSL-- 115

Query: 370 PKIIHRDVKAANILLD 385
             I++RD+K  NILLD
Sbjct: 116 -NIVYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 42/151 (27%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRL-------KEERTSGGELQFQTEVKIISMAVHRN 305
           ++G+G +G+V   R   DGK   +K+L       +E + +  E Q  +++K  ++  +R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 306 --------LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKI 353
                   L  + GFC               G +  +L+E++  L P    ++W  +  +
Sbjct: 67  SWEGEDGLLYIVMGFCE-------------GGDLYHKLKEQKGKLLPENQVVEWFVQIAM 113

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           AL       YLHE     I+HRD+K  N+ L
Sbjct: 114 AL------QYLHEK---HILHRDLKTQNVFL 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 7/96 (7%)

Query: 254 ILGRGGFGKV-----YKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 306
            LG G FGKV     Y    +D  + VAVK LK            +E+K++S +  H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI 101

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 342
           + L G CT     L++  Y   G + + LR ++ S 
Sbjct: 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 48/140 (34%), Positives = 66/140 (47%), Gaps = 19/140 (13%)

Query: 254 ILGRGGFGKVY-KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAV-HRNLLRL 309
           ++G+G FGKV    R +DG   AVK L+++     + Q     E  ++   + H  L+ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 310 -YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKI-ALGSARGLSYLH 365
            Y F T   EKL  V  Y+  G +   L RER    P      R +  A   A  + YLH
Sbjct: 62  HYSFQTA--EKLYFVLDYVNGGELFFHLQRERCFLEP------RARFYAAEVASAIGYLH 113

Query: 366 EHCDPKIIHRDVKAANILLD 385
                 II+RD+K  NILLD
Sbjct: 114 SL---NIIYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 26/81 (32%), Positives = 38/81 (46%), Gaps = 2/81 (2%)

Query: 69  VTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           V  +D+ N  L G +      + +L++L L  N   G +P S  +   L  LDLS N+ S
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFS 488

Query: 129 GPVPDN-GSFSQFTPISFENN 148
           G VP   GS S+   +    N
Sbjct: 489 GAVPRKLGSLSELMQLKLSEN 509

Length = 968

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 15/136 (11%)

Query: 257 RGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK-----IISMAVHRNLLRLY 310
           +G FG VY  +  + G   A+K LK  ++        T VK     ++       + +LY
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLK--KSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
               +     LV  Y+  G  AS L +    LP  DW   K+       G+  LH     
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLP-EDWA--KQYIAEVVLGVEDLH---QR 116

Query: 371 KIIHRDVKAANILLDE 386
            IIHRD+K  N+L+D+
Sbjct: 117 GIIHRDIKPENLLIDQ 132

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 254 ILGRGGFGKVYK------GRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 306
            LG G FGKV +      G+  +   VAVK LK    +       +E+KI+S +  H+N+
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 339
           + L G CT     L++  Y   G + + LR++ 
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 17/141 (12%)

Query: 254 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 309
           ++GRG + KV    L    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYLHE 366
           +    T +    V  +++ G +   + +RQ  LP  +   R    +I+L     L++LHE
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHM-QRQRKLP--EEHARFYSAEISLA----LNFLHE 114

Query: 367 HCDPKIIHRDVKAANILLDED 387
                II+RD+K  N+LLD +
Sbjct: 115 R---GIIYRDLKLDNVLLDAE 132

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 40.4 bits (94), Expect = 8e-04
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 10/141 (7%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAVHRN 305
           F  +  +GRG F +VY+   L DG  VA+K+++  +   +        E+ ++    H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR--ERQSSLPPLDWPTRKKIALGSARGLSY 363
           +++ Y       E  +V      G ++  ++  ++Q  L P     +  + L SA  L +
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEH 121

Query: 364 LHEHCDPKIIHRDVKAANILL 384
           +H     +++HRD+K AN+ +
Sbjct: 122 MHSR---RVMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 12/143 (8%)

Query: 249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRN 305
           F +  +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI--ALGSARGLSY 363
           ++ L     T     LV   M  G     L+    ++    +   + +  A     GL  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGD----LKFHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 364 LHEHCDPKIIHRDVKAANILLDE 386
           LH     +I++RD+K  NILLD+
Sbjct: 118 LHRE---RIVYRDLKPENILLDD 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 18/38 (47%), Positives = 26/38 (68%), Gaps = 2/38 (5%)

Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           KI++   RGL+YL E    KI+HRDVK +NIL++   +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGE 138

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 22/142 (15%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 310
           LG+GGFG+V   ++ + GK+ A K+L ++R     GE     E +I+       ++ L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSAR---GLSYL 364
            F  + T   LV   M  G +   +    ER   +        +++   SA+   G+ +L
Sbjct: 61  AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM--------ERVIHYSAQITCGILHL 111

Query: 365 HEHCDPKIIHRDVKAANILLDE 386
           H      I++RD+K  N+LLD+
Sbjct: 112 HSM---DIVYRDMKPENVLLDD 130

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 7/103 (6%)

Query: 247 DGFSNKNILGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS- 299
           DG     ILG G FGKV +G      R      VAVK LK    S  +    +E+KI++ 
Sbjct: 37  DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTH 96

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 342
           +  H N++ L G CT      ++  Y   G + + L + + + 
Sbjct: 97  LGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 26/144 (18%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKE-ERTSGGEL------QFQTEVKIISMAVHRNLL 307
           LG+G FG VY   + D K VA +RLK  +    GEL      Q   E +++S   H  ++
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 308 RLYG-------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
           + +        FC  +TE      Y     +  +L E + +   L      +  +    G
Sbjct: 66  KFHASFLERDAFCI-ITE------YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           + Y+H+    +I+HRD+KA NI L
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFL 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 40.1 bits (93), Expect = 0.001
 Identities = 43/139 (30%), Positives = 63/139 (45%), Gaps = 12/139 (8%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRLY 310
           +LG+G FGKV   R  A GK  A+K LK+E     +      TE +++    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
               T      V  Y+  G +   L RER  S     +   + ++      L YLH    
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-----ALDYLHSG-- 114

Query: 370 PKIIHRDVKAANILLDEDA 388
            KI++RD+K  N++LD+D 
Sbjct: 115 -KIVYRDLKLENLMLDKDG 132

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 35.6 bits (83), Expect = 0.002
 Identities = 14/37 (37%), Positives = 23/37 (62%)

Query: 92  NLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           NL+ L L+NN L+ +   +   + +L +LDLS N L+
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT 37

Length = 60

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 46/155 (29%), Positives = 66/155 (42%), Gaps = 19/155 (12%)

Query: 238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL-KEERTSGGELQFQTEV 295
            + +L++  + F    ++GRG FG+V   R    K V A+K L K E     +  F  E 
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 296 KIISMAVHRN---LLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTR 350
           + I MA H N   +++L        +K L  V  YM  G + + +        P  W  R
Sbjct: 94  RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI---PEKW-AR 145

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
              A      L  +H       IHRDVK  N+LLD
Sbjct: 146 FYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLD 176

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 35/152 (23%)

Query: 254 ILGRGGFGKVY----KGRLADGKLVAVKRLKE----ERTSGGELQFQTEVKIISMAVHRN 305
           +LG G +GKV+     G    GKL A+K LK+    ++    E   +TE +++  AV R 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE-HTRTERQVLE-AVRRC 64

Query: 306 --LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---- 359
             L+ L+    T T+  L+  Y+  G + + L +R+                   R    
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE------------HFTESEVRVYIA 112

Query: 360 ----GLSYLHEHCDPKIIHRDVKAANILLDED 387
                L +LH+     II+RD+K  NILLD +
Sbjct: 113 EIVLALDHLHQL---GIIYRDIKLENILLDSE 141

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 24/151 (15%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVH 303
           D F    ++GRG FG+V+  R    G++ A+K L++            + E  I++ A  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 304 RNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKI-----ALG 356
             +++LY   +   E+ L  V  YM  G + + L  R+   P  +   R  I     AL 
Sbjct: 61  PWIVKLY--YSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPE-ET-ARFYIAELVLALD 115

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           S   L +         IHRD+K  NIL+D D
Sbjct: 116 SVHKLGF---------IHRDIKPDNILIDAD 137

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 28/131 (21%), Positives = 61/131 (46%), Gaps = 13/131 (9%)

Query: 263 VYKGRLADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFCTTVTEKL 320
           +YKG   + K V ++  K+       L    + E+K +      N+L++YGF   + + L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 321 ----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 376
               L+  Y T G +   L + +     L + T+  +A+   +GL  L+++      +++
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN 148

Query: 377 VKAANILLDED 387
           + + + L+ E+
Sbjct: 149 LTSVSFLVTEN 159

Length = 283

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.5 bits (83), Expect = 0.002
 Identities = 15/38 (39%), Positives = 24/38 (63%), Gaps = 2/38 (5%)

Query: 91  KNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
            NLE L L+NN ++ L    L+ + +L  LDLS N+++
Sbjct: 1   TNLETLDLSNNQITDL--PPLSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)

Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKE-ERTSGGELQFQTEVKIISMA 301
           ++  D F   + LG G  G V K +     L+  ++L   E       Q   E++++   
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
               ++  YG   +  E  +   +M  GS+   L+E +  +P        K+++   RGL
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPE---EILGKVSIAVLRGL 116

Query: 362 SYLHEHCDPKIIHRDVKAANILLD 385
           +YL E    +I+HRDVK +NIL++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVN 138

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 30/154 (19%)

Query: 255 LGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQ---------------- 290
           LG+G    +Y GRL         + ++     L E   +G EL+                
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 291 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 350
           F     ++S   H +L  ++G C   +E ++V  ++ +G +   LR+ +  + P+ W   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAWKIT 121

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
               L SA  LSYL    D  ++H +V A NILL
Sbjct: 122 VAQQLASA--LSYLE---DKNLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 38/140 (27%), Positives = 60/140 (42%), Gaps = 20/140 (14%)

Query: 255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G  G V   R    G+ VAVK +   +    EL F  EV I+    H+N++ +Y   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87

Query: 314 TTVTEKLLVYPYMTNGSVAS-----RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
               E  ++  ++  G++       RL E Q +           +     + L YLH   
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA----------TVCESVLQALCYLHSQ- 136

Query: 369 DPKIIHRDVKAANILLDEDA 388
              +IHRD+K+ +ILL  D 
Sbjct: 137 --GVIHRDIKSDSILLTLDG 154

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 42/152 (27%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVK--------RLKEERTSGGELQFQTEVKIISMAVHRN 305
           +G G FG+V+  R        A+K        RLK+E+          E +++    H  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRVLKEVSHPF 62

Query: 306 LLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---- 359
           ++RL+   T   ++ L  +  Y+  G + S LR               + +  +      
Sbjct: 63  IIRLF--WTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYAS 108

Query: 360 ----GLSYLHEHCDPKIIHRDVKAANILLDED 387
                L YLH     +I++RD+K  NILLD++
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKE 137

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 10/98 (10%)

Query: 293 TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP-YMTNGSVASRLRERQSSLPPLDWPTRK 351
           TE  I+    H ++++L G  T      L+ P Y T+  +   L  +++ +   D    +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRN-IAICDILAIE 188

Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           +  L   R + YLHE+   +IIHRD+KA NI ++   D
Sbjct: 189 RSVL---RAIQYLHEN---RIIHRDIKAENIFINHPGD 220

Length = 391

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 31/148 (20%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT--EVKIISMAV-HRNLLRL 309
           +LG+G FGKV    L    +  A+K LK++     +    T  E +++++A  H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 310 YGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR-------- 359
             FCT  T++ L  V  Y+  G +   ++               +     AR        
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQSS------------GRFDEARARFYAAEIIC 107

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDED 387
           GL +LH+     II+RD+K  N+LLD+D
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKD 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 38.8 bits (91), Expect = 0.003
 Identities = 14/30 (46%), Positives = 21/30 (70%), Gaps = 3/30 (10%)

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
           RGL Y+H      +IHRD+K +N+L++ED 
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDC 144

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 15/140 (10%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQFQT-EVKIISMAVHRNLLRLYG 311
           +G+G FG+VY+ R  D  ++ A+K L K+E  +  E+     E  I+   +      + G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 312 F---CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEH 367
                 T ++  LV  YM+ G +   L +++          R K  +      L +LH++
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFSE----DRAKFYIAELVLALEHLHKY 115

Query: 368 CDPKIIHRDVKAANILLDED 387
               I++RD+K  NILLD  
Sbjct: 116 ---DIVYRDLKPENILLDAT 132

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	399
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.96
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.96
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.95
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.95
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.95
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.94
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.94
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.94
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.94
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.94
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.94
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.94
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.93
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.93
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.93
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.93
KOG0198	313	consensus MEKK and related serine/threonine protei	99.93
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.93
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.93
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.93
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.93
KOG0605	550	consensus NDR and related serine/threonine kinases	99.93
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.93
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.93
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.92
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.92
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.92
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.92
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.92
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.92
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.92
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.92
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.92
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.92
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.92
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.92
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.92
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.92
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.92
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.92
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.92
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.91
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.91
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.91
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.91
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.91
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.91
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.91
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.91
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.91
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.91
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.91
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.91
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.91
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.91
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.91
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.91
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.91
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.91
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.91
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.91
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.91
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.91
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.91
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.91
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.91
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.91
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.91
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.9
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.9
KOG0578	550	consensus p21-activated serine/threonine protein k	99.9
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.9
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.9
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.9
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.9
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.9
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.9
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.9
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.9
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.9
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.9
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.9
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.9
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.9
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.9
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.9
PHA02988	283	hypothetical protein; Provisional	99.9
KOG0610	459	consensus Putative serine/threonine protein kinase	99.9
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.9
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.9
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.9
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.9
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.9
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.9
PTZ00267	478	NIMA-related protein kinase; Provisional	99.9
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.9
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.9
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.9
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.9
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.9
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.9
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.9
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.9
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.9
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.9
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.9
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.9
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.9
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.9
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.9
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.9
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.9
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.9
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.89
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.89
PHA03212	391	serine/threonine kinase US3; Provisional	99.89
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.89
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.89
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.89
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.89
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.89
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.89
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.89
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.89
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.89
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.89
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.89
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.89
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.89
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.89
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.89
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.89
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.89
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.89
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.89
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.89
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.89
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.89
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.89
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.89
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.89
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.89
PTZ00283	496	serine/threonine protein kinase; Provisional	99.89
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.89
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.89
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.89
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.89
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.89
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.89
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.89
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.89
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.89
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.89
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.89
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.89
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.89
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.89
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.89
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.89
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.89
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.89
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.89
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.89
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.89
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.89
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.89
KOG0586	596	consensus Serine/threonine protein kinase [General	99.89
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.89
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.89
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.88
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.88
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.88
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.88
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.88
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.88
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.88
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.88
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.88
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.88
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.88
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.88
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.88
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.88
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.88
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.88
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.88
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.88
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.88
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.88
PHA03211	461	serine/threonine kinase US3; Provisional	99.88
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.88
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.88
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.88
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.88
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.88
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.88
PHA03209	357	serine/threonine kinase US3; Provisional	99.88
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.88
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.88
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.88
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.88
PTZ00036	440	glycogen synthase kinase; Provisional	99.88
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.88
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.88
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.88
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.88
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.88
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.88
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.88
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.88
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.88
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.88
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.88
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.88
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.87
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.87
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.87
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.87
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.87
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.87
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.87
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.87
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.87
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.87
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.87
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.87
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.87
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.87
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.87
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.87
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.87
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.87
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.87
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.87
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.87
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.87
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.87
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.87
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.87
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.87
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.87
KOG0589	426	consensus Serine/threonine protein kinase [General	99.87
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.87
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.87
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.87
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.87
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.87
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.87
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.87
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.87
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.87
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.87
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.87
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.87
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.86
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.86
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.86
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.86
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.86
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.86
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.86
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.86
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.86
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.86
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.86
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.86
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.86
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.86
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.86
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.86
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.86
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.86
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.86
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.86
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.86
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.86
PHA03207	392	serine/threonine kinase US3; Provisional	99.86
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.86
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.86
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.86
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.86
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.86
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.86
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.86
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.86
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.85
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.85
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.85
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.85
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.85
KOG0584	632	consensus Serine/threonine protein kinase [General	99.85
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.85
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.85
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.85
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.85
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.85
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.85
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.85
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.85
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.85
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.85
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.85
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.85
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.85
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.85
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.85
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.85
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.85
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.85
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.84
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.84
PLN00009	294	cyclin-dependent kinase A; Provisional	99.84
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.84
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.84
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.84
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.84
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.84
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.84
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.84
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.84
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.84
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.84
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.84
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.84
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.83
PHA03210	501	serine/threonine kinase US3; Provisional	99.83
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.83
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.83
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.83
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.83
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.83
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.83
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.83
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.83
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.83
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.83
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.83
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.83
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.82
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.82
PTZ00284	467	protein kinase; Provisional	99.82
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.82
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.82
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.82
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.82
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.82
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.82
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.82
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.82
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.81
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.81
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.8
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.8
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.8
PHA02882	294	putative serine/threonine kinase; Provisional	99.79
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.79
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.78
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.78
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.78
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.78
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.78
KOG1152	772	consensus Signal transduction serine/threonine kin	99.77
PLN03150	623	hypothetical protein; Provisional	99.77
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.77
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.77
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.75
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.74
smart00090	237	RIO RIO-like kinase.	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.72
PRK12274	218	serine/threonine protein kinase; Provisional	99.72
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.72
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.71
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.71
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.71
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.7
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.69
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.67
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.66
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.63
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.61
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.61
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.57
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.49
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.47
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.46
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.43
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.32
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
PLN00181	793	protein SPA1-RELATED; Provisional	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.19
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.18
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.09
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.08
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.02
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.01
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	99.01
PLN03150	623	hypothetical protein; Provisional	98.89
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.85
KOG3087	229	consensus Serine/threonine protein kinase [General	98.82
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.72
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.61
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.6
KOG1243	690	consensus Protein kinase [General function predict	98.56
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.53
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.52
PRK09902	216	hypothetical protein; Provisional	98.49
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.43
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.37
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.29
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.25
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.2
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.14
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.09
PLN02876	822	acyl-CoA dehydrogenase	98.04
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.01
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.95
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.94
PRK10593	297	hypothetical protein; Provisional	97.91
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	97.88
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.87
PF01636	239	APH: Phosphotransferase enzyme family This family	97.86
KOG0617	264	consensus Ras suppressor protein (contains leucine	97.83
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.83
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.81
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.64
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	97.57
KOG0472	565	consensus Leucine-rich repeat protein [Function un	97.48
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.46
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.44
KOG0617	264	consensus Ras suppressor protein (contains leucine	97.41
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.36
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.31
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.3
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	97.22
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	97.21
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.21
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.2
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.18
KOG0472	565	consensus Leucine-rich repeat protein [Function un	97.0
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.97
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	96.96
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	96.89
PRK05231	319	homoserine kinase; Provisional	96.64
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.61
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	96.59
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	96.45
KOG0606	1205	consensus Microtubule-associated serine/threonine	96.45
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.42
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	96.39
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.28
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	96.2
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	96.18
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.13
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	96.0

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.2e-39  Score=349.76  Aligned_cols=294  Identities=28%  Similarity=0.551  Sum_probs=203.3

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+|++|.++|.+|..+.++++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|..+.+..+...++.|
T Consensus       524 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~  603 (968)
T PLN00113        524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAG  603 (968)
T ss_pred             CCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcC
Confidence            45667777777777777777777777777777777777777777777777777778777888888777777777888888


Q ss_pred             ccccCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCcceeeeeeehhHHHHhhHhhhheeeeeccCCCccccCCCCC
Q 015852          148 NLNLCGPNTKK---PCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAE  224 (399)
Q Consensus       148 n~~lcg~~~~~---~c~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~v~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~  224 (399)
                      |+.+||.....   +|..                .......++++++++++++++++++++++++++++..+.. ..+.+
T Consensus       604 n~~lc~~~~~~~~~~c~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  666 (968)
T PLN00113        604 NIDLCGGDTTSGLPPCKR----------------VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELK-RVENE  666 (968)
T ss_pred             CccccCCccccCCCCCcc----------------ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccc-ccccc
Confidence            88888753211   1110                0111122233333333333333333333333333221110 00100


Q ss_pred             Cc-hhhhh---cccccccHHHHHHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHh
Q 015852          225 DD-SELQL---GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIIS  299 (399)
Q Consensus       225 ~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~  299 (399)
                      .. .+...   .....++++++   ...+...++||+|+||.||+|+. .++..||||+++....     ...+|++.++
T Consensus       667 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~  738 (968)
T PLN00113        667 DGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMG  738 (968)
T ss_pred             cccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHh
Confidence            00 00000   00111233332   34577789999999999999986 5789999999854321     1235688899


Q ss_pred             cCCCCCccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 015852          300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKA  379 (399)
Q Consensus       300 ~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~  379 (399)
                      +++|||||+++|+|.+.+..++||||+++|+|.++++.       ++|.++.+|+.|+|+||+|||+.+.++|+||||||
T Consensus       739 ~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp  811 (968)
T PLN00113        739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP  811 (968)
T ss_pred             hCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence            99999999999999999999999999999999999952       78999999999999999999988788999999999


Q ss_pred             CceeeCCCCceeec
Q 015852          380 ANILLDEDADQSSK  393 (399)
Q Consensus       380 ~NILld~~~~~~i~  393 (399)
                      +||++|.++++++.
T Consensus       812 ~Nil~~~~~~~~~~  825 (968)
T PLN00113        812 EKIIIDGKDEPHLR  825 (968)
T ss_pred             HhEEECCCCceEEE
Confidence            99999999988764

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-39  Score=308.05  Aligned_cols=161  Identities=53%  Similarity=0.907  Sum_probs=148.4

Q ss_pred             ccccccHHHHHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeee
Q 015852          233 QLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF  312 (399)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~  312 (399)
                      ....|+++++..+|++|+..++||+|+||.||+|.+.++..||||++....... ..+|.+|++++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456799999999999999999999999999999999999999999886554332 5579999999999999999999999


Q ss_pred             eecCCc-eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          313 CTTVTE-KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       313 ~~~~~~-~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      |.+.+. .+||||||++|+|.++|+.....  +++|.+|++||.++|+||+|||+.+.|+||||||||+|||||+++++|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            999984 99999999999999999976543  689999999999999999999999999999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       218 lsDFG  222 (361)
T KOG1187|consen  218 LSDFG  222 (361)
T ss_pred             ccCcc
Confidence            99993

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=8.9e-31  Score=243.19  Aligned_cols=144  Identities=29%  Similarity=0.413  Sum_probs=127.3

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||+||+|+++ ++..||||.+.... .....+.+..|+++++.++|||||++++++..++..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            356777788999999999999975 67899999996553 2333446889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC------Cceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED------ADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~------~~~~i~df~  396 (399)
                      |||.+|||..+++.++    .+++.....+..|+|.||++||++   +||||||||+||||+..      -..||+||+
T Consensus        89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            9999999999999875    388999999999999999999999   99999999999999976      346999993

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.96  E-value=6.1e-30  Score=245.22  Aligned_cols=142  Identities=35%  Similarity=0.569  Sum_probs=124.6

Q ss_pred             CCCceeeccCCceEEEEEeCCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCC-ceEEEEecCC
Q 015852          250 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVYPYMT  327 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~  327 (399)
                      ...+.||+|+||+||+|.++....||||++....... ...+|.+|+.+|.+++|||||+++|+|..+. ...+|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3345699999999999999766569999996543222 2458999999999999999999999999887 7899999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCceeeCCCC-ceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-IIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      +|+|.++++..  ....++|..++.+|.|||+||.|||++   + ||||||||+|||++.++ .+||+||+
T Consensus       124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence            99999999874  223599999999999999999999998   6 99999999999999998 99999994

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-29  Score=230.04  Aligned_cols=141  Identities=31%  Similarity=0.439  Sum_probs=126.5

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC-ceEEEEecC
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~  326 (399)
                      ++..+.||+|..|+||+++++ +++.+|+|++.........+++.+|+++++..+||+||+++|.|.... +..++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            334578999999999999975 688999999966555555668999999999999999999999999988 599999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+|+|+.++...+    .+++...-+|+.+|.+||.|||+ +   +||||||||+|||++..|++||+||+
T Consensus       161 DgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  161 DGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             CCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecccc
Confidence            9999999997642    37888999999999999999996 5   89999999999999999999999995

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=242.94  Aligned_cols=140  Identities=35%  Similarity=0.531  Sum_probs=126.6

Q ss_pred             CCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +...+.||+|.||.||.|.+.....||+|.++...  .....|.+|+.+|++++|+|||+++|+|...+.++||||||+.
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            33457799999999999999888899999997652  3345799999999999999999999999998899999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      |+|.++|+...+  ..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+||
T Consensus       286 GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDF  347 (468)
T KOG0197|consen  286 GSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDF  347 (468)
T ss_pred             CcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccc
Confidence            999999997332  3478899999999999999999999   9999999999999999999999999

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.96  E-value=5.8e-29  Score=250.06  Aligned_cols=153  Identities=32%  Similarity=0.534  Sum_probs=133.8

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV  316 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~  316 (399)
                      ...+.+....+.||+|+||+||+|+..      +...||||.++.....+..++|++|++++..++|||||+|+|.|...
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            334455566788999999999999742      34689999998877666777999999999999999999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCC----------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSS----------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  386 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~  386 (399)
                      +..+||+|||..|||.++|+.+...          .++++..+.+.||.|||.||+||.++   .+|||||..+|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            9999999999999999999864321          23488899999999999999999999   9999999999999999


Q ss_pred             CCceeeccc-ccc
Q 015852          387 DADQSSKTI-LRR  398 (399)
Q Consensus       387 ~~~~~i~df-~~~  398 (399)
                      +..+||+|| +.|
T Consensus       639 ~l~VKIsDfGLsR  651 (774)
T KOG1026|consen  639 NLVVKISDFGLSR  651 (774)
T ss_pred             ceEEEecccccch
Confidence            999999999 444

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.9e-28  Score=236.70  Aligned_cols=143  Identities=28%  Similarity=0.483  Sum_probs=129.9

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ..|...++||+|+|+.||+++. .+|+.||+|++....  .........+||++.+.++|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            3577889999999999999996 789999999996533  2333457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|++|+|.++++.++    +++++++..+..||+.||.|||++   +|||||||-.|++|++++++||+||+
T Consensus        98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence            9999999999998543    599999999999999999999999   99999999999999999999999994

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.2e-28  Score=225.30  Aligned_cols=143  Identities=27%  Similarity=0.407  Sum_probs=124.2

Q ss_pred             cCCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccc------cHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSG------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      +.|...+.||+|+||.|-+|. ..+|+.||||+++......      ......+|+++|++++|||||++++++..++..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            446667899999999999996 4689999999996544322      122357999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC---Cceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~---~~~~i~df~  396 (399)
                      |||||||++|+|.+.+-..+    .+.......++.|+..|+.|||++   +|+||||||+|||+..+   .-.||+||+
T Consensus       252 YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             EEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence            99999999999999997654    366777899999999999999999   99999999999999877   568999995

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=5.9e-28  Score=227.74  Aligned_cols=139  Identities=35%  Similarity=0.524  Sum_probs=120.2

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHh--cCCCCCccceeeeeecCC----ceEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS--MAVHRNLLRLYGFCTTVT----EKLL  321 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~l  321 (399)
                      .....++||+|+||.||||.+. ++.||||++...    ....|..|-.+.+  .++|+||++++++-....    +.+|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            3444578999999999999985 489999999532    3446877777765  568999999999877665    7899


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcC------CCCCceecCCCCCceeeCCCCceeeccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH------CDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      |+||.+.|+|.++|..+     ..+|....+|+.-+++||+|||+.      ..|+|+|||||++|||+..|++..|+||
T Consensus       286 Vt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            99999999999999875     379999999999999999999985      4678999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       361 G  361 (534)
T KOG3653|consen  361 G  361 (534)
T ss_pred             c
Confidence            3

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=242.70  Aligned_cols=145  Identities=31%  Similarity=0.469  Sum_probs=133.5

Q ss_pred             CCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ...+.++||.|.||+||+|+++    ....||||.+|.....+.+.+|+.|+.+|++++||||++|.|+.......++|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3566799999999999999875    245899999999888888889999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc-ccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI-LRR  398 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df-~~~  398 (399)
                      |||+||+|+.+|+++.+   .+++.+...+.++||.||.||.++   +.|||||.++|||++.+...||+|| +-|
T Consensus       710 EyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             hhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccccee
Confidence            99999999999998764   488999999999999999999999   9999999999999999999999999 444

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=7.1e-28  Score=228.90  Aligned_cols=141  Identities=29%  Similarity=0.500  Sum_probs=123.1

Q ss_pred             CCCCCceeeccCCceEEEEE-eCCCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecC--CceEEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  323 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~  323 (399)
                      .|+..+.||+|.||.||+|+ ..+|+.||+|+++-+..... .....+||.+|++++||||++|.+...+.  ...|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            35556789999999999998 56899999999976653333 33568999999999999999999998876  6899999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      |||+. ||.-++....   ..++..++..++.|++.||+|+|+.   +|+|||||.+|||||.+|..||+||
T Consensus       198 eYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDF  262 (560)
T KOG0600|consen  198 EYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADF  262 (560)
T ss_pred             ecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccc
Confidence            99986 8888876532   2488999999999999999999999   9999999999999999999999999

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-28  Score=236.10  Aligned_cols=152  Identities=28%  Similarity=0.448  Sum_probs=132.6

Q ss_pred             HHHHHHHhcCCCCCceeeccCCceEEEEEeCC--C--CE-EEEEEcccc--cccccHHHHHHHHHHHhcCCCCCccceee
Q 015852          239 LRELQVATDGFSNKNILGRGGFGKVYKGRLAD--G--KL-VAVKRLKEE--RTSGGELQFQTEVKIISMAVHRNLLRLYG  311 (399)
Q Consensus       239 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~--~~-vAvK~l~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g  311 (399)
                      .+.++...++....+.||+|+||.||+|++..  +  .. ||||..+..  .......+|++|+++|+.++|||||+++|
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            34556667777777999999999999998642  2  23 899998752  22334558999999999999999999999


Q ss_pred             eeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       312 ~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      ++......++|||+|.||+|.++|++...   .++..++..++.++|+||+|||++   ++|||||.++|||++.+..+|
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence            99999999999999999999999998653   488999999999999999999999   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       303 ISDFG  307 (474)
T KOG0194|consen  303 ISDFG  307 (474)
T ss_pred             eCccc
Confidence            99993

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=219.54  Aligned_cols=146  Identities=29%  Similarity=0.401  Sum_probs=130.1

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ..++|+..++||+|+||+||.++. ++++.+|+|++++.....  +......|..++..++||.||++.-.+++.+..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            346789999999999999999975 568999999997654322  24468899999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc-cc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI-LR  397 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df-~~  397 (399)
                      |+||+.||.|..+|.+.+    .+++..+..++.+|+.||.|||+.   +||||||||+|||||++|.++++|| ++
T Consensus       103 Vld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~  172 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLC  172 (357)
T ss_pred             EEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccc
Confidence            999999999999998643    388888999999999999999999   9999999999999999999999999 44

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.94  E-value=4.8e-27  Score=207.06  Aligned_cols=141  Identities=27%  Similarity=0.462  Sum_probs=126.1

Q ss_pred             CCCCCceeeccCCceEEEEE-eCCCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .|...+.+|+|.||.||+|+ ..+|+.||||+++.....+. ...-.+||..++.++|+||+.+++++-+.+...+|+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            45566889999999999998 46899999999976654433 34689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      |+. +|+..++.+.   -.++-.+...++.++.+|++|+|++   .|+||||||.|+|++++|..||+||
T Consensus        83 m~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADF  145 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADF  145 (318)
T ss_pred             ccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecc
Confidence            985 8999998653   3578889999999999999999999   8999999999999999999999999

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.94  E-value=2e-27  Score=230.19  Aligned_cols=150  Identities=31%  Similarity=0.482  Sum_probs=133.0

Q ss_pred             cHHHHHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecC
Q 015852          238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTV  316 (399)
Q Consensus       238 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~  316 (399)
                      +.+++.+..+.+...+.||+|+||+||+|++..  .||||+++.+....+ .+.|.+|+.++++-+|.||+-+.|+|..+
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            446677777777888999999999999999854  499999976654433 34799999999999999999999999988


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .. .+|+.||++-+|+.+||..+.   .++..+...||.|||+||.|||.+   +|||||||+.||++.+++++||+||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence            76 999999999999999997653   588899999999999999999999   99999999999999999999999995

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.94  E-value=4.4e-27  Score=226.42  Aligned_cols=147  Identities=26%  Similarity=0.384  Sum_probs=131.8

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..+.....+.||+|.||+|..++...+..||||+++.+.......+|.+|+++|.+++|||||+|+|+|..++...+++|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            34445667889999999999999988899999999988777777899999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||++|+|.+++.++...  ..+-...++|+.|||.||+||.+.   ++||||+.++|||+|.++++||+||+
T Consensus       616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfg  682 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFG  682 (807)
T ss_pred             HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcc
Confidence            99999999999876432  234456778999999999999998   99999999999999999999999993

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.94  E-value=7.4e-27  Score=223.71  Aligned_cols=145  Identities=27%  Similarity=0.359  Sum_probs=127.3

Q ss_pred             HhcCCCCCceeeccCCceEEEEE-eCCCCEEEEEEccccccccc--HHHHHHHHHHHhcC-CCCCccceeeeeecCCceE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  320 (399)
                      ...+|..++.||+|+|++||+|+ ..+++.||||++.+...-.+  ..-...|-..|.++ .||.|++|+-.|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            44678889999999999999997 45789999999965442222  22355677788888 7999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+||+++|+|.+++++.+    .++......++.+|..||+|||++   +||||||||+|||||+||.++|+||+
T Consensus       151 FvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecc
Confidence            9999999999999998764    489999999999999999999999   99999999999999999999999996

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=3.6e-27  Score=205.01  Aligned_cols=147  Identities=30%  Similarity=0.429  Sum_probs=130.2

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +.++|+.++.||+|.||.||.|+.+ ++-.||+|++.+..-  ..-..++.+|+++-+.++||||+++++++.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4567899999999999999999864 677999999855432  2334579999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||.+.|+++..|++...  ..++......++.|+|.||.|+|..   +||||||||+|+|++.+++.|++||+
T Consensus       100 ilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             EEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCC
Confidence            9999999999999986432  3478888889999999999999998   99999999999999999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.94  E-value=7.1e-27  Score=209.41  Aligned_cols=142  Identities=22%  Similarity=0.327  Sum_probs=120.1

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccH-HHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~-~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .|+....+|+|+||.||+++.+ +|+.||||++.+....... +--++|++++++++|+|+|.|+++|......++|+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            3555678999999999999965 6999999999655433332 2478999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |..--| +.|.....   .++.....++..|+++|+.|+|++   +||||||||+|||+..++.+|++||+
T Consensus        83 ~dhTvL-~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFG  146 (396)
T KOG0593|consen   83 CDHTVL-HELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFG  146 (396)
T ss_pred             cchHHH-HHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccch
Confidence            986444 44433322   267788999999999999999999   99999999999999999999999994

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=5.7e-27  Score=217.08  Aligned_cols=142  Identities=23%  Similarity=0.450  Sum_probs=128.3

Q ss_pred             CCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccH--HHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~--~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +|+..+.||+|.||+|-++. ...|+.||||.++++...+..  ..+.+||++|+.++||||+.++.+|...+.+.+|||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            35555789999999999997 467999999999876544332  368999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |..+|.|++|+.+++    .++..+...+.+||..|+.|.|.+   +++|||||-+|||||.++++||+||+
T Consensus       134 YaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  134 YASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             ecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence            999999999998875    488999999999999999999999   99999999999999999999999995

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.93  E-value=3.6e-26  Score=204.40  Aligned_cols=146  Identities=27%  Similarity=0.421  Sum_probs=129.3

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .++|+..+.||.|+||+|...+.+ +|.-+|+|++.....-+  ..+...+|..+++.+.||.++++.+.+.+.+..+||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            356777899999999999999865 58899999996543222  233577899999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc--ccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI--LRR  398 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df--~~~  398 (399)
                      |||+++|.|.++|++.+    .++.+....+|.+|+.||+|||+.   .|++|||||+|||||.+|-.||.||  ++|
T Consensus       123 meyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             EeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            99999999999998754    489999999999999999999999   9999999999999999999999999  554

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.93  E-value=4e-26  Score=219.82  Aligned_cols=150  Identities=30%  Similarity=0.433  Sum_probs=125.7

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  316 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  316 (399)
                      +..++|...+.||+|+||.||+|..      .+++.||||+++..........+.+|+.++..+ +||||++++++|...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3456788889999999999999963      235689999997543333345689999999999 899999999998765


Q ss_pred             C-ceEEEEecCCCCChhhHhhhcCCC------------------------------------------------------
Q 015852          317 T-EKLLVYPYMTNGSVASRLRERQSS------------------------------------------------------  341 (399)
Q Consensus       317 ~-~~~lv~e~~~~gsL~~~L~~~~~~------------------------------------------------------  341 (399)
                      + ..+++|||+++|+|.++++.....                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            4 578999999999999999753211                                                      


Q ss_pred             ----CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          342 ----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       342 ----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                          ..++++.+...++.|+++||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG  219 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  219 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecc
Confidence                12478889999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.8e-27  Score=211.20  Aligned_cols=150  Identities=26%  Similarity=0.380  Sum_probs=126.7

Q ss_pred             CCCCCceeeccCCceEEEEE-eCCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceee-eeecCCc-eEEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYG-FCTTVTE-KLLVY  323 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lv~  323 (399)
                      +|.+.+.||+|+||+|||+. ..+|..+|.|.++-+... ...+....|+.++++++|||||++++ .+.+..+ ..+||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            35556889999999999997 568999999999743322 33457999999999999999999998 4555555 78999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceeeCCCCceeeccc-ccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKTI-LRR  398 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlK~~NILld~~~~~~i~df-~~~  398 (399)
                      |||..|+|...++..+.....+++....++..|+++||..+|+. -++  |+||||||.||+||.+|.+|++|| ++|
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            99999999999987555555688999999999999999999994 234  999999999999999999999999 555

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.6e-27  Score=221.95  Aligned_cols=145  Identities=27%  Similarity=0.406  Sum_probs=127.2

Q ss_pred             cCCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCC-ceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT-EKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lv~  323 (399)
                      ++|...+.||.|.||.||+|+ ..++..||||+++.....-++..=++|+..++++. |||||++.+.+.+.+ ..++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            456667889999999999998 45789999999976544433334578999999999 999999999999887 899999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc-ccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI-LRR  398 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df-~~~  398 (399)
                      |||.. +|+++++.+.   ..++..++..|+.||.+||+|+|.+   ++.|||+||+|||+.....+||+|| +.|
T Consensus        90 E~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   90 EFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             Hhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence            99974 9999998763   3689999999999999999999999   9999999999999999999999999 555

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=209.65  Aligned_cols=142  Identities=31%  Similarity=0.512  Sum_probs=123.7

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC--ceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e  324 (399)
                      ++...+.||+|+||.||.+... +|...|||.+....... ...+.+|+.+|.+++|||||+++|......  ...+.||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            4555689999999999999864 58999999985542222 446899999999999999999999865555  5889999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~~i~df~  396 (399)
                      |+++|+|.+++...+.   .++......+..||++||+|||++   +||||||||+|||++. ++++||+||+
T Consensus        97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG  163 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFG  163 (313)
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCc
Confidence            9999999999987643   488999999999999999999999   9999999999999999 7999999996

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.93  E-value=2e-25  Score=211.75  Aligned_cols=147  Identities=29%  Similarity=0.456  Sum_probs=125.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeCC-----------------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLAD-----------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL  309 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l  309 (399)
                      ++|...+.||+|+||.||++...+                 +..||+|.++.........+|.+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            457778899999999999997532                 347999998754333344579999999999999999999


Q ss_pred             eeeeecCCceEEEEecCCCCChhhHhhhcCC---------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 015852          310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH  374 (399)
Q Consensus       310 ~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  374 (399)
                      ++++...+..+++|||+++|+|.+++.....               ....++|.....++.|++.||+|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999999865321               113478889999999999999999998   9999


Q ss_pred             cCCCCCceeeCCCCceeecccc
Q 015852          375 RDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       375 rDlK~~NILld~~~~~~i~df~  396 (399)
                      |||||+|||+++++.+||+||+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG  183 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFG  183 (304)
T ss_pred             cCcchhheEEcCCccEEECCCc
Confidence            9999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-25  Score=209.84  Aligned_cols=146  Identities=26%  Similarity=0.387  Sum_probs=131.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .++|+..++||.|.-+.||+|+. +.++.||||++.-+........+.+|+..|+.++||||++++..|....+.|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            35677889999999999999985 57899999999776655555679999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||.+|++.++++..-..  .+++..+..|..++.+||.|||.+   +-||||||+.|||||+||.+|++||.
T Consensus       105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence            99999999999875332  278889999999999999999999   99999999999999999999999993

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-25  Score=211.70  Aligned_cols=145  Identities=28%  Similarity=0.381  Sum_probs=121.4

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-------------ccHHHHHHHHHHHhcCCCCCcccee
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-------------GGELQFQTEVKIISMAVHRNLLRLY  310 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~  310 (399)
                      ..+.|...+.||+|.||+|-+|+. .+++.||||++.+....             ...+...+||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            345678889999999999999985 47899999999532110             1123678999999999999999999


Q ss_pred             eeeecC--CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC
Q 015852          311 GFCTTV--TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       311 g~~~~~--~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~  388 (399)
                      .+..++  +..|||+|||..|.+...=..    ...++..++.+|..++..||+|||.+   +||||||||+|+||++++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            998765  468999999999987544221    12288999999999999999999999   999999999999999999


Q ss_pred             ceeecccc
Q 015852          389 DQSSKTIL  396 (399)
Q Consensus       389 ~~~i~df~  396 (399)
                      .+||+||+
T Consensus       248 ~VKIsDFG  255 (576)
T KOG0585|consen  248 TVKISDFG  255 (576)
T ss_pred             cEEeeccc
Confidence            99999996

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=7.1e-26  Score=235.47  Aligned_cols=147  Identities=33%  Similarity=0.510  Sum_probs=130.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCC--CC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLAD--GK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      .+..+..+.||+|+||.||+|.+.+  +.    .||||.++...+.....+|.+|..+|+.++|||||+++|.|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4455667899999999999998643  33    49999998776666677899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCC---CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          320 LLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ++++|||++|+|..+|++.+.   ....++-.+.+.++.|||+|+.||+++   ++|||||.++|+||++...+||+||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            999999999999999997532   123578889999999999999999999   9999999999999999999999999

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.93  E-value=1.9e-25  Score=214.01  Aligned_cols=146  Identities=21%  Similarity=0.320  Sum_probs=130.4

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ...++|+...+||+|+||.||.++- .+|..+|+|++++....  ......+.|-.+|...++|+||+|+-.|.+.+.+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            3567899999999999999999985 57999999999765322  22335788999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||||++|||+..+|...+    .|+......++.+.+.|++-+|..   ++|||||||+|+|||..|..|++||+
T Consensus       218 LiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             EEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccc
Confidence            9999999999999998754    488888999999999999999999   99999999999999999999999994

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-25  Score=214.87  Aligned_cols=145  Identities=26%  Similarity=0.382  Sum_probs=127.0

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc----ccHHHHHHHHHHHhcCC-CCCccceeeeeecCCc
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE  318 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~  318 (399)
                      ....|...+.||+|+||+|+.|+. .++..||+|.+......    .......+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            345788889999999999999975 47899999977543111    22335678999999999 9999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-Cceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~~i~df~  396 (399)
                      .++||||+.+|+|.+++..+.    ++.+....++..|++.|++|+|++   +|+||||||+|||+|.+ +++||+||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            999999999999999998732    477899999999999999999999   99999999999999999 999999994

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.93  E-value=9.3e-26  Score=204.71  Aligned_cols=142  Identities=27%  Similarity=0.435  Sum_probs=122.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeee--cCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCT--TVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lv  322 (399)
                      +.|+..+.|++|+||.||+|+. ++++.||+|+++.+..... -..-++||.++.+++|||||.+..+..  +.+..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            3466678899999999999985 5789999999986653322 235789999999999999999988765  35679999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ||||+. ||.+++....   .++...+...+..|+.+|++|||.+   -|+|||||++|+|+...|..||+||
T Consensus       156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEeccc
Confidence            999985 8999998654   3578889999999999999999999   8999999999999999999999999

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.92  E-value=4.4e-25  Score=205.33  Aligned_cols=144  Identities=26%  Similarity=0.377  Sum_probs=127.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .+|+..+.||+|+||.||+|.+.    .+..||+|.++..........|.+|+.+++.++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            45777899999999999999753    35689999997654434445799999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++....   ..++|.....++.|++.||+|||+.   +++||||||+|||++.++.++++||+
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg  152 (266)
T cd05064          85 TEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR  152 (266)
T ss_pred             EEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCc
Confidence            99999999999997643   2478999999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.92  E-value=4.9e-26  Score=209.41  Aligned_cols=139  Identities=29%  Similarity=0.443  Sum_probs=113.2

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC-----ceEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKLLV  322 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv  322 (399)
                      |...+++|+|+||.||+|.+. +++.||||+...+...     --+|.++|++++|||||+|.-++....     ..-+|
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            455689999999999999864 5789999988544321     246889999999999999988876532     23489


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-Cceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~~i~df~  396 (399)
                      |||||. +|++.++........++.-...-+..|+.+||+|||+.   +|+||||||+|+|+|.+ |..||+||+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence            999996 89999985322223466667888999999999999998   99999999999999988 789999994

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.92  E-value=2.8e-25  Score=217.13  Aligned_cols=149  Identities=30%  Similarity=0.385  Sum_probs=127.5

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCC
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  317 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  317 (399)
                      ..++|...+.||+|+||.||+|+.      .++..||||+++..........+.+|+.++..+ +||||++++++|...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345677889999999999999963      245689999997544333445789999999999 8999999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCC--------------------------------------------------------
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSS--------------------------------------------------------  341 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~--------------------------------------------------------  341 (399)
                      ..++||||+++|+|.++++.....                                                        
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            999999999999999999753210                                                        


Q ss_pred             ---------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          342 ---------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       342 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                                     ...++|.....++.|+++||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG  259 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFG  259 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCc
Confidence                           12478899999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.92  E-value=5.5e-25  Score=214.17  Aligned_cols=143  Identities=20%  Similarity=0.314  Sum_probs=126.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||+||+++.. +++.||+|+++....  ......+.+|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36788899999999999999854 688999999864322  122336888999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence            9999999999997643    488999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.92  E-value=4.1e-25  Score=203.33  Aligned_cols=144  Identities=26%  Similarity=0.410  Sum_probs=121.4

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCC-ccceeeeeecCC------ce
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRN-LLRLYGFCTTVT------EK  319 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~  319 (399)
                      |...+.||+|+||+||+|+. .+|+.||+|+++..... ..-..-.+|+.+++.++|+| ||+|++++.+.+      ..
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            44456799999999999985 57899999999765442 22235689999999999999 999999998877      78


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+||+.. +|..++.........++-.....+..|+.+||+|+|++   +|+||||||+|||++++|..|++||+
T Consensus        93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence            899999974 89999986542112355578899999999999999999   99999999999999999999999993

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=7.9e-25  Score=214.14  Aligned_cols=143  Identities=19%  Similarity=0.302  Sum_probs=125.6

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||+||+++. .+++.||||++.....  ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3677789999999999999985 4788999999854321  122346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+|++||+
T Consensus        81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999997542    478888889999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=6.5e-25  Score=213.60  Aligned_cols=143  Identities=22%  Similarity=0.352  Sum_probs=126.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||+||+++.. +++.||||+++....  ......+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36788899999999999999864 688999999964321  122335788999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence            9999999999997643    478899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.92  E-value=9.4e-25  Score=213.93  Aligned_cols=142  Identities=23%  Similarity=0.271  Sum_probs=125.3

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .|...+.||+|+||+||+|+. .+++.||+|+++.....  .....+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            467778999999999999985 46889999999653221  223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCc
Confidence            999999999997643    378888899999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=6.3e-25  Score=207.16  Aligned_cols=143  Identities=24%  Similarity=0.302  Sum_probs=126.2

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||++... +++.||+|.+.....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            35777899999999999999864 688999999854321  122346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.++++...    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence            9999999999997643    478889999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.92  E-value=1.5e-24  Score=204.19  Aligned_cols=143  Identities=27%  Similarity=0.436  Sum_probs=125.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            45777899999999999999864 68899999986544333344688999999999999999999999998899999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++ |+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        85 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG  148 (288)
T cd07871          85 LD-SDLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFG  148 (288)
T ss_pred             CC-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence            98 499998875432   367889999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.92  E-value=1e-24  Score=209.49  Aligned_cols=143  Identities=22%  Similarity=0.310  Sum_probs=126.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++....  ......+.+|+.++..++||||+++++++...+..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46777899999999999999865 688999999864321  122346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence            9999999999997643    377888899999999999999998   99999999999999999999999994

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.92  E-value=1.4e-24  Score=207.88  Aligned_cols=137  Identities=27%  Similarity=0.327  Sum_probs=121.5

Q ss_pred             ceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCC
Q 015852          253 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      ++||+|+||.||+++. .+++.||+|+++....  ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986 4789999999865432  122346889999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG  140 (323)
T cd05571          81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCC
Confidence            9999987643    478999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.92  E-value=3.4e-25  Score=212.82  Aligned_cols=141  Identities=26%  Similarity=0.417  Sum_probs=126.0

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||.||||+- .+.+.||+|.+.+... .++.+...+|+++++.++|||||.+++.|++..+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            3566678899999999999985 4688999999855433 3334569999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      |+.+ +|..+|....    .+.+.....|+.++..||.|||+.   +|+|||+||+|||++..+.+|++||
T Consensus        82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdF  144 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDF  144 (808)
T ss_pred             hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechh
Confidence            9987 9999998654    388999999999999999999999   9999999999999999999999999

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.92  E-value=1e-24  Score=212.71  Aligned_cols=148  Identities=24%  Similarity=0.311  Sum_probs=128.6

Q ss_pred             HHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCC
Q 015852          241 ELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  317 (399)
Q Consensus       241 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  317 (399)
                      ++....++|+..+.||+|+||.||+++.. +++.+|+|.+.....  ......+.+|+.+++.++||||+++++++...+
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            33445577888999999999999999864 688999999854321  122345889999999999999999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..++||||+++|+|.+++...     .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecc
Confidence            999999999999999999653     267888999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.92  E-value=9.1e-25  Score=213.43  Aligned_cols=151  Identities=29%  Similarity=0.415  Sum_probs=127.6

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeec
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  315 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  315 (399)
                      ....++|...+.||+|+||.||+++.      .++..||+|.++..........+.+|+.+++.+ +|+||++++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            34455788889999999999999873      134579999997544333344688999999999 89999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCC-------------------------------------------------------
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQS-------------------------------------------------------  340 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~-------------------------------------------------------  340 (399)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999999999999864321                                                       


Q ss_pred             -----------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          341 -----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       341 -----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                                 ...++++.+..+++.|+++||+|||+.   +|+||||||+|||+++++.++|+||+
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfG  257 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFG  257 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeece
Confidence                       012478889999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.92  E-value=2.1e-24  Score=206.76  Aligned_cols=137  Identities=26%  Similarity=0.328  Sum_probs=121.2

Q ss_pred             ceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCC
Q 015852          253 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      ++||+|+||.||+++. .+++.||+|.++.....  .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999985 46899999998654321  22346788999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  140 (323)
T cd05595          81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccH
Confidence            9999887543    478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.92  E-value=1.8e-24  Score=208.69  Aligned_cols=144  Identities=24%  Similarity=0.291  Sum_probs=125.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCC--CCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      .++|...+.||+|+||.||+|....  +..||+|.+.....  ......+.+|+.++..++||||+++++++...+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3567888999999999999997543  36899999854321  2233468899999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCC
Confidence            999999999999997643    378899999999999999999998   99999999999999999999999995

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.92  E-value=1.8e-24  Score=211.90  Aligned_cols=142  Identities=24%  Similarity=0.296  Sum_probs=124.8

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .|...+.||+|+||.||+|+. .+++.||+|.+.....  ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            467789999999999999985 4688999999864321  1223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECC
Confidence            999999999997542    367888889999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.91  E-value=2e-24  Score=211.13  Aligned_cols=142  Identities=23%  Similarity=0.294  Sum_probs=125.1

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +|+..+.||+|+||.||+++. .+++.||+|.+.....  ......+.+|+++++.++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            577889999999999999985 4688999999854321  1223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++....    .++......++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999997643    367788888999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=3e-24  Score=206.13  Aligned_cols=137  Identities=28%  Similarity=0.345  Sum_probs=121.5

Q ss_pred             ceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCC
Q 015852          253 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      ++||+|+||.||+++. .+++.||+|+++....  ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 4689999999965432  222346889999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|..++....    .+++.+...++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG  140 (328)
T cd05593          81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFG  140 (328)
T ss_pred             CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCc
Confidence            9999886542    478999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.8e-24  Score=201.65  Aligned_cols=139  Identities=32%  Similarity=0.447  Sum_probs=118.5

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHh--cCCCCCccceeeeeecC----CceEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS--MAVHRNLLRLYGFCTTV----TEKLL  321 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~--~l~H~niv~l~g~~~~~----~~~~l  321 (399)
                      .....+.||+|+||+||+|.++ |+.||||++.    ..++..+.+|.++.+  .++|+||+.+++.-...    .+.||
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~----srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS----SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             eeEEEEEecCccccceeecccc-CCceEEEEec----ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            3566789999999999999995 6789999984    334456777777764  68999999998875433    36899


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-----CDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++|.++|||+++|...     .++-...++++.-+|.||++||..     ..|.|.|||||+.|||+..++...|+|++
T Consensus       287 vTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             eeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            99999999999999763     488889999999999999999974     57899999999999999999999999994

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.91  E-value=2.7e-24  Score=205.17  Aligned_cols=143  Identities=27%  Similarity=0.469  Sum_probs=123.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.++.........+|.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            45888899999999999999853 333    48999986543334455799999999999999999999998764 5679


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||+++|+|.++++....   .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccc
Confidence            9999999999999986432   478889999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.91  E-value=4.1e-24  Score=202.66  Aligned_cols=143  Identities=27%  Similarity=0.450  Sum_probs=125.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            57888899999999999999865 68899999986543333344678999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++ ++|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        85 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          85 VH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             CC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCC
Confidence            96 688888865432   478888999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.5e-24  Score=207.00  Aligned_cols=142  Identities=23%  Similarity=0.303  Sum_probs=126.3

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +|...+.||+|+||.||+|+.. +++.||+|+++.....  .....+.+|++++..++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5777899999999999999865 5889999998654322  233468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        82 ~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          82 YVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence            999999999997543    478889999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.91  E-value=1.6e-24  Score=213.07  Aligned_cols=151  Identities=28%  Similarity=0.380  Sum_probs=128.1

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeec
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT  315 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~  315 (399)
                      ....++|...+.||+|+||.||+|+..      .+..||||+++..........|.+|+.+++.+. ||||++++++|..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            334567888899999999999999742      234799999975544344457999999999996 9999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCC-------------------------------------------------------
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQS-------------------------------------------------------  340 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~-------------------------------------------------------  340 (399)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999999875321                                                       


Q ss_pred             -------------------------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCcee
Q 015852          341 -------------------------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  383 (399)
Q Consensus       341 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NIL  383 (399)
                                                           ....+++.++..++.|+++||+|||+.   +|+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                 012477888999999999999999998   9999999999999


Q ss_pred             eCCCCceeecccc
Q 015852          384 LDEDADQSSKTIL  396 (399)
Q Consensus       384 ld~~~~~~i~df~  396 (399)
                      +++++.+|++||+
T Consensus       270 l~~~~~~kL~DfG  282 (400)
T cd05105         270 LAQGKIVKICDFG  282 (400)
T ss_pred             EeCCCEEEEEeCC
Confidence            9999999999995

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.91  E-value=3.2e-24  Score=201.72  Aligned_cols=143  Identities=29%  Similarity=0.393  Sum_probs=124.5

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      |...+.||+|+||.||++.. .+++.||+|.+......  .....+.+|+.++..++|+||+++.+++...+..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            56678999999999999985 57899999998643221  2234588999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|..++.....  ..+++.....++.|++.||+|||+.   +|+||||||+|||+++++.++|+||+
T Consensus        82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg  147 (285)
T cd05631          82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLG  147 (285)
T ss_pred             cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999988865322  2478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.91  E-value=6.7e-24  Score=203.35  Aligned_cols=137  Identities=26%  Similarity=0.322  Sum_probs=120.5

Q ss_pred             ceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCC
Q 015852          253 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      +.||+|+||.||+++. .+++.||+|.++.....  .....+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 47889999999654322  22346788999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|..++....    .+++.....++.|++.||+|||+ .   +|+||||||+|||+++++.+||+||+
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg  141 (325)
T cd05594          81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG  141 (325)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCC
Confidence            9999886542    47899999999999999999997 6   89999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.8e-24  Score=203.93  Aligned_cols=135  Identities=21%  Similarity=0.289  Sum_probs=119.9

Q ss_pred             eeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ||+|+||.||+++.. +++.||+|.++....  ......+.+|+.++..++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999864 688999999864321  22334688999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++....    .+++.....++.|+++||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg  138 (312)
T cd05585          81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFG  138 (312)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECc
Confidence            99997542    478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.91  E-value=2e-24  Score=210.71  Aligned_cols=145  Identities=22%  Similarity=0.273  Sum_probs=126.2

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ...++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.+++.++||||+++++++...+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34567888899999999999999864 688999999864321  122335789999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+++|+|.++++..     .++......++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecc
Confidence            999999999999998753     267778888999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.91  E-value=9.2e-24  Score=196.19  Aligned_cols=144  Identities=31%  Similarity=0.463  Sum_probs=127.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|+..+.||+|+||.||+|+..    +...||||.++..........|.+|+.+++.++|+||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            56888899999999999999864    24579999987554444445799999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg  151 (266)
T cd05033          84 TEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG  151 (266)
T ss_pred             EEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccc
Confidence            999999999999976432   588999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.91  E-value=3.3e-24  Score=198.81  Aligned_cols=140  Identities=35%  Similarity=0.577  Sum_probs=120.6

Q ss_pred             CceeeccCCceEEEEEeC-----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          252 KNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      .+.||+|+||.||+|.+.     .+..|+||.++..........|.+|++.+.+++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            478999999999999875     256899999965443334568999999999999999999999999888899999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.++|+...  ...+++..+..|+.|+++||+|||+.   +++|+||+++||++++++.+||+||+
T Consensus        84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTT
T ss_pred             ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            9999999998862  23589999999999999999999998   99999999999999999999999994

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.91  E-value=5.8e-24  Score=204.15  Aligned_cols=144  Identities=23%  Similarity=0.294  Sum_probs=126.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            35777899999999999999854 688999999965432  123346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence            99999999999976522   478899999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.5e-25  Score=213.13  Aligned_cols=154  Identities=29%  Similarity=0.412  Sum_probs=135.6

Q ss_pred             HHHHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC
Q 015852          239 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  317 (399)
Q Consensus       239 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  317 (399)
                      +++++....++...+.||-|.||.||.|.|+ -.-.||||.++++.  ....+|+.|+.+|+.++|||+|+|+|+|....
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            4667777778888899999999999999986 46789999998764  34558999999999999999999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc-c
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI-L  396 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df-~  396 (399)
                      ..|||+|||.+|+|.+||++....  .+.--..+.+|.||+.||+||...   ++|||||.++|+|+.++..+||+|| +
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence            999999999999999999986432  245556789999999999999998   9999999999999999999999999 5


Q ss_pred             ccC
Q 015852          397 RRL  399 (399)
Q Consensus       397 ~~~  399 (399)
                      -|+
T Consensus       412 sRl  414 (1157)
T KOG4278|consen  412 SRL  414 (1157)
T ss_pred             hhh
Confidence            553

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.6e-24  Score=203.97  Aligned_cols=144  Identities=22%  Similarity=0.297  Sum_probs=125.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|.+.....  ......|.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            35777899999999999999864 688999999864221  222345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++.+...   .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence            99999999999975322   378888999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.91  E-value=8.3e-24  Score=203.29  Aligned_cols=145  Identities=26%  Similarity=0.345  Sum_probs=127.5

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.++..........+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            357888899999999999999865 6889999998654333334579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++....    .+++.....++.|++.||.|||+..  +|+||||||+|||+++++.++|+||+
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCc
Confidence            999999999997643    3788899999999999999999752  59999999999999999999999994

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.91  E-value=5.8e-24  Score=206.71  Aligned_cols=143  Identities=20%  Similarity=0.334  Sum_probs=126.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.++..++|+||+++++.+...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36777899999999999999864 688999999864321  222346888999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999997643    478889999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=4.8e-24  Score=208.15  Aligned_cols=150  Identities=23%  Similarity=0.313  Sum_probs=130.0

Q ss_pred             HHHHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeec
Q 015852          239 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  315 (399)
Q Consensus       239 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  315 (399)
                      +.++....++|...+.||+|+||.||+++.. +++.+|+|.+.....  ......+.+|+.+++.++||||+++++.+..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4445566688999999999999999999865 688999999854221  1223357899999999999999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ....++||||+++|+|.++++..     .++......++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999998653     267788889999999999999998   9999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       187 G  187 (371)
T cd05622         187 G  187 (371)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.91  E-value=9.6e-24  Score=203.05  Aligned_cols=145  Identities=26%  Similarity=0.349  Sum_probs=127.2

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .++|+..+.||+|+||.||++... ++..+|+|.++..........+.+|+++++.++|+||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367888899999999999999865 6888999988654333334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++....    .+++.....++.+++.||+|||+..  +|+||||||+|||+++++.+|++||+
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCC
Confidence            999999999997643    3788888999999999999999741  69999999999999999999999994

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.91  E-value=6.2e-24  Score=198.62  Aligned_cols=149  Identities=26%  Similarity=0.407  Sum_probs=127.3

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCc
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  318 (399)
                      ..++|+..+.||+|+||.||+|...      ++..||+|.++.........+|.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567888899999999999998742      3467999998644332334468999999999999999999999998899


Q ss_pred             eEEEEecCCCCChhhHhhhcCCC------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceee
Q 015852          319 KLLVYPYMTNGSVASRLRERQSS------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  392 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i  392 (399)
                      .++||||+++|+|.++++.....      ...++|.....++.|++.||+|||+.   +++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999999763221      12467889999999999999999998   9999999999999999999999


Q ss_pred             cccc
Q 015852          393 KTIL  396 (399)
Q Consensus       393 ~df~  396 (399)
                      +||+
T Consensus       161 ~dfg  164 (277)
T cd05062         161 GDFG  164 (277)
T ss_pred             CCCC
Confidence            9995

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.91  E-value=1.1e-23  Score=194.63  Aligned_cols=142  Identities=29%  Similarity=0.433  Sum_probs=126.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ++|+..+.||+|+||.||+++..++..+|+|.++..  ......|.+|+.+++.++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            346667889999999999999888888999988643  223457899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.++++....   .++|..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g  145 (256)
T cd05114          82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFG  145 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCC
Confidence            99999999975432   478999999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.91  E-value=7e-24  Score=203.80  Aligned_cols=144  Identities=20%  Similarity=0.263  Sum_probs=125.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|.+.....  ......+.+|..++..++|+||+++.+++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46778899999999999999864 678999999864221  122335888999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence            99999999999976422   478888999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.91  E-value=9.5e-24  Score=196.42  Aligned_cols=140  Identities=28%  Similarity=0.353  Sum_probs=119.1

Q ss_pred             eeeccCCceEEEEEeCC---CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCC
Q 015852          254 ILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  330 (399)
Q Consensus       254 ~lG~G~fg~Vy~~~~~~---~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  330 (399)
                      .||+|+||.||+|...+   ...+++|.+...........|.+|++.++.++|+||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997532   357888887544333334468999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCC-CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          331 VASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       331 L~~~L~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |.+++...... ....++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  145 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYG  145 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccc
Confidence            99999765322 12346778899999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.91  E-value=9.2e-24  Score=201.76  Aligned_cols=137  Identities=28%  Similarity=0.359  Sum_probs=120.8

Q ss_pred             ceeeccCCceEEEEEe----CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          253 NILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~----~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      +.||+|+||.||+++.    .+++.||+|+++..... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    35789999999654322 223457889999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  143 (318)
T cd05582          82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG  143 (318)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeecc
Confidence            999999997542    478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.7e-24  Score=205.73  Aligned_cols=142  Identities=25%  Similarity=0.341  Sum_probs=126.7

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +|...+.||+|+||.||+|+.. +++.||+|+++.....  .....+.+|+.++..++|+||+++++++...+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            5777899999999999999864 6899999998654321  233468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++...    ..+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        82 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          82 YMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence            99999999999765    2478899999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.91  E-value=7.5e-24  Score=199.37  Aligned_cols=150  Identities=27%  Similarity=0.422  Sum_probs=127.4

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  317 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  317 (399)
                      +..++|+..+.||+|+||.||+|...      .+..||+|.++..........+.+|+.+++.++|+||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34567888899999999999999643      245899998865433333446889999999999999999999999989


Q ss_pred             ceEEEEecCCCCChhhHhhhcCC------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          318 EKLLVYPYMTNGSVASRLRERQS------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      ..+++|||+++|+|.++++....      .....++.....++.|++.||.|||+.   +|+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999975321      123456788899999999999999998   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      ++||+
T Consensus       160 L~Dfg  164 (288)
T cd05061         160 IGDFG  164 (288)
T ss_pred             ECcCC
Confidence            99994

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.91  E-value=8.2e-24  Score=198.39  Aligned_cols=139  Identities=29%  Similarity=0.400  Sum_probs=120.5

Q ss_pred             eeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ||+|+||+||++... +++.||+|.+.......  ....+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999864 68899999986432221  224578899999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..++.........+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  142 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLG  142 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCc
Confidence            988865333334588999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.91  E-value=4e-24  Score=207.32  Aligned_cols=137  Identities=24%  Similarity=0.347  Sum_probs=118.8

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      |+..+.||+|+||.||+++.. +++.||||.+...........+.+|+++++.++|+||+++++++...+..++||||++
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            445678999999999999864 6899999998654333334578999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+|....        ..++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccc
Confidence            99986532        245667788999999999999998   99999999999999999999999994

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-24  Score=217.97  Aligned_cols=144  Identities=26%  Similarity=0.389  Sum_probs=123.1

Q ss_pred             CCCCceeeccCCceEEEEEeCCC-CEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeee-eec------CCce
Q 015852          249 FSNKNILGRGGFGKVYKGRLADG-KLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGF-CTT------VTEK  319 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~~-~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~-~~~------~~~~  319 (399)
                      +++.++|.+|+|+.||.++...+ ..||+|++-.. ....-....+||++|+.|+ |+|||.+++. ...      ..+.
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            44568999999999999997655 99999998543 2333446899999999998 9999999993 221      2367


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|.||||++|.|-+++..+...  .|++.++++|+.++++|+++||.. +|+|||||||.+||||+.++.-|++||+
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence            8999999999999999876543  389999999999999999999986 8899999999999999999999999996

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.91  E-value=1e-23  Score=201.95  Aligned_cols=137  Identities=27%  Similarity=0.352  Sum_probs=119.8

Q ss_pred             ceeeccCCceEEEEEe----CCCCEEEEEEcccccc---cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          253 NILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.||+|+||.||+++.    .+++.||+|.++....   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    3578999999865321   12233578899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++....    .+.+.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  145 (323)
T cd05584          82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFG  145 (323)
T ss_pred             CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCc
Confidence            99999999997543    367788889999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.91  E-value=1.4e-23  Score=193.29  Aligned_cols=138  Identities=32%  Similarity=0.493  Sum_probs=122.4

Q ss_pred             ceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          253 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      +.||+|+||.||+|.. .+++.+|+|.+...........|.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3689999999999986 478899999886543333345799999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++++...   ..+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+|++||+
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  139 (252)
T cd05084          81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFG  139 (252)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccc
Confidence            99997543   2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.90  E-value=7.1e-24  Score=208.52  Aligned_cols=151  Identities=26%  Similarity=0.378  Sum_probs=127.4

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeec
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT  315 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~  315 (399)
                      ....++|...+.||+|+||.||+|++.      .++.||+|+++..........+.+|+.++..+. ||||++++++|..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            334455677789999999999999853      345899999975433333446899999999997 9999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCC-------------------------------------------------------
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQS-------------------------------------------------------  340 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~-------------------------------------------------------  340 (399)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            9999999999999999999975321                                                       


Q ss_pred             ---------------------------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCc
Q 015852          341 ---------------------------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  381 (399)
Q Consensus       341 ---------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~N  381 (399)
                                                             ....++|.....++.|++.||+|||+.   +|+||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                   112467888899999999999999988   99999999999


Q ss_pred             eeeCCCCceeecccc
Q 015852          382 ILLDEDADQSSKTIL  396 (399)
Q Consensus       382 ILld~~~~~~i~df~  396 (399)
                      ||+++++.+|++||+
T Consensus       270 iLl~~~~~~kL~DfG  284 (401)
T cd05107         270 VLICEGKLVKICDFG  284 (401)
T ss_pred             EEEeCCCEEEEEecC
Confidence            999999999999994

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.90  E-value=1.6e-23  Score=194.96  Aligned_cols=140  Identities=26%  Similarity=0.350  Sum_probs=118.8

Q ss_pred             eeeccCCceEEEEEeCCC---CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCC
Q 015852          254 ILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  330 (399)
Q Consensus       254 ~lG~G~fg~Vy~~~~~~~---~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  330 (399)
                      .||+|+||.||+|+..++   ..+++|.++..........|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   34667776544333345579999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          331 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       331 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |.+++++........++.....++.|+++||+|||+.   +++||||||+|||++.++.++++||+
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg  144 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYG  144 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccc
Confidence            9999986543333466777889999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.5e-24  Score=206.78  Aligned_cols=141  Identities=25%  Similarity=0.379  Sum_probs=125.7

Q ss_pred             cCCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ..|.....||+|+.|.||.++ ..+++.||||++..... ....-..+|+.+|+..+|+|||+++..|...++.|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            346677889999999999997 56788999999955432 2233578999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++|+|.+.+...     .+++.++..|+.++++||+|||.+   +|+|||||.+|||++.++++||+||+
T Consensus       352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFG  414 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFG  414 (550)
T ss_pred             cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeee
Confidence            9999999998654     388999999999999999999999   99999999999999999999999994

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.90  E-value=1.6e-23  Score=201.23  Aligned_cols=137  Identities=25%  Similarity=0.342  Sum_probs=120.3

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|+||.||+++.. +++.||+|.++.....  .....+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999864 6889999999754322  2233578899999888 699999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  141 (329)
T cd05588          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  141 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCc
Confidence            99999886542    488999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.90  E-value=1.5e-23  Score=196.63  Aligned_cols=147  Identities=29%  Similarity=0.441  Sum_probs=125.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-----CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|+..+.||+|+||+||+|..     .++..+|+|.++..........|.+|+++++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4567778999999999999974     24578999999754333333578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCC-------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC
Q 015852          322 VYPYMTNGSVASRLRERQS-------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~  388 (399)
                      +|||+++|+|.+++.....             ....+++.+...++.|++.||+|||+.   +|+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999864321             012478889999999999999999998   999999999999999999


Q ss_pred             ceeecccc
Q 015852          389 DQSSKTIL  396 (399)
Q Consensus       389 ~~~i~df~  396 (399)
                      .+|++||+
T Consensus       162 ~~kl~dfg  169 (283)
T cd05090         162 HVKISDLG  169 (283)
T ss_pred             cEEecccc
Confidence            99999994

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=1.5e-23  Score=201.43  Aligned_cols=142  Identities=25%  Similarity=0.302  Sum_probs=123.0

Q ss_pred             CCCCCceeeccCCceEEEEEe----CCCCEEEEEEccccccc---ccHHHHHHHHHHHhcCC-CCCccceeeeeecCCce
Q 015852          248 GFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTS---GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vAvK~l~~~~~~---~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~  319 (399)
                      +|...+.||+|+||.||+++.    .+++.||+|.++.....   .....+.+|+.++..++ |+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            366778999999999999875    35789999998643221   22335788999999994 99999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++..+.    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCc
Confidence            99999999999999997643    378899999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.90  E-value=1.1e-23  Score=203.50  Aligned_cols=149  Identities=30%  Similarity=0.410  Sum_probs=124.3

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC-
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV-  316 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-  316 (399)
                      ..++|...+.||+|+||.||+|..      .+++.||||+++..........+.+|+.++..+ +|+||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            345788889999999999999963      346789999997544333344688999999999 689999999988654 


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCC-------------------------------------------------------
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSS-------------------------------------------------------  341 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~-------------------------------------------------------  341 (399)
                      ...+++|||+++|+|.++++.....                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            4578999999999999998753210                                                       


Q ss_pred             --------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          342 --------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       342 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                              ...++|.+...++.|+++||+|||+.   +|+||||||+|||+++++++|++||+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg  224 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  224 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecc
Confidence                    02367888999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.90  E-value=1.6e-23  Score=200.50  Aligned_cols=137  Identities=28%  Similarity=0.404  Sum_probs=119.3

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|+||.||+|+.. +++.||+|.++....  ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999864 578999999865432  22234577888888765 799999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg  141 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFG  141 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecc
Confidence            99999987543    378899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.90  E-value=1.6e-23  Score=200.75  Aligned_cols=142  Identities=25%  Similarity=0.337  Sum_probs=122.4

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCC-CccceeeeeecCCceEEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~  323 (399)
                      +|...+.||+|+||.||+|+.. +++.||+|+++....  ......+..|.+++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4667789999999999999864 578999999865432  22334688899999988765 5888999998889999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence            9999999999987543    378899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.90  E-value=1.6e-23  Score=201.42  Aligned_cols=144  Identities=21%  Similarity=0.275  Sum_probs=125.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+++.. +++.+|+|.+.....  ......|.+|+.++..++|+||+++.+++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            35777899999999999999865 578899999854221  122335888999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++++...   .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence            99999999999976322   478889999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.90  E-value=1.9e-23  Score=198.70  Aligned_cols=143  Identities=25%  Similarity=0.426  Sum_probs=125.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            45777899999999999999864 67899999987554444445688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++ +|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  149 (309)
T cd07872          86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (309)
T ss_pred             CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            985 88888865432   378889999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.90  E-value=2.2e-23  Score=200.20  Aligned_cols=137  Identities=27%  Similarity=0.360  Sum_probs=119.1

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|+||.||+++.. +++.||+|.++.....  .....+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 6889999999654322  2233577888888765 799999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG  141 (329)
T cd05618          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  141 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCC
Confidence            99998886542    478899999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.90  E-value=2.3e-23  Score=193.76  Aligned_cols=144  Identities=29%  Similarity=0.421  Sum_probs=125.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-C---CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~---~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .+|...+.||+|+||.||+|+.. +   +..+|+|.++..........|.+|+.++..++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            35677899999999999999753 2   3479999986544333445799999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++....   ..+++.+...++.|++.||+|||+.   +++||||||+|||++.++.++++||.
T Consensus        84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd05066          84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFG  151 (267)
T ss_pred             EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCC
Confidence            99999999999997643   2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.90  E-value=2.6e-23  Score=193.54  Aligned_cols=141  Identities=31%  Similarity=0.393  Sum_probs=120.8

Q ss_pred             ceeeccCCceEEEEEeC---CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCC
Q 015852          253 NILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      +.||+|+||.||+|...   ++..+|+|.++..........|.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            35899999999999754   345799998865543333457899999999999999999999999999999999999999


Q ss_pred             ChhhHhhhcCC-CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          330 SVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       330 sL~~~L~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|.++++.... .....++.....++.|++.||+|||+.   +++||||||+||++++++.++++||+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg  145 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYG  145 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcc
Confidence            99999976432 222457778889999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=7.9e-24  Score=210.84  Aligned_cols=138  Identities=30%  Similarity=0.476  Sum_probs=123.9

Q ss_pred             CceeeccCCceEEEEEe-CCC----CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          252 KNILGRGGFGKVYKGRL-ADG----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~-~~~----~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      .++||+|+||+||+|.+ +.|    .+||+|++..........++++|+..|.+++|||+++|+|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            48899999999999975 333    4799999987766666778999999999999999999999998766 78999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +.|+|.++++.++..   +.-...+.+..|||+||.|||.+   ++|||||.++|||+.+-..+||.||+
T Consensus       780 P~G~LlDyvr~hr~~---igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg  843 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDN---IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG  843 (1177)
T ss_pred             ccchHHHHHHHhhcc---ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence            999999999987653   56678899999999999999998   99999999999999999999999995

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.90  E-value=1.8e-23  Score=200.35  Aligned_cols=140  Identities=29%  Similarity=0.402  Sum_probs=119.6

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHH---hcCCCCCccceeeeeecCCceEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKII---SMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      |...+.||+|+||.||+++.. +++.||||.++....  ......+.+|+.++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            445688999999999999864 689999999964421  12233566666554   577899999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|..+++..     .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG  146 (324)
T ss_pred             EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCccc
Confidence            9999999999888642     489999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.90  E-value=3.4e-23  Score=190.41  Aligned_cols=138  Identities=33%  Similarity=0.523  Sum_probs=123.4

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCChh
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  332 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  332 (399)
                      ++||+|+||.||+|...++..+|+|.++..........|.+|+++++.++||||+++++++...+..++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999999865543333446899999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          333 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       333 ~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++....   ..+++.....++.|++.||.|+|+.   +++||||||+||++++++.++++||+
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g  138 (250)
T cd05085          81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFG  138 (250)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCc
Confidence            9987543   2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.90  E-value=2.2e-23  Score=199.37  Aligned_cols=137  Identities=27%  Similarity=0.373  Sum_probs=116.7

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHH-HHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|+||.||+++.. +++.||+|.+.....  ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 688999999864322  122334555554 67889999999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|...+....    .++......++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  141 (321)
T cd05603          81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (321)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCC
Confidence            99998886542    367888889999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.90  E-value=2.1e-23  Score=199.60  Aligned_cols=137  Identities=31%  Similarity=0.443  Sum_probs=119.3

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|+||.||+++.. +++.||+|.++....  ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 688999999865421  22334577888888766 699999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG  141 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  141 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCC
Confidence            99999987643    378899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.2e-23  Score=195.98  Aligned_cols=143  Identities=29%  Similarity=0.398  Sum_probs=124.5

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      |+..+.||+|+||+||++.. .+++.||+|.+......  .....+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            66678999999999999986 46889999998643222  1233578899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++.....  ..+++.....++.|++.||+|||+.   +|+||||||+||++++++.++|+||+
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05605          82 MNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             cCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCC
Confidence            999999988865322  3488999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7.7e-24  Score=208.36  Aligned_cols=146  Identities=28%  Similarity=0.421  Sum_probs=126.4

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCC-CCCccceeeeeecCCc
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE  318 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~  318 (399)
                      ....++|....+||+|+||+|+.++.+ +++.+|||.++++..  .++.+..+.|-+++.... ||.+++++.++++.+.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345578899999999999999999975 688999999987643  334456788888877665 9999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+.||||+.||++..+.+..     .++...+..+|..|+.||+|||++   +||+||||-+|||||.+|.+||+||+
T Consensus       444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccc
Confidence            99999999999955444422     489999999999999999999999   99999999999999999999999993

>PHA02988 hypothetical protein; Provisional

Probab=99.90  E-value=4.7e-23  Score=193.68  Aligned_cols=138  Identities=19%  Similarity=0.294  Sum_probs=119.4

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeeeec----CCceEEEEec
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPY  325 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~  325 (399)
                      ...||+|++|.||+|.+ +|+.||||+++.......  ...|.+|+.++++++||||++++|++.+    ....+++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 688999999965432221  2468899999999999999999999876    3467899999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++++..    .++|.....++.+++.||.|||+..  +++||||||+|||+++++.+|++||+
T Consensus       104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg  168 (283)
T PHA02988        104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHG  168 (283)
T ss_pred             CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccc
Confidence            99999999997643    4789999999999999999999732  67899999999999999999999994

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=9.2e-24  Score=196.76  Aligned_cols=143  Identities=29%  Similarity=0.315  Sum_probs=125.8

Q ss_pred             CCCCCceeeccCCceEEEEEeCC-CCEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .|...+.||.|.-|+||.+++++ +..+|+|++.+......  ..+...|-++|+.++||.+++|++.+.++...+++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            45556789999999999999764 68999999965543322  2357778899999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ||+||+|..+.++...  ..++...+..+|.+|..||+|||-.   +||.|||||+||||-+||.+-++||
T Consensus       158 yCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             cCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence            9999999999887544  3588899999999999999999999   9999999999999999999999999

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.90  E-value=2.5e-23  Score=197.35  Aligned_cols=147  Identities=29%  Similarity=0.477  Sum_probs=125.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC--EEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|+..+.||+|+||.||+|+.. ++.  .+|+|.++..........|.+|++++.++ +|+||+++++++...+..+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46777899999999999999864 444  46888775433333445788999999999 899999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCce
Q 015852          323 YPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  390 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~  390 (399)
                      |||+++|+|.++++....            ....+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999999976431            123578999999999999999999998   99999999999999999999


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      ||+||+
T Consensus       164 kl~dfg  169 (303)
T cd05088         164 KIADFG  169 (303)
T ss_pred             EeCccc
Confidence            999995

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.2e-23  Score=196.82  Aligned_cols=147  Identities=28%  Similarity=0.424  Sum_probs=125.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeCC---------------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceee
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLAD---------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG  311 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g  311 (399)
                      ++|...+.||+|+||.||+++...               ...||+|.++..........|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            467778999999999999986532               23589999875543333457999999999999999999999


Q ss_pred             eeecCCceEEEEecCCCCChhhHhhhcCC--------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCcee
Q 015852          312 FCTTVTEKLLVYPYMTNGSVASRLRERQS--------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  383 (399)
Q Consensus       312 ~~~~~~~~~lv~e~~~~gsL~~~L~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NIL  383 (399)
                      ++...+..++||||+++++|.+++.....        ....++|..+..++.|++.||+|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            99999999999999999999999965321        112468899999999999999999998   9999999999999


Q ss_pred             eCCCCceeecccc
Q 015852          384 LDEDADQSSKTIL  396 (399)
Q Consensus       384 ld~~~~~~i~df~  396 (399)
                      +++++.+|++||+
T Consensus       162 l~~~~~~kl~dfg  174 (295)
T cd05097         162 VGNHYTIKIADFG  174 (295)
T ss_pred             EcCCCcEEecccc
Confidence            9999999999994

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.6e-23  Score=192.57  Aligned_cols=145  Identities=29%  Similarity=0.403  Sum_probs=128.8

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..++|+..+.||+|+||.||+|...+++.||+|.++...  ....+|.+|+.++++++|+||+++++++...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            345678889999999999999998777889999986532  234579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++....  ...++|.....++.|++.||.|||+.   +|+||||||+||++++++.++|+||.
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg  148 (261)
T cd05068          82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFG  148 (261)
T ss_pred             cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcc
Confidence            999999999997643  23478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.90  E-value=3.4e-23  Score=191.51  Aligned_cols=141  Identities=30%  Similarity=0.448  Sum_probs=125.6

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      +|...+.||+|+||.||.++..++..+|+|.++...  .....|.+|+.++.+++||||+++++++...+..+++|||++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            466678899999999999988777789999986432  234579999999999999999999999998888999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+|.++++....   .++|..+..++.|++.||+|||+.   +++|+||||+||++++++.+|++||.
T Consensus        83 ~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g  145 (256)
T cd05113          83 NGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFG  145 (256)
T ss_pred             CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCc
Confidence            9999999976432   478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.90  E-value=2.8e-23  Score=198.31  Aligned_cols=137  Identities=26%  Similarity=0.395  Sum_probs=116.8

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhc-CCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|+||.||+|+.. +++.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 678999999865432  1223345666666654 5899999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  141 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFG  141 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCc
Confidence            99999987543    378889999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.90  E-value=3.1e-23  Score=197.27  Aligned_cols=144  Identities=28%  Similarity=0.337  Sum_probs=126.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||++... ++..+|+|.++.........++.+|++++..++||||+++++++...+..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            35778899999999999999864 67889999886543333344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.++++...    .+++.....++.|+++||.|||+.+  +++||||||+|||+++++.++++||+
T Consensus        81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCC
Confidence            99999999997642    4788899999999999999999732  79999999999999999999999994

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=1.8e-23  Score=210.66  Aligned_cols=144  Identities=17%  Similarity=0.223  Sum_probs=124.1

Q ss_pred             CCCCceeeccCCceEEEEEeC-C-CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-D-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~-~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      |...+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+++.++|||||++++++...+..++||||+
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            667789999999999999743 4 6788888764321 222335788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.++++.......++++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFg  214 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFG  214 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCc
Confidence            99999999876433334688889999999999999999998   99999999999999999999999994

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.90  E-value=3.1e-23  Score=198.61  Aligned_cols=137  Identities=28%  Similarity=0.398  Sum_probs=117.3

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHH-HHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|+||+||+|+.. +++.||+|++......  .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999864 6899999998643221  22234555554 56889999999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg  141 (323)
T cd05575          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (323)
T ss_pred             CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccC
Confidence            99999987542    478889999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.90  E-value=2.3e-23  Score=195.67  Aligned_cols=142  Identities=18%  Similarity=0.287  Sum_probs=122.7

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.||+++.. +++.||+|+++..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            5777899999999999999875 6789999998654322 2234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++.+..+....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          82 VEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            9988776554322    2478889999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.90  E-value=2.5e-23  Score=200.05  Aligned_cols=140  Identities=19%  Similarity=0.363  Sum_probs=119.7

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC-----ceEE
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKLL  321 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~l  321 (399)
                      |+..+.||+|+||.||+|+. .+++.||||+++..... .....+.+|+.+++.++||||+++++++....     ..++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            56678999999999999985 46899999998643222 22346889999999999999999999885432     4799


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+. ++|.+++....    .+++.....++.|+++||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        82 v~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg  148 (338)
T cd07859          82 VFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFG  148 (338)
T ss_pred             EEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCc
Confidence            999996 68998886542    488999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=7.6e-24  Score=207.18  Aligned_cols=142  Identities=26%  Similarity=0.382  Sum_probs=127.2

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      -|..++-||+|+-|.|-.|+. .+|+.+|||++......  .......+|+.+|+.+.||||+++++++......|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            356678899999999999985 58999999999654222  223368899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|.|.++|..++    ++...+..++..||..|+.|.|+.   +|+||||||+|+|||...++||+||+
T Consensus        93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence            999999999998764    488899999999999999999999   99999999999999999999999996

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.90  E-value=1.5e-23  Score=201.99  Aligned_cols=149  Identities=32%  Similarity=0.441  Sum_probs=124.2

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC-
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV-  316 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-  316 (399)
                      ..++|...+.||+|+||.||+|...      +++.||+|+++..........+.+|+.++.++ +|+||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3456888899999999999999632      34789999986543333344688899999999 799999999988754 


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCC-------------------------------------------------------
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSS-------------------------------------------------------  341 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~-------------------------------------------------------  341 (399)
                      ...+++|||+++|+|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            4678999999999999998653211                                                       


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          342 --LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       342 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                        ..+++|..+..++.||+.||+|||+.   +|+||||||+|||+++++.++|+||+
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG  218 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  218 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccc
Confidence              12578999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.90  E-value=2.3e-23  Score=196.32  Aligned_cols=150  Identities=30%  Similarity=0.459  Sum_probs=128.1

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  316 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  316 (399)
                      ...++|+..+.||+|+||.||++...      ....+|+|.++.........++.+|+.++.++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34456777899999999999999753      23679999987543333344688999999999 799999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcC------------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  384 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl  384 (399)
                      +..+++|||+++|+|.++++...            .....+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence            99999999999999999997532            1234588999999999999999999998   99999999999999


Q ss_pred             CCCCceeecccc
Q 015852          385 DEDADQSSKTIL  396 (399)
Q Consensus       385 d~~~~~~i~df~  396 (399)
                      ++++.+|++||+
T Consensus       166 ~~~~~~kL~Dfg  177 (293)
T cd05053         166 TEDHVMKIADFG  177 (293)
T ss_pred             cCCCeEEeCccc
Confidence            999999999994

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.90  E-value=2.3e-23  Score=192.85  Aligned_cols=144  Identities=27%  Similarity=0.415  Sum_probs=127.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .++|...+.||+|+||.||+|...++..||+|.+....  .....+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            35677889999999999999998888889999886432  2345789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.++++....  ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||+
T Consensus        83 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  148 (261)
T cd05072          83 MAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFG  148 (261)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCc
Confidence            999999999976422  2478899999999999999999998   99999999999999999999999993

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.90  E-value=3e-23  Score=198.66  Aligned_cols=142  Identities=25%  Similarity=0.342  Sum_probs=121.7

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      +|...+.||+|+||.||+|+.. +++.||+|.++....  ......+..|..++..+ +|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4667789999999999999865 578999999865432  12223467777777766 5899999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence            9999999999987543    378899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.90  E-value=3.8e-23  Score=197.43  Aligned_cols=137  Identities=26%  Similarity=0.399  Sum_probs=118.3

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhc-CCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|+||.||+++.. +++.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999865 688999999865432  2223356777777764 5899999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++.+...++.|+++||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05620          81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG  141 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccC
Confidence            99999987642    378889999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.90  E-value=3.6e-23  Score=198.35  Aligned_cols=137  Identities=27%  Similarity=0.374  Sum_probs=117.4

Q ss_pred             ceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHH-HHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||+||+++. .+++.||+|++......  .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 47899999998643221  22234555654 56789999999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG  141 (325)
T cd05604          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFG  141 (325)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecC
Confidence            99998887542    478899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.90  E-value=4e-23  Score=197.28  Aligned_cols=137  Identities=28%  Similarity=0.434  Sum_probs=118.5

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhc-CCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||+||+|+.. +++.||+|.++....  ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 578999999865422  2223356677777765 5899999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|.+++....    .+++.+...++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05619          81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFG  141 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCC
Confidence            99999997542    478899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.90  E-value=3.1e-23  Score=198.61  Aligned_cols=141  Identities=25%  Similarity=0.342  Sum_probs=121.5

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEe
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      |...++||+|+||.||+++. .+++.||+|.++....  ......+..|..++..+. |++|+++.+++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            56678999999999999985 4688999999865422  223345788888888776 5778889999998899999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++....    .+++.+...++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        82 y~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          82 YVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             CCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence            999999999987542    488999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.90  E-value=4.4e-23  Score=190.61  Aligned_cols=141  Identities=31%  Similarity=0.437  Sum_probs=125.5

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      +|+..+.||+|+||.||++...++..+|+|.+....  .....|.+|+++++.++|+||+++++++...+..+++|||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            466778999999999999988777789999885432  233468899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|.++++....   .++|.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||+
T Consensus        83 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg  145 (256)
T cd05059          83 NGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFG  145 (256)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcc
Confidence            9999999976432   478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.90  E-value=4.8e-23  Score=191.28  Aligned_cols=147  Identities=18%  Similarity=0.277  Sum_probs=127.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||.||+|+. .+++.||||.++....  ......+.+|+++++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4678889999999999999985 4788999998754322  222346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++.........+++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||.
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence            99999999998865333333578888999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.90  E-value=3.7e-23  Score=193.35  Aligned_cols=147  Identities=31%  Similarity=0.521  Sum_probs=127.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|...+.||+|+||.||+|...      +++.||||.++..........|.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            34666789999999999999753      247899999865543334457999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCC----------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCce
Q 015852          321 LVYPYMTNGSVASRLRERQS----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  390 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~  390 (399)
                      ++|||+++|+|.++++....          ....+++.+...++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            99999999999999976421          123478899999999999999999998   99999999999999999999


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      +++||+
T Consensus       162 kl~d~g  167 (280)
T cd05049         162 KIGDFG  167 (280)
T ss_pred             EECCcc
Confidence            999994

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.90  E-value=5.1e-23  Score=194.61  Aligned_cols=147  Identities=26%  Similarity=0.441  Sum_probs=125.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC--EEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|+..++||+|+||.||+|... ++.  .+++|.++..........|.+|++++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46778899999999999999864 333  57888886443333345789999999988 799999999999998899999


Q ss_pred             EecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCce
Q 015852          323 YPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  390 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~  390 (399)
                      +||+++|+|.++++....            ....+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999976321            112478899999999999999999998   99999999999999999999


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      ||+||+
T Consensus       159 kl~dfg  164 (297)
T cd05089         159 KIADFG  164 (297)
T ss_pred             EECCcC
Confidence            999995

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.90  E-value=3.8e-23  Score=196.10  Aligned_cols=150  Identities=27%  Similarity=0.435  Sum_probs=127.3

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC--------CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeee
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT  314 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~  314 (399)
                      ...++|...+.||+|+||.||+++..        ++..||+|.++..........+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34456778899999999999999641        24579999986543333345789999999999 7999999999999


Q ss_pred             cCCceEEEEecCCCCChhhHhhhcCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCce
Q 015852          315 TVTEKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  382 (399)
Q Consensus       315 ~~~~~~lv~e~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NI  382 (399)
                      .....+++|||+++|+|.+++......            ...++|.++..++.|++.||+|||+.   +|+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            999999999999999999999764321            12478889999999999999999998   999999999999


Q ss_pred             eeCCCCceeecccc
Q 015852          383 LLDEDADQSSKTIL  396 (399)
Q Consensus       383 Lld~~~~~~i~df~  396 (399)
                      ++++++.+|++||+
T Consensus       169 li~~~~~~kl~D~g  182 (304)
T cd05101         169 LVTENNVMKIADFG  182 (304)
T ss_pred             EEcCCCcEEECCCc
Confidence            99999999999994

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.90  E-value=5.5e-23  Score=193.60  Aligned_cols=146  Identities=32%  Similarity=0.442  Sum_probs=124.3

Q ss_pred             CCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +|...+.||+|+||.||+|...      ....+|+|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3566789999999999999742      2357899988654433334578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCC--------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCc
Q 015852          322 VYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  381 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~N  381 (399)
                      ++||+.+|+|.+++.....                    ....+++.....++.|++.||+|||+.   +|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999875321                    113478999999999999999999998   99999999999


Q ss_pred             eeeCCCCceeecccc
Q 015852          382 ILLDEDADQSSKTIL  396 (399)
Q Consensus       382 ILld~~~~~~i~df~  396 (399)
                      ||+++++.+||+||+
T Consensus       158 ill~~~~~~kl~dfg  172 (290)
T cd05045         158 VLVAEGRKMKISDFG  172 (290)
T ss_pred             EEEcCCCcEEecccc
Confidence            999999999999993

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.89  E-value=6.3e-23  Score=192.43  Aligned_cols=143  Identities=27%  Similarity=0.442  Sum_probs=122.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC--Cce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~  319 (399)
                      .+|...+.||+|+||.||++...     ++..||+|.++... ......|.+|+++++.++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            35677789999999999999742     57899999986432 22344789999999999999999999987543  467


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+||+++|+|.+++....   ..++|..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg  153 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG  153 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence            89999999999999997543   2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.89  E-value=5.2e-23  Score=194.39  Aligned_cols=147  Identities=27%  Similarity=0.412  Sum_probs=125.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-----------------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-----------------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL  309 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l  309 (399)
                      ++|+..+.||+|+||.||+++..                 +...+|+|.++..........|.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788899999999999998532                 2346999998654333344579999999999999999999


Q ss_pred             eeeeecCCceEEEEecCCCCChhhHhhhcCCC-------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCce
Q 015852          310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSS-------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  382 (399)
Q Consensus       310 ~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NI  382 (399)
                      ++++...+..+++|||+++|+|.+++......       ...+++.+...++.|++.||+|||+.   +|+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999999764321       12477889999999999999999998   999999999999


Q ss_pred             eeCCCCceeecccc
Q 015852          383 LLDEDADQSSKTIL  396 (399)
Q Consensus       383 Lld~~~~~~i~df~  396 (399)
                      |+++++.++++||+
T Consensus       162 li~~~~~~~l~dfg  175 (296)
T cd05095         162 LVGKNYTIKIADFG  175 (296)
T ss_pred             EEcCCCCEEeccCc
Confidence            99999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=4.2e-23  Score=202.67  Aligned_cols=136  Identities=24%  Similarity=0.291  Sum_probs=121.4

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..+|+..+.||+|+||.||++.. .+++.||+|....       ..+.+|+++++.++||||+++++++......++++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            35789999999999999999985 4688999997532       247889999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++. ++|..++....    .+++.+.+.++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG  227 (391)
T PHA03212        164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG  227 (391)
T ss_pred             cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCC
Confidence            995 78988886543    378999999999999999999998   99999999999999999999999995

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.89  E-value=6.4e-23  Score=192.56  Aligned_cols=142  Identities=27%  Similarity=0.447  Sum_probs=123.5

Q ss_pred             CCCCceeeccCCceEEEEEe-----CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEE
Q 015852          249 FSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  321 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  321 (399)
                      |+..+.||+|+||.||.++.     .++..||+|.++..........+.+|+.+++.++|+|++++.+++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            56678899999999999974     257789999986553333345799999999999999999999998775  56789


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|||+++++|.+++....   ..++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+
T Consensus        86 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             EEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCc
Confidence            999999999999996542   2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-23  Score=203.21  Aligned_cols=152  Identities=28%  Similarity=0.447  Sum_probs=132.6

Q ss_pred             HHHHHHhcCCCCCceeeccCCceEEEEEeCC---C--CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeee
Q 015852          240 RELQVATDGFSNKNILGRGGFGKVYKGRLAD---G--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT  314 (399)
Q Consensus       240 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---~--~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~  314 (399)
                      .+.+...+.....++||+|.||.||+|.+.+   |  ..||||..+.+...+..+.|++|..+|+.++|||||+|+|.|.
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence            3445555666778999999999999997532   2  3699999998777777778999999999999999999999997


Q ss_pred             cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecc
Q 015852          315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  394 (399)
Q Consensus       315 ~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~d  394 (399)
                      + ...|+|||.++.|.|.++|+..+.   .++......++.|++.+|+|||+.   ++|||||.++|||+.+...+|++|
T Consensus       462 e-~P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD  534 (974)
T KOG4257|consen  462 E-QPMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD  534 (974)
T ss_pred             c-cceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence            5 468999999999999999987654   477888899999999999999999   999999999999999999999999


Q ss_pred             c-ccc
Q 015852          395 I-LRR  398 (399)
Q Consensus       395 f-~~~  398 (399)
                      | +-|
T Consensus       535 FGLSR  539 (974)
T KOG4257|consen  535 FGLSR  539 (974)
T ss_pred             cchhh
Confidence            9 444

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.89  E-value=6.9e-23  Score=191.95  Aligned_cols=147  Identities=31%  Similarity=0.493  Sum_probs=125.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeCC------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|+..+.||+|+||.||+|....      ...||+|.++..........|.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357777899999999999997532      25799999865443333456899999999999999999999999888999


Q ss_pred             EEEecCCCCChhhHhhhcCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC
Q 015852          321 LVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~  388 (399)
                      ++|||+++|+|.+++......            ...+++.....++.|++.||+|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999999754211            13478889999999999999999998   999999999999999999


Q ss_pred             ceeecccc
Q 015852          389 DQSSKTIL  396 (399)
Q Consensus       389 ~~~i~df~  396 (399)
                      .++|+||+
T Consensus       162 ~~~L~dfg  169 (283)
T cd05048         162 TVKISDFG  169 (283)
T ss_pred             cEEECCCc
Confidence            99999994

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.89  E-value=6.5e-23  Score=192.15  Aligned_cols=143  Identities=27%  Similarity=0.416  Sum_probs=119.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|...+.||+|+||+||+|.+. +++    .+++|.+..........++..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            35677789999999999999863 444    4788877533222233467888889999999999999998754 45778


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||+++|+|.++++....   .++|.....++.|++.||+|||+.   +++||||||+|||+++++.+|++||+
T Consensus        86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCc
Confidence            9999999999999976432   488999999999999999999998   89999999999999999999999994

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.89  E-value=4.8e-23  Score=195.74  Aligned_cols=148  Identities=30%  Similarity=0.429  Sum_probs=126.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC--------CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  316 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  316 (399)
                      .++|...+.||+|+||.||+++..        +...+|+|.++.........++.+|+.++..+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            356888899999999999999742        23479999987543333344688899999999 799999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  384 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl  384 (399)
                      +..++||||+++|+|.++++.....            ...++|.+++.++.|++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            9999999999999999999864321            12488999999999999999999998   99999999999999


Q ss_pred             CCCCceeecccc
Q 015852          385 DEDADQSSKTIL  396 (399)
Q Consensus       385 d~~~~~~i~df~  396 (399)
                      ++++.++++||+
T Consensus       174 ~~~~~~kL~dfg  185 (307)
T cd05098         174 TEDNVMKIADFG  185 (307)
T ss_pred             cCCCcEEECCCc
Confidence            999999999994

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.89  E-value=5.6e-23  Score=191.26  Aligned_cols=143  Identities=29%  Similarity=0.458  Sum_probs=125.1

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CC---CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      +|...+.||+|+||.||+|... ++   ..||||.++.........+|..|+.+++.++||||+++.+++......++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            3566789999999999999864 23   3699999865433333457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.++++....   .+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++||+
T Consensus        85 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg  151 (269)
T cd05065          85 EFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG  151 (269)
T ss_pred             ecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCc
Confidence            99999999999976432   478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.89  E-value=5.2e-23  Score=197.45  Aligned_cols=137  Identities=28%  Similarity=0.362  Sum_probs=119.8

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||+||+++.. +++.||+|+++.....  .....+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 6789999999754322  2233578899988877 699999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYG  141 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccc
Confidence            99999886542    488999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.89  E-value=8.8e-23  Score=189.26  Aligned_cols=147  Identities=20%  Similarity=0.301  Sum_probs=129.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||.||+|... +++.||+|.++....  ......+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            56788899999999999999875 789999998864222  222457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++.........+++.+...++.+++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence            99999999999875433334578999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.89  E-value=6.2e-23  Score=196.71  Aligned_cols=137  Identities=28%  Similarity=0.368  Sum_probs=115.8

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHH-HHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEV-KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||+||+++.. +++.||+|++.....  ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999864 678899999864321  12223444444 456889999999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|.+++....    .+.......++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG  141 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  141 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCC
Confidence            99999997643    367788888999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.89  E-value=6.6e-23  Score=191.86  Aligned_cols=144  Identities=28%  Similarity=0.446  Sum_probs=123.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      .++|...+.||+|+||+||+|+. .+++    .||+|.++..........+.+|+.++..++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            34677789999999999999985 3444    48999986554444455789999999999999999999998754 577


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++||+++|+|.++++...   ..+++...+.++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCC
Confidence            9999999999999997643   2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.89  E-value=7.3e-23  Score=190.24  Aligned_cols=145  Identities=28%  Similarity=0.493  Sum_probs=126.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CC---CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      .++|+..+.||+|+||.||+|+.. ++   ..+|+|.++..........+.+|+++++.++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346777899999999999999864 33   37999998654333344579999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|||+++++|.++++...   ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++++||+
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  152 (268)
T cd05063          84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFG  152 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCc
Confidence            999999999999997643   2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.89  E-value=6.8e-23  Score=195.83  Aligned_cols=137  Identities=30%  Similarity=0.425  Sum_probs=119.8

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||+||+++.. +++.||+|.++....  ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 578999999975432  22234577888888877 699999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.++|+||+
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  141 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFG  141 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccC
Confidence            99999887543    488999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.89  E-value=5.9e-23  Score=214.86  Aligned_cols=147  Identities=22%  Similarity=0.340  Sum_probs=126.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|+++......  ...+|.+|+++++.++||||+++++++...+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46778899999999999999864 68899999986543222  2346999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCC-------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQS-------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++.....       .....++...+.++.|+++||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211       112356788899999999999999998   99999999999999999999999994

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.89  E-value=4.1e-23  Score=194.19  Aligned_cols=148  Identities=30%  Similarity=0.488  Sum_probs=127.9

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      .++|+..+.||+|+||.||+++..      ++..||+|.++.........+|.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            456888899999999999999753      46789999986544333345799999999999999999999999998899


Q ss_pred             EEEEecCCCCChhhHhhhcCC------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCc
Q 015852          320 LLVYPYMTNGSVASRLRERQS------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  381 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~N  381 (399)
                      +++|||+++|+|.++++....                  ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            999999999999999975321                  112477889999999999999999998   99999999999


Q ss_pred             eeeCCCCceeecccc
Q 015852          382 ILLDEDADQSSKTIL  396 (399)
Q Consensus       382 ILld~~~~~~i~df~  396 (399)
                      |++++++.++++||+
T Consensus       161 il~~~~~~~~l~dfg  175 (288)
T cd05050         161 CLVGENMVVKIADFG  175 (288)
T ss_pred             eEecCCCceEECccc
Confidence            999999999999995

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.89  E-value=5.3e-23  Score=192.52  Aligned_cols=149  Identities=26%  Similarity=0.412  Sum_probs=128.0

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCC-----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec-CCc
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTE  318 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~  318 (399)
                      ..++|...++||+|+||.||+|....     +..|++|+++..........+.+|+.+++.++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34677888999999999999998654     678999998654433445568999999999999999999998876 467


Q ss_pred             eEEEEecCCCCChhhHhhhcCCC----CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSS----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  394 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~d  394 (399)
                      .++++||+++|+|.+++......    ...+++.++..++.|++.||+|||+.   +++||||||+||++++++.+|++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            88999999999999999764321    14588999999999999999999998   999999999999999999999999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       161 ~g  162 (280)
T cd05043         161 NA  162 (280)
T ss_pred             CC
Confidence            94

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.89  E-value=4.6e-23  Score=192.47  Aligned_cols=148  Identities=28%  Similarity=0.427  Sum_probs=127.0

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      .++|...+.||+|+||.||+|...      ++..||+|.+...........+.+|+.++..++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            456777899999999999999753      24689999986543333345789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCC------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeec
Q 015852          320 LLVYPYMTNGSVASRLRERQSS------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  393 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~  393 (399)
                      +++|||+++|+|.+++......      ...++|.....++.|++.||.|||+.   +|+||||||+||++++++.+|++
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            9999999999999999754321      22478899999999999999999998   99999999999999999999999


Q ss_pred             ccc
Q 015852          394 TIL  396 (399)
Q Consensus       394 df~  396 (399)
                      ||+
T Consensus       162 dfg  164 (277)
T cd05032         162 DFG  164 (277)
T ss_pred             Ccc
Confidence            994

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.89  E-value=9e-23  Score=188.87  Aligned_cols=135  Identities=24%  Similarity=0.368  Sum_probs=117.4

Q ss_pred             eeccCCceEEEEEeC---CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          255 LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ||+|+||.||+|.+.   ++..||+|.+...........|.+|+.++++++|+||+++++++. ....++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999753   355799999865543333456999999999999999999999875 4568899999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++....   ..+++..+.+++.|+++||+|||+.   +++||||||+|||++.++.+|++||+
T Consensus        82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg  140 (257)
T cd05115          82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFG  140 (257)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCC
Confidence            99997543   2488999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.89  E-value=4.3e-23  Score=190.96  Aligned_cols=145  Identities=30%  Similarity=0.443  Sum_probs=128.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ..+|+..+.||+|+||.||+|...++..+|+|.++... ......+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34577789999999999999998778999999986542 22344689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.++++....  ..+++.+...++.|++.||+|||+.   +|+||||||+||++++++.+|++||+
T Consensus        84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g  149 (261)
T cd05148          84 MEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG  149 (261)
T ss_pred             cccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence            999999999976432  3478999999999999999999998   89999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=6e-23  Score=191.95  Aligned_cols=136  Identities=26%  Similarity=0.346  Sum_probs=114.5

Q ss_pred             eeeccCCceEEEEEeCC-------------------------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccc
Q 015852          254 ILGRGGFGKVYKGRLAD-------------------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR  308 (399)
Q Consensus       254 ~lG~G~fg~Vy~~~~~~-------------------------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~  308 (399)
                      .||+|+||.||+|.+..                         ...|++|.+.... ......|.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            58999999999997421                         1358899885432 222346889999999999999999


Q ss_pred             eeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC
Q 015852          309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       309 l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~  388 (399)
                      ++++|......++||||+++|+|..+++....   .+++..+..++.|+++||+|||+.   +|+||||||+|||+++++
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence            99999999999999999999999999875332   478899999999999999999998   999999999999998654


Q ss_pred             c-------eeecccc
Q 015852          389 D-------QSSKTIL  396 (399)
Q Consensus       389 ~-------~~i~df~  396 (399)
                      .       .|++||+
T Consensus       155 ~~~~~~~~~kl~d~g  169 (274)
T cd05076         155 LAEGTSPFIKLSDPG  169 (274)
T ss_pred             cccCccceeeecCCc
Confidence            2       6899984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.89  E-value=9.2e-23  Score=190.30  Aligned_cols=147  Identities=25%  Similarity=0.473  Sum_probs=126.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|.....||+|+||.||+|+..      +.+.+++|.+...........+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46777889999999999999853      346799998854322223457999999999999999999999999888999


Q ss_pred             EEEecCCCCChhhHhhhcCCCC-----CCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSL-----PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      +||||+++|+|.++++......     ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997654221     2589999999999999999999998   9999999999999999999999998


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      .
T Consensus       162 ~  162 (275)
T cd05046         162 S  162 (275)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.89  E-value=1.3e-22  Score=189.06  Aligned_cols=141  Identities=30%  Similarity=0.493  Sum_probs=120.7

Q ss_pred             ceeeccCCceEEEEEeC-CCC--EEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~--~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|+||.||+|+.. ++.  .+++|.++..........+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46899999999999864 343  47889886543333445789999999999 799999999999999999999999999


Q ss_pred             CChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|.++++....            ....+++.+...++.|++.||+|||+.   +++||||||+||++++++.+|++||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999976431            112478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.3e-22  Score=187.19  Aligned_cols=143  Identities=30%  Similarity=0.487  Sum_probs=127.4

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .++|+..+.||+|+||.||++... ++.||+|.++....  ...++.+|+.+++.++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            346777899999999999999874 78899999865432  345799999999999999999999999988899999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++.....  ..++|.....++.|++.||.|||+.   +++||||||+||++++++.++++||.
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g  147 (256)
T cd05039          82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFG  147 (256)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccc
Confidence            999999999976532  2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.89  E-value=8.3e-23  Score=199.50  Aligned_cols=141  Identities=26%  Similarity=0.338  Sum_probs=121.5

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC-----ceE
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  320 (399)
                      +|+..+.||+|+||.||++.. .+++.||+|++...... .....+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            467789999999999999985 47899999998543221 22346889999999999999999999998776     789


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+||+. ++|.+.+....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  148 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFG  148 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccc
Confidence            9999997 57888775432    488999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.89  E-value=6.2e-23  Score=194.63  Aligned_cols=147  Identities=29%  Similarity=0.380  Sum_probs=126.8

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCC
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  317 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  317 (399)
                      ..++|...+.||+|+||.||++..      .++..||+|.++..........+.+|+.+++++ +|+||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            345688889999999999999963      134579999986543333344689999999999 7999999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..+++|||+++|+|.++++....  ..+++.+...++.|++.||+|||+.   +|+|+||||+|||+++++.++++||+
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence            99999999999999999975432  2378999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.89  E-value=7.6e-23  Score=195.05  Aligned_cols=149  Identities=28%  Similarity=0.444  Sum_probs=126.5

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC--------CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeec
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  315 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  315 (399)
                      ..++|...+.||+|+||.||+++..        ....+|+|.++..........+.+|+.+++.+ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3456778899999999999999641        24579999986543333344688999999999 69999999999998


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCcee
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  383 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NIL  383 (399)
                      ....+++|||+++|+|.+++.....            ....++|.+...++.|++.||+|||+.   +|+||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence            8889999999999999999976431            123488999999999999999999998   9999999999999


Q ss_pred             eCCCCceeecccc
Q 015852          384 LDEDADQSSKTIL  396 (399)
Q Consensus       384 ld~~~~~~i~df~  396 (399)
                      +++++.+|++||+
T Consensus       167 l~~~~~~kL~Dfg  179 (314)
T cd05099         167 VTEDNVMKIADFG  179 (314)
T ss_pred             EcCCCcEEEcccc
Confidence            9999999999995

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.89  E-value=1e-22  Score=192.03  Aligned_cols=148  Identities=28%  Similarity=0.398  Sum_probs=127.3

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCC-----------------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccc
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLAD-----------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR  308 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~  308 (399)
                      ..+|...+.||+|+||.||++....                 +..||+|.+...........+.+|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3467788999999999999987532                 24689999875543344557999999999999999999


Q ss_pred             eeeeeecCCceEEEEecCCCCChhhHhhhcCC-------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCc
Q 015852          309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  381 (399)
Q Consensus       309 l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~N  381 (399)
                      +++++...+..++++||+++++|.+++.....       ....+++.....++.|++.||+|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999998999999999999999999976531       112578999999999999999999998   99999999999


Q ss_pred             eeeCCCCceeecccc
Q 015852          382 ILLDEDADQSSKTIL  396 (399)
Q Consensus       382 ILld~~~~~~i~df~  396 (399)
                      |++++++.++++||+
T Consensus       161 ili~~~~~~~l~dfg  175 (296)
T cd05051         161 CLVGKNYTIKIADFG  175 (296)
T ss_pred             eeecCCCceEEcccc
Confidence            999999999999994

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=4.2e-23  Score=208.51  Aligned_cols=149  Identities=21%  Similarity=0.234  Sum_probs=126.1

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC-----
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----  317 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----  317 (399)
                      ..++|...+.||+|+||+||+++. .+++.||||.+...... .....+.+|+..+..++|+|++++...+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            345788889999999999999985 57899999998654322 23346889999999999999999887765432     


Q ss_pred             ---ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecc
Q 015852          318 ---EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  394 (399)
Q Consensus       318 ---~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~d  394 (399)
                         ..++||||+++|+|.++++.+......+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               25799999999999999986544445688899999999999999999998   999999999999999999999999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       187 FG  188 (496)
T PTZ00283        187 FG  188 (496)
T ss_pred             cc
Confidence            95

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.89  E-value=1.1e-22  Score=192.51  Aligned_cols=143  Identities=27%  Similarity=0.450  Sum_probs=125.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            45777899999999999999864 67899999986544344444688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++ ++|.+++.....   .+++.....++.|+++||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  149 (301)
T cd07873          86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (301)
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCc
Confidence            97 589988875432   478889999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.89  E-value=1.1e-22  Score=187.86  Aligned_cols=135  Identities=27%  Similarity=0.431  Sum_probs=116.8

Q ss_pred             ceeeccCCceEEEEEeCC-C----------CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          253 NILGRGGFGKVYKGRLAD-G----------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~-~----------~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +.||+|+||.||+|...+ +          ..+++|.++.....  ...|.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            468999999999998753 3          25788877543222  5679999999999999999999999988 77899


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-------ceeecc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-------DQSSKT  394 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-------~~~i~d  394 (399)
                      ||||+++|+|.++++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++       .++++|
T Consensus        78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            9999999999999986432   478999999999999999999998   999999999999999988       799999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       152 fg  153 (259)
T cd05037         152 PG  153 (259)
T ss_pred             CC
Confidence            95

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.89  E-value=2.1e-23  Score=205.88  Aligned_cols=144  Identities=28%  Similarity=0.415  Sum_probs=123.3

Q ss_pred             CCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC------ceEEE
Q 015852          250 SNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------EKLLV  322 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv  322 (399)
                      ...+.||+|+||.||+|+. .+|+.||||.++............+|++++++++|+|||++.+.-.+..      ...++
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            3457899999999999994 5799999999987766666778999999999999999999998765443      56899


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC--CCc--eeeccccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DAD--QSSKTILR  397 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~--~~~--~~i~df~~  397 (399)
                      ||||.+|||...|.+-. ....++..+.+.+..+++.||.|||++   +||||||||.||++-.  |+.  -|++||+.
T Consensus        96 mEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999998653 334589999999999999999999998   9999999999999854  343  59999964

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.3e-22  Score=187.77  Aligned_cols=145  Identities=30%  Similarity=0.450  Sum_probs=129.1

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..++|...+.||+|+||.||++...+++.+|||.+....  ....++.+|+.+++.++|+||+++++++......+++||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            446788889999999999999998778889999986432  234579999999999999999999999998889999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++.....  ..+++..+..++.+++.||+|||+.   +++|+||||+||++++++.++++||+
T Consensus        82 ~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          82 YMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             ccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccc
Confidence            9999999999976432  2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.89  E-value=1.6e-22  Score=188.27  Aligned_cols=144  Identities=28%  Similarity=0.413  Sum_probs=118.5

Q ss_pred             CCCceeeccCCceEEEEEeCC-CC--EEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC------Cce
Q 015852          250 SNKNILGRGGFGKVYKGRLAD-GK--LVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEK  319 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~~-~~--~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~  319 (399)
                      ...+.||+|+||.||+|+..+ +.  .+|+|.++..... .....|.+|+++++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999998654 33  6899988654322 2234689999999999999999999987532      246


Q ss_pred             EEEEecCCCCChhhHhhhcC--CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++||+++|+|.+++....  .....+++.....++.|++.||+|||+.   +|+||||||+|||+++++.++|+||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            89999999999999875322  1223478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.89  E-value=1.7e-22  Score=190.11  Aligned_cols=143  Identities=29%  Similarity=0.492  Sum_probs=117.6

Q ss_pred             CCCCCceeeccCCceEEEEEe-C-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeeeec-----C
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-A-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTT-----V  316 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~  316 (399)
                      +|...+.||+|+||+||+|+. . +++.||+|.++...... ....+.+|+.+++.+   +||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            577789999999999999985 3 46789999986543222 233566777776655   69999999998852     3


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ...++||||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++||+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            45789999997 689999875432  2478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.89  E-value=1.8e-22  Score=187.52  Aligned_cols=142  Identities=27%  Similarity=0.410  Sum_probs=125.6

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|+..+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            4677889999999999999985 578899999985432 22234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.++++...    .+++.+...++.|++.||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg  151 (267)
T cd06646          88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFG  151 (267)
T ss_pred             CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCc
Confidence            99999999987542    478899999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.89  E-value=1e-22  Score=195.92  Aligned_cols=148  Identities=29%  Similarity=0.432  Sum_probs=125.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC--------CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  316 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  316 (399)
                      ..+|...+.||+|+||.||+++..        ....||+|.++.........++.+|+.++.++ +|+||++++++|...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            345777899999999999999642        12368999886543333445789999999999 799999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  384 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl  384 (399)
                      +..++++||+++|+|.+++.....            ....++|.++..++.|++.||+|||+.   +|+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            999999999999999999976421            123478999999999999999999998   99999999999999


Q ss_pred             CCCCceeecccc
Q 015852          385 DEDADQSSKTIL  396 (399)
Q Consensus       385 d~~~~~~i~df~  396 (399)
                      ++++.+||+||.
T Consensus       168 ~~~~~~kL~Dfg  179 (334)
T cd05100         168 TEDNVMKIADFG  179 (334)
T ss_pred             cCCCcEEECCcc
Confidence            999999999994

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-23  Score=202.16  Aligned_cols=132  Identities=32%  Similarity=0.496  Sum_probs=116.9

Q ss_pred             CCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++..+-||.|+-|.||.|++. ++.||||+++..        -..+|.-|++++|+||+.+.|+|......+||||||+.
T Consensus       126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            344567999999999999985 578999988543        23568889999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |-|++.|+...    .+.-...+.+..+||.||.|||.+   .|||||||+-||||..+..+||+||+
T Consensus       197 GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFG  257 (904)
T KOG4721|consen  197 GQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFG  257 (904)
T ss_pred             ccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecccc
Confidence            99999998754    356677788899999999999999   99999999999999999999999996

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.89  E-value=1.3e-22  Score=187.73  Aligned_cols=144  Identities=28%  Similarity=0.406  Sum_probs=125.9

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..++|...+.||+|+||.||+|...+++.||+|.+....  .....|.+|+.+++.++|+||+++++++ ..+..+++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e   80 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITE   80 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEE
Confidence            345677889999999999999998888999999986432  2345789999999999999999999986 4567899999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++.....  ..+++.+...++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          81 YMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             cCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCc
Confidence            9999999999875432  3578999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.89  E-value=1.3e-22  Score=194.57  Aligned_cols=140  Identities=23%  Similarity=0.315  Sum_probs=121.6

Q ss_pred             Cceeecc--CCceEEEEEe-CCCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          252 KNILGRG--GFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       252 ~~~lG~G--~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      .++||+|  +|++||++.. .+++.||+|+++....... ...+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4789999  6789999986 4789999999965433222 3357789999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||.
T Consensus        83 ~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~  146 (327)
T cd08227          83 YGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR  146 (327)
T ss_pred             CCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccc
Confidence            9999999975422  2478999999999999999999998   99999999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.89  E-value=1.5e-22  Score=190.46  Aligned_cols=146  Identities=28%  Similarity=0.461  Sum_probs=125.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|...+.||+|+||+||++...      ++..+|+|.+.... ......+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46777899999999999999742      34568999885432 223446999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCC---------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          321 LVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      ++|||+++++|.+++.....         ....+++.....++.|++.||+|||+.   +++||||||+|||+++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            99999999999999975421         223489999999999999999999998   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      ++||+
T Consensus       161 l~dfg  165 (288)
T cd05093         161 IGDFG  165 (288)
T ss_pred             eccCC
Confidence            99994

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=1.4e-22  Score=190.00  Aligned_cols=139  Identities=30%  Similarity=0.459  Sum_probs=120.6

Q ss_pred             CCCceeeccCCceEEEEEe-----CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEEE
Q 015852          250 SNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  322 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  322 (399)
                      ...+.||+|+||+||.+..     .++..||+|.++..........|.+|+++++.++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6678999999999987643     357789999986543333445789999999999999999999988654  357899


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++...     .+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.++++||+
T Consensus        87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence            9999999999999753     389999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.89  E-value=1.6e-22  Score=187.55  Aligned_cols=143  Identities=29%  Similarity=0.411  Sum_probs=125.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .+|...+.||+|+||.||+|... +++.||+|.++..  .....++.+|+++++.++|+||+++++++...+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            34667789999999999999864 5889999998643  22344689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++.....  ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+|++||.
T Consensus        84 ~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~  149 (263)
T cd05052          84 MTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  149 (263)
T ss_pred             CCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCc
Confidence            999999999976432  3478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.6e-22  Score=189.25  Aligned_cols=143  Identities=27%  Similarity=0.484  Sum_probs=123.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|...+.||+|+||.||+|... ++.    .+|+|.++..........+.+|+.+++.++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45667789999999999999854 333    6899988655433334578999999999999999999999987 78899


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||+++|+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||.
T Consensus        86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCc
Confidence            9999999999999976432   478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.89  E-value=2e-22  Score=187.45  Aligned_cols=145  Identities=30%  Similarity=0.430  Sum_probs=121.7

Q ss_pred             CCCCceeeccCCceEEEEEeC-C---CCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCc-----
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  318 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~---~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----  318 (399)
                      |...+.||+|+||.||+|... +   +..||+|.++...... ....+.+|++.++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456788999999999999864 2   3679999987543322 23468999999999999999999998876554     


Q ss_pred             -eEEEEecCCCCChhhHhhhcCC--CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          319 -KLLVYPYMTNGSVASRLRERQS--SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       319 -~~lv~e~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                       .++++||+++|+|..++.....  ....+++.....++.|++.||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             6899999999999999865321  123578999999999999999999998   9999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       158 g  158 (273)
T cd05035         158 G  158 (273)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.89  E-value=1.1e-22  Score=190.21  Aligned_cols=148  Identities=31%  Similarity=0.403  Sum_probs=126.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      .++|...+.||+|+||.||+|...      .+..||+|.+...........|.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            456788899999999999999864      35689999886544333445799999999999999999999999998899


Q ss_pred             EEEEecCCCCChhhHhhhcCCC---CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeec
Q 015852          320 LLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSK  393 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~  393 (399)
                      +++|||+++|+|.+++......   ...++|..+..++.||+.||+|||+.   +++||||||+||++++++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            9999999999999999764321   12588999999999999999999998   899999999999999765   58999


Q ss_pred             ccc
Q 015852          394 TIL  396 (399)
Q Consensus       394 df~  396 (399)
                      ||+
T Consensus       162 dfg  164 (277)
T cd05036         162 DFG  164 (277)
T ss_pred             cCc
Confidence            994

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.89  E-value=1e-22  Score=189.05  Aligned_cols=147  Identities=20%  Similarity=0.304  Sum_probs=127.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||.||++.. .+++.+|||.+......  ....++.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3567778999999999999985 57899999987543221  22346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++.........+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++++||+
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence            99999999999875333334578999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.89  E-value=1.8e-22  Score=189.03  Aligned_cols=137  Identities=26%  Similarity=0.350  Sum_probs=118.7

Q ss_pred             eeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ||+|+||.||+++.. +++.||+|.+......  .....+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 6899999998643222  1233466799999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++.....  ..+++.....++.|++.||+|||+.   +|+||||||+||++++++.++|+||+
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg  140 (277)
T cd05607          81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLG  140 (277)
T ss_pred             HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeece
Confidence            988865432  2478999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.89  E-value=1.4e-22  Score=189.87  Aligned_cols=147  Identities=24%  Similarity=0.331  Sum_probs=123.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHH-HhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|+..+.||+|+||.||+++.. +++.||+|+++.........++..|+.. ++..+||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            35777899999999999999864 6899999998654333334456666665 667789999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++ |+|.+++.........+++.....++.|++.||+|||+++  +++||||||+||++++++.+||+||+
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg  149 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG  149 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecc
Confidence            997 7898888764333346899999999999999999999753  79999999999999999999999994

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.89  E-value=8.4e-23  Score=191.49  Aligned_cols=145  Identities=25%  Similarity=0.375  Sum_probs=122.8

Q ss_pred             CCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      |...+.||+|+||.||+|...      +++.||+|+++..........|.+|+.++..++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            444578999999999999753      24689999997543322234688999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCce
Q 015852          323 YPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  390 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~  390 (399)
                      +||+++++|.+++.....            ....+++.....++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence            999999999999863211            112478888999999999999999998   99999999999999999999


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      |++||+
T Consensus       164 kl~Dfg  169 (283)
T cd05091         164 KISDLG  169 (283)
T ss_pred             Eecccc
Confidence            999995

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.89  E-value=1.7e-22  Score=190.01  Aligned_cols=143  Identities=28%  Similarity=0.367  Sum_probs=123.9

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      |...+.||+|+||+||++.. .+++.+|+|.+......  .....+.+|+++++.++|+|++++.+++...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            45568899999999999986 46889999998543222  1233578899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++.....  ..+++.....++.|++.||.|||+.   +|+||||||+||++++++.++++||+
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg  147 (285)
T cd05632          82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCC
Confidence            999999988865422  2489999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.89  E-value=1.8e-22  Score=189.06  Aligned_cols=138  Identities=25%  Similarity=0.356  Sum_probs=121.5

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +|+..++||+|+||.||+|.. .+++.||+|.+...........+.+|+.++..++||||+++++++...+..+++|||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            466778999999999999985 5788999999865433333456899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|..+.        .+++.....++.|++.||+|||+.   +|+|+||||+|||++.++.++|+||+
T Consensus        82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg  140 (279)
T cd06619          82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFG  140 (279)
T ss_pred             CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCC
Confidence            999986552        267788899999999999999998   99999999999999999999999994

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=7.6e-23  Score=199.27  Aligned_cols=144  Identities=25%  Similarity=0.369  Sum_probs=127.1

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ...|.....||+|.|++|..++.. ++..||+|.+.+...... .+.+.+|+++|..++|||||+++.+.......|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            456777899999999999999854 688999999976543332 345899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+.+|.+++++.+...    ........+..|+..+++|+|++   .|||||||++|||||.+++.||+||.
T Consensus       135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfg  200 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFG  200 (596)
T ss_pred             EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccc
Confidence            99999999999987642    44577888899999999999999   99999999999999999999999995

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.89  E-value=2.1e-22  Score=186.82  Aligned_cols=142  Identities=26%  Similarity=0.458  Sum_probs=125.1

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc-----ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      +|...+.||+|+||.||+|...+++.+|+|.++.....     .....+.+|+++++.++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            36677899999999999998888899999988643221     1123588999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+|+||||+||++++++.++++||.
T Consensus        81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  147 (265)
T cd06631          81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFG  147 (265)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccch
Confidence            99999999999997542    378889999999999999999998   89999999999999999999999994

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.89  E-value=2e-22  Score=189.73  Aligned_cols=143  Identities=25%  Similarity=0.466  Sum_probs=125.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            46777899999999999999865 68899999986543333334578899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +.+ +|.+++.....   .+++.....++.|++.||.|||+.   +|+||||||+||++++++.++++||+
T Consensus        85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  148 (291)
T cd07844          85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFG  148 (291)
T ss_pred             CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccc
Confidence            984 99998875432   478899999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.4e-22  Score=194.67  Aligned_cols=135  Identities=24%  Similarity=0.271  Sum_probs=114.8

Q ss_pred             eeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcC---CCCCccceeeeeecCCceEEEEecCCC
Q 015852          255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA---VHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ||+|+||+||+|+.. +++.||||++......  .....+..|..++...   +||||+++++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999864 6899999998543211  1222455666666554   699999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....    .+++.....++.|+++||+|||+.   +|+||||||+|||+++++.++|+||+
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (330)
T cd05586          81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFG  141 (330)
T ss_pred             ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCC
Confidence            99999987542    478899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-23  Score=203.30  Aligned_cols=141  Identities=31%  Similarity=0.449  Sum_probs=121.8

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      |+..+.||.|+||.||-++. .+.+.||||++.-......  ..++..|+..++.++|||+|.+.|+|......|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            45567899999999999985 5788999999854333222  23689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |- |+-.+++.-.+.   ++..-.+..|+.+...||+|||++   +.||||||+.|||+.+.|.+|++||+
T Consensus       108 Cl-GSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFG  171 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFG  171 (948)
T ss_pred             Hh-ccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecccc
Confidence            96 577777765443   577888999999999999999999   99999999999999999999999996

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.88  E-value=2.5e-22  Score=186.36  Aligned_cols=142  Identities=27%  Similarity=0.419  Sum_probs=123.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ++|...+.||+|+||.||+|+..+...||+|.++...  .....|.+|+++++.++|+||+++++++. ....+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            4577788999999999999988766789999986432  23347899999999999999999999874 45678999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.++++....  ..++|..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+||+
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg  147 (262)
T cd05071          83 SKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  147 (262)
T ss_pred             CCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCC
Confidence            99999999976422  2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.88  E-value=2e-22  Score=186.54  Aligned_cols=143  Identities=28%  Similarity=0.443  Sum_probs=124.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .++|...+.||+|+||.||++...++..+|+|.++....  ....|.+|+.++++++|+|++++++++. ....+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            346777889999999999999988888899999865322  2356999999999999999999999875 4568899999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.++++....  ..+++.++..++.+++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg  147 (260)
T cd05070          82 MSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFG  147 (260)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCce
Confidence            999999999976422  3478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.88  E-value=2.1e-22  Score=187.29  Aligned_cols=147  Identities=25%  Similarity=0.363  Sum_probs=126.1

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +.+++.+.....||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            445667777789999999999999854 67889999885432 2234478999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCC--ChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPL--DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~~i~df~  396 (399)
                      ++||+++++|.++++....   .+  ++.....++.|++.||+|||+.   +|+||||||+||+++. ++.++++||+
T Consensus        83 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EEecCCCCCHHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecch
Confidence            9999999999999986422   24  7788889999999999999998   9999999999999987 6789999994

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.88  E-value=2.7e-22  Score=188.63  Aligned_cols=143  Identities=27%  Similarity=0.371  Sum_probs=123.8

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      |+..+.||+|+||.||++... +++.||+|.+.......  ....+.+|+.+++.++|+|++++.+.+...+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            556688999999999999864 68899999986432222  123578899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++++||+
T Consensus        82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05630          82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG  147 (285)
T ss_pred             cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecc
Confidence            999999999865322  2478899999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.88  E-value=1.9e-22  Score=210.51  Aligned_cols=143  Identities=31%  Similarity=0.399  Sum_probs=126.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|+++......  ....+.+|+.++..++|+||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56777899999999999999865 68899999986432221  2346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.++++...    .+++.....|+.||+.||+|||..   +||||||||+|||++.++.+||+||+
T Consensus        84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence            9999999999997542    378888999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.88  E-value=4e-22  Score=183.76  Aligned_cols=141  Identities=34%  Similarity=0.531  Sum_probs=124.5

Q ss_pred             ceeeccCCceEEEEEeCC----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||.||++....    +..|++|.++..........+.+|++.++.++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998653    7889999997654433355799999999999999999999999998999999999999


Q ss_pred             CChhhHhhhcCCC-----CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSS-----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|.+++......     ...+++.....++.|++.||+|||+.   +++||||||+||++++++.++++||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg  150 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFG  150 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccc
Confidence            9999999875211     24589999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.88  E-value=4.4e-22  Score=183.60  Aligned_cols=144  Identities=17%  Similarity=0.296  Sum_probs=125.8

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +|+..+.||+|+||.||++... +++.+|+|.++..........+.+|+.+++.++|+||+++.+.+...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            3566789999999999999854 688999999864433334457889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.+++.....  ..+++.....++.|++.||.|||+.   +|+|+||||+||++++++.++++||+
T Consensus        81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg  145 (255)
T cd08219          81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFG  145 (255)
T ss_pred             CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccC
Confidence            99999999875322  2478889999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.88  E-value=2.8e-22  Score=188.74  Aligned_cols=144  Identities=25%  Similarity=0.380  Sum_probs=124.3

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +++|...+.||+|+||.||+|.. .+++.||+|.++..........+.+|+.+++.++|+||+++.+++...+..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            45788889999999999999985 46889999998654433334467899999999999999999999999989999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+. +++.+++....   ..+.+.....++.|++.||+|||+.   +|+||||||+||+++.+++++|+||+
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence            996 77877765432   2367888899999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.88  E-value=3.7e-22  Score=183.90  Aligned_cols=144  Identities=24%  Similarity=0.357  Sum_probs=126.3

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.||++... +++.|++|.+.... .......+.+|+++++.++|||++++++++...+..+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3666789999999999999864 68899999885432 223345789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.++++....  ..+++.....++.|++.||.|||+.   +++||||||+||++++++.++++||+
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~  146 (256)
T cd08529          81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLG  146 (256)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccc
Confidence            999999999986422  3578899999999999999999988   99999999999999999999999994

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.7e-22  Score=184.76  Aligned_cols=143  Identities=27%  Similarity=0.432  Sum_probs=125.8

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc----cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|...+.||+|+||.||++.. .+++.+|+|.++......    ....+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688889999999999999985 468899999886432211    22368899999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++|+||+
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg  149 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  149 (263)
T ss_pred             EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999999999987642    378888999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=1.7e-22  Score=189.64  Aligned_cols=146  Identities=25%  Similarity=0.356  Sum_probs=126.3

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +|+..+.||+|+||.||++... ++..||+|.++..........+.+|+.++.+++|+||+++++++...+..+++|||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            4667789999999999999875 789999998865433333457899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|.++++... ....+++.....++.+++.||.|||+.+  +|+||||||+||+++.++.++++||+
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecC
Confidence            9999999987532 1235899999999999999999999632  89999999999999999999999995

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.88  E-value=4.3e-23  Score=180.49  Aligned_cols=148  Identities=28%  Similarity=0.342  Sum_probs=129.4

Q ss_pred             cCCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC-----CceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~  320 (399)
                      .+|...+.||+|+|+.||.++ ..+++.+|+|++.... .++....++|++..++++||||+++++++...     .+.|
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            456777999999999999998 6788999999996543 34445689999999999999999999887643     3489


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|...|+|.+.+.........+++.+.+.|+.+|++||++||+. .|+.+||||||.|||+.+++++.+.||+
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            99999999999999987655555689999999999999999999998 5679999999999999999999999995

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.88  E-value=3.3e-22  Score=185.19  Aligned_cols=142  Identities=28%  Similarity=0.405  Sum_probs=123.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ++|...+.||+|+||.||++....+..+|+|.+....  .....|.+|+.+++.++|+|++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4567778999999999999988777789999885432  23456899999999999999999998875 45688999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.++++....  ..++|..+..++.|++.||+|||+.   +++||||||+||++++++.++++||+
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg  147 (260)
T cd05069          83 GKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFG  147 (260)
T ss_pred             CCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCc
Confidence            99999999976432  3478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.88  E-value=4e-23  Score=172.64  Aligned_cols=140  Identities=23%  Similarity=0.415  Sum_probs=120.2

Q ss_pred             CCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccH-HHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          250 SNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~-~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      ...+.||+|.||+||+|+ ..+++.||+|+++.+...+.. ..-.+|+.+++.++|+|||++++...++...-+|+|||.
T Consensus         5 dkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd   84 (292)
T KOG0662|consen    5 DKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_pred             HHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh
Confidence            334779999999999998 457889999999765443332 357899999999999999999999988999999999996


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                       .+|..+.....   ..++-.....++.|+.+||.|.|++   ++.|||+||.|.|++.+|+.|++||+
T Consensus        85 -qdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfg  146 (292)
T KOG0662|consen   85 -QDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFG  146 (292)
T ss_pred             -HHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccc
Confidence             47877775432   3478888889999999999999999   99999999999999999999999993

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=3.5e-22  Score=185.50  Aligned_cols=137  Identities=26%  Similarity=0.380  Sum_probs=115.9

Q ss_pred             ceeeccCCceEEEEEeCC-------------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          253 NILGRGGFGKVYKGRLAD-------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~-------------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      +.||+|+||.||+|...+             ...|++|.+.... ......|.+|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            358999999999997532             2258888875432 22334688999999999999999999999998899


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc-------eee
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-------QSS  392 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~-------~~i  392 (399)
                      +++|||+++|+|..+++...   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.       +++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence            99999999999999887543   2478999999999999999999998   9999999999999987764       789


Q ss_pred             cccc
Q 015852          393 KTIL  396 (399)
Q Consensus       393 ~df~  396 (399)
                      +||+
T Consensus       154 ~d~g  157 (262)
T cd05077         154 SDPG  157 (262)
T ss_pred             CCCC
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.88  E-value=2.6e-23  Score=184.14  Aligned_cols=143  Identities=27%  Similarity=0.376  Sum_probs=122.9

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc---c----HHHHHHHHHHHhcCC-CCCccceeeeeecCC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG---G----ELQFQTEVKIISMAV-HRNLLRLYGFCTTVT  317 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~---~----~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~  317 (399)
                      +.|...++||+|..+.|.++.. .+|+.+|+|++.......   .    ...-.+|+.+++++. ||+|+++.++|.++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            3567778999999999998865 478899999985332211   1    123567999998875 999999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..++|+|.|+.|.|.++|...-    .++.....+|+.|+.+|++|||..   +||||||||+|||+|++++++|+||+
T Consensus        97 F~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence            9999999999999999997653    488999999999999999999999   99999999999999999999999993

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.88  E-value=3.1e-22  Score=184.77  Aligned_cols=138  Identities=35%  Similarity=0.450  Sum_probs=121.0

Q ss_pred             ceeeccCCceEEEEEeCC--C--CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLAD--G--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~--~--~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ++||+|++|.||+|.+.+  +  ..||+|.++..........|.+|+.++++++|+||+++++.+.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  36999999765443344579999999999999999999999888 888999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|.+++.....  ..++|.....++.|+++||+|||+.   +++||||||+||+++.++.+|++||+
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg  142 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFG  142 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccc
Confidence            999999987532  3589999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.88  E-value=3e-22  Score=185.47  Aligned_cols=144  Identities=24%  Similarity=0.374  Sum_probs=125.9

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..++|...+.||+|+||.||++...++..+|+|.++..  ......|.+|+++++.++|+||+++.+++.. ...+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            34567888999999999999998777788999988643  2233478999999999999999999999877 77899999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||.
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          81 FMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             eCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCc
Confidence            9999999999976432  3478899999999999999999988   99999999999999999999999993

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=2.4e-22  Score=200.39  Aligned_cols=137  Identities=23%  Similarity=0.265  Sum_probs=121.0

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..+|...+.||+|+||.||++... +++.||||....       ..+.+|++++++++|+|||++++++...+..+++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            346888899999999999999865 578899996421       246789999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+. ++|.+++....   ..++|.++..|+.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       241 ~~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFG  305 (461)
T PHA03211        241 KYR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFG  305 (461)
T ss_pred             ccC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccC
Confidence            995 78998886542   2589999999999999999999998   99999999999999999999999995

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.88  E-value=4.1e-22  Score=186.47  Aligned_cols=143  Identities=26%  Similarity=0.420  Sum_probs=124.2

Q ss_pred             CCCCCceeeccCCceEEEEEeC-----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec--CCceE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  320 (399)
                      .|...+.||+|+||.||++++.     +++.+|||.++..........|.+|+.+++.++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4566688999999999999853     3678999998654332234579999999999999999999999877  55789


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|||+++++|.+++.....   .++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+
T Consensus        85 lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             EEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence            99999999999999976432   488999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.88  E-value=4.6e-22  Score=184.14  Aligned_cols=138  Identities=31%  Similarity=0.458  Sum_probs=116.3

Q ss_pred             ceeeccCCceEEEEEeC----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec-CCceEEEEecCC
Q 015852          253 NILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPYMT  327 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~  327 (399)
                      +.||+|+||.||+|...    +...+|+|.+...........+.+|+.+++.++||||+++++++.. .+..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    2357999988543222334578899999999999999999998764 456789999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+|.++++....   ..++.....++.|++.||+|||+.   +++||||||+|||+++++.+|++||+
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg  143 (262)
T cd05058          81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFG  143 (262)
T ss_pred             CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcc
Confidence            9999999975432   357788899999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.88  E-value=3.7e-22  Score=188.05  Aligned_cols=142  Identities=30%  Similarity=0.393  Sum_probs=125.8

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +|+..+.||+|+||.||++... +++.+|+|.++.....  .....+.+|++++++++||||+++++++......+++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            5777899999999999999864 6889999998643221  223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+||+
T Consensus        82 ~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          82 YVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             cCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence            999999999997652    478899999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.88  E-value=6.5e-22  Score=182.34  Aligned_cols=141  Identities=27%  Similarity=0.436  Sum_probs=124.5

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc----ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      |...+.||+|+||+||+|... +++.|++|.+......    .....+.+|+.+++.++|+||+++++++......++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            566789999999999999875 7889999988543211    12346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.++++...    .+++.....++.|++.||+|||+.   +|+|+||||+||++++++.+||+||.
T Consensus        82 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~  147 (258)
T cd06632          82 ELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFG  147 (258)
T ss_pred             EecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999997542    478999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.88  E-value=2e-22  Score=189.10  Aligned_cols=153  Identities=26%  Similarity=0.345  Sum_probs=128.1

Q ss_pred             HHHHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeee--
Q 015852          239 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT--  314 (399)
Q Consensus       239 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~--  314 (399)
                      ++.+....++|+..+.||+|+||.||++... +++.+|+|.++..  ......+.+|+.+++.+ +|+||+++++++.  
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3455567788999999999999999999864 6789999987542  22234688899999998 6999999999874  


Q ss_pred             ---cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          315 ---TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       315 ---~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                         ..+..+++|||+++|+|.++++........+++.....++.|+++||.|||+.   +|+||||||+||++++++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence               33568999999999999998865332233578889999999999999999998   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      ++||+
T Consensus       165 l~dfg  169 (286)
T cd06638         165 LVDFG  169 (286)
T ss_pred             EccCC
Confidence            99994

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.88  E-value=6.3e-22  Score=182.79  Aligned_cols=141  Identities=28%  Similarity=0.445  Sum_probs=122.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeee-cCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT-TVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||++... +..+|+|.++..   .....|.+|+.+++.++|+|++++++++. ..+..++++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46777899999999999999764 778999988543   23447899999999999999999999765 44568999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.++++....  ..+++.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||+
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg  147 (256)
T cd05082          82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFG  147 (256)
T ss_pred             CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCc
Confidence            999999999976432  2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=3.7e-22  Score=193.90  Aligned_cols=139  Identities=24%  Similarity=0.327  Sum_probs=121.7

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ....+|...+.||+|+||.||+|+.. +++.||+|.....       ....|+.++++++|+||+++++++......++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            34457999999999999999999865 5778999975322       245689999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||+. |+|.+++....   ..++|..+..|+.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       136 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             EEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence            99995 68988887543   2588999999999999999999998   99999999999999999999999995

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.88  E-value=4.9e-22  Score=186.29  Aligned_cols=144  Identities=21%  Similarity=0.361  Sum_probs=124.5

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.||+|+.. +++.||+|.++...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            3667789999999999999864 68899999986543222 234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++ ++|.+++..... ...+++.....++.|++.||+|||+.   +|+||||||+||++++++.++|+||+
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  146 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFG  146 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECccc
Confidence            98 689888865332 23588999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.88  E-value=5.5e-22  Score=185.92  Aligned_cols=143  Identities=23%  Similarity=0.359  Sum_probs=124.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++...... .....+.+|+.+++.++|+|++++++++......+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            35777889999999999999875 6889999988644322 223458899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++++.|..++....    .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||+
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccc
Confidence            999998888765432    478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.88  E-value=5.6e-22  Score=182.93  Aligned_cols=144  Identities=22%  Similarity=0.316  Sum_probs=126.0

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..++||+|+||.||.++. .+++.+++|.+.... ......++.+|++++++++|+||+++++++...+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            366779999999999999875 468899999885432 223345789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++....  ...+++.+...++.|++.||+|||+.   +++||||||+||++++++.+||+||.
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~  146 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFG  146 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCc
Confidence            99999999997643  23578999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.88  E-value=5.2e-22  Score=182.62  Aligned_cols=138  Identities=29%  Similarity=0.466  Sum_probs=123.0

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCChh
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  332 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  332 (399)
                      +.||+|+||.||++...+++.||+|.++..........|.+|+.+++.++|+||+++++++......+++|||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999976689999998865433333457999999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          333 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       333 ~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++....   .+++.....++.+++.||+|||+.   +++||||||+||+++.++.++++||+
T Consensus        81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g  138 (251)
T cd05041          81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFG  138 (251)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecc
Confidence            99976432   478899999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.88  E-value=2.7e-22  Score=199.94  Aligned_cols=142  Identities=23%  Similarity=0.325  Sum_probs=116.2

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC--------
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  316 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------  316 (399)
                      ..+|...+.||+|+||.||+|.. .+++.||||++....     ....+|+.+++.++||||+++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            35688889999999999999986 468899999884321     2345799999999999999998876432        


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeeccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  395 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df  395 (399)
                      ...++||||+++ +|.+++.........+++.....++.|++.||+|||+.   +|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            235689999985 77777754322334588999999999999999999998   999999999999999765 6999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       216 G  216 (440)
T PTZ00036        216 G  216 (440)
T ss_pred             c
Confidence            4

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.88  E-value=4.9e-22  Score=187.28  Aligned_cols=145  Identities=28%  Similarity=0.453  Sum_probs=124.1

Q ss_pred             CCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +|...+.||+|+||.||+++..      ++..+++|.++... ......+.+|+++++.++|+||+++++++...+..++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            4666789999999999999742      34568999885432 2223468999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc
Q 015852          322 VYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  389 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~  389 (399)
                      ||||+++++|.+++.....            ....++|..+..++.|++.||+|||+.   +|+||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            9999999999999975421            113478999999999999999999998   9999999999999999999


Q ss_pred             eeecccc
Q 015852          390 QSSKTIL  396 (399)
Q Consensus       390 ~~i~df~  396 (399)
                      ++++||+
T Consensus       162 ~~l~dfg  168 (291)
T cd05094         162 VKIGDFG  168 (291)
T ss_pred             EEECCCC
Confidence            9999994

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=2.7e-22  Score=188.25  Aligned_cols=144  Identities=24%  Similarity=0.331  Sum_probs=125.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|+..+.||+|+||+||++... +++.||+|.+...........+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            34566688999999999999854 68899999886543333445799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++++..    .+++.....++.+++.||.|||+..  +++||||||+||++++++.++++||+
T Consensus        85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~g  149 (284)
T cd06620          85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFG  149 (284)
T ss_pred             CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCC
Confidence            99999999987642    4789999999999999999999731  79999999999999999999999995

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.88  E-value=3.1e-22  Score=193.67  Aligned_cols=142  Identities=25%  Similarity=0.354  Sum_probs=125.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv  322 (399)
                      +.|...+.||+|.||.||+++.. +|+.+|+|.++......  ......+|+.+|+.+. |||||.+.+.+.+....++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            45677789999999999999865 59999999996654432  2357899999999999 99999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC----Cceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED----ADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~----~~~~i~df~  396 (399)
                      ||++.+|.|.+.+...     .++..+...++.|++.++.|||+.   +|+||||||+|+|+...    +..|++||+
T Consensus       115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999875     278999999999999999999998   99999999999999865    368999995

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.88  E-value=5.2e-22  Score=187.82  Aligned_cols=141  Identities=23%  Similarity=0.353  Sum_probs=125.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .+|...+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            4678889999999999999985 5789999999854322 2334688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++.+.     .+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.++++||+
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg  160 (297)
T cd06656          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  160 (297)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence            9999999998653     378889999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.88  E-value=6.3e-22  Score=182.97  Aligned_cols=135  Identities=25%  Similarity=0.380  Sum_probs=116.9

Q ss_pred             eeeccCCceEEEEEe---CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCC
Q 015852          254 ILGRGGFGKVYKGRL---ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       254 ~lG~G~fg~Vy~~~~---~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      .||+|+||.||+|.+   .++..+|+|+++..... ....++.+|+.+++.++|+||+++++++. .+..+++|||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964   35788999998644322 22446899999999999999999999875 45678999999999


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||+
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg  140 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFG  140 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCc
Confidence            9999997542    478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.88  E-value=5.6e-22  Score=184.06  Aligned_cols=143  Identities=26%  Similarity=0.413  Sum_probs=122.2

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc----ccHHHHHHHHHHHhcCCCCCccceeeeeecC--Cce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~  319 (399)
                      .+|...+.||+|+||.||++.. .++..||+|.+......    .....+.+|+.+++.++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4677889999999999999986 46889999988533211    1123688899999999999999999988664  457


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+|+||||+||++++++.++|+||+
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCc
Confidence            79999999999999987542    367888999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.88  E-value=5.6e-22  Score=188.21  Aligned_cols=143  Identities=21%  Similarity=0.321  Sum_probs=125.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||++... +++.|++|.+......  .....+.+|+.+++.++||||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            35777899999999999999864 5789999988654321  22346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence            9999999999997542    478899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.88  E-value=4.8e-22  Score=185.07  Aligned_cols=143  Identities=24%  Similarity=0.335  Sum_probs=122.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeCC----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...+.||+|+||.||+|...+    ...||+|.............|.+|+.+++.++||||+++++++.. ...+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            456777899999999999998533    346899988654333344579999999999999999999998865 557899


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++....   ..+++..+..++.+++.||+|||+.   +++||||||+||+++.++.++++||.
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g  152 (270)
T cd05056          85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFG  152 (270)
T ss_pred             EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCc
Confidence            99999999999997643   2478999999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.88  E-value=1.4e-22  Score=187.06  Aligned_cols=140  Identities=32%  Similarity=0.471  Sum_probs=122.1

Q ss_pred             CCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccH-HHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          250 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~-~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      ...+.||+|+||+||+++.. +++.+|+|.+......... ....+|+.+++.++||||+++++++......+++|||++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            34588999999999999865 5678999999655332222 234569999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++++++++++||+
T Consensus        82 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg  143 (260)
T PF00069_consen   82 GGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFG  143 (260)
T ss_dssp             TEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGT
T ss_pred             cccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            999999998332    478999999999999999999999   99999999999999999999999995

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.88  E-value=4.3e-22  Score=188.85  Aligned_cols=143  Identities=28%  Similarity=0.481  Sum_probs=121.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|...+.||+|+||.||+|... ++.    .+|+|.+..........++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45667789999999999999853 443    57889886543333344689999999999999999999998754 4678


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||+++|+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+||++++++.+||+||+
T Consensus        86 v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             eehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccc
Confidence            9999999999999876432   478889999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.88  E-value=7.2e-22  Score=186.54  Aligned_cols=141  Identities=26%  Similarity=0.426  Sum_probs=124.0

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc---c-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS---G-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      |+..+.||+|+||.||+|... +++.||+|.++.....   . ....+..|+++++.++|+||+++++++...+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            566788999999999999864 6889999999654322   1 2335778999999999999999999999988999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+ +|+|.+++....   ..+++.....++.|+++||+|||+.   +|+|+||||+||+++.++.++|+||.
T Consensus        82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg  147 (298)
T cd07841          82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFG  147 (298)
T ss_pred             ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccce
Confidence            999 999999997543   2489999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.88  E-value=6.9e-22  Score=184.07  Aligned_cols=141  Identities=27%  Similarity=0.418  Sum_probs=122.7

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--c-------cHHHHHHHHHHHhcCCCCCccceeeeeecCCc
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--G-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  318 (399)
                      |...+.||+|+||.||+|.. .+++.+|+|.++.....  .       ....+.+|+.+++.++|+|++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            55668999999999999975 46889999987532111  1       11357889999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||+++|+|.++++..    ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.++++||.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecc
Confidence            99999999999999999765    2478889999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.87  E-value=6.3e-22  Score=187.18  Aligned_cols=141  Identities=22%  Similarity=0.352  Sum_probs=125.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++.+......++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            3577778999999999999985 4688999998864332 2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++...     .+++.+...++.|++.||+|||+.   +|+||||||+||+++.++.++|+||+
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccc
Confidence            9999999998643     378899999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=3.8e-22  Score=186.73  Aligned_cols=144  Identities=31%  Similarity=0.430  Sum_probs=126.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .++|...+.||+|+||.||++... ++..+|+|.++... ......|.+|+++++.++|+||+++++.+......++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            345777788999999999999864 68899999985432 2233468999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++.....   .+++.....++.|++.||.|||+.   +|+||||||+||+++.++..+++||+
T Consensus        83 ~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          83 FCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             ccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCc
Confidence            9999999999876432   488999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.87  E-value=3.9e-22  Score=187.07  Aligned_cols=142  Identities=24%  Similarity=0.394  Sum_probs=124.8

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.||+|... +++.||+|.+....... ....+.+|+++++.++||||+++++++...+..++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5677799999999999999875 58899999986433222 234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|..+.....    .++|.+...++.|++.||+|||+.   +|+||||+|+||++++++.++++||+
T Consensus        82 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          82 VDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             CCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeee
Confidence            99999988765432    378999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=8.3e-22  Score=182.11  Aligned_cols=136  Identities=30%  Similarity=0.468  Sum_probs=118.5

Q ss_pred             ceeeccCCceEEEEEeC-C---CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~---~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||.||+|... .   +..+|+|.++.........++.+|+.+++.++|+||+++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999753 2   26899999875544334557999999999999999999999876 4567999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|.+++....    .+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+|++||.
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~  140 (257)
T cd05060          80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFG  140 (257)
T ss_pred             CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccc
Confidence            99999997653    478999999999999999999998   99999999999999999999999993

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.87  E-value=4.7e-22  Score=185.11  Aligned_cols=145  Identities=31%  Similarity=0.484  Sum_probs=123.7

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC------
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV------  316 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------  316 (399)
                      +.+.|+..+.||+|+||.||+|... +++.||+|.+...  ......+.+|+.++.++ +|+||+++.+++...      
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            3455777788999999999999864 6889999998543  23345688999999888 699999999998753      


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ...+++|||+++|+|.+++.....  ..++|.....++.|++.||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence            357899999999999999976432  2478999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.87  E-value=4e-22  Score=187.73  Aligned_cols=154  Identities=31%  Similarity=0.414  Sum_probs=129.2

Q ss_pred             cHHHHHHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeec
Q 015852          238 SLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  315 (399)
Q Consensus       238 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  315 (399)
                      .+.++..++++|...+.||+|+||.||++.. .+++.+|+|.+....  .....+.+|+.++.++ +|||++++++++..
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            3344555678899999999999999999986 468899999885431  2234678899999888 79999999999875


Q ss_pred             C-----CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCce
Q 015852          316 V-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  390 (399)
Q Consensus       316 ~-----~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~  390 (399)
                      .     +..++||||+++|+|.++++........+++.....++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     357999999999999999875332334588999999999999999999998   99999999999999999999


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      +++||+
T Consensus       168 kl~dfg  173 (291)
T cd06639         168 KLVDFG  173 (291)
T ss_pred             EEeecc
Confidence            999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.87  E-value=8.9e-22  Score=184.43  Aligned_cols=144  Identities=26%  Similarity=0.460  Sum_probs=125.7

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +|+..+.||+|++|.||+|+.. +++.||||.++..........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4677789999999999999974 688999999875544334456788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++ +|.+++..... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g  145 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFG  145 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecc
Confidence            85 88888865432 23589999999999999999999998   99999999999999999999999993

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.87  E-value=1.1e-21  Score=180.72  Aligned_cols=142  Identities=34%  Similarity=0.512  Sum_probs=124.8

Q ss_pred             CCCceeeccCCceEEEEEeCC-----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          250 SNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~~-----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +..+.||+|+||.||+++..+     +..||+|.++..........+.+|++++..++|+||+++++++...+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456889999999999998643     378999999655433345579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++......  .+++.+...++.|++.||+|||+.   +++||||||+||++++++.++++||+
T Consensus        82 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       82 YMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             ccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence            99999999999764321  178999999999999999999999   99999999999999999999999994

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.6e-22  Score=185.91  Aligned_cols=140  Identities=24%  Similarity=0.403  Sum_probs=119.4

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccc-cccccHHHHHHHHHHHhcCCCCCccceeeeeec-----CCceE
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-----VTEKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~  320 (399)
                      .|...+.||+|+||.|..+.. .+|+.||||++... ......++-.+|+.+++.++|+||+.+.+.+..     .+..|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            344468899999999999985 57899999998532 223334578899999999999999999988765     35689


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      +|+|+|+ -+|...++...    .++......+..|+.+||.|+|+.   +|+||||||+|+|++.+.+.||+||
T Consensus       103 iV~elMe-tDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen  103 LVFELME-TDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             EehhHHh-hHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence            9999994 58999987653    378888999999999999999999   9999999999999999999999999

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.87  E-value=3.2e-22  Score=187.06  Aligned_cols=140  Identities=31%  Similarity=0.480  Sum_probs=122.9

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      |+..+.||+|+||.||+|.. .+++.||+|.++..........+.+|+++++.++||||+++++++...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            34457799999999999985 46789999988644333334578999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|.+++...     .+++.....++.|+++|++|||+.   +++|+||||+||++++++.++++||+
T Consensus        86 ~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06642          86 GGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccc
Confidence            99999998642     478899999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.87  E-value=7.8e-22  Score=184.87  Aligned_cols=146  Identities=31%  Similarity=0.465  Sum_probs=124.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      .++...+.||+|+||.||++...      ++..+|+|.++... ......|.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            35666789999999999999632      35689999886432 233447999999999999999999999999989999


Q ss_pred             EEEecCCCCChhhHhhhcCCC-----------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc
Q 015852          321 LVYPYMTNGSVASRLRERQSS-----------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  389 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~  389 (399)
                      ++|||+++|+|.++++.....           ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            999999999999999764311           12478999999999999999999998   9999999999999999999


Q ss_pred             eeecccc
Q 015852          390 QSSKTIL  396 (399)
Q Consensus       390 ~~i~df~  396 (399)
                      ++++||+
T Consensus       161 ~kL~dfg  167 (280)
T cd05092         161 VKIGDFG  167 (280)
T ss_pred             EEECCCC
Confidence            9999994

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.87  E-value=4.2e-22  Score=185.06  Aligned_cols=141  Identities=26%  Similarity=0.399  Sum_probs=124.1

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +|...+.||+|+||.||+|+. .+++.||+|.++.... .....+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            455567899999999999985 4688999999864422 22335788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|.+++....    .+++.+...++.|++.||.|||+.   +|+||||||+||+++.++.++++||+
T Consensus        89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          89 GGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcce
Confidence            9999999987543    478999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.87  E-value=1.7e-23  Score=187.56  Aligned_cols=139  Identities=28%  Similarity=0.467  Sum_probs=124.9

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      |...+.||+|+||.||++.++ .|+.+|+|.+..+   .+.++...|+.+|++++.|++|+++|.|......|+|||||-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            444577999999999999764 6999999998543   345578999999999999999999999998899999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .|+..++++.+..   +++..++..+......||+|||..   .-||||||+.|||++.+|.+|++||+
T Consensus       112 AGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFG  174 (502)
T KOG0574|consen  112 AGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFG  174 (502)
T ss_pred             CCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcc
Confidence            9999999987643   688999999999999999999998   88999999999999999999999994

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.87  E-value=5.7e-22  Score=192.63  Aligned_cols=141  Identities=23%  Similarity=0.280  Sum_probs=119.2

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC------
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  317 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------  317 (399)
                      .++|...+.||+|+||.||++.. .+++.||+|.+...... .....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46788889999999999999986 46889999998644322 23446889999999999999999999886543      


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..++||||+.+ +|.+.++.      .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence            46899999975 56666543      267888899999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.87  E-value=6.1e-22  Score=191.18  Aligned_cols=143  Identities=24%  Similarity=0.334  Sum_probs=120.8

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC------
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  316 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------  316 (399)
                      ..++|...+.||+|+||.||+|.. .+++.||||.+...... .....+.+|+.+++.++|+||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            346788889999999999999985 46889999998643222 2234578899999999999999999887533      


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ...++++|++ +++|.+++...     .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence            3468999987 78998887532     378999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.87  E-value=1.3e-21  Score=180.51  Aligned_cols=142  Identities=27%  Similarity=0.479  Sum_probs=125.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      .+|+..+.||+|+||.||++...++..+|+|.++...  .....|.+|+++++.++|||++++++++......+++|||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            3566678999999999999987777889999886432  23447999999999999999999999999988999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|.++++....   .+++.....++.+++.||+|||+.   +++||||||+||+++.++.++++||.
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  145 (256)
T cd05112          82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFG  145 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCc
Confidence            99999999975432   478999999999999999999998   89999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=7.3e-22  Score=185.74  Aligned_cols=147  Identities=27%  Similarity=0.349  Sum_probs=125.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~  323 (399)
                      ++|...+.||+|++|.||++... +++.+|+|.+..........++.+|+++++.++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35677789999999999999864 68899999986543333445799999999999999999999988653  3678999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++.........+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++++||+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecc
Confidence            99999999998765333334578889999999999999999998   99999999999999999999999994

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.87  E-value=4.9e-22  Score=184.66  Aligned_cols=141  Identities=32%  Similarity=0.492  Sum_probs=120.4

Q ss_pred             ceeeccCCceEEEEEeCC-------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          253 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~-------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.||+|+||.||+|+..+       ++.+|+|.+...........|.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999997532       2579999886543333445799999999999999999999999998999999999


Q ss_pred             CCCCChhhHhhhcCC---CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-----ceeecccc
Q 015852          326 MTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-----DQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-----~~~i~df~  396 (399)
                      +++|+|.++++....   ....++|.++..++.|++.||+|||+.   +++|+||||+||+++.+.     .++++||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999975322   123478999999999999999999988   899999999999999888     89999994

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.87  E-value=1.3e-21  Score=184.45  Aligned_cols=143  Identities=29%  Similarity=0.413  Sum_probs=125.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.|...+.||+|+||.||+|+.. +++.+++|.+... .......+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            45777789999999999999864 5889999998543 222344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|..++.+...   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||+
T Consensus        91 ~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  155 (292)
T cd06644          91 CPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFG  155 (292)
T ss_pred             CCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCc
Confidence            999999988865432   478999999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.2e-23  Score=193.68  Aligned_cols=142  Identities=33%  Similarity=0.447  Sum_probs=128.3

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      .|+..+.||+|+||.||+|.. .+++.||+|++..+...+...+..+|+.++..++++||.+++|.+.....++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            466668999999999999985 5788999999988777777778999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+|++.+.|+...    .+++....-|.+++..||.|||++   +.+|||||+.|||+..+|++|++||+
T Consensus        94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Dfg  156 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFG  156 (467)
T ss_pred             cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecc
Confidence            9999999997542    246677778899999999999999   99999999999999999999999995

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.2e-21  Score=186.72  Aligned_cols=144  Identities=30%  Similarity=0.336  Sum_probs=126.4

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +|+..+.||+|+||.||++... +++.||+|.+.......  ....+.+|++++..++|+||+++++.+......+++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5777789999999999999865 58999999986543222  33468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+.+++|.+++....  ...+++.....++.|++.||+|||..   +++||||||+||+++.++.++++||.
T Consensus        82 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          82 YCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             ecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence            999999999987532  23588999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=1.6e-21  Score=180.99  Aligned_cols=141  Identities=28%  Similarity=0.454  Sum_probs=123.1

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccccc--------HHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~--------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      |.....||+|+||.||+|.. .+++.+|+|.+........        ...+.+|+.+++.++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            55678999999999999985 4678999998854322211        13588999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++||+++++|.+++....    .+++.....++.|++.||+|||+.   +++||||||+||++++++.++++||+
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             EEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccC
Confidence            99999999999999997642    478889999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.87  E-value=1.2e-21  Score=181.75  Aligned_cols=142  Identities=29%  Similarity=0.427  Sum_probs=123.8

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc-----cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +|+..+.||+|+||.||++.. .+++.+|+|.++......     ....+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            366778999999999999985 578899999986433211     23468999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      |+||+++++|.+++....    ++++.....++.|++.||+|||+.   +++||||||+||+++.++ .++++||+
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccc
Confidence            999999999999997542    478899999999999999999998   999999999999999876 58999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.87  E-value=1.5e-21  Score=182.66  Aligned_cols=140  Identities=31%  Similarity=0.472  Sum_probs=123.9

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      |+..+.||+|+||.||+|.. .++..+|+|.+...........+.+|+.++..++||||+++++++...+..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            55668899999999999985 46889999987543333334568899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|.+++...     .+++.....++.+++.|+.|||+.   +++|+||||+||+++.++.++++||.
T Consensus        86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg  146 (277)
T cd06641          86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG  146 (277)
T ss_pred             CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecc
Confidence            99999998642     478999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.87  E-value=1.1e-21  Score=183.89  Aligned_cols=140  Identities=30%  Similarity=0.449  Sum_probs=122.2

Q ss_pred             CCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          250 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +..+.||+|+||.||++... ++..+++|.+.... ......+.+|+++++.++|+|++++++++...+..++|+||+++
T Consensus         8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            44577999999999999865 57788999885432 22334688999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|..++....   .++++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++++||+
T Consensus        87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccc
Confidence            99999886532   2588999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.87  E-value=1.6e-21  Score=179.59  Aligned_cols=141  Identities=30%  Similarity=0.457  Sum_probs=126.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeCC-CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|+..+.||+|+||.||+|.... ++.+++|.++....   ..++.+|+++++.++|+||+++++++......++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            567788999999999999998754 78999999864422   45799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++....   ..+++.....++.|++.||.|||+.   +++||||+|+||++++++.++++||+
T Consensus        80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg  144 (256)
T cd06612          80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG  144 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccc
Confidence            99999999997543   2478999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.87  E-value=1.3e-21  Score=180.47  Aligned_cols=140  Identities=30%  Similarity=0.471  Sum_probs=121.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ++|+..+.||+|+||.||++.. +++.||+|.++..   .....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            3577789999999999999975 6778999988543   2234789999999999999999999998654 578999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||+
T Consensus        81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg  145 (254)
T cd05083          81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFG  145 (254)
T ss_pred             CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCc
Confidence            99999999976432  2478899999999999999999998   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.87  E-value=2.2e-22  Score=192.93  Aligned_cols=145  Identities=24%  Similarity=0.357  Sum_probs=127.2

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCc-eEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-KLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~  323 (399)
                      ++|...+++|+|+||.++..+.+ +++.+++|.+........ +..-.+|+.++++++|||||.+.+.+...+. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            45677799999999999988754 677899999976554433 3367899999999999999999999999888 89999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|++||++.+.+.+.++  ..++..+...+..|+..|+.|||+.   +|+|||||+.||++..+..++++||+
T Consensus        84 ~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG  151 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG  151 (426)
T ss_pred             eecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence            99999999999987653  3478889999999999999999988   99999999999999999999999993

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.87  E-value=6.4e-22  Score=188.93  Aligned_cols=139  Identities=27%  Similarity=0.349  Sum_probs=120.6

Q ss_pred             CceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCC
Q 015852          252 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      .++||+|.||+||-|+.+ +|+.||||++.+.... ..+.++++|+.+++.++||.||.+.-.|++++..++|||-+.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            388999999999999864 7999999999665543 44557999999999999999999999999999999999999876


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeecccc
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  396 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~df~  396 (399)
                      -|+-+|...++   .++......++.||..||.|||.+   +|+|+||||+|||+.+..   .+|++||+
T Consensus       649 MLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  649 MLEMILSSEKG---RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             HHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccc
Confidence            66666665443   477888889999999999999999   999999999999998654   57999994

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.87  E-value=1.6e-21  Score=180.46  Aligned_cols=141  Identities=30%  Similarity=0.485  Sum_probs=125.2

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      |+..+.||+|+||.||+|... +++.|++|.++..... .....+.+|+++++.++|+||+++++.+...+..++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            666789999999999999864 6889999998654332 23457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|.++++...    .+++..+..++.+++.||+|||+.   +|+|+||||+||++++++.+||+||+
T Consensus        82 ~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g  144 (264)
T cd06626          82 SGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFG  144 (264)
T ss_pred             CCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence            9999999997642    368889999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.87  E-value=9.2e-22  Score=182.31  Aligned_cols=143  Identities=31%  Similarity=0.404  Sum_probs=127.0

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +|+..+.||+|+||.||++... +++.+|+|.+..........++.+|+++++.++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            4666788999999999999875 688999999866543444557899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|.+++....   ..+++.....++.|++.||+|||+ .   +++||||||+||++++++.++++||+
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g  146 (265)
T cd06605          82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFG  146 (265)
T ss_pred             CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            9999999997643   357888999999999999999999 7   99999999999999999999999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=2.2e-21  Score=179.41  Aligned_cols=143  Identities=31%  Similarity=0.454  Sum_probs=126.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||++... +++.+++|.+...... ....+.+|+++++.++||||+++++++...+..+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            56778899999999999999864 6788999998654322 345789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++....   ..+++.....++.|++.||+|||+.   +|+|+||||+||++++++.++++||+
T Consensus        82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  146 (262)
T cd06613          82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFG  146 (262)
T ss_pred             CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccc
Confidence            99999999987642   2478899999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.87  E-value=2.2e-21  Score=180.31  Aligned_cols=143  Identities=27%  Similarity=0.435  Sum_probs=122.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc----ccHHHHHHHHHHHhcCCCCCccceeeeeec--CCce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~  319 (399)
                      .+|+..+.||+|+||.||++.. .++..||+|.++.....    .....+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3678889999999999999985 46889999988543211    122358899999999999999999998865  3567


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++|+||+
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCC
Confidence            89999999999999997542    378889999999999999999988   99999999999999999999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.87  E-value=8.3e-22  Score=182.10  Aligned_cols=142  Identities=26%  Similarity=0.350  Sum_probs=125.9

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +|+..+.||+|+||.||++... +++.||+|.+......  .....+.+|++++++++||||+++++++......++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            3667789999999999999865 6889999998643322  234579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++...    .++++.....++.|+++||.|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~  145 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFN  145 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecc
Confidence            99999999999764    2478899999999999999999998   99999999999999999999999993

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.87  E-value=2.8e-22  Score=181.14  Aligned_cols=144  Identities=25%  Similarity=0.391  Sum_probs=124.7

Q ss_pred             HHHHHHHhcCCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecC
Q 015852          239 LRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV  316 (399)
Q Consensus       239 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~  316 (399)
                      ++++-..++     ++||+|+|+.|-.+. +.+|..+|||++.+. ....+.+..+|++++...+ |+||++|++++.++
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            455555554     789999999999987 678999999999654 2333446788999987775 99999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeec
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSK  393 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~  393 (399)
                      +..|||||-|.+|+|.+.+++++    .+++.+..+++.+||.||.|||..   +|.||||||+|||..+-.   .+||+
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence            99999999999999999998875    388999999999999999999999   999999999999987654   57999


Q ss_pred             cc
Q 015852          394 TI  395 (399)
Q Consensus       394 df  395 (399)
                      ||
T Consensus       222 Df  223 (463)
T KOG0607|consen  222 DF  223 (463)
T ss_pred             cc
Confidence            99

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.87  E-value=4.3e-22  Score=184.28  Aligned_cols=137  Identities=25%  Similarity=0.387  Sum_probs=116.0

Q ss_pred             ceeeccCCceEEEEEeCC--------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          253 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +.||+|+||.||+|....        ...+|+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            468999999999997532        2348888774332 2223468899999999999999999999999889999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc--------eeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--------QSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~--------~~i~df~  396 (399)
                      |+++|+|.++++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+++        .+++||+
T Consensus        80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999999976432   478999999999999999999998   9999999999999998876        4888884

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.87  E-value=1.5e-21  Score=182.58  Aligned_cols=141  Identities=30%  Similarity=0.454  Sum_probs=124.4

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      .|+..+.||+|+||.||+|... ++..||+|.++..........+.+|+.+++.++|+||+++++++......++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3556688999999999999864 688999998864433333457899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.+++...     ++++.+...++.|++.||+|||+.   +++|+||+|+||+++.++.++++||+
T Consensus        85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg  146 (277)
T cd06640          85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccc
Confidence            999999998642     378888999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.87  E-value=8.4e-22  Score=191.13  Aligned_cols=142  Identities=23%  Similarity=0.291  Sum_probs=119.5

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC------
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  316 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------  316 (399)
                      ..++|...+.||+|+||.||++... .++.||||.+...... .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3467888899999999999999854 6889999998654322 2234688999999999999999999988643      


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ...+++|||+++ ++.+.+..      .+++.....++.|+++||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            246899999975 67666643      277888999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.5e-21  Score=182.16  Aligned_cols=141  Identities=30%  Similarity=0.408  Sum_probs=126.0

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +|+..+.||.|+||.||+|+.. +++.||+|.+...........+.+|+.+++.++|+|++++.+++......++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            4666788999999999999864 688999999865433334456899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|.++++..     .+++.....++.|++.||.|||+.   +++||||+|+||++++++.++++||+
T Consensus        82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  143 (274)
T cd06609          82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG  143 (274)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence            999999998753     478999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.87  E-value=2.4e-21  Score=179.18  Aligned_cols=142  Identities=29%  Similarity=0.438  Sum_probs=127.5

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +|+..+.||+|++|.||++... +++.|++|++...........+.+|+..+..++|+|++++++++...+..++++||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5777899999999999999875 589999999865433333457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|.+++...    ..+++.....++.|+++||+|||+ .   +++||||+|+||+++.++.++++||.
T Consensus        82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCc
Confidence            999999999764    247899999999999999999999 8   99999999999999999999999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=9.3e-23  Score=209.55  Aligned_cols=151  Identities=24%  Similarity=0.296  Sum_probs=133.0

Q ss_pred             HHHHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeec
Q 015852          239 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTT  315 (399)
Q Consensus       239 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  315 (399)
                      ..++....++|.+.++||+|+||.|...+++ +++.||+|++.+...-  .....|.+|-.+|...+.+.|+++.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4566777889999999999999999999874 6889999999653221  122358899999999999999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ....|+|||||+||+|..+|.+..    .++...+..++..|..||.-+|+.   +.|||||||+|||||..|.+|++||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            999999999999999999998754    377788889999999999999999   9999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       220 G  220 (1317)
T KOG0612|consen  220 G  220 (1317)
T ss_pred             h
Confidence            5

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.86  E-value=3.1e-21  Score=178.76  Aligned_cols=146  Identities=29%  Similarity=0.424  Sum_probs=128.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|+..+.||+|+||+||+|.. .++..+|+|++...........+.+|++.++.++|+|++++++.+...+..++++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            3678889999999999999985 467899999986544333445799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.++++.... ...+++.....++.|++.||+|||+.   +|+||||||+||++++++..+++||.
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~  147 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFG  147 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence            999999999976422 12478999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.86  E-value=2.1e-21  Score=182.77  Aligned_cols=142  Identities=27%  Similarity=0.332  Sum_probs=122.6

Q ss_pred             CCCCCceeeccCCceEEEEEe----CCCCEEEEEEcccccc---cccHHHHHHHHHHHhcC-CCCCccceeeeeecCCce
Q 015852          248 GFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  319 (399)
                      +|+..+.||+|+||.||+++.    .+|+.||+|+++....   ......+.+|+.++..+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            356678999999999999975    3688999999864322   12234688899999999 599999999999988889


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++++|.+++....    .+++.....++.|+++||+|||+.   +++||||||+|||+++++.++|+||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCc
Confidence            99999999999999997643    377888889999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=1.7e-21  Score=187.07  Aligned_cols=135  Identities=21%  Similarity=0.227  Sum_probs=107.6

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC--CCCEEEEEEcccccc----cccHHHHHHHHHHHhcCCCCCccc-eeeeeecC
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLR-LYGFCTTV  316 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~----~~~~~~f~~E~~~l~~l~H~niv~-l~g~~~~~  316 (399)
                      ...++|...+.||+|+||+||+|...  +++.+|||++.....    ......|.+|++++..++|+|+++ ++.+    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34567889999999999999999864  577789998753211    112346999999999999999985 4432    


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCceeeCCCCceeeccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTI  395 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-K~~NILld~~~~~~i~df  395 (399)
                      +..++||||+++++|... ..       ..   ...++.+++++|+|||+.   +|+|||| ||+|||++.++.+||+||
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            457999999999999632 11       01   145778999999999998   9999999 999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       157 G  157 (365)
T PRK09188        157 Q  157 (365)
T ss_pred             c
Confidence            3

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.86  E-value=1.7e-21  Score=182.67  Aligned_cols=143  Identities=22%  Similarity=0.424  Sum_probs=124.4

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.||+|+.. +++.||||.++...... ....+.+|++++++++||||+++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4677789999999999999864 68899999986543222 234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +. ++|.+++.....  ..+++.....++.|++.||+|||+.   +++||||||+||++++++.+|++||.
T Consensus        81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg  145 (284)
T cd07860          81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  145 (284)
T ss_pred             cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            96 689988875432  3578999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.86  E-value=2.2e-21  Score=181.82  Aligned_cols=142  Identities=26%  Similarity=0.392  Sum_probs=125.3

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++|+||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            3566788999999999999864 688999999865432 22244799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      + +++|.+++....   ..+++.++..++.|+++||+|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeee
Confidence            9 999999987543   3588999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.86  E-value=1.7e-21  Score=189.66  Aligned_cols=141  Identities=22%  Similarity=0.284  Sum_probs=119.3

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecC------C
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  317 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~  317 (399)
                      .++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467888899999999999999854 688999999865332 22334688999999999999999999987543      3


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..++||||+++ +|.+.+..      .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence            46899999975 67777643      267888999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.86  E-value=9.5e-22  Score=206.77  Aligned_cols=154  Identities=16%  Similarity=0.265  Sum_probs=125.4

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeec--CCc
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTE  318 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~  318 (399)
                      ....++|...+.||+|+||.||+++.. ++..+|+|.+...... .....|..|+.++..++|||||++++++..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            344567888899999999999999864 5778999988643322 223468999999999999999999998854  346


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC----CCceecCCCCCceeeCCC-------
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD----PKIIHRDVKAANILLDED-------  387 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDlK~~NILld~~-------  387 (399)
                      .++||||+++|+|.++|.........+++.....|+.||+.||+|||+...    .+||||||||+||||+.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            889999999999999997643333458999999999999999999998531    359999999999999753       


Q ss_pred             ----------Cceeecccc
Q 015852          388 ----------ADQSSKTIL  396 (399)
Q Consensus       388 ----------~~~~i~df~  396 (399)
                                ..+||+||+
T Consensus       169 ~~~~~n~ng~~iVKLsDFG  187 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFG  187 (1021)
T ss_pred             cccccccCCCCceEEccCC
Confidence                      348999995

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.86  E-value=2.1e-21  Score=179.38  Aligned_cols=149  Identities=23%  Similarity=0.336  Sum_probs=124.1

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeec--CCceEEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVY  323 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~  323 (399)
                      +|+..+.||+|+||.||++.. .+++.+|+|.++..... .....+.+|+.+++.++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            366778999999999999985 46889999998643322 223468899999999999999999998764  34578999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++.........+++.....++.|++.||+|||..+  ..+++|+||||+||++++++.+|++||+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence            999999999999765333446899999999999999999999332  3399999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.86  E-value=1.2e-21  Score=183.69  Aligned_cols=141  Identities=22%  Similarity=0.434  Sum_probs=122.2

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      |+..+.||+|+||.||+|+.. +|+.||+|.++..... .....+.+|+++++.++|+||+++++++......++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            566788999999999999864 6889999998643222 22346788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      + ++|.+++....   ..+++.....++.|+++||.|||+.   +|+||||||+||+++.++.++|+||+
T Consensus        82 ~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  144 (284)
T cd07839          82 D-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFG  144 (284)
T ss_pred             C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccc
Confidence            7 58888876532   2488999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.86  E-value=2.3e-21  Score=182.76  Aligned_cols=146  Identities=25%  Similarity=0.388  Sum_probs=122.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCC-CCCccceeeeeecCCc-----
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE-----  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~-----  318 (399)
                      ++|+..+.||+|+||.||+|... +++.||+|.++...... ....+.+|+.+++.++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            35777899999999999999864 68899999886543222 2346888999999995 6999999999887665     


Q ss_pred             eEEEEecCCCCChhhHhhhcCCC-CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~~i~df~  396 (399)
                      .+++|||+++ +|.+++...... ...+++.....++.||+.||+|||+.   +|+||||||+||+++. ++.+|++||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 898888654322 34578999999999999999999998   9999999999999999 8899999994

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.86  E-value=2.7e-21  Score=178.33  Aligned_cols=144  Identities=20%  Similarity=0.301  Sum_probs=125.5

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.+|+++. .+++.||+|.+..... .....++.+|+.+++.++|+||+++.+++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            366778999999999999985 4688999999864322 22334789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++.....  ..+++.+...++.|++.||+|||+.   +++|+||+|+||+++.+++++++||.
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~  146 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFG  146 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999999876432  2468889999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.3e-21  Score=181.00  Aligned_cols=140  Identities=26%  Similarity=0.452  Sum_probs=124.1

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC---CCCccceeeeeecCCceEEEEe
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      |+..+.||+|+||.||+|.. .+++.||+|.++.........++.+|+.+++.++   |||++++++++......+++||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            55668899999999999986 5788999999865433344456889999998886   9999999999998889999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.++++..     .+++.....++.|++.||.|||+.   +|+||||+|+||++++++.++++||+
T Consensus        83 ~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          83 YAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             cCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence            99999999998643     478999999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.86  E-value=2.1e-21  Score=183.66  Aligned_cols=141  Identities=21%  Similarity=0.363  Sum_probs=125.5

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .+|+..+.||+|+||.||+|.. .+++.|++|.+.... ......+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            3477788999999999999985 578999999885432 23345688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++...     .+++.++..++.+++.||+|||+.   +++||||||+||+++.++.++++||+
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg  160 (296)
T cd06655          98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG  160 (296)
T ss_pred             cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999988643     378999999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.86  E-value=3.8e-21  Score=179.12  Aligned_cols=145  Identities=27%  Similarity=0.400  Sum_probs=119.3

Q ss_pred             CCCCceeeccCCceEEEEEeC----CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC------
Q 015852          249 FSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  317 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------  317 (399)
                      |...++||+|+||.||+|...    +++.||||.++..... ....++.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            445688999999999999753    3678999998654322 22346889999999999999999999886532      


Q ss_pred             ceEEEEecCCCCChhhHhhhcC--CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ..++++||+++|+|..++....  .....+++.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875422  1223478889999999999999999998   9999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       158 g  158 (273)
T cd05074         158 G  158 (273)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.7e-21  Score=179.43  Aligned_cols=143  Identities=27%  Similarity=0.427  Sum_probs=122.2

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc----cccHHHHHHHHHHHhcCCCCCccceeeeeecC--Cce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~  319 (399)
                      .+|...+.||+|+||.||+|.. .+++.||+|.+.....    ......+.+|++++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3677889999999999999985 4688999998743211    12234688999999999999999999998764  457


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++||+++++|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||+++.++.++|+||+
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccc
Confidence            89999999999999987542    378888999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.86  E-value=2.6e-21  Score=181.77  Aligned_cols=142  Identities=29%  Similarity=0.446  Sum_probs=116.6

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeeeecC-----Cc
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTTV-----TE  318 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~-----~~  318 (399)
                      |...+.||+|+||+||+|+.. +++.||+|.++...... ....+.+|++++..+   +||||+++++++...     ..
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            666789999999999999864 68899999986543222 223466777776655   799999999987642     34


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++|||++ ++|.+++.....  ..+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence            789999998 589888875422  2478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.86  E-value=2.9e-21  Score=180.62  Aligned_cols=137  Identities=29%  Similarity=0.402  Sum_probs=119.8

Q ss_pred             eeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       255 lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ||+|+||+||++.. .+++.+|+|.+.....  ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999975 4688999999854321  22234578899999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++.....  ..+++.+...++.|++.||.|||+.   +++||||||+||++++++.++++||+
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg  140 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLG  140 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence            999976532  2478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.86  E-value=2e-21  Score=183.20  Aligned_cols=143  Identities=24%  Similarity=0.373  Sum_probs=123.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  322 (399)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++...... ....+.+|+.++..++||||+++++++...  ...+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            45777789999999999999875 68899999986543222 223578899999999999999999998877  789999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+. ++|.+++.....   .+++.....++.|++.||+|||+.   +++||||||+||++++++.++++||+
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence            99998 599998876432   489999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.86  E-value=2.9e-22  Score=180.49  Aligned_cols=148  Identities=26%  Similarity=0.409  Sum_probs=122.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC---C--CCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeec-CCce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA---D--GKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~---~--~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~  319 (399)
                      ..|+....||+|.||.||+|.-.   +  .+.+|+|+++.+..... ...-.+|+.+++.++||||++|..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            45777889999999999999532   2  34799999976543322 3467899999999999999999998877 7788


Q ss_pred             EEEEecCCCCChhhHhhhcCC-CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC----Cceeecc
Q 015852          320 LLVYPYMTNGSVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED----ADQSSKT  394 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~----~~~~i~d  394 (399)
                      ++++||.+. +|.++++-++. ....+.-.....|..||..|+.|||++   =|+||||||.|||+..|    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999985 89888875432 223567778899999999999999999   69999999999999988    8899999


Q ss_pred             c-ccc
Q 015852          395 I-LRR  398 (399)
Q Consensus       395 f-~~~  398 (399)
                      | +.|
T Consensus       180 lGlaR  184 (438)
T KOG0666|consen  180 LGLAR  184 (438)
T ss_pred             ccHHH
Confidence            9 555

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.86  E-value=3e-22  Score=196.69  Aligned_cols=139  Identities=29%  Similarity=0.432  Sum_probs=121.9

Q ss_pred             CceeeccCCceEEEEEeC--CCC--EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          252 KNILGRGGFGKVYKGRLA--DGK--LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~--~~~--~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      .++||+|.||.|++|.|.  .|+  .||||.++.+.......+|++|+.+|.+++|+|+++|+|...+ ...+||+|.++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            478999999999999875  343  6899999876554455589999999999999999999999887 67889999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .|+|.+.|++...  ..+-......++.|||.||+||.++   ++|||||.++|+||.....+||+||+
T Consensus       194 lGSLldrLrka~~--~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKK--AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             cchHHHHHhhccc--cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence            9999999998332  3466677889999999999999999   99999999999999999999999993

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.86  E-value=3.6e-21  Score=183.59  Aligned_cols=138  Identities=22%  Similarity=0.339  Sum_probs=113.0

Q ss_pred             CceeeccCCceEEEEEeC---CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec--CCceEEEEecC
Q 015852          252 KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM  326 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~  326 (399)
                      .+.||+|+||+||+|+..   +++.||+|.++...   ....+.+|+.+++.++||||+++++++..  ....+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            367999999999999854   46789999985432   23457899999999999999999998854  34578999998


Q ss_pred             CCCChhhHhhhcCC-----CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee----CCCCceeecccc
Q 015852          327 TNGSVASRLRERQS-----SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl----d~~~~~~i~df~  396 (399)
                      . ++|.+++.....     ....+++.....++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            6 588888754221     122478888999999999999999998   99999999999999    456789999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.86  E-value=3e-21  Score=180.91  Aligned_cols=136  Identities=28%  Similarity=0.355  Sum_probs=114.0

Q ss_pred             eeeccCCceEEEEEe-CCCCEEEEEEcccccccc--cHHHHHHHHHHH---hcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          254 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKII---SMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       254 ~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      +||+|+||.||++.. .+++.+|+|.+.......  ....+.+|..++   ...+|+||+++.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999986 468899999886443221  122344554433   34579999999999998889999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.++++||+
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCC
Confidence            999999987543    489999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=9.2e-22  Score=193.06  Aligned_cols=137  Identities=28%  Similarity=0.421  Sum_probs=119.4

Q ss_pred             ceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      -+||+|.||+||.|+.. +...+|||.+... .....+-+.+||.+.+.++|.|||+++|.|.+.+...+.||-++||+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek-dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK-DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc-cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            57999999999999854 4567999998543 333445689999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCC--ChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCceeecccc
Q 015852          332 ASRLRERQSSLPPL--DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~~i~df~  396 (399)
                      .++|+..-   +++  .+...-.+..||.+||.|||++   .|||||||-+|||++. .|..||+||+
T Consensus       660 SsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFG  721 (1226)
T KOG4279|consen  660 SSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFG  721 (1226)
T ss_pred             HHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccc
Confidence            99998643   345  5777888999999999999999   9999999999999985 6789999994

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.86  E-value=2e-21  Score=191.11  Aligned_cols=137  Identities=25%  Similarity=0.283  Sum_probs=119.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC---CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ...|...+.||+|+||.||++...   .+..||+|.+...      ..+.+|+++++.++||||+++++++......+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            346888899999999999999743   3578999987532      2356899999999999999999999998999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+. ++|.+++...    ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus       165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence            99996 6888888432    2489999999999999999999998   99999999999999999999999994

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.86  E-value=2.3e-21  Score=179.11  Aligned_cols=135  Identities=28%  Similarity=0.401  Sum_probs=120.2

Q ss_pred             eeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ||+|+||.||+++.. +++.+++|.+......  .....+.+|++++++++|+||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 5899999998654321  2334688999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++....    .+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++||+
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg  138 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFG  138 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecc
Confidence            99997643    478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.86  E-value=3.8e-21  Score=178.82  Aligned_cols=147  Identities=24%  Similarity=0.341  Sum_probs=121.6

Q ss_pred             CCCCCceeeccCCceEEEEEeCC--CCEEEEEEcccccc---------cccHHHHHHHHHHHh-cCCCCCccceeeeeec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRLKEERT---------SGGELQFQTEVKIIS-MAVHRNLLRLYGFCTT  315 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vAvK~l~~~~~---------~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~  315 (399)
                      +|+..+.||+|+||.||++....  ++.+|+|.+.....         .....++.+|+.++. .++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36677899999999999998754  67899998753221         111235778888776 4799999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      .+..+++|||+++++|.+++.........+++.....++.|++.||.|||+..  +++|+||||+||++++++.++++||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988653222345888899999999999999999631  7999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       159 g  159 (269)
T cd08528         159 G  159 (269)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.86  E-value=1.7e-21  Score=183.82  Aligned_cols=136  Identities=26%  Similarity=0.361  Sum_probs=120.2

Q ss_pred             CceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCC
Q 015852          252 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  330 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  330 (399)
                      ...||+|+||.||++.. .++..||||.+.... ......+.+|+..++.++|+||+++++.+...+..+++|||+++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            35699999999999986 468899999885432 2234468899999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          331 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       331 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |.+++...     .+++.+...++.|++.||+|||+.   +|+||||||+||++++++.++++||+
T Consensus       106 L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg  163 (292)
T cd06658         106 LTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFG  163 (292)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCc
Confidence            99988542     378899999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.86  E-value=2.6e-21  Score=183.11  Aligned_cols=136  Identities=24%  Similarity=0.333  Sum_probs=120.6

Q ss_pred             CceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCC
Q 015852          252 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  330 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  330 (399)
                      ...||+|+||.||++... +++.||+|.+.... ......+.+|+.++..++||||+++++++...+..++++||+++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            456999999999999864 68899999985432 2334568899999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          331 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       331 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |.+++...     .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.++|+||+
T Consensus       105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg  162 (297)
T cd06659         105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG  162 (297)
T ss_pred             HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeech
Confidence            99987542     378999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.86  E-value=5.4e-21  Score=176.32  Aligned_cols=144  Identities=23%  Similarity=0.328  Sum_probs=122.9

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC-CceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-TEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e  324 (399)
                      +|+..+.||+|++|.||++... +++.||+|.+...... .....+.+|+++++.++|+|++++.+.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4677899999999999999854 5789999998643322 2334688999999999999999999887643 45789999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++.....  ..+++.++..++.+++.|++|||+.   +|+||||||+||+++.++..+++||.
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEeccc
Confidence            9999999999976422  2478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=5.2e-21  Score=177.86  Aligned_cols=147  Identities=32%  Similarity=0.440  Sum_probs=126.5

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCC-----
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT-----  317 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-----  317 (399)
                      .+++|+..+.||+|+||.||+|... +++.+++|.+....  .....+.+|+.+++++ +|+||+++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4578888999999999999999874 67899999885432  2335789999999998 6999999999997644     


Q ss_pred             -ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 -~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                       ..+++|||+++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++++||.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             47999999999999999876432234588999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.86  E-value=5.4e-21  Score=179.58  Aligned_cols=144  Identities=27%  Similarity=0.433  Sum_probs=128.6

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++.|+..+.||+|+||.||++... +++.+++|.++....  ....+.+|+++++.++|+|++++++++...+..++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4456777789999999999999875 688999999864332  3457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++....   ..+++..+..++.+++.||+|||..   +|+|+||||+||+++.++.++|+||.
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~  161 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG  161 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence            9999999999998753   2589999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.86  E-value=4.3e-21  Score=181.17  Aligned_cols=141  Identities=23%  Similarity=0.364  Sum_probs=125.0

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            5677789999999999999975 467899999985332 22344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++.+.     .+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++|+||+
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg  160 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  160 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCc
Confidence            9999999998753     368899999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.86  E-value=4.5e-21  Score=181.37  Aligned_cols=146  Identities=28%  Similarity=0.436  Sum_probs=123.9

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC----
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----  317 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----  317 (399)
                      ...++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+++++.++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34567888899999999999999875 6889999998654322 22346788999999999999999999987654    


Q ss_pred             ------ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          318 ------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       318 ------~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                            ..++++||+++ ++...+....   ..+++.....++.|++.||+|||+.   +|+||||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  68999999986 7777765432   2589999999999999999999998   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       157 l~dfg  161 (302)
T cd07864         157 LADFG  161 (302)
T ss_pred             eCccc
Confidence            99994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=2.3e-21  Score=171.09  Aligned_cols=134  Identities=17%  Similarity=0.246  Sum_probs=104.0

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccccH--------HHH-----------------HHHHHHHhcCCCCCcc
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE--------LQF-----------------QTEVKIISMAVHRNLL  307 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~--------~~f-----------------~~E~~~l~~l~H~niv  307 (399)
                      ..||+|+||.||+|...+|+.||||+++........        ..|                 ..|++.+..+.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            679999999999999878999999999754321111        122                 3499999999888775


Q ss_pred             ceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHH-hcCCCCCceecCCCCCceeeCC
Q 015852          308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRDVKAANILLDE  386 (399)
Q Consensus       308 ~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlK~~NILld~  386 (399)
                      ....+..  ...++||||++++++.......    ..+++.+...++.|++.+|.|+ |+.   +|+||||||+|||++ 
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            4443322  2348999999998776543222    2478889999999999999999 677   899999999999999 


Q ss_pred             CCceeecccc
Q 015852          387 DADQSSKTIL  396 (399)
Q Consensus       387 ~~~~~i~df~  396 (399)
                      ++.+++.||+
T Consensus       153 ~~~v~LiDFG  162 (190)
T cd05147         153 DGKLYIIDVS  162 (190)
T ss_pred             CCcEEEEEcc
Confidence            5789999995

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.85  E-value=6.7e-21  Score=180.98  Aligned_cols=143  Identities=30%  Similarity=0.431  Sum_probs=122.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ..|...+.||+|+||.||+|... +++.||+|.+......  .....+.+|+++++.++||||+++.+++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            34777789999999999999864 6889999988543222  22346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||++ |++.+++.....   .+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.++++||+
T Consensus        95 e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          95 EYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             HhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence            9997 677777654322   488999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.85  E-value=4.3e-21  Score=184.76  Aligned_cols=142  Identities=21%  Similarity=0.338  Sum_probs=121.1

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC-----ce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~  319 (399)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.++..........+.+|+.+++.++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            35788889999999999999985 4789999999864333333446889999999999999999998876443     47


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++||+. ++|.+.+...     .+++.....++.|+++||+|||+.   +|+||||||+||+++.++.++++||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence            89999997 4888777542     488999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.85  E-value=7.8e-21  Score=175.04  Aligned_cols=144  Identities=28%  Similarity=0.397  Sum_probs=123.8

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|...+.||+|+||.||++.. .+++.+|+|.+..... ......+.+|++++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            366778999999999999985 4688999999854322 22344789999999999999999999999888899999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      +++++|.+++.....  ..+++.....++.++++||+|||++   +|+|+||||+||+++++. .++++||.
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCC
Confidence            999999999976432  2478899999999999999999998   999999999999998654 57999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.85  E-value=4.3e-21  Score=180.04  Aligned_cols=142  Identities=25%  Similarity=0.341  Sum_probs=123.2

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+++++.++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5677889999999999999865 5889999998654322 2235789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++.+..+....    ..+++.+...++.|++.||+|||+.   +++||||||+||++++++.+|++||+
T Consensus        82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          82 VERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeee
Confidence            9987776665432    2378999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.85  E-value=7.6e-21  Score=176.09  Aligned_cols=135  Identities=26%  Similarity=0.360  Sum_probs=119.9

Q ss_pred             eeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ||+|+||.||+++.. +++.+|+|.+......  .....+.+|+.+++.++||||+++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999864 5889999998643322  2345699999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++....    .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++||.
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~  138 (262)
T cd05572          81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFG  138 (262)
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCC
Confidence            99997642    378889999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.85  E-value=1.1e-21  Score=191.42  Aligned_cols=140  Identities=26%  Similarity=0.429  Sum_probs=118.7

Q ss_pred             CceeeccCCceEEEEEeC-CCCEEEEEEccccc---ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCc--eEEEEec
Q 015852          252 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER---TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE--KLLVYPY  325 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lv~e~  325 (399)
                      ..+||+|+|-+||||... +|..||.-.++...   .....++|..|+.+|+.|+|+|||+++.++.+...  .-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            478999999999999853 57777765543322   22233579999999999999999999999987665  6789999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-Cceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~~i~df~  396 (399)
                      |..|+|..|+++.+.    ++......+++||.+||.|||++ +|+|||||||.+||+|+.+ |++||+|++
T Consensus       125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchh
Confidence            999999999987653    77888999999999999999998 8899999999999999965 799999983

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.85  E-value=1.2e-20  Score=173.52  Aligned_cols=146  Identities=26%  Similarity=0.393  Sum_probs=127.8

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|...+.||+|+||.||++... ++..+++|++...... .....+.+|+++++.++|+|++++.+.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            3666788999999999999864 6889999998654322 3344688999999999999999999999988999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++.........+++.....++.+++.||+|||+.   +++|+||+|+||++++++.++++||.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcc
Confidence            999999999987532234689999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.85  E-value=6.4e-21  Score=175.74  Aligned_cols=144  Identities=19%  Similarity=0.350  Sum_probs=124.2

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.||++... ++..+|+|.+...... .....+.+|+.+++.++|+||+++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            3667789999999999999864 5889999998543222 2334688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      +++++|.+++.....  ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++ .++++||.
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccc
Confidence            999999999976432  2478999999999999999999998   999999999999999886 46999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.85  E-value=6.9e-21  Score=182.69  Aligned_cols=139  Identities=29%  Similarity=0.407  Sum_probs=119.6

Q ss_pred             ceeecc--CCceEEEEEe-CCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRG--GFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G--~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ..||+|  +||+||+++. .+++.||+|.+....... ....+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  8999999986 478999999986443222 234688999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++.+++.....  ..+++.....++.|++.||+|||+.   +|+||||||+|||++.++..+++||.
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~  146 (328)
T cd08226          84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLS  146 (328)
T ss_pred             CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechH
Confidence            999999876432  2478888999999999999999988   99999999999999999999999983

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.85  E-value=1e-20  Score=176.99  Aligned_cols=140  Identities=24%  Similarity=0.322  Sum_probs=118.8

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecC--CceEEEEe
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV--TEKLLVYP  324 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e  324 (399)
                      |+..+.||+|+||.||+++. .+++.||+|.++............+|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            34567899999999999985 4688999999865433333334567888888885 99999999999887  88999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++ |++.+.+....   ..++|.+...++.|++.||+|||+.   +++||||||+||+++. +.+||+||+
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg  144 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFG  144 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecc
Confidence            997 58888887543   2489999999999999999999998   9999999999999999 999999994

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.85  E-value=1e-20  Score=180.20  Aligned_cols=138  Identities=23%  Similarity=0.347  Sum_probs=112.7

Q ss_pred             CceeeccCCceEEEEEeC---CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec--CCceEEEEecC
Q 015852          252 KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM  326 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~  326 (399)
                      ...||+|+||.||+|+..   ++..||+|.++...   ....+.+|+.+++.++||||+++++++..  ....++++||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            367999999999999864   45789999885432   23467899999999999999999998854  45678999998


Q ss_pred             CCCChhhHhhhcC-----CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee----CCCCceeecccc
Q 015852          327 TNGSVASRLRERQ-----SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl----d~~~~~~i~df~  396 (399)
                      .+ +|.+++....     .....+++.....++.|++.||+|||+.   +|+||||||+|||+    ++++.+||+||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            74 7877775321     1123478888999999999999999998   99999999999999    566789999994

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.85  E-value=7.6e-21  Score=178.10  Aligned_cols=152  Identities=30%  Similarity=0.463  Sum_probs=126.8

Q ss_pred             cHHHHHHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeec
Q 015852          238 SLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  315 (399)
Q Consensus       238 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  315 (399)
                      ++.++....+.|+..+.||+|+||.||+|+. .+++.+|+|.+...  .....++..|+.++.++ +|+||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            3445555667788889999999999999986 46889999987433  22334688899988888 69999999999853


Q ss_pred             ------CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc
Q 015852          316 ------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  389 (399)
Q Consensus       316 ------~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~  389 (399)
                            ....+++|||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence                  3567999999999999999976432  2477888899999999999999998   9999999999999999999


Q ss_pred             eeecccc
Q 015852          390 QSSKTIL  396 (399)
Q Consensus       390 ~~i~df~  396 (399)
                      ++|+||+
T Consensus       160 ~~l~dfg  166 (282)
T cd06636         160 VKLVDFG  166 (282)
T ss_pred             EEEeeCc
Confidence            9999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.85  E-value=8.1e-21  Score=177.81  Aligned_cols=142  Identities=28%  Similarity=0.432  Sum_probs=123.2

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEecC
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      |+..+.||+|+||.||+|... +++.|++|++.............+|+..+++++ |+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            455688999999999999975 578999999865433333334667999999999 999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                       +|+|.+++.....  ..+++..+..++.|++.+|.|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~  144 (283)
T cd07830          81 -EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFG  144 (283)
T ss_pred             -CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecc
Confidence             8899999876531  3478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.4e-22  Score=195.26  Aligned_cols=140  Identities=26%  Similarity=0.342  Sum_probs=120.7

Q ss_pred             CCCceeeccCCceEEEEEeCC-CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          250 SNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      .+...||.|+||+||++..++ +-..|.|++... ......+|+-||+++..++||+||+|++.|...+..|++.|||.|
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            334568999999999998654 445667777432 223344799999999999999999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |....++-+-.   ..++..++..++.|++.||.|||++   +|||||||+.|||++-||+++++||+
T Consensus       114 GAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFG  175 (1187)
T KOG0579|consen  114 GAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFG  175 (1187)
T ss_pred             chHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccc
Confidence            99999887643   2588999999999999999999999   99999999999999999999999995

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.85  E-value=6e-21  Score=190.82  Aligned_cols=149  Identities=21%  Similarity=0.333  Sum_probs=115.9

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-----------------CCCCEEEEEEcccccccc-------------cHHHHHHH
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-----------------ADGKLVAVKRLKEERTSG-------------GELQFQTE  294 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vAvK~l~~~~~~~-------------~~~~f~~E  294 (399)
                      ..++|...+.||+|+||.||+|..                 ..++.||||+++......             ....+..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999963                 234679999986432110             11234457


Q ss_pred             HHHHhcCCCCCc-----cceeeeeec--------CCceEEEEecCCCCChhhHhhhcCCC--------------------
Q 015852          295 VKIISMAVHRNL-----LRLYGFCTT--------VTEKLLVYPYMTNGSVASRLRERQSS--------------------  341 (399)
Q Consensus       295 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~L~~~~~~--------------------  341 (399)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++.....                    
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776655     677787753        35689999999999999998753211                    


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          342 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       342 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ...++|..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFG  354 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFG  354 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCc
Confidence            11356788899999999999999998   89999999999999999999999994

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.85  E-value=1.1e-20  Score=179.58  Aligned_cols=144  Identities=28%  Similarity=0.433  Sum_probs=122.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  321 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  321 (399)
                      .++|+..+.||+|+||.||+|... +++.||+|.++...... ....+.+|+.+++.++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357888899999999999999864 68999999986443222 223567899999999999999999998754  46799


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+. ++|.+++....   ..+++.+...++.|++.||+|||+.   +++||||||+||++++++.+||+||+
T Consensus        86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            999997 48888886532   3589999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.85  E-value=7.4e-21  Score=175.09  Aligned_cols=146  Identities=25%  Similarity=0.354  Sum_probs=126.7

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|+||.||+++. .+++.+++|.+..... .....++.+|+++++.++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            366678999999999999975 4688999999864332 22344688999999999999999999999998999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++.........+++.....++.|++.||+|||+.   +++|+||+|+||++++++..|++||.
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeecc
Confidence            999999999876433334588999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.85  E-value=1.7e-20  Score=179.09  Aligned_cols=141  Identities=31%  Similarity=0.455  Sum_probs=121.4

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      |...+.||+|+||.||+++. .++..+|+|.+......  .....+.+|+++++.++|+|++++++++...+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            55568899999999999985 46889999998543222  2234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++ |++.+.+....   ..++|.++..++.+++.||.|||+.   +|+||||||+||+++.++.++++||.
T Consensus       107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg  170 (317)
T cd06635         107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  170 (317)
T ss_pred             CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCC
Confidence            97 57877775432   2488999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.85  E-value=1.2e-20  Score=176.79  Aligned_cols=141  Identities=28%  Similarity=0.467  Sum_probs=122.4

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEEEEe
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVYP  324 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e  324 (399)
                      |+..+.||+|+||.||+|+.. +++.+|+|.++... .......+.+|+++++.++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            455688999999999999865 58899999997553 222334688999999999999999999999887  78999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++ +|.+++....   ..+++.....++.|+++||+|||+.   +++|+||||+||++++++.++++||+
T Consensus        81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g  145 (287)
T cd07840          81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFG  145 (287)
T ss_pred             cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccc
Confidence            9984 8888886542   2588999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.85  E-value=1.1e-20  Score=179.21  Aligned_cols=144  Identities=29%  Similarity=0.470  Sum_probs=121.2

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCc-----
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  318 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----  318 (399)
                      .++|+..+.||+|+||.||+|... +++.||||.+...... .....+.+|+.+++.++||||+++++++...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            346888899999999999999864 6889999988543322 223356789999999999999999999876543     


Q ss_pred             ---eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          319 ---KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       319 ---~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                         .++||||+. ++|.+++....   ..+++.+...++.|++.||+|||++   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence               499999997 48888876542   2478999999999999999999998   9999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       164 g  164 (310)
T cd07865         164 G  164 (310)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.85  E-value=1.4e-20  Score=179.09  Aligned_cols=144  Identities=23%  Similarity=0.381  Sum_probs=120.4

Q ss_pred             CCCCceeeccCCceEEEEEeC---CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  321 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  321 (399)
                      |...+.||+|+||.||+|...   +++.||+|.+.....  ......+.+|+.++..++||||+++++++...  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            566788999999999999864   478999999865321  22234678899999999999999999999887  78999


Q ss_pred             EEecCCCCChhhHhhhcCCC-CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC----CCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE----DADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~----~~~~~i~df~  396 (399)
                      ||||+++ ++.+++...... ...++......++.|++.||+|||+.   +|+||||||+||+++.    ++.+|++||+
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999985 677766543222 22578888999999999999999998   9999999999999999    8999999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.85  E-value=7.6e-21  Score=177.36  Aligned_cols=142  Identities=27%  Similarity=0.362  Sum_probs=126.0

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  323 (399)
                      +|...+.||+|+||.||++... +++.||+|.+.....  ......+.+|..++++++ |+||+++++++...+..+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            5777889999999999999864 789999999865322  122346889999999999 999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++....    .+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++++||.
T Consensus        82 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          82 EYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCc
Confidence            9999999999997643    489999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=2.2e-20  Score=171.53  Aligned_cols=142  Identities=29%  Similarity=0.471  Sum_probs=125.5

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|+..+.||+|++|.||++... +++.|++|.+...... .....+.+|++++++++|+|++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            3666789999999999999864 6789999998654322 2234689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+||.
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  144 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFG  144 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccc
Confidence            9999999998764    2489999999999999999999998   99999999999999999999999993

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.85  E-value=1.1e-20  Score=182.63  Aligned_cols=143  Identities=24%  Similarity=0.364  Sum_probs=121.5

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC-----
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----  317 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----  317 (399)
                      ..++|+..+.||+|+||.||++.. .++..||||++...... .....+.+|+.+++.++|+||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            456788889999999999999985 47899999998543222 22346889999999999999999999887543     


Q ss_pred             -ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 -~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                       ..++||||+ +++|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             358999998 67898887542     478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.84  E-value=1e-20  Score=182.90  Aligned_cols=150  Identities=23%  Similarity=0.315  Sum_probs=125.4

Q ss_pred             cHHHHHHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeec
Q 015852          238 SLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  315 (399)
Q Consensus       238 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  315 (399)
                      ...++...+++|...+.||+|+||.||++.. .+++.||+|+++.... ......+.+|+.++..++|+||+++.+++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3455667778999999999999999999985 5788999999864322 2223468889999999999999999998754


Q ss_pred             C------CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc
Q 015852          316 V------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  389 (399)
Q Consensus       316 ~------~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~  389 (399)
                      .      ...++++|++ +++|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            3      3367777776 78998887542     378999999999999999999998   9999999999999999999


Q ss_pred             eeecccc
Q 015852          390 QSSKTIL  396 (399)
Q Consensus       390 ~~i~df~  396 (399)
                      ++++||+
T Consensus       159 ~kl~dfg  165 (345)
T cd07877         159 LKILDFG  165 (345)
T ss_pred             EEEeccc
Confidence            9999994

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.84  E-value=2e-20  Score=175.94  Aligned_cols=139  Identities=24%  Similarity=0.361  Sum_probs=122.6

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      |...+.||+|++|.||++.. .+++.+++|+++... ......+.+|+.+++.++|+||+++++++...+..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            44457899999999999985 468899999885332 2234468899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|.+++...     .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus       100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g  160 (285)
T cd06648         100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG  160 (285)
T ss_pred             CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence            99999998762     378899999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.84  E-value=1.9e-20  Score=176.53  Aligned_cols=144  Identities=23%  Similarity=0.402  Sum_probs=121.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|+..+.||+|++|.||+|+.. +++.||+|.+...... .....+.+|+++++.++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            45777899999999999999864 6889999998654322 223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~~i~df~  396 (399)
                      |++ ++|.+++.....  ..+++.....++.|++.||+|||+.   +++||||||+||++++ ++.+|++||+
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence            996 588888765322  2357788889999999999999998   9999999999999996 4568999994

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.84  E-value=1.5e-20  Score=176.05  Aligned_cols=142  Identities=24%  Similarity=0.432  Sum_probs=123.2

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      |+..+.||+|++|.||+|.. .++..||+|++....... ....+.+|+++++.++|+|++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            45568899999999999986 478999999986543222 2346889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      + ++|.+++.....  ..+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++||.
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~  144 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFG  144 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecc
Confidence            5 689999876432  2488999999999999999999998   99999999999999999999999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.84  E-value=8.5e-23  Score=178.33  Aligned_cols=144  Identities=23%  Similarity=0.316  Sum_probs=122.1

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++.|+..++||+|.|+.||++.. .+|+.+|+|.+..... ....+++.+|+.+.+.++|||||+|...+.+....++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            34566678999999999999864 5788899998854332 224457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~df~  396 (399)
                      |+|.|++|..-+..+.    ..++...-.+..||.++|.|.|.+   +|||||+||+|+|+.+..   .+|++||+
T Consensus        90 e~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   90 DLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             ecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccc
Confidence            9999999988776652    366778888999999999999999   999999999999998644   47999995

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.84  E-value=2.7e-20  Score=170.35  Aligned_cols=142  Identities=33%  Similarity=0.504  Sum_probs=126.5

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++.++.++|+|++++++++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            3666789999999999999875 688999999865433 34457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|.+++....   ..+++.....++.++++||+|||..   +++||||+|+||++++++.++|+||.
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~  143 (253)
T cd05122          80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFG  143 (253)
T ss_pred             CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecc
Confidence            9999999987643   3589999999999999999999998   99999999999999999999999994

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.84  E-value=2e-20  Score=175.28  Aligned_cols=136  Identities=28%  Similarity=0.362  Sum_probs=113.6

Q ss_pred             eeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHH---HHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          254 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVK---IISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       254 ~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      +||+|+||.||++.. .+++.||+|.+......  .....+..|..   .++...||||+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 46889999988543222  11223444443   4455689999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+|..++...    ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg  142 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  142 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCc
Confidence            99999988653    2489999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.84  E-value=1.1e-20  Score=177.75  Aligned_cols=141  Identities=28%  Similarity=0.334  Sum_probs=121.6

Q ss_pred             CCCCceeeccCCceEEEEEe----CCCCEEEEEEcccccc---cccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceE
Q 015852          249 FSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  320 (399)
                      |+..+.||+|+||.||+++.    .+++.||||.++....   ......+.+|+.++..+ +|+||+++.+.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            56678899999999999874    3568899999864321   12234688999999999 5999999999999888999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+++|+|.+++....    .+++.....++.|+++||+|||+.   +++||||||+||++++++.++++||+
T Consensus        82 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          82 LILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             EEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECc
Confidence            9999999999999987542    478889999999999999999988   99999999999999999999999994

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.84  E-value=1.6e-20  Score=177.35  Aligned_cols=145  Identities=24%  Similarity=0.426  Sum_probs=120.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCC-CCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|+..+.||+|+||.||+|...+ ++.||||.++.........++.+|+.++.+.. |+||+++++++......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567778999999999999999764 88999999865433333445777887666665 999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||++ +++.+++.....   .+++..+..++.|++.||+|||+.+  +|+||||||+||++++++.++|+||+
T Consensus        94 e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          94 ELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             eccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccc
Confidence            9985 477776654322   5889999999999999999999731  89999999999999999999999994

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.84  E-value=9.5e-21  Score=182.22  Aligned_cols=142  Identities=23%  Similarity=0.361  Sum_probs=121.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeec----CCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~  320 (399)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+.+++.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5788889999999999999985 46899999998654322 233467889999999999999999988753    34579


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+. |+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.+||+||+
T Consensus        85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence            9999996 68988886432    388999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.84  E-value=2.7e-20  Score=171.03  Aligned_cols=141  Identities=33%  Similarity=0.495  Sum_probs=125.5

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEEEEe
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVYP  324 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e  324 (399)
                      |...+.||+|++|.||+|... +++.|++|.+...... .....+.+|+..+++++|+||+++++.+...  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            566789999999999999875 6889999998654321 2345789999999999999999999999888  88999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++....    .+++..+..++.++++||+|||+.   +++|+||+|+||+++.++.++|+||.
T Consensus        82 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          82 YVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             ecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccc
Confidence            999999999997643    589999999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.84  E-value=1.4e-20  Score=179.27  Aligned_cols=136  Identities=24%  Similarity=0.241  Sum_probs=114.4

Q ss_pred             eeccCCceEEEEEeCCCCEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCChhh
Q 015852          255 LGRGGFGKVYKGRLADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS  333 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~  333 (399)
                      +|.|+++.||+++. +++.||||+++... .......+.+|+++++.++|+||+++++++...+..+++|||+++|+|.+
T Consensus        10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED   88 (314)
T ss_pred             hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence            44445555555544 68899999986542 22334579999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          334 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       334 ~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++.....  ..+++.....++.|+++||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        89 ~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~  146 (314)
T cd08216          89 LLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLR  146 (314)
T ss_pred             HHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCc
Confidence            9986432  2477888999999999999999999   99999999999999999999999994

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.8e-20  Score=172.11  Aligned_cols=137  Identities=25%  Similarity=0.342  Sum_probs=114.9

Q ss_pred             ceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHH-HhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||.||+|.. .+++.||+|.++.....  .....+..|..+ ....+|+|++++++++...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999986 46889999998543211  112234555544 4556899999999999999999999999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|.++++...    .+++.....++.|++.||.|||+.   +++||||+|+||++++++.++++||+
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  142 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFG  142 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecc
Confidence            99999997543    478889999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.84  E-value=1.9e-20  Score=176.72  Aligned_cols=135  Identities=25%  Similarity=0.371  Sum_probs=119.9

Q ss_pred             ceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          253 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ..||+|+||.||++.. .+++.||+|.+... .......+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            5699999999999986 47889999987532 222344689999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++...     .+++.....++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus       105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg  161 (292)
T cd06657         105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  161 (292)
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccc
Confidence            9987542     378899999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.84  E-value=1.7e-20  Score=180.70  Aligned_cols=142  Identities=23%  Similarity=0.380  Sum_probs=120.5

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc-ccccHHHHHHHHHHHhcC-CCCCccceeeeeecC--CceE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV--TEKL  320 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~  320 (399)
                      .++|+..+.||+|+||.||+|... +++.+|+|++.... .......+.+|+.++..+ +|+||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            356777889999999999999865 68899999885432 122234577899999999 999999999998654  3579


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||++ ++|.+++...     .++|.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||+
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            9999997 5998888653     478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.83  E-value=8.4e-21  Score=186.67  Aligned_cols=141  Identities=27%  Similarity=0.411  Sum_probs=121.4

Q ss_pred             CCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-C-----CCccceeeeeecCCceE
Q 015852          248 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-H-----RNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~  320 (399)
                      .|...++||+|+||.|.+|. ..+++.||||+++....  ...+-..|+.+|..++ |     -|+|++++++...+..+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            57778999999999999997 45799999999976432  2334567888888877 3     48999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC--ceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA--DQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~--~~~i~df~  396 (399)
                      ||+|.+. -+|+++++....  ..++......|+.||+.||.+||..   +|||+||||+||||.+-.  .+||.||+
T Consensus       265 iVfELL~-~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             eeehhhh-hhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            9999986 599999987643  3488899999999999999999998   999999999999998754  78999995

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=3.5e-20  Score=163.82  Aligned_cols=134  Identities=18%  Similarity=0.215  Sum_probs=105.7

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEccccccccc-------------------------HHHHHHHHHHHhcCCCCCc
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-------------------------ELQFQTEVKIISMAVHRNL  306 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~-------------------------~~~f~~E~~~l~~l~H~ni  306 (399)
                      ...||+|+||.||+|+..+|+.||||+++.......                         ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            367999999999999977899999999875421100                         1124678899999999988


Q ss_pred             cceeeeeecCCceEEEEecCCCCChhhH-hhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceee
Q 015852          307 LRLYGFCTTVTEKLLVYPYMTNGSVASR-LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILL  384 (399)
Q Consensus       307 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILl  384 (399)
                      .....+...  ..++||||++++++... +..     ..++..+...++.+++.++.|+|+ .   +|+||||||+|||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            655544333  34899999998865433 332     136677889999999999999999 7   99999999999999


Q ss_pred             CCCCceeecccc
Q 015852          385 DEDADQSSKTIL  396 (399)
Q Consensus       385 d~~~~~~i~df~  396 (399)
                      + ++.++++||+
T Consensus       152 ~-~~~~~liDFG  162 (190)
T cd05145         152 H-DGKPYIIDVS  162 (190)
T ss_pred             E-CCCEEEEEcc
Confidence            9 8999999994

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.83  E-value=3.4e-20  Score=179.78  Aligned_cols=141  Identities=23%  Similarity=0.314  Sum_probs=119.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecC------C
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  317 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~  317 (399)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+..... ......+.+|+.+++.++|+||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            46788889999999999999985 4789999999854322 22234678899999999999999999988643      2


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..++||||+. ++|.+.+...      +++.....++.|++.||+|||+.   +|+||||||+||+++.++.+|++||+
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            4689999996 5888877532      67888999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.83  E-value=7.2e-21  Score=192.67  Aligned_cols=147  Identities=19%  Similarity=0.250  Sum_probs=112.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCC--CCEEEEEE--------------cccc--cccccHHHHHHHHHHHhcCCCCCcc
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLAD--GKLVAVKR--------------LKEE--RTSGGELQFQTEVKIISMAVHRNLL  307 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vAvK~--------------l~~~--~~~~~~~~f~~E~~~l~~l~H~niv  307 (399)
                      .++|...+.||+|+||+||++..+.  +...+.|.              +...  ........+.+|+.+++.++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4678899999999999999986532  22222221              1000  0111233588999999999999999


Q ss_pred             ceeeeeecCCceEEEEecCCCCChhhHhhhcCCC-CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC
Q 015852          308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  386 (399)
Q Consensus       308 ~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~  386 (399)
                      ++++++...+..++++|++. ++|.+++...... .......+...|+.|++.||+|||+.   +||||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            99999999999999999985 5777776543211 11223456778999999999999998   9999999999999999


Q ss_pred             CCceeecccc
Q 015852          387 DADQSSKTIL  396 (399)
Q Consensus       387 ~~~~~i~df~  396 (399)
                      ++.+||+||+
T Consensus       303 ~~~vkL~DFG  312 (501)
T PHA03210        303 DGKIVLGDFG  312 (501)
T ss_pred             CCCEEEEeCC
Confidence            9999999994

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.83  E-value=2.6e-20  Score=178.80  Aligned_cols=145  Identities=24%  Similarity=0.365  Sum_probs=123.2

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeec-CCce
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEK  319 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~  319 (399)
                      ...+++|+..+.||+|+||.||++.. .+++.||+|++..... ......+.+|++++..++||||+++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            34567888899999999999999985 4789999998854332 2234568899999999999999999998865 4578


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++||+ +++|.++++..     .+++.....++.|+++||+|||+.   +|+||||||+||++++++.++++||+
T Consensus        86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccc
Confidence            8999998 56898888642     367788889999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7.8e-21  Score=181.15  Aligned_cols=142  Identities=25%  Similarity=0.332  Sum_probs=123.6

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      |...+.||+|.|+.|-.+++ -+|..||||++.+...... .-.+.+|++.|+.++|||||+|+.+..+....|||+|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            55668899999999999874 4899999999965433322 235889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~~i~df~  396 (399)
                      .+|+|++|+-++..+   +.+....++..||..|+.|.|..   .+|||||||+||.+-+ -|-+|+.||+
T Consensus       100 D~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             CCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence            999999999887543   78888999999999999999998   8999999999998654 5789999996

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.83  E-value=4.3e-20  Score=177.59  Aligned_cols=137  Identities=27%  Similarity=0.312  Sum_probs=118.6

Q ss_pred             CceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-------------cHHHHHHHHHHHhcCCCCCccceeeeeecCC
Q 015852          252 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-------------GELQFQTEVKIISMAVHRNLLRLYGFCTTVT  317 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-------------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  317 (399)
                      .+.||+|+||+||+|... +++.||||.++......             ....+.+|+++++.++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            477999999999999854 68899999885432221             0124778999999999999999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..+++|||+. |+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.++++||+
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence            9999999997 68999886532    378889999999999999999998   99999999999999999999999994

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=4.7e-21  Score=198.53  Aligned_cols=147  Identities=25%  Similarity=0.370  Sum_probs=116.5

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC------
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  316 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------  316 (399)
                      .-..+|+..++||+|+||.||+++-+ ||+.||||++.............+|+.++.+++|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            44567888899999999999999855 89999999997654333344688999999999999999987533110      


Q ss_pred             --------------------------------------------------------------------------------
Q 015852          317 --------------------------------------------------------------------------------  316 (399)
Q Consensus       317 --------------------------------------------------------------------------------  316 (399)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHH
Q 015852          317 ---------------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY  363 (399)
Q Consensus       317 ---------------------------------~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~y  363 (399)
                                                       ...||-||||+.-.+.++++......   .-....++.++|++||+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence                                             01367788888777777776542210   234567889999999999


Q ss_pred             HhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          364 LHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       364 LH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|++   +||||||||.||++|++..+||+||+
T Consensus       713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFG  742 (1351)
T KOG1035|consen  713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFG  742 (1351)
T ss_pred             HHhC---ceeeccCCcceeEEcCCCCeeecccc
Confidence            9999   99999999999999999999999994

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.83  E-value=2.7e-20  Score=172.15  Aligned_cols=144  Identities=22%  Similarity=0.276  Sum_probs=119.3

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc----ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      |...+.||+|+||.||+++.. .+..+++|.++...    ......++..|+.+++.++||||+++++++......+++|
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            566789999999999999864 34456666654322    1122335778999999999999999999999888999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.++++........+++.....++.|++.||.|||+.   +++|+||||+||++++ +.++++||+
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g  150 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFG  150 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccC
Confidence            99999999999876433334689999999999999999999998   9999999999999985 569999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=7.9e-21  Score=184.92  Aligned_cols=142  Identities=23%  Similarity=0.298  Sum_probs=121.9

Q ss_pred             CCCCCceeeccCCceEEEEE-eCCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      -|...+.||-|+||+|..++ .++...+|.|.+++...-  ........|-.+|...+.+.||+|+-.|.+.+.+|.|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            36677889999999999986 456778999998643211  112246778889999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++||++.++|-+.+    .+.+.....++.++..|+++.|..   ++|||||||+|||||.||.+|+.||+
T Consensus       710 YIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             ccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence            999999999997653    377777888889999999999999   99999999999999999999999993

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.83  E-value=2.8e-20  Score=174.81  Aligned_cols=146  Identities=25%  Similarity=0.358  Sum_probs=118.2

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +|...+.||+|+||.||++... +++.+|+|.+...........+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4445678999999999999864 688999999865433334457899999999986 99999999999998899999999


Q ss_pred             CCCCChhhHhhhc-CCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRER-QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +.. ++.++.... ......+++.....++.+++.||+|||+.+  +|+||||||+||++++++.++++||+
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg  153 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFG  153 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecc
Confidence            874 554433210 011135888999999999999999999632  79999999999999999999999994

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.83  E-value=1.1e-19  Score=173.16  Aligned_cols=141  Identities=31%  Similarity=0.442  Sum_probs=120.8

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      |...+.||+|+||+||+|+. .+++.|++|.+......  .....+.+|+++++.++|+|++++++++......+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            45557799999999999986 46889999998543222  2224688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +. |++.+++....   .++++.++..++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus       103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633         103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecC
Confidence            96 67888776532   2488999999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.83  E-value=2.6e-20  Score=191.95  Aligned_cols=152  Identities=26%  Similarity=0.389  Sum_probs=131.3

Q ss_pred             HHHHHhcCCCCCceeeccCCceEEEEEeC----C----CCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceee
Q 015852          241 ELQVATDGFSNKNILGRGGFGKVYKGRLA----D----GKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYG  311 (399)
Q Consensus       241 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g  311 (399)
                      .++...+++...+.+|+|.||.|++|...    .    ...||||.++......+...+..|+++|+.+. |+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34555566666779999999999999742    1    34799999987776656668999999998875 999999999


Q ss_pred             eeecCCceEEEEecCCCCChhhHhhhcC---CC-------C--CCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 015852          312 FCTTVTEKLLVYPYMTNGSVASRLRERQ---SS-------L--PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKA  379 (399)
Q Consensus       312 ~~~~~~~~~lv~e~~~~gsL~~~L~~~~---~~-------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~  379 (399)
                      +|...+..++|+||+..|+|.++|+..+   .-       .  ..++..+.+.++.|||.||+||++.   ++|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999999876   00       0  1378889999999999999999999   999999999


Q ss_pred             CceeeCCCCceeeccc
Q 015852          380 ANILLDEDADQSSKTI  395 (399)
Q Consensus       380 ~NILld~~~~~~i~df  395 (399)
                      +|||+.++..+||+||
T Consensus       447 RNVLi~~~~~~kIaDF  462 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADF  462 (609)
T ss_pred             hhEEecCCCEEEEccc
Confidence            9999999999999999

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.83  E-value=4.1e-20  Score=178.04  Aligned_cols=142  Identities=22%  Similarity=0.363  Sum_probs=120.6

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecC-----Cce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  319 (399)
                      .+|...+.||+|+||.||+++. .+++.||||.++.... ......+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            3577788999999999999985 4689999999865322 22234678899999999999999999987654     347


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++||+. ++|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||+++.++.+||+||+
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            99999996 68888886532    488999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.83  E-value=5.3e-20  Score=177.67  Aligned_cols=140  Identities=25%  Similarity=0.394  Sum_probs=118.0

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC------c
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------E  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~  318 (399)
                      ++|...+.||+|+||.||+|.. .+++.||+|+++..... .....+.+|+.+++.++|+||+++++++....      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            6788889999999999999985 46899999998643222 22346889999999999999999999886543      4


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++++||+.. +|..+...      .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.++++||+
T Consensus        95 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             EEEEeccccc-CHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence            5899999974 67665421      378899999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.83  E-value=1.1e-19  Score=169.27  Aligned_cols=141  Identities=26%  Similarity=0.300  Sum_probs=115.2

Q ss_pred             HHHhcCCCCCcee--eccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHh-cCCCCCccceeeeeecCCc
Q 015852          243 QVATDGFSNKNIL--GRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       243 ~~~~~~~~~~~~l--G~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~  318 (399)
                      ....++|...+.+  |+|+||.||+++. .++..+|+|.+.......    .  |+.... ..+|+|++++++.+...+.
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            3334556665665  9999999999985 468889999885432111    1  222222 1269999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      .++||||+++|+|.+++....    .++|.+...++.|+++||+|||+.   +++||||||+||+++.++ .++++||+
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999997643    589999999999999999999998   899999999999999999 99999994

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.82  E-value=7e-21  Score=179.19  Aligned_cols=147  Identities=28%  Similarity=0.395  Sum_probs=128.1

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ..+.|..-++||+|+||.||-++. .+|+.+|.|.+.+...  ...+.--+.|-.++.+++.+.||.+--.|.+++...+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            345688889999999999999986 4799999998844322  2233346788999999999999999888999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+..|.||+|.-+|.....  +.++......+|.+|+.||++||+.   +||.||+||+|||||+.|.++|+|++
T Consensus       263 VLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             EEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence            9999999999999887643  4589999999999999999999999   99999999999999999999999984

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.82  E-value=6.2e-20  Score=171.60  Aligned_cols=141  Identities=26%  Similarity=0.436  Sum_probs=122.9

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      |...+.||+|++|.||++... +++.+++|.++..... .....+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            345678999999999999864 6889999998654332 23446889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++ ++.+++....   ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.++++||.
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~  143 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFG  143 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeee
Confidence            85 8888887643   3588999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PTZ00284 protein kinase; Provisional

Probab=99.82  E-value=2.8e-20  Score=187.08  Aligned_cols=144  Identities=19%  Similarity=0.308  Sum_probs=113.8

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCC------CCCccceeeeeec
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV------HRNLLRLYGFCTT  315 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~g~~~~  315 (399)
                      ....++|...+.||+|+||+||+|... +++.||||+++...  .....+..|+.++..++      |.+++++++++..
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            345677888999999999999999864 67899999986421  11223455666555554      4568889888876


Q ss_pred             C-CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceeeCCCC-----
Q 015852          316 V-TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDA-----  388 (399)
Q Consensus       316 ~-~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILld~~~-----  388 (399)
                      . ...++|||++ +++|.+++.+..    .+++.....|+.|++.||+|||+ .   +||||||||+|||++.++     
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence            4 4577888887 678988887542    48899999999999999999997 4   899999999999999776     


Q ss_pred             -----------ceeecccc
Q 015852          389 -----------DQSSKTIL  396 (399)
Q Consensus       389 -----------~~~i~df~  396 (399)
                                 .+||+||+
T Consensus       275 ~~~~~~~~~~~~vkl~DfG  293 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLG  293 (467)
T ss_pred             ccccccCCCCceEEECCCC
Confidence                       38999996

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.82  E-value=3.8e-20  Score=177.49  Aligned_cols=141  Identities=23%  Similarity=0.360  Sum_probs=122.4

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCC-----ceE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  320 (399)
                      +|...+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|+.+++.++|+||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            3667789999999999999864 588999999865432 233447899999999999999999999987765     789


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|||++ ++|.+++....    .+++.....++.+++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg  148 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFG  148 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccC
Confidence            9999998 58888886532    588999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.82  E-value=5.8e-20  Score=171.71  Aligned_cols=141  Identities=30%  Similarity=0.476  Sum_probs=123.0

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      |+..+.||+|.||.||+|+.. +++.+|+|.++.... ......+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            345578999999999999865 589999999865432 222346889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      + ++|.+++....   ..+++..+..++.+++.||+|||+.   +|+||||+|+||++++++.++|+||+
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g  143 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFG  143 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCC
Confidence            8 59999997643   2488999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.82  E-value=1e-19  Score=170.45  Aligned_cols=142  Identities=28%  Similarity=0.467  Sum_probs=118.4

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeeeecCCc-----
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTTVTE-----  318 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~-----  318 (399)
                      |+..+.||+|+||.||+|+.. +++.||+|.++...... ....+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            455688999999999999976 48899999996443322 223566787766554   69999999999988776     


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++|||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++++||+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence            899999997 489888875432  2489999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.82  E-value=4.3e-21  Score=199.76  Aligned_cols=144  Identities=33%  Similarity=0.450  Sum_probs=123.9

Q ss_pred             cCCCCCceeeccCCceEEEEE-eCCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      -++.....||.|.||.||.|. ..+|...|+|.++-.... .......+|+.++..++|||+|+++|.-.+.+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            345667889999999999997 678999999988643222 223357899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  397 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~~  397 (399)
                      ||++|+|.+.+...+    ..++.....+..|++.|++|||++   +||||||||.||+||.+|-.|.+||+.
T Consensus      1315 yC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             HhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccc
Confidence            999999999997543    255666677888999999999999   999999999999999999999999974

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.82  E-value=9.3e-20  Score=173.30  Aligned_cols=141  Identities=31%  Similarity=0.455  Sum_probs=120.4

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      |+..+.||+|+||.||+|+.. +++.+|+|.+.....  .....++.+|+++++.++|+|++++.+++......++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            455578999999999999864 678999998854321  22234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +. |++.+++....   ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++++||+
T Consensus        97 ~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          97 CL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             cC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence            97 68888776432   2478899999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.82  E-value=1.3e-20  Score=160.98  Aligned_cols=152  Identities=26%  Similarity=0.346  Sum_probs=125.6

Q ss_pred             HHHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHH-hcCCCCCccceeeeeecCCce
Q 015852          242 LQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       242 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~~~~~  319 (399)
                      +++..++......||+|++|.|-+-++ .+|+..|||+++.....+...+.++|+.+. +....|.+|.++|........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            445555666678899999999988775 479999999997666555566788888864 556799999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++.||.|. -||..+-++.-.......+...-+||..|..||.|||++-  .+||||+||+|||+|.+|.+|++||+
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence            99999996 4777776653333345777888899999999999999974  79999999999999999999999995

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.82  E-value=5.9e-20  Score=174.25  Aligned_cols=144  Identities=30%  Similarity=0.446  Sum_probs=120.4

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCC------
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  317 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------  317 (399)
                      .++|+..+.||+|+||.||+|+.. +++.+|+|.+....... ....+.+|+++++.++|+||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888899999999999999864 68899999885443222 2335788999999999999999998875433      


Q ss_pred             --ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          318 --EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       318 --~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                        ..++++||+.. ++...+....   ..+++.....++.|+++||+|||+.   +|+||||||+||++++++.++++||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              35899999975 6777765432   2488999999999999999999998   9999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      .
T Consensus       160 g  160 (311)
T cd07866         160 G  160 (311)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.82  E-value=8.6e-20  Score=175.39  Aligned_cols=141  Identities=24%  Similarity=0.351  Sum_probs=116.7

Q ss_pred             CCCCCceeeccCCceEEEEEeC-C--CCEEEEEEcccccccc-cHHHHHHHHHHHhcC-CCCCccceeeeeecC----Cc
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-D--GKLVAVKRLKEERTSG-GELQFQTEVKIISMA-VHRNLLRLYGFCTTV----TE  318 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~--~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~  318 (399)
                      +|...+.||+|+||.||+++.. +  +..||+|.+....... ....+.+|++++.++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3566788999999999999864 4  7789999986432222 234688899999998 599999999875432    45


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++++||+. ++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++|+||+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg  150 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFG  150 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCC
Confidence            678888886 68998886432    488999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.82  E-value=1.2e-19  Score=166.64  Aligned_cols=135  Identities=33%  Similarity=0.364  Sum_probs=120.0

Q ss_pred             eeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          255 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ||+|+||.||++... +++.+|+|.++......  ....+..|+.+++.++|+||+++++.+......+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 58899999986543222  234689999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++....    .+++.....++.|++.||.|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~  138 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFG  138 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecC
Confidence            99997643    478999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=1.5e-19  Score=161.18  Aligned_cols=135  Identities=17%  Similarity=0.211  Sum_probs=103.5

Q ss_pred             CCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcC-----CCCCccceeeeeecCC---ceE
Q 015852          249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-----VHRNLLRLYGFCTTVT---EKL  320 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~  320 (399)
                      ++..++||+|+||.||.  .++....+||++.... ......+.+|+..++.+     .||||++++|++.+..   ..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34568899999999996  4332334689875432 22345799999999999     5799999999998864   333


Q ss_pred             -EEEec--CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHH-HHHhcCCCCCceecCCCCCceeeCCC----Cceee
Q 015852          321 -LVYPY--MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL-SYLHEHCDPKIIHRDVKAANILLDED----ADQSS  392 (399)
Q Consensus       321 -lv~e~--~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlK~~NILld~~----~~~~i  392 (399)
                       +|+||  +++|+|.+++.+.     .+++.  ..++.++..++ +|||++   +|+||||||+|||++.+    ..++|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence             78999  6689999999653     14443  35577888777 999999   99999999999999843    37999


Q ss_pred             cccc
Q 015852          393 KTIL  396 (399)
Q Consensus       393 ~df~  396 (399)
                      .||.
T Consensus       151 iDg~  154 (210)
T PRK10345        151 CDNI  154 (210)
T ss_pred             EECC
Confidence            9963

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-20  Score=171.20  Aligned_cols=145  Identities=28%  Similarity=0.344  Sum_probs=126.1

Q ss_pred             HhcCCCCCceeeccCCceEEEEE-eCCCCEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ..++|...++||+|.||+|..++ ..+++.+|+|+++++..-..  ...-+.|-++++..+||.+..|.-.++..+..+.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            34677888999999999999997 45799999999987653322  2245778999999999999999888899999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||..+|.|.-+|...+    .++......+-..|..||.|||++   +||.||||-+|.|+|.||.+||+||+
T Consensus       246 VMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFG  313 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFG  313 (516)
T ss_pred             EEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecc
Confidence            999999999999887643    378888888999999999999999   99999999999999999999999993

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-19  Score=182.82  Aligned_cols=150  Identities=30%  Similarity=0.438  Sum_probs=128.3

Q ss_pred             HHHHHHhcCCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeec--
Q 015852          240 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT--  315 (399)
Q Consensus       240 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~--  315 (399)
                      +.+...++-|.+.++||+|.+|.||+++ .++++.+|+|++....  +.+.+...|.++++.. +|||++.++|++.-  
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3344456778888999999999999998 4578899999886543  3444677788888766 59999999999853  


Q ss_pred             ---CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceee
Q 015852          316 ---VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  392 (399)
Q Consensus       316 ---~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i  392 (399)
                         ++++|+|||||.+|+..++++...  ...++|..+..|++.+++||.+||..   .++|||+|-.|||++.++++|+
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence               568999999999999999998765  34589999999999999999999999   9999999999999999999999


Q ss_pred             cccc
Q 015852          393 KTIL  396 (399)
Q Consensus       393 ~df~  396 (399)
                      .||+
T Consensus       165 vDFG  168 (953)
T KOG0587|consen  165 VDFG  168 (953)
T ss_pred             eeee
Confidence            9995

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.80  E-value=2.2e-19  Score=164.13  Aligned_cols=126  Identities=21%  Similarity=0.204  Sum_probs=109.7

Q ss_pred             cCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCChhhHhh
Q 015852          258 GGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR  336 (399)
Q Consensus       258 G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~  336 (399)
                      |.||.||+++. .+++.+|+|+++...      .+.+|...+....||||+++++++...+..+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            88999999985 478899999986432      23345555555679999999999999999999999999999999987


Q ss_pred             hcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          337 ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       337 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ...    .+++.....++.|+++||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~  130 (237)
T cd05576          78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS  130 (237)
T ss_pred             Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeccc
Confidence            643    388999999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.80  E-value=1.3e-19  Score=175.02  Aligned_cols=142  Identities=25%  Similarity=0.366  Sum_probs=121.5

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCc-----
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  318 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----  318 (399)
                      .++|...+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+.+++.++|+|++++.+++...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            467888899999999999999864 678999999864322 2223457789999999999999999988766554     


Q ss_pred             -eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 -KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 -~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                       .++|+||+ +++|.+++...     .+++.....++.|+++||+|||+.   +|+||||||+||++++++.++|+||+
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence             89999998 57999988642     488999999999999999999998   99999999999999999999999994

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.80  E-value=2.1e-19  Score=173.47  Aligned_cols=140  Identities=26%  Similarity=0.362  Sum_probs=117.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC---------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV---------  316 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~---------  316 (399)
                      .+|...+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+++++.++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            4677789999999999999986 4688999999854332 3345688999999999999999999776543         


Q ss_pred             -----CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCce
Q 015852          317 -----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQ  390 (399)
Q Consensus       317 -----~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~  390 (399)
                           ...+++|||++ ++|.+++...     .+++.....++.|++.||+|||+.   +|+||||||+||+++. +..+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 34789999997 5888887542     378899999999999999999998   9999999999999985 4578


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      +++||+
T Consensus       155 kl~dfg  160 (342)
T cd07854         155 KIGDFG  160 (342)
T ss_pred             EECCcc
Confidence            999994

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.79  E-value=1.3e-18  Score=164.43  Aligned_cols=142  Identities=21%  Similarity=0.260  Sum_probs=104.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeCC----CCEEEEEEccccccccc-H---------HHHHHHHHHHhcCCCCCccceeee
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGG-E---------LQFQTEVKIISMAVHRNLLRLYGF  312 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vAvK~l~~~~~~~~-~---------~~f~~E~~~l~~l~H~niv~l~g~  312 (399)
                      ..|...+.||+|+||+||+|...+    +..+|+|.......... +         .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            467888999999999999998653    34566665422211100 0         112333445667899999999987


Q ss_pred             eecCC----ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC
Q 015852          313 CTTVT----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       313 ~~~~~----~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~  388 (399)
                      +....    ..++++|++.. ++.+.+....    ..++.....|+.|+++||+|||+.   +|+||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            65543    34677777643 5666654321    256788899999999999999998   999999999999999999


Q ss_pred             ceeecccc
Q 015852          389 DQSSKTIL  396 (399)
Q Consensus       389 ~~~i~df~  396 (399)
                      .++|+||+
T Consensus       164 ~~~l~DFG  171 (294)
T PHA02882        164 RGYIIDYG  171 (294)
T ss_pred             cEEEEEcC
Confidence            99999994

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=5.3e-21  Score=167.78  Aligned_cols=141  Identities=32%  Similarity=0.530  Sum_probs=116.5

Q ss_pred             CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecC--------Cc
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------TE  318 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~~  318 (399)
                      |.....||+|.||+||+|+.+ +|+.||+|++--+.. ..--..-.+|+.++..++|+|++.+++.|.+.        ..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            334467999999999999865 578899987633222 22223568899999999999999999998653        23


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++|+++|+. +|.-+|.....   .++..++.+++.++..||.|+|+.   .|+|||+||.|+||+.|+..|++||+
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            7899999985 88888876432   478899999999999999999999   99999999999999999999999994

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.78  E-value=1.2e-19  Score=162.86  Aligned_cols=139  Identities=24%  Similarity=0.315  Sum_probs=116.2

Q ss_pred             cCCCC-CceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeec----CCce
Q 015852          247 DGFSN-KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT----VTEK  319 (399)
Q Consensus       247 ~~~~~-~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~----~~~~  319 (399)
                      ++|+. .++||-|-.|+|..+.. .+++.+|+|++...      ..-++|+++.-+.. |||||+++++|..    ....
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            34433 37899999999999975 47889999998532      24678898876664 9999999998864    3467


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC---CCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~---~~~~~i~df~  396 (399)
                      ++|||.|+||.|.+.+++++.  .++++.+.-.|+.||+.|+.|||+.   +|.||||||+|+|...   |...|++||+
T Consensus       135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence            899999999999999988754  3589999999999999999999999   9999999999999975   4467999994

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.78  E-value=3.1e-18  Score=154.07  Aligned_cols=142  Identities=34%  Similarity=0.481  Sum_probs=124.4

Q ss_pred             CCCCceeeccCCceEEEEEeCC-CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCC
Q 015852          249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      |...+.||+|++|.||++...+ ++.+|+|.+...........+.+|++.+..++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            3456889999999999998764 889999998654322134578999999999999999999999998899999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|.+++.....   .+++.....++.++++++.|||..   +++|+|++|+||+++.++.++++||.
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g  143 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFG  143 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCc
Confidence            9999999976432   178899999999999999999998   99999999999999999999999994

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.3e-19  Score=170.10  Aligned_cols=144  Identities=26%  Similarity=0.381  Sum_probs=119.9

Q ss_pred             CCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccH------HHHHHHHHHHhcCCCCCccceeeeeecC-Cce
Q 015852          248 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE------LQFQTEVKIISMAVHRNLLRLYGFCTTV-TEK  319 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~------~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~  319 (399)
                      +|-..++||+|+|+.||++. +...+.||||+-.....+.++      +.-.+|..+.+.+.||.||++++++.-+ +..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            35556789999999999996 456788999976433333222      2357899999999999999999999754 456


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC---Cceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~---~~~~i~df~  396 (399)
                      +-|+|||++-+|.-+|+.++    .++..+...|+.||..||.||.+. .|+|||-||||.||||-+.   |++||.||+
T Consensus       544 CTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            78999999999999998764    378899999999999999999987 7899999999999999754   688999995

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.78  E-value=1.9e-20  Score=165.54  Aligned_cols=141  Identities=28%  Similarity=0.379  Sum_probs=114.3

Q ss_pred             CCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHH-hcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          251 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ....||.|+||+|+|-.++ .|+..|||+++......+.++++.|.++. +.-+-||||+++|.+-.++..|+-||.|. 
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence            3466999999999998764 69999999998766656666899898864 55569999999999999999999999996 


Q ss_pred             CChhhHhh---hcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLR---ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      -|+..+..   .-+.  ..+++.-.-.|.....+||.||-+..  .|||||+||+|||+|..|.+|++||+
T Consensus       147 ~SlDklYk~vy~vq~--~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG  213 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQK--SRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG  213 (361)
T ss_pred             hhHHHHHHHHHHHHh--ccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence            35544332   2111  23566667788888899999998764  89999999999999999999999994

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.2e-19  Score=168.95  Aligned_cols=145  Identities=24%  Similarity=0.331  Sum_probs=123.2

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcC-CCCCccceeeeeecCCceE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  320 (399)
                      ...+|....+||+|+||+|..++-+ +.+.+|||+++++..-+  ..+--+.|-+++... +-|.++++..++++.+..|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3456888899999999999999754 57789999998765322  222345566666655 4788999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .||||+.+|+|.-.+++-+    .+.++.+..+|.+||-||-|||++   +||.||||-+|||||.+|.+||+||+
T Consensus       427 FVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFG  495 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  495 (683)
T ss_pred             eEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecc
Confidence            9999999999999998754    377889999999999999999999   99999999999999999999999995

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.77  E-value=5.7e-19  Score=170.66  Aligned_cols=143  Identities=24%  Similarity=0.342  Sum_probs=121.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc------ccHH-HHHHHHHHHhcCC---CCCccceeeeeec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS------GGEL-QFQTEVKIISMAV---HRNLLRLYGFCTT  315 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~-~f~~E~~~l~~l~---H~niv~l~g~~~~  315 (399)
                      .+|+....+|+|+||.|+.|.++ +...|.||.+.++..-      +... ..-.||.+|..++   |+||++++.+|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35777899999999999999875 4678999998654321      1111 3567999999998   9999999999999


Q ss_pred             CCceEEEEecC-CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecc
Q 015852          316 VTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  394 (399)
Q Consensus       316 ~~~~~lv~e~~-~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~d  394 (399)
                      .+..|++||-. ++-+|.+++..+    +.+++.+...|..||+.|+++||++   +|||||||-+||.+|.+|-+|+.|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            99999999965 566889998654    3489999999999999999999999   999999999999999999999999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       714 fg  715 (772)
T KOG1152|consen  714 FG  715 (772)
T ss_pred             cc
Confidence            96

>PLN03150 hypothetical protein; Provisional

Probab=99.77  E-value=1.8e-18  Score=178.60  Aligned_cols=107  Identities=35%  Similarity=0.604  Sum_probs=78.6

Q ss_pred             cCChhHHHHHHHHHhhcCCCCCCCCCCCCCCCCCC-----cceeeeeCCC-----CCEEEEEeCCCCceeecChhhccCc
Q 015852           22 ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLC-----TWFHITCNPE-----GSVTRVDLGNAALSGELAPELGQLK   91 (399)
Q Consensus        22 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c-----~w~gv~c~~~-----~~v~~l~l~~~~l~g~ip~~l~~l~   91 (399)
                      ...+.|++||+++|..+.++..  .+|+.   +||     .|.||+|+.+     ..|+.|+|++|+++|.+|+++++|+
T Consensus       368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~  442 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR  442 (623)
T ss_pred             ccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence            3567899999999999977642  47963   566     6999999521     1477777777777777777777777


Q ss_pred             CCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC
Q 015852           92 NLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  133 (399)
Q Consensus        92 ~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~  133 (399)
                      +|+.|+|++|+|+|.+|..+..+++|+.|||++|+|+|.+|.
T Consensus       443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~  484 (623)
T PLN03150        443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE  484 (623)
T ss_pred             CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCch
Confidence            777777777777777777777777777777777777776664

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.77  E-value=8.7e-20  Score=178.83  Aligned_cols=143  Identities=29%  Similarity=0.418  Sum_probs=127.3

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .++|.....+|.|.||.|||++. ..++..|||.++.+... ......+|+-+++..+|+|||.++|.+...+..++.||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            45778888999999999999985 57899999999765433 33357789999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||-+|+|.+.-+...    +++..++...++...+||.|||+.   +-+|||||-.|||+.+.+++|++||+
T Consensus        93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfg  157 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFG  157 (829)
T ss_pred             ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccC
Confidence            999999999887543    588889999999999999999999   88999999999999999999999995

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.77  E-value=6.4e-18  Score=149.46  Aligned_cols=136  Identities=37%  Similarity=0.541  Sum_probs=120.4

Q ss_pred             eeccCCceEEEEEeCC-CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCChhh
Q 015852          255 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS  333 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~  333 (399)
                      ||+|.+|.||++...+ ++.+++|.+...........+.+|+..++.++|++++++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 889999998654332234579999999999999999999999999899999999999999999


Q ss_pred             HhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCceeecccc
Q 015852          334 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       334 ~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~~i~df~  396 (399)
                      ++....   ..+++..+..++.+++++++|||+.   +++|+||+|+||+++. ++.++++||.
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~  138 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFG  138 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCC
Confidence            997642   2478999999999999999999999   9999999999999999 8999999993

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.75  E-value=1.8e-18  Score=153.62  Aligned_cols=138  Identities=25%  Similarity=0.431  Sum_probs=113.5

Q ss_pred             CceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEecCCCC
Q 015852          252 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      ...||.|+.|.|++++.+ +|..+|||.+.......+.++++..+.++.+-+ .|.||+-+|||......++-||.|.. 
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence            356999999999999865 689999999976555444556777787776654 89999999999999999999998853 


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      .++.+|+.-..   ++.+...-++...+..||.||-+.+  +|||||+||+|||+|+.|++|++||
T Consensus       176 C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDF  236 (391)
T KOG0983|consen  176 CAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDF  236 (391)
T ss_pred             HHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecc
Confidence            45555554322   4666677788899999999999875  8999999999999999999999999

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1e-17  Score=150.35  Aligned_cols=131  Identities=17%  Similarity=0.222  Sum_probs=110.1

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccc-------cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.||+|++|.||+|.. ++..+++|.........       ....+.+|+.++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 66789999765332111       113578899999999999998888887777888999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++...       .+ .+..++.+++.+|.++|+.   +++|||++|+|||++ ++.+++.||.
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~  139 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFG  139 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECC
Confidence            9999999998642       22 7889999999999999998   999999999999999 7899999994

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.75  E-value=3.7e-18  Score=174.51  Aligned_cols=144  Identities=23%  Similarity=0.252  Sum_probs=101.1

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-C----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeee------e
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-D----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF------C  313 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~  313 (399)
                      ..++|...+.||+|+||.||+|+.. +    +..||+|++.....   ...+..|  .+....+.++..+...      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4567888999999999999999864 4    68999998753211   1112221  1222223333322211      2


Q ss_pred             ecCCceEEEEecCCCCChhhHhhhcCCCC----------------CCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 015852          314 TTVTEKLLVYPYMTNGSVASRLRERQSSL----------------PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  377 (399)
Q Consensus       314 ~~~~~~~lv~e~~~~gsL~~~L~~~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  377 (399)
                      ......++||||+.+++|.+++.......                ..........++.|++.||+|||+.   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            34567899999999999999987532100                0111234557899999999999998   9999999


Q ss_pred             CCCceeeCC-CCceeecccc
Q 015852          378 KAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       378 K~~NILld~-~~~~~i~df~  396 (399)
                      ||+|||+++ ++.+||+||+
T Consensus       282 KP~NILl~~~~~~~KL~DFG  301 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLG  301 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCC
Confidence            999999996 5789999994

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.74  E-value=1.4e-17  Score=151.07  Aligned_cols=131  Identities=35%  Similarity=0.492  Sum_probs=116.6

Q ss_pred             CCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCChhhHhhh
Q 015852          259 GFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE  337 (399)
Q Consensus       259 ~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~  337 (399)
                      +||.||+|... +++.+++|++...........+.+|++.+++++|+|++++.+++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 58999999986543332256799999999999999999999999998999999999999999999876


Q ss_pred             cCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          338 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       338 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..    .+++.....++.++++++.|||..   +++|+||+|+||++++++.++++||.
T Consensus        81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~  132 (244)
T smart00220       81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFG  132 (244)
T ss_pred             cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEcccc
Confidence            43    278899999999999999999998   99999999999999999999999994

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=1.2e-17  Score=152.33  Aligned_cols=137  Identities=14%  Similarity=0.115  Sum_probs=104.9

Q ss_pred             CCCCCceeeccCCceEEEEE--eCCCCEEEEEEcccccccc-----------------------cHHHHHHHHHHHhcCC
Q 015852          248 GFSNKNILGRGGFGKVYKGR--LADGKLVAVKRLKEERTSG-----------------------GELQFQTEVKIISMAV  302 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~--~~~~~~vAvK~l~~~~~~~-----------------------~~~~f~~E~~~l~~l~  302 (399)
                      .|...+.||+|+||.||+|.  ..+|+.||+|.++......                       ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            36677899999999999998  5689999999986432110                       0123568999999887


Q ss_pred             CCC--ccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCC
Q 015852          303 HRN--LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-IIHRDVKA  379 (399)
Q Consensus       303 H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlK~  379 (399)
                      +..  +.+++++    ...++||||+++++|........    .+...+...++.|++.+++|||..   + |+||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            633  3333332    24589999999988876543221    245556788999999999999999   8 99999999


Q ss_pred             CceeeCCCCceeecccc
Q 015852          380 ANILLDEDADQSSKTIL  396 (399)
Q Consensus       380 ~NILld~~~~~~i~df~  396 (399)
                      +||+++ ++++++.||.
T Consensus       178 ~NIli~-~~~i~LiDFg  193 (237)
T smart00090      178 YNILVH-DGKVVIIDVS  193 (237)
T ss_pred             hhEEEE-CCCEEEEECh
Confidence            999999 8899999994

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=1.5e-17  Score=147.92  Aligned_cols=131  Identities=22%  Similarity=0.171  Sum_probs=102.9

Q ss_pred             CCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc---------------------ccHHHHHHHHHHHhcCCCCC--
Q 015852          249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---------------------GGELQFQTEVKIISMAVHRN--  305 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------------------~~~~~f~~E~~~l~~l~H~n--  305 (399)
                      |...+.||+|+||.||++...+|+.||||+++.....                     .....+..|...+..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            6667899999999999999888999999987543210                     00113677888888888874  


Q ss_pred             ccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC
Q 015852          306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  385 (399)
Q Consensus       306 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld  385 (399)
                      +.+.++    ....+++|||+++++|......          .....++.+++.++.++|+.   +|+||||||+||+++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~  159 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD  159 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence            444443    2456899999999998765421          23467889999999999998   999999999999999


Q ss_pred             CCCceeecccc
Q 015852          386 EDADQSSKTIL  396 (399)
Q Consensus       386 ~~~~~~i~df~  396 (399)
                      ++++++|+||+
T Consensus       160 ~~~~~~liDfg  170 (198)
T cd05144         160 DDEKIYIIDWP  170 (198)
T ss_pred             CCCcEEEEECC
Confidence            99999999994

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=1.9e-17  Score=147.24  Aligned_cols=127  Identities=17%  Similarity=0.235  Sum_probs=103.7

Q ss_pred             eeeccCCceEEEEEeCCCCEEEEEEcccccccc-------cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          254 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       254 ~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      +||+|+||.||+|.+ ++..+++|.........       ...++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 56789999864322111       1235778999999999988776666666677789999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|.+.+....           ..++.+++.+|.++|+.   +++|+|+||+||+++ ++.+++.||.
T Consensus        80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg  134 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFG  134 (199)
T ss_pred             CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECC
Confidence            9999998875421           07899999999999998   999999999999999 8999999994

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=2.4e-17  Score=168.31  Aligned_cols=132  Identities=15%  Similarity=0.203  Sum_probs=106.5

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEE-ccccccc------ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKR-LKEERTS------GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~-l~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      .|...+.||+|+||.||+|.+.+.. +++|+ +......      .....+.+|++++..++|++++....++......+
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            3456789999999999999875443 33333 2221111      11235889999999999999999888888777889


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+++++|.+++.            ....++.+++++|.|||+.   +|+|||+||+|||+ +++.++|+||+
T Consensus       413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence            9999999999998875            3467899999999999998   99999999999999 67899999993

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=8.6e-19  Score=155.58  Aligned_cols=138  Identities=25%  Similarity=0.345  Sum_probs=112.6

Q ss_pred             CCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC-----ceEEE
Q 015852          250 SNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKLLV  322 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv  322 (399)
                      +..+.||-|+||.||.... ++|+.||.|++...... ...+.+.+|+.++..++|.|++..++...-..     +.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3447899999999999875 57999999988543211 22346889999999999999999988765432     56788


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      +|.|. .+|.+++...    .+++-....-+..||.+||.|||+.   +|.||||||.|.|++++...||+||
T Consensus       136 TELmQ-SDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDF  200 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDF  200 (449)
T ss_pred             HHHHH-hhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccc
Confidence            88885 4676666543    3477778888999999999999999   9999999999999999999999999

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=5.5e-17  Score=142.67  Aligned_cols=127  Identities=18%  Similarity=0.141  Sum_probs=100.7

Q ss_pred             CCceeeccCCceEEEEEeCCCCEEEEEEccccccccc---HHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEecC
Q 015852          251 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG---ELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~---~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ....|++|+||+||.+.- .+..++.+.+........   ...|.+|+++|+++. |+++.+++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999997655 677788777754433211   224889999999996 5789999886    4579999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-K~~NILld~~~~~~i~df~  396 (399)
                      .+.+|.+.+..           ....+..|++++|+|+|++   +|+|||| ||+|||+++++.++|+||+
T Consensus        81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence            99998654321           1135678899999999999   9999999 7999999999999999994

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.72  E-value=7.4e-18  Score=169.29  Aligned_cols=139  Identities=29%  Similarity=0.348  Sum_probs=109.7

Q ss_pred             CCCCceeeccCCce-EEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEecC
Q 015852          249 FSNKNILGRGGFGK-VYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       249 ~~~~~~lG~G~fg~-Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      |...+++|.|+-|+ ||+|.+ +++.||||++-.+.    ..-..+|+..++.-+ |||||++++.-.+....|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            56668899999876 799998 57899999984332    123568999888775 999999999988899999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC---CC--ceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DA--DQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~---~~--~~~i~df~  396 (399)
                      . -+|.+++...........-.....+..|++.||++||+.   +||||||||.||||+.   ++  .++|+||+
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccc
Confidence            7 499999976411111111134467788999999999997   9999999999999987   34  68999994

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.71  E-value=3.8e-18  Score=148.02  Aligned_cols=135  Identities=21%  Similarity=0.376  Sum_probs=113.9

Q ss_pred             cCCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCC--ceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT--EKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lv  322 (399)
                      ++|+..+.+|+|.+++||.|. ..+.+.+.||.+++..    .....+|+.++..++ ||||++|++...++.  ...++
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            456677889999999999997 4677889999997542    346899999999998 999999999988765  35799


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeeccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  395 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df  395 (399)
                      +||+.+-+...+..       .++-.++..+..++..||.|.|+.   +|+|||+||.|+++|... +.++.|.
T Consensus       114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence            99999988776653       256678889999999999999999   999999999999999654 6677775

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=8.7e-18  Score=153.03  Aligned_cols=146  Identities=25%  Similarity=0.347  Sum_probs=124.0

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccH--HHHHHHHHHHhcC-CCCCccceeeeeecCCce
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~--~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  319 (399)
                      ....+|...++||+|+|++|..+++ ++.+.+|+|+++++...+.+  .-.+.|-.+.... +||.+|.+..++.+....
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            3456789999999999999999986 47889999999876543322  2345555555444 699999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +.|.||+++|+|.-+++..++    ++...+..+...|..||.|||+.   +||.||||-+|||+|.+|.+|+.|++
T Consensus       327 ffvieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             EEEEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccc
Confidence            999999999999988876543    78888999999999999999999   99999999999999999999999984

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.71  E-value=1.3e-17  Score=154.72  Aligned_cols=154  Identities=24%  Similarity=0.315  Sum_probs=130.1

Q ss_pred             HHHHHHHhcCCCCCceeeccCCceEEEEEeCC------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeee
Q 015852          239 LRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF  312 (399)
Q Consensus       239 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~  312 (399)
                      .+++.+..+++....++-+|.||+||+|.+++      .+.|-||.++...+......|+.|..++..+.|||+..+.+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            46677778888889999999999999996643      346788888776666556679999999999999999999999


Q ss_pred             eecC-CceEEEEecCCCCChhhHhhhcCC----CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC
Q 015852          313 CTTV-TEKLLVYPYMTNGSVASRLRERQS----SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  387 (399)
Q Consensus       313 ~~~~-~~~~lv~e~~~~gsL~~~L~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~  387 (399)
                      +... +..++.|.++.-|+|..+|+..+.    ....++-.+.+.++.|++.|++|||++   +|||.||.++|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            8764 467899999999999999984332    123466678889999999999999999   99999999999999999


Q ss_pred             Cceeeccc
Q 015852          388 ADQSSKTI  395 (399)
Q Consensus       388 ~~~~i~df  395 (399)
                      ..+|++|=
T Consensus       433 LqVkltDs  440 (563)
T KOG1024|consen  433 LQVKLTDS  440 (563)
T ss_pred             eeEEeccc
Confidence            99999985

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=5.2e-17  Score=145.66  Aligned_cols=136  Identities=10%  Similarity=0.089  Sum_probs=109.8

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccH--HH------HHHHHHHHhcCCCCCccceeeeeecC
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE--LQ------FQTEVKIISMAVHRNLLRLYGFCTTV  316 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~--~~------f~~E~~~l~~l~H~niv~l~g~~~~~  316 (399)
                      ...+|...+++|+|+||.||.... ++..+|+|.+++.......  ..      |.+|+..+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            356788999999999999999765 5668999999755433221  12      68999999999999999998886533


Q ss_pred             --------CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC
Q 015852          317 --------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       317 --------~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~  388 (399)
                              ...+++|||++|.+|.++..        ++.    ....+++.++..+|+.   +++|||+||+|+++++++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence                    35789999999999977732        221    2456899999999999   999999999999999988


Q ss_pred             ceeeccccc
Q 015852          389 DQSSKTILR  397 (399)
Q Consensus       389 ~~~i~df~~  397 (399)
                       +++.||+.
T Consensus       173 -i~liDfg~  180 (232)
T PRK10359        173 -LRIIDLSG  180 (232)
T ss_pred             -EEEEECCC
Confidence             99999953

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.8e-18  Score=163.70  Aligned_cols=144  Identities=24%  Similarity=0.280  Sum_probs=123.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCC-CEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADG-KLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ..++.....||-|+||.|-..+.... ..+|+|.+++....  +.+.....|-.+|...+.|.||+++..|.+....|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            34455566799999999998876543 35899988754432  2333577889999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||-|-||.+...|++++    .++......++..+.+|++|||++   +||.|||||+|+|||.+|-+|+-||+
T Consensus       499 mEaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             HHhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence            99999999999999875    388888999999999999999999   99999999999999999999999994

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.69  E-value=3.1e-17  Score=145.64  Aligned_cols=140  Identities=21%  Similarity=0.333  Sum_probs=112.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceee-eeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYG-FCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g-~~~~~~~~~lv~  323 (399)
                      +.|.+.+.+|+|.||++..++++ ..+.+++|.+.....  ...+|.+|..---.+ .|.||+.-++ .+++.+..+.++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            45777789999999999999976 466789998865432  244799988654444 4999997654 466777788999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC-CC-Cceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-ED-ADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld-~~-~~~~i~df~  396 (399)
                      ||+|.|+|.+-+...+     +-+....+++.|++.|+.|||+.   ++||||||.+|||+- .| ..+|++||+
T Consensus       102 E~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             ccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence            9999999998886532     56677899999999999999999   999999999999984 33 478999994

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=1.3e-16  Score=153.81  Aligned_cols=141  Identities=21%  Similarity=0.281  Sum_probs=120.2

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .|+..+.||+|+.++||++...+.+.+|+|++.....+. ....|.+|+..|.+++ |.+||+|++|-..++.+||||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            367778999999999999998888899999886543332 2346999999999996 99999999999999999999997


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      =+ -+|..+|+++...  ..+| .+..+-.|+..++.++|.+   +|||.||||.|.|+- .|..|+.||+
T Consensus       442 Gd-~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFG  504 (677)
T KOG0596|consen  442 GD-IDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFG  504 (677)
T ss_pred             cc-ccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeec
Confidence            64 6999999876432  2345 6778889999999999999   999999999999987 5889999995

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.66  E-value=1.2e-16  Score=156.88  Aligned_cols=139  Identities=24%  Similarity=0.329  Sum_probs=114.1

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHh-cCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++.|.....+|.|+|+.|-++.. .+++..+||++.....     +-.+|+.++. .-+||||+++.+.+....+.|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            45667777799999999999875 5688899999955411     2345665544 446999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee-CCCCceeeccccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL-DEDADQSSKTILR  397 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl-d~~~~~~i~df~~  397 (399)
                      |++.+|-+.+.+.....    .. ..+..|+.+++.++.|||++   +||||||||+|||+ ++.+..+|+||+.
T Consensus       396 e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~  462 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGF  462 (612)
T ss_pred             hhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEech
Confidence            99999988877765421    22 67778999999999999998   99999999999999 5889999999964

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.66  E-value=5.6e-16  Score=169.34  Aligned_cols=125  Identities=34%  Similarity=0.657  Sum_probs=107.2

Q ss_pred             cCChhHHHHHHHHHhhcCCCCCCCCCCCCCCCCCCcceeeeeCCCCCEEEEEeCCCCceeecChhhccCcCCCeEeccCC
Q 015852           22 ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN  101 (399)
Q Consensus        22 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n  101 (399)
                      ...+.|.+||++||.++.+|.+.+.+|+. ..++|.|.||+|+..++|+.|+|++|+++|.+|+.+..+++|+.|+|++|
T Consensus        25 ~~~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n  103 (968)
T PLN00113         25 MLHAEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN  103 (968)
T ss_pred             CCCHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence            44668999999999999988888999964 46899999999987789999999999999999999999999999999999


Q ss_pred             ccccccccccc-CCCCCcEEecCCCcCcccCCCCCCCCcccccccccc
Q 015852          102 SLSGLIPTSLT-TITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  148 (399)
Q Consensus       102 ~l~G~ip~~~~-~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~n  148 (399)
                      +++|.+|..+. .+++|++||+++|+++|.+|.. .+.++..+++++|
T Consensus       104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~-~l~~L~~L~Ls~n  150 (968)
T PLN00113        104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG-SIPNLETLDLSNN  150 (968)
T ss_pred             ccCCcCChHHhccCCCCCEEECcCCccccccCcc-ccCCCCEEECcCC
Confidence            99999998776 8999999999999999988852 3344444444444

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1.2e-15  Score=128.40  Aligned_cols=129  Identities=17%  Similarity=0.131  Sum_probs=108.9

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCC--CCccceeeeeecCCceEEEEecCCCC
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      .+.||+|.++.||++...+ ..+++|..+....   ...+.+|+..+..++|  .++.+++++....+..++++||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4679999999999999754 7899998854422   3468899999999986  58999988888778899999999987


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      .+..+           ++.....++.+++++++++|.....+++|+|+||+||++++++.+++.||
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df  133 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDW  133 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEec
Confidence            76543           44567788999999999999875557999999999999999899999999

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=7.1e-16  Score=135.67  Aligned_cols=131  Identities=20%  Similarity=0.241  Sum_probs=92.5

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEccccccccc-HHH----------------------HHHHHHHHhcCCCCC--c
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQ----------------------FQTEVKIISMAVHRN--L  306 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~-~~~----------------------f~~E~~~l~~l~H~n--i  306 (399)
                      .+.||+|+||.||+|...+++.||||+++....... ...                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            367999999999999987899999998864322111 111                      134555555554433  3


Q ss_pred             cceeeeeecCCceEEEEecCCCCChhhH-hhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceee
Q 015852          307 LRLYGFCTTVTEKLLVYPYMTNGSVASR-LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILL  384 (399)
Q Consensus       307 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILl  384 (399)
                      .+.+++    ...+++|||++++.+... +....     .. .+...++.+++.++.++|. .   +|+||||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            333332    245899999999654321 21110     11 4567899999999999998 6   99999999999999


Q ss_pred             CCCCceeecccc
Q 015852          385 DEDADQSSKTIL  396 (399)
Q Consensus       385 d~~~~~~i~df~  396 (399)
                      + ++.+++.||+
T Consensus       149 ~-~~~~~liDfg  159 (187)
T cd05119         149 D-DGKVYIIDVP  159 (187)
T ss_pred             E-CCcEEEEECc
Confidence            9 8999999994

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=8.7e-16  Score=146.29  Aligned_cols=134  Identities=22%  Similarity=0.350  Sum_probs=108.9

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-----C---CCccceeeeeecC-
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----H---RNLLRLYGFCTTV-  316 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-----H---~niv~l~g~~~~~-  316 (399)
                      .+|...+.||-|.|++||.+.. .+.+.||+|+.+...  ...+.-+.||+++++++     |   .+||+|++.|... 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            5677789999999999999984 567889999986432  22234678999998764     2   3699999999753 


Q ss_pred             ---CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC
Q 015852          317 ---TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  387 (399)
Q Consensus       317 ---~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~  387 (399)
                         ...+||+|++ |-+|..++.....+  .+......+|+.||..||.|||+.|  +|||-||||+|||+...
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence               3678999998 56888888765433  3778899999999999999999998  99999999999999765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.61  E-value=1.5e-15  Score=142.60  Aligned_cols=140  Identities=21%  Similarity=0.348  Sum_probs=119.2

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCc
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE  318 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~  318 (399)
                      .....|...+.||+|.|++||++...    ..+.||+|.+......   .....|++++..+. +.||+++.+++...+.
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            33456778899999999999999753    4678999998554332   25789999998875 9999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      ..+|+||++.-+-.+++..       ++..+...+...+..||+|+|..   +||||||||+|+|.+... .-.+.||+
T Consensus       110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            9999999999998888864       56788899999999999999999   999999999999999765 45788884

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.61  E-value=6.7e-16  Score=140.17  Aligned_cols=138  Identities=25%  Similarity=0.321  Sum_probs=109.5

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccc-cccccHHHHHHHHHHHhcCCCCCccceeeeeecC------Cce
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEK  319 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~  319 (399)
                      +|.....+|.|.- .|..+.. -.+++||+|++... ......++-.+|..++..+.|+||++++.++.-.      .+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            3445566777766 4444432 25788999987433 2223344678899999999999999999998643      357


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|||||. ++|...++..      ++-.+...|..|+..|+.|||+.   +|+||||||+||++..++..||.||+
T Consensus        97 y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            89999996 5888887732      67778899999999999999999   99999999999999999999999993

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.59  E-value=8.4e-15  Score=140.23  Aligned_cols=141  Identities=21%  Similarity=0.273  Sum_probs=113.5

Q ss_pred             CCCCCceeeccCCceEEEEEeCCC--CEEEEEEcccccccccHHHHHHHHHHHhcCCC----CCccceeeee-ecCCceE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADG--KLVAVKRLKEERTSGGELQFQTEVKIISMAVH----RNLLRLYGFC-TTVTEKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~  320 (399)
                      .|...+.||+|+||.||.+.....  ..+|+|........... .+..|+.++..+..    +++.++++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            688889999999999999986443  47888876544332222 57778888877763    5888888888 4777889


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-----Cceeeccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-----ADQSSKTI  395 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-----~~~~i~df  395 (399)
                      +||+.+ +.+|.++.....  ...++-.+.+.|+.|+..+|+++|+.   +++||||||+|+++...     ....+.||
T Consensus        98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            999876 679999775543  23588899999999999999999999   99999999999999965     35899999

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=1.7e-14  Score=131.87  Aligned_cols=132  Identities=16%  Similarity=0.175  Sum_probs=100.1

Q ss_pred             Cceee-ccCCceEEEEEeCCCCEEEEEEccccc----------c--cccHHHHHHHHHHHhcCCCCCc--cceeeeeecC
Q 015852          252 KNILG-RGGFGKVYKGRLADGKLVAVKRLKEER----------T--SGGELQFQTEVKIISMAVHRNL--LRLYGFCTTV  316 (399)
Q Consensus       252 ~~~lG-~G~fg~Vy~~~~~~~~~vAvK~l~~~~----------~--~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~  316 (399)
                      ..+|| .|+.|+||..+.. +..++||......          .  ......+.+|++++..++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            36788 8999999998875 6678888774311          0  0122358889999999998885  6667664432


Q ss_pred             C----ceEEEEecCCC-CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          317 T----EKLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       317 ~----~~~lv~e~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      .    ..++|+||+++ .+|.+++...     +++.    ....+++.++.+||+.   +|+||||||+|||++.+++++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2    23599999997 6898887542     2332    2356899999999999   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      +.||.
T Consensus       183 LIDfg  187 (239)
T PRK01723        183 LIDFD  187 (239)
T ss_pred             EEECC
Confidence            99995

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.57  E-value=3.1e-14  Score=133.93  Aligned_cols=142  Identities=34%  Similarity=0.467  Sum_probs=121.2

Q ss_pred             CCCCceeeccCCceEEEEEeCCCCEEEEEEccccccccc--HHHHHHHHHHHhcCCCC-CccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~  325 (399)
                      |.....||.|+||.||++...  ..+++|.+........  ...|.+|+.++..+.|+ +++++...+......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            445678999999999999876  7899999976554443  55799999999999988 799999999777778999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      +.++++.+++...... ..+.......+..|++.++.|+|+.   +++|||+||+||+++.+. ..++.||+
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence            9999999777654211 2477888999999999999999999   899999999999999998 79999995

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.55  E-value=1.9e-14  Score=126.06  Aligned_cols=141  Identities=20%  Similarity=0.251  Sum_probs=113.7

Q ss_pred             hcCCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCC-CCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~  323 (399)
                      ...|...+.||.|+||.+|.|. ..+|+.||||.=....   ..-++..|..+.+.++| ..|..+..+..+...-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3467888999999999999997 5689999999753322   22257788888888875 45666777778888889999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~df~  396 (399)
                      |.. +.+|++++.-...   .++-.+.+-+|-|+..-++|+|.+   ++|||||||+|.|+.-+.   ...+.||+
T Consensus        91 dLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             ecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEecc
Confidence            987 6789888765422   377788999999999999999999   899999999999988654   57899993

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=7.8e-14  Score=138.32  Aligned_cols=136  Identities=22%  Similarity=0.235  Sum_probs=97.0

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccccc---------------------------------------cHHHHH
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG---------------------------------------GELQFQ  292 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---------------------------------------~~~~f~  292 (399)
                      .+.||+|++|.||+|++.+|+.||||+.++.....                                       .+.+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            37899999999999999999999999986532100                                       011355


Q ss_pred             HHHHHHhcC----CCCCccceeeeee-cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHH-HHHHHhc
Q 015852          293 TEVKIISMA----VHRNLLRLYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR-GLSYLHE  366 (399)
Q Consensus       293 ~E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~  366 (399)
                      +|+..+.++    +|.+-+.+-..+. ..+..++||||++|++|.+........   .   .+..++..+++ .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence            566655544    3333344333332 244579999999999998887542111   1   24556666666 4678888


Q ss_pred             CCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          367 HCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       367 ~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .   +++|+|+||.||++++++.+++.||+
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG  302 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFG  302 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCC
Confidence            7   99999999999999999999999994

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=2.8e-14  Score=149.48  Aligned_cols=146  Identities=23%  Similarity=0.291  Sum_probs=113.3

Q ss_pred             HHHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC---CCCccceeeeeecCC
Q 015852          241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVT  317 (399)
Q Consensus       241 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~  317 (399)
                      +.++..+.|.+.+.||+|+||+||+|...+|+.||+|+=+....+.    |.--.+++.+|+   -+-|..+...+.-.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            3344556677889999999999999998889999999876654442    222223344444   234455555556677


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-------Cce
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-------ADQ  390 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-------~~~  390 (399)
                      ..++|+||.+.|+|.+++...    ..++|...+.++.|+++-++.||..   +|||+||||+|.||...       -..
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             cceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence            889999999999999999733    3489999999999999999999999   99999999999998632       246


Q ss_pred             eeccccc
Q 015852          391 SSKTILR  397 (399)
Q Consensus       391 ~i~df~~  397 (399)
                      +|.||+|
T Consensus       841 ~lIDfG~  847 (974)
T KOG1166|consen  841 YLIDFGR  847 (974)
T ss_pred             EEEeccc
Confidence            9999986

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.47  E-value=2.5e-13  Score=124.24  Aligned_cols=139  Identities=20%  Similarity=0.275  Sum_probs=111.4

Q ss_pred             CCCCCceeeccCCceEEEEE-eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEec
Q 015852          248 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .|..++.||+|+||+.+.|+ +-++++||||.=...   .+.-++..|.+..+.+. -+.|...+-+......-.||+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            57778999999999999997 668999999964221   22235777887777765 57777777666666667899998


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-----ceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-----DQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-----~~~i~df~  396 (399)
                      + +.||+++..-.+.   .++..+...||.|+..-++|+|++   .+|.|||||+|.||..-+     .++|.||+
T Consensus       106 L-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             h-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEecc
Confidence            7 6788888765432   478899999999999999999999   999999999999998654     47899995

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.46  E-value=1.2e-13  Score=128.37  Aligned_cols=134  Identities=20%  Similarity=0.296  Sum_probs=108.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC------CccceeeeeecCCc
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR------NLLRLYGFCTTVTE  318 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~------niv~l~g~~~~~~~  318 (399)
                      +.+|.....+|+|.||+|-++... .+..||||+++...  .....-+-|++++.++.+.      -+|.+.+++...+.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            567888899999999999999753 57899999997542  2233456788999888432      26677788888889


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  387 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~  387 (399)
                      ..+|+|.+ |-|++++|....  ..++.......|+.|++++++|||+.   .++|-||||+|||+-+.
T Consensus       166 iCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss  228 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS  228 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence            99999987 459999998753  34577889999999999999999999   99999999999998643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.43  E-value=3.4e-14  Score=126.49  Aligned_cols=137  Identities=25%  Similarity=0.431  Sum_probs=113.9

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCCh
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      ..|.+...|+.|+|++..+. +.+|+++... .....++|.+|...++.+.||||..++|.|.++....++..||+.|+|
T Consensus       196 tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            44778889999999997554 4457664332 233345799999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeec
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  393 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~  393 (399)
                      +..|++...  ...+-.+.++++.++|+|++|||+. .|-|.--.|.+..|++|+|.+++|+
T Consensus       275 ynvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  275 YNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence            999997543  3467789999999999999999997 5556666899999999999998874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.42  E-value=2.3e-13  Score=130.74  Aligned_cols=144  Identities=20%  Similarity=0.245  Sum_probs=118.0

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC------CCCccceeeeeecCCc
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV------HRNLLRLYGFCTTVTE  318 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~g~~~~~~~  318 (399)
                      -..|......|+|-|+.|.+|.. ..|..||||++....  ...+.=+.|+++|.+|.      --|.++|+..|...+.
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            34576677789999999999985 357899999996542  22234577999998885      3478999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc-eeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-QSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~-~~i~df~  396 (399)
                      ++||+|-+. -+|.+.|.+.+.. ..|.......++.|+..||..|-..   +|+|.||||.|||+++.-+ .||+||+
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence            999999775 5899999876543 3477788899999999999999987   9999999999999998764 6999995

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.32  E-value=1.3e-12  Score=131.48  Aligned_cols=138  Identities=22%  Similarity=0.236  Sum_probs=89.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeCC-CCEEEEEEccccccc---------------------c------------------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTS---------------------G------------------  286 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~~~---------------------~------------------  286 (399)
                      ..|+. +.||+|++|.||+|++.+ |+.||||++++....                     .                  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 789999999999999877 999999999754210                     0                  


Q ss_pred             cHHHHHHHHHHHhcC----CCCCccceeeeeec-CCceEEEEecCCCCChhhHh--hhcCCCCCCCChHHHHHHHHHHHH
Q 015852          287 GELQFQTEVKIISMA----VHRNLLRLYGFCTT-VTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIALGSAR  359 (399)
Q Consensus       287 ~~~~f~~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~L--~~~~~~~~~l~~~~~~~i~~~ia~  359 (399)
                      .+.+|.+|+..+.++    .+.+.+.+-..+.+ ....++||||+.|+.+.++-  ....     .+   +..++...++
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-----~d---~~~la~~~v~  270 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-----TD---MKLLAERGVE  270 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-----CC---HHHHHHHHHH
Confidence            011355566554444    24444444444432 45678999999999997742  2211     11   1222222211


Q ss_pred             H-HHHHhcCCCCCceecCCCCCceeeCCCC----ceeecccc
Q 015852          360 G-LSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  396 (399)
Q Consensus       360 g-L~yLH~~~~~~ivHrDlK~~NILld~~~----~~~i~df~  396 (399)
                      . +.-+...   +++|+|+||.||+++.++    ..++.||+
T Consensus       271 ~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFG  309 (537)
T PRK04750        271 VFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFG  309 (537)
T ss_pred             HHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecc
Confidence            1 2223344   899999999999999998    89999995

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1.2e-11  Score=106.84  Aligned_cols=126  Identities=20%  Similarity=0.179  Sum_probs=92.0

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCcc-ceeeeeecCCceEEEEecCCCCCh
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL-RLYGFCTTVTEKLLVYPYMTNGSV  331 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~gsL  331 (399)
                      +.++.|.++.||+.+.. +..+++|.......  ....+..|+..+..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            56889999999999875 67899998754321  123467888888888765554 444433  3345899999999887


Q ss_pred             hhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCceeeCCCCceeecccc
Q 015852          332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       332 ~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ...  .       .   ....+..+++++|+.||+..  ...++|+|++|.||+++ ++.+++.||.
T Consensus        79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~  132 (170)
T cd05151          79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWE  132 (170)
T ss_pred             ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecc
Confidence            543  0       0   11345678999999999972  22369999999999999 6689999993

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.24  E-value=4.5e-12  Score=135.68  Aligned_cols=89  Identities=11%  Similarity=0.014  Sum_probs=68.2

Q ss_pred             cCCC-CCccceeeee-------ecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCC
Q 015852          300 MAVH-RNLLRLYGFC-------TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK  371 (399)
Q Consensus       300 ~l~H-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  371 (399)
                      .++| +||.++++++       ......+.++||+ .++|.++|....   ..+++.++..++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3445 5788888877       2233566778887 569999997532   3488999999999999999999998   9


Q ss_pred             ceecCCCCCceeeCCCCceeeccc
Q 015852          372 IIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       372 ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      |+||||||+||||+..++.|++||
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~  124 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIES  124 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeec
Confidence            999999999999965444443333

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1.1e-10  Score=105.02  Aligned_cols=139  Identities=17%  Similarity=0.223  Sum_probs=105.5

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC--CccceeeeeecCC---ceEEEEecCC
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGFCTTVT---EKLLVYPYMT  327 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~~---~~~lv~e~~~  327 (399)
                      +.|+.|.++.||+++..+|+.+++|.............+..|.+++..+++.  ++.+++.+.....   ..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            5689999999999988777889999875433222334688999999988763  4566777765532   5689999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC---------------------------------------  368 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------  368 (399)
                      +.++.+.+..     ..++..+...++.++++.|.+||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888776532     13567778888888888888888631                                       


Q ss_pred             --------------CCCceecCCCCCceeeCC--CCceeecccc
Q 015852          369 --------------DPKIIHRDVKAANILLDE--DADQSSKTIL  396 (399)
Q Consensus       369 --------------~~~ivHrDlK~~NILld~--~~~~~i~df~  396 (399)
                                    ...++|+|+++.||+++.  ++.+.|.||-
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e  202 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWE  202 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecc
Confidence                          245799999999999998  5667899983

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=2.3e-11  Score=113.97  Aligned_cols=89  Identities=25%  Similarity=0.294  Sum_probs=67.9

Q ss_pred             CCCCCccceeeeeecC---------------------------CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHH
Q 015852          301 AVHRNLLRLYGFCTTV---------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI  353 (399)
Q Consensus       301 l~H~niv~l~g~~~~~---------------------------~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i  353 (399)
                      .+|||||++.++|.+.                           ...|+||.-.+ .+|.+++..+.     .+...+.-|
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~  346 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVI  346 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHH
Confidence            4699999999887532                           23577776554 37888876542     455566778


Q ss_pred             HHHHHHHHHHHhcCCCCCceecCCCCCceeeC--CCCc--eeecccccc
Q 015852          354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDAD--QSSKTILRR  398 (399)
Q Consensus       354 ~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld--~~~~--~~i~df~~~  398 (399)
                      ..|+.+|+.|||.+   +|.|||+|++|||+.  +|..  ..|+||+|=
T Consensus       347 laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             HHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEccccee
Confidence            88999999999999   999999999999975  4443  379999873

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=1.5e-11  Score=125.96  Aligned_cols=138  Identities=22%  Similarity=0.258  Sum_probs=104.8

Q ss_pred             CCceeeccCCceEEEEEe-CCCCEEEEEEccccc-ccccH----HHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          251 NKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGE----LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~-~~~~~----~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..+++|.|++|.|+.... ...+..+.|..+... ....+    ..+..|..+-..++|+|++..+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            468899999997777653 233434444332100 11111    125567777788999999888777776666666699


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++ +|...+....    .+.-.++-.+..|+..|+.|+|+.   +|.|||+|++|++++.++..||.||+
T Consensus       402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence            9999 9999987541    266677888999999999999999   99999999999999999999999995

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.09  E-value=8.2e-10  Score=97.10  Aligned_cols=131  Identities=15%  Similarity=0.165  Sum_probs=92.3

Q ss_pred             ceeeccCCceEEEEEeCC-------CCEEEEEEcccccc-----------c----------ccHHHH----HHHHHHHhc
Q 015852          253 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERT-----------S----------GGELQF----QTEVKIISM  300 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~-------~~~vAvK~l~~~~~-----------~----------~~~~~f----~~E~~~l~~  300 (399)
                      ..||.|.=+.||.|...+       +..+|||+.+....           +          .....+    .+|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999997543       47899997753211           0          001122    378888888


Q ss_pred             CCC--CCccceeeeeecCCceEEEEecCCCCChhh-HhhhcCCCCCCCChHHHHHHHHHHHHHHHHH-hcCCCCCceecC
Q 015852          301 AVH--RNLLRLYGFCTTVTEKLLVYPYMTNGSVAS-RLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRD  376 (399)
Q Consensus       301 l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrD  376 (399)
                      +..  -++.+++.+    ...++||||+.+..+.. .++..     .++..+...+..++..+|.++ |..   +|||+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            763  455666654    56789999998754422 23221     133445667788999999999 666   999999


Q ss_pred             CCCCceeeCCCCceeecccc
Q 015852          377 VKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       377 lK~~NILld~~~~~~i~df~  396 (399)
                      |++.|||++ ++.+.+.||.
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~  169 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVS  169 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECC
Confidence            999999997 5789999994

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.08  E-value=2.3e-11  Score=120.22  Aligned_cols=139  Identities=24%  Similarity=0.251  Sum_probs=112.9

Q ss_pred             eeeccCCceEEEEE----eCCCCEEEEEEccccccccc-HHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEecCC
Q 015852          254 ILGRGGFGKVYKGR----LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       254 ~lG~G~fg~Vy~~~----~~~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      ++|+|.||.|+..+    .+.+..+|.|.++....... ......|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999998763    23477899998865433222 124556677777777 9999999999999999999999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccccccC
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL  399 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~~~~  399 (399)
                      +|+|...+.+..    .++......+...++-+++++|..   +|+|||+|++||++|.+|.+++.||..|+
T Consensus        81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglsk  145 (612)
T KOG0603|consen   81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSK  145 (612)
T ss_pred             cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhh
Confidence            999988886543    356667777778899999999999   99999999999999999999999997653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.02  E-value=1.7e-09  Score=100.28  Aligned_cols=141  Identities=23%  Similarity=0.344  Sum_probs=88.4

Q ss_pred             CCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCC----------CCccceeeeee---
Q 015852          251 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVH----------RNLLRLYGFCT---  314 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H----------~niv~l~g~~~---  314 (399)
                      ..+.||.|+++.||.++.. +++.+|||.......  ....+++.+|.-....+.+          -.++..++...   
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            3578999999999999864 689999998743332  2233457777655544333          11221122211   


Q ss_pred             ------cCC--------ceEEEEecCCCCChhhHhh---hcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 015852          315 ------TVT--------EKLLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  377 (399)
Q Consensus       315 ------~~~--------~~~lv~e~~~~gsL~~~L~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  377 (399)
                            ...        ..+++|+-+ .+||.+++.   ........+....++.+..|+.+-+++||+.   ++||+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence                  110        235677766 468877754   2222112234556677789999999999999   9999999


Q ss_pred             CCCceeeCCCCceeeccc
Q 015852          378 KAANILLDEDADQSSKTI  395 (399)
Q Consensus       378 K~~NILld~~~~~~i~df  395 (399)
                      ||+|++++.+|...++||
T Consensus       172 ~~~nfll~~~G~v~Lg~F  189 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDF  189 (288)
T ss_dssp             SGGGEEE-TTS-EEE--G
T ss_pred             ceeeEEEcCCCCEEEcCh
Confidence            999999999999999999

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.01  E-value=6.1e-11  Score=123.30  Aligned_cols=139  Identities=25%  Similarity=0.261  Sum_probs=110.6

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHH---HHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~---E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++...+.||+++|=+|.+|+.+.|. |.||++-.....-.-..|.+   |++ ....+|||.+.+.-.-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4566788999999999999998887 88898744332222233443   444 566789999999887777777888888


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+.+ +|++.|..+    +-+...+.+-|+.|+..||.-.|..   +|+|+|||.+|||++.-.=+.++||+
T Consensus       102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence            8864 788888654    2366677788999999999999999   99999999999999998889999996

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=99.01  E-value=3.1e-10  Score=74.32  Aligned_cols=40  Identities=38%  Similarity=0.844  Sum_probs=31.1

Q ss_pred             hhHHHHHHHHHhhcC-CCCCCCCCCCCCC-CCCCcceeeeeC
Q 015852           25 NAEVDALYIFKSKLQ-DPNNSLQSWDNLP-GNLCTWFHITCN   64 (399)
Q Consensus        25 ~~~~~~l~~~k~~~~-~~~~~l~~w~~~~-~~~c~w~gv~c~   64 (399)
                      ++|++||++||.++. +|.+.+.+|+.+. .+||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            579999999999998 5778999998764 799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PLN03150 hypothetical protein; Provisional

Probab=98.89  E-value=2.4e-09  Score=111.11  Aligned_cols=94  Identities=36%  Similarity=0.656  Sum_probs=83.1

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCC--CCCcccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG--SFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~--~~~~~~~~~  144 (399)
                      .+++.|+|++|+|+|.+|+.++.+++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|..-  .+.++..+.
T Consensus       442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~  521 (623)
T PLN03150        442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN  521 (623)
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence            478999999999999999999999999999999999999999999999999999999999999999642  123456778


Q ss_pred             cccccccCCCCCCCCC
Q 015852          145 FENNLNLCGPNTKKPC  160 (399)
Q Consensus       145 ~~~n~~lcg~~~~~~c  160 (399)
                      +.+|..+|+.+....|
T Consensus       522 ~~~N~~lc~~p~l~~C  537 (623)
T PLN03150        522 FTDNAGLCGIPGLRAC  537 (623)
T ss_pred             ecCCccccCCCCCCCC
Confidence            9999999986654555

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=2.1e-08  Score=85.77  Aligned_cols=128  Identities=17%  Similarity=0.219  Sum_probs=96.5

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEE-ccccccccc------HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKR-LKEERTSGG------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~-l~~~~~~~~------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ..+++|+=+.+|.+.+-+ ..+.+|. +++.+....      ..+-.+|+.++.+++--.|....-+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            357899999999997643 3455553 333322211      12467899999888766666666667788889999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++-.|.+.+...           +..++..|-+-+.-||..   +|||+||.++||++..+. +.+.||+
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfG  136 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFG  136 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECC
Confidence            9999988888643           255677788888899999   999999999999999765 9999993

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.85  E-value=4.2e-09  Score=103.90  Aligned_cols=94  Identities=23%  Similarity=0.322  Sum_probs=85.3

Q ss_pred             HhcCCCCCccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCc-eecC
Q 015852          298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI-IHRD  376 (399)
Q Consensus       298 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vHrD  376 (399)
                      |+.+.|.|+.+++|.+......+.|.+||..|+|.+.+....   ..++|.-...+..+++.||+|+|+-   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            456889999999999999999999999999999999998632   3589999999999999999999986   55 9999


Q ss_pred             CCCCceeeCCCCceeeccccc
Q 015852          377 VKAANILLDEDADQSSKTILR  397 (399)
Q Consensus       377 lK~~NILld~~~~~~i~df~~  397 (399)
                      ++++|+++|..+..|++||+-
T Consensus        75 l~s~nClvd~~w~lklt~~Gl   95 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGL   95 (484)
T ss_pred             eccccceeeeeEEEEechhhh
Confidence            999999999999999999953

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.85  E-value=4e-08  Score=91.10  Aligned_cols=138  Identities=15%  Similarity=0.100  Sum_probs=95.5

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEccccccc----------ccHHHHHHHHHHHhcCCCCCc--cceeeeeec-----
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS----------GGELQFQTEVKIISMAVHRNL--LRLYGFCTT-----  315 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----------~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~-----  315 (399)
                      +++-+.....|++.++ +|+.+.||........          .....+.+|...+.++...+|  .+++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4454444445777666 5678999966322110          111247788888877754333  344556543     


Q ss_pred             CCceEEEEecCCCC-ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-------C
Q 015852          316 VTEKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-------D  387 (399)
Q Consensus       316 ~~~~~lv~e~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-------~  387 (399)
                      ....++|+|++++- +|.+++.....  .+.+...+..++.+++..+.-||..   +|+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23478999999986 79888854221  1234566778999999999999999   9999999999999985       4


Q ss_pred             Cceeecccc
Q 015852          388 ADQSSKTIL  396 (399)
Q Consensus       388 ~~~~i~df~  396 (399)
                      ..+.+.||.
T Consensus       182 ~~~~LIDl~  190 (268)
T PRK15123        182 LKLSVIDLH  190 (268)
T ss_pred             ceEEEEECC
Confidence            678999995

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.82  E-value=5.3e-08  Score=83.04  Aligned_cols=140  Identities=14%  Similarity=0.189  Sum_probs=100.4

Q ss_pred             CCceeeccCCceEEEEEeCCCCEEEEEE-cccccccc------cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          251 NKNILGRGGFGKVYKGRLADGKLVAVKR-LKEERTSG------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~~~~~vAvK~-l~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ...++-+|+-+.|+++.+. |+...||. +.+.+...      ...+..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578899999999999874 56666663 32222211      1235788999998877555555555666777778999


Q ss_pred             ecCCC-CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc---eeecccc
Q 015852          324 PYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  396 (399)
Q Consensus       324 e~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~---~~i~df~  396 (399)
                      ||+++ .++.+++......  +-+-......+..|-+.+.-||..   .|||+||..+||++.+++.   +.+.||+
T Consensus        90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeec
Confidence            99986 4778887764321  111222367888899999999999   9999999999999988774   4688884

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=7.4e-08  Score=84.35  Aligned_cols=121  Identities=20%  Similarity=0.244  Sum_probs=77.8

Q ss_pred             eEEEEEeCCCCEEEEEEcccccc------------cc---------c----HHHHHHHHHHHhcCCCC--Cccceeeeee
Q 015852          262 KVYKGRLADGKLVAVKRLKEERT------------SG---------G----ELQFQTEVKIISMAVHR--NLLRLYGFCT  314 (399)
Q Consensus       262 ~Vy~~~~~~~~~vAvK~l~~~~~------------~~---------~----~~~f~~E~~~l~~l~H~--niv~l~g~~~  314 (399)
                      .||.|...+|..+|||.-+....            ..         .    .....+|.+.|.++..-  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            38999988899999997753211            00         0    12367899999998865  45666654  


Q ss_pred             cCCceEEEEecCC--CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHH-hcCCCCCceecCCCCCceeeCCCCcee
Q 015852          315 TVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       315 ~~~~~~lv~e~~~--~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                        ....+||||++  +..+..+ ....     ++......+..++.+.+..+ |..   +|+|+||.+.|||++++ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~l-~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRL-KDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCH-HHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhhH-Hhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence              24579999999  5444443 3221     11234566777777766664 676   99999999999999988 999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      +.||.
T Consensus       147 iIDf~  151 (188)
T PF01163_consen  147 IIDFG  151 (188)
T ss_dssp             E--GT
T ss_pred             EEecC
Confidence            99995

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.61  E-value=2.8e-07  Score=83.52  Aligned_cols=130  Identities=22%  Similarity=0.233  Sum_probs=90.6

Q ss_pred             CCCceeeccCCceEEEEEeCCCCEEEEEEccccccc----------------c-----cHHHHHHHHHHHhcCCCC--Cc
Q 015852          250 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS----------------G-----GELQFQTEVKIISMAVHR--NL  306 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----------------~-----~~~~f~~E~~~l~~l~H~--ni  306 (399)
                      ...+.||-|.=+.||.|..+.|.++|||.=+.....                .     ....-.+|.+.|.++...  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            345889999999999999989999999964322110                0     112357788999988755  66


Q ss_pred             cceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC
Q 015852          307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  386 (399)
Q Consensus       307 v~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~  386 (399)
                      .+.+++    +...+||||+++-.|...=         ++-...-.|...|.+-+.-.-+.   ++||+|+.+=||++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            666553    5678999999986654432         11122233344444444433344   8999999999999999


Q ss_pred             CCceeeccc
Q 015852          387 DADQSSKTI  395 (399)
Q Consensus       387 ~~~~~i~df  395 (399)
                      ||++.+.||
T Consensus       238 dg~~~vIDw  246 (304)
T COG0478         238 DGDIVVIDW  246 (304)
T ss_pred             CCCEEEEeC
Confidence            999999998

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.60  E-value=3.2e-08  Score=97.87  Aligned_cols=147  Identities=18%  Similarity=0.168  Sum_probs=113.6

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEe--CCCCEEEEEEcccccccccHH-HHHHHHHHHhcC-CCCCccceeeeeecCCce
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRL--ADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vAvK~l~~~~~~~~~~-~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  319 (399)
                      ..+.+|.....||.|.|+.|++...  .++..|++|.+.........+ .-..|+.+...+ .|.+++++...+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3455788889999999999999864  367899999886554332222 234555555544 499999988888888888


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-Cceeeccccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTILR  397 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~~i~df~~  397 (399)
                      ++--||++++++.....-.    ..++...++++..+++.++.++|+.   .++|+|+||+||++..+ +.-+++||++
T Consensus       342 ~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence            8999999999887665321    1366778889999999999999988   99999999999999986 6778888853

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.56  E-value=3.2e-07  Score=92.10  Aligned_cols=116  Identities=19%  Similarity=0.196  Sum_probs=93.5

Q ss_pred             eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCCh
Q 015852          268 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW  347 (399)
Q Consensus       268 ~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~  347 (399)
                      ..++.+|.|...+.... .......+-+..++.++||||++++......+..|+|+|-+.  .|..++.+..       -
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------K  103 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------H
Confidence            45788888888765433 222346677888999999999999999999999999999885  5677776532       2


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          348 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       348 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ......+.||+.||.|||+.|  +++|++|--+.|++++.|+-|+++|
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggl  149 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGL  149 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeee
Confidence            334456789999999999776  8999999999999999999999998

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.53  E-value=5.9e-07  Score=80.27  Aligned_cols=100  Identities=18%  Similarity=0.199  Sum_probs=77.9

Q ss_pred             HHHHHHHHHhcCCC--CCccceeeeeecCC----ceEEEEecCCC-CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHH
Q 015852          290 QFQTEVKIISMAVH--RNLLRLYGFCTTVT----EKLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLS  362 (399)
Q Consensus       290 ~f~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lv~e~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~  362 (399)
                      ...+|...+..+..  -.+.+.+++.....    ..++|+|++++ -+|.+++.....    .+-.....++.++++.++
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence            57778877766653  34555666665532    34799999998 479999876322    445567889999999999


Q ss_pred             HHhcCCCCCceecCCCCCceeeCCCC---ceeecccc
Q 015852          363 YLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  396 (399)
Q Consensus       363 yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~df~  396 (399)
                      -||..   +|+|+|++++|||++.+.   ++.+.||-
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld  166 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLD  166 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcch
Confidence            99999   999999999999999987   88999993

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.52  E-value=3.7e-08  Score=101.28  Aligned_cols=142  Identities=23%  Similarity=0.301  Sum_probs=109.7

Q ss_pred             CCCCceeeccCCceEEEEEeC--CCCEEEEEEccccc-ccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEe
Q 015852          249 FSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~-~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      |...+.||+|+|+.|-.....  ....+|+|.+.... ..........|..+-..+. |+|++++++.....+..++..|
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            445566999999998877542  34567777764432 1112223444666666676 9999999999999999999999


Q ss_pred             cCCCCChhhHh-hhcCCCCCCCChHHHHHHHHHHHHHHHHHh-cCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          325 YMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L-~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      |..+|++.+.+ ....   ...+-...-.+..|+..++.|+| +.   ++.|||+||+|.+++..+ ..+++||.
T Consensus       102 ~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             cccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCch
Confidence            99999999888 3321   12445567788899999999999 76   899999999999999999 99999994

>PRK09902 hypothetical protein; Provisional

Probab=98.49  E-value=2.9e-06  Score=75.10  Aligned_cols=134  Identities=19%  Similarity=0.190  Sum_probs=96.7

Q ss_pred             eeccCCceEEEEEeCCCCEEEEEEccccc--c---cccHHHHHHHHHHHhcCCCCC--ccceeeeee-cC----CceEEE
Q 015852          255 LGRGGFGKVYKGRLADGKLVAVKRLKEER--T---SGGELQFQTEVKIISMAVHRN--LLRLYGFCT-TV----TEKLLV  322 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~---~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~-~~----~~~~lv  322 (399)
                      -|+|+-+.|++-.+. |+.+=+|+-....  .   +-.+..|.+|...+..+...+  +.++. ++. ..    -..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            366788888887764 3468888764111  1   234557999999998876333  44444 332 21    135799


Q ss_pred             EecCCC-CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc--eeeccc
Q 015852          323 YPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTI  395 (399)
Q Consensus       323 ~e~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~--~~i~df  395 (399)
                      +|-+.+ -+|.+++.+..  ..+.+...+..+..+++..++-||..   ++.|+|+.+.||+++.+++  +++.||
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEh
Confidence            997764 68888886532  22356677789999999999999999   9999999999999987666  899999

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.43  E-value=3e-07  Score=65.09  Aligned_cols=60  Identities=37%  Similarity=0.571  Sum_probs=52.8

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcC
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  127 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l  127 (399)
                      +++.|++++|+++.--+..+.++++|+.|++++|.++.--|..+..+++|+.|++++|++
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            678999999999844445788999999999999999977777899999999999999975

...

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=1.7e-06  Score=86.98  Aligned_cols=135  Identities=19%  Similarity=0.202  Sum_probs=89.4

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEccccccc---------------------c------------------cHHHHHH
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---------------------G------------------GELQFQT  293 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------------------~------------------~~~~f~~  293 (399)
                      +.|+.++-|.||+|++.+|+.||||+.++....                     .                  .+.+|.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            789999999999999999999999998653210                     0                  0112445


Q ss_pred             HHHHHhcC----CCCCccceeeeee-cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHH-HHHHhcC
Q 015852          294 EVKIISMA----VHRNLLRLYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG-LSYLHEH  367 (399)
Q Consensus       294 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~  367 (399)
                      |...+.++    ++..=+++-..|. ..+...|+|||++|-.+.+.......   ..+   +..++..++++ +.-+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d---~k~ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GID---RKELAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHhc
Confidence            55555433    3333333434443 35678899999999888887432211   133   34444443333 2222223


Q ss_pred             CCCCceecCCCCCceeeCCCCceeecccc
Q 015852          368 CDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       368 ~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                         +++|.|..|.||+++.++..-..||+
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDfG  310 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDFG  310 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcCc
Confidence               89999999999999999999999994

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.29  E-value=5.3e-07  Score=83.26  Aligned_cols=95  Identities=26%  Similarity=0.428  Sum_probs=78.5

Q ss_pred             HhcCCCCCccceeeeeecC-----CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCc
Q 015852          298 ISMAVHRNLLRLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI  372 (399)
Q Consensus       298 l~~l~H~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  372 (399)
                      +-.+.|.|||+++.|+.+.     .....+.|||..|++.++|++.+.....+....-.+++-||..||.|||+ |+|+|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence            3345699999999887653     34678899999999999999755444445556668899999999999998 48999


Q ss_pred             eecCCCCCceeeCCCCceeec
Q 015852          373 IHRDVKAANILLDEDADQSSK  393 (399)
Q Consensus       373 vHrDlK~~NILld~~~~~~i~  393 (399)
                      +|+++..+-|++..++-+|+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             ccCCcchhheeecCCceEEec
Confidence            999999999999999888775

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.25  E-value=1.4e-05  Score=72.47  Aligned_cols=73  Identities=12%  Similarity=0.105  Sum_probs=51.4

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCC--ccceeeeeecCCceEEEEecCCCC
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      ...||+|..+.||+.   .+..+++|......   ......+|.++++.+..-.  +.+.++++...+...++||+++|.
T Consensus         6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             heeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            367999999999984   24456778765322   2334688898888776433  456677776666678899999986


Q ss_pred             C
Q 015852          330 S  330 (399)
Q Consensus       330 s  330 (399)
                      +
T Consensus        80 ~   80 (226)
T TIGR02172        80 R   80 (226)
T ss_pred             c
Confidence            3

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=5.3e-06  Score=83.23  Aligned_cols=136  Identities=17%  Similarity=0.121  Sum_probs=84.3

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccc------------------------------------cHHHHHHHHH
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG------------------------------------GELQFQTEVK  296 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~------------------------------------~~~~f~~E~~  296 (399)
                      +.||.-+.|.||+|++++|+.||||+-++.-...                                    .+.+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999876532110                                    0123555654


Q ss_pred             HHh----cCCCCCc---cceeeeeec-CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 015852          297 IIS----MAVHRNL---LRLYGFCTT-VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC  368 (399)
Q Consensus       297 ~l~----~l~H~ni---v~l~g~~~~-~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  368 (399)
                      -..    .++|-+.   |.+-..+.+ .....|+||||+|..+.+.-.-...+   .+-.....-+.++..-+-+-    
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~~qIf~----  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYLEQIFK----  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHHHHHHh----
Confidence            433    3445551   222233322 34678999999998877654322222   33333222222222222222    


Q ss_pred             CCCceecCCCCCceeeCC----CCceeecccc
Q 015852          369 DPKIIHRDVKAANILLDE----DADQSSKTIL  396 (399)
Q Consensus       369 ~~~ivHrDlK~~NILld~----~~~~~i~df~  396 (399)
                       .+++|.|-.|.||+++.    ++++.+.||+
T Consensus       320 -~GffHaDPHPGNilv~~~~~~~~~ivllDhG  350 (538)
T KOG1235|consen  320 -TGFFHADPHPGNILVRPNPEGDEEIVLLDHG  350 (538)
T ss_pred             -cCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence             28999999999999994    6678888884

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=5.1e-06  Score=72.97  Aligned_cols=99  Identities=22%  Similarity=0.265  Sum_probs=77.9

Q ss_pred             HHHHHHHhcCCC-CCccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 015852          292 QTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP  370 (399)
Q Consensus       292 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  370 (399)
                      ..|.-+++.+.+ +++.+++|+|    ..+++.||...+++...-.. ......-+|..|.+||.++.+.+.++++...-
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            457778888876 6999999999    35789999998766532100 00111358999999999999999999986444


Q ss_pred             CceecCCCCCceeeCCCCceeeccc
Q 015852          371 KIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       371 ~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      .+.-.|++++|+-+++++++|+.|.
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDl  106 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDL  106 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEec
Confidence            6888999999999999999999996

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.20  E-value=1.2e-06  Score=91.84  Aligned_cols=106  Identities=25%  Similarity=0.396  Sum_probs=71.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.|..|+||.||..+++ +.+.+|+|.-+..       -..+-  ++.....|.               .|   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-------lilRn--ilt~a~npf---------------vv---  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-------LILRN--ILTFAGNPF---------------VV---  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccc-------hhhhc--cccccCCcc---------------ee---
Confidence            57888899999999999999875 4567787432211       01110  122222222               22   


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  397 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~~  397 (399)
                         ||-...++..+    ++.        .+.+.+++|||+.   +|+|||+||+|.+|+.-|.+|+.||..
T Consensus       136 ---gDc~tllk~~g----~lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgL  189 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG----PLP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGL  189 (1205)
T ss_pred             ---chhhhhcccCC----CCc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhh
Confidence               55555554322    121        1227899999999   999999999999999999999999953

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.14  E-value=1.6e-05  Score=77.89  Aligned_cols=130  Identities=15%  Similarity=0.107  Sum_probs=96.2

Q ss_pred             CceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec----CCceEEEEecCCC-CChhh
Q 015852          260 FGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPYMTN-GSVAS  333 (399)
Q Consensus       260 fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~~-gsL~~  333 (399)
                      -.+.||+.. .||..|..|+++....... ..-..-++.++++.|.|+|++..++..    +....+||+|.|+ ++|++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            356799974 5899999999954332211 122344677889999999999988863    3467899999986 67777


Q ss_pred             HhhhcCCC-----------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeec
Q 015852          334 RLRERQSS-----------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  393 (399)
Q Consensus       334 ~L~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~  393 (399)
                      +.-.....           .....+.....++.|+..||.++|+.   ++.-+-|-+++||++.++.++|+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS  435 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRIS  435 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEe
Confidence            65432111           12245677888999999999999998   88889999999999998876654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.09  E-value=6.4e-06  Score=71.17  Aligned_cols=52  Identities=33%  Similarity=0.301  Sum_probs=45.4

Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceee
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  392 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i  392 (399)
                      |+|.++++.+..   .++|.++..|+.|++.||+|||++   +      ||+|||++.++.+|+
T Consensus         1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~   52 (176)
T smart00750        1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL   52 (176)
T ss_pred             CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee
Confidence            789999976432   489999999999999999999988   4      999999999988775

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN02876 acyl-CoA dehydrogenase

Probab=98.04  E-value=5.7e-05  Score=81.39  Aligned_cols=79  Identities=13%  Similarity=0.296  Sum_probs=56.2

Q ss_pred             CceeeccCCceEEEEEeCCC---CEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCc--cceeeeeecC---CceEEE
Q 015852          252 KNILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNL--LRLYGFCTTV---TEKLLV  322 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~---~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv  322 (399)
                      .+.++.|.+..+|+....++   ..+++|+............+.+|.++++.+. |.++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46688999999999876553   3577776543322223346889999999886 6665  6777877654   457899


Q ss_pred             EecCCCCC
Q 015852          323 YPYMTNGS  330 (399)
Q Consensus       323 ~e~~~~gs  330 (399)
                      |||+++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99999764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.01  E-value=6.7e-06  Score=81.71  Aligned_cols=141  Identities=21%  Similarity=0.103  Sum_probs=104.5

Q ss_pred             CCCCceeec--cCCceEEEEEe---CCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEE
Q 015852          249 FSNKNILGR--GGFGKVYKGRL---ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       249 ~~~~~~lG~--G~fg~Vy~~~~---~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l  321 (399)
                      |....-+|.  |.+|.||.+..   .++..+|+|+-+.... ......-.+|.....+++ |+|.++....+...+..++
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi  195 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI  195 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence            445577899  99999999976   3678899997432221 112223455666666665 9999998888888899999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHH----HHHHHhcCCCCCceecCCCCCceeeCCC-Cceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~~i~df~  396 (399)
                      -+|++. .+|.++.+....   .+.......+..+..+    ||.++|+.   +++|-|+||.||++..+ ...+..||+
T Consensus       196 qtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  196 QTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence            999886 677777765322   1333444555556666    99999998   99999999999999999 788888884

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.95  E-value=8.4e-05  Score=68.08  Aligned_cols=74  Identities=9%  Similarity=0.069  Sum_probs=50.0

Q ss_pred             eeccCC-ceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEecCCCCChh
Q 015852          255 LGRGGF-GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  332 (399)
Q Consensus       255 lG~G~f-g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~  332 (399)
                      |-.|.. ..||+.... +..+.||......    .....+|++++..+. +--+.+++++....+..++||||++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444555 778998764 3677888764332    224677888877764 334556777766666689999999987765


Q ss_pred             h
Q 015852          333 S  333 (399)
Q Consensus       333 ~  333 (399)
                      .
T Consensus        81 ~   81 (244)
T cd05150          81 A   81 (244)
T ss_pred             H
Confidence            4

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.94  E-value=1e-05  Score=53.01  Aligned_cols=37  Identities=46%  Similarity=0.697  Sum_probs=29.5

Q ss_pred             cCCCeEeccCCcccccccccccCCCCCcEEecCCCcCc
Q 015852           91 KNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  128 (399)
Q Consensus        91 ~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~  128 (399)
                      ++|+.|++++|+++ .||+.+++|++|+.|++++|+++
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            36888888888888 68878888889999999888876

...

>PRK10593 hypothetical protein; Provisional

Probab=97.91  E-value=0.00018  Score=68.07  Aligned_cols=78  Identities=15%  Similarity=0.110  Sum_probs=55.4

Q ss_pred             CCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCC---CCccceeeeeec---CCceEEEE
Q 015852          250 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH---RNLLRLYGFCTT---VTEKLLVY  323 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lv~  323 (399)
                      ...+.||.|..+.||+-...+++ +.+|..+..   .....|..|.+.++.+.-   -.+.+++++|..   .+..++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARSF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEeccc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34567999999999998765564 566764321   122368899998887753   357778877754   35689999


Q ss_pred             ecCCCCCh
Q 015852          324 PYMTNGSV  331 (399)
Q Consensus       324 e~~~~gsL  331 (399)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=97.88  E-value=4e-06  Score=82.05  Aligned_cols=74  Identities=19%  Similarity=0.211  Sum_probs=64.6

Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  397 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~~  397 (399)
                      ..++.|++|...+|.+||..+.. ....+|...+.++.|++.|+.|   +   +.+|||+||.||....+...||+||+-
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            46899999999999999975433 2346788999999999999999   4   799999999999999999999999975


Q ss_pred             c
Q 015852          398 R  398 (399)
Q Consensus       398 ~  398 (399)
                      +
T Consensus       403 ~  403 (516)
T KOG1033|consen  403 V  403 (516)
T ss_pred             e
Confidence            4

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.87  E-value=7.4e-05  Score=66.53  Aligned_cols=133  Identities=15%  Similarity=0.162  Sum_probs=81.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHH---------HHHHHHHHhcCCCC---Cccceeeee
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ---------FQTEVKIISMAVHR---NLLRLYGFC  313 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~---------f~~E~~~l~~l~H~---niv~l~g~~  313 (399)
                      ..+|...+++-......|.+-+. +++.+.+|..+..... .++.         ..+++..+..++..   ....++-+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            34566666666666666666555 4678889987654321 1111         12333333333222   222222222


Q ss_pred             e-----cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC
Q 015852          314 T-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       314 ~-----~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~  388 (399)
                      .     -....+++|||++|..|.+...        ++.    .++..+++++.-+|..   ++.|+|..|+|+++++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~-~  171 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN-N  171 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC-C
Confidence            1     1234568999999988766532        221    2455677889999999   9999999999999995 4


Q ss_pred             ceeecccc
Q 015852          389 DQSSKTIL  396 (399)
Q Consensus       389 ~~~i~df~  396 (399)
                      ..++.||.
T Consensus       172 ~i~iID~~  179 (229)
T PF06176_consen  172 GIRIIDTQ  179 (229)
T ss_pred             cEEEEECc
Confidence            58999993

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.86  E-value=8.3e-05  Score=67.01  Aligned_cols=77  Identities=16%  Similarity=0.219  Sum_probs=53.7

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCC--ccceeeeeec---CCceEEEEecCC
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFCTT---VTEKLLVYPYMT  327 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~---~~~~~lv~e~~~  327 (399)
                      +.++.|..+.||+....+ ..+++|.....   .......+|..++..+....  +.+++.++..   ....+++|+|++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            578999999999999877 58999986433   22345778888887765333  4566664432   234689999999


Q ss_pred             CCChhh
Q 015852          328 NGSVAS  333 (399)
Q Consensus       328 ~gsL~~  333 (399)
                      +..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=97.83  E-value=3.2e-06  Score=71.22  Aligned_cols=79  Identities=35%  Similarity=0.644  Sum_probs=64.8

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCC-CCCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP-DNGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP-~~~~~~~~~~~~~  145 (399)
                      ..++.+-|++|+++ .+||.++.|.+|+.|++++|++. .+|+++++++.|+.|+++-|.+.- +| ..++|..+..+++
T Consensus        33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~-lprgfgs~p~levldl  109 (264)
T KOG0617|consen   33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNI-LPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhc-CccccCCCchhhhhhc
Confidence            47889999999998 78999999999999999999998 799999999999999999999863 33 2345555555555


Q ss_pred             ccc
Q 015852          146 ENN  148 (399)
Q Consensus       146 ~~n  148 (399)
                      .-|
T Consensus       110 tyn  112 (264)
T KOG0617|consen  110 TYN  112 (264)
T ss_pred             ccc
Confidence            444

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.83  E-value=0.0002  Score=64.64  Aligned_cols=148  Identities=20%  Similarity=0.254  Sum_probs=91.7

Q ss_pred             ccHHHHHHHhcCCCCCceee---ccCCceEEEEEeCCCCEEEEEEccccccccc------------------HH-----H
Q 015852          237 FSLRELQVATDGFSNKNILG---RGGFGKVYKGRLADGKLVAVKRLKEERTSGG------------------EL-----Q  290 (399)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~lG---~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~------------------~~-----~  290 (399)
                      .+.+.+....++....++.|   +|.-+.||+|...++..+|||+.+.......                  ..     .
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            44455555555555555544   5666679999988899999998865432110                  00     1


Q ss_pred             HHHHHHHHhcCC--CCCccceeeeeecCCceEEEEecCCCC-ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcC
Q 015852          291 FQTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH  367 (399)
Q Consensus       291 f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  367 (399)
                      -.+|..-|.++.  +-.+.+.+++.    .-.|||||+... .-.-.|..-     ++...+...+-.++.+++.-|-..
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHh
Confidence            234555555553  33344444432    346999999753 222222211     122224566677777888777763


Q ss_pred             CCCCceecCCCCCceeeCCCCceeecccc
Q 015852          368 CDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       368 ~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +  ++||+||..=|||+. ++++.|.||.
T Consensus       186 a--~LVHgDLSEyNiL~~-~~~p~iID~~  211 (268)
T COG1718         186 A--GLVHGDLSEYNILVH-DGEPYIIDVS  211 (268)
T ss_pred             c--CcccccchhhheEEE-CCeEEEEECc
Confidence            2  899999999999999 8999999984

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.81  E-value=0.00033  Score=61.95  Aligned_cols=132  Identities=20%  Similarity=0.297  Sum_probs=89.0

Q ss_pred             CCCceeeccCCceEEEEEeCCCCEEEEEEccccc---------------ccccHHHHHHHHHHHhcCC------CCCccc
Q 015852          250 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEER---------------TSGGELQFQTEVKIISMAV------HRNLLR  308 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---------------~~~~~~~f~~E~~~l~~l~------H~niv~  308 (399)
                      +....||+|+.=.||.  +++.....||+++...               ......++.+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3457899999988886  4445557888886554               0112345666666554444      889999


Q ss_pred             eeeeeecCCceEEEEecCCC------CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCce
Q 015852          309 LYGFCTTVTEKLLVYPYMTN------GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  382 (399)
Q Consensus       309 l~g~~~~~~~~~lv~e~~~~------gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NI  382 (399)
                      ++|+..+....-+|+|.+.+      -+|.+++....     ++.    .+...+-+=-.||-.+   .|+.+|++|+||
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NI  149 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNI  149 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH----HHHHHHHHHHHHHHHc---CCeecCCCcccE
Confidence            99999999999999998754      35777775431     333    2333333445666666   899999999999


Q ss_pred             eeCCCC----ceeeccc
Q 015852          383 LLDEDA----DQSSKTI  395 (399)
Q Consensus       383 Lld~~~----~~~i~df  395 (399)
                      ++....    ...|.|-
T Consensus       150 v~~~~~~~~~~lvlIDG  166 (199)
T PF10707_consen  150 VVQRRDSGEFRLVLIDG  166 (199)
T ss_pred             EEEecCCCceEEEEEeC
Confidence            998554    3455553

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.64  E-value=0.00042  Score=59.31  Aligned_cols=122  Identities=18%  Similarity=0.214  Sum_probs=81.5

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccc-eeeeeecCCceEEEEecCCCCC
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR-LYGFCTTVTEKLLVYPYMTNGS  330 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~~~gs  330 (399)
                      .+.|++|.+|.||.|.+.. ..+|+|+-+.+   .....+..|++++..+.-.++.+ ++.|    +..++.|||+.|-.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~   98 (201)
T COG2112          27 EKELAKGTTSVVYLGEWRG-GEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhcccccEEEEeeccC-ceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcc
Confidence            4679999999999999864 47888876543   34457999999998888766654 3333    23345699999988


Q ss_pred             hhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCceeeCCCCceeeccc
Q 015852          331 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTI  395 (399)
Q Consensus       331 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-K~~NILld~~~~~~i~df  395 (399)
                      |.+.-...       +-.+    ...+++.---|-..   +|-|..| .|...++-.+.++.|.||
T Consensus        99 L~~~~~~~-------~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDF  150 (201)
T COG2112          99 LGKLEIGG-------DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDF  150 (201)
T ss_pred             hhhhhhcc-------cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEc
Confidence            87665421       1112    22333332223333   8888888 466666666669999999

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=97.57  E-value=5.4e-05  Score=53.38  Aligned_cols=59  Identities=37%  Similarity=0.557  Sum_probs=47.0

Q ss_pred             cCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccccccc
Q 015852           91 KNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus        91 ~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      ++|+.|++++|+++.--+..+..+++|++|++++|.++.--|. ...+.++..+.+++|.
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            4689999999999955556889999999999999999855443 2456677777787774

...

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=97.48  E-value=4.5e-05  Score=72.47  Aligned_cols=56  Identities=38%  Similarity=0.522  Sum_probs=30.1

Q ss_pred             EEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcC
Q 015852           70 TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  127 (399)
Q Consensus        70 ~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l  127 (399)
                      +.+.+++|.++ .+|..+..+++|..|+|++|.|. .+|.+++++..|+.+|+|+|.|
T Consensus       415 T~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrF  470 (565)
T KOG0472|consen  415 TDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRF  470 (565)
T ss_pred             HHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccccc
Confidence            34444444432 44555555555555555555554 4555555555555555555554

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.46  E-value=0.0018  Score=63.36  Aligned_cols=76  Identities=14%  Similarity=0.177  Sum_probs=52.2

Q ss_pred             ceeeccCCceEEEEEeCCC-CEEEEEEcccccc------cccHHHHHHHHHHHhcCC---CCCccceeeeeecCCceEEE
Q 015852          253 NILGRGGFGKVYKGRLADG-KLVAVKRLKEERT------SGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~-~~vAvK~l~~~~~------~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv  322 (399)
                      +.||.|.+..||+....+| +.+.||.-.....      .....++..|.+.|..+.   ..++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5789999999999998776 4899997532111      112335677777776642   3456677765  44557899


Q ss_pred             EecCCCCC
Q 015852          323 YPYMTNGS  330 (399)
Q Consensus       323 ~e~~~~gs  330 (399)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.44  E-value=0.0019  Score=58.66  Aligned_cols=73  Identities=16%  Similarity=0.235  Sum_probs=45.7

Q ss_pred             ceeeccCCceEEEEEeCC--CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeeeecCCceEEEEecCCCC
Q 015852          253 NILGRGGFGKVYKGRLAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~--~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      +.|..|-...+|+....+  ++.|.+|........  ...-.+|+.++..+....+ .++++...    ..++|||+++.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            456778888999988664  668888876433211  1123467777777754333 34444322    24799999986


Q ss_pred             Ch
Q 015852          330 SV  331 (399)
Q Consensus       330 sL  331 (399)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=97.41  E-value=2.9e-05  Score=65.57  Aligned_cols=61  Identities=26%  Similarity=0.532  Sum_probs=55.2

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  130 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~  130 (399)
                      .+..+++++|++. .+|.+++.|+.|+.|+++-|.|+ .+|..|++++.|+.|||++|+++-.
T Consensus        57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~  117 (264)
T KOG0617|consen   57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNEN  117 (264)
T ss_pred             hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccc
Confidence            5678999999987 88999999999999999999997 6889999999999999999998753

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.36  E-value=0.0017  Score=57.22  Aligned_cols=124  Identities=23%  Similarity=0.312  Sum_probs=85.4

Q ss_pred             cCCCCCceeeccCC-ceEEEEEeCCCCEEEEEEcccc---c-------cc----------ccHHHHHHHHHHHhcCC---
Q 015852          247 DGFSNKNILGRGGF-GKVYKGRLADGKLVAVKRLKEE---R-------TS----------GGELQFQTEVKIISMAV---  302 (399)
Q Consensus       247 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~~vAvK~l~~~---~-------~~----------~~~~~f~~E~~~l~~l~---  302 (399)
                      .+++..+.||.|.- |.||+.+. +|+.+|+|..+.-   .       ..          .....|..|++..++++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            56777899999999 99999998 4679999993210   0       00          01124888999887775   


Q ss_pred             CCCc--cceeeeeecC------------------CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHH
Q 015852          303 HRNL--LRLYGFCTTV------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS  362 (399)
Q Consensus       303 H~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~  362 (399)
                      +.++  |+.+||..-.                  ....||.||++...             .+    ..+-+.+|.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHHHHHHH
Confidence            4455  8888886321                  11356777766533             01    2233556777788


Q ss_pred             HHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          363 YLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       363 yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+|..   +|+-+|+|++|..     +-++.||.
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs  204 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFS  204 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEecc
Confidence            89988   9999999999975     55777874

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.31  E-value=0.00021  Score=46.71  Aligned_cols=36  Identities=44%  Similarity=0.745  Sum_probs=32.1

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLS  104 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~  104 (399)
                      .++.|+|++|+++ .||+++++|++|+.|++++|+++
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            4788999999999 79999999999999999999998

...

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.30  E-value=0.0023  Score=58.26  Aligned_cols=73  Identities=14%  Similarity=0.152  Sum_probs=42.9

Q ss_pred             ceeeccCCc-eEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC---CccceeeeeecCC---ceEEEEec
Q 015852          253 NILGRGGFG-KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---NLLRLYGFCTTVT---EKLLVYPY  325 (399)
Q Consensus       253 ~~lG~G~fg-~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lv~e~  325 (399)
                      +.|+.|+.. .||+.    +..+.+|..+..   .....+.+|.+++..+...   .+.++++.....+   ..+++||+
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            456766665 58874    234667764331   1234688899888777532   2333444333221   34789999


Q ss_pred             CCCCChh
Q 015852          326 MTNGSVA  332 (399)
Q Consensus       326 ~~~gsL~  332 (399)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=97.22  E-value=7.8e-05  Score=74.55  Aligned_cols=81  Identities=35%  Similarity=0.445  Sum_probs=46.8

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCccccccccc-ccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTS-LTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      .++.||||+|+|. ++|..+..-.++-.|+||+|++. +||.+ +.+++.|-+||||+|.|.---|....+..+..+.++
T Consensus       104 dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls  181 (1255)
T KOG0444|consen  104 DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLS  181 (1255)
T ss_pred             cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcC
Confidence            3455555555554 45555555555555555555554 45543 345666666666666665444444556667778888


Q ss_pred             cccc
Q 015852          147 NNLN  150 (399)
Q Consensus       147 ~n~~  150 (399)
                      +|+.
T Consensus       182 ~NPL  185 (1255)
T KOG0444|consen  182 NNPL  185 (1255)
T ss_pred             CChh
Confidence            8874

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=97.21  E-value=7.5e-05  Score=74.69  Aligned_cols=64  Identities=27%  Similarity=0.461  Sum_probs=33.5

Q ss_pred             CEEEEEeCCCCce-eecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC
Q 015852           68 SVTRVDLGNAALS-GELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  133 (399)
Q Consensus        68 ~v~~l~l~~~~l~-g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~  133 (399)
                      ++.++++..|+|. ..||+++..|.-|+.||||+|+|. +.|..+....++-+||||+|++. .||+
T Consensus        79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn  143 (1255)
T KOG0444|consen   79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPN  143 (1255)
T ss_pred             hhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCc
Confidence            3444555555553 335555555555555555555554 45555555555555555555543 3443

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.21  E-value=0.0022  Score=60.41  Aligned_cols=139  Identities=14%  Similarity=0.106  Sum_probs=80.7

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCC--ccceeeee------ecCCceEEEE
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFC------TTVTEKLLVY  323 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lv~  323 (399)
                      .+.+..|....+|+....++ .+++|+...    ........|++++..+.+..  +.+++...      ...+..++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            45677787789999876444 688888753    12234566777776664332  44444321      2234568999


Q ss_pred             ecCCCCChhh--------------HhhhcCCC-------CCCCChHHHHH----------HHHHHHHHHHHHhc----CC
Q 015852          324 PYMTNGSVAS--------------RLRERQSS-------LPPLDWPTRKK----------IALGSARGLSYLHE----HC  368 (399)
Q Consensus       324 e~~~~gsL~~--------------~L~~~~~~-------~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~  368 (399)
                      ||++|..+..              .+|.....       .....|.....          ....+...+.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876432              11111000       01123332211          11223444555553    12


Q ss_pred             CCCceecCCCCCceeeCCCCceeeccc
Q 015852          369 DPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       369 ~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ...++|+|+.|.|||++++....|.||
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDf  200 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDF  200 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeeh
Confidence            346999999999999999877789998

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.20  E-value=4.6e-05  Score=62.05  Aligned_cols=63  Identities=22%  Similarity=0.377  Sum_probs=54.4

Q ss_pred             CCCEEEEEeCCCCceeecChhhcc-CcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCccc
Q 015852           66 EGSVTRVDLGNAALSGELAPELGQ-LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  130 (399)
Q Consensus        66 ~~~v~~l~l~~~~l~g~ip~~l~~-l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~  130 (399)
                      .-.++.++|++|.|. .+|+.+.. .+.++.|+|++|.++ .+|.+++.++.|+.+|+++|.|+-.
T Consensus        52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~  115 (177)
T KOG4579|consen   52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAE  115 (177)
T ss_pred             CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccc
Confidence            347899999999987 67777765 458999999999998 6999999999999999999998754

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.18  E-value=0.00021  Score=61.78  Aligned_cols=80  Identities=31%  Similarity=0.448  Sum_probs=33.5

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccc-cCCCCCcEEecCCCcCcc--cCCCCCCCCccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLSG--PVPDNGSFSQFTPI  143 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~-~~l~~L~~l~ls~N~l~G--~iP~~~~~~~~~~~  143 (399)
                      ..+..|+|++|+++ .++ .+..++.|+.|++++|.++. ++..+ ..+++|+.|++++|++..  .+-....+..+..+
T Consensus        42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            36889999999987 444 47778999999999999984 55444 368999999999998864  11112345556667


Q ss_pred             cccccc
Q 015852          144 SFENNL  149 (399)
Q Consensus       144 ~~~~n~  149 (399)
                      ++.|||
T Consensus       119 ~L~~NP  124 (175)
T PF14580_consen  119 SLEGNP  124 (175)
T ss_dssp             E-TT-G
T ss_pred             eccCCc
Confidence            777776

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=97.00  E-value=0.00022  Score=67.85  Aligned_cols=76  Identities=29%  Similarity=0.412  Sum_probs=62.2

Q ss_pred             EEeCCCCceeecChhhc-cCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccccccc
Q 015852           72 VDLGNAALSGELAPELG-QLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN  150 (399)
Q Consensus        72 l~l~~~~l~g~ip~~l~-~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~n~~  150 (399)
                      +.++.|++. .+|.+.. .|.+|..|||..|++. ++|..+.-+.+|+.||+|+|.+++--++.+++ .+..+.++||+.
T Consensus       233 lh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl  309 (565)
T KOG0472|consen  233 LHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL  309 (565)
T ss_pred             HHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence            333444433 4666655 7888999999999998 79999999999999999999999988888888 888899999984

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.97  E-value=0.012  Score=54.32  Aligned_cols=134  Identities=15%  Similarity=0.081  Sum_probs=72.3

Q ss_pred             eeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeeeecCCceEEEEecCCCCChhh
Q 015852          255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMTNGSVAS  333 (399)
Q Consensus       255 lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~gsL~~  333 (399)
                      +..|-.+.+|+... +++.+.+|........- .....+|.++++.+....+ .+++...    ..++||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            45577788998874 46678888754322111 1235678888877764433 3344432    2368999999866532


Q ss_pred             --------------H---hhhcCCCCCCCChHHH-HHHHH---------HHHHHHHHHhcC-----CCCCceecCCCCCc
Q 015852          334 --------------R---LRERQSSLPPLDWPTR-KKIAL---------GSARGLSYLHEH-----CDPKIIHRDVKAAN  381 (399)
Q Consensus       334 --------------~---L~~~~~~~~~l~~~~~-~~i~~---------~ia~gL~yLH~~-----~~~~ivHrDlK~~N  381 (399)
                                    .   +|.......+++.... ..+-.         .+.+-+..+-..     ..+.++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                          1   1211111112222111 11110         111112222111     13468999999999


Q ss_pred             eeeCCCCceeeccc
Q 015852          382 ILLDEDADQSSKTI  395 (399)
Q Consensus       382 ILld~~~~~~i~df  395 (399)
                      |++++++ ..+.||
T Consensus       158 il~~~~~-~~lIDw  170 (256)
T TIGR02721       158 LVVTPQG-LKLIDW  170 (256)
T ss_pred             EEEeCCC-CEEEec
Confidence            9999877 689998

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=96.96  E-value=0.00037  Score=73.51  Aligned_cols=73  Identities=22%  Similarity=0.312  Sum_probs=37.1

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~  146 (399)
                      .+..|+|++|+|++ +|..   .+.|+.|++++|.|++ ||...   .+|+.|++++|+++ .+|.. ..+..+..+.++
T Consensus       383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            45666777776663 5532   2456666666666653 44322   23455555555554 44432 233344444455


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|+
T Consensus       454 ~N~  456 (788)
T PRK15387        454 GNP  456 (788)
T ss_pred             CCC
Confidence            544

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.90  E-value=0.0045  Score=58.09  Aligned_cols=74  Identities=16%  Similarity=0.248  Sum_probs=46.3

Q ss_pred             CCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC---CCCccceeeeeecCCceEEEEecCC
Q 015852          251 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      ..+.++-|....+|+.. .+++.+.||.-..    .....|..|.+-|+.+.   --.+.+.+++....+..++++||++
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            34668888889999877 5677899997642    12235888888777663   4457788888877777899999998


Q ss_pred             CC
Q 015852          328 NG  329 (399)
Q Consensus       328 ~g  329 (399)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            77

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN03210 Resistant to P

Probab=96.89  E-value=0.0015  Score=73.15  Aligned_cols=82  Identities=21%  Similarity=0.271  Sum_probs=62.0

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..+..++|+++..-+.+| .++.+++|+.|+|++|.....+|.++.++++|+.|++++++.-+.+|....+..+..+.+.
T Consensus       634 ~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Ls  712 (1153)
T PLN03210        634 TGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLS  712 (1153)
T ss_pred             CCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCC
Confidence            467778887766556676 4788888888888888777888888888888888888887666777866556666666666


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       713 gc~  715 (1153)
T PLN03210        713 GCS  715 (1153)
T ss_pred             CCC
Confidence            654

syringae 6; Provisional

>PRK05231 homoserine kinase; Provisional

Probab=96.64  E-value=0.057  Score=51.44  Aligned_cols=27  Identities=22%  Similarity=0.294  Sum_probs=23.2

Q ss_pred             CCCceecCCCCCceeeCCCCceeeccc
Q 015852          369 DPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       369 ~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ..+++|+|+.+.|||++.+...-|.||
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf  212 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDF  212 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEec
Confidence            447999999999999997655679999

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.61  E-value=0.069  Score=50.62  Aligned_cols=140  Identities=13%  Similarity=0.121  Sum_probs=77.7

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC--Cccceeeee------ecCCceEEEE
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGFC------TTVTEKLLVY  323 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~lv~  323 (399)
                      ...++.|....+|+....++ .+.+|......   .......|.+++..+...  .+.+++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45677777788999876555 56778764321   122344556666555322  234444321      1234568999


Q ss_pred             ecCCCCChhh--------------HhhhcCCCC--------CCCChHHHHH------------HHHHHHHHHHHHhc---
Q 015852          324 PYMTNGSVAS--------------RLRERQSSL--------PPLDWPTRKK------------IALGSARGLSYLHE---  366 (399)
Q Consensus       324 e~~~~gsL~~--------------~L~~~~~~~--------~~l~~~~~~~------------i~~~ia~gL~yLH~---  366 (399)
                      ||++|..+..              .+|......        ..-.|.....            ....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            9998854321              122211110        0012322111            11223345555543   


Q ss_pred             -CCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          367 -HCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       367 -~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                       .....++|+|+.+.||++++++...|.||
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDf  212 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDF  212 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeec
Confidence             23458999999999999999877789998

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=96.59  E-value=0.0004  Score=72.49  Aligned_cols=82  Identities=27%  Similarity=0.413  Sum_probs=57.6

Q ss_pred             CCEEEEEeCCCCceeecCh-hhccCcCCCeEeccCCcccc----------------------cccccccCCCCCcEEecC
Q 015852           67 GSVTRVDLGNAALSGELAP-ELGQLKNLELLRLNNNSLSG----------------------LIPTSLTTITSLNILDLS  123 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~-~l~~l~~L~~l~l~~n~l~G----------------------~ip~~~~~l~~L~~l~ls  123 (399)
                      ..+..|+|++|+|. ++|. .+.++..|+.|+||+|.|+-                      ..| ++.+++.|+++|+|
T Consensus       383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS  460 (1081)
T KOG0618|consen  383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLS  460 (1081)
T ss_pred             cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecc
Confidence            36778888888775 5553 46677777777777777751                      244 67788899999999


Q ss_pred             CCcCc-ccCCCCCCCCcccccccccccc
Q 015852          124 NNRLS-GPVPDNGSFSQFTPISFENNLN  150 (399)
Q Consensus       124 ~N~l~-G~iP~~~~~~~~~~~~~~~n~~  150 (399)
                      .|+|+ +.+|......++..++++||..
T Consensus       461 ~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  461 CNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             cchhhhhhhhhhCCCcccceeeccCCcc
Confidence            99986 3455433336777888888873

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=96.45  E-value=0.00049  Score=68.51  Aligned_cols=67  Identities=28%  Similarity=0.359  Sum_probs=38.5

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  133 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~  133 (399)
                      .++..|+|++|+++--=+.++..|..|+.|+|++|.++-.---.|..+++|+.|||++|.+++.|-+
T Consensus       317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED  383 (873)
T KOG4194|consen  317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED  383 (873)
T ss_pred             ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence            3566666666666633334455555555555555555422222344566777777777777776653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=96.45  E-value=0.0006  Score=72.26  Aligned_cols=146  Identities=18%  Similarity=0.213  Sum_probs=94.6

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ...++|...+-+-+|.++.++-+.-. .|...+.|.......  .........+-.+.-..+||-+++..-.+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34566777777888899988876532 343444443322111  001111222222222234566665544444556788


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++++|..+++|...|+....    .+..-.......+.+.++|||..   .++|||+||.|.|...++..+++||.
T Consensus       881 L~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~  949 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFG  949 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccc
Confidence            99999999999999987542    33333344455677899999987   79999999999999999999999984

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.42  E-value=0.031  Score=52.22  Aligned_cols=26  Identities=31%  Similarity=0.497  Sum_probs=21.4

Q ss_pred             CCceecCCCCCceeeCCCCc-eeeccc
Q 015852          370 PKIIHRDVKAANILLDEDAD-QSSKTI  395 (399)
Q Consensus       370 ~~ivHrDlK~~NILld~~~~-~~i~df  395 (399)
                      +.++|+|+.+.|||+++++. .-|.||
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDW  211 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDW  211 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECc
Confidence            46899999999999997554 358887

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=96.39  E-value=0.0015  Score=35.72  Aligned_cols=21  Identities=48%  Similarity=0.759  Sum_probs=13.6

Q ss_pred             CCCeEeccCCcccccccccccC
Q 015852           92 NLELLRLNNNSLSGLIPTSLTT  113 (399)
Q Consensus        92 ~L~~l~l~~n~l~G~ip~~~~~  113 (399)
                      +|++|||++|+|+ .||+++++
T Consensus         1 ~L~~Ldls~n~l~-~ip~~~~~   21 (22)
T PF00560_consen    1 NLEYLDLSGNNLT-SIPSSFSN   21 (22)
T ss_dssp             TESEEEETSSEES-EEGTTTTT
T ss_pred             CccEEECCCCcCE-eCChhhcC
Confidence            3567777777777 67766543

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.28  E-value=0.04  Score=52.06  Aligned_cols=74  Identities=19%  Similarity=0.275  Sum_probs=44.4

Q ss_pred             ceeeccCCceEEEEEeCC-------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeeeecCCceEEEEe
Q 015852          253 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~-------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e  324 (399)
                      +.+..|-...+|+....+       ++.+.+|.......  ......+|.+++..+....+ .++++++.    -.+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence            345556667899887654       47888888644321  11234667777766653333 34455443    236899


Q ss_pred             cCCCCChh
Q 015852          325 YMTNGSVA  332 (399)
Q Consensus       325 ~~~~gsL~  332 (399)
                      |++|..+.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            99887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=96.20  E-value=0.0064  Score=64.49  Aligned_cols=34  Identities=32%  Similarity=0.430  Sum_probs=19.9

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLS  104 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~  104 (399)
                      .++.|+|++|+++ .+|..+.  .+|+.|+|++|+|+
T Consensus       200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt  233 (754)
T PRK15370        200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT  233 (754)
T ss_pred             CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc
Confidence            4567777777776 4565443  35555555555554

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=96.18  E-value=0.0036  Score=66.24  Aligned_cols=52  Identities=29%  Similarity=0.342  Sum_probs=32.7

Q ss_pred             cCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccccc
Q 015852           91 KNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  149 (399)
Q Consensus        91 ~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~n~  149 (399)
                      .+|+.|+|++|+|++ +|..   .++|+.|++++|+|++ +|..  ...+..+.+.+|.
T Consensus       382 ~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l--~~~L~~L~Ls~Nq  433 (788)
T PRK15387        382 SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML--PSGLLSLSVYRNQ  433 (788)
T ss_pred             cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc--hhhhhhhhhccCc
Confidence            357778888888874 6643   2567788888888874 6643  2234445555554

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.13  E-value=0.084  Score=49.97  Aligned_cols=26  Identities=23%  Similarity=0.229  Sum_probs=22.9

Q ss_pred             CCCceecCCCCCceeeCCCCceeeccc
Q 015852          369 DPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       369 ~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ..+++|+|+.+.||+++. +.+.|.||
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDf  211 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDF  211 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEEC
Confidence            357899999999999998 67889999

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=96.00  E-value=0.0082  Score=63.69  Aligned_cols=58  Identities=24%  Similarity=0.418  Sum_probs=40.7

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCC
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  132 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP  132 (399)
                      ..+.++|++++++ .+|..+.  +.|+.|+|++|+++ .+|..+.  ++|+.|++++|+|+ .+|
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP  236 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIP  236 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCC
Confidence            4678888888877 4666553  46888888888888 5776554  46777777777776 344

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	399
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-84
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-82
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-05
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-05
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-05
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-05
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-05
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-05
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-05
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  309 bits (791), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 147/178 (82%), Positives = 160/178 (89%)
Query: 210 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 269
           RR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGRLA
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 270 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 329
           DG LVAVKRLKEER  GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           SVAS LRER  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 178

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  301 bits (772), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 144/170 (84%), Positives = 155/170 (91%)
Query: 218 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK 277
           FFDVPAE+D E+ LGQLKRFSLRELQVA+D F NKNILGRGGFGKVYKGRLADG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 278 RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 337
           RLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 338 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/152 (44%), Positives = 93/152 (61%), Gaps = 4/152 (2%)
Query: 236 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV 295
           R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   E +S G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 296 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 355
           + +S   H +L+ L GFC    E +L+Y YM NG++   L         + W  R +I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/152 (44%), Positives = 93/152 (61%), Gaps = 4/152 (2%)
Query: 236 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV 295
           R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   E +S G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 296 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 355
           + +S   H +L+ L GFC    E +L+Y YM NG++   L         + W  R +I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 69/168 (41%), Positives = 96/168 (57%), Gaps = 14/168 (8%)
Query: 228 ELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK- 280
           E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 281 --EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER 338
             +  T   + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 339 QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 125 DGT-PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 69/168 (41%), Positives = 96/168 (57%), Gaps = 14/168 (8%)
Query: 228 ELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK- 280
           E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 281 --EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER 338
             +  T   + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 339 QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 125 DGT-PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 68/159 (42%), Positives = 93/159 (58%), Gaps = 14/159 (8%)
Query: 237 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 287
           FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 288 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 347
           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL     + PPL W
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 126
Query: 348 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 127 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 162

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/159 (42%), Positives = 90/159 (56%), Gaps = 14/159 (8%)
Query: 237 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 287
           FS  EL+  T+ F  +      N  G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 288 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 347
           + QF  E+K+ +   H NL+ L GF +   +  LVY Y  NGS+  RL     + PPL W
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT-PPLSW 123
Query: 348 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 124 HXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 159

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 255 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 307
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 368 CDPKIIHRDVKAANIL---LDEDADQSSKT 394
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 255 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 307
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 368 CDPKIIHRDVKAANIL---LDEDADQSSKT 394
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 255 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 307
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 368 CDPKIIHRDVKAANIL---LDEDADQSSKT 394
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T      +V   +  G   + LR   +    L   T  ++   +A G+ YL   C    I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 374 HRDVKAANILLDE 386
           HRD+ A N L+ E
Sbjct: 236 HRDLAARNCLVTE 248

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T      +V   +  G   + LR   +    L   T  ++   +A G+ YL   C    I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 374 HRDVKAANILLDE 386
           HRD+ A N L+ E
Sbjct: 236 HRDLAARNCLVTE 248

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 18/163 (11%)
Query: 242 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGGELQFQTEVKII 298
           L++     + + I+G GGFGKVY+     G  VAVK  +   +E  S      + E K+ 
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 299 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIAL 355
           +M  H N++ L G C       LV  +   G +   L  ++  +PP   ++W      A+
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNW------AV 112
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI 395
             ARG++YLH+     IIHRD+K++NIL+    E+ D S+K +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 148
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 149 --ASKKFVHRDLAARNCMLDE 167

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 167
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 168 --ASKKFVHRDLAARNCMLDE 186

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 168
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 169 --ASKKFVHRDLAARNCMLDE 187

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 147
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 148 --ASKKFVHRDLAARNCMLDE 166

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 149
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 149
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 148
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 149 --ASKKFVHRDLAARNCMLDE 167

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 146
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 147 --ASKKFVHRDLAARNCMLDE 165

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 144
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 145 --ASKKFVHRDLAARNCMLDE 163

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 141
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 142 --ASKKFVHRDLAARNCMLDE 160

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 11/143 (7%)
Query: 250 SNKNILGRGGFGKVYKGRL--ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHR 304
           + + ++G G FG+VYKG L  + GK    VA+K LK   T    + F  E  I+    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N++RL G  +     +++  YM NG++   LRE+      L      +   G A G+ YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYL 163
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
               +   +HRD+ A NIL++ +
Sbjct: 164 ---ANMNYVHRDLAARNILVNSN 183

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELAN 124
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELAN 124
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 69/145 (47%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R  + K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     K+IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLL 141

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 136
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLL 158

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 147
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 148 --ASKKFVHRDLAARNCMLDE 166

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 145
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLL 167

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 154
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 155 --ASKKFVHRDLAARNCMLDE 173

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 150
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 151 --ASKKFVHRDLAARNCMLDE 169

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 149
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G G FG V+ G   +   VA+K +KE   S  E  F  E +++    H  L++LYG C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 375 RDVKAANILLDED 387
           RD+ A N L+ E+
Sbjct: 147 RDLAARNCLVGEN 159

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 149
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 150
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 151 --ASKKFVHRDLAARNCMLDE 169

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 254 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 310 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 365
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 208
Query: 366 EHCDPKIIHRDVKAANILLDE 386
                K +HRD+ A N +LDE
Sbjct: 209 --ASKKFVHRDLAARNCMLDE 227

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 145
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLL 167

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 121
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLL 143

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 121
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLL 143

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 31/160 (19%)
Query: 255 LGRGGFGKVYKGRLADG-------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           +G G FG+V++ R A G        +VAVK LKEE ++  +  FQ E  +++   + N++
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 308 RLYGFCTTVTEKLLVYPYMTNG--------------------SVASRLRERQSSLPPLDW 347
           +L G C       L++ YM  G                     +++R R      PPL  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 348 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 118
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLL 140

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 375 RDVKAANILLDED 387
           RD+ A N L+ E+
Sbjct: 127 RDLAARNCLVGEN 139

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 375 RDVKAANILLDED 387
           RD+ A N L+ E+
Sbjct: 130 RDLAARNCLVGEN 142

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 123
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLL 145

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 310
           K  +G G FG V++     G  VAVK L E+      + +F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G  T      +V  Y++ GS+  RL  +  +   LD   R  +A   A+G++YLH   +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 371 KIIHRDVKAANILLDE 386
            I+HRD+K+ N+L+D+
Sbjct: 159 PIVHRDLKSPNLLVDK 174

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 375 RDVKAANILLDED 387
           RD+ A N L+ E+
Sbjct: 125 RDLAARNCLVGEN 137

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 234 LKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ 292
           L    L  L+     F    ++G G +G+VYKGR +  G+L A+K +  + T   E + +
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIK 68
Query: 293 TEVKIIS-MAVHRNLLRLYGFCTT-----VTEKL-LVYPYMTNGSVASRLRERQSSLPPL 345
            E+ ++   + HRN+   YG         + ++L LV  +   GSV   ++  + +    
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 346 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           +W     I     RGLS+LH+H   K+IHRD+K  N+LL E+A+
Sbjct: 129 EWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 116
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            LSY H     ++IHRD+K  N+LL
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLL 138

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 227 SELQLGQLKRFSLRELQVATDGFSN------------------KNI-----LGRGGFGKV 263
           SELQ  + K   LR   + TD   N                  KNI     LG G FG+V
Sbjct: 28  SELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 87
Query: 264 YKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT 317
           Y+G+++          VAVK L E  +   EL F  E  IIS   H+N++R  G      
Sbjct: 88  YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147
Query: 318 EKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            + ++   M  G + S LRE      + SSL  LD      +A   A G  YL E+    
Sbjct: 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQYLEEN---H 201
Query: 372 IIHRDVKAANILL 384
            IHRD+ A N LL
Sbjct: 202 FIHRDIAARNCLL 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 227 SELQLGQLKRFSLRELQVATDGFSN------------------KNI-----LGRGGFGKV 263
           SELQ  + K   LR   + TD   N                  KNI     LG G FG+V
Sbjct: 5   SELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 64
Query: 264 YKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT 317
           Y+G+++          VAVK L E  +   EL F  E  IIS   H+N++R  G      
Sbjct: 65  YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 124
Query: 318 EKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            + ++   M  G + S LRE      + SSL  LD      +A   A G  YL E+    
Sbjct: 125 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQYLEEN---H 178
Query: 372 IIHRDVKAANILL 384
            IHRD+ A N LL
Sbjct: 179 FIHRDIAARNCLL 191

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 155 YLEEN---HFIHRDIAARNCLL 173

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 310
           K  +G G FG V++     G  VAVK L E+      + +F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G  T      +V  Y++ GS+  RL  +  +   LD   R  +A   A+G++YLH   +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 371 KIIHRDVKAANILLDE 386
            I+HR++K+ N+L+D+
Sbjct: 159 PIVHRNLKSPNLLVDK 174

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q   + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELAN 123
Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
            LSY H     ++IHRD+K  N+LL  + +
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGE 150

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           Q   + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELAN 123
Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
            LSY H     ++IHRD+K  N+LL  + +
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGE 150

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 LV  +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 375 RDVKAANILLDED 387
           RD+ A N L+ E+
Sbjct: 128 RDLAARNCLVGEN 140

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 172 YLEEN---HFIHRDIAARNCLL 190

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 155 YLEEN---HFIHRDIAARNCLL 173

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 14/142 (9%)
Query: 252 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           + ++G G FG+V +GRL A GK    VA+K LK   T     +F +E  I+    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           RL G  T     +++  +M NG++ S  RL + Q ++  L    R     G A G+ YL 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR-----GIASGMRYLA 135
Query: 366 EHCDPKIIHRDVKAANILLDED 387
           E      +HRD+ A NIL++ +
Sbjct: 136 EM---SYVHRDLAARNILVNSN 154

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 146
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 147 YLEEN---HFIHRDIAARNCLL 165

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/148 (34%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 254 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI--ISMAVHRNLLRLYG 311
           ++GRG +G VYKG L D + VAVK      +      F  E  I  + +  H N+ R   
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 312 FCTTVT-----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH- 365
               VT     E LLV  Y  NGS+   L     SL   DW +  ++A    RGL+YLH 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 366 -----EHCDPKIIHRDVKAANILLDEDA 388
                +H  P I HRD+ + N+L+  D 
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDG 157

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 162 YLEEN---HFIHRDIAARNCLL 180

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 14/142 (9%)
Query: 252 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           + ++G G FG+V +GRL A GK    VA+K LK   T     +F +E  I+    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           RL G  T     +++  +M NG++ S  RL + Q ++  L    R     G A G+ YL 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR-----GIASGMRYLA 133
Query: 366 EHCDPKIIHRDVKAANILLDED 387
           E      +HRD+ A NIL++ +
Sbjct: 134 EM---SYVHRDLAARNILVNSN 152

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 255 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 362
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 363 YLHEHCDPKIIHRDVKAANILL 384
           YL E+     IHRD+ A N LL
Sbjct: 182 YLEEN---HFIHRDIAARNCLL 200

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V  G+      VAVK +KE   S  E +F  E + +    H  L++ YG C+
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 +V  Y++NG + + LR     L P       ++      G+++L  H   + IH
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 375 RDVKAANILLDED 387
           RD+ A N L+D D
Sbjct: 128 RDLAARNCLVDRD 140

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 252 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           + ++G G FG+V  G L   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            L G  T  T  +++  +M NGS+ S LR+       +      +   G A G+ YL   
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL--- 151
Query: 368 CDPKIIHRDVKAANILLDED 387
            D   +HRD+ A NIL++ +
Sbjct: 152 ADMNYVHRDLAARNILVNSN 171

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 LV+ +M +G ++  LR ++         T   + L    G++YL E     +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEE---ASVIH 126
Query: 375 RDVKAANILLDED 387
           RD+ A N L+ E+
Sbjct: 127 RDLAARNCLVGEN 139

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 232 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF 291
           G L     +E++V       + ++GRG FG V K +    K VA+K+++ E        F
Sbjct: 1   GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---F 49
Query: 292 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 351
             E++ +S   H N+++LYG C  +    LV  Y   GS+ + L   +  LP        
Sbjct: 50  IVELRQLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAM 106
Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
              L  ++G++YLH      +IHRD+K  N+LL
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 139

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSN 183

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 375 RDVKAANILLDEDAD----------QSSKTILRR 398
           RD+KA NIL   D D          ++++TI RR
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 192

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 18  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 131
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSN 154

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 35  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 91
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 92  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 148
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 149 KYLS---DMGYVHRDLAARNILINSN 171

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 45  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 101
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 158
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSN 181

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 249 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 296
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 297 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 344
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 345 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           LD P  + + +G         ++G+ YL E    K++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 249 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 296
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 297 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 344
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 345 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           LD P  + + +G         ++G+ YL E    K++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           +T  +  +V  +    S+   L    +S    +      IA  +ARG+ YLH      II
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 143 HRDLKSNNIFLHED 156

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 375 RDVKAANILLDEDAD 389
           RD+KA NIL   D D
Sbjct: 159 RDLKAGNILFTLDGD 173

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 375 RDVKAANILLDEDAD 389
           RD+KA NIL   D D
Sbjct: 159 RDLKAGNILFTLDGD 173

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T    +L +      GS  S      +S    +      IA  +ARG+ YLH      II
Sbjct: 78  TK--PQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 131 HRDLKSNNIFLHED 144

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T    +L +      GS  S      +S    +      IA  +ARG+ YLH      II
Sbjct: 90  TK--PQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 143 HRDLKSNNIFLHED 156

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 255 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 84
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 357
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           A G+ YL        +HRD+   N L+ +
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQ 170

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 255 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 78
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 357
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           A G+ YL        +HRD+   N L+ +
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQ 164

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           + ++GRG FG V K +    K VA+K+++ E        F  E++ +S   H N+++LYG
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYG 68
Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            C  +    LV  Y   GS+ + L   +  LP           L  ++G++YLH      
Sbjct: 69  AC--LNPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 372 IIHRDVKAANILL 384
           +IHRD+K  N+LL
Sbjct: 126 LIHRDLKPPNLLL 138

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 255 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 107
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 357
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           A G+ YL        +HRD+   N L+ +
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQ 193

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 18/140 (12%)
Query: 253 NILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
            +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 364
           RL G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 133
Query: 365 HEHCDPKIIHRDVKAANILL 384
            E    +++HRD+ A N+L+
Sbjct: 134 EER---RLVHRDLAARNVLV 150

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 238 SLRELQVATDGFSNK--NILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQF 291
           ++RE     D    K   ++G G FG+V  GRL   GK    VA+K LK   T      F
Sbjct: 18  AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 77
Query: 292 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 351
            +E  I+    H N++ L G  T     +++  YM NGS+ + LR+       +      
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 137
Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   G   G+ YL    D   +HRD+ A NIL++ +
Sbjct: 138 R---GIGSGMKYLS---DMSAVHRDLAARNILVNSN 167

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 36/170 (21%)
Query: 249 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 296
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 297 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 344
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 345 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           LD P  + + +G         ++G+ YL E     ++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAE 185

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 18/140 (12%)
Query: 253 NILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
            +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 364
           RL G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 156
Query: 365 HEHCDPKIIHRDVKAANILL 384
            E    +++HRD+ A N+L+
Sbjct: 157 EER---RLVHRDLAARNVLV 173

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 9/142 (6%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F+  + +G+G FG+VYKG     K +VA+K +  E         Q E+ ++S      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           R +G     T+  ++  Y+  GS    L+       PL+      I     +GL YLH  
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE 135
Query: 368 CDPKIIHRDVKAANILLDEDAD 389
              + IHRD+KAAN+LL E  D
Sbjct: 136 ---RKIHRDIKAANVLLSEQGD 154

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEV 295
            SL + ++     + K+ LG G FG+VY+G      L VAVK LKE+     E  F  E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEA 58
Query: 296 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKI 353
            ++    H NL++L G CT      ++  +MT G++   LRE  RQ             +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVV 110
Query: 354 ALGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 387
            L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 111 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 238 SLRELQVATDGFSNK--NILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQF 291
           ++RE     D    K   ++G G FG+V  GRL   GK    VA+K LK   T      F
Sbjct: 3   AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 62
Query: 292 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 351
            +E  I+    H N++ L G  T     +++  YM NGS+ + LR+       +      
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 122
Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   G   G+ YL    D   +HRD+ A NIL++ +
Sbjct: 123 R---GIGSGMKYLS---DMSYVHRDLAARNILVNSN 152

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 252 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           + ++G G FG+V  GRL   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            L G  T     +++  YM NGS+ + LR+       +      +   G   G+ YL   
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLS-- 127
Query: 368 CDPKIIHRDVKAANILLDED 387
            D   +HRD+ A NIL++ +
Sbjct: 128 -DMSYVHRDLAARNILVNSN 146

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  + ++   P L  P+ 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 252 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           + ++G G FG+V  G L   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            L G  T  T  +++  +M NGS+ S LR+       +      +   G A G+ YL   
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL--- 125
Query: 368 CDPKIIHRDVKAANILLDED 387
            D   +HR + A NIL++ +
Sbjct: 126 ADMNYVHRALAARNILVNSN 145

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-----DWPTRKKIALGS---A 358
            L G CT     L+V   +   G++++ LR +++   P      D+ T + +   S   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDE 386
           +G+ +L      K IHRD+ A NILL E
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSE 179

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  + ++   P L  P+ 
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 164

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 75
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 132
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 133 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 160

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVK 296
           SL + ++     + K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 59
Query: 297 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 354
           ++    H NL++L G CT      ++  +MT G++   LRE  RQ             + 
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVL 111
Query: 355 LGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 387
           L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 112 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 93
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 150
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 151 FRSLAYIHSF---GICHRDIKPQNLLLDPD 177

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 87
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 144
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 145 FRSLAYIHSF---GICHRDIKPQNLLLDPD 171

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 82
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 139
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 140 FRSLAYIHSF---GICHRDIKPQNLLLDPD 166

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-----DWPTRKKIALGS---A 358
            L G CT     L+V   +   G++++ LR +++   P      D+ T + +   S   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDE 386
           +G+ +L      K IHRD+ A NILL E
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSE 179

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 167

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 168

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGEL 289
           F   E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    +
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 290 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLD 346
           +F  E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 347 WPTRKK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            P+  K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 165

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 78
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 135
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 136 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 163

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 79
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 136
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 137 FRSLAYIHSF---GICHRDIKPQNLLLDPD 163

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 102
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 159
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 160 FRSLAYIHSF---GICHRDIKPQNLLLDPD 186

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 143
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPD 170

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 18  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V   M NGS+ S LR+  +    +      +   G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 131
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSN 154

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEV 295
            SL + ++     + K+ LG G +G+VY+G      L VAVK LKE+     E  F  E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEA 58
Query: 296 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKI 353
            ++    H NL++L G CT      ++  +MT G++   LRE  RQ             +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVV 110
Query: 354 ALGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 387
            L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 111 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 159

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 305
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 306 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 143
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPD 170

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 22/151 (14%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL--------DWPTRKKIALGS- 357
            L G CT     L+V   +   G++++ LR +++   P         D+ T + +   S 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 358 --ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             A+G+ +L      K IHRD+ A NILL E
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V   M NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSN 183

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 160 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 196

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 301
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++RL G  T     ++V   M NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 161

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 167

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 168

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 306
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNI 109
Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 166
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPD 192

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 249 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 143
Query: 368 CDPKIIHRDVKAANILLDEDAD 389
              K IHRD+KAAN+LL E  +
Sbjct: 144 ---KKIHRDIKAANVLLSEHGE 162

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 306
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNI 154
Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 211
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 212 RSLAYIHSF---GICHRDIKPQNLLLDPD 237

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 306
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 111
Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 168
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 169 RSLAYIHSF---GICHRDIKPQNLLLDPD 194

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 306
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNI 109
Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 166
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPD 192

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 357
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 358 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 249 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 138
Query: 368 CDPKIIHRDVKAANILLDEDAD 389
              K IHRD+KAAN+LL E  +
Sbjct: 139 ---KKIHRDIKAANVLLSEHGE 157

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 87/175 (49%), Gaps = 20/175 (11%)
Query: 219 FDVPAEDDSELQ-LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLV-- 274
           +D+P  ++   Q  G+    +L  +   T+ F    +LG G FG VYKG  + +G+ V  
Sbjct: 12  YDIPTTENLYFQGSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKI 70
Query: 275 --AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA 332
             A+K L+E  +     +   E  +++   + ++ RL G C T T +L+    M  G + 
Sbjct: 71  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLL 129
Query: 333 SRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
             +RE + ++     L+W       +  A+G++YL    D +++HRD+ A N+L+
Sbjct: 130 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLV 175

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 357
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 358 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 306
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 113
Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 170
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 171 RSLAYIHSF---GICHRDIKPQNLLLDPD 196

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 357
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 358 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           +T  +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---II 126
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 21/150 (14%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-------DWPTRKKIALGS-- 357
            L G CT     L+V   +   G++++ LR +++   P        D+ T + +   S  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 358 -ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
            A+G+ +L      K IHRD+ A NILL E
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSE 183

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 232 GQLKRFSLRELQVATDG---FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG 287
           G LK   + EL    D    FS+   +G G FG VY  R + + ++VA+K++        
Sbjct: 36  GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95
Query: 288 ELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP 344
           E ++Q    EV+ +    H N ++  G         LV  Y   GS +  L   +    P
Sbjct: 96  E-KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---P 150
Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
           L       +  G+ +GL+YLH H    +IHRDVKA NILL E
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSE 189

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 208 YWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 267
           Y++   P   F+   AE  +  + G+  R   RE++ +      + I+G G  G+V  GR
Sbjct: 15  YFQGKLPEPQFY---AEPHTYEEPGRAGRSFTREIEASR--IHIEKIIGSGDSGEVCYGR 69
Query: 268 L-ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 323
           L   G+    VA+K LK   T      F +E  I+    H N++RL G  T     ++V 
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129
Query: 324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 383
            YM NGS+ + LR        +       +  G   G+ YL    D   +HRD+ A N+L
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 384 LDED 387
           +D +
Sbjct: 184 VDSN 187

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 249 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 368 CDPKIIHRDVKAANILLDEDAD 389
              K IHRD+KAAN+LL E  +
Sbjct: 124 ---KKIHRDIKAANVLLSEHGE 142

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 357
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 358 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSE 185

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 249 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 368 CDPKIIHRDVKAANILLDEDAD 389
              K IHRD+KAAN+LL E  +
Sbjct: 124 ---KKIHRDIKAANVLLSEHGE 142

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 372
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 125
Query: 373 IHRDVKAANILLDE 386
           +HRD+ A N L+++
Sbjct: 126 LHRDLAARNCLVND 139

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 208 YWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 267
           Y++   P   F+   AE  +  + G+  R   RE++ +      + I+G G  G+V  GR
Sbjct: 15  YFQGKLPEPQFY---AEPHTYEEPGRAGRSFTREIEASR--IHIEKIIGSGDSGEVCYGR 69
Query: 268 L-ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 323
           L   G+    VA+K LK   T      F +E  I+    H N++RL G  T     ++V 
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129
Query: 324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 383
            YM NGS+ + LR        +       +  G   G+ YL    D   +HRD+ A N+L
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 384 LDED 387
           +D +
Sbjct: 184 VDSN 187

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 308 RLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 357
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 358 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 357
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 358 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSE 220

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 308 RLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 357
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 358 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 372
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 373 IHRDVKAANILLDEDA 388
           +HRD+ A N L+++  
Sbjct: 127 LHRDLAARNCLVNDQG 142

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 357
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 358 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLV 154

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLV 154

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 372
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 373 IHRDVKAANILLDE 386
           +HRD+ A N L+++
Sbjct: 122 LHRDLAARNCLVND 135

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 10/135 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-II 373
                 ++  YM NG + + LRE +          + +  L   + +    E+ + K  +
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRF-------QTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 374 HRDVKAANILLDEDA 388
           HRD+ A N L+++  
Sbjct: 143 HRDLAARNCLVNDQG 157

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 69/136 (50%), Gaps = 12/136 (8%)
Query: 255 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           LG G +G VYK      G++VA+K++  E     +LQ    E+ I+      ++++ YG 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
               T+  +V  Y   GSV+  +R R  +L   +  T   I   + +GL YLH     + 
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT---ILQSTLKGLEYLHFM---RK 146
Query: 373 IHRDVKAANILLDEDA 388
           IHRD+KA NILL+ + 
Sbjct: 147 IHRDIKAGNILLNTEG 162

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 308 RLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 357
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 358 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 372
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 373 IHRDVKAANILLDEDA 388
           +HRD+ A N L+++  
Sbjct: 142 LHRDLAARNCLVNDQG 157

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLV 151

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 76
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 128
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 129 EKKNFIHRDLAARNCLVGEN 148

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 127
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 79
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 131
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 132 EKKNFIHRDLAARNCLVGEN 151

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 372
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 373 IHRDVKAANILLDEDA 388
           +HRD+ A N L+++  
Sbjct: 127 LHRDLAARNCLVNDQG 142

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 12/142 (8%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 304
           FS+   +G G FG VY  R + + ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N ++  G         LV  Y   GS +  L   +    PL       +  G+ +GL+YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYL 131
Query: 365 HEHCDPKIIHRDVKAANILLDE 386
           H H    +IHRDVKA NILL E
Sbjct: 132 HSH---NMIHRDVKAGNILLSE 150

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 127
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 76
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 128
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 129 EKKNFIHRDLAARNCLVGEN 148

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 372
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 132
Query: 373 IHRDVKAANILLDEDA 388
           +HRD+ A N L+++  
Sbjct: 133 LHRDLAARNCLVNDQG 148

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIMQ-LMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLV 151

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 88
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 140
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 141 EKKNFIHRDLAARNCLVGEN 160

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 253 NILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
            +LG G FG VYKG  + DG+     VA+K L+E  +     +   E  +++      + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYL 364
           RL G C T T + LV   M  G +   +RE   R  S   L+W       +  A+G+SYL
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYL 135
Query: 365 HEHCDPKIIHRDVKAANILL 384
               D +++HRD+ A N+L+
Sbjct: 136 E---DVRLVHRDLAARNVLV 152

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---II 126
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---II 126
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 128
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 129 HRDLKSNNIFLHED 142

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 13/144 (9%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           F+    +G+G FG+V+KG   D +   +VA+K +  E         Q E+ ++S      
Sbjct: 25  FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           + + YG     ++  ++  Y+  GS    LR       P D      +     +GL YLH
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLH 137
Query: 366 EHCDPKIIHRDVKAANILLDEDAD 389
                K IHRD+KAAN+LL E  D
Sbjct: 138 SE---KKIHRDIKAANVLLSEQGD 158

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 131
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 132 HRDLKSNNIFLHED 145

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 131
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 132 HRDLKSNNIFLHED 145

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 87  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 139
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 140 MNYLE---DRRLVHRDLAARNVLV 160

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 83  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 135
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 136 MNYLE---DRRLVHRDLAARNVLV 156

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 71  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 124 MNYLE---DRRLVHRDLAARNVLV 144

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 132
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 146
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 147 HRDLKSNNIFLHED 160

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 154
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 155 HRDLKSNNIFLHED 168

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 12/149 (8%)
Query: 247 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           D +  + ++G G    V     A  K  VA+KR+  E+      +   E++ +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSAR 359
           ++  Y       E  LV   ++ GSV   ++      E +S +  LD  T   I      
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--LDESTIATILREVLE 132
Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDEDA 388
           GL YLH++     IHRDVKA NILL ED 
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDG 158

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 153
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 154 HRDLKSNNIFLHED 167

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 293
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 350
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 351 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            K   +A   A G++YL+ +   K +HRD+ A N  + ED
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAED 161

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 154
Query: 374 HRDVKAANILLDED 387
           HRD+K+ NI L ED
Sbjct: 155 HRDLKSNNIFLHED 168

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 12/149 (8%)
Query: 247 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           D +  + ++G G    V     A  K  VA+KR+  E+      +   E++ +S   H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSAR 359
           ++  Y       E  LV   ++ GSV   ++      E +S +  LD  T   I      
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--LDESTIATILREVLE 127
Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDEDA 388
           GL YLH++     IHRDVKA NILL ED 
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDG 153

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 252 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 355
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 140 DVARGMDYLSQ---KQFIHRDLAARNILVGEN 168

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 20/150 (13%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
           R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     LV  Y + G V   L           W  ++K A    R +    ++C  K 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAH-------GW-MKEKEARAKFRQIVSAVQYCHQKF 126
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 127 IVHRDLKAENLLLDADMN 144

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ--AFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM  GS+   L+  +     L  P     +   A G++Y+        IH
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIH 133
Query: 375 RDVKAANILLDE 386
           RD++AAN+L+ E
Sbjct: 134 RDLRAANVLVSE 145

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 248 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 252 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 355
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGEN 178

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A G
Sbjct: 74  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEG 126
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 127 MNYLE---DRRLVHRDLAARNVLV 147

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQ 290
           F   E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 291 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 344
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 15/147 (10%)
Query: 253 NILGRGGFGKVYKGRL--ADGK--LVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLL 307
            ILG G FG V +G L   DG    VAVK +K + +S  E+ +F +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 308 RLYGFCTTVTEK-----LLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALGSARG 360
           RL G C  ++ +     +++ P+M  G + + L   +    P   P  T  K  +  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 361 LSYLHEHCDPKIIHRDVKAANILLDED 387
           + YL        +HRD+ A N +L +D
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDD 183

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKL---VAVKRLKEERTSGGELQFQTEVKII 298
           ++     + + ++G G FG+V  GRL   GK    VA+K LK   T      F  E  I+
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 299 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
               H N++ L G  T     ++V  YM NGS+ + L++       +      +   G +
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR---GIS 134
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
            G+ YL    D   +HRD+ A NIL++ +
Sbjct: 135 AGMKYL---SDMGYVHRDLAARNILINSN 160

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQ 290
           F   E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++
Sbjct: 4   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 63
Query: 291 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 344
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 64  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 123
Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 124 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 163

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTE 294
           E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++F  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 295 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 348
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 349 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 131 EMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQ 290
           F   E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 291 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 344
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQ 290
           F   E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 291 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 344
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVK 296
           S+ + ++     + K+ LG G +G+VY G      L VAVK LKE+     E  F  E  
Sbjct: 23  SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 80
Query: 297 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 356
           ++    H NL++L G CT      +V  YM  G++   LRE               + L 
Sbjct: 81  VMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE------EVTAVVLLY 134
Query: 357 SARGLSYLHEHCDPK-IIHRDVKAANILLDED 387
            A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 135 MATQISSAMEYLEKKNFIHRDLAARNCLVGEN 166

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 255 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 308
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 134
Query: 369 DPKIIHRDVKAANILL 384
             + IHRD+ A N+LL
Sbjct: 135 --RFIHRDLAARNLLL 148

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 10/138 (7%)
Query: 252 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           + ++G G FG+V  GRL   GK    VA+K LK   T      F  E  I+    H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            L G  T     ++V  +M NG++ + LR+       +      +   G A G+ YL   
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR---GIAAGMRYL--- 161
Query: 368 CDPKIIHRDVKAANILLD 385
            D   +HRD+ A NIL++
Sbjct: 162 ADMGYVHRDLAARNILVN 179

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 255 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 308
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 369 DPKIIHRDVKAANILL 384
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 255 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 308
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 369 DPKIIHRDVKAANILL 384
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 255 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 308
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 140
Query: 369 DPKIIHRDVKAANILL 384
             + IHRD+ A N+LL
Sbjct: 141 --RFIHRDLAARNLLL 154

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 255 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 308
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 140
Query: 369 DPKIIHRDVKAANILL 384
             + IHRD+ A N+LL
Sbjct: 141 --RFIHRDLAARNLLL 154

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQ-FQTEVKIISMAVH 303
           + F   N+LG+G F  VY+   +  G  VA+K + K+     G +Q  Q EVKI     H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            ++L LY +        LV     NG +   L+ R   + P      +        G+ Y
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLY 127
Query: 364 LHEHCDPKIIHRDVKAANILLDEDAD 389
           LH H    I+HRD+  +N+LL  + +
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMN 150

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 19/157 (12%)
Query: 236 RFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE---RTSGGELQF 291
           ++SL++ Q+          LG G FG+V+  R   +G+  A+K LK+E   R    E   
Sbjct: 2   KYSLQDFQIL-------RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE-HT 53
Query: 292 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 351
             E  ++S+  H  ++R++G      +  ++  Y+  G + S LR+ Q   P    P  K
Sbjct: 54  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPN---PVAK 109
Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
             A      L YLH      II+RD+K  NILLD++ 
Sbjct: 110 FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNG 143

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 255 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 308
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 134
Query: 369 DPKIIHRDVKAANILL 384
             + IHRD+ A N+LL
Sbjct: 135 --RFIHRDLAARNLLL 148

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 255 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 308
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 369 DPKIIHRDVKAANILL 384
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ--AFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  +M  GS+   L+  +     L  P     +   A G++Y+        IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIH 132
Query: 375 RDVKAANILLDE 386
           RD++AAN+L+ E
Sbjct: 133 RDLRAANVLVSE 144

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 19/151 (12%)
Query: 252 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           K  LG G FGKV+           D  LVAVK LK+  +      F  E ++++   H +
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 76
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------PPLDWPTRK--KIALG 356
           +++ YG C      ++V+ YM +G +   LR             PP +    +   IA  
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            A G+ YL        +HRD+   N L+ E+
Sbjct: 137 IAAGMVYL---ASQHFVHRDLATRNCLVGEN 164

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           +   D F     LG+G FG VY  R    K + A+K L   +    G E Q + E++I S
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LR+Y +        L+  +   G +   L++        D           A 
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 126
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            L Y HE    K+IHRD+K  N+L+
Sbjct: 127 ALHYCHER---KVIHRDIKPENLLM 148

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 88  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 141
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 142 RDLRAANILVSD 153

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +L  G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 74  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 127
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 128 RDLRAANILVSD 139

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 81  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 134
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 135 RDLRAANILVSD 146

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 282
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 334
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHR++ A N L+ E+
Sbjct: 335 EKKNFIHRNLAARNCLVGEN 354

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 84  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 137
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 138 RDLRAANILVSD 149

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 85  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 139 RDLRAANILVSD 150

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAV--KRLKEERTSGGELQFQTEVKIISM 300
           +  D F +  +LGRGGFG+V+  ++ A GKL A      K  +   G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 300
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 300
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 80  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 133
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 134 RDLRAANILVSD 145

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 15/145 (10%)
Query: 255 LGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG+G FG VY+G   D         VAVK + E  +    ++F  E  ++      +++R
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSARGLS 362
           L G  +     L+V   M +G + S LR      E     PP       ++A   A G++
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YL+     K +HRD+ A N ++  D
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHD 165

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 254
Query: 315 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 372 IIHRDVKAANILLDED 387
            +HRD+ A N+L+ ED
Sbjct: 310 FVHRDLAARNVLVSED 325

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 67
Query: 315 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 122
Query: 372 IIHRDVKAANILLDED 387
            +HRD+ A N+L+ ED
Sbjct: 123 FVHRDLAARNVLVSED 138

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 82
Query: 315 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 372 IIHRDVKAANILLDED 387
            +HRD+ A N+L+ ED
Sbjct: 138 FVHRDLAARNVLVSED 153

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 300
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 87  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 140
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 141 RDLRAANILVSD 152

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +LG G FG VYKG  + +G+     VA+  L+E  +     +   E  +++   +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 111 PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 163
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 164 MNYLE---DRRLVHRDLAARNVLV 184

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G+G FG V  G     K VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 20  IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 73
Query: 315 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 128
Query: 372 IIHRDVKAANILLDED 387
            +HRD+ A N+L+ ED
Sbjct: 129 FVHRDLAARNVLVSED 144

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 85  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 139 RDLRAANILVSD 150

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +L  G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 10/145 (6%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 299
           +   D F     LG+G FG VY  R    K + A+K L   +    G E Q + E++I S
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              H N+LR+Y +        L+  +   G +   L++        D           A 
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 125
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            L Y HE    K+IHRD+K  N+L+
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLM 147

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 321
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 373
Query: 369 DPK-IIHRDVKAANILLDED 387
           + K  IHR++ A N L+ E+
Sbjct: 374 EKKNFIHRNLAARNCLVGEN 393

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 63/133 (47%), Gaps = 10/133 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+      VAVK LK    +  + Q F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
           T      +V  +    S+   L  +++            IA  +A+G+ YLH      II
Sbjct: 102 TK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLI---DIARQTAQGMDYLHA---KNII 154
Query: 374 HRDVKAANILLDE 386
           HRD+K+ NI L E
Sbjct: 155 HRDMKSNNIFLHE 167

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 245 ATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 303
           ++  F     LG G +  VYKG     G  VA+K +K +   G       E+ ++    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSARGL 361
            N++RLY    T  +  LV+ +M N  +   +  R     P  L+    K       +GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 362 SYLHEHCDPKIIHRDVKAANILLDE 386
           ++ HE+   KI+HRD+K  N+L+++
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINK 143

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 252 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 355
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             ARG+ YL +    + IHR++ A NIL+ E+
Sbjct: 147 DVARGMDYLSQ---KQFIHRNLAARNILVGEN 175

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 303
           F    +L  G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 360
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 89  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 142
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 143 RDLRAANILVSD 154

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  GK VAV+ + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  GK VAV+ + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 9/144 (6%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAV 302
           + + + N  ++G G +G V K R  D G++VA+K+  E        +    E+K++    
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H NL+ L   C       LV+ ++ +    + L + +     LD+   +K       G+ 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 363 YLHEHCDPKIIHRDVKAANILLDE 386
           + H H    IIHRD+K  NIL+ +
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQ 159

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I  +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRX--------KEKEARAKFRQIVSAVQYCHQKF 133
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADXN 151

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 313 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 363
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 86  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 364 LHEHCDPKIIHRDVKAANILLDEDA 388
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 141 IHRN---KILHRDMKAANVLITRDG 162

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 313 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 363
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 85  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 364 LHEHCDPKIIHRDVKAANILLDEDA 388
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 140 IHRN---KILHRDMKAANVLITRDG 161

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 239 LRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKI 297
           L+E  +  +      ++G+G FG+VY GR      VA++ +  ER +  +L+ F+ EV  
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
                H N++   G C +     ++       ++ S +R+ +     LD    ++IA   
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEI 139
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLD 385
            +G+ YLH      I+H+D+K+ N+  D
Sbjct: 140 VKGMGYLHA---KGILHKDLKSKNVFYD 164

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 313 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 363
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 86  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 364 LHEHCDPKIIHRDVKAANILLDEDA 388
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 141 IHRN---KILHRDMKAANVLITRDG 162

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTE 294
           E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++F  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 295 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 348
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 349 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              ++A   A G++YL+     K +HR++ A N ++  D
Sbjct: 131 EMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHD 166

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 255 LGRGGFGKVYKGRLAD--GKLVAVKRLKEER-TSGGELQFQTEVKII---SMAVHRNLLR 308
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 309 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGL 361
           L+  CT       T+  LV+ +     V   L      +P    PT   K +     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 362 SYLHEHCDPKIIHRDVKAANILL 384
            +LH H   +++HRD+K  NIL+
Sbjct: 134 DFLHSH---RVVHRDLKPQNILV 153

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTE 294
           E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++F  E
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 71
Query: 295 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 348
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 72  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 131
Query: 349 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              ++A   A G++YL+     K +HR++ A N ++  D
Sbjct: 132 EMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHD 167

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVH 303
           +   + LG G F  VYK R  +  ++VA+K++K     E   G       E+K++    H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            N++ L       +   LV+ +M    +   +++    L P      K   L + +GL Y
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP---SHIKAYMLMTLQGLEY 127
Query: 364 LHEHCDPKIIHRDVKAANILLDEDA 388
           LH+H    I+HRD+K  N+LLDE+ 
Sbjct: 128 LHQHW---ILHRDLKPNNLLLDENG 149

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 69
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 70  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 124
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 125 VHRDLRAANILVGEN 139

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 71
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 72  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 126
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 127 VHRDLRAANILVGEN 141

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 247
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 248 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 302
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 303 VHRDLRAANILVGEN 317

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKIRHEKLVQLYA--- 80
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVCEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 329
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 385 VHRDLRAANILVGEN 399

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 73
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 74  VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 128
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 129 VHRDLRAANILVGEN 143

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 70
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 71  VVSEEPIXIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 125
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 126 VHRDLRAANILVGEN 140

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 309
           + LG G FGKV  G+    G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           Y   +T ++  +V  Y++ G +   + +       LD    +++      G+ Y H H  
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCHRHM- 136
Query: 370 PKIIHRDVKAANILLD 385
             ++HRD+K  N+LLD
Sbjct: 137 --VVHRDLKPENVLLD 150

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 255 LGRGGFGKVYKGRLAD--GKLVAVKRLK-EERTSGGELQFQTEVKII---SMAVHRNLLR 308
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 309 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGL 361
           L+  CT       T+  LV+ +     V   L      +P    PT   K +     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 362 SYLHEHCDPKIIHRDVKAANILL 384
            +LH H   +++HRD+K  NIL+
Sbjct: 134 DFLHSH---RVVHRDLKPQNILV 153

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 255 LGRGGFGKVYKGRLAD--GKLVAVKRLKEER-TSGGELQFQTEVKII---SMAVHRNLLR 308
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 309 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGL 361
           L+  CT       T+  LV+ +     V   L      +P    PT   K +     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 362 SYLHEHCDPKIIHRDVKAANILL 384
            +LH H   +++HRD+K  NIL+
Sbjct: 134 DFLHSH---RVVHRDLKPQNILV 153

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 185

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTEN 180

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 356
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 357 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 182

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 75  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 128
Query: 375 RDVKAANILLDE 386
           R+++AANIL+ +
Sbjct: 129 RNLRAANILVSD 140

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 28/171 (16%)
Query: 222 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVK--- 277
           P+E  +++     K   LR+L+V          LG G FG V+KG  + +G+ + +    
Sbjct: 16  PSEKANKVLARIFKETELRKLKV----------LGSGVFGTVHKGVWIPEGESIKIPVCI 65
Query: 278 RLKEERTSGGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 336
           ++ E+++     Q  T+  + I    H +++RL G C   + + LV  Y+  GS+   +R
Sbjct: 66  KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVR 124
Query: 337 ERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           + + +L P   L+W       +  A+G+ YL EH    ++HR++ A N+LL
Sbjct: 125 QHRGALGPQLLLNW------GVQIAKGMYYLEEH---GMVHRNLAARNVLL 166

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  G+ VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKY 134
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 135 IVHRDLKAENLLLDGDMN 152

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 62
Query: 313 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 117
Query: 366 EHC-----DPKIIHRDVKAANILLDEDA 388
                    P I HRD+K+ NIL+ ++ 
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNG 145

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKII 298
           +AT  +     +G G +G VYK R    G  VA+K ++    EE      ++    ++ +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 299 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALG 356
               H N++RL   C T      +   +    V   LR      PP   P  T K +   
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILL 384
             RGL +LH +C   I+HRD+K  NIL+
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVGEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 63
Query: 313 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 118
Query: 366 EHC-----DPKIIHRDVKAANILLDEDA 388
                    P I HRD+K+ NIL+ ++ 
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNG 146

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKII 298
           +AT  +     +G G +G VYK R    G  VA+K ++    EE      ++    ++ +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 299 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALG 356
               H N++RL   C T      +   +    V   LR      PP   P  T K +   
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILL 384
             RGL +LH +C   I+HRD+K  NIL+
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-----SLPPLDWPTRK-------KI 353
           ++ L G CT      ++  Y + G++   L+ R+      S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 17/144 (11%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 313 CTTVTEKL--------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           C T             LV+ +  +  +A  L    + L        K++      GL Y+
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H +   KI+HRD+KAAN+L+  D 
Sbjct: 142 HRN---KILHRDMKAANVLITRDG 162

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
              +  ++  +   G+V + + E    L     P  + +       L++LH     +IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 375 RDVKAANILLDEDAD 389
           RD+KA N+L+  + D
Sbjct: 133 RDLKAGNVLMTLEGD 147

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 373 IHRDVKAANILLDED 387
           +HRD+ AANIL+ E+
Sbjct: 136 VHRDLAAANILVGEN 150

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 88
Query: 313 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 143
Query: 366 -----EHCDPKIIHRDVKAANILLDEDA 388
                    P I HRD+K+ NIL+ ++ 
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNG 171

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 65/139 (46%), Gaps = 12/139 (8%)
Query: 254 ILGRGGFGKVYK-GRLADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           +LG+G FG+  K      G+++ +K L   +E T   +  F  EVK++    H N+L+  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET---QRTFLKEVKVMRCLEHPNVLKFI 73
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G          +  Y+  G++   ++   S  P   W  R   A   A G++YLH     
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP---WSQRVSFAKDIASGMAYLHSM--- 127
Query: 371 KIIHRDVKAANILLDEDAD 389
            IIHRD+ + N L+ E+ +
Sbjct: 128 NIIHRDLNSHNCLVRENKN 146

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 65
Query: 313 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 120
Query: 366 -----EHCDPKIIHRDVKAANILLDEDA 388
                    P I HRD+K+ NIL+ ++ 
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNG 148

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-----SLPPLDWPTRK-------KI 353
           ++ L G CT      ++  Y + G++   L+ R+      S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKII 298
           +AT  +     +G G +G VYK R    G  VA+K ++    EE      ++    ++ +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 299 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALG 356
               H N++RL   C T      +   +    V   LR      PP   P  T K +   
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILL 384
             RGL +LH +C   I+HRD+K  NIL+
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 101
Query: 313 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 156
Query: 366 EHC-----DPKIIHRDVKAANILLDEDA 388
                    P I HRD+K+ NIL+ ++ 
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNG 184

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 353
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 227

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 74/140 (52%), Gaps = 18/140 (12%)
Query: 253 NILGRGGFGKVYKG-RLADGKLVAVK---RLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
            +LG G FG V+KG  + +G+ + +    ++ E+++     Q  T+  + I    H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 364
           RL G C   + + LV  Y+  GS+   +R+ + +L P   L+W       +  A+G+ YL
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 131
Query: 365 HEHCDPKIIHRDVKAANILL 384
            EH    ++HR++ A N+LL
Sbjct: 132 EEH---GMVHRNLAARNVLL 148

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
              +  ++  +   G+V + + E    L     P  + +       L++LH     +IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 375 RDVKAANILLDEDAD 389
           RD+KA N+L+  + D
Sbjct: 141 RDLKAGNVLMTLEGD 155

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 68
Query: 313 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 123
Query: 366 EHC-----DPKIIHRDVKAANILLDEDA 388
                    P I HRD+K+ NIL+ ++ 
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNG 151

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+ G       VA+K LK    S     F  E +I+    H  L++LY    
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE--SFLEEAQIMKKLKHDKLVQLYA--- 71
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM  GS+   L++ +     L  P    +A   A G++Y+        
Sbjct: 72  VVSEEPIYIVTEYMNKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERM---NY 126
Query: 373 IHRDVKAANILL 384
           IHRD+++ANIL+
Sbjct: 127 IHRDLRSANILV 138

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 22/151 (14%)
Query: 252 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           K  LG G FGKV+           D  LVAVK LK+  T      FQ E ++++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLPPLDWPTRK-----------KI 353
           +++ YG C      ++V+ YM +G +   LR     ++  +D   R+            I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           A   A G+ YL        +HRD+   N L+
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLV 166

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 353
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 175

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ G +   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVMEYMSKGCLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 353
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 179

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 353
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 353
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 178

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  G+ VA+K + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     L+  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYCHQKR 134
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 135 IVHRDLKAENLLLDADMN 152

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM+ G +   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGCLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 29/175 (16%)
Query: 231 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERT 284
           + Q K+  L+E+ ++   F  +  LG   FGKVYKG L   A G   + VA+K LK++  
Sbjct: 12  INQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 285 SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--------- 335
                +F+ E  + +   H N++ L G  T      +++ Y ++G +   L         
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 336 ------RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
                 R  +S+L P   P    +    A G+ YL  H    ++H+D+   N+L+
Sbjct: 130 GSTDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  G+ VA+K + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 371
             T     L+  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYCHQKR 131
Query: 372 IIHRDVKAANILLDEDAD 389
           I+HRD+KA N+LLD D +
Sbjct: 132 IVHRDLKAENLLLDADMN 149

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 9/143 (6%)
Query: 250 SNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           S   ILG G FG+V+K    A G  +A K +K       E + + E+ +++   H NL++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQ 150
Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LY    +  + +LV  Y+  G +  R+ +   +L  LD     K       G+ ++H+  
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMHQMY 207
Query: 369 DPKIIHRDVKAANIL-LDEDADQ 390
              I+H D+K  NIL ++ DA Q
Sbjct: 208 ---ILHLDLKPENILCVNRDAKQ 227

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 77
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM  GS+   L+        L  P    ++   A G++Y+        
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETGKY--LRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 133 VHRDLRAANILVGEN 147

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 77
Query: 315 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
            V+E+   +V  YM  GS+   L+        L  P    ++   A G++Y+        
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETGKY--LRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 373 IHRDVKAANILLDED 387
           +HRD++AANIL+ E+
Sbjct: 133 VHRDLRAANILVGEN 147

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 8/132 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G  G+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  YM NGS+   L+    S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 375 RDVKAANILLDE 386
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 24/154 (15%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ---------SSLPPLDWPTRKKI--- 353
           ++ L G CT      ++  Y + G++   L+ R+          S  P +  + K +   
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 171

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEG 143

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 254 ILGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 306
           +LG G FGKV         +      VAVK LKE+  S       +E+K+++ +  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--PLDWPTRKKI----------- 353
           + L G CT      L++ Y   G + + LR ++       +++  +K++           
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 354 ------ALGSARGLSYLH-EHCDPKIIHRDVKAANILL 384
                 A   A+G+ +L  + C    +HRD+ A N+L+
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLV 205

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 68/143 (47%), Gaps = 16/143 (11%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLP-----PLDWPTRKKIALGSARGL 361
            L G CT     L++  Y   G + + LR + ++ L      PL+       +   A+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 362 SYLHEHCDPKIIHRDVKAANILL 384
           ++L        IHRDV A N+LL
Sbjct: 166 AFL---ASKNCIHRDVAARNVLL 185

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G +G VYK + + G++VA+KR++ +    G       E+ ++    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 372
            +     LV+ +M    +   L E ++ L      ++ KI L    RG+++ H+H   +I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 373 IHRDVKAANILLDEDA 388
           +HRD+K  N+L++ D 
Sbjct: 141 LHRDLKPQNLLINSDG 156

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G +G VYK + + G++VA+KR++ +    G       E+ ++    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 372
            +     LV+ +M    +   L E ++ L      ++ KI L    RG+++ H+H   +I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 373 IHRDVKAANILLDEDA 388
           +HRD+K  N+L++ D 
Sbjct: 141 LHRDLKPQNLLINSDG 156

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEG 141

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 28/156 (17%)
Query: 255 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 305
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW---PTRK----------- 351
           ++ L G CT      ++  Y + G++   L+ R+   P L++   P+             
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYCYNPSHNPEEQLSSKDLV 153
Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 60/138 (43%), Gaps = 10/138 (7%)
Query: 247 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTS--GGELQFQTEVKIISMAVH 303
           D F     LG+G FG VY  R      +VA+K L + +    G E Q + E++I +   H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            N+LRLY +        L+  Y   G +   L++  +     D      I    A  L Y
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT----FDEQRTATIMEELADALMY 138
Query: 364 LHEHCDPKIIHRDVKAAN 381
            H     K+IHRD+K  N
Sbjct: 139 CH---GKKVIHRDIKPEN 153

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 255 LGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            G CT        L+  ++ +GS+   L + ++    ++   + K A+   +G+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145
Query: 368 CDPKIIHRDVKAANILLDED 387
              + +HRD+ A N+L++ +
Sbjct: 146 ---QYVHRDLAARNVLVESE 162

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 239 LRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKI 297
           L E     D   ++ +LG+G +G VY GR L++   +A+K +  ER S        E+ +
Sbjct: 14  LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIAL 72
Query: 298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN---GSVASRLRERQSSLP----PLDWPTR 350
                H+N+++  G   + +E   +  +M     GS+++ LR +   L      + + T+
Sbjct: 73  HKHLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
           + +      GL YLH   D +I+HRD+K  N+L++
Sbjct: 130 QIL-----EGLKYLH---DNQIVHRDIKGDNVLIN 156

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 19/142 (13%)
Query: 255 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 307
           LG G FGKV            G++VAVK LKE    G +L+  +Q E++I+    H +++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 308 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           +  G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH 128
Query: 366 EHCDPKIIHRDVKAANILLDED 387
                  IHR + A N+LLD D
Sbjct: 129 AQ---HYIHRALAARNVLLDND 147

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 68/143 (47%), Gaps = 16/143 (11%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLP-----PLDWPTRKKIALGSARGL 361
            L G CT     L++  Y   G + + LR + ++ L      PL+       +   A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 362 SYLHEHCDPKIIHRDVKAANILL 384
           ++L        IHRDV A N+LL
Sbjct: 174 AFL---ASKNCIHRDVAARNVLL 193

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 255 LGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+++ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            G CT        L+  ++ +GS+   L + ++    ++   + K A+   +G+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 133
Query: 368 CDPKIIHRDVKAANILLDED 387
              + +HRD+ A N+L++ +
Sbjct: 134 ---QYVHRDLAARNVLVESE 150

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 19/142 (13%)
Query: 255 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 307
           LG G FGKV            G++VAVK LKE    G +L+  +Q E++I+    H +++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 308 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           +  G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH 129
Query: 366 EHCDPKIIHRDVKAANILLDED 387
                  IHR + A N+LLD D
Sbjct: 130 AQ---HYIHRALAARNVLLDND 148

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 251 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ----FQTEVKIISMAVHRNL 306
           +  ++G+G FG VY G   D     ++   +  +   E+Q    F  E  ++    H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 307 LRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGL 361
           L L G      E L  ++ PYM +G +   +R  Q +      PT K +    L  ARG+
Sbjct: 85  LALIGIMLP-PEGLPHVLLPYMCHGDLLQFIRSPQRN------PTVKDLISFGLQVARGM 137
Query: 362 SYLHEHCDPKIIHRDVKAANILLDE 386
            YL E    K +HRD+ A N +LDE
Sbjct: 138 EYLAEQ---KFVHRDLAARNCMLDE 159

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 66/151 (43%), Gaps = 13/151 (8%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQT--EVKII 298
           +AT  +     +G G +G VYK R    G  VA+K  R+      GG L   T  EV ++
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 299 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 353
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILV 153

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEG 142

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----------SSLPPLDWPTRKKIALGS 357
            L G CT     L++  Y   G + + LR ++          S  P     +R  +   S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 358 --ARGLSYLHEHCDPKIIHRDVKAANILL 384
             A+G+++L        IHRDV A N+LL
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLL 199

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 313
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 374 HRDVKAANILLDEDAD 389
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 313
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 374 HRDVKAANILLDEDAD 389
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 255 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHSQ 136
Query: 368 CDPKIIHRDVKAANILLDED 387
                IHR++ A N+LLD D
Sbjct: 137 ---HYIHRNLAARNVLLDND 153

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 313
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 374 HRDVKAANILLDEDAD 389
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 20/153 (13%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 299
           E     D   ++ +LG+G +G VY GR L++   +A+K +  ER S        E+ +  
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIALHK 60
Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTN---GSVASRLRERQSSLP----PLDWPTRKK 352
              H+N+++  G   + +E   +  +M     GS+++ LR +   L      + + T++ 
Sbjct: 61  HLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 117
Query: 353 IALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
           +      GL YLH   D +I+HRD+K  N+L++
Sbjct: 118 L-----EGLKYLH---DNQIVHRDIKGDNVLIN 142

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE---RTSGGELQFQTEVKII 298
           ++  D F    +LG+G FGKV   R+ + G L AVK LK++   +    E    TE +I+
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT-MTEKRIL 77
Query: 299 SMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           S+A +   L     C    ++L  V  ++  G +   +++ +      D    +  A   
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEI 133
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
              L +LH   D  II+RD+K  N+LLD + 
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDHEG 161

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 67/147 (45%), Gaps = 20/147 (13%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPL-----DWPTRKKIALGS-- 357
            L G CT     L++  Y   G + + LR +   L   P          TR  +   S  
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILL 384
           A+G+++L        IHRDV A N+LL
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLL 197

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 239 LRELQVATDGFSNKNILGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ-FQT 293
           L ++ +    F+   +LG+G FG V + +L   DG  V  AVK LK +  +  +++ F  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEK------LLVYPYMTNGSV-----ASRLRERQSSL 342
           E   +    H ++ +L G       K      +++ P+M +G +     ASR+ E   +L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 343 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           P     T  +  +  A G+ YL        IHRD+ A N +L ED
Sbjct: 135 P---LQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 255 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 136
Query: 368 CDPKIIHRDVKAANILLDED 387
                IHR++ A N+LLD D
Sbjct: 137 ---HYIHRNLAARNVLLDND 153

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GLS+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 255 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           LG G +  VYKG+  L D  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
             T     LV+ Y+ +  +   L +  +    ++    K       RGL+Y H     K+
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNI---INMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 373 IHRDVKAANILLDE 386
           +HRD+K  N+L++E
Sbjct: 122 LHRDLKPQNLLINE 135

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 255 LGRGGFGKVYKG---RLAD-GKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
           LG+G F K++KG    + D G+L    V +K L +   +  E  F+    ++S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           +  YG C    E +LV  ++  GS+ + L++ ++ +  L W  + ++A   A  + +L E
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAAAMHFLEE 131
Query: 367 HCDPKIIHRDVKAANILLDEDADQSS 392
           +    +IH +V A NILL  + D+ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKT 154

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD---------WPTRKKIALGS- 357
            L G CT     L++  Y   G + + LR R+S +   D           TR  +   S 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 358 -ARGLSYLHEHCDPKIIHRDVKAANILL 384
            A+G+++L        IHRDV A N+LL
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLL 197

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 34/174 (19%)
Query: 232 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERTS 285
           G+LK  SL  ++   +       LG   FGKVYKG L   A G   + VA+K LK++   
Sbjct: 1   GKLKEISLSAVRFMEE-------LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG 53
Query: 286 GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL---------- 335
               +F+ E  + +   H N++ L G  T      +++ Y ++G +   L          
Sbjct: 54  PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 113
Query: 336 -----RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
                R  +S+L P   P    +    A G+ YL  H    ++H+D+   N+L+
Sbjct: 114 STDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 161

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 81  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 134
Query: 375 RDVKAANILL 384
           RD++AANIL+
Sbjct: 135 RDLRAANILV 144

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMA 301
           V  + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++   
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDA 388
           ++ H H   +++HRD+K  N+L++ + 
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEG 144

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 71/146 (48%), Gaps = 25/146 (17%)
Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISM--AVHRNLLRL 309
            +  RG FG V+K +L + + VAVK    +++ S     +Q E ++ S+    H N+L+ 
Sbjct: 30  EVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-----WQNEYEVYSLPGMKHENILQF 83
Query: 310 YGF---CTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
            G     T+V   L L+  +   GS++  L+    S     W     IA   ARGL+YLH
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS-----WNELCHIAETMARGLAYLH 138
Query: 366 EHC-------DPKIIHRDVKAANILL 384
           E          P I HRD+K+ N+LL
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLL 164

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 248 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 301
Query: 375 RDVKAANILL 384
           RD++AANIL+
Sbjct: 302 RDLRAANILV 311

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 374
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 254 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 375 RDVKAANILL 384
           RD++AANIL+
Sbjct: 308 RDLRAANILV 317

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 360
           H N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKDFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDA 388
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 116 LAFCHSH---RVLHRDLKPENLLINTEG 140

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 244 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 297
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 79
Query: 298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 355
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 133
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 396
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 244 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 297
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 85
Query: 298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 355
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 139
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 396
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 140 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 177

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 299
           +A +      ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+ 
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 300 MAVHRNLLRLYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
              H ++++L G        +++  YPY   G +   L   ++SL  L   T    +L  
Sbjct: 65  NLDHPHIVKLIGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQI 118
Query: 358 ARGLSYLHE-HCDPKIIHRDVKAANILL 384
            + ++YL   +C    +HRD+   NIL+
Sbjct: 119 CKAMAYLESINC----VHRDIAVRNILV 142

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEG 142

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEG 142

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEG 141

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEG 141

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEG 141

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEG 144

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 59/140 (42%), Gaps = 15/140 (10%)
Query: 255 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 310 YGFC--TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            G C         LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 153
Query: 368 CDPKIIHRDVKAANILLDED 387
                IHRD+ A N+LLD D
Sbjct: 154 ---HYIHRDLAARNVLLDND 170

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEG 142

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 299
           +A +      ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+ 
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 300 MAVHRNLLRLYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
              H ++++L G        +++  YPY   G +   L   ++SL  L   T    +L  
Sbjct: 81  NLDHPHIVKLIGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQI 134
Query: 358 ARGLSYLHE-HCDPKIIHRDVKAANILL 384
            + ++YL   +C    +HRD+   NIL+
Sbjct: 135 CKAMAYLESINC----VHRDIAVRNILV 158

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 29/162 (17%)
Query: 242 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 298
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLL 56
Query: 299 SMAVHRNLLRLYGF----------CTTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 344
           +   H+ ++R Y             T V +K  ++    Y  NG++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             W   ++I       LSY+H      IIHRD+K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDE 151

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 255 LGRGGFGKVYKG---RLAD-GKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
           LG+G F K++KG    + D G+L    V +K L +   +  E  F+    ++S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           +  YG C    E +LV  ++  GS+ + L++ ++ +  L W  + ++A   A  + +L E
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAWAMHFLEE 131
Query: 367 HCDPKIIHRDVKAANILLDEDADQSS 392
           +    +IH +V A NILL  + D+ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKT 154

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           + +L  GGF  VY+ + +  G+  A+KRL            Q    +  ++ H N+++  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ-- 90
Query: 311 GFCTTVT----------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
            FC+  +           + L+   +  G +   L++ +S   PL   T  KI   + R 
Sbjct: 91  -FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRA 148
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           + ++H    P IIHRD+K  N+LL
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLL 171

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEG 147

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 244 VATDGFSNKNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 299
           +A +      ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+ 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 300 MAVHRNLLRLYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
              H ++++L G        +++  YPY   G +   L   ++SL  L   T    +L  
Sbjct: 69  NLDHPHIVKLIGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQI 122
Query: 358 ARGLSYLHE-HCDPKIIHRDVKAANILL 384
            + ++YL   +C    +HRD+   NIL+
Sbjct: 123 CKAMAYLESINC----VHRDIAVRNILV 146

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT--EVKI 297
           ++++  + F    +LG+G FGKV+        +  A+K LK++     +    T  E ++
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 298 ISMAVHRNLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 355
           +S+A     L  + FCT  T++    V  Y+  G +   ++    S    D       A 
Sbjct: 72  LSLAWEHPFLT-HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAA 126
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
               GL +LH      I++RD+K  NILLD+D 
Sbjct: 127 EIILGLQFLHS---KGIVYRDLKLDNILLDKDG 156

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEG 141

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 135
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 136 ---GTKRYIHRDLATRNILVENE 155

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 129
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 130 ---GTKRYIHRDLATRNILVENE 149

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEG 147

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 136
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 137 ---GTKRYIHRDLATRNILVENE 156

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 161
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 162 ---GTKRYIHRDLATRNILVENE 181

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 243 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 301
           Q   +   N   +G G  G+V+K R    G ++AVK++   R SG + + +  +  + + 
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM---RRSGNKEENKRILMDLDVV 77
Query: 302 VHRN----LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           +  +    +++ +G   T T+  +    M  G+ A +L++R     P+      K+ +  
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQG--PIPERILGKMTVAI 133
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDE 386
            + L YL E     +IHRDVK +NILLDE
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDE 160

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 149 ---GTKRYIHRDLATRNILVENE 168

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 244 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 297
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 46  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 102
Query: 298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 355
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 156
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 396
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 157 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 194

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 128
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 129 ---GTKRYIHRDLATRNILVENE 148

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 23/146 (15%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           +G+G +G+V+ G+   G+ VAVK      T       +TE+    +  H N+L   GF  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFT--TEEASWFRETEIYQTVLMRHENIL---GFIA 98
Query: 315 -------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
                  + T+  L+  Y  NGS+   L+        LD  +  K+A  S  GL +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 368 C-----DPKIIHRDVKAANILLDEDA 388
                  P I HRD+K+ NIL+ ++ 
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNG 179

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 149 ---GTKRYIHRDLATRNILVENE 168

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 244 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 297
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 47  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 103
Query: 298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 355
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 157
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 396
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 158 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 195

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 137
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 138 ---GTKRYIHRDLATRNILVENE 157

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 21/147 (14%)
Query: 248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 306
            ++N  ++G G FG V++ +L +   VA+K+ L+++R    ELQ    VK      H N+
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HPNV 94
Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           + L  F  +  +K        +L Y   T    +    + + ++P L     K       
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML---LIKLYMYQLL 151
Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLD 385
           R L+Y+H      I HRD+K  N+LLD
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLD 175

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 134
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 135 ---GTKRYIHRDLATRNILVENE 154

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I +M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 20/140 (14%)
Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 97
Query: 314 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 146
Query: 369 DPKIIHRDVKAANILLDEDA 388
              +IHRD+K+ +ILL  D 
Sbjct: 147 --GVIHRDIKSDSILLTHDG 164

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 302
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 360
           H N+++L     T  +  LV+ +     V   L++    S+L  +  P  K       +G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEH-----VDQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDA 388
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 20/140 (14%)
Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86
Query: 314 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 135
Query: 369 DPKIIHRDVKAANILLDEDA 388
              +IHRD+K+ +ILL  D 
Sbjct: 136 --GVIHRDIKSDSILLTHDG 153

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 20/140 (14%)
Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 95
Query: 314 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 144
Query: 369 DPKIIHRDVKAANILLDEDA 388
              +IHRD+K+ +ILL  D 
Sbjct: 145 --GVIHRDIKSDSILLTHDG 162

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L+   ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 20/140 (14%)
Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 90
Query: 314 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 139
Query: 369 DPKIIHRDVKAANILLDEDA 388
              +IHRD+K+ +ILL  D 
Sbjct: 140 --GVIHRDIKSDSILLTHDG 157

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 19/143 (13%)
Query: 252 KNILGRGGFGKV-----YKGRLADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAVHR 304
           +  LG G FGKV     YK +    + VA+K +  +  + S   ++ + E+  + +  H 
Sbjct: 14  RETLGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           ++++LY   TT T+ ++V  Y   G +   + E++     +     ++        + Y 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYC 124
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H H   KI+HRD+K  N+LLD++
Sbjct: 125 HRH---KIVHRDLKPENLLLDDN 144

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 20/140 (14%)
Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 217
Query: 314 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 267
Query: 369 DPKIIHRDVKAANILLDEDA 388
              +IHRD+K+ +ILL  D 
Sbjct: 268 ---VIHRDIKSDSILLTHDG 284

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT--EVKI 297
           ++++  + F    +LG+G FGKV+        +  A+K LK++     +    T  E ++
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 298 ISMAVHRNLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 355
           +S+A     L  + FCT  T++    V  Y+  G +   ++    S    D       A 
Sbjct: 71  LSLAWEHPFLT-HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAA 125
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
               GL +LH      I++RD+K  NILLD+D 
Sbjct: 126 EIILGLQFLHS---KGIVYRDLKLDNILLDKDG 155

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 29/156 (18%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------------------PPLDWP 348
            L G CT     L++  Y   G + + LR +  ++                    PL+  
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 349 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
                +   A+G+++L        IHRDV A N+LL
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 191

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 140
Query: 314 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 190
Query: 369 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 398
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 191 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 224 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 282
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 166 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 224
Query: 283 R--TSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 337
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L  
Sbjct: 225 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-- 282
Query: 338 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 283 --SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 326

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 224 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 282
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 283 R--TSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 337
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L  
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-- 283
Query: 338 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 224 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 282
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 283 R--TSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 337
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L  
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-- 283
Query: 338 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 224 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 282
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 283 R--TSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 337
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L  
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-- 283
Query: 338 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 239 LRELQVATDGFSNKN-------ILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQ 290
           + EL+    G SN          +GRG F  VYKG   +  + VA   L++ + +  E Q
Sbjct: 11  IEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ 70
Query: 291 -FQTEVKIISMAVHRNLLRLY-GFCTTVTEK---LLVYPYMTNGSVASRL-RERQSSLPP 344
            F+ E + +    H N++R Y  + +TV  K   +LV    T+G++ + L R +   +  
Sbjct: 71  RFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV 130
Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           L    R+ +     +GL +LH    P IIHRD+K  NI +
Sbjct: 131 LRSWCRQIL-----KGLQFLHTRT-PPIIHRDLKCDNIFI 164

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 13  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 122
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 123 GITHRDIKPENLLLDE 138

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 17/140 (12%)
Query: 249 FSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
           F    +LG G F +V+  K RL  GKL A+K +K+   +  +   + E+ ++    H N+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHENI 68
Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS---Y 363
           + L     + T   LV   ++ G +  R+ ER          T K  +L   + LS   Y
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY-------TEKDASLVIQQVLSAVKY 121
Query: 364 LHEHCDPKIIHRDVKAANIL 383
           LHE+    I+HRD+K  N+L
Sbjct: 122 LHEN---GIVHRDLKPENLL 138

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 231 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 286
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 287 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD 346
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+ E+        
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--- 115
Query: 347 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 388
                ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 116 -RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 231 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 286
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 287 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD 346
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+ E+        
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--- 115
Query: 347 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 388
                ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 116 -RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 255 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 311
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 127
Query: 372 IIHRDVKAANILLDE 386
           I+HRD+K  N+LLDE
Sbjct: 128 IVHRDLKPENLLLDE 142

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 255 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 311
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 133
Query: 372 IIHRDVKAANILLDE 386
           I+HRD+K  N+LLDE
Sbjct: 134 IVHRDLKPENLLLDE 148

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 255 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 311
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 132
Query: 372 IIHRDVKAANILLDE 386
           I+HRD+K  N+LLDE
Sbjct: 133 IVHRDLKPENLLLDE 147

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 231 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 286
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 287 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD 346
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+ E+        
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--- 115
Query: 347 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 388
                ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 116 -RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 255 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 311
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 123
Query: 372 IIHRDVKAANILLDE 386
           I+HRD+K  N+LLDE
Sbjct: 124 IVHRDLKPENLLLDE 138

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  ++  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 246 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 302
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 303 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           L Y+H      ++H D+K +NI +
Sbjct: 126 LRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 67/151 (44%), Gaps = 28/151 (18%)
Query: 253 NILGRGGFGKVYKGRLADGKLVAVK--RLKEERTSGGELQFQTEVKIISM--AVHRNLLR 308
            I  RG FG V+K +L +   VAVK   L+++++      +Q+E +I S     H NLL+
Sbjct: 21  EIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQS------WQSEREIFSTPGMKHENLLQ 73
Query: 309 LYGF----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
                        E  L+  +   GS+   L+        + W     +A   +RGLSYL
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGN-----IITWNELCHVAETMSRGLSYL 128
Query: 365 HEHC--------DPKIIHRDVKAANILLDED 387
           HE           P I HRD K+ N+LL  D
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSD 159

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           +  K  LG GGFG V +    D G+ VA+K+ ++E +     ++  E++I+    H N++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 308 RLYGFCTTVTE------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
                   + +       LL   Y   G +   L + ++     + P R  ++  S+  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-AL 135
Query: 362 SYLHEHCDPKIIHRDVKAANILL 384
            YLHE+   +IIHRD+K  NI+L
Sbjct: 136 RYLHEN---RIIHRDLKPENIVL 155

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           +  K  LG GGFG V +    D G+ VA+K+ ++E +     ++  E++I+    H N++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 308 RLYGFCTTVTE------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
                   + +       LL   Y   G +   L + ++     + P R  ++  S+  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-AL 134
Query: 362 SYLHEHCDPKIIHRDVKAANILL 384
            YLHE+   +IIHRD+K  NI+L
Sbjct: 135 RYLHEN---RIIHRDLKPENIVL 154

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 246 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 302
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 303 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           L Y+H      ++H D+K +NI +
Sbjct: 126 LRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 246 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 302
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 63
Query: 303 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           L Y+H      ++H D+K +NI +
Sbjct: 124 LRYIHSMS---LVHMDIKPSNIFI 144

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 19/123 (15%)
Query: 271 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 330
           GK VAVK++   +    EL F  EV I+    H N++ +Y       E  +V  ++  G+
Sbjct: 70  GKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGA 128
Query: 331 VA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
           +      +R+ E Q +           + L   R LSYLH   +  +IHRD+K+ +ILL 
Sbjct: 129 LTDIVTHTRMNEEQIA----------TVCLSVLRALSYLH---NQGVIHRDIKSDSILLT 175
Query: 386 EDA 388
            D 
Sbjct: 176 SDG 178

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+ +++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+ +++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 365 HEHCDPKIIHRDVKAANILLDEDA 388
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 131
Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHR++   NIL++ +
Sbjct: 132 ---GTKRYIHRNLATRNILVENE 151

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 246 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 302
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 67
Query: 303 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 361 LSYLHEHCDPKIIHRDVKAANILL 384
           L Y+H      ++H D+K +NI +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFI 148

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 66/146 (45%), Gaps = 23/146 (15%)
Query: 255 LGRGGFGKV--YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           LG GGF  V   +G L DG   A+KR+        E + Q E  +  +  H N+LRL  +
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAY 94
Query: 313 CT----TVTEKLLVYPYMTNGSV---ASRLRERQSSLPPLDWPTRKKIA---LGSARGLS 362
           C        E  L+ P+   G++     RL+++ + L      T  +I    LG  RGL 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL------TEDQILWLLLGICRGLE 148
Query: 363 YLHEHCDPKIIHRDVKAANILLDEDA 388
            +H        HRD+K  NILL ++ 
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEG 171

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 309
           + LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 310 YGFCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
           Y   +T T+  +V  Y++ G +        R+ E ++          +++       + Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----------RRLFQQILSAVDY 126
Query: 364 LHEHCDPKIIHRDVKAANILLD 385
            H H    ++HRD+K  N+LLD
Sbjct: 127 CHRHM---VVHRDLKPENVLLD 145

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 253 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 309
           + LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 310 YGFCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
           Y   +T T+  +V  Y++ G +        R+ E ++          +++       + Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----------RRLFQQILSAVDY 126
Query: 364 LHEHCDPKIIHRDVKAANILLD 385
            H H    ++HRD+K  N+LLD
Sbjct: 127 CHRHM---VVHRDLKPENVLLD 145

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 67
Query: 313 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 366 -----EHCDPKIIHRDVKAANILLDEDA 388
                    P I HRD+K+ NIL+ ++ 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNG 150

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 67
Query: 313 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 366 -----EHCDPKIIHRDVKAANILLDEDA 388
                    P I HRD+K+ NIL+ ++ 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNG 150

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 20/150 (13%)
Query: 244 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 297
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 79
Query: 298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 355
           +    H N+ +LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 133
Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLD 385
               G++Y H++   KI+HRD+K  N+LL+
Sbjct: 134 QVLSGITYXHKN---KIVHRDLKPENLLLE 160

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 96
Query: 313 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 151
Query: 366 -----EHCDPKIIHRDVKAANILLDEDA 388
                    P I HRD+K+ NIL+ ++ 
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNG 179

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQT-EVKIISMAVH 303
           + F    ILG G F  V   R LA  +  A+K L K       ++ + T E  ++S   H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 304 RNLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
              ++LY FC    EKL     Y  NG +   +R+  S     D    +         L 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALE 151
Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YLH      IIHRD+K  NILL+ED
Sbjct: 152 YLH---GKGIIHRDLKPENILLNED 173

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 309
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 125
Query: 370 PKIIHRDVKAANILLDEDA 388
             II+RD+K  N+LLD + 
Sbjct: 126 -GIIYRDLKLDNVLLDSEG 143

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 309
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 129
Query: 370 PKIIHRDVKAANILLDEDA 388
             II+RD+K  N+LLD + 
Sbjct: 130 -GIIYRDLKLDNVLLDSEG 147

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 309
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 140
Query: 370 PKIIHRDVKAANILLDEDA 388
             II+RD+K  N+LLD + 
Sbjct: 141 -GIIYRDLKLDNVLLDSEG 158

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 261 GKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VT 317
           G+++KGR   G  + VK LK  + ++     F  E   + +  H N+L + G C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV 377
              L+  +M  GS+ + L E  + +  +D     K AL  ARG+++LH   +P I    +
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-LEPLIPRHAL 139
Query: 378 KAANILLDED 387
            + ++++DED
Sbjct: 140 NSRSVMIDED 149

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 9/149 (6%)
Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F  K  LG G F +V      A GKL AVK + ++   G E   + E+ ++    H N++
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            L     +     LV   ++ G +  R+ E+       D  T  +  L +   + YLH  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEK-GFYTEKDASTLIRQVLDA---VYYLHRM 139
Query: 368 CDPKIIHRDVKAANILLDEDADQSSKTIL 396
               I+HRD+K  N+L     D+ SK ++
Sbjct: 140 ---GIVHRDLKPENLLY-YSQDEESKIMI 164

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 27/144 (18%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G +G+V++G L  G+ VAVK    ++E++   E    TE+    +  H N+L   GF
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE----TEIYNTVLLRHDNIL---GF 67
Query: 313 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
             +        T+  L+  Y  +GS+   L +RQ+  P L      ++A+ +A GL++LH
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFL-QRQTLEPHL----ALRLAVSAACGLAHLH 122
Query: 366 -----EHCDPKIIHRDVKAANILL 384
                    P I HRD K+ N+L+
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLV 146

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 242 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 298
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLL 56
Query: 299 SMAVHRNLLRLYGF----------CTTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 344
           +   H+ ++R Y             T V +K  ++    Y  N ++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD 116
Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             W   ++I       LSY+H      IIHRD+K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDE 151

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 26/147 (17%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 307
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 70
Query: 308 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 361
             Y    +     E  LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 124
Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDA 388
            YL      + +HRD+ A NIL++ +A
Sbjct: 125 EYLGSR---RCVHRDLAARNILVESEA 148

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 353
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 354 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 384
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 167 SYQVAKGMAFLASKNC----IHRDLAARNILL 194

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 344
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 344
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 353
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           +   A+G+++L        IHRD+ A NILL
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILL 178

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 255 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G  G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 371 KIIHRDVKAANILLDE 386
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 344
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 28  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 344
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 88  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 125

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 353
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           +   A+G+++L        IHRD+ A NILL
Sbjct: 169 SYQVAKGMAFL---ASKNCIHRDLAARNILL 196

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 12/144 (8%)
Query: 246 TDGFSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEER--TSGGELQFQTEVKIISMA 301
           +D +     LG G +G+V   K +L  G   A+K +K+    T+        EV ++   
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N+++LY F        LV      G +   +  RQ     +D     K  L    G 
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLS---GT 117
Query: 362 SYLHEHCDPKIIHRDVKAANILLD 385
           +YLH+H    I+HRD+K  N+LL+
Sbjct: 118 TYLHKH---NIVHRDLKPENLLLE 138

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 353
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 354 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 384
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 174 SYQVAKGMAFLASKNC----IHRDLAARNILL 201

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 255 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 353
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           +   A+G+++L        IHRD+ A NILL
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILL 201

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 12/148 (8%)
Query: 242 LQVATDGFSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEER--TSGGELQFQTEVKI 297
            Q  +D +     LG G +G+V   K +L  G   A+K +K+    T+        EV +
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAV 74
Query: 298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           +    H N+++LY F        LV      G +   +  RQ     +D     K  L  
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLS- 132
Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLD 385
             G +YLH+H    I+HRD+K  N+LL+
Sbjct: 133 --GTTYLHKH---NIVHRDLKPENLLLE 155

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 15/140 (10%)
Query: 255 LGRGGFGK-VYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G G FGK +      DG+   +K +   R S  E +  + EV +++   H N+++    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSL----PPLDWPTRKKIALGSARGLSYLHEHC 368
                   +V  Y   G +  R+  ++  L      LDW  +  +AL         H H 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK--------HVH- 142
Query: 369 DPKIIHRDVKAANILLDEDA 388
           D KI+HRD+K+ NI L +D 
Sbjct: 143 DRKILHRDIKSQNIFLTKDG 162

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 9/132 (6%)
Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGF 312
           +G G +G V+K R  D G++VA+K+  E        +    E++++    H NL+ L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
                   LV+ Y  + +V   L   Q  +P       K I   + + +++ H+H     
Sbjct: 71  FRRKRRLHLVFEY-CDHTVLHELDRYQRGVPE---HLVKSITWQTLQAVNFCHKH---NC 123
Query: 373 IHRDVKAANILL 384
           IHRDVK  NIL+
Sbjct: 124 IHRDVKPENILI 135

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 17/149 (11%)
Query: 247 DGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAV 302
           D +  +++LG G F +V    LA+ K    LVA+K + ++   G E   + E+ ++    
Sbjct: 18  DIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 74
Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N++ L     +     L+   ++ G +  R+ E+             ++       + 
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE----RDASRLIFQVLDAVK 130
Query: 363 YLHEHCDPKIIHRDVKAANIL---LDEDA 388
           YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 10/105 (9%)
Query: 290 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS------RLRERQSSLP 343
            F+ E++II+   +   L   G  T   E  ++Y YM N S+         L +  +   
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 344 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 388
           P+     K I        SY+H   +  I HRDVK +NIL+D++ 
Sbjct: 149 PI--QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNG 189

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 309
           ++GRG + KV   RL    ++ A++ +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 172
Query: 370 PKIIHRDVKAANILLDEDA 388
             II+RD+K  N+LLD + 
Sbjct: 173 -GIIYRDLKLDNVLLDSEG 190

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 15/136 (11%)
Query: 255 LGRGGFGKVYKGRLADGKLVAVKRL-----KEERTSGGELQFQTEVKIISMAVHRNLLRL 309
           LG G +G+V    L   K+  V+R      K   ++    +   EV ++ +  H N+++L
Sbjct: 45  LGSGAYGEVL---LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           Y F        LV      G +   +  R      +D     K  L    G++YLH+H  
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLS---GVTYLHKH-- 155
Query: 370 PKIIHRDVKAANILLD 385
             I+HRD+K  N+LL+
Sbjct: 156 -NIVHRDLKPENLLLE 170

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 255 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 313 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 369
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 370 -PKIIHRDVKAANILLD 385
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 255 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 313 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 369
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 370 -PKIIHRDVKAANILLD 385
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 255 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 312
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 313 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 369
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 370 -PKIIHRDVKAANILLD 385
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 63/151 (41%), Gaps = 4/151 (2%)
Query: 247 DGFSNKNILGRGGFGKVY-KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           D F  K  LG G FG V+     + G    +K + ++R+     Q + E++++    H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           +++++          +V      G +  R+   Q+    L      ++       L+Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 366 EHCDPKIIHRDVKAANILLDEDADQSSKTIL 396
                 ++H+D+K  NIL  + +  S   I+
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKII 169

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 242 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 300
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 361 LSYLHEHCDPKIIHRDVKAANILLD 385
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVN 139

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 242 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 300
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 361 LSYLHEHCDPKIIHRDVKAANILLD 385
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVN 139

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 242 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 300
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 361 LSYLHEHCDPKIIHRDVKAANILLD 385
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVN 139

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 242 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 300
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 361 LSYLHEHCDPKIIHRDVKAANILLD 385
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVN 139

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 242 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 300
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 361 LSYLHEHCDPKIIHRDVKAANILLD 385
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVN 139

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 64/144 (44%), Gaps = 24/144 (16%)
Query: 255 LGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           LGRG FG+V+  R+ D   G   AVK+++ E     EL         +      ++ LYG
Sbjct: 82  LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEELM------ACAGLTSPRIVPLYG 133
Query: 312 FCTTVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSA-RGLSYLHEHC 368
               V E   V  +M    G    +L + Q  LP      R    LG A  GL YLH   
Sbjct: 134 ---AVREGPWVNIFMELLEGGSLGQLVKEQGCLPE----DRALYYLGQALEGLEYLHSR- 185
Query: 369 DPKIIHRDVKAANILLDEDADQSS 392
             +I+H DVKA N+LL  D   ++
Sbjct: 186 --RILHGDVKADNVLLSSDGSHAA 207

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 64/144 (44%), Gaps = 24/144 (16%)
Query: 255 LGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           LGRG FG+V+  R+ D   G   AVK+++ E     EL         +      ++ LYG
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEELM------ACAGLTSPRIVPLYG 152
Query: 312 FCTTVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSA-RGLSYLHEHC 368
               V E   V  +M    G    +L + Q  LP      R    LG A  GL YLH   
Sbjct: 153 ---AVREGPWVNIFMELLEGGSLGQLVKEQGCLPE----DRALYYLGQALEGLEYLHSR- 204
Query: 369 DPKIIHRDVKAANILLDEDADQSS 392
             +I+H DVKA N+LL  D   ++
Sbjct: 205 --RILHGDVKADNVLLSSDGSHAA 226

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 26/147 (17%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 307
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 73
Query: 308 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 361
             Y    +        LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 127
Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDA 388
            YL      + +HRD+ A NIL++ +A
Sbjct: 128 EYLGSR---RCVHRDLAARNILVESEA 151

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 255 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 307
           LGRG FGKV +       +    + VAVK LKE  T+       TE+KI++ +  H N++
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 308 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQ 339
            L G CT     L+V   Y   G++++ L+ ++
Sbjct: 95  NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKR 127

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 26/147 (17%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 307
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 74
Query: 308 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 361
             Y    +        LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 128
Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDA 388
            YL      + +HRD+ A NIL++ +A
Sbjct: 129 EYLGSR---RCVHRDLAARNILVESEA 152

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 242 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 298
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVXLL 56
Query: 299 SMAVHRNLLRLYGF----------CTTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 344
           +   H+ ++R Y             T V +K  ++    Y  N ++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD 116
Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 386
             W   ++I       LSY+H      IIHR++K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRNLKPXNIFIDE 151

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 10/162 (6%)
Query: 228 ELQLGQLKRFSLRELQVAT---DGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEER 283
           E Q  +L+ F  ++ +V     D F   + LG G  G V+K      G ++A K +  E 
Sbjct: 46  EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 105
Query: 284 TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP 343
                 Q   E++++       ++  YG   +  E  +   +M  GS+   L+ +   +P
Sbjct: 106 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIP 164
Query: 344 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
                   K+++   +GL+YL E    KI+HRDVK +NIL++
Sbjct: 165 ---EQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVN 201

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 26/147 (17%)
Query: 255 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 307
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 86
Query: 308 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 361
             Y    +        LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 140
Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDA 388
            YL      + +HRD+ A NIL++ +A
Sbjct: 141 EYLGSR---RCVHRDLAARNILVESEA 164

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 243 QVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 301
           ++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++   
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
               ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +GL
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKGL 120
Query: 362 SYLHEHCDPKIIHRDVKAANILLD 385
           +YL E    KI+HRDVK +NIL++
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVN 142

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 304
           +D F  ++ LGRG    VY+ +     K  A+K LK  +T   ++  +TE+ ++    H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKI-VRTEIGVLLRLSHP 108
Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T TE  LV   +T G +  R+ E+            K+I       ++YL
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI----LEAVAYL 164
Query: 365 HEHCDPKIIHRDVKAANIL 383
           HE+    I+HRD+K  N+L
Sbjct: 165 HEN---GIVHRDLKPENLL 180

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAV 302
           +D +    ILG GG  +V+  R L D + VAVK L+ +  R     L+F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 303 HRNLLRLY--GFCTTVTEKLLVYPYMTNGSV-ASRLRERQSSLPPLDWPTRKKIALGSAR 359
           H  ++ +Y  G   T    L   PY+    V    LR+   +  P+      ++   + +
Sbjct: 71  HPAIVAVYDTGEAETPAGPL---PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 360 GLSYLHEHCDPKIIHRDVKAANILL 384
            L++ H++    IIHRDVK ANIL+
Sbjct: 128 ALNFSHQN---GIIHRDVKPANILI 149

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 11/136 (8%)
Query: 254 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLY 310
           ++G+G FGKV   R  A+    AVK L+++       E    +E  ++   V    L   
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 311 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
            F     +KL  V  Y+  G +   L+  +  L P      +  A   A  L YLH    
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAEIASALGYLHSL-- 158
Query: 370 PKIIHRDVKAANILLD 385
             I++RD+K  NILLD
Sbjct: 159 -NIVYRDLKPENILLD 173

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 243 QVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 301
           ++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++   
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
               ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +GL
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKGL 144
Query: 362 SYLHEHCDPKIIHRDVKAANILLD 385
           +YL E    KI+HRDVK +NIL++
Sbjct: 145 TYLREK--HKIMHRDVKPSNILVN 166

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 69/160 (43%), Gaps = 44/160 (27%)
Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---- 304
            +++  LGRG FG+V+             R+K+++T      FQ  VK + + V R    
Sbjct: 74  MTHQPRLGRGSFGEVH-------------RMKDKQTG-----FQCAVKKVRLEVFRVEEL 115
Query: 305 ---------NLLRLYGFCTTVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKI 353
                     ++ LYG    V E   V  +M    G    +L ++   LP      R   
Sbjct: 116 VACAGLSSPRIVPLYG---AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE----DRALY 168
Query: 354 ALGSA-RGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
            LG A  GL YLH     +I+H DVKA N+LL  D  +++
Sbjct: 169 YLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAA 205

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 7/144 (4%)
Query: 243 QVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 301
           ++  D F   + LG G  G V K      G ++A K +  E       Q   E++++   
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
               ++  YG   +  E  +   +M  GS+   L+E +     +      K+++   RGL
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGL 127
Query: 362 SYLHEHCDPKIIHRDVKAANILLD 385
           +YL E    +I+HRDVK +NIL++
Sbjct: 128 AYLREKH--QIMHRDVKPSNILVN 149

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	399
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-113
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-80
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-75
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-48
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-41
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-35
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-33
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-09
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-23
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-16
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-22
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-22
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-21
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-21
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-21
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-21
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-19
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-18
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-17
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-14
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-04
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-14
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-14
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-13
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-13
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-05
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-12
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-12
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-12
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-12
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-11
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-04
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-04
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-10
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-10
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-10
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-09
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-08
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-07
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-04
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-04
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  334 bits (858), Expect = e-113
 Identities = 145/170 (85%), Positives = 156/170 (91%)

Query: 218 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK 277
           FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGRLADG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 278 RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 337
           RLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 338 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  249 bits (637), Expect = 1e-80
 Identities = 68/173 (39%), Positives = 94/173 (54%), Gaps = 14/173 (8%)

Query: 224 EDDSELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVK 277
               E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 278 RLKEERTSG---GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASR 334
           +L           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  R
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 335 LRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           L     + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE 
Sbjct: 121 LSCLDGT-PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  235 bits (603), Expect = 2e-75
 Identities = 71/167 (42%), Positives = 96/167 (57%), Gaps = 6/167 (3%)

Query: 222 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKE 281
            A   S L   +  R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73

Query: 282 ERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS 340
           E  S  G  +F+TE++ +S   H +L+ L GFC    E +L+Y YM NG++   L     
Sbjct: 74  E--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131

Query: 341 SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               + W  R +I +G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  164 bits (417), Expect = 8e-48
 Identities = 43/162 (26%), Positives = 65/162 (40%), Gaps = 19/162 (11%)

Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 296
                L   +       +  RG FG V+K +L   + VAVK    +       Q + EV 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVY 70

Query: 297 IISMAVHRNLLRLYGFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 352
            +    H N+L+  G          +  L+  +   GS++  L+        + W     
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCH 125

Query: 353 IALGSARGLSYLHEH-------CDPKIIHRDVKAANILLDED 387
           IA   ARGL+YLHE          P I HRD+K+ N+LL  +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  146 bits (371), Expect = 2e-41
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 28/184 (15%)

Query: 223 AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE 281
           A   SE    +L   +  E++        +  +G+GGFG V+KGR + D  +VA+K L  
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54

Query: 282 ERTSGGEL------QFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPYMTNGSV 331
             + G         +FQ EV I+S   H N+++LYG        V E      ++  G +
Sbjct: 55  GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVME------FVPCGDL 108

Query: 332 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS 391
             RL ++     P+ W  + ++ L  A G+ Y+  + +P I+HRD+++ NI L    + +
Sbjct: 109 YHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENA 164

Query: 392 SKTI 395
               
Sbjct: 165 PVCA 168

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  147 bits (372), Expect = 4e-41
 Identities = 50/164 (30%), Positives = 68/164 (41%), Gaps = 23/164 (14%)

Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 296
            +  E  +  D      ++GRG +G VYKG L D + VAVK             F  E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS----FANRQNFINEKN 57

Query: 297 IISMAV--HRNLLRLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPT 349
           I  + +  H N+ R       V      E LLV  Y  NGS+   L          DW +
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVS 112

Query: 350 RKKIALGSARGLSYLHE------HCDPKIIHRDVKAANILLDED 387
             ++A    RGL+YLH       H  P I HRD+ + N+L+  D
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  142 bits (360), Expect = 1e-39
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 16/143 (11%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 310
           K  +G G FG V++     G  VAVK L E+      +  F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 311 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           G  T       VTE      Y++ GS+   L  +  +   LD   R  +A   A+G++YL
Sbjct: 101 GAVTQPPNLSIVTE------YLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H + +P I+HR++K+ N+L+D+ 
Sbjct: 154 H-NRNPPIVHRNLKSPNLLVDKK 175

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  142 bits (359), Expect = 2e-39
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 15/140 (10%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           + ++GRG FG V K +    K VA+K+++ E        F  E++ +S   H N+++LYG
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYG 68

Query: 312 FCTT----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            C      V E      Y   GS+ + L   +  LP           L  ++G++YLH  
Sbjct: 69  ACLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 368 CDPKIIHRDVKAANILLDED 387
               +IHRD+K  N+LL   
Sbjct: 122 QPKALIHRDLKPPNLLLVAG 141

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  137 bits (348), Expect = 3e-38
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 21/152 (13%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEER---TSGGELQFQTEVKIISMAVHRNLLR 308
           + I+G GGFGKVY+     G  VAVK  + +     S      + E K+ +M  H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 309 LYGFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           L G C        V E      +   G +   L  ++     +        A+  ARG++
Sbjct: 71  LRGVCLKEPNLCLVME------FARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMN 119

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDADQSSKT 394
           YLH+     IIHRD+K++NIL+ +  +    +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  137 bits (347), Expect = 5e-38
 Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 19/145 (13%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 310
              L     G+++KGR   G  + VK LK    S  + + F  E   + +  H N+L + 
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 311 GFCTT--------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           G C +        +T       +M  GS+ + L E  +    +D     K AL  ARG++
Sbjct: 74  GACQSPPAPHPTLITH------WMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMA 125

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           +LH   +P I    + + ++++DED
Sbjct: 126 FLH-TLEPLIPRHALNSRSVMIDED 149

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  130 bits (328), Expect = 6e-35
 Identities = 38/143 (26%), Positives = 62/143 (43%), Gaps = 20/143 (13%)

Query: 252 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
             +LG+G FG+  K      G+++ +K L        +  F  EVK++    H N+L+  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 311 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           G          +TE      Y+  G++   ++   S      W  R   A   A G++YL
Sbjct: 74  GVLYKDKRLNFITE------YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYL 124

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H      IIHRD+ + N L+ E+
Sbjct: 125 HSM---NIIHRDLNSHNCLVREN 144

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  128 bits (324), Expect = 1e-34
 Identities = 47/139 (33%), Positives = 65/139 (46%), Gaps = 20/139 (14%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG VYKG+   G  VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 314 T-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           T      VT+      +    S+   L   +      +      IA  +ARG+ YLH   
Sbjct: 90  TAPQLAIVTQ------WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK- 139

Query: 369 DPKIIHRDVKAANILLDED 387
              IIHRD+K+ NI L ED
Sbjct: 140 --SIIHRDLKSNNIFLHED 156

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (325), Expect = 2e-34
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 21/143 (14%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 310
             ++G+G FG+VY GR   G+ VA++ +  ER +  +L+ F+ EV       H N++   
Sbjct: 38  GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 311 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           G C +      +T            ++ S +R+ +     LD    ++IA    +G+ YL
Sbjct: 96  GACMSPPHLAIITS------LCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYL 146

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H      I+H+D+K+ N+  D  
Sbjct: 147 HAK---GILHKDLKSKNVFYDNG 166

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  125 bits (316), Expect = 2e-33
 Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 28/165 (16%)

Query: 234 LKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT 293
           ++R   R++ +          +G+G +G+V++G    G+ VAVK          E  +  
Sbjct: 2   MQRTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFR 49

Query: 294 EVKIISMAV--HRNLLRLYGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDW 347
           E ++ +  +  H N+L       T         L+  Y   GS+   L+        LD 
Sbjct: 50  ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDT 104

Query: 348 PTRKKIALGSARGLSYLHE-----HCDPKIIHRDVKAANILLDED 387
            +  +I L  A GL++LH         P I HRD+K+ NIL+ ++
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  126 bits (317), Expect = 4e-33
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 21/146 (14%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLY 310
             +G+G +G+V+ G+   G+ VAVK          E  +  E +I    +  H N+L   
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97

Query: 311 GFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
                   + T+  L+  Y  NGS+   L+        LD  +  K+A  S  GL +LH 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHT 152

Query: 367 -----HCDPKIIHRDVKAANILLDED 387
                   P I HRD+K+ NIL+ ++
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKN 178

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  120 bits (303), Expect = 4e-31
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 21/146 (14%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLY 310
             +G+G FG+V++G+   G+ VAVK          E  +  E +I    +  H N+L   
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102

Query: 311 GFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
                   T T+  LV  Y  +GS+   L         +      K+AL +A GL++LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHM 157

Query: 367 -----HCDPKIIHRDVKAANILLDED 387
                   P I HRD+K+ NIL+ ++
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKN 183

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  117 bits (295), Expect = 1e-29
 Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 19/143 (13%)

Query: 252 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
              +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 311 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           G CT       V E       +  G   + LR   + L      T  ++   +A G+ YL
Sbjct: 179 GVCTQKQPIYIVME------LVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYL 229

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                   IHRD+ A N L+ E 
Sbjct: 230 ESK---CCIHRDLAARNCLVTEK 249

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (281), Expect = 3e-28
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 15/148 (10%)

Query: 252 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 306
             ILG G FG V +G L         VAVK +K + +S  E++ F +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 307 LRLYGFCT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSAR 359
           +RL G C       + + +++ P+M  G + + L   +    P   P +   K  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDED 387
           G+ YL        +HRD+ A N +L +D
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDD 183

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  110 bits (278), Expect = 5e-28
 Identities = 48/140 (34%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 253 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
            ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 309 LYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           L G C       L V PYM +G + + +R    +    D        L  A+G+ YL   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASK 147

Query: 368 CDPKIIHRDVKAANILLDED 387
              K +HRD+ A N +LDE 
Sbjct: 148 ---KFVHRDLAARNCMLDEK 164

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (277), Expect = 8e-28
 Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 13/143 (9%)

Query: 252 KNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
              LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 307 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           ++  G CT        L+  ++ +GS+   L + ++ +       + K A+   +G+ YL
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL---KQQLKYAVQICKGMDYL 142

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + +HRD+ A N+L++ +
Sbjct: 143 GSR---QYVHRDLAARNVLVESE 162

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  110 bits (276), Expect = 2e-27
 Identities = 42/143 (29%), Positives = 59/143 (41%), Gaps = 15/143 (10%)

Query: 252 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
              LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 307 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           ++  G C         LV  Y+  GS+   L      L  L        A     G++YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H       IHRD+ A N+LLD D
Sbjct: 151 HAQ---HYIHRDLAARNVLLDND 170

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (275), Expect = 3e-27
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 22/145 (15%)

Query: 253 NILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
            +LG G FG VYKG            VA+K L+E  +     +   E  +++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 308 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           RL G C T     +T+       M  G +   +RE + ++            +  A+G++
Sbjct: 81  RLLGICLTSTVQLITQ------LMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YL +    +++HRD+ A N+L+   
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTP 153

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (273), Expect = 3e-27
 Identities = 40/141 (28%), Positives = 57/141 (40%), Gaps = 11/141 (7%)

Query: 252 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
             ++G+G FG VY G   D        A+K L           F  E  ++    H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 308 RLYGFCTTVTE-KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
            L G          ++ PYM +G +   +R  Q +             L  ARG+ YL E
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYLAE 142

Query: 367 HCDPKIIHRDVKAANILLDED 387
               K +HRD+ A N +LDE 
Sbjct: 143 Q---KFVHRDLAARNCMLDES 160

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  108 bits (273), Expect = 4e-27
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 15/148 (10%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
              LG+G FG VY+G             VA+K + E  +    ++F  E  ++      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRK---KIALGSAR 359
           ++RL G  +     L++   MT G + S LR      ++ P L  P+     ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDED 387
           G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAED 174

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  108 bits (272), Expect = 6e-27
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 16/149 (10%)

Query: 252 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 306
             +LG+G FG V + +L         VAVK LK +  +  +++ F  E   +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 307 LRLYGFCT------TVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSA 358
            +L G          +   +++ P+M +G + + L   +    P  L   T  +  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
            G+ YL        IHRD+ A N +L ED
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAED 173

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  108 bits (272), Expect = 1e-26
 Identities = 47/140 (33%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 253 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
            ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 309 LYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           L G C       L V PYM +G + + +R    +    D        L  A+G+ +L   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASK 211

Query: 368 CDPKIIHRDVKAANILLDED 387
              K +HRD+ A N +LDE 
Sbjct: 212 ---KFVHRDLAARNCMLDEK 228

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (267), Expect = 1e-26
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 8/136 (5%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
              +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            C       LV  +M +G ++  LR ++         T   + L    G++YL E     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEA---C 124

Query: 372 IIHRDVKAANILLDED 387
           +IHRD+ A N L+ E+
Sbjct: 125 VIHRDLAARNCLVGEN 140

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (268), Expect = 1e-26
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 21/145 (14%)

Query: 252 KNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
             ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+    H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 308 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           +L G         + E          G +   L   ++SL      T    +L   + ++
Sbjct: 77  KLIGIIEEEPTWIIME------LYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMA 127

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YL        +HRD+   NIL+   
Sbjct: 128 YLESI---NCVHRDIAVRNILVASP 149

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  106 bits (267), Expect = 2e-26
 Identities = 34/143 (23%), Positives = 59/143 (41%), Gaps = 21/143 (14%)

Query: 254 ILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
            +G G FG V++G     +     VA+K  K   +     +F  E   +    H ++++L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 310 YGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G  T      + E        T G + S L+ R+ SL      +    A   +  L+YL
Sbjct: 82  IGVITENPVWIIME------LCTLGELRSFLQVRKYSLDL---ASLILYAYQLSTALAYL 132

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + +HRD+ A N+L+  +
Sbjct: 133 ESK---RFVHRDIAARNVLVSSN 152

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  109 bits (274), Expect = 3e-26
 Identities = 52/269 (19%), Positives = 86/269 (31%), Gaps = 31/269 (11%)

Query: 131 VPDNGSFSQFTPISFENNLNLCGPNTK--KPCSGSPPFSPPPPFGPTSSPGRNKSNAAIP 188
           +P+   F     +     L   G      + C  S   +      PT     +       
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282

Query: 189 VGVALGAALLFAVP--VIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVAT 246
               L +      P  +      R        F+ P  D  EL+    K+  L+   +  
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKD---KKLFLKRDNLLI 339

Query: 247 DGFSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVH 303
                   LG G FG V +G     K    VA+K LK+        +   E +I+    +
Sbjct: 340 A----DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395

Query: 304 RNLLRLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
             ++RL G C       V E          G +   L  ++  +P        ++    +
Sbjct: 396 PYIVRLIGVCQAEALMLVME------MAGGGPLHKFLVGKREEIPV---SNVAELLHQVS 446

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
            G+ YL E      +HR++ A N+LL   
Sbjct: 447 MGMKYLEEK---NFVHRNLAARNVLLVNR 472

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  106 bits (267), Expect = 3e-26
 Identities = 36/146 (24%), Positives = 62/146 (42%), Gaps = 22/146 (15%)

Query: 252 KNILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
             +LG G FG V+KG            V +K ++++            +  I    H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 307 LRLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
           +RL G C       VT+      Y+  GS+   +R+ + +L P          +  A+G+
Sbjct: 78  VRLLGLCPGSSLQLVTQ------YLPLGSLLDHVRQHRGALGP---QLLLNWGVQIAKGM 128

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YL EH    ++HR++ A N+LL   
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSP 151

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (265), Expect = 3e-26
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)

Query: 252 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
              LG+G FG V   R        G++VAVK+L+   T      F+ E++I+    H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 73

Query: 307 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           ++  G C +   +   L+  Y+  GS+   L++ +  +         +      +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQICKGMEYL 130

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 131 GTK---RYIHRDLATRNILVENE 150

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (266), Expect = 4e-26
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)

Query: 252 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
              LG+G FG V   R        G++VAVK+L+   T      F+ E++I+    H N+
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 104

Query: 307 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           ++  G C +   +   L+  Y+  GS+   L++ +  +         +      +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQICKGMEYL 161

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + IHRD+   NIL++ +
Sbjct: 162 GTK---RYIHRDLATRNILVENE 181

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  106 bits (266), Expect = 4e-26
 Identities = 47/147 (31%), Positives = 63/147 (42%), Gaps = 12/147 (8%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
              LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRKKIALGSARGLS 362
           ++R  G       + ++   M  G + S LRE     S    L       +A   A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDAD 389
           YL E+     IHRD+ A N LL     
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGP 178

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (264), Expect = 4e-26
 Identities = 35/144 (24%), Positives = 55/144 (38%), Gaps = 20/144 (13%)

Query: 252 KNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
              LG G FG V +G     K    VA+K LK+        +   E +I+    +  ++R
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 309 LYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
           L G C       V E          G +   L  ++  +P        ++    + G+ Y
Sbjct: 75  LIGVCQAEALMLVME------MAGGGPLHKFLVGKREEIPV---SNVAELLHQVSMGMKY 125

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           L E      +HRD+ A N+LL   
Sbjct: 126 LEEK---NFVHRDLAARNVLLVNR 146

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  105 bits (264), Expect = 4e-26
 Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 11/138 (7%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 311
            +GRG F  VYKG        VA   L++ + +  E  +F+ E +++    H N++R Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 312 -FCTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            + +TV  K  +      MT+G++ + L+        +     +       +GL +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 368 CDPKIIHRDVKAANILLD 385
             P IIHRD+K  NI + 
Sbjct: 149 -TPPIIHRDLKCDNIFIT 165

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  105 bits (264), Expect = 4e-26
 Identities = 39/136 (28%), Positives = 61/136 (44%), Gaps = 8/136 (5%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
              LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            CT      ++  YM NG + + LRE +            ++       + YL      +
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---Q 140

Query: 372 IIHRDVKAANILLDED 387
            +HRD+ A N L+++ 
Sbjct: 141 FLHRDLAARNCLVNDQ 156

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  104 bits (263), Expect = 5e-26
 Identities = 42/136 (30%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
              LG G FG V  G+      VAVK +KE   S  E +F  E + +    H  L++ YG
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            C+      +V  Y++NG + + LR     L P       ++      G+++L  H   +
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESH---Q 124

Query: 372 IIHRDVKAANILLDED 387
            IHRD+ A N L+D D
Sbjct: 125 FIHRDLAARNCLVDRD 140

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  104 bits (262), Expect = 8e-26
 Identities = 34/134 (25%), Positives = 68/134 (50%), Gaps = 8/134 (5%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +LG+G +G VY GR L++   +A+K + E  +   +     E+ +     H+N+++  G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87

Query: 313 CTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            +     + ++   +  GS+++ LR +   L   +  T          GL YLH++   +
Sbjct: 88  FSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIGFYTKQILEGLKYLHDN---Q 142

Query: 372 IIHRDVKAANILLD 385
           I+HRD+K  N+L++
Sbjct: 143 IVHRDIKGDNVLIN 156

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  105 bits (265), Expect = 1e-25
 Identities = 45/147 (30%), Positives = 62/147 (42%), Gaps = 12/147 (8%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
              LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK---KIALGSARGLS 362
           ++R  G       + ++   M  G + S LRE +                +A   A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDAD 389
           YL E+     IHRD+ A N LL     
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGP 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  104 bits (261), Expect = 1e-25
 Identities = 52/145 (35%), Positives = 64/145 (44%), Gaps = 23/145 (15%)

Query: 254 ILGRGGFGKVYKGRL--ADGKL--VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 307
            LG G FG V +G      GK   VAVK LK +  S  E    F  EV  +    HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 308 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           RLYG   T     VTE          GS+  RLR+ Q         T  + A+  A G+ 
Sbjct: 85  RLYGVVLTPPMKMVTE------LAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMG 135

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YL      + IHRD+ A N+LL   
Sbjct: 136 YLESK---RFIHRDLAARNLLLATR 157

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  103 bits (260), Expect = 1e-25
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 18/141 (12%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
              LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYA 75

Query: 312 FCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
             T      +TE      YM NGS+   L+        L       +A   A G++++ E
Sbjct: 76  VVTQEPIYIITE------YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 367 HCDPKIIHRDVKAANILLDED 387
                 IHRD++AANIL+ + 
Sbjct: 128 R---NYIHRDLRAANILVSDT 145

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  104 bits (262), Expect = 1e-25
 Identities = 42/140 (30%), Positives = 62/140 (44%), Gaps = 10/140 (7%)

Query: 252 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           + I+G G  G+V  GRL         VA+K LK   T      F +E  I+    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           RL G  T     ++V  YM NGS+ + LR                +  G   G+ YL + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI---MQLVGMLRGVGAGMRYLSDL 170

Query: 368 CDPKIIHRDVKAANILLDED 387
                +HRD+ A N+L+D +
Sbjct: 171 ---GYVHRDLAARNVLVDSN 187

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  107 bits (270), Expect = 2e-25
 Identities = 37/97 (38%), Positives = 55/97 (56%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           +LG+  +SG +  E+G L+ L +L L++N L G IP +++ +T L  +DLSNN LSGP+P
Sbjct: 662 NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

Query: 133 DNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPP 169
           + G F  F P  F NN  LCG    +    +      
Sbjct: 722 EMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAH 758

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 99.2 bits (248), Expect = 1e-22
 Identities = 45/139 (32%), Positives = 62/139 (44%), Gaps = 11/139 (7%)

Query: 23  SANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALS-- 80
           S   E+  L  FK  L D N  L  W +   N CT+  +TC     VT +DL +  L+  
Sbjct: 9   SLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCRD-DKVTSIDLSSKPLNVG 65

Query: 81  -GELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 139
              ++  L  L  LE L L+N+ ++G +        SL  LDLS N LSGPV    S   
Sbjct: 66  FSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGS 124

Query: 140 FTPISF----ENNLNLCGP 154
            + + F     N L+  G 
Sbjct: 125 CSGLKFLNVSSNTLDFPGK 143

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 79.2 bits (196), Expect = 5e-16
 Identities = 28/83 (33%), Positives = 46/83 (55%), Gaps = 2/83 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++  + L N  L+GE+   +G+L+NL +L+L+NNS SG IP  L    SL  LDL+ N  
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550

Query: 128 SGPVPDNGSFSQFTPISFENNLN 150
           +G +P   +  + +     N + 
Sbjct: 551 NGTIPA--AMFKQSGKIAANFIA 571

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 78.4 bits (194), Expect = 7e-16
 Identities = 32/114 (28%), Positives = 51/114 (44%), Gaps = 10/114 (8%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN 101
           +N+      +  NLC       NP+ ++  + L N   +G++ P L     L  L L+ N
Sbjct: 377 SNNFSG--PILPNLCQ------NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN 428

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCGP 154
            LSG IP+SL +++ L  L L  N L G +P           +  + N +L G 
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN-DLTGE 481

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 31/114 (27%), Positives = 46/114 (40%), Gaps = 12/114 (10%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN 101
            N L+    +P  L            ++  + L    L+GE+   L    NL  + L+NN
Sbjct: 451 LNMLEG--EIPQELMYV--------KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCGP 154
            L+G IP  +  + +L IL LSNN  SG +P   G       +    N    G 
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN-LFNGT 553

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 27/82 (32%), Positives = 37/82 (45%), Gaps = 1/82 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
            +  + L    LSG +   LG L  L  L+L  N L G IP  L  + +L  L L  N L
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478

Query: 128 SGPVPDN-GSFSQFTPISFENN 148
           +G +P    + +    IS  NN
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNN 500

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 75.7 bits (187), Expect = 7e-15
 Identities = 35/108 (32%), Positives = 48/108 (44%), Gaps = 7/108 (6%)

Query: 50  NLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQ--LKNLELLRLNNNSLSGLI 107
              G L        N   S+  +DL +   SG + P L Q     L+ L L NN  +G I
Sbjct: 354 EFSGELPESL---TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410

Query: 108 PTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCGP 154
           P +L+  + L  L LS N LSG +P + GS S+   +    N  L G 
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN-MLEGE 457

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 31/82 (37%), Positives = 44/82 (53%), Gaps = 1/82 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
            +  + L    L GE+  EL  +K LE L L+ N L+G IP+ L+  T+LN + LSNNRL
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502

Query: 128 SGPVPDN-GSFSQFTPISFENN 148
           +G +P   G       +   NN
Sbjct: 503 TGEIPKWIGRLENLAILKLSNN 524

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 23/87 (26%), Positives = 42/87 (48%), Gaps = 3/87 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++  +D+ +   S  + P LG    L+ L ++ N LSG    +++T T L +L++S+N+ 
Sbjct: 201 NLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259

Query: 128 SGPVPDNGSFSQFTPISFENNLNLCGP 154
            GP+P          +S   N    G 
Sbjct: 260 VGPIPP-LPLKSLQYLSLAEN-KFTGE 284

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 73.0 bits (180), Expect = 5e-14
 Identities = 21/88 (23%), Positives = 32/88 (36%), Gaps = 4/88 (4%)

Query: 70  TRVDLGNAALSGELAPEL-GQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             + L     +GE+   L G    L  L L+ N   G +P    + + L  L LS+N  S
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331

Query: 129 GPVPDN--GSFSQFTPISFENNLNLCGP 154
           G +P +          +    N    G 
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFN-EFSGE 358

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 8/92 (8%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPT-SLTTITSLNILDLSNNR 126
           ++T +DL      G + P  G    LE L L++N+ SG +P  +L  +  L +LDLS N 
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354

Query: 127 LSGPVPDNGSFSQFTP----ISFENNLNLCGP 154
            SG +P+  S +  +     +   +N N  GP
Sbjct: 355 FSGELPE--SLTNLSASLLTLDLSSN-NFSGP 383

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 6/90 (6%)

Query: 70  TRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTIT-SLNILDLSNNRL 127
             + L +   SGEL  + L +++ L++L L+ N  SG +P SLT ++ SL  LDLS+N  
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380

Query: 128 SGPVPD---NGSFSQFTPISFENNLNLCGP 154
           SGP+         +    +  +NN    G 
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNN-GFTGK 409

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 6/90 (6%)

Query: 68  SVTRVDLGNAALSGELAPEL---GQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSN 124
           S+  +DL   ++SG              L+ L ++ N +SG +   ++   +L  LD+S+
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSS 209

Query: 125 NRLSGPVPDNGSFSQFTPISFENNLNLCGP 154
           N  S  +P  G  S    +    N  L G 
Sbjct: 210 NNFSTGIPFLGDCSALQHLDISGN-KLSGD 238

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 15/90 (16%), Positives = 29/90 (32%), Gaps = 2/90 (2%)

Query: 44  SLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSL 103
              + + + G    +  I  +                G  + +L +L       + +   
Sbjct: 563 GKIAANFIAGKRYVY--IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVY 620

Query: 104 SGLIPTSLTTITSLNILDLSNNRLSGPVPD 133
            G    +     S+  LD+S N LSG +P 
Sbjct: 621 GGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 27/84 (32%), Positives = 39/84 (46%), Gaps = 5/84 (5%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTT-ITSLNILDLSNNRLSGPV 131
           ++ +    G + P    LK+L+ L L  N  +G IP  L+    +L  LDLS N   G V
Sbjct: 253 NISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310

Query: 132 PDN-GSFSQFTPISFENNLNLCGP 154
           P   GS S    ++  +N N  G 
Sbjct: 311 PPFFGSCSLLESLALSSN-NFSGE 333

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 59.5 bits (145), Expect = 8e-10
 Identities = 19/86 (22%), Positives = 32/86 (37%), Gaps = 6/86 (6%)

Query: 73  DLGNAALSGEL-APELGQLKNLELLRLNNNSLSGLIPTSLTT---ITSLNILDLSNNRLS 128
           ++ +  L          +L +LE+L L+ NS+SG              L  L +S N++S
Sbjct: 132 NVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 191

Query: 129 GPVPDNGSFSQFTPISFENNLNLCGP 154
           G V           +   +N N    
Sbjct: 192 GDVDV-SRCVNLEFLDVSSN-NFSTG 215

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 23/110 (20%), Positives = 40/110 (36%), Gaps = 15/110 (13%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN 101
           NN L     +P  +            ++  + L N + SG +  ELG  ++L  L LN N
Sbjct: 499 NNRLT--GEIPKWIGRL--------ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLN 150
             +G IP ++          ++ N ++G       +           NL 
Sbjct: 549 LFNGTIPAAM----FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  104 bits (261), Expect = 2e-25
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 22/145 (15%)

Query: 253 NILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
            +LG G FG VYKG            VA+K L+E  +     +   E  +++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 308 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           RL G C T     +T+       M  G +   +RE + ++            +  A+G++
Sbjct: 81  RLLGICLTSTVQLITQ------LMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YL +    +++HRD+ A N+L+   
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTP 153

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  103 bits (259), Expect = 2e-25
 Identities = 37/143 (25%), Positives = 60/143 (41%), Gaps = 8/143 (5%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIIS-MAVHRN 305
           F     +G G FG V+K     DG + A+KR K     S  E     EV   + +  H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 306 LLRLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           ++R +       + +L+   Y   GS+A  + E    +        K + L   RGL Y+
Sbjct: 73  VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H      ++H D+K +NI +   
Sbjct: 132 HSM---SLVHMDIKPSNIFISRT 151

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  103 bits (260), Expect = 2e-25
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 2/94 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           +  ++ L   +L+ +L  ++G  KNL  L L NN + G +P  LT +  L+ L++S N L
Sbjct: 222 NTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 128 SGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCS 161
            G +P  G+  +F   ++ NN  LCG      C+
Sbjct: 281 CGEIPQGGNLQRFDVSAYANNKCLCGSPL-PACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 97.6 bits (244), Expect = 4e-23
 Identities = 40/160 (25%), Positives = 59/160 (36%), Gaps = 34/160 (21%)

Query: 27  EVDALYIFKSKLQDPNNSLQSW-DNLPGNLCTWFHITCNPEGSVTRV---DLGNAALSGE 82
           +  AL   K  L +P  +L SW         TW  + C+ +    RV   DL    L   
Sbjct: 7   DKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65

Query: 83  LA---------------------------PELGQLKNLELLRLNNNSLSGLIPTSLTTIT 115
                                        P + +L  L  L + + ++SG IP  L+ I 
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 116 SLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCGP 154
           +L  LD S N LSG +P +  S      I+F+ N  + G 
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN-RISGA 164

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 3/87 (3%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             + + +  +SG +   L Q+K L  L  + N+LSG +P S++++ +L  +    NR+SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 130 PVPDN-GSFSQ-FTPISFENNLNLCGP 154
            +PD+ GSFS+ FT ++   N  L G 
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN-RLTGK 189

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 71.4 bits (176), Expect = 5e-14
 Identities = 23/65 (35%), Positives = 34/65 (52%), Gaps = 1/65 (1%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSL-NILDLSNNRLS 128
             +D    ALSG L P +  L NL  +  + N +SG IP S  + + L   + +S NRL+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187

Query: 129 GPVPD 133
           G +P 
Sbjct: 188 GKIPP 192

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 71.0 bits (175), Expect = 7e-14
 Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 2/82 (2%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
            +    L+G++ P    L NL  + L+ N L G       +  +   + L+ N L+  + 
Sbjct: 180 TISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

Query: 133 DNGSFSQFTPISFENNLNLCGP 154
             G       +   NN  + G 
Sbjct: 239 KVGLSKNLNGLDLRNN-RIYGT 259

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 63.3 bits (155), Expect = 2e-11
 Identities = 16/67 (23%), Positives = 29/67 (43%), Gaps = 2/67 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNL-ELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
           ++  +      +SG +    G    L   + ++ N L+G IP +   + +L  +DLS N 
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208

Query: 127 LSGPVPD 133
           L G    
Sbjct: 209 LEGDASV 215

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (259), Expect = 2e-25
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 15/149 (10%)

Query: 252 KNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 303
              LG+G F K++KG               V +K L +   +  E  F     ++S   H
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMMSKLSH 71

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
           ++L+  YG C    E +LV  ++  GS+ + L++ ++ +       + ++A   A  + +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI---LWKLEVAKQLAAAMHF 128

Query: 364 LHEHCDPKIIHRDVKAANILLDEDADQSS 392
           L E+    +IH +V A NILL  + D+ +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKT 154

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  102 bits (257), Expect = 4e-25
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 8/137 (5%)

Query: 252 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
           G CT      ++  +MT G++   LRE       +       +A   +  + YL +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKK--- 130

Query: 371 KIIHRDVKAANILLDED 387
             IHRD+ A N L+ E+
Sbjct: 131 NFIHRDLAARNCLVGEN 147

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  102 bits (256), Expect = 4e-25
 Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 22/143 (15%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
              +G+G FG V  G    G  VAVK +K + T      F  E  +++   H NL++L G
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 81

Query: 312 FCTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
                      VTE      YM  GS+   LR R  S   L      K +L     + YL
Sbjct: 82  VIVEEKGGLYIVTE------YMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYL 133

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
             +     +HRD+ A N+L+ ED
Sbjct: 134 EGN---NFVHRDLAARNVLVSED 153

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  103 bits (259), Expect = 4e-25
 Identities = 35/143 (24%), Positives = 62/143 (43%), Gaps = 14/143 (9%)

Query: 252 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
            + LG+G FG V   R        G LVAVK+L+       +  FQ E++I+       +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFI 86

Query: 307 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           ++  G       +   LV  Y+ +G +   L+  ++ L           +    +G+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQICKGMEYL 143

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
                 + +HRD+ A NIL++ +
Sbjct: 144 GSR---RCVHRDLAARNILVESE 163

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  106 bits (265), Expect = 5e-25
 Identities = 41/196 (20%), Positives = 74/196 (37%), Gaps = 36/196 (18%)

Query: 201 VPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGF 260
           V V     +      E  + +P+  D E+Q  +++                   +G G F
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL---------------GRCIGEGQF 403

Query: 261 GKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT- 315
           G V++G     +     VA+K  K   +     +F  E   +    H ++++L G  T  
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463

Query: 316 ----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
               + E        T G + S L+ R+ SL      +    A   +  L+YL      +
Sbjct: 464 PVWIIME------LCTLGELRSFLQVRKFSLDL---ASLILYAYQLSTALAYLESK---R 511

Query: 372 IIHRDVKAANILLDED 387
            +HRD+ A N+L+  +
Sbjct: 512 FVHRDIAARNVLVSSN 527

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  102 bits (256), Expect = 6e-25
 Identities = 35/143 (24%), Positives = 54/143 (37%), Gaps = 22/143 (15%)

Query: 254 ILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 309
            LG G FG V KG     K+   VAVK LK E            E  ++    +  ++R+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 310 YGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
            G C       V E          G +   L++ +     +      ++    + G+ YL
Sbjct: 84  IGICEAESWMLVME------MAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL 133

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
            E      +HRD+ A N+LL   
Sbjct: 134 EES---NFVHRDLAARNVLLVTQ 153

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  103 bits (258), Expect = 6e-25
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 11/141 (7%)

Query: 252 KNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
           + ++G G FG+VYKG L          VA+K LK   T    + F  E  I+    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           +RL G  +     +++  YM NG++   LRE+              +  G A G+ YL  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV---LQLVGMLRGIAAGMKYLAN 165

Query: 367 HCDPKIIHRDVKAANILLDED 387
                 +HRD+ A NIL++ +
Sbjct: 166 M---NYVHRDLAARNILVNSN 183

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (255), Expect = 7e-25
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 21/154 (13%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
              LG   FGKVYKG L           VA+K LK++       +F+ E  + +   H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTRKKI 353
           ++ L G  T      +++ Y ++G +   L  R            ++    L+ P    +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               A G+ YL  H    ++H+D+   N+L+ + 
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 164

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (261), Expect = 9e-25
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
             LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 313 CT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            +      VTE      YM+ GS+   L+        L  P    +A   A G++Y+   
Sbjct: 248 VSEEPIYIVTE------YMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM 299

Query: 368 CDPKIIHRDVKAANILLDED 387
                +HRD++AANIL+ E+
Sbjct: 300 ---NYVHRDLRAANILVGEN 316

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  102 bits (257), Expect = 1e-24
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 10/140 (7%)

Query: 252 KNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
             ++G G FG+V  GRL         VA+K LK   T      F  E  I+    H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           RL G  T     ++V  YM NGS+ S LR+  +            +  G A G+ YL + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV---IQLVGMLRGIASGMKYLSDM 166

Query: 368 CDPKIIHRDVKAANILLDED 387
                +HRD+ A NIL++ +
Sbjct: 167 ---GYVHRDLAARNILINSN 183

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (253), Expect = 2e-24
 Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 22/154 (14%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           K  LG G FGKV+     +        LVAVK LK+  T      FQ E ++++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTRKKI 353
           +++ YG C      ++V+ YM +G +   LR              + +   L       I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   A G+ YL        +HRD+   N L+  +
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 169

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  101 bits (254), Expect = 2e-24
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 19/152 (12%)

Query: 252 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLL 307
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++     H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK------------KIAL 355
            L G C       L   Y  +G++   LR+ +       +                  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGEN 178

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  103 bits (259), Expect = 2e-24
 Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 22/143 (15%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
              +G+G FG V  G    G  VAVK +K + T      F  E  +++   H NL++L G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 253

Query: 312 FCTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
                      VTE      YM  GS+   LR R  S   L      K +L     + YL
Sbjct: 254 VIVEEKGGLYIVTE------YMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYL 305

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
             +     +HRD+ A N+L+ ED
Sbjct: 306 EGN---NFVHRDLAARNVLVSED 325

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  101 bits (253), Expect = 2e-24
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 10/149 (6%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           D +  + ++G G    V         + VA+KR+  E+      +   E++ +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 306 LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWP-TRKKIAL---GSARG 360
           ++  Y     V ++L LV   ++ GSV   ++   +             IA        G
Sbjct: 75  IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           L YLH++     IHRDVKA NILL ED  
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGS 159

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  101 bits (254), Expect = 2e-24
 Identities = 41/153 (26%), Positives = 60/153 (39%), Gaps = 20/153 (13%)

Query: 252 KNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 304
              LG G FGKV +              VAVK LK    +  +    +E+KI+S    H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------KIA 354
           N++ L G CT     L++  Y   G + + LR +   L                     +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 355 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              A+G+++L        IHRDV A N+LL   
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  100 bits (252), Expect = 3e-24
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 21/162 (12%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 308 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           + YG       KL ++  Y+  GS    L        PLD      I     +GL YLH 
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS 137

Query: 367 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 398
               K IHRD+KAAN+LL E  +          Q + T ++R
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  100 bits (252), Expect = 3e-24
 Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 17/157 (10%)

Query: 240 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL----KEERTSGGELQFQTE 294
             + +    +     LG GGF  V     L DG   A+KR+    +++R      + Q E
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-----EAQRE 76

Query: 295 VKIISMAVHRNLLRLYGFC----TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 350
             +  +  H N+LRL  +C        E  L+ P+   G++ + +   +     L     
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             + LG  RGL  +H        HRD+K  NILL ++
Sbjct: 137 LWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDE 170

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  102 bits (257), Expect = 3e-24
 Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 18/140 (12%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
             LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251

Query: 313 CTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            T      +TE      +M  GS+   L+  + S  PL  P     +   A G++++ + 
Sbjct: 252 VTKEPIYIITE------FMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 303

Query: 368 CDPKIIHRDVKAANILLDED 387
                IHRD++AANIL+   
Sbjct: 304 ---NYIHRDLRAANILVSAS 320

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (250), Expect = 5e-24
 Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 23/156 (14%)

Query: 252 KNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 304
              LGRG FG+V +            + VAVK LKE  T        +E+KI+     H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 305 NLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRK------------ 351
           N++ L G CT     L ++  +   G++++ LR +++   P                   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             +   A+G+ +L      K IHRD+ A NILL E 
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  100 bits (250), Expect = 7e-24
 Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 24/157 (15%)

Query: 252 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 302
              LG G FG+V                  VAVK LK++ T        +E++++ M   
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTR 350
           H+N++ L G CT      ++  Y + G++   LR R            +     + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                  ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.3 bits (248), Expect = 8e-24
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 28/166 (16%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 306
           +     LG G FGKVYK +    G L A K ++ +  S  EL+ +  E++I++   H  +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYI 78

Query: 307 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLS 362
           ++L G       KL ++  +   G+V + + E    L      T  +I +        L+
Sbjct: 79  VKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGL------TEPQIQVVCRQMLEALN 131

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 398
           +LH     +IIHRD+KA N+L+  + D          ++ KT+ +R
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  102 bits (255), Expect = 8e-24
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
             LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 313 CT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            +      VTE      YM+ GS+   L+        L  P    +A   A G++Y+   
Sbjct: 331 VSEEPIYIVTE------YMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM 382

Query: 368 CDPKIIHRDVKAANILLDED 387
                +HRD++AANIL+ E+
Sbjct: 383 ---NYVHRDLRAANILVGEN 399

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 21/153 (13%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           K  LG G FGKV+     +        LVAVK LKE  +      FQ E ++++M  H++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQH 104

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----------QSSLPPLDWPTRKKIA 354
           ++R +G CT     L+V+ YM +G +   LR               +  PL       +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 355 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              A G+ YL        +HRD+   N L+ + 
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  100 bits (250), Expect = 1e-23
 Identities = 33/149 (22%), Positives = 58/149 (38%), Gaps = 11/149 (7%)

Query: 246 TDGFSNKNILGRG--GFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMA 301
              +    ++G+G      V   R    G+ V V+R+  E  S   + F Q E+ +  + 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 302 VHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
            H N++           +L +V  +M  GS    +         ++      I  G  + 
Sbjct: 84  NHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKA 140

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           L Y+H       +HR VKA++IL+  D  
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGK 166

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (250), Expect = 1e-23
 Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 24/157 (15%)

Query: 252 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 302
              LG G FG+V                  VAVK LK++ T        +E++++ M   
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTR 350
           H+N++ L G CT      ++  Y + G++   LR R            +     + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                  ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 46/162 (28%), Positives = 64/162 (39%), Gaps = 29/162 (17%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
              LG G FGKV K      K       VAVK LKE  +        +E  ++    H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----------------QSSLPPLDWP 348
           +++LYG C+     LL+  Y   GS+   LRE                      P     
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 349 TRK---KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           T       A   ++G+ YL E    K++HRD+ A NIL+ E 
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEG 186

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  101 bits (252), Expect = 2e-23
 Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 253 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           + LG G +G+VY+G        VAVK LKE+       +F  E  ++    H NL++L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
            CT      ++  +MT G++   LRE       +       +A   +  + YL +     
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 372 IIHRDVKAANILLDED 387
            IHR++ A N L+ E+
Sbjct: 339 FIHRNLAARNCLVGEN 354

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 29/162 (17%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
              +G G FG+V++ R           +VAVK LKEE ++  +  FQ E  +++   + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER--------------------QSSLPPL 345
           +++L G C       L++ YM  G +   LR                          PPL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 346 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 98.3 bits (245), Expect = 3e-23
 Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 14/180 (7%)

Query: 209 WRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR- 267
           W              ED+  + L +  +    E +      +++  +GRG FG+V++ + 
Sbjct: 20  WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79

Query: 268 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT 327
              G   AVK+++ E           E+   +      ++ LYG         +    + 
Sbjct: 80  KQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133

Query: 328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            GS+   +++       L           +  GL YLH     +I+H DVKA N+LL  D
Sbjct: 134 GGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSD 186

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 24/157 (15%)

Query: 252 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 302
              LG G FG+V                  VAVK LK + T        +E++++ M   
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------- 351
           H+N++ L G CT      ++  Y + G++   L+ R+       +               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 352 -KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 227

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 98.1 bits (245), Expect = 5e-23
 Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 29/162 (17%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 304
             +LG G FGKV                VAVK LKE+  S       +E+K+++    H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS------- 357
           N++ L G CT      L++ Y   G + + LR ++      +     +  L         
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 358 ------------ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                       A+G+ +L        +HRD+ A N+L+   
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG 208

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 6e-23
 Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 24/157 (15%)

Query: 252 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 304
              LG G FGKV +              VAVK LK            +E+K++S    H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKK----------- 352
           N++ L G CT     L++  Y   G + + LR  R S +     P   +           
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 353 --IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              +   A+G+++L        IHRD+ A NILL   
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 96.1 bits (240), Expect = 9e-23
 Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 11/137 (8%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRL-KEE-RTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           LG+G F  VY+   +  G  VA+K + K+    +G   + Q EVKI     H ++L LY 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHCDP 370
           +        LV     NG +   L+ R       +   R  +  +    G+ YLH H   
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS--ENEARHFMHQI--ITGMLYLHSH--- 131

Query: 371 KIIHRDVKAANILLDED 387
            I+HRD+  +N+LL  +
Sbjct: 132 GILHRDLTLSNLLLTRN 148

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 24/156 (15%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F    +LG+G FG+V K R   D +  A+K+++   T        +EV +++   H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQYVV 65

Query: 308 RLYGF------------CTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLD-WPTRKKI 353
           R Y                     L +   Y  NG++   +     +    + W   ++I
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
                  LSY+H      IIHRD+K  NI +DE  +
Sbjct: 126 LEA----LSYIHSQ---GIIHRDLKPMNIFIDESRN 154

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 43/199 (21%)

Query: 227 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS 285
           S+     L    L  L+     F    ++G G +G+VYKGR +  G+L A+K +      
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--- 60

Query: 286 GGELQ-FQTEVKIIS-MAVHRNLLRLYG-----FCTTVTEKL-LVYPYMTNGSVA----- 332
           G E +  + E+ ++   + HRN+   YG         + ++L LV  +   GSV      
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 333 ---SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
              + L+E   +           I     RGLS+LH+H   K+IHRD+K  N+LL E+A+
Sbjct: 121 TKGNTLKEEWIAY----------ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167

Query: 390 ----------QSSKTILRR 398
                     Q  +T+ RR
Sbjct: 168 VKLVDFGVSAQLDRTVGRR 186

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 15/158 (9%)

Query: 235 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQT 293
           +    + + V    +S    +G GG  KV++      ++ A+K +  E      L  ++ 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75

Query: 294 EVKIISMAVHRNL--LRLYGFCTTVTEKLLVYPYM--TNGSVASRLRERQSSLPPLDWPT 349
           E+  ++     +   +RLY +  T      +Y  M   N  + S L++++S    +D   
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWE 128

Query: 350 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           RK         +  +H+H    I+H D+K AN L+ + 
Sbjct: 129 RKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG 163

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 32/140 (22%), Positives = 61/140 (43%), Gaps = 15/140 (10%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL--LRL 309
             +G GG  KV++      ++ A+K +  E      L  ++ E+  ++     +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 310 YGFCTTVTEKLLVYPYM--TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           Y +  T      +Y  M   N  + S L++++S    +D   RK         +  +H+H
Sbjct: 75  YDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH 127

Query: 368 CDPKIIHRDVKAANILLDED 387
               I+H D+K AN L+ + 
Sbjct: 128 ---GIVHSDLKPANFLIVDG 144

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 30/144 (20%), Positives = 61/144 (42%), Gaps = 6/144 (4%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQF-QTEVKIISMAVH 303
             F  +  +GRG F +VY+   L DG  VA+K+++  +            E+ ++    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            N+++ Y       E  +V      G ++  ++  +     +   T  K  +     L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           +H     +++HRD+K AN+ +   
Sbjct: 152 MHSR---RVMHRDIKPANVFITAT 172

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 33/154 (21%), Positives = 59/154 (38%), Gaps = 17/154 (11%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
             F     LGRGGFG V++ +   D    A+KR++         +   EVK ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 306 LLRLYGF---------CTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKI 353
           ++R +               + K+ +Y         ++   +  R +     +      I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHI 123

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            L  A  + +LH      ++HRD+K +NI    D
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 94.8 bits (236), Expect = 4e-22
 Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 7/153 (4%)

Query: 243 QVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 301
             +   +   +ILG+G    V++GR    G L A+K                E +++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 302 VHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
            H+N+++L+      T +   L+  +   GS+ + L E  ++   L       +      
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVG 123

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
           G+++L E+    I+HR++K  NI+     D  S
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 44/187 (23%), Positives = 65/187 (34%), Gaps = 18/187 (9%)

Query: 206 FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYK 265
           F    + +P    F   A +  +       R      Q     F   + LG G +G+V+K
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS----FQRLSRLGHGSYGEVFK 75

Query: 266 GR-LADGKLVAVKRL-KEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLV 322
            R   DG+L AVKR     R      +   EV     +  H   +RL        E  ++
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ---AWEEGGIL 132

Query: 323 YPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA 380
           Y        S+        +SLP             +   L++LH      ++H DVK A
Sbjct: 133 YLQTELCGPSLQQHCEAWGASLPE---AQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA 186

Query: 381 NILLDED 387
           NI L   
Sbjct: 187 NIFLGPR 193

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 95.3 bits (237), Expect = 7e-22
 Identities = 30/137 (21%), Positives = 61/137 (44%), Gaps = 11/137 (8%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL--LRL 309
             +G GG  KV++      ++ A+K +  E      L  ++ E+  ++     +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           Y +  T  + + +     N  + S L++++S    +D   RK         +  +H+H  
Sbjct: 122 YDYEIT-DQYIYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH-- 174

Query: 370 PKIIHRDVKAANILLDE 386
             I+H D+K AN L+ +
Sbjct: 175 -GIVHSDLKPANFLIVD 190

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 93.9 bits (234), Expect = 9e-22
 Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 6/166 (3%)

Query: 227 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS 285
           S    G+LK    +      +   +   +GRG +G V K      G+++AVKR++     
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 286 GGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP- 343
             + Q   ++ ++   +    +++ YG      +  +    M + S     +   S L  
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120

Query: 344 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
            +      KI L + + L++L E  + KIIHRD+K +NILLD   +
Sbjct: 121 VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGN 164

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 32/199 (16%)

Query: 212 TRPHEFFFDVPAEDDSELQ-----------LGQLKRFSLRELQVATD---GFSNKNILGR 257
              H   +D+P  ++   Q            G LK   + EL    D    FS+   +G 
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64

Query: 258 GGFGKVYKGR-LADGKLVAVKR--LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 314
           G FG VY  R + + ++VA+K+     ++++        EV+ +    H N ++  G C 
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CY 123

Query: 315 TVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYLHEHCDP 370
                  LV  Y   GS +  L   +  L         +IA    G+ +GL+YLH H   
Sbjct: 124 LREHTAWLVMEYC-LGSASDLLEVHKKPL------QEVEIAAVTHGALQGLAYLHSH--- 173

Query: 371 KIIHRDVKAANILLDEDAD 389
            +IHRDVKA NILL E   
Sbjct: 174 NMIHRDVKAGNILLSEPGL 192

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 27/156 (17%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           F    ++G GGFG+V+K +   DGK   +KR+K         + + EVK ++   H N++
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIV 67

Query: 308 RLYGF-------------CTTVTEKLLVYPYM---TNGSVASRLRERQSSLPPLDWPTRK 351
              G               ++ ++   ++  M     G++   + +R+     LD     
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLAL 125

Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           ++     +G+ Y+H     K+I+RD+K +NI L + 
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 7/153 (4%)

Query: 243 QVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 301
             +   +   +ILG+G    V++GR    G L A+K                E +++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 302 VHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
            H+N+++L+      T +   L+  +   GS+ + L E  ++   L       +      
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVG 123

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
           G+++L E+    I+HR++K  NI+     D  S
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 91.5 bits (228), Expect = 4e-21
 Identities = 32/139 (23%), Positives = 56/139 (40%), Gaps = 16/139 (11%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG+GGF K ++       ++ A K      L +        +   E+ I     H++++ 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 79

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
            +GF        +V       S+    + R+     L  P  +        G  YLH + 
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN- 134

Query: 369 DPKIIHRDVKAANILLDED 387
             ++IHRD+K  N+ L+ED
Sbjct: 135 --RVIHRDLKLGNLFLNED 151

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 15/147 (10%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHR 304
           + +     +G G FGK    +   DG+   +K +   R S  E +  + EV +++   H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARG 360
           N+++            +V  Y   G +  R+  ++  L      LDW    +I L     
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLA---- 137

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDED 387
           L ++H+    KI+HRD+K+ NI L +D
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKD 161

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 91.1 bits (227), Expect = 4e-21
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 10/136 (7%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 311
           LG+G FG VY  R      ++A+K L + +   +G E Q + EV+I S   H N+LRLYG
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
           +    T   L+  Y   G+V   L++        D           A  LSY H     +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---R 129

Query: 372 IIHRDVKAANILLDED 387
           +IHRD+K  N+LL   
Sbjct: 130 VIHRDIKPENLLLGSA 145

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 22/162 (13%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           ++    +G+G  G VY    +A G+ VA++++  ++    EL    E+ ++    + N++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80

Query: 308 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
                   V ++L +V  Y+  GS+   + E       +D      +     + L +LH 
Sbjct: 81  NYLD-SYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS 134

Query: 367 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 398
           +   ++IHRD+K+ NILL  D            Q +    +R
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 91.6 bits (228), Expect = 8e-21
 Identities = 32/139 (23%), Positives = 56/139 (40%), Gaps = 16/139 (11%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           LG+GGF K ++       ++ A K      L +        +   E+ I     H++++ 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
            +GF        +V       S+    + R+     L  P  +        G  YLH + 
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN- 160

Query: 369 DPKIIHRDVKAANILLDED 387
             ++IHRD+K  N+ L+ED
Sbjct: 161 --RVIHRDLKLGNLFLNED 177

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 90.9 bits (226), Expect = 9e-21
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 32/167 (19%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
             +   +G G  G V   R    G+ VAVK +   +    EL    EV I+    H N++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVV 105

Query: 308 RLYGFCTTVTEKL-LVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGL 361
            +Y     V E+L ++  ++  G++       RL E Q +           +     + L
Sbjct: 106 EMYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT----------VCEAVLQAL 154

Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 398
           +YLH      +IHRD+K+ +ILL  D            Q SK + +R
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 37/147 (25%), Positives = 61/147 (41%), Gaps = 6/147 (4%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHR 304
           + +     +G G +G+  K R  +DGK++  K L     +  E Q   +EV ++    H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 305 NLLRLYG-FCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           N++R Y          L +V  Y   G +AS + +       LD     ++       L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 363 YLHEHCDP--KIIHRDVKAANILLDED 387
             H   D    ++HRD+K AN+ LD  
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK 152

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 30/166 (18%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNL 306
           F     LG G +G VYK      G++VA+K++  E        +   E+ I+      ++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ----EIIKEISIMQQCDSPHV 86

Query: 307 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLS 362
           ++ YG        L +V  Y   GSV+  +R R  +L      T  +IA     + +GL 
Sbjct: 87  VKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL------TEDEIATILQSTLKGLE 139

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 398
           YLH     + IHRD+KA NILL+ +            Q + T+ +R
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 35/150 (23%), Positives = 64/150 (42%), Gaps = 5/150 (3%)

Query: 242 LQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-S 299
           ++V  D       LGRG +G V K R +  G+++AVKR++    S  + +   ++ I   
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
                  +  YG      +  +    M + S+    ++       +      KIA+   +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
            L +LH      +IHRDVK +N+L++    
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQ 148

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 89.4 bits (222), Expect = 9e-20
 Identities = 32/149 (21%), Positives = 60/149 (40%), Gaps = 12/149 (8%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
           F  K++LG G  G +    + D + VAVKR+  E  S        EV++      H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVI 81

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           R +        + +        ++   + ++  +   L+      +   +  GL++LH  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL 137

Query: 368 CDPKIIHRDVKAANILLDEDADQSSKTIL 396
               I+HRD+K  NIL+           +
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAM 163

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 12/137 (8%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 311
           LG+G FG VY  R   +  ++A+K L + +    G E Q + E++I S   H N+LR+Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHCDP 370
           +        L+  +   G +   L+ +       +  +   +  L  A  L Y HE    
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQ-KHGRFD--EQRSATFMEELADA--LHYCHER--- 133

Query: 371 KIIHRDVKAANILLDED 387
           K+IHRD+K  N+L+   
Sbjct: 134 KVIHRDIKPENLLMGYK 150

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 89.4 bits (221), Expect = 2e-19
 Identities = 41/150 (27%), Positives = 64/150 (42%), Gaps = 17/150 (11%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K  LG GGFG V +      G+ VA+K+ ++E +     ++  E++I+    H N++   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 311 ------GFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIA-LGSARGL 361
                          LL   Y   G +   L   E    L       R  ++ + SA  L
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP--IRTLLSDISSA--L 134

Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDADQS 391
            YLHE+   +IIHRD+K  NI+L     + 
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRL 161

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 23/153 (15%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKRLK----------------EERTSGGELQFQTEVKII 298
           L +G F K+      D K  A+K+ +                +         F+ E++II
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 299 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----SSLPPLDWPTRKKIA 354
           +   +   L   G  T   E  ++Y YM N S+            +    +     K I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 355 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                  SY+H   +  I HRDVK +NIL+D++
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN 188

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 15/176 (8%)

Query: 223 AEDDSELQLGQLKRFSLREL--------QVATDGFSNKNILGRGGFGKVYKGRL-ADGKL 273
            +   EL+L + +R  L           ++  D F   + LG G  G V+K      G +
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 274 VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS 333
           +A K +  E       Q   E++++       ++  YG   +  E  +   +M  GS+  
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 334 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
            L++       +      K+++   +GL+YL E    KI+HRDVK +NIL++   +
Sbjct: 121 VLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGE 170

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 18/165 (10%), Positives = 36/165 (21%), Gaps = 34/165 (20%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
            L  G    V+  R +   +  A+K   +  E +     +        +  +  +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 311 GFC--------------------------TTVTEKLLVYPYM--TNGSVASRLRERQSSL 342
                                          V   LL+ P        + S L       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 343 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                     +     R  + L       ++H      N+ +  D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPD 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 24/160 (15%), Positives = 58/160 (36%), Gaps = 11/160 (6%)

Query: 240 RELQVATDGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQT 293
            E Q+ +      ++LG G F +VY+          + +   +K  K        +  Q 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116

Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKK 352
            ++ +  ++    ++ Y         +LV    + G++ + +   + +    +       
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 353 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
            A+     +  +H+    +IIH D+K  N +L     +  
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 37/150 (24%), Positives = 60/150 (40%), Gaps = 12/150 (8%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 307
             ++ ILG G  G V       G+ VAVKR+  +           E+K+      H N++
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVI 72

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYL 364
           R Y   TT     +      N ++   +  +  S   L          +    A G+++L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 365 HEHCDPKIIHRDVKAANILLDEDADQSSKT 394
           H     KIIHRD+K  NIL+   +  ++  
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQ 158

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 8/154 (5%)

Query: 238 SLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK 296
             +  Q   +   N   +G G  G+V+K R    G ++AVK+++         +   ++ 
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75

Query: 297 IISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 355
           ++  +     +++ +G   T T+  +    M   +   + R +     P+      K+ +
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTV 131

Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
              + L YL E     +IHRDVK +NILLDE   
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQ 163

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 12/142 (8%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGF 312
           L  GGF  VY+ + +  G+  A+KRL              EV  +  ++ H N+++    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 313 CTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
            +   E+        L+   +  G +   L++ +S   PL   T  KI   + R + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMH 153

Query: 366 EHCDPKIIHRDVKAANILLDED 387
               P IIHRD+K  N+LL   
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQ 174

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 27/166 (16%), Positives = 55/166 (33%), Gaps = 35/166 (21%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVK--------------RLKEERTSGGELQ-------- 290
           +LG+       +      G+   V               ++KEE      L+        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 291 -----FQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM--TNGSVASRLRERQSS 341
                F     ++     + ++R+        V  +  +YP M     +    L    S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 342 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              L    R ++ L   R L+ LH +    ++H  ++  +I+LD+ 
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 242

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 34/150 (22%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVK---RLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           LG G +GKV +          AVK   + K  R   GE   + E++++    H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 311 GFCTTVTEK--LLVYPYMTNGS-------VASRLRERQSSLPPLDWPTRKK----IALGS 357
                  ++   +V  Y   G           R    Q+                I    
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA---------HGYFCQLID--- 120

Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             GL YLH      I+H+D+K  N+LL   
Sbjct: 121 --GLEYLHSQ---GIVHKDIKPGNLLLTTG 145

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 27/166 (16%), Positives = 51/166 (30%), Gaps = 35/166 (21%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQTEVKII------------ 298
           +LG+       +      G+   V      E   S    Q + EV  +            
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 299 ----SMAVHRNLLRLYGFCT-----------TVTEKLLVYPYM--TNGSVASRLRERQSS 341
                     +L++                  V  +  +YP M     +    L    S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 342 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              L    R ++ L   R L+ LH +    ++H  ++  +I+LD+ 
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 247

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 34/151 (22%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISMAVHR--NL 306
           LG GGFG VY G  ++D   VA+K     R+ +        +   EV ++         +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 307 LRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IALG 356
           +RL  +       +L+              +    L+E  +         R     +   
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---------RSFFWQVL-- 159

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               + + H      ++HRD+K  NIL+D +
Sbjct: 160 --EAVRHCHNC---GVLHRDIKDENILIDLN 185

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 28/144 (19%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           LG G +G+V         + VAVK +  +R        + E+ I  M  H N+++ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 314 TTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 363
                + L   Y + G +         + E  +         ++     +A     G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMA-----GVVY 120

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           LH      I HRD+K  N+LLDE 
Sbjct: 121 LHGI---GITHRDIKPENLLLDER 141

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 19/156 (12%)

Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKI-- 297
           AT  +     +G G +G VYK R    G  VA+K ++     GG      +   EV +  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 298 -ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRK 351
            +    H N++RL   C T          LV+ ++    + + L +     P L   T K
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPAETIK 123

Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            +     RGL +LH +    I+HRD+K  NIL+   
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG 156

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 36/144 (25%), Positives = 56/144 (38%), Gaps = 28/144 (19%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           LG G +G+V         + VAVK +  +R        + E+ I  M  H N+++ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 314 TTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 363
                + L   Y + G           + E  +         ++     +A     G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMA-----GVVY 120

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           LH      I HRD+K  N+LLDE 
Sbjct: 121 LHGI---GITHRDIKPENLLLDER 141

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 304
           + +     +G G +G VYK + + G++VA+KR++ +    G +      E+ ++    H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHP 79

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N++ L     +     LV+ +M    +   L E ++ L        K       RG+++ 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD---SQIKIYLYQLLRGVAHC 135

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H+H   +I+HRD+K  N+L++ D
Sbjct: 136 HQH---RILHRDLKPQNLLINSD 155

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 35/153 (22%), Positives = 54/153 (35%), Gaps = 36/153 (23%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISM----AVHR 304
           LG+GGFG V+ G  L D   VA+K     R+         +    EV ++        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IA 354
            ++RL  +  T    +LV              +    L E  S         R     + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---------RCFFGQVV 149

Query: 355 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                 + + H      ++HRD+K  NIL+D  
Sbjct: 150 ----AAIQHCHSR---GVVHRDIKDENILIDLR 175

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 48/267 (17%), Positives = 82/267 (30%), Gaps = 47/267 (17%)

Query: 138 SQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAAL 197
                   +N  N      ++     P  +         S   + S +A           
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANL--------- 54

Query: 198 LFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGR 257
                       +       +F     +D        K F           +  K+++GR
Sbjct: 55  --LAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGR 104

Query: 258 GGFGKVYKGR-LADGKLVAVK-------RLKEERTSGGELQFQTEVKII-SMAVHRNLLR 308
           G    V +    A G   AVK       RL  E+        + E  I+  +A H +++ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 309 LYGFCTTVTEKLLVYPYMTNGS-----VAS-RLRERQSSLPPLDWPTRKKIALGSARGLS 362
           L     + +   LV+  M  G           L E+++            I       +S
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSLLEAVS 214

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDAD 389
           +LH +    I+HRD+K  NILLD++  
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQ 238

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 23/142 (16%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +G+G F KV   R +  G+ VA+K + K +       +   EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 313 CTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLH 365
             T     L+  Y + G V        R++E+++         R K   + SA  + Y H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA---------RSKFRQIVSA--VQYCH 131

Query: 366 EHCDPKIIHRDVKAANILLDED 387
           +     I+HRD+KA N+LLD D
Sbjct: 132 QKR---IVHRDLKAENLLLDAD 150

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 35/149 (23%), Positives = 59/149 (39%), Gaps = 16/149 (10%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 301
           D +     LG G +G+VYK       + VA+KR++ E    G      T   EV ++   
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG---VPGTAIREVSLLKEL 90

Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            HRN++ L           L++ Y       + L++     P +     K        G+
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145

Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDADQ 390
           ++ H     + +HRD+K  N+LL      
Sbjct: 146 NFCHSR---RCLHRDLKPQNLLLSVSDAS 171

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 16/140 (11%)

Query: 255 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 312
           +  GG G +Y       +G+ V +K L     +  +     E + ++  VH ++++++ F
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 313 CTTVTEKLLVYPYM-----TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
                       Y+        S+     +       L         L     LSYLH  
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI 201

Query: 368 CDPKIIHRDVKAANILLDED 387
               +++ D+K  NI+L E+
Sbjct: 202 ---GLVYNDLKPENIMLTEE 218

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 301
             +     +G+G FG+V+K R    G+ VA+K++  E    G   F  T   E+KI+ + 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73

Query: 302 VHRNLLRLYGFCTTVTEKL--------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 353
            H N++ L   C T             LV+ +  +  +A  L               K++
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL---SEIKRV 129

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                 GL Y+H +   KI+HRD+KAAN+L+  D
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRD 160

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 74.1 bits (183), Expect = 5e-15
 Identities = 35/146 (23%), Positives = 72/146 (49%), Gaps = 14/146 (9%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 303
           + F     +G G +G VYK R    G++VA+K+++ +  + G +      E+ ++    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNH 61

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGL 361
            N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +GL
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
           ++ H H   +++HRD+K  N+L++ +
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTE 139

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 74.5 bits (183), Expect = 6e-15
 Identities = 32/185 (17%), Positives = 50/185 (27%), Gaps = 44/185 (23%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVK----RLKEERTSGGELQFQTEVKIISMAVHRNL 306
           K  +G+G +G V          + A+K        +       + +TEV+++    H N+
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR------- 359
            RLY          LV      G +  +L                K  +           
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 360 -----------------------------GLSYLHEHCDPKIIHRDVKAANILLDEDADQ 390
                                         L YLH      I HRD+K  N L   +   
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207

Query: 391 SSKTI 395
             K +
Sbjct: 208 EIKLV 212

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 73.7 bits (182), Expect = 6e-15
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 304
           + +     +G G +G VYK +   G+  A+K+++ E+   G +   T  E+ I+    H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHS 60

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++LY    T    +LV+ ++    +   L   +  L      T K   L    G++Y 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLES---VTAKSFLLQLLNGIAYC 116

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H+    +++HRD+K  N+L++ +
Sbjct: 117 HDR---RVLHRDLKPQNLLINRE 136

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 27/188 (14%)

Query: 224 EDDSELQLGQLKRF-------SLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADG 271
            ++SE+ L   +         ++ +  V      ++      LG G  G+V         
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160

Query: 272 KLVAVK-------RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP 324
           K VA++        +   R +   L  +TE++I+    H  ++++  F     +  +V  
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLE 219

Query: 325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
            M  G +  ++   +     L   T K         + YLHE+    IIHRD+K  N+LL
Sbjct: 220 LMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272

Query: 385 DEDADQSS 392
               +   
Sbjct: 273 SSQEEDCL 280

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 74.9 bits (184), Expect = 8e-15
 Identities = 36/183 (19%), Positives = 74/183 (40%), Gaps = 20/183 (10%)

Query: 222 PAEDDSELQLGQLKRFSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAV 276
            + +         K++  + +++  D   +       LG G FG V++    A G   A 
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187

Query: 277 KRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 336
           K +     S  E   + E++ +S+  H  L+ L+       E +++Y +M+ G +  ++ 
Sbjct: 188 KFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246

Query: 337 ERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
           +  + +   +       A+   R    GL ++HE+     +H D+K  NI+         
Sbjct: 247 DEHNKMSEDE-------AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 296

Query: 393 KTI 395
           K I
Sbjct: 297 KLI 299

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 12/146 (8%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 301
             +   + LG G F  VYK R     ++VA+K++K    S  +    +T   E+K++   
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N++ L       +   LV+ +M    +   +++    L P      K   L + +GL
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP---SHIKAYMLMTLQGL 125

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            YLH+H    I+HRD+K  N+LLDE+
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDEN 148

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 8/142 (5%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           + +   + LG G +  VYKG+      LVA+K ++ E   G       EV ++    H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           ++ L+    T     LV+ Y+    +   L +  + +        K       RGL+Y H
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINM---HNVKLFLFQLLRGLAYCH 117

Query: 366 EHCDPKIIHRDVKAANILLDED 387
                K++HRD+K  N+L++E 
Sbjct: 118 RQ---KVLHRDLKPQNLLINER 136

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 35/151 (23%), Positives = 53/151 (35%), Gaps = 34/151 (22%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEER-------TSGGELQFQTEVKIISMAVHRNL 306
           LG G FG V+        K V VK +K+E+             +   E+ I+S   H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 307 LRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IALG 356
           +++           LV     +G           RL E  +               +   
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA---------SYIFRQLV-- 140

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               + YL       IIHRD+K  NI++ ED
Sbjct: 141 --SAVGYLRLK---DIIHRDIKDENIVIAED 166

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 11/144 (7%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 303
           + + N  ++G G +G V K R    G++VA+K+  E       ++     E+K++    H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRH 83

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            NL+ L   C       LV+ ++ + ++   L    + L        +K       G+ +
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDY---QVVQKYLFQIINGIGF 139

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
            H H    IIHRD+K  NIL+ + 
Sbjct: 140 CHSH---NIIHRDIKPENILVSQS 160

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 30/144 (20%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           +G G FG     R     +LVAVK +  ER +  +   Q E+       H N++R     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 314 TTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 363
            T T   ++  Y + G +      A R  E ++         R      ++     G+SY
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEA---------RFFFQQLLS-----GVSY 131

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
            H     +I HRD+K  N LLD  
Sbjct: 132 CHSM---QICHRDLKLENTLLDGS 152

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 12/115 (10%)

Query: 40  DPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLN 99
           + N  L  W   PG       ++ N  G VT + L     SG +   +GQL  LE+L L 
Sbjct: 61  NFNKELDMWGAQPG-------VSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALG 113

Query: 100 NNSLSG----LIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 150
           ++          P  ++   S                D      F+ +  ++ +N
Sbjct: 114 SHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI-KDCIN 167

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 65.8 bits (161), Expect = 8e-12
 Identities = 11/86 (12%), Positives = 27/86 (31%)

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLS 123
           N   +    +   A        +   LK+L  + + N      +PT L  +  + +++++
Sbjct: 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281

Query: 124 NNRLSGPVPDNGSFSQFTPISFENNL 149
            NR          +           +
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKI 307

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 18/89 (20%), Positives = 36/89 (40%), Gaps = 10/89 (11%)

Query: 70  TRVDLGNAALSG-------ELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL 122
           + +D     +          L P   +  N+  + L+NN +S       +T + L+ ++L
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464

Query: 123 SNNRLSGPVPDNGSFSQFTPISFENNLNL 151
             N L+  +P N    +    +F+N   L
Sbjct: 465 MGNMLTE-IPKNSLKDE--NENFKNTYLL 490

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 13/72 (18%), Positives = 26/72 (36%), Gaps = 2/72 (2%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             ++     L G+L P  G    L  L L  N ++ +          +  L  ++N+L  
Sbjct: 333 GMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391

Query: 130 PVPDNGSFSQFT 141
            +P+       +
Sbjct: 392 -IPNIFDAKSVS 402

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 14/81 (17%), Positives = 29/81 (35%), Gaps = 8/81 (9%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGL-------IPTSLTTITSLNIL 120
           +V+ ++L N  +S            L  + L  N L+ +          +      L  +
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493

Query: 121 DLSNNRLSGPVPDNGSFSQFT 141
           DL  N+L+  + D+   +   
Sbjct: 494 DLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 14/81 (17%), Positives = 26/81 (32%), Gaps = 11/81 (13%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGL--------IPTSLTTITSLNILD 121
           T V++ N     +L   L  L  ++L+ +  N                       + I+ 
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311

Query: 122 LSNNRL-SGPVPDNGSFSQFT 141
           +  N L + PV    S  +  
Sbjct: 312 IGYNNLKTFPVET--SLQKMK 330

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 17/88 (19%), Positives = 24/88 (27%), Gaps = 5/88 (5%)

Query: 81  GELAPELGQLKNLELLRLNNNSLSGLIPT-SLTTITSLNILDLSNNRLSGPVPDNGSFSQ 139
            +          L  + L  N L+ L      TT+  L  +DLS N  S       + S 
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSST 537

Query: 140 FTPISFENNLNLCGPNTKKPCSGSPPFS 167
                  N  +  G           P  
Sbjct: 538 LKGFGIRNQRDAQGNR----TLREWPEG 561

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 9/84 (10%), Positives = 28/84 (33%), Gaps = 6/84 (7%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           D        E    +    +L  L++ +N +  +         ++++LD+ +N       
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITP---NISVLDIKDNPNISIDL 604

Query: 133 D---NGSFSQFTPISFENNLNLCG 153
                   +    + ++   ++ G
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQDIRG 628

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 15/88 (17%), Positives = 29/88 (32%), Gaps = 9/88 (10%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNN------NSLSGLIPTSLTTITSLNILDLSNNR 126
           DL   + S     +      L+   + N      N      P  +T   SL  L + +N 
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577

Query: 127 LSGPVPDNGSFSQFTPISFENNLNLCGP 154
           +   V +       + +  ++N N+   
Sbjct: 578 IRK-VNEK-ITPNISVLDIKDNPNISID 603

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 11/55 (20%), Positives = 26/55 (47%), Gaps = 1/55 (1%)

Query: 79  LSGELAPELGQLKNLELLRLNNNSLSGL-IPTSLTTITSLNILDLSNNRLSGPVP 132
              +   +    + ++++ +  N+L    + TSL  +  L +L+   N+L G +P
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 6/55 (10%), Positives = 23/55 (41%), Gaps = 7/55 (12%)

Query: 86  ELGQLKNLELLRLNNNSLSGLIPTSLTTI-------TSLNILDLSNNRLSGPVPD 133
           +   +  +  +  + N +  +   +   +        +++ ++LSNN++S    +
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 10/107 (9%), Positives = 30/107 (28%), Gaps = 21/107 (19%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGL-------------------IP 108
             T++   +  ++  ++  + +L  L    + N+                          
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242

Query: 109 TSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCGP 154
                +  L  +++ N      +P    +  +   I+   N  + G 
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 9/87 (10%), Positives = 20/87 (22%), Gaps = 7/87 (8%)

Query: 50  NLPGNLCTWFHITCNPEG-----SVTRVDLGNAALSGELAPELG--QLKNLELLRLNNNS 102
            L  +          P+G     S  +                      +L    +N++ 
Sbjct: 111 ALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDP 170

Query: 103 LSGLIPTSLTTITSLNILDLSNNRLSG 129
               I  S         +   +N ++ 
Sbjct: 171 QQKSIKKSSRITLKDTQIGQLSNNITF 197

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 14/155 (9%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVH 303
           ++ +     LG G +G+V   R        A+K +++   S         EV ++ +  H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGL 361
            N+++LY F        LV      G +   +  R        +       I      G+
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGV 149

Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 395
           +YLH+H    I+HRD+K  N+LL+     +  K +
Sbjct: 150 TYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 29/144 (20%), Positives = 62/144 (43%), Gaps = 11/144 (7%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 303
             +     +G G +G V+K +     ++VA+KR++ +    G +      E+ ++    H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKH 60

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
           +N++RL+    +  +  LV+ +     +          L P      K       +GL +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGF 116

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
            H      ++HRD+K  N+L++ +
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRN 137

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 33/144 (22%), Positives = 61/144 (42%), Gaps = 15/144 (10%)

Query: 255 LGRGGFGKVYKGR---LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           +GRG +G VYK +     D K  A+K+++     G  +    E+ ++    H N++ L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85

Query: 312 FCTTVTEKL--LVYPYM----TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
              +  ++   L++ Y      +     R  +       L     K +      G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 366 EHCDPKIIHRDVKAANILLDEDAD 389
            +    ++HRD+K ANIL+  +  
Sbjct: 146 AN---WVLHRDLKPANILVMGEGP 166

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 36/183 (19%), Positives = 70/183 (38%), Gaps = 20/183 (10%)

Query: 222 PAEDDSELQLGQLKRFSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAV 276
              D  +      K++  + ++V      +       LG G FG V++    A G++   
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81

Query: 277 KRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 336
           K +            + E+ I++   H  L+ L+       E +L+  +++ G +  R+ 
Sbjct: 82  KFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140

Query: 337 ERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
                +   +        +   R    GL ++HEH    I+H D+K  NI+ +     S 
Sbjct: 141 AEDYKMSEAE-------VINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV 190

Query: 393 KTI 395
           K I
Sbjct: 191 KII 193

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 42/148 (28%), Positives = 60/148 (40%), Gaps = 17/148 (11%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVK--------RLKEERTSGGELQFQTEVKII-SMA 301
           K ILGRG    V +       K  AVK            E           EV I+  ++
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            H N+++L     T T   LV+  M  G +   L E+ +    L     +KI       +
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVI 137

Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDAD 389
             LH+     I+HRD+K  NILLD+D +
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMN 162

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 71.4 bits (176), Expect = 4e-14
 Identities = 36/145 (24%), Positives = 63/145 (43%), Gaps = 13/145 (8%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAV 302
           + +     +G G +G V+K R    G++VA+K+  E        +      E++++    
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK--IALREIRMLKQLK 60

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H NL+ L           LV+ Y  + +V   L   Q  +P       K I   + + ++
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPE---HLVKSITWQTLQAVN 116

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           + H+H     IHRDVK  NIL+ + 
Sbjct: 117 FCHKH---NCIHRDVKPENILITKH 138

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 37/146 (25%), Positives = 68/146 (46%), Gaps = 30/146 (20%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYG 311
           LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 312 FCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGL 361
             +T T+  +V  Y++ G +        R+ E ++         R+     ++      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA---------RRLFQQILS-----AV 124

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            Y H H    ++HRD+K  N+LLD  
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAH 147

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 31/146 (21%), Positives = 61/146 (41%), Gaps = 5/146 (3%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           K  LG G FG V+     + G    +K + ++R+     Q + E++++    H N+++++
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
                     +V      G +  R+   Q+    L      ++       L+Y H     
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143

Query: 371 KIIHRDVKAANILLDEDADQSS-KTI 395
            ++H+D+K  NIL  + +  S  K I
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKII 169

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 15/148 (10%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
           ++N  ++G G FG V++ +L +   VA+K++ +++          E++I+ +  H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-----RELQIMRIVKHPNVVD 96

Query: 309 LYGFCTTVTEKL------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           L  F  +  +K       LV  Y+   +V    R        +     K       R L+
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 363 YLHEHCDPKIIHRDVKAANILLDEDADQ 390
           Y+H      I HRD+K  N+LLD  +  
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGV 180

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 24/186 (12%)

Query: 211 RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 270
              P + F D         +  Q K    +   +  D F +  +LGRGGFG+V+  ++  
Sbjct: 155 GQAPFQEFLDSLYFL----RFLQWKWLEAQ--PMGEDWFLDFRVLGRGGFGEVFACQMKA 208

Query: 271 -GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPY 325
            GKL A K+L ++R     G      E KI++    R ++ L Y F T     L LV   
Sbjct: 209 TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLCLVMTI 266

Query: 326 MTNGSVASRLRERQSSLPPLDWPTRK----KIALGSARGLSYLHEHCDPKIIHRDVKAAN 381
           M  G +   +       P    P       +I  G    L +LH+     II+RD+K  N
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPEN 319

Query: 382 ILLDED 387
           +LLD+D
Sbjct: 320 VLLDDD 325

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 8/148 (5%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
            S   ILG G FG+V+K    A G  +A K +K       E + + E+ +++   H NL+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           +LY    +  + +LV  Y+  G +  R+ +   +L  LD     K       G+ ++H+ 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQM 206

Query: 368 CDPKIIHRDVKAANILLDEDADQSSKTI 395
               I+H D+K  NIL      +  K I
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKII 231

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 70.7 bits (174), Expect = 8e-14
 Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 7/146 (4%)

Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 303
           ++  F     LG G +  VYKG     G  VA+K +K +   G       E+ ++    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTN--GSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
            N++RLY    T  +  LV+ +M N             +    L+    K       +GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP-RGLELNLVKYFQWQLLQGL 121

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
           ++ HE+   KI+HRD+K  N+L+++ 
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKR 144

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 35/159 (22%), Positives = 67/159 (42%), Gaps = 22/159 (13%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVH 303
            + ++   +LG+G FG+V K +     +  AVK + +      +      EV+++    H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGS 357
            N+++L+      +   +V    T G +   +       E  ++          +I    
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQV 130

Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 395
             G++Y+H+H    I+HRD+K  NILL+        K I
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 29/146 (19%), Positives = 54/146 (36%), Gaps = 11/146 (7%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL----QFQTEVKIISMAVHRNL 306
             ++G+G F  V +      G+  AVK +   + +          + E  I  M  H ++
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           + L    ++     +V+ +M    +   + +R  +                   L Y H+
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 367 HCDPKIIHRDVKAANILL---DEDAD 389
           +    IIHRDVK   +LL   +  A 
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAP 171

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 39/169 (23%), Positives = 60/169 (35%), Gaps = 52/169 (30%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVK-------------------------RLKEERTSGGE 288
           +G+G +G V       D    A+K                              +  G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 289 LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLD 346
            Q   E+ I+    H N+++L        E  L  V+  +  G V             ++
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127

Query: 347 WPTRKKIALGSAR--------GLSYLHEHCDPKIIHRDVKAANILLDED 387
            PT K ++   AR        G+ YLH     KIIHRD+K +N+L+ ED
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGED 173

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 37/156 (23%), Positives = 72/156 (46%), Gaps = 15/156 (9%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAV 302
           +D +  + +LG+G FG+V   +    G+  AVK + + +            EV+++    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARG 360
           H N+++LY F        LV    T G +   +  R+       +      +I      G
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSG 138

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 395
           ++Y+H++   KI+HRD+K  N+LL+  +  ++ + I
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 37/155 (23%), Positives = 59/155 (38%), Gaps = 28/155 (18%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVK-------RLKEERTSGGELQFQTEVKIISMAVH 303
              LG G  G+V         K VA+K        +   R +   L  +TE++I+    H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGS 357
             ++++  F     +  +V   M  G          RL+E    L         ++ L  
Sbjct: 75  PCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKL------YFYQMLL-- 125

Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
              + YLHE+    IIHRD+K  N+LL    +   
Sbjct: 126 --AVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 16/149 (10%)

Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           +++  ++G G FG VY+ +L D G+LVA+K++ +++          E++I+    H N++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIV 110

Query: 308 RLYGFCTTVTEKL------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
           RL  F  +  EK       LV  Y+   +V    R    +   L     K       R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDADQ 390
           +Y+H      I HRD+K  N+LLD D   
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAV 195

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 30/146 (20%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 311
           LG G FGKV  G+    G  VAVK L  ++  +     + + E++ + +  H ++++LY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 312 FCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGL 361
             +T ++  +V  Y++ G +        RL E++S         R+     ++     G+
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES---------RRLFQQILS-----GV 129

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            Y H H    ++HRD+K  N+LLD  
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAH 152

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 35/138 (25%), Positives = 55/138 (39%), Gaps = 14/138 (10%)

Query: 255 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 309
           LG GG   VY     D  L   VA+K +        E    F+ EV   S   H+N++ +
Sbjct: 19  LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
                      LV  Y+   +++  +        PL   T          G+ + H+   
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM-- 130

Query: 370 PKIIHRDVKAANILLDED 387
            +I+HRD+K  NIL+D +
Sbjct: 131 -RIVHRDIKPQNILIDSN 147

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 27/157 (17%)

Query: 247 DGFSNKNILGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQF-QT---EVKI--- 297
             +     +G G +GKV+K R     G+ VA+KR++ +    G      +   EV +   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRH 67

Query: 298 ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRE--RQSSLPPLDWPTR 350
           +    H N++RL+  CT           LV+ ++        L     +   P +   T 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETI 122

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           K +     RGL +LH H   +++HRD+K  NIL+   
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 21/137 (15%), Positives = 39/137 (28%), Gaps = 14/137 (10%)

Query: 12  STIVLVALPMISANA-EVDALYIFKSKLQDPNNSLQSWDNLPG----------NLCTWFH 60
              V + L   +    +  AL      L   N    S                 L  W  
Sbjct: 254 DANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGD 313

Query: 61  ---ITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSL 117
              +  +  G VT + L      G +   +GQL  L++L    +S +           + 
Sbjct: 314 QPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373

Query: 118 NILDLSNNRLSGPVPDN 134
           ++ +   +R+       
Sbjct: 374 DMSEERKHRIRMHYKKM 390

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 13/88 (14%), Positives = 26/88 (29%), Gaps = 1/88 (1%)

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLS 123
           N        +   A            LK+L  + L N      +P  L  +  L  L+++
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523

Query: 124 NNRLSGPVPDNGSFSQFTPISFENNLNL 151
            NR          +++      +    +
Sbjct: 524 CNRGISAAQLKADWTRL-ADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 10/57 (17%), Positives = 20/57 (35%), Gaps = 1/57 (1%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
              G    L  L+L+ N +  +          +  L  S+N+L   +P+  +     
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVY 644

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 12/67 (17%), Positives = 29/67 (43%), Gaps = 3/67 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 144
            +  +  N   + L+ N +         T + ++ + LSNN ++  +P+N    +    +
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPENSLKPK--DGN 723

Query: 145 FENNLNL 151
           ++N   L
Sbjct: 724 YKNTYLL 730

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.9 bits (119), Expect = 9e-07
 Identities = 17/95 (17%), Positives = 33/95 (34%), Gaps = 9/95 (9%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRL------NNNSLSGLIPTSLTTITSLNILD 121
            ++ +D+     S     +      L+   +        N +    PT +TT  SL  L 
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812

Query: 122 LSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT 156
           + +N +   V +     Q   +   +N N+    T
Sbjct: 813 IGSNDIRK-VDEK-LTPQLYILDIADNPNISIDVT 845

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 13/69 (18%), Positives = 29/69 (42%), Gaps = 2/69 (2%)

Query: 81  GELAPELGQLKNLELLRLNNNSLSGL-IPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 139
             LA +      +++  +  N+L       SL  +  L +LD  +N++   +   G+  +
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVK 596

Query: 140 FTPISFENN 148
            T +  + N
Sbjct: 597 LTDLKLDYN 605

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 9/68 (13%), Positives = 21/68 (30%), Gaps = 19/68 (27%)

Query: 85  PELGQLKNLELLRLNNNSLSGL-------------------IPTSLTTITSLNILDLSNN 125
             + +L  L+++   N+  +                        S + +  L  ++L N 
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501

Query: 126 RLSGPVPD 133
                +PD
Sbjct: 502 PNMTQLPD 509

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 11/45 (24%), Positives = 18/45 (40%), Gaps = 2/45 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             L ++  L LL   +N +  L   +  T   L  L L  N++  
Sbjct: 567 ASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDYNQIEE 609

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 14/91 (15%), Positives = 31/91 (34%), Gaps = 20/91 (21%)

Query: 85  PELGQLKNLELLRLNNNSLSGL------IPTSLTTITSLNILDLSNNRLSGPVP------ 132
           PE+  +K    + L +  +  L      I  ++  +T L I+  +N+  +          
Sbjct: 412 PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWED 471

Query: 133 ---DNGSFSQFTPISFEN-----NLNLCGPN 155
              D     +   +S+ N     ++ L    
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCP 502

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 299
            D +     LG G F  V K R  + G   A K     + +  R      + + EV I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
             +H N++ L+      T+ +L+   ++ G +   L +++S        + ++      +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------LSEEEAT-SFIK 122

Query: 360 ----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 393
               G++YLH     KI H D+K  NI+L +       
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 299
            D +     LG G F  V K R  + G   A K     + +  R      + + EV I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
             +H N++ L+      T+ +L+   ++ G +   L +++S        + ++      +
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------LSEEEAT-SFIK 122

Query: 360 ----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 393
               G++YLH     KI H D+K  NI+L +       
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 36/149 (24%), Positives = 63/149 (42%), Gaps = 37/149 (24%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHRNLLRLYG 311
           LG G FGKV         + VA+K +  +     ++  +   E+  + +  H ++++LY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 312 FCTTVTEKLLVYPY---------MTNGSVASRLRERQSSLPPLDWPTRKK----IALGSA 358
             TT T+ ++V  Y         +       R+ E +          R+     I     
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKK----RMTEDEG---------RRFFQQIIC---- 119

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
             + Y H H   KI+HRD+K  N+LLD++
Sbjct: 120 -AIEYCHRH---KIVHRDLKPENLLLDDN 144

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 33/151 (21%), Positives = 60/151 (39%), Gaps = 25/151 (16%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 309
           K  LG+G F  V +      G   A K +  ++ S  + Q  + E +I     H N++RL
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GL 361
           +      +   LV+  +T G +   +  R+         +        A          +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFY-------SEAD-----ASHCIQQILESI 118

Query: 362 SYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
           +Y H +    I+HR++K  N+LL   A  ++
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAA 146

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 25/160 (15%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 299
            D +     LG G F  V K R    GK  A K     RL   R      + + EV I+ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA----- 354
              H N++ L+      T+ +L+   ++ G +   L E++S        T  +       
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-------LTEDEATQFLKQ 116

Query: 355 -LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 393
            L    G+ YLH     +I H D+K  NI+L +    + +
Sbjct: 117 ILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 38/176 (21%), Positives = 70/176 (39%), Gaps = 17/176 (9%)

Query: 222 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK 280
            A      Q+G+   F +      +D +  K  LG+G F  V +      G   A K + 
Sbjct: 4   MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63

Query: 281 EERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 339
            ++ S  + Q  + E +I     H N++RL+      +   LV+  +T G +   +  R+
Sbjct: 64  TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123

Query: 340 SSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQS 391
                    +    A    +     ++Y H +    I+HR++K  N+LL   A  +
Sbjct: 124 FY-------SEAD-ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 20/148 (13%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRL 309
           +++LG G   +V     L   +  AVK ++++       +   EV+++     HRN+L L
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLEL 76

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 364
             F        LV+  M  GS+ S + +R+            + +     + SA  L +L
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF-------NELEASVVVQDVASA--LDFL 127

Query: 365 HEHCDPKIIHRDVKAANILLDEDADQSS 392
           H      I HRD+K  NIL +     S 
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSP 152

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 68.0 bits (167), Expect = 6e-13
 Identities = 32/155 (20%), Positives = 65/155 (41%), Gaps = 17/155 (10%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 304
            + +     LGRG FG V++    +  K    K +K       ++  + E+ I+++A HR
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----G 360
           N+L L+    ++ E ++++ +++   +  R+      L   +        +         
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEA 114

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 395
           L +LH H    I H D++  NI+       + K I
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKII 146

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 14/180 (7%)

Query: 215 HEFFFDVPAED--DSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-G 271
           HE+    P  D  DS      L+   L    V  + F    +LG+GGFG+V   ++   G
Sbjct: 150 HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATG 209

Query: 272 KLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMT 327
           K+ A K+L+++R     GE     E +I+     R ++ L Y + T   + L LV   M 
Sbjct: 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMN 267

Query: 328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            G +   +                  A     GL  LH     +I++RD+K  NILLD+ 
Sbjct: 268 GGDLKFHI--YHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH 322

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 67.6 bits (166), Expect = 7e-13
 Identities = 33/148 (22%), Positives = 63/148 (42%), Gaps = 19/148 (12%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 309
             +LG+G FG+V K +     +  AVK + +      +      EV+++    H N+++L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 364
           +      +   +V    T G +   + +R+         +    A     + S   ++Y+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRF-------SEHDAARIIKQVFSG--ITYM 137

Query: 365 HEHCDPKIIHRDVKAANILLDEDADQSS 392
           H+H    I+HRD+K  NILL+       
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCD 162

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 54/183 (29%), Positives = 79/183 (43%), Gaps = 30/183 (16%)

Query: 219 FDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK 277
           F    E D   +  Q K   L    +  + FS   I+GRGGFG+VY  R AD GK+ A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220

Query: 278 RLKEER--TSGGELQFQTEVKI---ISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGS 330
            L ++R     GE     E  +   +S      ++ + Y F T   +KL  +   M  G 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGD 278

Query: 331 VASRL-RERQSSLPPLDWPTRKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
           +   L +    S          +     I LG    L ++H      +++RD+K ANILL
Sbjct: 279 LHYHLSQHGVFSEA------DMRFYAAEIILG----LEHMHNR---FVVYRDLKPANILL 325

Query: 385 DED 387
           DE 
Sbjct: 326 DEH 328

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 27/146 (18%), Positives = 59/146 (40%), Gaps = 17/146 (11%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 309
              LG+G F  V +   +  G+  A   +  ++ S  + Q  + E +I  +  H N++RL
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLH 365
           +   +      L++  +T G +   +  R+         +    A    +     + + H
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYY-------SEAD-ASHCIQQILEAVLHCH 127

Query: 366 EHCDPKIIHRDVKAANILLDEDADQS 391
           +     ++HR++K  N+LL      +
Sbjct: 128 QM---GVVHRNLKPENLLLASKLKGA 150

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 25/160 (15%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 299
            D +     LG G F  V K R  + G   A K     R K  R        + EV I+ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA----- 354
              H N++ L+      T+ +L+   +  G +   L E++S        T ++       
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------LTEEEATEFLKQ 122

Query: 355 -LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 393
            L    G+ YLH     +I H D+K  NI+L +      +
Sbjct: 123 ILN---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 156

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 34/142 (23%), Positives = 61/142 (42%), Gaps = 18/142 (12%)

Query: 255 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 309
           LG GG  +V+  R  D +    VAVK L+ +          F+ E +  +   H  ++ +
Sbjct: 20  LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 310 Y--GFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           Y  G   T    L  +V  Y+   ++   +        P+      ++   + + L++ H
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH 133

Query: 366 EHCDPKIIHRDVKAANILLDED 387
           ++    IIHRDVK ANI++   
Sbjct: 134 QN---GIIHRDVKPANIMISAT 152

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 34/138 (24%), Positives = 53/138 (38%), Gaps = 14/138 (10%)

Query: 255 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 309
           +GRGG G VY+    D      VA+K + E  +S    +   Q E +        +++ +
Sbjct: 42  VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
           + F     +  +    +    +A+ LR +     PL  P    I       L   H    
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA-- 153

Query: 370 PKIIHRDVKAANILLDED 387
               HRDVK  NIL+  D
Sbjct: 154 -GATHRDVKPENILVSAD 170

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 29/155 (18%), Positives = 60/155 (38%), Gaps = 24/155 (15%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-H 303
           TDG+  K  +G G +    +    A     AVK + + +    E     E++I+     H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQH 75

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSA 358
            N++ L           +V   M  G +  ++  ++         + ++ +     +   
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF-------SEREASAVLFTITKT 128

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 393
             + YLH      ++HRD+K +NIL  +++     
Sbjct: 129 --VEYLHAQ---GVVHRDLKPSNILYVDESGNPES 158

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 14/151 (9%)

Query: 246 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVH 303
            D F  + + G+G FG V  G+    G  VA+K+ +++ R    ELQ    ++ +++  H
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78

Query: 304 RNLLRLYGFCTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 356
            N+++L  +  T+ E+        +V  Y+   ++    R              K     
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             R +  LH      + HRD+K  N+L++E 
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEA 167

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 32/170 (18%), Positives = 61/170 (35%), Gaps = 33/170 (19%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK------------EERTSGGELQFQ 292
            + +     LG G +G+V   +        A+K +K             +       +  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 293 TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLD 346
            E+ ++    H N+++L+          LV  +   G +  ++       E  ++     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA----- 149

Query: 347 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 395
                 I      G+ YLH+H    I+HRD+K  NILL+      + K +
Sbjct: 150 -----NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 64.5 bits (158), Expect = 6e-12
 Identities = 34/148 (22%), Positives = 59/148 (39%), Gaps = 21/148 (14%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           +N +GRG +G+V            A K++ +      + +F+ E++I+    H N++RLY
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLY 72

Query: 311 GFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
                 T+  LV    T G            RE  ++         K +       ++Y 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR------IMKDV----LSAVAYC 122

Query: 365 HEHCDPKIIHRDVKAANILLDEDADQSS 392
           H+     + HRD+K  N L   D+  S 
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSP 147

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 8/102 (7%)

Query: 252 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HR 304
              LGRG FG+V +         A  + VAVK LKE  T        +E+KI+     H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 305 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL 345
           N++ L G CT     L+V   +   G++++ LR +++   P 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 15/156 (9%)

Query: 238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGEL-QFQTE 294
            L+E+++  D F    ++GRG F +V   ++   G++ A+K + K +    GE+  F+ E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111

Query: 295 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 352
             ++     R + +L + F       L LV  Y   G + + L  +     P +   R  
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLS-KFGERIPAEM-ARFY 167

Query: 353 IA-LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +A +  A  +  +H       +HRD+K  NILLD  
Sbjct: 168 LAEIVMA--IDSVHRL---GYVHRDIKPDNILLDRC 198

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 29/188 (15%), Positives = 60/188 (31%), Gaps = 54/188 (28%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG- 311
            +GRGGFG V++ +   D    A+KR++         +   EVK ++   H  ++R +  
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 312 -------------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
                            + ++   +P  +   + +   + +   P     T  ++   S 
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 359 RGLSYLH-EHCDP--------------------------------------KIIHRDVKA 379
           +   Y+  + C                                         ++HRD+K 
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192

Query: 380 ANILLDED 387
           +NI    D
Sbjct: 193 SNIFFTMD 200

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTE 294
            ++++++  + F    ++GRG FG+V   +L +  K+ A+K L K E     E   F+ E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 295 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 352
             ++     + +  L Y F       L LV  Y   G + + L + +  LP  +   R  
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPE-EM-ARFY 180

Query: 353 IA-LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           +A +  A  +  +H+      +HRD+K  NIL+D +
Sbjct: 181 LAEMVIA--IDSVHQL---HYVHRDIKPDNILMDMN 211

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 27/149 (18%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHR-NLLRLYG 311
           LGRG F  V +    + G+  A K LK+ R           E+ ++ +A     ++ L+ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 312 FCTTVTEKLLVYPYMTNG--------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
                +E +L+  Y   G         +A  + E             K+I      G+ Y
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR------LIKQI----LEGVYY 146

Query: 364 LHEHCDPKIIHRDVKAANILL---DEDAD 389
           LH++    I+H D+K  NILL       D
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGD 172

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 34/148 (22%), Positives = 63/148 (42%), Gaps = 21/148 (14%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
             +LG G F +V+  +    GKL A+K +K +  +  +   + E+ ++    H N++ L 
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 311 GFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
               + T   LV   ++ G             E+ +SL        +++       + YL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQV----LSAVKYL 122

Query: 365 HEHCDPKIIHRDVKAANILLDEDADQSS 392
           HE+    I+HRD+K  N+L     + S 
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSK 147

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 14/61 (22%), Positives = 24/61 (39%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           DL    L          L +L++L +++N+   L       + SL +LD S N +     
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535

Query: 133 D 133
            
Sbjct: 536 Q 536

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 13/84 (15%), Positives = 29/84 (34%), Gaps = 10/84 (11%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           S   +DL    L    +        L++L L+   +  +   +  +++ L+ L L+ N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 128 SGPVPDNGSFSQFTPISFENNLNL 151
                           +F    +L
Sbjct: 89  QSLALG----------AFSGLSSL 102

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 15/70 (21%), Positives = 30/70 (42%), Gaps = 3/70 (4%)

Query: 73  DLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 131
            +   +      P+   +L+NL  L L+   L  L PT+  +++SL +L++S+N      
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510

Query: 132 PDNGSFSQFT 141
                +    
Sbjct: 511 TF--PYKCLN 518

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 12/64 (18%), Positives = 21/64 (32%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             +DL    +          L +L  L L  N +  L   + + ++SL  L      L+ 
Sbjct: 55  QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114

Query: 130 PVPD 133
               
Sbjct: 115 LENF 118

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 12/69 (17%), Positives = 25/69 (36%), Gaps = 1/69 (1%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
            L    +          L +L+ L     +L+ L    +  + +L  L++++N +     
Sbjct: 82  ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FK 140

Query: 133 DNGSFSQFT 141
               FS  T
Sbjct: 141 LPEYFSNLT 149

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 10/66 (15%), Positives = 23/66 (34%), Gaps = 1/66 (1%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
            +  +D  ++ L           L+NL  L +++             ++SL +L ++ N 
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456

Query: 127 LSGPVP 132
                 
Sbjct: 457 FQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 18/84 (21%), Positives = 38/84 (45%), Gaps = 2/84 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGL-IPTSLTTITSLNILDLSNNR 126
           S+ ++      L+      +G LK L+ L + +N +    +P   + +T+L  LDLS+N+
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160

Query: 127 LSGPVPDN-GSFSQFTPISFENNL 149
           +      +     Q   ++   +L
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDL 184

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 11/63 (17%), Positives = 25/63 (39%), Gaps = 1/63 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTI-TSLNILDLSNNR 126
           S+  +++ +             L +L++L  + N +       L    +SL  L+L+ N 
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554

Query: 127 LSG 129
            + 
Sbjct: 555 FAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 5/87 (5%)

Query: 68  SVTRVDL-GNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNI----LDL 122
           ++  +++  N   S +L      L NLE L L++N +  +  T L  +  + +    LDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 123 SNNRLSGPVPDNGSFSQFTPISFENNL 149
           S N ++   P      +   ++  NN 
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNF 211

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 4/95 (4%)

Query: 41  PNNSLQSWDNLPGNLCTWFHITCNPE-GSVTRVDLGNAALS--GELAPELGQLKNLELLR 97
           P   L+S   L        +     +  S+  +DL    LS  G  +       +L+ L 
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 98  LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           L+ N +   + ++   +  L  LD  ++ L     
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 22/72 (30%), Positives = 30/72 (41%), Gaps = 2/72 (2%)

Query: 79  LSGELAPELGQLKNLELLRLNNNSLS--GLIPTSLTTITSLNILDLSNNRLSGPVPDNGS 136
             G  A     L +LE L L+ N LS  G    S    TSL  LDLS N +     +   
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG 394

Query: 137 FSQFTPISFENN 148
             Q   + F+++
Sbjct: 395 LEQLEHLDFQHS 406

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 16/104 (15%), Positives = 31/104 (29%), Gaps = 6/104 (5%)

Query: 50  NLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSG-LIP 108
            +    CT   +          +DL    ++  + P   +   L  L L NN  S  ++ 
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218

Query: 109 TSLTTITSLNILDLSNNRLSG----PVPDNGSFSQFTPISFENN 148
           T +  +  L +  L              D  +      ++ E  
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 23/135 (17%), Positives = 33/135 (24%), Gaps = 33/135 (24%)

Query: 36  SKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLEL 95
             L      L   D    ++   F    N   +V+   L +  +      +       + 
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLF----NCLTNVSSFSLVSVTIER--VKDFSYNFGWQH 308

Query: 96  LRLNNNSLSGL-------------------IPTSLTTITSLNILDLSNNRLSGPVPDNGS 136
           L L N                            S   + SL  LDLS N L        S
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL--------S 360

Query: 137 FSQFTPISFENNLNL 151
           F      S     +L
Sbjct: 361 FKGCCSQSDFGTTSL 375

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 13/80 (16%), Positives = 23/80 (28%), Gaps = 15/80 (18%)

Query: 87  LGQLKNLELLRLNNNSLS---GLIPTSLTTITSLNILDLSNNRLSGPVP----------- 132
           L  L NL +       L      I      +T+++   L +  +                
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 133 -DNGSFSQFTPISFENNLNL 151
             N  F QF  +  ++   L
Sbjct: 311 LVNCKFGQFPTLKLKSLKRL 330

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 31/163 (19%)

Query: 238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTE 294
            +R+L++  + +    ++GRG FG+V   R     K+ A+K L K E     +   F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119

Query: 295 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 352
             I++ A    +++L Y F       L +V  YM  G + + +                 
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMS-------------NYD 164

Query: 353 IALGSAR--------GLSYLHEHCDPKIIHRDVKAANILLDED 387
           +    AR         L  +H       IHRDVK  N+LLD+ 
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS 204

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 61.5 bits (150), Expect = 9e-11
 Identities = 29/148 (19%), Positives = 60/148 (40%), Gaps = 26/148 (17%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRL 309
              LG G F    K       +  AVK + +      E   Q E+  +     H N+++L
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKL 71

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 364
           +          LV   +  G +  R+++++         +  + +     L SA  +S++
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHF-------SETEASYIMRKLVSA--VSHM 122

Query: 365 HEHCDPKIIHRDVKAANILL---DEDAD 389
           H+     ++HRD+K  N+L    +++ +
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLE 147

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 16/138 (11%), Positives = 37/138 (26%), Gaps = 16/138 (11%)

Query: 255 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 309
            G     + ++    D  L   VA+  +  +     ++     +    +S      + R+
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
                T    L+V  ++  GS+            P       +     A      H    
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSP---VGAIRAMQSLAAAADAAHRA-- 148

Query: 370 PKIIHRDVKAANILLDED 387
             +       + + +  D
Sbjct: 149 -GVALSIDHPSRVRVSID 165

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 29/153 (18%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAV-HRNLLR 308
           K +LG G  GKV +      G+  A+K L    +        + EV     A    +++ 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVC 86

Query: 309 LYGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSAR 359
           +      +       L++   M  G + SR++ER          T ++ A     +G+A 
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-----AFTEREAAEIMRDIGTA- 140

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
            + +LH H    I HRDVK  N+L       + 
Sbjct: 141 -IQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.7 bits (146), Expect = 2e-10
 Identities = 33/196 (16%), Positives = 53/196 (27%), Gaps = 45/196 (22%)

Query: 232 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK--RLKEERTSGGEL 289
            Q          + T+       +G G FG+V++   AD   VA+K   ++      G  
Sbjct: 6   SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSH 63

Query: 290 Q-----FQTEVKI---------ISMAVHRNLLRLYGF--CTTVTEKLLVYPYM----TNG 329
           Q        E+ I                  + L            LL+  +     T G
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 330 SVASRLRERQSSLPPL-------------------DWPTRKKIALGSARGLSYLHEHCDP 370
           S   R    +     +                      T K I       L+        
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181

Query: 371 KIIHRDVKAANILLDE 386
           +  HRD+   N+LL +
Sbjct: 182 RFEHRDLHWGNVLLKK 197

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 47/174 (27%), Positives = 67/174 (38%), Gaps = 20/174 (11%)

Query: 222 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRL- 279
            AE        Q  +   +  +   + F    ILG G F  V   R  A  +  A+K L 
Sbjct: 5   AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64

Query: 280 KEERTSGGELQF-QTEVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 337
           K       ++ +   E  ++S   H   ++LY       EKL     Y  NG +   +R+
Sbjct: 65  KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRK 123

Query: 338 RQSSLPPLDWPTRK----KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             S     D    +    +I       L YLH      IIHRD+K  NILL+ED
Sbjct: 124 IGS----FDETCTRFYTAEIVSA----LEYLHGK---GIIHRDLKPENILLNED 166

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 38/195 (19%), Positives = 68/195 (34%), Gaps = 29/195 (14%)

Query: 210 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-L 268
               PH      P       Q        +++  +  D      +LG G  GKV +    
Sbjct: 25  TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84

Query: 269 ADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEK----LLV 322
              +  A+K L    +        + EV++   A    +++R+      +       L+V
Sbjct: 85  RTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137

Query: 323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYLHEHCDPKIIHRDV 377
              +  G + SR+++R          T ++ +     +G A  + YLH      I HRDV
Sbjct: 138 MECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEA--IQYLHSI---NIAHRDV 187

Query: 378 KAANILLDEDADQSS 392
           K  N+L       + 
Sbjct: 188 KPENLLYTSKRPNAI 202

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 19/146 (13%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 310
           ++ LGRG    VY+ +     K  A+K LK    +  +   +TE+ ++    H N+++L 
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHE 366
               T TE  LV   +T G +  R+ E+          + +  A  + +     ++YLHE
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYY-------SERD-AADAVKQILEAVAYLHE 166

Query: 367 HCDPKIIHRDVKAANILLDEDADQSS 392
           +    I+HRD+K  N+L    A  + 
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAP 189

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 58.3 bits (142), Expect = 1e-09
 Identities = 45/146 (30%), Positives = 70/146 (47%), Gaps = 28/146 (19%)

Query: 255 LGRGGFGKVY---KGRLAD-GKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRL 309
           LG+G FGKV+   K   +D  +L A+K LK+        ++ + E  I+    H  +++L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 310 -YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGL 361
            Y F T    KL L+  ++  G + +RL +E   +          K     +AL     L
Sbjct: 92  HYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLAELALA----L 139

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            +LH      II+RD+K  NILLDE+
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEE 162

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 33/152 (21%), Positives = 61/152 (40%), Gaps = 27/152 (17%)

Query: 252 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRL 309
             +LG G  GKV +       +  A+K L++        + + EV++   A    +++R+
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRI 76

Query: 310 YGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARG 360
                 +       L+V   +  G + SR+++R          T ++ +     +G A  
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEA-- 129

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDADQSS 392
           + YLH      I HRDVK  N+L       + 
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAI 158

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 18/70 (25%), Positives = 24/70 (34%), Gaps = 1/70 (1%)

Query: 73  DLGNAALSGELAP-ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 131
           DLG   +  EL   E   L+N+  + L+ N    L   S   + SL  L L    L    
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470

Query: 132 PDNGSFSQFT 141
                F    
Sbjct: 471 SSPSPFQPLR 480

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 1/84 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++T +DL    L+         L  LE   L  N++  L   SL  + ++  L+L  +  
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308

Query: 128 SGPVPDNGSFSQFTPISFENNLNL 151
              +    S  +    SF+    L
Sbjct: 309 KQSISLA-SLPKIDDFSFQWLKCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 14/92 (15%), Positives = 31/92 (33%), Gaps = 2/92 (2%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN 101
           +N+L             + +       +  ++L +             L  L+++ L  N
Sbjct: 513 HNNLARLWKHANPGGPIYFLKGLS--HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 133
           +L+ L  +      SL  L+L  N ++     
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 18/74 (24%), Positives = 33/74 (44%), Gaps = 2/74 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++T ++L +  L    A    +   L  L +  N++S L P     +  L +L+L +N L
Sbjct: 26  NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85

Query: 128 SGPVPDNGSFSQFT 141
           S       +F+  T
Sbjct: 86  SQLSD--KTFAFCT 97

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 20/78 (25%), Positives = 31/78 (39%)

Query: 67  GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
            S T+  +  A+L          LK LE L + +N + G+     T + +L  L LSN+ 
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364

Query: 127 LSGPVPDNGSFSQFTPIS 144
            S     N +F       
Sbjct: 365 TSLRTLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 19/69 (27%), Positives = 27/69 (39%), Gaps = 2/69 (2%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           +L +  LS           NL  L L +NS+  +         +L  LDLS+N LS    
Sbjct: 79  NLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL 138

Query: 133 DNGSFSQFT 141
             G+  Q  
Sbjct: 139 --GTQVQLE 145

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 3/86 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++T + L + ++         + KNL  L L++N LS     +   + +L  L LSNN++
Sbjct: 98  NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157

Query: 128 SGPVPDNGSFSQFTPISFENNLNLCG 153
                +      F   S +  L L  
Sbjct: 158 QALKSE--ELDIFANSSLK-KLELSS 180

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 4/86 (4%)

Query: 68  SVTRVDLGNAALSG--ELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNN 125
           S+ R+ L   AL            L+NL +L L+NN+++ +    L  +  L ILDL +N
Sbjct: 455 SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514

Query: 126 RLSGPVPDNGSFSQFTPISFENNLNL 151
            L+       +         +   +L
Sbjct: 515 NLA--RLWKHANPGGPIYFLKGLSHL 538

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 16/69 (23%), Positives = 29/69 (42%), Gaps = 2/69 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKN--LELLRLNNNSLSGLIPTSLTTITSLNILDLSNN 125
           ++  + L N  +    + EL    N  L+ L L++N +    P     I  L  L L+N 
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 126 RLSGPVPDN 134
           +L   + + 
Sbjct: 206 QLGPSLTEK 214

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 15/98 (15%), Positives = 34/98 (34%), Gaps = 8/98 (8%)

Query: 50  NLPGNLCTWFHITCN-----PEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLS 104
           +L  +  +   +T           +  ++L    +S   +     L +LE+L L  N + 
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418

Query: 105 GLIP-TSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
             +       + ++  + LS N+         SF+   
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTR--NSFALVP 454

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 14/74 (18%), Positives = 25/74 (33%), Gaps = 1/74 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTI-TSLNILDLSNNR 126
            +  +DLG   L+   A       +L+ L L  N ++ +          +L  LD+  N 
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620

Query: 127 LSGPVPDNGSFSQF 140
                     F  +
Sbjct: 621 FDCTCESIAWFVNW 634

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 15/68 (22%), Positives = 28/68 (41%), Gaps = 2/68 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGL--IPTSLTTITSLNILDLSNN 125
           ++  + L               + +L+ L L   +L  +   P+    + +L ILDLSNN
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490

Query: 126 RLSGPVPD 133
            ++    D
Sbjct: 491 NIANINDD 498

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 21/87 (24%), Positives = 35/87 (40%), Gaps = 6/87 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLT---TITSLNILDLSN 124
           S+ +++L +  +          +  L  L LNN  L   +   L      TS+  L LSN
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231

Query: 125 NRLSGPVPDNGSFSQFTPISFENNLNL 151
           ++LS     N +F      +    L+L
Sbjct: 232 SQLST--TSNTTFLGLKWTNLT-MLDL 255

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 13/70 (18%), Positives = 24/70 (34%), Gaps = 9/70 (12%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNN---------SLSGLIPTSLTTITSLNILDLS 123
            L    +    +  L  L N+  L L  +         SL  +   S   +  L  L++ 
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME 337

Query: 124 NNRLSGPVPD 133
           +N + G   +
Sbjct: 338 DNDIPGIKSN 347

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 18/140 (12%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQF-QTEVKIISMAVHRNLLRL-Y 310
           +G+G FGKV   +  D  K+ A+K + K++     E++    E++I+    H  L+ L Y
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 311 GFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIA-LGSARGLSYLHEH 367
            F     E + +V   +  G +   L +             +  I  L  A  L YL   
Sbjct: 83  SFQDE--EDMFMVVDLLLGGDLRYHLQQNVHFKEET----VKLFICELVMA--LDYLQNQ 134

Query: 368 CDPKIIHRDVKAANILLDED 387
              +IIHRD+K  NILLDE 
Sbjct: 135 ---RIIHRDMKPDNILLDEH 151

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 45/151 (29%), Positives = 62/151 (41%), Gaps = 39/151 (25%)

Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLK---------EERTSGGELQFQTEVKIISMAV-H 303
           +G+G FGKV   R  A+    AVK L+         E+          +E  ++   V H
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI-------MSERNVLLKNVKH 98

Query: 304 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 356
             L+ L+ F     +KL  V  Y+  G +   L RER    P      R +     IA  
Sbjct: 99  PFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASA 151

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               L YLH      I++RD+K  NILLD  
Sbjct: 152 ----LGYLHSL---NIVYRDLKPENILLDSQ 175

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 29/188 (15%), Positives = 64/188 (34%), Gaps = 48/188 (25%)

Query: 242 LQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIIS 299
           L+ ++  +S    LG G FG V +    + GK  A+K++ ++       +++  E+ I+ 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--------- 350
           +  H N+++L  +  T  ++    P   +       +    +                  
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 351 ---------KKIALGSA-------------------RGLSYLHEHCDPKIIHRDVKAANI 382
                     K+                        R + ++H      I HRD+K  N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172

Query: 383 LLDEDADQ 390
           L++   + 
Sbjct: 173 LVNSKDNT 180

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 56.3 bits (136), Expect = 7e-09
 Identities = 49/226 (21%), Positives = 80/226 (35%), Gaps = 53/226 (23%)

Query: 202 PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKN-------- 253
            +I    W       F  + P E +      Q     L++   A   F + +        
Sbjct: 73  FIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAE 132

Query: 254 ----------------------ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ 290
                                 +LG+G FGKV   +    G+  A+K LK+E     +  
Sbjct: 133 EMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV 192

Query: 291 FQT--EVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLD 346
             T  E +++  + H  L  L  +     ++L  V  Y   G +   L RER  S     
Sbjct: 193 AHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED--- 248

Query: 347 WPTRKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              R +     I       L YLH   +  +++RD+K  N++LD+D
Sbjct: 249 ---RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLENLMLDKD 285

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 36/148 (24%), Positives = 61/148 (41%), Gaps = 18/148 (12%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTEVKIISMAVH 303
           D F     LG G FG+V   +  + G   A+K L K++     +++    E +I+     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----KIALGSAR 359
             L++L       +   +V  Y+  G + S LR           P  +    +I L    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT--- 153

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDED 387
              YLH      +I+RD+K  N+L+D+ 
Sbjct: 154 -FEYLHSL---DLIYRDLKPENLLIDQQ 177

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 40/163 (24%)

Query: 243 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKE---------ERTSGGELQFQ 292
           +V  + F    +LG+G FGKV   R  A G+  A+K L++           T        
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-------V 53

Query: 293 TEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPT 349
           TE +++    H  L  L Y F T   ++L  V  Y   G +   L RER  +        
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEE------ 105

Query: 350 RKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           R +     I       L YLH      +++RD+K  N++LD+D
Sbjct: 106 RARFYGAEIVSA----LEYLHSR---DVVYRDIKLENLMLDKD 141

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 55.6 bits (135), Expect = 7e-09
 Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 44/155 (28%)

Query: 255 LGRGGFGKVYKGRLA----DGKLVAVKRLKE----------ERTSGGELQFQTEVKIISM 300
           LG+GG+GKV++ R       GK+ A+K LK+            T       + E  I+  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-------KAERNILEE 77

Query: 301 AVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK----- 352
             H  ++ L Y F T    KL L+  Y++ G +  +L RE                    
Sbjct: 78  VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAE 129

Query: 353 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           I++     L +LH+     II+RD+K  NI+L+  
Sbjct: 130 ISMA----LGHLHQK---GIIYRDLKPENIMLNHQ 157

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 55.2 bits (134), Expect = 9e-09
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 34/160 (21%)

Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLK---------EERTSGGELQFQ 292
           + +   F     LG G FG+V+  R    G+  A+K LK          E T        
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-------N 54

Query: 293 TEVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRK 351
            E  ++S+  H  ++R++G      +++ ++  Y+  G + S LR+ Q        P  K
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKSQR----FPNPVAK 109

Query: 352 ----KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               ++ L     L YLH      II+RD+K  NILLD++
Sbjct: 110 FYAAEVCLA----LEYLHSK---DIIYRDLKPENILLDKN 142

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 43/152 (28%), Positives = 61/152 (40%), Gaps = 41/152 (26%)

Query: 255 LGRGGFGKVYKGRL-ADGKLVAVKRLK---------EERTSGGELQFQTEVKIISMAV-H 303
           LG+G FGKV+        +  A+K LK          E T         E +++S+A  H
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT-------MVEKRVLSLAWEH 77

Query: 304 RNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IAL 355
             L  +   F T   E L  V  Y+  G +   +    +  L       R       I L
Sbjct: 78  PFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIIL 129

Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           G    L +LH      I++RD+K  NILLD+D
Sbjct: 130 G----LQFLHSK---GIVYRDLKLDNILLDKD 154

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 16/67 (23%), Positives = 28/67 (41%), Gaps = 2/67 (2%)

Query: 75  GNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 134
           GN+     L+       NL  L L+   L  +      T+  L +L++S+N L     D+
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF--LDS 514

Query: 135 GSFSQFT 141
             ++Q  
Sbjct: 515 SHYNQLY 521

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 13/61 (21%), Positives = 24/61 (39%), Gaps = 2/61 (3%)

Query: 82  ELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQF 140
             +P     L +LE L      L+ L    +  + +L  L++++N +         FS  
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNL 152

Query: 141 T 141
           T
Sbjct: 153 T 153

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 2/69 (2%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           DL    L          L  L+LL +++N+L  L  +    + SL+ LD S NR+     
Sbjct: 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET--S 536

Query: 133 DNGSFSQFT 141
                    
Sbjct: 537 KGILQHFPK 545

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 10/84 (11%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           S   +DL    L    +        L+ L L+   +  +   +   +  L+ L L+ N +
Sbjct: 33  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92

Query: 128 SGPVPDNGSFSQFTPISFENNLNL 151
                       F+P SF    +L
Sbjct: 93  QS----------FSPGSFSGLTSL 106

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 12/68 (17%), Positives = 23/68 (33%), Gaps = 1/68 (1%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
            +  +D  ++ L           L+ L  L ++  +           +TSLN L ++ N 
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNS 459

Query: 127 LSGPVPDN 134
                  N
Sbjct: 460 FKDNTLSN 467

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 15/72 (20%), Positives = 25/72 (34%), Gaps = 2/72 (2%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             +DL    +          L +L  L L  N +    P S + +TSL  L     +L+ 
Sbjct: 59  QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118

Query: 130 PVPDNGSFSQFT 141
              ++    Q  
Sbjct: 119 --LESFPIGQLI 128

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 18/85 (21%), Positives = 39/85 (45%), Gaps = 2/85 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGL-IPTSLTTITSLNILDLSNNR 126
           S+  +      L+   +  +GQL  L+ L + +N +    +P   + +T+L  +DLS N 
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164

Query: 127 LSGPVPDNGSFSQFTPISFENNLNL 151
           +     ++  F +  P     +L++
Sbjct: 165 IQTITVNDLQFLRENPQVNL-SLDM 188

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 11/61 (18%), Positives = 24/61 (39%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
            +  +++ +  L    +    QL +L  L  + N +            SL   +L+NN +
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

Query: 128 S 128
           +
Sbjct: 558 A 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 17/74 (22%), Positives = 31/74 (41%), Gaps = 4/74 (5%)

Query: 68  SVTRVDLGNAALS--GELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNN 125
           S++ +DL   ALS  G  +       +L  L L+ N    ++  +   +  L  LD  ++
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409

Query: 126 RLSGPVPDNGSFSQ 139
            L   V +  +F  
Sbjct: 410 TLKR-VTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 13/89 (14%), Positives = 32/89 (35%), Gaps = 5/89 (5%)

Query: 68  SVTRVDLGNAALSG-ELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNI----LDL 122
           ++ ++++ +  +   +L      L NL  + L+ N +  +    L  +         LD+
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188

Query: 123 SNNRLSGPVPDNGSFSQFTPISFENNLNL 151
           S N +           +   ++   N N 
Sbjct: 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNS 217

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 16/53 (30%), Positives = 23/53 (43%), Gaps = 2/53 (3%)

Query: 80  SGELAPELGQLKNLELLRLNNNSLSGLIPTSLT--TITSLNILDLSNNRLSGP 130
            G ++ +   L +L  L L+ N+LS     S +     SL  LDLS N     
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM 391

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 13/84 (15%), Positives = 23/84 (27%), Gaps = 10/84 (11%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           S   ++     L         +L NL  L L    +  +   +  +   L+ L L+ N L
Sbjct: 34  STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93

Query: 128 SGPVPDNGSFSQFTPISFENNLNL 151
                           +      L
Sbjct: 94  IF----------MAETALSGPKAL 107

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 15/62 (24%), Positives = 22/62 (35%), Gaps = 1/62 (1%)

Query: 80  SGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 139
           S     +L  L +L+ L L+ N    L   +      L +LDL+  RL         F  
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQN 423

Query: 140 FT 141
             
Sbjct: 424 LH 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 13/69 (18%), Positives = 19/69 (27%), Gaps = 2/69 (2%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
            L    L       L   K L+ L      +S +    L    +L  L L +N +S    
Sbjct: 87  VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS--I 144

Query: 133 DNGSFSQFT 141
                    
Sbjct: 145 KLPKGFPTE 153

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 14/74 (18%), Positives = 24/74 (32%), Gaps = 2/74 (2%)

Query: 70  TRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             +DL    L  + A      L  L++L L+++ L          + +L  L+L  N   
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462

Query: 129 GPVPD-NGSFSQFT 141
                   S     
Sbjct: 463 KGNIQKTNSLQTLG 476

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 18/86 (20%), Positives = 40/86 (46%), Gaps = 2/86 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNI--LDLSNN 125
           ++  + LG+  +S    P+    + L++L   NN++  L    ++++       L+L+ N
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189

Query: 126 RLSGPVPDNGSFSQFTPISFENNLNL 151
            ++G  P     + F  ++F    NL
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNL 215

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 13/60 (21%), Positives = 21/60 (35%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
           T +DL    +             L+ L L  N L  +  T+L+   +L  L      +S 
Sbjct: 60  TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 14/62 (22%), Positives = 23/62 (37%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++  +      +S      L   K LE L L +N +S +          L +LD  NN +
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165

Query: 128 SG 129
             
Sbjct: 166 HY 167

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 19/74 (25%), Positives = 26/74 (35%), Gaps = 2/74 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
            +  +DL    LS EL   L  L  L+ L L+ N    L   S +   SL  L +  N  
Sbjct: 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337

Query: 128 SGPVPDNGSFSQFT 141
              +   G      
Sbjct: 338 RLELGT-GCLENLE 350

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 16/55 (29%), Positives = 29/55 (52%)

Query: 79  LSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 133
            + +    L  L  LE+L L+   LS +   + T++  +N +DLS+NRL+    +
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 12/75 (16%), Positives = 26/75 (34%), Gaps = 1/75 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPT-SLTTITSLNILDLSNNR 126
           ++ ++ L                 +L  L +  N+    + T  L  + +L  LDLS++ 
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361

Query: 127 LSGPVPDNGSFSQFT 141
           +      N      +
Sbjct: 362 IETSDCCNLQLRNLS 376

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 18/74 (24%), Positives = 28/74 (37%), Gaps = 3/74 (4%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           SV  ++L         +        L+ L L    LS  +P+ L  +++L  L LS N+ 
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKF 313

Query: 128 SGPVPDNGSFSQFT 141
                   S S F 
Sbjct: 314 EN--LCQISASNFP 325

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 20/88 (22%), Positives = 37/88 (42%), Gaps = 5/88 (5%)

Query: 50  NLPGNLCTWFHITCNPE----GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSG 105
           NL GN     +I         G +  + L    LS         LK +  + L++N L+ 
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514

Query: 106 LIPTSLTTITSLNILDLSNNRLSGPVPD 133
               +L+ +  +  L+L++N +S  +P 
Sbjct: 515 SSIEALSHLKGI-YLNLASNHISIILPS 541

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 1/62 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
            +  VDL +  L+      L  LK + L  L +N +S ++P+ L  ++    ++L  N L
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSLLPILSQQRTINLRQNPL 559

Query: 128 SG 129
             
Sbjct: 560 DC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 17/65 (26%), Positives = 24/65 (36%), Gaps = 3/65 (4%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLI---PTSLTTITSLNILDLSN 124
            +  ++L ++ L          L  L+ L L  N           SL T+  L IL LS 
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485

Query: 125 NRLSG 129
             LS 
Sbjct: 486 CDLSS 490

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 11/56 (19%), Positives = 25/56 (44%), Gaps = 1/56 (1%)

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           D+ +  +S  +   L ++ ++E + L  +    +   +    + L  LDL+   LS
Sbjct: 237 DMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 12/86 (13%), Positives = 26/86 (30%), Gaps = 3/86 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLEL--LRLNNNSLSGLIPTSLTTITSLNILDLSNN 125
            +  +D  N A+      ++  L+      L LN N ++G I            L+    
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGT 212

Query: 126 RLSGPVPDNGSFSQFTPISFENNLNL 151
           +    +      S    +      ++
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDM 238

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 44/204 (21%), Positives = 77/204 (37%), Gaps = 51/204 (25%)

Query: 214 PHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKN------------ILGRGGFG 261
            H   +D+P  ++   Q          +  + T      +            ++GRG + 
Sbjct: 7   HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66

Query: 262 KVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-HRNLLRLY 310
           KV   RL    ++ A++ +K+         +         QTE  +   A  H  L+ L+
Sbjct: 67  KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV-------QTEKHVFEQASNHPFLVGLH 119

Query: 311 GFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLSY 363
             C     +L  V  Y+  G +   + R+R+            +     I+L     L+Y
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLA----LNY 168

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           LHE     II+RD+K  N+LLD +
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSE 189

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 25/145 (17%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRL 309
           +LG+G FGKV         +L AVK LK++      +++    E +++++      L +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 310 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLS 362
           +  C    ++L  V  Y+  G +   + +  +   P              IA+G    L 
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIG----LF 456

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           +L       II+RD+K  N++LD +
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSE 478

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 53.4 bits (129), Expect = 5e-08
 Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 39/151 (25%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-H 303
           LG+G FGKV         +L AVK LK+         E T         E +++++    
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-------MVEKRVLALPGKP 80

Query: 304 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 356
             L +L+  C    ++L  V  Y+  G +   + +  +   P              IA+G
Sbjct: 81  PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIG 133

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               L +L       II+RD+K  N++LD +
Sbjct: 134 ----LFFLQSK---GIIYRDLKLDNVMLDSE 157

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 45/156 (28%)

Query: 255 LGRGGFGKVY---KGRLAD-GKLVAVKRLK----------EERTSGGELQFQTEVKIISM 300
           LG G +GKV+   K    D GKL A+K LK           E T       +TE +++  
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-------RTERQVLEH 114

Query: 301 AVHRN-LLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK---- 352
                 L+ L Y F T    KL L+  Y+  G + + L +  + +          +    
Sbjct: 115 IRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVG 166

Query: 353 -IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
            I L     L +LH+     II+RD+K  NILLD +
Sbjct: 167 EIVLA----LEHLHKL---GIIYRDIKLENILLDSN 195

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.0 bits (128), Expect = 7e-08
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 39/151 (25%)

Query: 255 LGRGGFGKVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-H 303
           LG+G FGKV   R+ + G L AVK LK+         E T        TE +I+S+A  H
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT-------MTEKRILSLARNH 83

Query: 304 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 356
             L +L+  C    ++L  V  ++  G +   + + R+          R +     I   
Sbjct: 84  PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEIISA 136

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               L +LH+     II+RD+K  N+LLD +
Sbjct: 137 ----LMFLHDK---GIIYRDLKLDNVLLDHE 160

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 34/169 (20%), Positives = 64/169 (37%), Gaps = 42/169 (24%)

Query: 246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQT---------EV 295
              ++ +  +  G +G V  G  ++G  VA+KR+    + G  +              E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 296 KIISMAVHRNLLRLYG-FCTTVTEKL----LVYPYMTNGSVASRLRERQSSLPP------ 344
           ++++   H N+L L   F       +    LV   M    +A  + +++  + P      
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 345 ----LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
               L              GL  LH   +  ++HRD+   NILL ++ D
Sbjct: 140 MYHIL-------------LGLHVLH---EAGVVHRDLHPGNILLADNND 172

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 52.6 bits (127), Expect = 9e-08
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 25/145 (17%)

Query: 254 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRL 309
           ++GRG + KV   RL    ++ A+K +K+E      ++ + QTE  +   A  H  L+ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 310 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLS 362
           +  C     +L  V  Y+  G +   + R+R+            +     I+L     L+
Sbjct: 76  H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLA----LN 124

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YLHE     II+RD+K  N+LLD +
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSE 146

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 33/158 (20%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR------NL 306
           ++G+G FG+V K       + VA+K ++ E+      Q   E++I+     +      N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 307 LRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGS 357
           + +          C    E L           +  L E  +++       P  +K A   
Sbjct: 162 IHMLENFTFRNHICM-TFELL-----------SMNLYELIKKNKFQGFSLPLVRKFAHSI 209

Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 395
            + L  LH++   +IIH D+K  NILL +      K I
Sbjct: 210 LQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVI 244

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 51.4 bits (124), Expect = 2e-07
 Identities = 15/45 (33%), Positives = 20/45 (44%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             L  L  L  L LNNN L       +  +T+L  L LS N ++ 
Sbjct: 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 50.2 bits (121), Expect = 4e-07
 Identities = 15/59 (25%), Positives = 28/59 (47%), Gaps = 2/59 (3%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             + L N  L  E    +G L NL  L L+ N ++ + P  L +++ ++  D +N  + 
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.9 bits (115), Expect = 3e-06
 Identities = 11/45 (24%), Positives = 21/45 (46%), Gaps = 2/45 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             L  L +L       N ++ + P  +  +T LN L + NN+++ 
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.5 bits (114), Expect = 3e-06
 Identities = 16/65 (24%), Positives = 30/65 (46%), Gaps = 3/65 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPI 143
             +  L  L++L + +N +S +    L  ++ LN L L+NN+L     +  G  +  T +
Sbjct: 259 NAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316

Query: 144 SFENN 148
               N
Sbjct: 317 FLSQN 321

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.2 bits (113), Expect = 5e-06
 Identities = 14/64 (21%), Positives = 27/64 (42%), Gaps = 2/64 (3%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 144
             L  L NL  L LN +++S + P  L  +T +  L+L  N     +    + +    ++
Sbjct: 104 SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLT 161

Query: 145 FENN 148
              +
Sbjct: 162 VTES 165

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.2 bits (113), Expect = 5e-06
 Identities = 12/45 (26%), Positives = 22/45 (48%), Gaps = 2/45 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             +  L +L  L LN N +  + P  L ++TSL+      N+++ 
Sbjct: 171 TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.2 bits (113), Expect = 5e-06
 Identities = 9/45 (20%), Positives = 19/45 (42%), Gaps = 2/45 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             L  +  L  L +  + +  + P  +  +T L  L L+ N++  
Sbjct: 149 SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 13/48 (27%), Positives = 23/48 (47%), Gaps = 2/48 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
             +  L NLE L LN N ++ + P  L+ +  L  L +  N+++    
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA 105

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 12/62 (19%), Positives = 28/62 (45%), Gaps = 4/62 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++  ++L    ++      L  L  L  L +  N ++    ++L  +T+L  L L+ + +
Sbjct: 67  NLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNI 122

Query: 128 SG 129
           S 
Sbjct: 123 SD 124

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 43.7 bits (104), Expect = 6e-05
 Identities = 12/82 (14%), Positives = 35/82 (42%), Gaps = 5/82 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
              R  L  A+++        +L+++  L +    ++ +    +  +T+L  L+L+ N++
Sbjct: 23  EGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQI 78

Query: 128 SGPVPDNGSFSQFTPISFENNL 149
           +  +    +  + T +    N 
Sbjct: 79  TD-ISPLSNLVKLTNLYIGTNK 99

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 41.0 bits (97), Expect = 4e-04
 Identities = 6/62 (9%), Positives = 21/62 (33%), Gaps = 3/62 (4%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE 146
              L       L   S++ ++      + S+  L ++  +++  +      +    ++  
Sbjct: 18  DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLN 74

Query: 147 NN 148
            N
Sbjct: 75  GN 76

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 16/108 (14%), Positives = 42/108 (38%), Gaps = 1/108 (0%)

Query: 36  SKLQDPNNSLQSWDNLPGNLCTWF-HITCNPEGSVTRVDLGNAALSGELAPELGQLKNLE 94
           S+++  + +L    +   +       +      ++ R+ +    L  +L+     L+ ++
Sbjct: 254 SEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313

Query: 95  LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTP 142
            + + N+ +  +  +    + SL  LDLS N +      N +     P
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 14/83 (16%), Positives = 29/83 (34%), Gaps = 2/83 (2%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
           ++  + +GN     E+       L +L  L +   SL      SL +I  ++ L L  + 
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183

Query: 127 LSGPVPDNGS-FSQFTPISFENN 148
            +  +       S    +   + 
Sbjct: 184 SAFLLEIFADILSSVRYLELRDT 206

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 16/55 (29%), Positives = 24/55 (43%), Gaps = 1/55 (1%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
              L +LE L L++N LS L  +    ++SL  L+L  N     +     F   T
Sbjct: 70  FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT-LGVTSLFPNLT 123

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 17/77 (22%), Positives = 24/77 (31%), Gaps = 3/77 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLI---PTSLTTITSLNILDLSN 124
            V R+ + N+ +          LK+LE L L+ N +               SL  L LS 
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370

Query: 125 NRLSGPVPDNGSFSQFT 141
           N L              
Sbjct: 371 NHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 16/61 (26%), Positives = 33/61 (54%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++  +DL    ++     +L    NL++L L ++ ++ +   +  ++ SL  LDLS+N L
Sbjct: 27  AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 128 S 128
           S
Sbjct: 87  S 87

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 28/112 (25%), Positives = 45/112 (40%), Gaps = 17/112 (15%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDL-GNAALSGELAPELGQLKNLELLRL-N 99
           +N L S   L     +WF     P  S+  ++L GN   +  +      L NL+ LR+ N
Sbjct: 83  DNHLSS---LS---SSWFG----PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132

Query: 100 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 151
             + S +       +TSLN L++    L      + S      I   ++L L
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRN--YQSQSLKSIRDI---HHLTL 179

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 9/43 (20%), Positives = 18/43 (41%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           P+      L +++++ N L  +       +TSL  + L  N  
Sbjct: 467 PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 11/69 (15%), Positives = 25/69 (36%), Gaps = 2/69 (2%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE 146
           L  ++++  L L+ +  + L+      ++S+  L+L +  L+               S  
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR--FQFSPLPVDEVSSPM 225

Query: 147 NNLNLCGPN 155
             L   G  
Sbjct: 226 KKLAFRGSV 234

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 31/168 (18%), Positives = 60/168 (35%), Gaps = 39/168 (23%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-----------A 301
            LG G F  V+  + + +   VA+K ++ ++        + E+K++              
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM 83

Query: 302 VHRNLLRLY------GFCTT----VTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPT 349
              ++L+L       G        V E L              L    ++     +    
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-----------GENLLALIKKYEHRGIPLIY 132

Query: 350 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR 397
            K+I+     GL Y+H  C   IIH D+K  N+L++      +   ++
Sbjct: 133 VKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIK 178

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 33/142 (23%), Positives = 65/142 (45%), Gaps = 28/142 (19%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLK---EERTSGGELQFQTEVKII-SMAVHRNLLRL 309
           LGRG + +V++   + + + V VK LK   +++        + E+KI+ ++    N++ L
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-------KREIKILENLRGGPNIITL 96

Query: 310 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI--ALGSARGLSYLH 365
                    +   LV+ ++ N    +  ++   +L   D   R  +   L   + L Y H
Sbjct: 97  ADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYD--IRFYMYEIL---KALDYCH 147

Query: 366 EHCDPKIIHRDVKAANILLDED 387
                 I+HRDVK  N+++D +
Sbjct: 148 SM---GIMHRDVKPHNVMIDHE 166

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 49.2 bits (118), Expect = 4e-07
 Identities = 15/56 (26%), Positives = 30/56 (53%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNN 125
            R+ +    ++ +  P L  L +L LL +++++    I T + T+  +N +DLS N
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 45.7 bits (109), Expect = 5e-06
 Identities = 13/48 (27%), Positives = 25/48 (52%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 134
           +  L NLE LR+    ++     +L+ +TSL +LD+S++     +   
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 11/59 (18%), Positives = 26/59 (44%), Gaps = 1/59 (1%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           T +D+ ++A    +  ++  L  +  + L+ N     I   L T+  L  L++  + + 
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 42.3 bits (100), Expect = 9e-05
 Identities = 8/48 (16%), Positives = 21/48 (43%), Gaps = 2/48 (4%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 134
           +    N++ L +NN   +   P  ++ +++L  L +    ++     N
Sbjct: 62  IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPN 107

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 39.9 bits (94), Expect = 5e-04
 Identities = 8/44 (18%), Positives = 15/44 (34%), Gaps = 2/44 (4%)

Query: 86  ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
            L  L  L+ L +  + +       +     LN L   +  + G
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 18/70 (25%), Positives = 29/70 (41%), Gaps = 1/70 (1%)

Query: 70  TRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             ++LG+      +  E    L NL +L L ++ +  L P +   +  L  L L    LS
Sbjct: 51  QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110

Query: 129 GPVPDNGSFS 138
             V  +G F 
Sbjct: 111 DAVLKDGYFR 120

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 15/86 (17%), Positives = 35/86 (40%), Gaps = 5/86 (5%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
            +  ++L    ++         L NL++L L+ N L  L  ++   +  +  +DL  N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350

Query: 128 SGPVPDNGSFSQFTPISFENNLNLCG 153
           +  +  + +F     +     L+L  
Sbjct: 351 A--IIQDQTFKFLEKL---QTLDLRD 371

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 6/92 (6%)

Query: 62  TCNPEGSVTRVDLGNAALSGELAPEL-----GQLKNLELLRLNNNSLSGLIPTSLTTITS 116
           T +   S+ ++ LG   L      EL       L +L++L LN+N L+ L P   + +T+
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505

Query: 117 LNILDLSNNRLSGPVPDNGSFSQFTPISFENN 148
           L  L L++NRL+  +  N   +    +    N
Sbjct: 506 LRGLSLNSNRLTV-LSHNDLPANLEILDISRN 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 17/84 (20%), Positives = 35/84 (41%), Gaps = 10/84 (11%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           SV  +DL +  +    +     LK+L++L L  N ++ +   +   + +L +L+LS N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 128 SGPVPDNGSFSQFTPISFENNLNL 151
                      +    +F     +
Sbjct: 327 ----------GELYSSNFYGLPKV 340

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 16/54 (29%), Positives = 24/54 (44%), Gaps = 3/54 (5%)

Query: 90  LKNLELLRLNNNSLS--GLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
           L +L  LRL    LS   L       + +L  LDLS N++   +  + SF +  
Sbjct: 96  LFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS-LYLHPSFGKLN 148

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 9/39 (23%), Positives = 18/39 (46%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L  +  + L  N ++ +   +   +  L  LDL +N L+
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 24/118 (20%), Positives = 44/118 (37%), Gaps = 9/118 (7%)

Query: 42  NNSLQSWDNLPGNLCTWF----HITCNPEG--SVTRVDLGNAALSG-ELAPELGQLKNLE 94
           +N+L +   +P ++   F     +   P+   +   + L    L   ++   L ++ +L+
Sbjct: 371 DNALTTIHFIP-SIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQ 429

Query: 95  LLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 151
           +L LN N  S        +   SL  L L  N L         +  F  +S    L L
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 17/90 (18%), Positives = 34/90 (37%), Gaps = 15/90 (16%)

Query: 62  TCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILD 121
           +C+ +G +         L+    P++  L   E L L+ N +  +  +S   +  L +L+
Sbjct: 1   SCSFDGRI--AFYRFCNLTQ--VPQV--LNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54

Query: 122 LSNNRLSGPVPDNGSFSQFTPISFENNLNL 151
           L +      +            +F N  NL
Sbjct: 55  LGSQYTPLTIDKE---------AFRNLPNL 75

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 20/86 (23%), Positives = 38/86 (44%), Gaps = 5/86 (5%)

Query: 68  SVTRVDL-GNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTIT--SLNILDLSN 124
           ++TR+DL  N   S  L P  G+L +L+ +  ++N +  +    L  +   +L+   L+ 
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183

Query: 125 NRLSGPVPDN--GSFSQFTPISFENN 148
           N L   V  +     + F  +  E  
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEIL 209

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 2/59 (3%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             +DL +  L+  + PE      +  + L NN L   I  +L    +L   DL  N   
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 17/61 (27%), Positives = 28/61 (45%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
                 + +++L   LA       N++ L L+ N LS +    L   T L +L+LS+N L
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 128 S 128
            
Sbjct: 71  Y 71

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 21/61 (34%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           +V  +DL    LS   A +L     LELL L++N L   +   L ++++L  LDL+NN +
Sbjct: 35  NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92

Query: 128 S 128
            
Sbjct: 93  Q 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 9/39 (23%), Positives = 20/39 (51%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
               ++ ++ ++SL   + +   +  ++  LDLS N LS
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS 47

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 9/56 (16%), Positives = 19/56 (33%), Gaps = 1/56 (1%)

Query: 86  ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
              + +  + + L NN ++ L        + +  LDL  N +   V      +   
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSD 169

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 14/44 (31%), Positives = 19/44 (43%), Gaps = 5/44 (11%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
            +L  L  L  L LNNN +       L    S+  L  +NN +S
Sbjct: 74  LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 13/47 (27%), Positives = 18/47 (38%), Gaps = 2/47 (4%)

Query: 82  ELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             A        LE L L  N +  +          L  LDLS+N+L+
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA 204

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 9/44 (20%), Positives = 18/44 (40%), Gaps = 1/44 (2%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
                   L+ L L++N L+  +     +   +  + L NN+L 
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 49.6 bits (119), Expect = 9e-07
 Identities = 32/107 (29%), Positives = 42/107 (39%), Gaps = 21/107 (19%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN 101
           NNSL+   +LP +L                +  GN  L  EL PEL  L  L  +  +NN
Sbjct: 162 NNSLKKLPDLPPSL--------------EFIAAGNNQLE-EL-PELQNLPFLTAIYADNN 205

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 148
           SL  L         SL  +   NN L    P+  +    T I  +NN
Sbjct: 206 SLKKLPD----LPLSLESIVAGNNILEEL-PELQNLPFLTTIYADNN 247

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 29/112 (25%), Positives = 47/112 (41%), Gaps = 21/112 (18%)

Query: 37  KLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELL 96
            L   NN+L++  +LP  L                + + N  L  +L PEL     L+++
Sbjct: 115 SLLVDNNNLKALSDLPPLL--------------EYLGVSNNQLE-KL-PELQNSSFLKII 158

Query: 97  RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 148
            ++NNSL  L         SL  +   NN+L   +P+  +    T I  +NN
Sbjct: 159 DVDNNSLKKLPD----LPPSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNN 205

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 28/107 (26%), Positives = 41/107 (38%), Gaps = 23/107 (21%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN 101
           N  L S   LP +L                +     +L+ EL      LK+L +   N  
Sbjct: 80  NLGLSSLPELPPHL--------------ESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 148
           +LS L P        L  L +SNN+L   +P+  + S    I  +NN
Sbjct: 125 ALSDLPP-------LLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNN 163

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 26/87 (29%), Positives = 36/87 (41%), Gaps = 17/87 (19%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN 101
           NNSL+   +LP +L                +  GN  L  EL PEL  L  L  +  +NN
Sbjct: 204 NNSLKKLPDLPLSL--------------ESIVAGNNILE-EL-PELQNLPFLTTIYADNN 247

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLS 128
            L  L P    ++ +LN+ D     L 
Sbjct: 248 LLKTL-PDLPPSLEALNVRDNYLTDLP 273

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 13/92 (14%), Positives = 34/92 (36%), Gaps = 9/92 (9%)

Query: 42  NNSLQSWDNLPGNLCT---WFHITCNPE--GSVTRVDLGNAALSGELAPELGQLKNLELL 96
            N L+ + ++P ++       H+   PE   ++ ++ +    L  E       +++L   
Sbjct: 366 YNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL--- 421

Query: 97  RLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           R+N+  +      +  T   L      ++   
Sbjct: 422 RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 29/169 (17%), Positives = 61/169 (36%), Gaps = 51/169 (30%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 295
            D +  ++++G G +G V +     + ++VA+K++           F+          E+
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103

Query: 296 KIISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTR 350
            I++   H +++++         +      +V                 S    L    R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA------------DSDFKKL---FR 148

Query: 351 KKIALGSA----------RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
             + L              G+ Y+H      I+HRD+K AN L+++D  
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCS 194

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 31/159 (19%)

Query: 253 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM------AVHRN 305
           +++G+G FG+V K     + + VA+K +K ++      Q Q EV+++ +       +   
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY 117

Query: 306 LLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALG 356
           ++ L          C  V E L           +  L +  R ++   +     +K A  
Sbjct: 118 IVHLKRHFMFRNHLCL-VFEML-----------SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 395
               L +L    +  IIH D+K  NILL      + K +
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 15/72 (20%), Positives = 25/72 (34%), Gaps = 2/72 (2%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 144
             L  L N+  L   +N +S L P  L  +T +  L L++   +    +  +        
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404

Query: 145 FENNLNLCGPNT 156
                 L  P T
Sbjct: 405 KNVTGALIAPAT 416

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 15/48 (31%), Positives = 21/48 (43%), Gaps = 2/48 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
             L  L  L  L LN N L  + P  ++ + +L  L L  N +S   P
Sbjct: 281 SPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 20/64 (31%), Positives = 28/64 (43%), Gaps = 3/64 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 144
             L  L NL  L L NN +S L P  L+ +T L  L L  N++S  +      +  T + 
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLE 293

Query: 145 FENN 148
              N
Sbjct: 294 LNEN 297

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 20/63 (31%), Positives = 32/63 (50%), Gaps = 4/63 (6%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
            R+D+ +  +S      L +L NLE L   NN +S + P  L  +T+L+ L L+ N+L  
Sbjct: 180 ERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235

Query: 130 PVP 132
              
Sbjct: 236 IGT 238

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 3/65 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 144
             L  L NL  L L NN ++ + P  L  +T+LN L+LS+N +S  +      +    +S
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-ISALSGLTSLQQLS 162

Query: 145 FENNL 149
           F N +
Sbjct: 163 FGNQV 167

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 15/65 (23%), Positives = 29/65 (44%), Gaps = 4/65 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
            VT +      +       +  L NL  +  +NN L+ + P  L  +T L  + ++NN++
Sbjct: 47  QVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102

Query: 128 SGPVP 132
           +   P
Sbjct: 103 ADITP 107

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 15/64 (23%), Positives = 30/64 (46%), Gaps = 3/64 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 144
             L  L  L  + +NNN ++ + P  L  +T+L  L L NN+++  +    + +    + 
Sbjct: 84  TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLE 140

Query: 145 FENN 148
             +N
Sbjct: 141 LSSN 144

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 20/107 (18%), Positives = 42/107 (39%), Gaps = 17/107 (15%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN 101
            N L+    +  NL            ++T + L    +S      +  L  L+ L   NN
Sbjct: 296 ENQLEDISPI-SNLK-----------NLTYLTLYFNNISDI--SPVSSLTKLQRLFFYNN 341

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 148
            +S +    L  +T++N L   +N++S  +    + ++ T +   + 
Sbjct: 342 KVSDVSS--LANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQ 385

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 10/65 (15%), Positives = 25/65 (38%), Gaps = 4/65 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
              +  LG   ++         L  +  L+ +   +  +    +  + +L  ++ SNN+L
Sbjct: 25  EKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQL 80

Query: 128 SGPVP 132
           +   P
Sbjct: 81  TDITP 85

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 3/48 (6%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
             L  L +L+ L   N  ++ L P  L  +T+L  LD+S+N++S    
Sbjct: 150 SALSGLTSLQQLSFGNQ-VTDLKP--LANLTTLERLDISSNKVSDISV 194

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 17/62 (27%), Positives = 28/62 (45%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
                 + +++L   LA       N++ L L+ N LS +    L   T L +L+LS+N L
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 128 SG 129
             
Sbjct: 71  YE 72

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 2/59 (3%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             +DL +  L+  + PE      +  + L NN L   I  +L    +L   DL  N   
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 9/56 (16%), Positives = 19/56 (33%), Gaps = 1/56 (1%)

Query: 86  ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
              + +  + + L NN ++ L        + +  LDL  N +   V      +   
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSD 169

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 11/62 (17%), Positives = 23/62 (37%), Gaps = 10/62 (16%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL 149
               ++ ++ ++SL   + +   +  ++  LDLS N L          SQ +        
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL----------SQISAADLAPFT 58

Query: 150 NL 151
            L
Sbjct: 59  KL 60

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 14/44 (31%), Positives = 19/44 (43%), Gaps = 5/44 (11%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
            +L  L  L  L LNNN +       L    S+  L  +NN +S
Sbjct: 74  LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 12/42 (28%), Positives = 17/42 (40%), Gaps = 2/42 (4%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
                 LE L L  N +  +          L  LDLS+N+L+
Sbjct: 165 AASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA 204

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 9/44 (20%), Positives = 18/44 (40%), Gaps = 1/44 (2%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
                   L+ L L++N L+  +     +   +  + L NN+L 
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 1/73 (1%)

Query: 70  TRVDLGNAALSGELAPEL-GQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             + +        +       L +L +L+L+ N    L   +   + +L +L L+   L 
Sbjct: 57  QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116

Query: 129 GPVPDNGSFSQFT 141
           G V     F   T
Sbjct: 117 GAVLSGNFFKPLT 129

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.0 bits (116), Expect = 2e-06
 Identities = 25/129 (19%), Positives = 50/129 (38%), Gaps = 7/129 (5%)

Query: 1   MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFH 60
           +E       L   +++ AL  +    E    +   S L+  +    ++ +   +     +
Sbjct: 377 LEPENKWCLLTIILLMRALDPLLYEKETLQYF---STLKAVDPMRAAYLDDLRSKFLLEN 433

Query: 61  -ITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNI 119
            +       V  + L +  L+  L   L QL  +  L L++N L   +P +L  +  L +
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEV 490

Query: 120 LDLSNNRLS 128
           L  S+N L 
Sbjct: 491 LQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 48.6 bits (115), Expect = 2e-06
 Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 13/89 (14%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
            VT +DL +  L   L P L  L+ LE+L+ ++N+L  +    +  +  L  L L NNRL
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRL 520

Query: 128 SGPVPDNGSFSQFTPISFENNL---NLCG 153
                     +   P+     L   NL G
Sbjct: 521 Q-------QSAAIQPLVSCPRLVLLNLQG 542

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 11/61 (18%), Positives = 25/61 (40%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           S   +DL    L    +        L++L L+   +  +   +  +++ L+ L L+ N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 128 S 128
            
Sbjct: 89  Q 89

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 8/82 (9%)

Query: 60  HITCNPEG------SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLT 112
           H      G      S+  + +   +      P+   +L+NL  L L+   L  L PT+  
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 113 TITSLNILDLSNNRLSGPVPDN 134
           +++SL +L++++N+L   VPD 
Sbjct: 492 SLSSLQVLNMASNQLKS-VPDG 512

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 11/55 (20%), Positives = 23/55 (41%), Gaps = 1/55 (1%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
              L +L+ L     +L+ L    +  + +L  L++++N +         FS  T
Sbjct: 96  FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSNLT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 9/55 (16%), Positives = 20/55 (36%), Gaps = 1/55 (1%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
              L+NL  L +++             ++SL +L ++ N           F++  
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELR 470

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 10/42 (23%), Positives = 17/42 (40%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
              L +L  L L  N +  L   + + ++SL  L      L+
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 9/58 (15%), Positives = 22/58 (37%), Gaps = 2/58 (3%)

Query: 84  APELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
           +       +L+ L L+ N +   + ++   +  L  LD  ++ L   + +   F    
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLR 421

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 18/84 (21%), Positives = 36/84 (42%), Gaps = 4/84 (4%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGL-IPTSLTTITSLNILDLSNNRLS 128
            ++      L+      +G LK L+ L + +N +    +P   + +T+L  LDLS+N++ 
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 129 GPVPDNGSFSQFTPISFEN-NLNL 151
                         +   N +L+L
Sbjct: 163 SIYC--TDLRVLHQMPLLNLSLDL 184

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 25/133 (18%), Positives = 37/133 (27%), Gaps = 29/133 (21%)

Query: 36  SKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG-ELAPELGQLKNLE 94
             L      L   D    ++   F+   N    V+   L +  +   +        ++LE
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTN----VSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 95  LLRLNNNSLSGLIPTSLTTI----------------TSLNILDLSNNRLSGPVPDNGSFS 138
           L+         L   SL  +                 SL  LDLS N L        SF 
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL--------SFK 362

Query: 139 QFTPISFENNLNL 151
                S     +L
Sbjct: 363 GCCSQSDFGTTSL 375

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 10/42 (23%), Positives = 18/42 (42%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
              L +L++L + +N L  +       +TSL  + L  N   
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 19/88 (21%), Positives = 40/88 (45%), Gaps = 5/88 (5%)

Query: 68  SVTRVDLGNAAL-SGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNI----LDL 122
           ++  +++ +  + S +L      L NLE L L++N +  +  T L  +  + +    LDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 123 SNNRLSGPVPDNGSFSQFTPISFENNLN 150
           S N ++   P      +   ++  NN +
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFD 212

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 24/86 (27%), Positives = 32/86 (37%), Gaps = 4/86 (4%)

Query: 45  LQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLS 104
              W +L    C +         S+ R+   +       A     L +LE L L+ N LS
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLS 360

Query: 105 --GLIPTSLTTITSLNILDLSNNRLS 128
             G    S    TSL  LDLS N + 
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI 386

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 36/153 (23%), Positives = 52/153 (33%), Gaps = 34/153 (22%)

Query: 255 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKI---------ISMAVHR 304
           +G GGFG +Y        +  A   +K E    G L    E+K          I   + R
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS--ELKFYQRVAKKDCIKKWIER 102

Query: 305 NLLRLYGF-----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK-------K 352
             L   G            K   Y +M    V  RL      L  +             +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFM----VMERL---GIDLQKISGQNGTFKKSTVLQ 155

Query: 353 IALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
           + +     L Y+HE+     +H D+KAAN+LL 
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLG 185

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 25/138 (18%), Positives = 47/138 (34%), Gaps = 7/138 (5%)

Query: 20  PMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEG-SVTRVDLGNAA 78
           P    ++  + L     +L     SL+               T   +  S+ R+ +  A 
Sbjct: 20  PKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAAR 79

Query: 79  LSGELAPELGQLKN---LELLRLNNNSLSGLIPTSLT--TITSLNILDLSNNRLSGPVPD 133
           +   +     ++     L+ L L N  ++G  P  L   T   LNIL+L N   +     
Sbjct: 80  IPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW 139

Query: 134 NGSFSQFTPISFENNLNL 151
                Q+     +  L++
Sbjct: 140 LAELQQWLKPGLK-VLSI 156

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 18/66 (27%), Positives = 23/66 (34%), Gaps = 2/66 (3%)

Query: 74  LGNAALSGELAP-ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
           LG   L   L P +   L+ L L      + SG+          L  LDLS+N L     
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD-AA 244

Query: 133 DNGSFS 138
              S  
Sbjct: 245 GAPSCD 250

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 20/91 (21%), Positives = 30/91 (32%), Gaps = 10/91 (10%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGN---AALSGELAPELGQLKNLELLRL 98
           +N       L   LC           ++  + L N      SG  +        L+ L L
Sbjct: 182 DNPELGERGLISALCP------LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235

Query: 99  NNNSLSGLIPTSLTTI-TSLNILDLSNNRLS 128
           ++NSL            + LN L+LS   L 
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 15/69 (21%), Positives = 27/69 (39%), Gaps = 4/69 (5%)

Query: 68  SVTRVDLGNAALSGELA--PELGQL--KNLELLRLNNNSLSGLIPTSLTTITSLNILDLS 123
            +  ++L N + +   A   EL Q     L++L +            +    +L+ LDLS
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181

Query: 124 NNRLSGPVP 132
           +N   G   
Sbjct: 182 DNPELGERG 190

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 40.3 bits (94), Expect = 7e-04
 Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 12/99 (12%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQ-LKNLELLRLNN 100
           N  +++   +   L             +  +DL + +L              L  L L+ 
Sbjct: 210 NAGMETPSGVCSALAAARV-------QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262

Query: 101 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 139
             L  + P  L     L++LDLS NRL    P      Q
Sbjct: 263 TGLKQV-PKGLPA--KLSVLDLSYNRLDR-NPSPDELPQ 297

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 6/93 (6%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPE-GSVTRVDLGNAALSGELAPELGQLKNLELLRLNN 100
              L     LP  L +      +    ++  + L    +   L   +  L+NL+ L++ N
Sbjct: 160 CPELTE---LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215

Query: 101 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 133
           + LS L   ++  +  L  LDL         P 
Sbjct: 216 SPLSAL-GPAIHHLPKLEELDLRGCTALRNYPP 247

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 46.1 bits (110), Expect = 9e-06
 Identities = 20/83 (24%), Positives = 30/83 (36%), Gaps = 3/83 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
            +  + +  A L  EL   + Q   LE L L  N L  L P S+ ++  L  L +     
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPE 162

Query: 128 SGPVPDN-GSFSQFTPISFENNL 149
              +P+   S           NL
Sbjct: 163 LTELPEPLASTDASGEHQGLVNL 185

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 8/47 (17%), Positives = 20/47 (42%)

Query: 82  ELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
            L  ++ +L  LE L L        +P+ +  + +  I+ +  +  +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 25/148 (16%), Positives = 50/148 (33%), Gaps = 14/148 (9%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCN-----PE--GSVTRVDLGNAALSGELAPELGQLKNLE 94
           NN L     LP +L     +  N     PE   S+  +D+    L   L     +  + E
Sbjct: 149 NNQLTMLPELPTSL-EVLSVRNNQLTFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSE 206

Query: 95  ----LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 150
                 R   N ++ + P ++ ++     + L +N LS  + ++ S     P      + 
Sbjct: 207 ETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265

Query: 151 LCGPNTKKPCSGSPPFSPPPPFGPTSSP 178
               + ++     P       + P +  
Sbjct: 266 FSMSDGQQNTLHRPLADAVTAWFPENKQ 293

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 30/119 (25%), Positives = 45/119 (37%), Gaps = 19/119 (15%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCN-----PE--GSVTRVDLGNAALSGELAPELGQLKNLE 94
           NN L     LP  L  + +   N     PE   S+  + + N  L+    PEL   ++LE
Sbjct: 129 NNQLTMLPELPALL-EYINADNNQLTMLPELPTSLEVLSVRNNQLTF--LPEL--PESLE 183

Query: 95  LLRLNNNSLSGLIPTSLTTITSL----NILDLSNNRLSGPVPDN-GSFSQFTPISFENN 148
            L ++ N L  L P                    NR++  +P+N  S      I  E+N
Sbjct: 184 ALDVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDN 240

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 40.3 bits (94), Expect = 9e-04
 Identities = 10/50 (20%), Positives = 16/50 (32%), Gaps = 2/50 (4%)

Query: 79  LSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
              +      + +   L   N N    L+   L  I   + L L+   LS
Sbjct: 25  TYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS 72

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 22/117 (18%), Positives = 36/117 (30%), Gaps = 11/117 (9%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCN-----PE--GSVTRVDLGNAALSGELAPELGQLKNLE 94
            N L S   LP  L     ++ N     P     +  + +    L+  L   L  L +  
Sbjct: 230 GNRLTSLPVLPSEL-KELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSET 287

Query: 95  LLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 151
            + L  N LS     +L  ITS      S   +   +    +  +   +       L
Sbjct: 288 TVNLEGNPLSERTLQALREITSAP--GYSGPIIRFDMAGASAPRETRALHLAAADWL 342

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 21/107 (19%), Positives = 34/107 (31%), Gaps = 30/107 (28%)

Query: 36  SKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLEL 95
           + L  P+N+L S   LP  L                +++    L+  L      L  L +
Sbjct: 64  TTLVIPDNNLTSLPALPPEL--------------RTLEVSGNQLT-SLPVLPPGLLELSI 108

Query: 96  LRLNNNSLSGLIPTSLTT--------------ITSLNILDLSNNRLS 128
                  L  L P+ L                   L  L +S+N+L+
Sbjct: 109 FSNPLTHLPAL-PSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA 154

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 24/113 (21%), Positives = 36/113 (31%), Gaps = 24/113 (21%)

Query: 37  KLQDPNNSLQSWDNLPGNLCTWFHITCN-----PE--GSVTRVDLGNAALSGELAPELGQ 89
           +L   +N L S   LP  L        N     P     +  + + +  L+  L     +
Sbjct: 145 ELSVSDNQLASLPALPSEL-CKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSE 202

Query: 90  LKNLELLRLNNNSLSGLIPTSLTT--------------ITSLNILDLSNNRLS 128
           L  L        SL  L P+ L                 + L  L +S NRL+
Sbjct: 203 LYKLWAYNNRLTSLPAL-PSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT 254

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 46.2 bits (110), Expect = 8e-06
 Identities = 30/146 (20%), Positives = 57/146 (39%), Gaps = 18/146 (12%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGF 312
           +G G FG +++G  L + + VA+K    E       Q + E +   +      +  +Y F
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
                  +LV   +  G     L +   R+ S+      T    A      +  +HE   
Sbjct: 75  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV-----KTVAMAAKQMLARVQSIHEKS- 126

Query: 370 PKIIHRDVKAANILLDEDADQSSKTI 395
             +++RD+K  N L+     +++  I
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMI 150

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 1e-05
 Identities = 34/201 (16%), Positives = 66/201 (32%), Gaps = 66/201 (32%)

Query: 206 FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNIL--GRGGFGK- 262
           FA +  +R   +           L+L    R +L EL+        KN+L  G  G GK 
Sbjct: 126 FAKYNVSRLQPY-----------LKL----RQALLELR------PAKNVLIDGVLGSGKT 164

Query: 263 VYKGRLADGKLVAVKRLKEERTSGGEL------QFQTEVKIISMAVHRNLLRLYGFCTTV 316
                +A   L      K +     ++         +   ++ M     L +L       
Sbjct: 165 W----VA---LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM-----LQKLL------ 206

Query: 317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 376
               +   + +    +S ++ R  S+         +  L   R L     + +  ++  +
Sbjct: 207 --YQIDPNWTSRSDHSSNIKLRIHSI---------QAEL---RRLLKSKPYENCLLVLLN 252

Query: 377 VKAANILLDEDA-DQSSKTIL 396
           V+ A      +A + S K +L
Sbjct: 253 VQNAKAW---NAFNLSCKILL 270

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 2e-04
 Identities = 65/480 (13%), Positives = 122/480 (25%), Gaps = 183/480 (38%)

Query: 15  VLVALPMISANAEVDALYIFK------SKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGS 68
            +     +  + +V     FK           P   L+    L       + I  N    
Sbjct: 165 WVAL--DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL------LYQIDPNWT-- 214

Query: 69  VTRVDLGNAALSGELAPELGQ--LKNLELLRLNNNSLSGLI-----------------PT 109
                  + + + +L     Q  L+ L   +   N L  L+                   
Sbjct: 215 ----SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKI 268

Query: 110 SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPP 169
            LTT        LS    +    D+ S +  TP   +   +L            P     
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMT-LTP---DEVKSLLLKYLDCRPQDLPR---- 320

Query: 170 PPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTR---------------- 213
                       +     P  +++ A  +    +  +  W+                   
Sbjct: 321 ------------EVLTTNPRRLSIIAESI-RDGLATWDNWKHVNCDKLTTIIESSLNVLE 367

Query: 214 PHEF---FFD---------VPA-----------EDDSELQLGQLKRFSLRELQVATDGFS 250
           P E+   F           +P            + D  + + +L ++SL           
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL----------- 416

Query: 251 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRL 309
                                     K+ KE   S   +  + +VK+ +  A+HR+++  
Sbjct: 417 ------------------------VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452

Query: 310 Y----GFCTTVTEKLLV--YPY------MTNGSVASRLRERQSSLPP----LDWPTRKKI 353
           Y     F +       +  Y Y      + N        ER +          +  +K  
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN----IEHPERMTLFRMVFLDFRFLEQKIR 508

Query: 354 ALGSARGLS---------------YLHEHCDPKIIHRDVKA---------ANILLDEDAD 389
              +A   S               Y+ ++ DPK   R V A          N++  +  D
Sbjct: 509 HDSTAWNASGSILNTLQQLKFYKPYICDN-DPK-YERLVNAILDFLPKIEENLICSKYTD 566

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.3 bits (106), Expect = 2e-05
 Identities = 14/94 (14%), Positives = 31/94 (32%), Gaps = 9/94 (9%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQ---LKNLELLRL 98
                 +D         F     P  ++  + + +A     +     +   L  LE + +
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFP--NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDI 286

Query: 99  NNNSLSG----LIPTSLTTITSLNILDLSNNRLS 128
           +   L+     L+   +  I  L  +++  N LS
Sbjct: 287 SAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 16/105 (15%), Positives = 35/105 (33%), Gaps = 15/105 (14%)

Query: 38  LQDPNNSLQSWD-NLPGNL-CTWFHITCNPEG-----------SVTRVDLGNAALSGELA 84
           ++      +  D NL  +      HI    +            +   V   N+ +  +L 
Sbjct: 3   VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP 61

Query: 85  PE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
              L   + +ELL LN+  +  +   +     ++  L +  N + 
Sbjct: 62  AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.5 bits (103), Expect = 9e-05
 Identities = 18/60 (30%), Positives = 29/60 (48%), Gaps = 3/60 (5%)

Query: 70  TRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             VDL    L  ++      +++ LE L ++NN L   +      I +L +LDLS+N L 
Sbjct: 251 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 308

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 2/62 (3%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
            V  ++L +  +  E+          ++ L +  N++  L P     +  L +L L  N 
Sbjct: 70  QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128

Query: 127 LS 128
           LS
Sbjct: 129 LS 130

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 12/44 (27%), Positives = 18/44 (40%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             L     L  + L+ N L  ++      +  L  L +SNNRL 
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 16/62 (25%), Positives = 24/62 (38%), Gaps = 2/62 (3%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE 146
                 L  L ++NN+L  +   +    TSL  L LS+NRL+  V            +  
Sbjct: 137 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL-SLIPSLFHANVS 194

Query: 147 NN 148
            N
Sbjct: 195 YN 196

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 18/62 (29%), Positives = 28/62 (45%), Gaps = 2/62 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQ-LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
           ++ ++ +G  A+   L P + Q +  L +L L  N LS L          L  L +SNN 
Sbjct: 94  TIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 152

Query: 127 LS 128
           L 
Sbjct: 153 LE 154

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 18/61 (29%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++  +DL +  L   +     Q   LE L L++NS+  L    L+T  +L  L LS+N  
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDW 351

Query: 128 S 128
            
Sbjct: 352 D 352

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 17/42 (40%), Positives = 22/42 (52%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L  L NL  L L+ NS+S +   SL     L  L L+NN+L 
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 11/51 (21%), Positives = 25/51 (49%)

Query: 88  GQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 138
              K L+ LR++ N ++ +  +    +  + +++L  N L     +NG+F 
Sbjct: 118 KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 30/152 (19%), Positives = 57/152 (37%), Gaps = 32/152 (21%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-----AVHRNLL 307
            +G G FG+V   + + + K  AVK ++  +        + E  I+         + N++
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY--TRSAKIEADILKKIQNDDINNNNIV 99

Query: 308 RLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSA 358
           + +G        C  + E L              L E   +++         K   +   
Sbjct: 100 KYHGKFMYYDHMCL-IFEPL-----------GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQ 390
           + L+YL +     + H D+K  NILLD+   +
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFE 176

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 9/51 (17%), Positives = 24/51 (47%)

Query: 88  GQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 138
               +L  LR+++N +  +     + + ++N +++  N L     + G+F 
Sbjct: 120 NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 14/42 (33%), Positives = 22/42 (52%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +   L  L L +N +  +   SL+ + +L  L L NN+LS
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 16/61 (26%), Positives = 23/61 (37%), Gaps = 3/61 (4%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL 149
           L  L  L L+NN LS  +P  L  +  L ++ L  N ++  V     F            
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VG-VNDFCPVGFGVKRAYY 296

Query: 150 N 150
           N
Sbjct: 297 N 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 17/61 (27%), Positives = 28/61 (45%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
             T +DL N  +S     +   L++L  L L NN +S +   + + +  L  L +S N L
Sbjct: 55  DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114

Query: 128 S 128
            
Sbjct: 115 V 115

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 18/61 (29%), Positives = 27/61 (44%), Gaps = 1/61 (1%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL 149
           L +LE L L+ N LS L  +    ++SL  L+L  N     + +   FS  T +      
Sbjct: 99  LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVG 157

Query: 150 N 150
           N
Sbjct: 158 N 158

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 20/61 (32%), Positives = 34/61 (55%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           +V  +DL N  ++     +L +  NL+ L L +N ++ +   S +++ SL  LDLS N L
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112

Query: 128 S 128
           S
Sbjct: 113 S 113

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 20/63 (31%), Positives = 31/63 (49%), Gaps = 3/63 (4%)

Query: 68  SVTRVDLGNAALSGELAPE--LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNN 125
               +DL +  LS  L  E    +L NL  L L++N L+ +   +   + +L  LDLS+N
Sbjct: 40  YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98

Query: 126 RLS 128
            L 
Sbjct: 99  HLH 101

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 16/62 (25%), Positives = 26/62 (41%), Gaps = 2/62 (3%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL 149
           L+ LE+L L NN +  +   +   +  L  L LS N++S   P          +     L
Sbjct: 111 LQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPV-ELIKDGNKLPKLMLL 168

Query: 150 NL 151
           +L
Sbjct: 169 DL 170

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 12/40 (30%), Positives = 20/40 (50%)

Query: 89  QLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
            + NL  L L++N L  L     + + +L +L L NN + 
Sbjct: 86  PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV 125

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 33/156 (21%), Positives = 59/156 (37%), Gaps = 37/156 (23%)

Query: 255 LGRGGFGKVYKGRLADGKLVAVKR---LKEERTSGGELQFQTEVKI---------ISMAV 302
           +G+GGFG +Y   +   + V       +K E +  G L    E+K          I   +
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQIQKWI 100

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR----ERQ-SSLPPL-DWPTRK----- 351
               L+  G           +    +       R    +R  S L  + +   ++     
Sbjct: 101 RTRKLKYLGVPK-------YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153

Query: 352 --KIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 385
             +++L     L Y+HEH     +H D+KA+N+LL+
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 16/88 (18%), Positives = 35/88 (39%), Gaps = 11/88 (12%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPEL-GQLKNLELLRLNN 100
            N L+    +                S+ ++D+   ++S +         K+L  L +++
Sbjct: 357 MNQLKELSKIAE----MTT----QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408

Query: 101 NSLSGLIPTSLTTITSLNILDLSNNRLS 128
           N L+  I   L     + +LDL +N++ 
Sbjct: 409 NILTDTIFRCLP--PRIKVLDLHSNKIK 434

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 14/53 (26%), Positives = 21/53 (39%), Gaps = 4/53 (7%)

Query: 89  QLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
             + LE L L++N L  +         +L  LDLS N     +P    F   +
Sbjct: 67  FNQELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFDA-LPICKEFGNMS 115

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 14/61 (22%), Positives = 28/61 (45%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
             T +++    +S     ++  L  L +L +++N +  L  +       L  LDLS+N+L
Sbjct: 22  KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81

Query: 128 S 128
            
Sbjct: 82  V 82

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 11/74 (14%), Positives = 24/74 (32%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++   +   +           ++     L  +NN L+  +  +   +T L  L L  N+L
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

Query: 128 SGPVPDNGSFSQFT 141
                     +Q  
Sbjct: 361 KELSKIAEMTTQMK 374

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 14/73 (19%), Positives = 23/73 (31%), Gaps = 6/73 (8%)

Query: 88  GQLKNLELLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE 146
               NL+ L L+ N+   L        ++ L  L LS   L        S      ++  
Sbjct: 87  HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE-----KSSVLPIAHLNIS 141

Query: 147 NNLNLCGPNTKKP 159
             L + G    + 
Sbjct: 142 KVLLVLGETYGEK 154

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 12/88 (13%), Positives = 32/88 (36%), Gaps = 8/88 (9%)

Query: 60  HITCNPEG------SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTT 113
           +I    +        +  +++ +      + P      NL  L + + +L+ +   ++  
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246

Query: 114 ITSLNILDLSNNRLSGPVPDNGSFSQFT 141
           +  L  L+LS N +S    +     +  
Sbjct: 247 LVYLRFLNLSYNPIS--TIEGSMLHELL 272

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.6 bits (103), Expect = 8e-05
 Identities = 22/76 (28%), Positives = 31/76 (40%), Gaps = 3/76 (3%)

Query: 56  CTWFHITCNPEG---SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLT 112
           C        PEG       +DLG   +      E     +LE L LN N +S + P +  
Sbjct: 18  CHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFN 77

Query: 113 TITSLNILDLSNNRLS 128
            + +L  L L +NRL 
Sbjct: 78  NLFNLRTLGLRSNRLK 93

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 10/39 (25%), Positives = 19/39 (48%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L NL  L ++ N +  L+      + +L  L++ +N L 
Sbjct: 103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 13/39 (33%), Positives = 21/39 (53%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L NL  L L +N L  +     T +++L  LD+S N++ 
Sbjct: 79  LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV 117

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 13/62 (20%), Positives = 31/62 (50%), Gaps = 2/62 (3%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
            +  ++L    +S  +    L +L  L+ ++L    L+ + P +   +  L +L++S N+
Sbjct: 249 YLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307

Query: 127 LS 128
           L+
Sbjct: 308 LT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 14/102 (13%), Positives = 38/102 (37%), Gaps = 16/102 (15%)

Query: 42  NNSLQS-----WDNLPG----NLCTWFHITCNPEG-----SVTRVDLGNAALSGELAPE- 86
           + ++ +     +  L       +  W ++           ++T + + +  L+  +    
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           +  L  L  L L+ N +S +  + L  +  L  + L   +L+
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 10/39 (25%), Positives = 21/39 (53%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +LE L L   +L+ +   +L+ +  L +L L +  ++
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 11/39 (28%), Positives = 19/39 (48%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L NL+ L + +N L  +   + + + SL  L L    L+
Sbjct: 127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 6e-05
 Identities = 13/42 (30%), Positives = 23/42 (54%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +L  L+ L L++N +SG +        +L  L+LS N++ 
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 18/60 (30%), Positives = 29/60 (48%), Gaps = 3/60 (5%)

Query: 70  TRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             VDL    L  ++      +++ LE L ++NN L   +      I +L +LDLS+N L 
Sbjct: 257 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 314

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 11/62 (17%), Positives = 25/62 (40%), Gaps = 2/62 (3%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
           +   V   N+ +  +L    L   + +ELL LN+  +  +   +     ++  L +  N 
Sbjct: 52  NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110

Query: 127 LS 128
           + 
Sbjct: 111 IR 112

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 2/62 (3%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
            V  ++L +  +  E+          ++ L +  N++  L P     +  L +L L  N 
Sbjct: 76  QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134

Query: 127 LS 128
           LS
Sbjct: 135 LS 136

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 18/62 (29%), Positives = 28/62 (45%), Gaps = 2/62 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQ-LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
           ++ ++ +G  A+   L P + Q +  L +L L  N LS L          L  L +SNN 
Sbjct: 100 TIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 158

Query: 127 LS 128
           L 
Sbjct: 159 LE 160

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 12/44 (27%), Positives = 18/44 (40%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             L     L  + L+ N L  ++      +  L  L +SNNRL 
Sbjct: 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 16/62 (25%), Positives = 24/62 (38%), Gaps = 2/62 (3%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE 146
                 L  L ++NN+L  +   +    TSL  L LS+NRL+  V            +  
Sbjct: 143 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL-SLIPSLFHANVS 200

Query: 147 NN 148
            N
Sbjct: 201 YN 202

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 20/79 (25%), Positives = 34/79 (43%), Gaps = 4/79 (5%)

Query: 50  NLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPT 109
            +  N     ++   P  ++  +DL +  L   +     Q   LE L L++NS+  L   
Sbjct: 284 YISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL--- 339

Query: 110 SLTTITSLNILDLSNNRLS 128
            L+T  +L  L LS+N   
Sbjct: 340 KLSTHHTLKNLTLSHNDWD 358

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 43.6 bits (103), Expect = 7e-05
 Identities = 14/44 (31%), Positives = 23/44 (52%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           P L  L  LE L ++ N    + P S   ++SL  L + N+++S
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 20/77 (25%), Positives = 38/77 (49%), Gaps = 3/77 (3%)

Query: 55  LCTWFHITCNPEG---SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSL 111
           +CT   ++  P+G   +   ++L    +    A     L +LE+L+L  NS+  +   + 
Sbjct: 60  VCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119

Query: 112 TTITSLNILDLSNNRLS 128
             + SLN L+L +N L+
Sbjct: 120 NGLASLNTLELFDNWLT 136

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 12/39 (30%), Positives = 23/39 (58%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +L+ L + N+ +S +   +   + SL  L+L++N LS
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 11/39 (28%), Positives = 19/39 (48%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +L  L L +N L+ +   +   ++ L  L L NN + 
Sbjct: 122 LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE 160

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 43.6 bits (103), Expect = 8e-05
 Identities = 14/61 (22%), Positives = 31/61 (50%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           +   ++L    +          L++LE+L+L+ N +  +   +   + +LN L+L +NRL
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124

Query: 128 S 128
           +
Sbjct: 125 T 125

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 13/44 (29%), Positives = 21/44 (47%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           P L  L  L+ L L+ N LS + P S   +  L  L +  +++ 
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 12/39 (30%), Positives = 19/39 (48%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L NL  L L +N L+ +   +   ++ L  L L NN + 
Sbjct: 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE 149

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 8/39 (20%), Positives = 21/39 (53%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +L+ L +  + +  +   +   + SL  ++L++N L+
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 13/42 (30%), Positives = 22/42 (52%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +L  L+ L L+ N + G +      + +L  L+LS N+L 
Sbjct: 67  LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 19/83 (22%), Positives = 31/83 (37%), Gaps = 14/83 (16%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP------------ 132
             L  L NL  + L NN +S + P  L   ++L I+ L+N  ++                
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246

Query: 133 DNGSFSQFTPISFENNLNLCGPN 155
              S +   P +  +N     PN
Sbjct: 247 KGPSGAPIAPATISDNGTYASPN 269

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 14/44 (31%), Positives = 22/44 (50%), Gaps = 2/44 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             L  L NL+ L + N  +S L P  L  ++ L  L   +N++S
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 9/44 (20%), Positives = 25/44 (56%), Gaps = 2/44 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             +  L++++ L L +  ++ + P  L  +++L +L L  N+++
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT 142

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 15/44 (34%), Positives = 22/44 (50%), Gaps = 2/44 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             +  L NL  L L +N ++ L P  L  +T +  L+LS N L 
Sbjct: 57  EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 38/169 (22%), Positives = 60/169 (35%), Gaps = 51/169 (30%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 295
            D +  K+++GRG +G VY        K VA+K++           F+          E+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREI 76

Query: 296 KIISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTR 350
            I++      ++RLY               +V                 S L  L    +
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA------------DSDLKKL---FK 121

Query: 351 KKIALGSA----------RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
             I L              G +++HE     IIHRD+K AN LL++D  
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCS 167

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 34/140 (24%), Positives = 49/140 (35%), Gaps = 12/140 (8%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGF 312
           +G G FG +Y G  +A G+ VA+K    E       Q   E KI   M     +  +   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
                  ++V   +  G     L    S    L   T   +A      + Y+H       
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSKN---F 126

Query: 373 IHRDVKAANILLDEDADQSS 392
           IHRDVK  N L+      + 
Sbjct: 127 IHRDVKPDNFLMGLGKKGNL 146

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 30/161 (18%), Positives = 48/161 (29%), Gaps = 23/161 (14%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNN 101
           N  L  +            +T N    +  +D   A ++ EL  +L Q   L  L LNN 
Sbjct: 274 NTQLIYFQAEGCRKIKELDVTHNT--QLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNT 328

Query: 102 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG----------SFSQFTPISFE----N 147
            L+ L    ++  T L  L   N  +       G          +  Q   +  E    N
Sbjct: 329 ELTEL---DVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTITMPKETLTNN 384

Query: 148 NLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIP 188
           +L +          G+P    P   G         +   + 
Sbjct: 385 SLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLS 425

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 17/92 (18%), Positives = 38/92 (41%), Gaps = 13/92 (14%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           ++T +D  N++++      + +L  L  L   +N+++ L  +     T+L  L   +N+L
Sbjct: 43  TLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITTLDLSQN---TNLTYLACDSNKL 97

Query: 128 SG-PVPDNG-------SFSQFTPISFENNLNL 151
           +   V             ++ T +    N  L
Sbjct: 98  TNLDVTPLTKLTYLNCDTNKLTKLDVSQNPLL 129

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 23/108 (21%), Positives = 42/108 (38%), Gaps = 11/108 (10%)

Query: 41  PNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNN 100
           P   L + D    N  T   ++ N    + R++     ++     +L Q   L  L  ++
Sbjct: 168 PQTQLTTLD-CSFNKITELDVSQNK--LLNRLNCDTNNIT---KLDLNQNIQLTFLDCSS 221

Query: 101 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 148
           N L+ +    +T +T L   D S N L+    D  + S+ T +     
Sbjct: 222 NKLTEI---DVTPLTQLTYFDCSVNPLT--ELDVSTLSKLTTLHCIQT 264

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 13/75 (17%), Positives = 26/75 (34%), Gaps = 11/75 (14%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG-PVPDNG-------S 136
            ++     L  L  + N ++ L    ++    LN L+   N ++   +  N        S
Sbjct: 164 LDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCS 220

Query: 137 FSQFTPISFENNLNL 151
            ++ T I       L
Sbjct: 221 SNKLTEIDVTPLTQL 235

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 29/157 (18%), Positives = 52/157 (33%), Gaps = 38/157 (24%)

Query: 254 ILGRGGFGKVYKG--RLADGKLVAVK--RLKEERTSGGELQFQTEVKIISM------AVH 303
            LG G FGKV +          VA+K  R   +         + E+ ++           
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81

Query: 304 RNLLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 354
              + +  +       C    E L                E  ++++  P   P  + +A
Sbjct: 82  FLCVLMSDWFNFHGHMCI-AFELL-----------GKNTFEFLKENNFQPYPLPHVRHMA 129

Query: 355 LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS 391
                 L +LHE+   ++ H D+K  NIL      ++
Sbjct: 130 YQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 18/146 (12%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGF 312
           +G G FG++  G+ L   + VA+K    E       Q   E +          + ++Y F
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 313 CTTVTEKLLVYPYMTNG-SVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
                   +V   +  G S+     L +R  SL      T   IA+     + Y+H    
Sbjct: 74  GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL-----KTVLMIAIQLISRMEYVHSKN- 125

Query: 370 PKIIHRDVKAANILLDEDADQSSKTI 395
             +I+RDVK  N L+    +++ + I
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVI 149

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 12/42 (28%), Positives = 19/42 (45%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
              L+ L+ L +NNN +  +       +  L  L L+NN L 
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 31/162 (19%), Positives = 60/162 (37%), Gaps = 38/162 (23%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 295
              + +   +G G +G V        G+ VA+K+L           FQ+         E+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74

Query: 296 KIISMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDW 347
            ++    H N++ L              +  LV P+M      + L++            
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL----KFSE 125

Query: 348 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
              + +     +GL Y+H      ++HRD+K  N+ ++ED +
Sbjct: 126 EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCE 164

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 32/159 (20%), Positives = 55/159 (34%), Gaps = 38/159 (23%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 298
           + N   +G G  G V         + VA+K+L           FQ          E+ ++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYRELVLM 78

Query: 299 SMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTR 350
               H+N++ L              +  +V   M      + L +  +      LD    
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQM----ELDHERM 129

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
             +      G+ +LH      IIHRD+K +NI++  D  
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 165

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 9/49 (18%), Positives = 21/49 (42%), Gaps = 2/49 (4%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 138
             +L+ L L+ N +   + ++   +  L  LD  ++ L   + +   F 
Sbjct: 77  TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFL 123

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 11/39 (28%), Positives = 21/39 (53%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +L++L +++N+   L       + SL +LD S N + 
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 17/54 (31%), Positives = 29/54 (53%)

Query: 75  GNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           GN+     L     +L+NL  L L+   L  L PT+  +++SL +L++S+N   
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 212

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 7/77 (9%)

Query: 62  TCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILD 121
           +C+     T +   +  L+    P  G   +   L L +N L  L       +T L  L 
Sbjct: 6   SCSG----TEIRCNSKGLTS--VPT-GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLS 58

Query: 122 LSNNRLSGPVPDNGSFS 138
           LS+N LS     + S  
Sbjct: 59  LSSNGLSFKGCCSQSDF 75

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 8/45 (17%), Positives = 18/45 (40%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 134
           L+NL  L +++             ++SL +L ++ N        +
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 40.0 bits (94), Expect = 9e-04
 Identities = 13/40 (32%), Positives = 22/40 (55%), Gaps = 1/40 (2%)

Query: 90  LKNLELLRL-NNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +LE+L++  N+     +P   T + +L  LDLS  +L 
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 27/105 (25%), Positives = 53/105 (50%), Gaps = 11/105 (10%)

Query: 37  KLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELL 96
            L+  + SL S ++        +  TC    S+  ++L +  L+G +   L     +++L
Sbjct: 404 SLETLDVSLNSLNSHA------YDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVL 455

Query: 97  RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
            L+NN +  + P  +T + +L  L++++N+L   VPD G F + T
Sbjct: 456 DLHNNRIMSI-PKDVTHLQALQELNVASNQLKS-VPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 15/53 (28%), Positives = 23/53 (43%), Gaps = 4/53 (7%)

Query: 89  QLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 141
             ++LE L +++N L  +    +    SL  LDLS N     +P    F   T
Sbjct: 98  FNQDLEYLDVSHNRLQNISCCPM---ASLRHLDLSFNDFDV-LPVCKEFGNLT 146

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 2/42 (4%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L  L  LE L L NN ++ +  T L+ +T L+ L L +N++S
Sbjct: 127 LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 40.9 bits (95), Expect = 6e-04
 Identities = 15/42 (35%), Positives = 20/42 (47%), Gaps = 2/42 (4%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L  LKNL  L L+ N +  L    L  +  L  L L +N +S
Sbjct: 83  LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS 122

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 40.5 bits (94), Expect = 8e-04
 Identities = 14/42 (33%), Positives = 22/42 (52%), Gaps = 2/42 (4%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L  LK L+ L L +N +S +    L  +  L  L L NN+++
Sbjct: 105 LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 40.5 bits (94), Expect = 9e-04
 Identities = 15/42 (35%), Positives = 22/42 (52%), Gaps = 2/42 (4%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +L  L+ L L +N +S +    L  +T L  L LS N +S
Sbjct: 149 LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS 188

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 30/153 (19%), Positives = 58/153 (37%), Gaps = 38/153 (24%)

Query: 254 ILGRGGFGKVYKG--RLADGKLVAVK--RLKEERTSGGELQFQTEVKIISM------AVH 303
            LG G FGKV +     A G+ VAVK  +  +          ++E++++           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE----AARSEIQVLEHLNTTDPNST 76

Query: 304 RNLLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 354
              +++  +       C  V E L                +  +++   P      +K+A
Sbjct: 77  FRCVQMLEWFEHHGHICI-VFELL-----------GLSTYDFIKENGFLPFRLDHIRKMA 124

Query: 355 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               + +++LH +   K+ H D+K  NIL  + 
Sbjct: 125 YQICKSVNFLHSN---KLTHTDLKPENILFVQS 154

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 33/161 (20%), Positives = 54/161 (33%), Gaps = 36/161 (22%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 295
              + N   +G G  G V         + VA+K+L           FQ          E+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112

Query: 296 KIISMAVHRNLLRLY------GFCTTVTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWP 348
            ++    H+N++ L              +  LV   M  N     ++         LD  
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHE 164

Query: 349 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
               +      G+ +LH      IIHRD+K +NI++  D  
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 202

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 16/49 (32%), Positives = 25/49 (51%), Gaps = 2/49 (4%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 138
           L  L+ L L +N+L  L   +   + +L  L L  NR+S  VP+  +F 
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPE-RAFR 174

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 12/39 (30%), Positives = 20/39 (51%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L +L+ L L+ N ++ + P +   +  L  L L  N LS
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 13/39 (33%), Positives = 21/39 (53%)

Query: 90  LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L NL  L L+ N +S +   +   + SL+ L L  NR++
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 40.0 bits (94), Expect = 8e-04
 Identities = 19/71 (26%), Positives = 32/71 (45%), Gaps = 1/71 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           +  R+ L    +S   A      +NL +L L++N L+ +   + T +  L  LDLS+N  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 128 SGPVPDNGSFS 138
              V    +F 
Sbjct: 93  LRSVDP-ATFH 102

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 30/139 (21%), Positives = 49/139 (35%), Gaps = 12/139 (8%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGF 312
           +G G FG++Y G  +   + VA+K    E       Q   E KI   +     +  +  F
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
                  +LV   +  G     L    S    L   T   +A      + ++H       
Sbjct: 72  GVEGDYNVLVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---F 124

Query: 373 IHRDVKAANILLDEDADQS 391
           +HRD+K  N L+      +
Sbjct: 125 LHRDIKPDNFLMGLGRRAN 143

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 33/157 (21%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 298
           + +   +G G +G V        G  VA+K+L           FQ+         E++++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLL 78

Query: 299 SMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 352
               H N++ L             T+  LV P+M  G+   +L + +     L     + 
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----KLGEDRIQF 132

Query: 353 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
           +     +GL Y+H      IIHRD+K  N+ ++ED +
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCE 166

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 40.5 bits (94), Expect = 6e-04
 Identities = 15/62 (24%), Positives = 25/62 (40%), Gaps = 1/62 (1%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
           ++T + + N      L    L  L  L  L +  + L  + P +      L+ L+LS N 
Sbjct: 32  NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91

Query: 127 LS 128
           L 
Sbjct: 92  LE 93

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 2/42 (4%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L  L  LE L L NN ++ +  T L+ +T L+ L L +N++S
Sbjct: 130 LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 169

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 40.3 bits (94), Expect = 7e-04
 Identities = 20/41 (48%), Positives = 23/41 (56%), Gaps = 2/41 (4%)

Query: 344 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 384
            L  P  KKI     +GL YLH  C  +IIH D+K  NILL
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL 180

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 33/156 (21%), Positives = 60/156 (38%), Gaps = 33/156 (21%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 298
           ++N + +G G +G V       +   VA+K++           F+          E+KI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---------PFEHQTYCQRTLREIKIL 79

Query: 299 SMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 353
               H N++ +       T +      +V   M   +   +L + Q     L        
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQ----HLSNDHICYF 133

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
                RGL Y+H      ++HRD+K +N+LL+   D
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCD 166

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 2/42 (4%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           L  LKNLE+L + NN L  +    L  ++ L +LDL  N ++
Sbjct: 124 LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT 163

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 17/44 (38%), Positives = 24/44 (54%), Gaps = 1/44 (2%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
              G L  L  L L++N L  L P    T+ +L +LD+S NRL+
Sbjct: 71  QVDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLT 113

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	399
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.98
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.98
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.98
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.95
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.95
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.95
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.94
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.94
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.94
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.94
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.94
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.94
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.94
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.94
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.94
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.94
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.94
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.94
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.93
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.93
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.93
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.93
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.93
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.93
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.93
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.93
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.93
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.93
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.93
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.93
3niz_A	311	Rhodanese family protein; structural genomics, str	99.93
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.93
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.93
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.93
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.93
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.93
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.93
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.93
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.93
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.93
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.93
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.93
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.93
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.93
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.93
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.93
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.93
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.93
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.93
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.93
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.93
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.93
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.93
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.93
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.93
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.92
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.92
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.92
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.92
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.92
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.92
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.92
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.92
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.92
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.92
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.92
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.92
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.92
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.92
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.92
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.92
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.92
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.92
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.92
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.92
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.92
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.92
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.92
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.92
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.92
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.92
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.92
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.92
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.92
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.92
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.92
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.92
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.92
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.92
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.92
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.92
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.92
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.92
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.92
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.92
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.92
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.92
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.92
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.92
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.92
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.92
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.92
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.92
3bhy_A	283	Death-associated protein kinase 3; death associate	99.92
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.92
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.92
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.92
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.92
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.92
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.92
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.92
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.92
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.92
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.92
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.91
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.91
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.91
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.91
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.91
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.91
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.91
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.91
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.91
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.91
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.91
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.91
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.91
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.91
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.91
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.91
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.91
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.91
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.91
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.91
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.91
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.91
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.91
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.91
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.91
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.91
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.91
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.91
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.91
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.91
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.91
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.91
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.91
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.91
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.91
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.91
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.91
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.91
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.91
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.91
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.91
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.91
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.91
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.91
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.91
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.91
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.91
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.9
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.9
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.9
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.9
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.9
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.9
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.9
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.9
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.9
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.9
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.9
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.9
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.9
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.9
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.9
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.9
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.9
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.89
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.89
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.89
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.89
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.89
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.89
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.89
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.89
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.89
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.89
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.89
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.89
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.89
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.88
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.88
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.88
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.88
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.88
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.88
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.88
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.88
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.88
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.88
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.87
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.86
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.86
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.85
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.85
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.83
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.73
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.65
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.6
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.5
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.37
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.97
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.95
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	98.95
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.91
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	98.89
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.84
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.77
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.75
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.73
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.71
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.7
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.68
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.63
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.63
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.6
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.6
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.59
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.58
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.58
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.57
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.56
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.55
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.55
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.54
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.53
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.53
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.52
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.51
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.51
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.51
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.51
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.49
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.49
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.48
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.47
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.45
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.45
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.43
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.42
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.4
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.4
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.4
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.39
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.38
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.37
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.37
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.37
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.36
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.36
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.36
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.35
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.34
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.34
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.34
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.33
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.33
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.32
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.31
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.3
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.29
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.29
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.28
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.28
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.28
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.26
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.26
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.24
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.21
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.17
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.17
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.16
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.12
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.1
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.03
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.02
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.02
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.02
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.02
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.01
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.0
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	97.97
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	97.97
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.95
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	97.95
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	97.94
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	97.94
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	97.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.88
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	97.86
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.86
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	97.85
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	97.85
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.84
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.84
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	97.84
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	97.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	97.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	97.82
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	97.8
1o6v_A	466	Internalin A; bacterial infection, extracellular r	97.76
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	97.75
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	97.74
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	97.73
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	97.72
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	97.66
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	97.62
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	97.6
1o6v_A	466	Internalin A; bacterial infection, extracellular r	97.59
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.58
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.54
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.46
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	97.46
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.45
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.06
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.93
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.91
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.82
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.82
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	96.78
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.76
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	96.66
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.53
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.41
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.4
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.28
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	96.24
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.19
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	96.14
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.75
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	95.39
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	94.93
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	94.78
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	94.77
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	94.67
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	94.64
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.51
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	92.84
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.6
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.09
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.16
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	89.32
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	89.01
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	88.92
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	88.81
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	87.29
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	85.64
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	84.06
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.88
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.48

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.9e-35  Score=275.76  Aligned_cols=145  Identities=26%  Similarity=0.409  Sum_probs=126.8

Q ss_pred             CCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      +...+.||+|+||+||+|++.      +++.||||+++.........+|.+|+.++++++|||||+++|+|.+.+..++|
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            444578999999999999863      46789999997665555566899999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCce
Q 015852          323 YPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  390 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~  390 (399)
                      ||||++|+|.++|+.+...            ...++|.+++.|+.|||+||+|||++   +||||||||+|||||+++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence            9999999999999754211            23589999999999999999999999   99999999999999999999


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      ||+||+
T Consensus       185 Ki~DFG  190 (308)
T 4gt4_A          185 KISDLG  190 (308)
T ss_dssp             EECCSC
T ss_pred             EECCcc
Confidence            999994

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.2e-35  Score=274.03  Aligned_cols=146  Identities=28%  Similarity=0.467  Sum_probs=126.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|...+.||+|+||+||+|++.      ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            45667789999999999999863      4678999999653 2333457999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcC---------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          321 LVYPYMTNGSVASRLRERQ---------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      +|||||++|+|.++|+...         .....++|.++..|+.|||+||+|||++   +||||||||+|||+|+++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            9999999999999998642         1234689999999999999999999998   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       169 i~DFG  173 (299)
T 4asz_A          169 IGDFG  173 (299)
T ss_dssp             ECCCS
T ss_pred             ECCcc
Confidence            99994

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=274.46  Aligned_cols=146  Identities=31%  Similarity=0.483  Sum_probs=127.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.. .....++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34556688999999999999864      4778999999653 2333457999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc
Q 015852          321 LVYPYMTNGSVASRLRERQS-----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  389 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~  389 (399)
                      +|||||++|+|.++++....           ...+++|.+++.|+.|||+||+|||+.   +||||||||+|||||+++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            99999999999999986432           123689999999999999999999998   9999999999999999999


Q ss_pred             eeecccc
Q 015852          390 QSSKTIL  396 (399)
Q Consensus       390 ~~i~df~  396 (399)
                      +||+||+
T Consensus       197 ~Ki~DFG  203 (329)
T 4aoj_A          197 VKIGDFG  203 (329)
T ss_dssp             EEECCCC
T ss_pred             EEEcccc
Confidence            9999994

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.8e-34  Score=266.66  Aligned_cols=143  Identities=29%  Similarity=0.422  Sum_probs=125.0

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ..+++...+.||+|+||+||+|++.+  .||||+++..... .....|.+|+.++++++|||||+++|+|.. +..++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            34567778999999999999998753  5999999754322 234579999999999999999999998865 5689999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||++|+|.++|+....   .++|.++..|+.|||+||+|||++   +||||||||+|||||+++.+||+||+
T Consensus       111 Ey~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             ECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             EcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence            99999999999976432   589999999999999999999998   99999999999999999999999994

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.1e-33  Score=267.14  Aligned_cols=145  Identities=21%  Similarity=0.315  Sum_probs=123.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++..... .....|.+|+.+++.++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5688889999999999999986 47999999999654322 234479999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||++|+|.+++.....  ..+++.+...|+.||+.||+|||++   +||||||||+||||++++.+||+||+
T Consensus       104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  170 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG  170 (350)
T ss_dssp             CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTT
T ss_pred             CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccc
Confidence            9999999999976532  2478889999999999999999999   99999999999999999999999994

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.1e-33  Score=261.47  Aligned_cols=143  Identities=27%  Similarity=0.345  Sum_probs=129.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||+||+|+. .+++.||||++....  .......+.+|+++++.++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4688889999999999999986 578999999996432  2233457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++++..    .+++.+...++.||+.||+|||++   +||||||||+|||+++++.+||+||+
T Consensus       112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            9999999999998753    489999999999999999999999   99999999999999999999999994

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.1e-33  Score=261.47  Aligned_cols=140  Identities=28%  Similarity=0.394  Sum_probs=119.3

Q ss_pred             CCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC----ceEEEEe
Q 015852          249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLLVYP  324 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~e  324 (399)
                      +...+.||+|+||+||+|++ +|+.||||+++...  .....+..|+..+..++|||||+++|+|...+    ..++|||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            45568899999999999998 58899999985432  11223445666677899999999999998654    5789999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-----CDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||++|+|.++|+..     .++|..+.+++.|+|+||+|||++     +.++||||||||+|||||+++++||+||+
T Consensus        82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            99999999999864     389999999999999999999986     35689999999999999999999999994

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.98  E-value=1e-32  Score=263.13  Aligned_cols=141  Identities=25%  Similarity=0.354  Sum_probs=127.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+.+|+.++|||||++++++.+.+..|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            34777789999999999999864 79999999996543 23344689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++|+|.+++...     .+++.+...++.||+.||+|||++   +||||||||+||||+.++.+||+||+
T Consensus       153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  215 (346)
T 4fih_A          153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  215 (346)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCc
Confidence            9999999999753     389999999999999999999999   99999999999999999999999994

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.98  E-value=1.7e-32  Score=258.15  Aligned_cols=146  Identities=21%  Similarity=0.320  Sum_probs=123.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC--------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--------  317 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------  317 (399)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++..........+.+|+.+|+.++|||||++++++...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3577889999999999999986 4789999999965443333457999999999999999999999987544        


Q ss_pred             ----ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeec
Q 015852          318 ----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  393 (399)
Q Consensus       318 ----~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~  393 (399)
                          ..++|||||++|+|.+++.... .....++.....|+.|+++||+|||++   +||||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                3689999999999999998653 223456777889999999999999999   99999999999999999999999


Q ss_pred             ccc
Q 015852          394 TIL  396 (399)
Q Consensus       394 df~  396 (399)
                      ||+
T Consensus       161 DFG  163 (299)
T 4g31_A          161 DFG  163 (299)
T ss_dssp             CCC
T ss_pred             cCc
Confidence            994

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.98  E-value=5.9e-33  Score=266.65  Aligned_cols=157  Identities=27%  Similarity=0.379  Sum_probs=134.1

Q ss_pred             ccHHHHHHHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCC-CCccce
Q 015852          237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRL  309 (399)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l  309 (399)
                      +...++++..++|+..+.||+|+||+||+|++.      .++.||||+++..........|.+|+.+|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            345667777888999999999999999999853      2358999999765544445679999999999965 899999


Q ss_pred             eeeeecC-CceEEEEecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 015852          310 YGFCTTV-TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  376 (399)
Q Consensus       310 ~g~~~~~-~~~~lv~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  376 (399)
                      +|+|... +..++|||||++|+|.++|+....            ....++|.++..|+.|||+||+|||++   +|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999765 468999999999999999986422            123489999999999999999999999   999999


Q ss_pred             CCCCceeeCCCCceeecccc
Q 015852          377 VKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       377 lK~~NILld~~~~~~i~df~  396 (399)
                      |||+|||+++++.+||+||+
T Consensus       211 LK~~NILl~~~~~vKi~DFG  230 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFG  230 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCG
T ss_pred             cCccceeeCCCCCEEECcch
Confidence            99999999999999999994

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=4.5e-32  Score=253.48  Aligned_cols=141  Identities=26%  Similarity=0.392  Sum_probs=121.0

Q ss_pred             CCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeec----CCceEEEEe
Q 015852          251 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYP  324 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e  324 (399)
                      ..+.||+|+||+||+|... ++..||+|++...... .....|.+|+.+++.++|||||++++++.+    ....++|||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            3467999999999999864 6889999999654332 234469999999999999999999999865    345789999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~~i~df~  396 (399)
                      ||++|+|.+++++..    .+++..+..++.||+.||+|||++ .++||||||||+||||+. ++.+||+||+
T Consensus       110 y~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A          110 LMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCc
Confidence            999999999998653    489999999999999999999998 234999999999999985 7899999994

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.97  E-value=5.5e-32  Score=264.40  Aligned_cols=141  Identities=25%  Similarity=0.354  Sum_probs=128.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.|+..+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.+|+.++|||||++++++.+.+..||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            45888899999999999999864 79999999996543 23344689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++|+|.++++..     .+++.+...|+.||+.||+|||++   +||||||||+||||+.++.+||+||+
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFG  292 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  292 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCT
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCc
Confidence            9999999999753     389999999999999999999999   99999999999999999999999994

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=7.3e-32  Score=249.99  Aligned_cols=142  Identities=24%  Similarity=0.408  Sum_probs=123.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++....  ......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5788999999999999999986 4799999999965432  223457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+ +|+|.+++.+..    .+++.+...++.|++.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus        93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence            999 689999998653    489999999999999999999999   99999999999999999999999994

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=5.6e-32  Score=257.29  Aligned_cols=137  Identities=24%  Similarity=0.288  Sum_probs=123.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.|...+.||+|+||+||+|+. .+|+.||||+++...      .+.+|+.+++.++|||||++++++.+.+..|+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            3466678899999999999986 468999999996432      135799999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      |++|+|.++++...    .+++.+...|+.||+.||+|||++   +||||||||+||||+.++ .+||+||+
T Consensus       132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCC
Confidence            99999999998653    489999999999999999999999   999999999999999998 59999994

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=1.6e-32  Score=257.83  Aligned_cols=143  Identities=27%  Similarity=0.320  Sum_probs=122.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC----CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|+..+.||+|+||+||+|+..    +++.||||+++..... .....+.+|+++++.++|||||++++++.+.+..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46888899999999999999752    4789999999654322 223468899999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||||++|+|.+++++..    .+++.+...++.|++.||+|||++   +||||||||+|||+++++.+||+||+
T Consensus       104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  171 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG  171 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccc
Confidence            999999999999998753    489999999999999999999999   99999999999999999999999994

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=3.9e-30  Score=244.74  Aligned_cols=175  Identities=81%  Similarity=1.241  Sum_probs=149.2

Q ss_pred             CCCCchhhhhcccccccHHHHHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcC
Q 015852          222 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA  301 (399)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l  301 (399)
                      +.+.......++...+++.++....++|...+.||+|+||.||+|+..+++.||||+++..........+.+|+.+++.+
T Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l   84 (326)
T 3uim_A            5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA   84 (326)
T ss_dssp             ----------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred             CcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence            34444455566778899999999999999999999999999999998889999999997655444445799999999999


Q ss_pred             CCCCccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCc
Q 015852          302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  381 (399)
Q Consensus       302 ~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~N  381 (399)
                      +||||+++++++...+..++||||+++|+|.++++........++|..+..++.|++.||+|||+.+.++|+||||||+|
T Consensus        85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  164 (326)
T 3uim_A           85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN  164 (326)
T ss_dssp             CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred             cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence            99999999999999999999999999999999998765555569999999999999999999999888899999999999


Q ss_pred             eeeCCCCceeecccc
Q 015852          382 ILLDEDADQSSKTIL  396 (399)
Q Consensus       382 ILld~~~~~~i~df~  396 (399)
                      ||++.++.+||+||+
T Consensus       165 il~~~~~~~kl~Dfg  179 (326)
T 3uim_A          165 ILLDEEFEAVVGDFG  179 (326)
T ss_dssp             EEECTTCCEEECCCS
T ss_pred             EEECCCCCEEeccCc
Confidence            999999999999994

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.5e-29  Score=246.96  Aligned_cols=142  Identities=23%  Similarity=0.399  Sum_probs=123.9

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeec------CCc
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT------VTE  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~  318 (399)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++..... .....+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            4678889999999999999986 47999999999654322 223468899999999999999999998764      356


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .|+|||||+ |+|.+++....    .+++.+...++.||+.||+|||++   +||||||||+|||++.++.+||+||+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence            899999996 78999997643    589999999999999999999999   99999999999999999999999994

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.95  E-value=1.1e-28  Score=252.10  Aligned_cols=144  Identities=28%  Similarity=0.377  Sum_probs=125.2

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHH---HHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQF---QTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f---~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      .++|...++||+|+||+||+|+.. +|+.||||+++....  .......   ..++.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467888999999999999999864 799999999964321  1222223   3346677889999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+||||++||+|.++|.+..    .+++.....++.||+.||+|||++   +||||||||+|||||.+|.+||+||+
T Consensus       268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccc
Confidence            99999999999999998753    489999999999999999999999   99999999999999999999999994

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.95  E-value=1.3e-28  Score=237.59  Aligned_cols=139  Identities=20%  Similarity=0.345  Sum_probs=123.7

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCce
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  319 (399)
                      ..+.|...+.||+|+||+||+|+.+    +++.||||.+...   ....++.+|++++..+ +|||||++++++.+.+..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            3567999999999999999999742    4678999998543   2345688999999888 699999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-Cceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~~i~df~  396 (399)
                      ++||||+++|+|.+++.       .+++.+...++.|++.||+|||++   +||||||||+|||++.+ +.+||+||+
T Consensus        96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999984       278899999999999999999999   99999999999999987 799999994

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.95  E-value=1e-27  Score=227.59  Aligned_cols=153  Identities=43%  Similarity=0.711  Sum_probs=135.9

Q ss_pred             HHHHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          240 RELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       240 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      .++...+++|...+.||+|+||.||+|+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+..
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            33445667899999999999999999998889999999986542 23345799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++.........++|.++..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999976544344689999999999999999999998   99999999999999999999999995

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.95  E-value=8.2e-28  Score=245.47  Aligned_cols=143  Identities=20%  Similarity=0.335  Sum_probs=127.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||+||+|+. .+|+.||+|+++... ......+.+|+.+|+.++|||||++++++.+.+..++||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            5788889999999999999986 479999999986532 22344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC--Cceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED--ADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~--~~~~i~df~  396 (399)
                      |++|+|.+++....   ..+++.+...++.||+.||+|||++   +|+||||||+|||++.+  +.+||+||+
T Consensus       236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence            99999999996543   2488999999999999999999999   99999999999999865  789999994

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.94  E-value=3.1e-27  Score=229.45  Aligned_cols=144  Identities=31%  Similarity=0.438  Sum_probs=128.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...+.||+|+||.||+|+..    ++..||||.++..........|.+|+.+++.++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            56888999999999999999864    56789999997654334455799999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.++++...   ..+++.++..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       125 ~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCc
Confidence            99999999999997643   2489999999999999999999999   99999999999999999999999994

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.94  E-value=4.4e-27  Score=228.09  Aligned_cols=148  Identities=28%  Similarity=0.440  Sum_probs=128.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEe--------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  316 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~--------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  316 (399)
                      .++|...+.||+|+||.||+|+.        .++..||||+++..........+.+|+++++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            35677789999999999999975        234579999997654333445799999999999 899999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  384 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl  384 (399)
                      +..++||||+++|+|.+++.....            ....+++.++..++.|+++||+|||+.   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999999987532            113478999999999999999999999   99999999999999


Q ss_pred             CCCCceeecccc
Q 015852          385 DEDADQSSKTIL  396 (399)
Q Consensus       385 d~~~~~~i~df~  396 (399)
                      +.++.+||+||+
T Consensus       237 ~~~~~~kl~DFG  248 (370)
T 2psq_A          237 TENNVMKIADFG  248 (370)
T ss_dssp             CTTCCEEECCCS
T ss_pred             CCCCCEEEcccc
Confidence            999999999994

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.94  E-value=7.5e-27  Score=221.90  Aligned_cols=146  Identities=21%  Similarity=0.320  Sum_probs=126.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC--------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--------  317 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------  317 (399)
                      ++|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+.+++.++||||+++++++....        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            45777899999999999999975 789999999975544444567999999999999999999999986543        


Q ss_pred             -------------------------------------------------ceEEEEecCCCCChhhHhhhcCCCCCCCChH
Q 015852          318 -------------------------------------------------EKLLVYPYMTNGSVASRLRERQSSLPPLDWP  348 (399)
Q Consensus       318 -------------------------------------------------~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~  348 (399)
                                                                       ..++||||+++|+|.+++..... ....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence                                                             27899999999999999986532 2345677


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          349 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       349 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  209 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG  209 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecC
Confidence            8899999999999999999   99999999999999999999999995

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.94  E-value=2.9e-27  Score=229.92  Aligned_cols=146  Identities=30%  Similarity=0.450  Sum_probs=129.6

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ..++|...+.||+|+||.||+|+.. +++.||||.++..........|.+|+.+++.++||||+++++++...+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3456777899999999999999975 789999999875433333346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.++++....   .+++.....++.|+++||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       192 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             ECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             EcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence            99999999999986432   478999999999999999999999   99999999999999999999999995

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.94  E-value=6.2e-27  Score=222.96  Aligned_cols=144  Identities=29%  Similarity=0.402  Sum_probs=127.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...+.||+|+||.||+|+..    .+..||||.++..........|.+|+.+++.++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            45667799999999999999874    34569999997654444455799999999999999999999999998899999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.++++...   ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       129 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             eeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCC
Confidence            99999999999997543   2489999999999999999999999   99999999999999999999999994

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.94  E-value=9.9e-27  Score=221.95  Aligned_cols=144  Identities=24%  Similarity=0.388  Sum_probs=129.0

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+|+. .+++.||||++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35678889999999999999986 57999999998654322 23346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence            9999999999997653    388999999999999999999999   99999999999999999999999994

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=3.7e-27  Score=233.22  Aligned_cols=153  Identities=20%  Similarity=0.279  Sum_probs=133.7

Q ss_pred             cHHHHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeee
Q 015852          238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCT  314 (399)
Q Consensus       238 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~  314 (399)
                      .+.++....++|...++||+|+||+||+|+.. +++.||+|+++....  ......+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34555666788999999999999999999975 578999999964321  122234899999999999999999999999


Q ss_pred             cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecc
Q 015852          315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  394 (399)
Q Consensus       315 ~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~d  394 (399)
                      +.+..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.   +||||||||+|||+|.++.+||+|
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            9999999999999999999998632   2489999999999999999999999   999999999999999999999999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       219 FG  220 (437)
T 4aw2_A          219 FG  220 (437)
T ss_dssp             CT
T ss_pred             hh
Confidence            95

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.94  E-value=1.7e-26  Score=218.02  Aligned_cols=143  Identities=25%  Similarity=0.440  Sum_probs=127.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||+||+++.. +++.||+|.+... .......|.+|+++++.++||||+++++++...+..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            45677799999999999999864 6899999988542 223345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++.....   .++|.++..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  153 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFG  153 (310)
T ss_dssp             CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCT
T ss_pred             cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecc
Confidence            999999999987432   489999999999999999999999   99999999999999999999999994

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.94  E-value=4.6e-26  Score=214.58  Aligned_cols=159  Identities=42%  Similarity=0.692  Sum_probs=140.2

Q ss_pred             ccccccHHHHHHHhcCCCCC------ceeeccCCceEEEEEeCCCCEEEEEEcccccc---cccHHHHHHHHHHHhcCCC
Q 015852          233 QLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVH  303 (399)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~f~~E~~~l~~l~H  303 (399)
                      ....+++.++...+++|...      +.||+|+||.||+|.. +++.||||++.....   ......+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34568899999999999877      8999999999999987 578999999865322   2224579999999999999


Q ss_pred             CCccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCcee
Q 015852          304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  383 (399)
Q Consensus       304 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NIL  383 (399)
                      |||+++++++...+..++||||+++|+|.+++..... ...++|..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            9999999999999999999999999999999975422 23589999999999999999999999   9999999999999


Q ss_pred             eCCCCceeecccc
Q 015852          384 LDEDADQSSKTIL  396 (399)
Q Consensus       384 ld~~~~~~i~df~  396 (399)
                      +++++.+||+||+
T Consensus       166 i~~~~~~kl~Dfg  178 (307)
T 2nru_A          166 LDEAFTAKISDFG  178 (307)
T ss_dssp             ECTTCCEEECCCT
T ss_pred             EcCCCcEEEeecc
Confidence            9999999999995

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.94  E-value=6.4e-27  Score=223.81  Aligned_cols=151  Identities=29%  Similarity=0.472  Sum_probs=131.8

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV  316 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~  316 (399)
                      ....++|...+.||+|+||.||+|+..      +++.||||.++..........|.+|+.+++.++||||+++++++...
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            344567888899999999999999863      34789999997654434445799999999999999999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCC--------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSS--------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  376 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  376 (399)
                      +..++||||+++|+|.+++......                    ...+++.++..++.|+++||+|||++   +|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            9999999999999999999864311                    14589999999999999999999999   999999


Q ss_pred             CCCCceeeCCCCceeecccc
Q 015852          377 VKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       377 lK~~NILld~~~~~~i~df~  396 (399)
                      |||+|||+++++.+||+||+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg  219 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFG  219 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCS
T ss_pred             CCcceEEECCCCeEEEeecC
Confidence            99999999999999999994

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.94  E-value=4e-26  Score=214.53  Aligned_cols=142  Identities=22%  Similarity=0.351  Sum_probs=128.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .++|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            35788899999999999999985 578999999986543 2334578999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++...     .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  161 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCC
Confidence            99999999999764     378999999999999999999999   99999999999999999999999995

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.94  E-value=1.8e-26  Score=221.00  Aligned_cols=143  Identities=24%  Similarity=0.330  Sum_probs=128.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||+||+++.. +++.||+|+++...  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56778899999999999999864 68999999996542  2234457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|..++....    .+++.....++.|++.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus        85 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG  150 (337)
T 1o6l_A           85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeecc
Confidence            9999999999997653    478999999999999999999999   99999999999999999999999994

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.94  E-value=4e-26  Score=216.97  Aligned_cols=152  Identities=22%  Similarity=0.296  Sum_probs=132.8

Q ss_pred             cccHHHHHHHhcC----------CCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC
Q 015852          236 RFSLRELQVATDG----------FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR  304 (399)
Q Consensus       236 ~~~~~~~~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~  304 (399)
                      .++.+++..+++.          |...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCC
Confidence            4566666666653          455678999999999999875 79999999986443 33445789999999999999


Q ss_pred             CccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee
Q 015852          305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  384 (399)
Q Consensus       305 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl  384 (399)
                      ||+++++++...+..++||||+++|+|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+|||+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            9999999999999999999999999999998643     489999999999999999999998   99999999999999


Q ss_pred             CCCCceeecccc
Q 015852          385 DEDADQSSKTIL  396 (399)
Q Consensus       385 d~~~~~~i~df~  396 (399)
                      +.++.+||+||+
T Consensus       175 ~~~~~~kl~Dfg  186 (321)
T 2c30_A          175 TLDGRVKLSDFG  186 (321)
T ss_dssp             CTTCCEEECCCT
T ss_pred             CCCCcEEEeeee
Confidence            999999999995

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=6.4e-27  Score=229.73  Aligned_cols=150  Identities=23%  Similarity=0.313  Sum_probs=131.7

Q ss_pred             HHHHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeec
Q 015852          239 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  315 (399)
Q Consensus       239 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  315 (399)
                      +.++....++|...+.||+|+||+||+++.. +++.||+|+++....  ......+.+|+.++..++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556778999999999999999999875 688999999864321  2223358899999999999999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      .+..++||||+++|+|.++++..     .+++.....++.|++.||+|||+.   +|+||||||+|||+|.++.+||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999764     378899999999999999999999   9999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       213 G  213 (410)
T 3v8s_A          213 G  213 (410)
T ss_dssp             T
T ss_pred             c
Confidence            4

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=6.2e-27  Score=229.98  Aligned_cols=153  Identities=21%  Similarity=0.273  Sum_probs=134.0

Q ss_pred             cHHHHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeee
Q 015852          238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCT  314 (399)
Q Consensus       238 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~  314 (399)
                      .+++.....++|...++||+|+||+||+++.. +++.||+|+++....  ......+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            44555666788999999999999999999874 789999999964321  122235889999999999999999999999


Q ss_pred             cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecc
Q 015852          315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  394 (399)
Q Consensus       315 ~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~d  394 (399)
                      +.+..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||+|.++.+||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            99999999999999999999986432   488999999999999999999999   999999999999999999999999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       206 FG  207 (412)
T 2vd5_A          206 FG  207 (412)
T ss_dssp             CT
T ss_pred             ch
Confidence            94

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.94  E-value=1.3e-26  Score=220.67  Aligned_cols=143  Identities=25%  Similarity=0.379  Sum_probs=125.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||+||+|+.. +++.||||++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            56778899999999999999865 78999999986544333345689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        87 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg  150 (323)
T 3tki_A           87 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (323)
T ss_dssp             CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEee
Confidence            99999999997542    488999999999999999999998   99999999999999999999999995

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.94  E-value=2.3e-26  Score=221.59  Aligned_cols=146  Identities=29%  Similarity=0.417  Sum_probs=127.9

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCce
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  319 (399)
                      ...++|...++||+|+||+||+++.. +++.||||+++...  .......+.+|..++..+ +||||+++++++...+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            34567888999999999999999864 68999999996542  223344688999999887 699999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccc
Confidence            99999999999999998753    389999999999999999999999   99999999999999999999999994

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.93  E-value=5.4e-27  Score=225.87  Aligned_cols=157  Identities=28%  Similarity=0.396  Sum_probs=133.6

Q ss_pred             ccHHHHHHHhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccce
Q 015852          237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRL  309 (399)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l  309 (399)
                      +...++....++|...+.||+|+||.||+|++      .+++.||||+++..........+.+|++++..+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            44556667778899999999999999999973      246789999997654444445799999999999 79999999


Q ss_pred             eeeeecCCc-eEEEEecCCCCChhhHhhhcCCC-----------------------------------------------
Q 015852          310 YGFCTTVTE-KLLVYPYMTNGSVASRLRERQSS-----------------------------------------------  341 (399)
Q Consensus       310 ~g~~~~~~~-~~lv~e~~~~gsL~~~L~~~~~~-----------------------------------------------  341 (399)
                      ++++...+. .++||||+++|+|.++++.....                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 88999999999999999865321                                               


Q ss_pred             ---------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          342 ---------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       342 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                                     ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg  238 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG  238 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCG
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEecc
Confidence                           11278899999999999999999999   99999999999999999999999994

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=3.7e-26  Score=211.19  Aligned_cols=142  Identities=27%  Similarity=0.437  Sum_probs=128.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ++|...+.||+|+||.||+|+..+++.||+|+++...  ....++.+|++++++++||||+++++++...+..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            4577779999999999999998888899999996543  23457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        88 ~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  151 (269)
T 4hcu_A           88 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  151 (269)
T ss_dssp             TTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred             CCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccc
Confidence            99999999976432   488999999999999999999999   99999999999999999999999994

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.93  E-value=1.8e-26  Score=223.58  Aligned_cols=147  Identities=31%  Similarity=0.411  Sum_probs=127.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|...+.||+|+||+||+|+..      +++.||||+++..........+.+|+.+++.++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            45677799999999999999843      466899999975544444557999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCC---CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeecc
Q 015852          321 LVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKT  394 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~d  394 (399)
                      +||||+++|+|.++++....   ....+++.++..++.|+++||+|||+.   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            99999999999999987542   223588999999999999999999999   999999999999999655   499999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       228 FG  229 (367)
T 3l9p_A          228 FG  229 (367)
T ss_dssp             CH
T ss_pred             Cc
Confidence            94

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=4e-26  Score=216.84  Aligned_cols=143  Identities=29%  Similarity=0.422  Sum_probs=128.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||+||+++.. +++.||+|+++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            46777899999999999999864 789999999965432  233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus        86 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg  151 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG  151 (318)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecC
Confidence            9999999999998643    488999999999999999999998   99999999999999999999999994

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=5.5e-26  Score=213.25  Aligned_cols=143  Identities=22%  Similarity=0.292  Sum_probs=127.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+++. .+++.||+|.+.......  ....|.+|+.++..++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            4577789999999999999985 468899999985433222  2346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    ++++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        91 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999998653    489999999999999999999999   99999999999999999999999994

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=3.5e-26  Score=219.61  Aligned_cols=147  Identities=25%  Similarity=0.412  Sum_probs=128.2

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcC-CCCCccceeeeeecCCc
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~  318 (399)
                      ....++|...+.||+|+||+||+|+.. +++.||+|+++....  ......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678888999999999999999975 688999999965421  23344678899888866 89999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeECh
Confidence            999999999999999998643    388999999999999999999999   99999999999999999999999995

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.93  E-value=4.4e-26  Score=222.71  Aligned_cols=144  Identities=26%  Similarity=0.351  Sum_probs=126.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  321 (399)
                      .++|...++||+|+||+||+++.. +++.||+|+++......  ....+.+|..++..+ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            456888899999999999999865 67899999997543222  223588899988776 89999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|..++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+|.++.+||+||+
T Consensus       131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecc
Confidence            999999999999998653    489999999999999999999999   99999999999999999999999994

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.93  E-value=9.7e-26  Score=217.87  Aligned_cols=144  Identities=24%  Similarity=0.327  Sum_probs=127.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-----cHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      .+.|...+.||+|+||.||+++.. +++.||+|.++......     ....+.+|+.+++.++||||+++++++......
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            356788899999999999999865 68999999996543221     245799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC----ceeeccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  395 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~----~~~i~df  395 (399)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999997542    489999999999999999999999   999999999999999887    7999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       164 G  164 (361)
T 2yab_A          164 G  164 (361)
T ss_dssp             S
T ss_pred             C
Confidence            4

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.93  E-value=3.6e-26  Score=215.78  Aligned_cols=148  Identities=30%  Similarity=0.434  Sum_probs=128.9

Q ss_pred             hcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      .++|...+.||+|+||.||+|+.      .+++.||||.++..........+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            45677789999999999999975      245789999997554434445799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCC--------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 015852          320 LLVYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKA  379 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~  379 (399)
                      ++||||+++|+|.+++.....                    ....+++.++..++.|+++||+|||++   +|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999987532                    112378899999999999999999999   999999999


Q ss_pred             CceeeCCCCceeecccc
Q 015852          380 ANILLDEDADQSSKTIL  396 (399)
Q Consensus       380 ~NILld~~~~~~i~df~  396 (399)
                      +|||+++++.+||+||+
T Consensus       179 ~NIli~~~~~~kl~Dfg  195 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFG  195 (314)
T ss_dssp             GGEEEETTTEEEECCCT
T ss_pred             heEEEcCCCCEEEcccc
Confidence            99999999999999994

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.93  E-value=1.4e-26  Score=218.97  Aligned_cols=149  Identities=28%  Similarity=0.407  Sum_probs=129.2

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ....++|...+.||+|+||.||+|+. +++.||||++....... ....|.+|++++++++||||+++++++...+..++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34456778889999999999999987 57889999986543222 23468999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +  |+||||||+|||++.++.+||+||+
T Consensus       112 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             EEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            9999999999999976421 12378999999999999999999998   6  9999999999999999999999994

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.93  E-value=6.4e-26  Score=209.39  Aligned_cols=143  Identities=28%  Similarity=0.424  Sum_probs=129.0

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .++|...+.||+|+||.||+|+..++..||+|+++...  ....++.+|+.++..++||||+++++++......++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            35677789999999999999998888899999996543  2345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+||+
T Consensus        85 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  149 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFG  149 (268)
T ss_dssp             CTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTT
T ss_pred             cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCc
Confidence            999999999976432   478999999999999999999999   99999999999999999999999994

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.93  E-value=4.8e-26  Score=216.99  Aligned_cols=144  Identities=25%  Similarity=0.333  Sum_probs=122.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEe----CCCCEEEEEEcccccc---cccHHHHHHHHHHHhcCCCCCccceeeeeecCCc
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  318 (399)
                      .++|...+.||+|+||.||+++.    .+++.||+|+++....   ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35677889999999999999986    4789999999975432   1223458899999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCC
Confidence            999999999999999997653    378899999999999999999999   99999999999999999999999995

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.93  E-value=4.8e-26  Score=221.58  Aligned_cols=143  Identities=25%  Similarity=0.349  Sum_probs=128.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|.+....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56777899999999999999864 68899999986432  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|..++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccc
Confidence            9999999999997642    488999999999999999999999   99999999999999999999999994

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.93  E-value=6.6e-26  Score=217.76  Aligned_cols=143  Identities=27%  Similarity=0.357  Sum_probs=126.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc--cHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...+.||+|+||+||+++.. +++.||+|+++......  ....+.+|..++..+ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            45777899999999999999875 68899999997543322  233588899999887 899999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG  155 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  155 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecc
Confidence            99999999999997653    388999999999999999999999   99999999999999999999999994

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.93  E-value=7.8e-26  Score=214.52  Aligned_cols=147  Identities=27%  Similarity=0.433  Sum_probs=115.9

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .++|...+.||+|+||.||+|... +++.||+|+++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            356888899999999999999864 6899999999755444444578999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCC--CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQS--SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |++ |+|.+++.....  ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  153 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFG  153 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCc
Confidence            998 699999875421  123488999999999999999999999   99999999999999999999999994

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.93  E-value=7e-26  Score=217.99  Aligned_cols=143  Identities=24%  Similarity=0.310  Sum_probs=128.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|+++...  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56777899999999999999865 68999999986442  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus       121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccc
Confidence            9999999999998653    388999999999999999999999   99999999999999999999999994

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.93  E-value=4.8e-26  Score=221.67  Aligned_cols=148  Identities=29%  Similarity=0.410  Sum_probs=128.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC--------CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  316 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  316 (399)
                      .++|...+.||+|+||.||+|+..        .+..||||+++..........+.+|+++++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            346677799999999999999852        23579999997654444445799999999999 899999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  384 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl  384 (399)
                      +..++||||+++|+|.+++......            ...+++.++..++.|++.||+|||+.   +|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            9999999999999999999875421            23589999999999999999999999   99999999999999


Q ss_pred             CCCCceeecccc
Q 015852          385 DEDADQSSKTIL  396 (399)
Q Consensus       385 d~~~~~~i~df~  396 (399)
                      ++++.+||+||+
T Consensus       225 ~~~~~~kL~DFG  236 (382)
T 3tt0_A          225 TEDNVMKIADFG  236 (382)
T ss_dssp             CTTCCEEECSCS
T ss_pred             cCCCcEEEcccC
Confidence            999999999994

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.93  E-value=1.5e-26  Score=230.36  Aligned_cols=147  Identities=22%  Similarity=0.366  Sum_probs=129.3

Q ss_pred             HHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          242 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       242 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +++..++|...+.||+|+||.||+|...++..||||+++...  .....|.+|+.+++.++||||+++++++. .+..++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            344556788889999999999999999888899999997543  34567999999999999999999999986 567899


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.++++....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus       260 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             EEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCC
Confidence            9999999999999975421  1378899999999999999999999   99999999999999999999999994

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.93  E-value=7.4e-26  Score=214.15  Aligned_cols=143  Identities=24%  Similarity=0.420  Sum_probs=124.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||+||+|+..+++.||+|+++....... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            56777899999999999999988899999999965433322 34689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++ |+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       101 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A          101 ME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             CS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence            98 58888887643   2488999999999999999999999   99999999999999999999999994

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.93  E-value=7.4e-26  Score=210.64  Aligned_cols=144  Identities=26%  Similarity=0.417  Sum_probs=126.5

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..++|...+.||+|+||.||+++..++..||+|+++...  ....++.+|++++..++||||+++++++...+..++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            345677789999999999999999888899999996543  234579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++.....   .+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       100 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A          100 YMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             CCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             ccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccc
Confidence            9999999999976322   488999999999999999999999   99999999999999999999999994

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.93  E-value=4.1e-26  Score=219.67  Aligned_cols=147  Identities=20%  Similarity=0.259  Sum_probs=126.8

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc----cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +.|...+.||+|+||.||+|.. .+++.||||+++....    ......+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4577789999999999999986 4689999999854321    1234579999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc---eeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~---~~i~df~  396 (399)
                      ||||+++|+|.+.+.........+++..+..++.|++.||+|||++   +|+||||||+|||++.+++   +||+||+
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999988875433333578999999999999999999999   9999999999999987765   9999994

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.93  E-value=8.3e-26  Score=211.18  Aligned_cols=143  Identities=24%  Similarity=0.434  Sum_probs=126.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+|+..+++.||+|+++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            457778999999999999999888999999998654322 2235788999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++ +|.+++....   ..+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  145 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFG  145 (288)
T ss_dssp             CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECc
Confidence            985 9999987643   2488999999999999999999999   99999999999999999999999995

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.93  E-value=5.1e-26  Score=228.92  Aligned_cols=146  Identities=27%  Similarity=0.392  Sum_probs=130.1

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ...++|...+.||+|+||.||+|+.. ++..||||.++...  ....+|.+|+.+++.++||||++++++|......++|
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            34456777899999999999999976 48899999996542  3355799999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.++++....  ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus       295 ~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             EECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             EEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecc
Confidence            999999999999986432  3488999999999999999999999   99999999999999999999999994

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.93  E-value=1.1e-25  Score=213.47  Aligned_cols=146  Identities=23%  Similarity=0.316  Sum_probs=127.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC--ceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~  323 (399)
                      +.|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+++++.++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            35677899999999999999865 589999999976554455567899999999999999999999988755  679999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee----CCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl----d~~~~~~i~df~  396 (399)
                      ||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+||+
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            99999999999986532 22389999999999999999999999   99999999999999    888889999994

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.5e-26  Score=218.96  Aligned_cols=151  Identities=26%  Similarity=0.415  Sum_probs=127.5

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeec
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  315 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  315 (399)
                      ....++|...+.||+|+||.||+|+.      .++..||||.++..........+.+|+.++..+ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            33456788889999999999999985      245689999997554444455799999999999 89999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCCC-------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQSS-------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  376 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  376 (399)
                      .+..++||||+++|+|.+++......                   ...+++..+..++.|++.||+|||+.   +|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            99999999999999999999865321                   12478999999999999999999999   999999


Q ss_pred             CCCCceeeCCCCceeecccc
Q 015852          377 VKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       377 lK~~NILld~~~~~~i~df~  396 (399)
                      |||+|||++.++.+||+||+
T Consensus       198 ikp~NIll~~~~~~kL~Dfg  217 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFG  217 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCG
T ss_pred             CChhhEEEcCCCcEEeCCCc
Confidence            99999999999999999994

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.93  E-value=1.1e-25  Score=223.83  Aligned_cols=143  Identities=28%  Similarity=0.434  Sum_probs=126.8

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC-ceEEEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVY  323 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~  323 (399)
                      ..++|...+.||+|+||.||+|... ++.||||.++...   ....|.+|+.+++.++||||+++++++.... ..++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            3456777899999999999999885 6799999997542   3457999999999999999999999987665 689999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.++++....  ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus       267 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  334 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  334 (450)
T ss_dssp             ECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCC
Confidence            99999999999987532  2368899999999999999999999   99999999999999999999999994

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.93  E-value=1.3e-25  Score=218.89  Aligned_cols=145  Identities=22%  Similarity=0.305  Sum_probs=129.0

Q ss_pred             cCCCCCceeecc--CCceEEEEEeC-CCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRG--GFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...+.||+|  +||.||+|+.. +++.||||+++....... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            457778999999  99999999975 789999999965443322 34688899999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       105 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             EECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             EEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccc
Confidence            999999999999986532  2488999999999999999999999   99999999999999999999999994

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.5e-25  Score=213.02  Aligned_cols=142  Identities=21%  Similarity=0.322  Sum_probs=126.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||++... +++.||+|.++..  ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            56777899999999999999865 6889999998643  22344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC--CCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~--~~~~~i~df~  396 (399)
                      +++|+|.+++....   ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+||+
T Consensus        83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            99999999997543   2488999999999999999999999   9999999999999997  7899999994

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.93  E-value=8.2e-26  Score=210.97  Aligned_cols=147  Identities=20%  Similarity=0.310  Sum_probs=129.2

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+++.. ++..+|+|++...........+.+|+++++.++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            45777899999999999999864 68899999997665555566899999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee---CCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl---d~~~~~~i~df~  396 (399)
                      +++|+|.+++.........+++..+..++.|+++||+|||+.   +|+||||||+|||+   +.++.+||+||+
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            999999999865422223589999999999999999999999   99999999999999   456789999994

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.93  E-value=8.7e-26  Score=211.98  Aligned_cols=143  Identities=25%  Similarity=0.368  Sum_probs=120.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-------------------------ccHHHHHHHHHHHh
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-------------------------GGELQFQTEVKIIS  299 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-------------------------~~~~~f~~E~~~l~  299 (399)
                      .++|...+.||+|+||.||+|+. .+++.||||++......                         .....+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            35677889999999999999986 46889999998643211                         11246899999999


Q ss_pred             cCCCCCccceeeeeec--CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 015852          300 MAVHRNLLRLYGFCTT--VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  377 (399)
Q Consensus       300 ~l~H~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  377 (399)
                      .++||||+++++++..  ....++||||+++|+|.+++..     ..+++.+...++.|+++||+|||+.   +|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999986  5578999999999999887543     2489999999999999999999999   9999999


Q ss_pred             CCCceeeCCCCceeecccc
Q 015852          378 KAANILLDEDADQSSKTIL  396 (399)
Q Consensus       378 K~~NILld~~~~~~i~df~  396 (399)
                      ||+|||++.++.+||+||+
T Consensus       164 kp~Nil~~~~~~~kl~Dfg  182 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFG  182 (298)
T ss_dssp             CGGGEEECTTSCEEECCCT
T ss_pred             CHHHEEECCCCCEEEecCC
Confidence            9999999999999999995

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.93  E-value=1.1e-25  Score=216.72  Aligned_cols=145  Identities=24%  Similarity=0.316  Sum_probs=128.4

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  320 (399)
                      ..++|...++||+|+||+||+++.. +++.||+|+++...  .......+..|..++..+ +||||+++++++...+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4567888899999999999999875 57899999996543  223345688999999887 7999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+|.++.+||+||+
T Consensus        98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            9999999999999998653    388999999999999999999999   99999999999999999999999994

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.93  E-value=5.8e-26  Score=215.86  Aligned_cols=143  Identities=30%  Similarity=0.419  Sum_probs=123.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCc----eEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE----KLL  321 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----~~l  321 (399)
                      .++|...+.||+|+||+||+|+.. ++.||||+++...  .....+.+|+.+++.++||||+++++++.....    .++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            356777899999999999999875 7899999986432  223356779999999999999999999987543    699


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC-------CCCceecCCCCCceeeCCCCceeecc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-------DPKIIHRDVKAANILLDEDADQSSKT  394 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------~~~ivHrDlK~~NILld~~~~~~i~d  394 (399)
                      ||||+++|+|.++++..     .++|..+..++.|+++||+|||+.+       .++|+||||||+|||++.++.+||+|
T Consensus       100 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999999764     3899999999999999999999862       34899999999999999999999999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       175 Fg  176 (322)
T 3soc_A          175 FG  176 (322)
T ss_dssp             CT
T ss_pred             CC
Confidence            94

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.93  E-value=1.4e-25  Score=210.75  Aligned_cols=143  Identities=27%  Similarity=0.438  Sum_probs=123.6

Q ss_pred             CCCCCceeeccCCceEEEEEe-----CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC--CceE
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  320 (399)
                      .|...+.||+|+||.||+|++     .+++.||||+++..........+.+|+.+++.++||||+++++++...  ...+
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            366678999999999999984     368899999997655445556799999999999999999999999876  5689


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       102 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence            99999999999999976432   488999999999999999999999   99999999999999999999999995

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.93  E-value=5.1e-26  Score=215.71  Aligned_cols=154  Identities=27%  Similarity=0.423  Sum_probs=132.5

Q ss_pred             HHHHHHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeee
Q 015852          240 RELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC  313 (399)
Q Consensus       240 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~  313 (399)
                      ++++...++|...+.||+|+||.||+|+..      +++.||||.+...........|.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            444555677888899999999999999753      36789999997554333445799999999999999999999999


Q ss_pred             ecCCceEEEEecCCCCChhhHhhhcC------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC
Q 015852          314 TTVTEKLLVYPYMTNGSVASRLRERQ------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  387 (399)
Q Consensus       314 ~~~~~~~lv~e~~~~gsL~~~L~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~  387 (399)
                      ...+..++||||+++|+|.+++....      .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence            99999999999999999999997532      1123578999999999999999999999   99999999999999999


Q ss_pred             Cceeecccc
Q 015852          388 ADQSSKTIL  396 (399)
Q Consensus       388 ~~~~i~df~  396 (399)
                      +.+||+||+
T Consensus       175 ~~~kl~Dfg  183 (322)
T 1p4o_A          175 FTVKIGDFG  183 (322)
T ss_dssp             CCEEECCTT
T ss_pred             CeEEECcCc
Confidence            999999994

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.93  E-value=1.8e-25  Score=212.88  Aligned_cols=143  Identities=26%  Similarity=0.330  Sum_probs=127.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-----cHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      +.|...+.||+|+||.||+++.. +++.||+|.++......     ....+.+|+.+++.++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45777899999999999999864 68999999986543221     2457999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC----ceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~----~~~i~df~  396 (399)
                      +||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++    .+||+||+
T Consensus        91 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999997542    489999999999999999999999   999999999999999988    79999994

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.93  E-value=7.9e-26  Score=218.62  Aligned_cols=145  Identities=16%  Similarity=0.236  Sum_probs=125.0

Q ss_pred             HhcCCCCCceeeccCCceEEEEE------eCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC---CCCccceeeeeec
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTT  315 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~  315 (399)
                      ..++|...+.||+|+||.||+|.      ..+++.||||+++..    ...++..|+.++..++   |+||+++++++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            34567778999999999999994      446889999998643    3446888888888877   9999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCC-CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC--------
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--------  386 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~--------  386 (399)
                      .+..++||||+++|+|.+++..... ....++|..+..|+.|+++||+|||+.   +||||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999975322 223589999999999999999999998   9999999999999998        


Q ss_pred             ---CCceeecccc
Q 015852          387 ---DADQSSKTIL  396 (399)
Q Consensus       387 ---~~~~~i~df~  396 (399)
                         ++.+||+||+
T Consensus       216 ~~~~~~~kl~DFG  228 (365)
T 3e7e_A          216 DDLSAGLALIDLG  228 (365)
T ss_dssp             ---CTTEEECCCT
T ss_pred             ccccCCEEEeeCc
Confidence               8999999995

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.93  E-value=1.4e-25  Score=214.27  Aligned_cols=149  Identities=28%  Similarity=0.444  Sum_probs=128.2

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC--------CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeec
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  315 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  315 (399)
                      ..++|...+.||+|+||.||+|+..        ++..||||+++..........+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3456778899999999999999853        46789999997654333445799999999999 89999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCcee
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  383 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NIL  383 (399)
                      .+..++||||+++|+|.+++......            ...+++..+..++.|+++||+|||+.   +|+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence            99999999999999999999865321            12478999999999999999999999   9999999999999


Q ss_pred             eCCCCceeecccc
Q 015852          384 LDEDADQSSKTIL  396 (399)
Q Consensus       384 ld~~~~~~i~df~  396 (399)
                      ++.++.+||+||+
T Consensus       190 l~~~~~~kL~Dfg  202 (334)
T 2pvf_A          190 VTENNVMKIADFG  202 (334)
T ss_dssp             ECTTCCEEECCCT
T ss_pred             EcCCCCEEEcccc
Confidence            9999999999994

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.93  E-value=4.6e-26  Score=214.93  Aligned_cols=149  Identities=29%  Similarity=0.389  Sum_probs=129.7

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCC
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  317 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~  317 (399)
                      ..++|...+.||+|+||.||+|+.      .+++.||||.++..........+.+|+.++..+ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            345677789999999999999974      346789999997554333445799999999999 8999999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCC--------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCcee
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSS--------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  383 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NIL  383 (399)
                      ..++||||+++|+|.+++......              ...+++..+..++.|+++||+|||+.   +|+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence            999999999999999999865321              12488999999999999999999999   9999999999999


Q ss_pred             eCCCCceeecccc
Q 015852          384 LDEDADQSSKTIL  396 (399)
Q Consensus       384 ld~~~~~~i~df~  396 (399)
                      ++.++.+||+||+
T Consensus       178 ~~~~~~~kl~Dfg  190 (313)
T 1t46_A          178 LTHGRITKICDFG  190 (313)
T ss_dssp             EETTTEEEECCCG
T ss_pred             EcCCCCEEEcccc
Confidence            9999999999994

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.93  E-value=2.3e-25  Score=208.51  Aligned_cols=143  Identities=20%  Similarity=0.394  Sum_probs=124.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||+||+|+.. +++.||||+++....... ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            45777899999999999999864 689999999965443332 3578999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++ ++.+.+....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence            9985 6666665432   2489999999999999999999999   99999999999999999999999994

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.93  E-value=1e-25  Score=214.64  Aligned_cols=143  Identities=27%  Similarity=0.473  Sum_probs=119.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|...+.||+|+||.||+|+.. +++    .||+|.++..........|.+|+.+++.++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            45777899999999999999853 444    468888865544455668999999999999999999999998754 789


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        94 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCc
Confidence            9999999999999987533   488999999999999999999999   99999999999999999999999994

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=1.8e-25  Score=209.10  Aligned_cols=141  Identities=10%  Similarity=-0.019  Sum_probs=123.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+.. +++.||||+++.......  ...|.+|+..+..++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            45777799999999999999875 589999999976543322  257999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++...      ....+...++.|++.||+|||++   +|+||||||+|||+++++.+||++++
T Consensus       111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence            999999999999542      34557889999999999999999   99999999999999999999998763

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.93  E-value=5.9e-26  Score=225.58  Aligned_cols=144  Identities=25%  Similarity=0.322  Sum_probs=119.9

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .++|...+.||+|+||.||+++. .+++.||||+++...  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35678889999999999999986 468999999996542  222334688999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+||+
T Consensus       227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCC
Confidence            99999999999997653    48899999999999999999998 7   89999999999999999999999994

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.93  E-value=6.5e-26  Score=214.33  Aligned_cols=143  Identities=24%  Similarity=0.358  Sum_probs=125.6

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeeeecCCce----
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK----  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~----  319 (399)
                      ++|...+.||+|+||.||+++. .+++.||||+++.......  ...|.+|+.++..++||||+++++++......    
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            4677789999999999999985 5788999999976433222  34689999999999999999999998765433    


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.++++...    .+++.+...++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             EEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence            89999999999999998653    489999999999999999999999   99999999999999999999999994

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.93  E-value=1.8e-25  Score=216.07  Aligned_cols=144  Identities=22%  Similarity=0.308  Sum_probs=126.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+|... +++.||+|+++..... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456888899999999999999864 6899999999654322 22346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++   .+||+||+
T Consensus       108 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             CCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            9999999999987542    488999999999999999999999   999999999999998765   49999994

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.93  E-value=1.3e-25  Score=209.06  Aligned_cols=144  Identities=23%  Similarity=0.312  Sum_probs=123.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCC----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      .++|...+.||+|+||.||+|....    +..||+|.++..........|.+|+.+++.++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3567778999999999999998642    45799999865443334457999999999999999999999984 467889


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccc
Confidence            999999999999998653   2488999999999999999999999   99999999999999999999999994

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.93  E-value=1.5e-25  Score=214.46  Aligned_cols=142  Identities=25%  Similarity=0.421  Sum_probs=126.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||++.....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4677789999999999999986 5789999999864321  223347899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+ +|+|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus        89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG  153 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFG  153 (336)
T ss_dssp             CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred             ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEec
Confidence            999 789999987653    489999999999999999999999   99999999999999999999999995

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=2.2e-25  Score=225.55  Aligned_cols=147  Identities=31%  Similarity=0.430  Sum_probs=130.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...++||+|+||+||+++.. +++.||+|+++....  ......+.+|+.++..++||||+++++++......++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56788899999999999999874 689999999965432  233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++.........+++.....++.||+.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecc
Confidence            99999999999986543344689999999999999999999999   99999999999999999999999994

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.92  E-value=7.8e-26  Score=214.66  Aligned_cols=150  Identities=26%  Similarity=0.391  Sum_probs=120.1

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeCC-C---CEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCc
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLAD-G---KLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  318 (399)
                      ...++|...+.||+|+||.||+|+... +   ..||||.++..... .....+.+|+.+++.++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345678888999999999999998653 3   27999999654322 234579999999999999999999999987665


Q ss_pred             e------EEEEecCCCCChhhHhhhcCC--CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCce
Q 015852          319 K------LLVYPYMTNGSVASRLRERQS--SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  390 (399)
Q Consensus       319 ~------~lv~e~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~  390 (399)
                      .      +++|||+++|+|.+++.....  ....+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            5      899999999999999975421  222588999999999999999999999   99999999999999999999


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      ||+||+
T Consensus       177 kl~Dfg  182 (323)
T 3qup_A          177 CVADFG  182 (323)
T ss_dssp             EECCCC
T ss_pred             EEeecc
Confidence            999995

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.92  E-value=9.8e-26  Score=224.36  Aligned_cols=146  Identities=27%  Similarity=0.425  Sum_probs=128.3

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      +...++|...+.||+|+||.||+|...++..||||+++...  .....|.+|+.+++.++||||+++++++.. +..++|
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            34455677789999999999999999887889999997543  234579999999999999999999999876 678999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.++++....  ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus       257 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCc
Confidence            999999999999975321  2478999999999999999999999   99999999999999999999999994

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.92  E-value=7e-26  Score=212.23  Aligned_cols=143  Identities=25%  Similarity=0.443  Sum_probs=124.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-----CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC--Cce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~  319 (399)
                      ++|...+.||+|+||.||++++     .+++.||||+++... ......|.+|+.+++.++||||+++++++...  ...
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            4567779999999999999984     257899999986432 22334799999999999999999999998653  458


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence            999999999999999986532   488999999999999999999998   99999999999999999999999994

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.92  E-value=2.5e-25  Score=215.08  Aligned_cols=141  Identities=24%  Similarity=0.272  Sum_probs=126.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+++.. +++.||||++....  .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            46777899999999999999865 78999999986432  2234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc--eeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~--~~i~df~  396 (399)
                      +++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+||+
T Consensus        98 ~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           98 ASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             CCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence            99999999997653    388999999999999999999999   9999999999999998776  9999995

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.92  E-value=2.3e-25  Score=222.54  Aligned_cols=143  Identities=25%  Similarity=0.434  Sum_probs=128.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+.. +|+.||||+++....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46777899999999999999865 789999999964322  223457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEecc
Confidence            9999999999997542    489999999999999999999999   99999999999999999999999994

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.92  E-value=1.9e-25  Score=207.68  Aligned_cols=148  Identities=25%  Similarity=0.369  Sum_probs=126.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .++|...+.||+|+||.||+|+.. +++.||+|.++..... ....++.+|+..+..+ +||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            356778899999999999999875 7899999998654322 2345788999999888 899999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC---------------
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---------------  387 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~---------------  387 (399)
                      |||+++|+|.+++.........+++..+..++.|++.||+|||++   +|+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999986432223589999999999999999999999   99999999999999954               


Q ss_pred             ----Cceeecccc
Q 015852          388 ----ADQSSKTIL  396 (399)
Q Consensus       388 ----~~~~i~df~  396 (399)
                          ..+||+||+
T Consensus       167 ~~~~~~~kl~Dfg  179 (289)
T 1x8b_A          167 ASNKVMFKIGDLG  179 (289)
T ss_dssp             ---CCCEEECCCT
T ss_pred             cCCceEEEEcccc
Confidence                478999995

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.92  E-value=1.5e-25  Score=217.44  Aligned_cols=143  Identities=27%  Similarity=0.348  Sum_probs=118.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHH-HhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...++||+|+||+||+++.. +++.||+|+++.....  .....+.+|..+ ++.++||||+++++++...+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            45777899999999999999865 6889999999654322  223356677776 5778999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus       118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCc
Confidence            99999999999998653    378899999999999999999999   99999999999999999999999994

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=3e-25  Score=204.51  Aligned_cols=142  Identities=27%  Similarity=0.420  Sum_probs=128.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ++|...+.||+|+||.||+++..+++.||+|.++...  .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            4567778999999999999998888899999996543  23457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        86 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg  149 (267)
T 3t9t_A           86 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  149 (267)
T ss_dssp             TTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTT
T ss_pred             CCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccc
Confidence            99999999986532   478999999999999999999999   99999999999999999999999994

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.92  E-value=2.2e-25  Score=205.59  Aligned_cols=145  Identities=26%  Similarity=0.393  Sum_probs=125.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+.. ++.||||+++..... .....|.+|+.+++.++||||+++++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            46777899999999999999985 788999999754322 2234699999999999999999999999887  6789999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||+|||+. .++|+||||||+|||+++++.++++||
T Consensus        89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             cccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEec
Confidence            99999999999986432  2589999999999999999999998 122999999999999999999999887

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.92  E-value=2.7e-25  Score=225.74  Aligned_cols=146  Identities=27%  Similarity=0.363  Sum_probs=129.3

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .++|...++||+|+||.||+++.. +++.||+|++....  .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            456888899999999999999864 78999999986532  223345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++.....  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus       263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFG  331 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLG  331 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecc
Confidence            999999999999976432  2488999999999999999999999   99999999999999999999999994

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.92  E-value=4e-26  Score=217.63  Aligned_cols=152  Identities=27%  Similarity=0.366  Sum_probs=130.4

Q ss_pred             HHHHhcCCCCCceeeccCCceEEEEEeC-CC-----CEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeee
Q 015852          242 LQVATDGFSNKNILGRGGFGKVYKGRLA-DG-----KLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT  314 (399)
Q Consensus       242 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~-----~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~  314 (399)
                      +....++|...+.||+|+||.||+|... ++     ..||+|.++..........+.+|+.+++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3445677888899999999999999863 22     479999997654334455799999999999 8999999999999


Q ss_pred             cCCceEEEEecCCCCChhhHhhhcCC----------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee
Q 015852          315 TVTEKLLVYPYMTNGSVASRLRERQS----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  384 (399)
Q Consensus       315 ~~~~~~lv~e~~~~gsL~~~L~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl  384 (399)
                      ..+..++||||+++|+|.+++.....          ....+++..+..++.|++.||+|||+.   +|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence            99999999999999999999975321          023478999999999999999999999   99999999999999


Q ss_pred             CCCCceeecccc
Q 015852          385 DEDADQSSKTIL  396 (399)
Q Consensus       385 d~~~~~~i~df~  396 (399)
                      +.++.+||+||+
T Consensus       198 ~~~~~~kl~Dfg  209 (333)
T 2i1m_A          198 TNGHVAKIGDFG  209 (333)
T ss_dssp             EGGGEEEBCCCG
T ss_pred             CCCCeEEECccc
Confidence            999999999994

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=2.4e-25  Score=212.63  Aligned_cols=144  Identities=29%  Similarity=0.462  Sum_probs=126.2

Q ss_pred             cCCCCCceeeccCCceEEEEEeCC-----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ..|...+.||+|+||.||+|+...     +..||||.++..........+.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            345556899999999999997532     236999999755433344579999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.+++....   ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       124 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCC
Confidence            999999999999998643   2488999999999999999999999   99999999999999999999999994

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.92  E-value=3.1e-25  Score=208.03  Aligned_cols=138  Identities=28%  Similarity=0.409  Sum_probs=118.4

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhc--CCCCCccceeeeeecC----Cce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTV----TEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~~~  319 (399)
                      .++|...+.||+|+||.||+|+. +++.||||++...    ....+.+|.+++..  ++||||+++++++...    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            35688889999999999999988 6889999998543    23456666666655  8999999999987542    457


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHh--------cCCCCCceecCCCCCceeeCCCCcee
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--------EHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      ++||||+++|+|.++++..     .+++..+..++.|++.||+|||        +.   +|+||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            8999999999999999643     4899999999999999999999        66   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       154 l~Dfg  158 (301)
T 3q4u_A          154 IADLG  158 (301)
T ss_dssp             ECCCT
T ss_pred             EeeCC
Confidence            99995

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.92  E-value=3.1e-25  Score=205.39  Aligned_cols=143  Identities=25%  Similarity=0.377  Sum_probs=128.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+|+.. +++.||||.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            46777899999999999999865 68999999986554444456799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++...    ..+++.....++.|+++||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence            9999999998653    2488999999999999999999999   99999999999999999999999995

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.92  E-value=2e-25  Score=211.10  Aligned_cols=143  Identities=24%  Similarity=0.213  Sum_probs=121.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhc-CCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||+||+|+.. +++.||||++...... .....+..|+..+.. .+||||+++++++...+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46788899999999999999875 7899999988543322 222345566655544 48999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+ +|+|.+++.....   .++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       137 e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             ECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             ecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence            999 6799999876532   489999999999999999999998   99999999999999999999999995

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.9e-25  Score=216.84  Aligned_cols=142  Identities=33%  Similarity=0.489  Sum_probs=121.7

Q ss_pred             CCCCceeeccCCceEEEEEeC--CC--CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec-CCceEEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA--DG--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVY  323 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~--~~--~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~  323 (399)
                      |...+.||+|+||.||+|+..  ++  ..||||.++..........|.+|+.+++.++||||+++++++.. .+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            445688999999999999853  22  36899998754444445679999999999999999999998754 45778999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.++++...   ..+++.+...++.|+++||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       171 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG  237 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  237 (373)
T ss_dssp             ECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             ECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence            9999999999997543   2478999999999999999999999   99999999999999999999999994

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.92  E-value=1.7e-26  Score=220.76  Aligned_cols=141  Identities=19%  Similarity=0.225  Sum_probs=116.2

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccc-------cccHHHHHHHHHHHhcCC---------CCCcccee
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-------SGGELQFQTEVKIISMAV---------HRNLLRLY  310 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-------~~~~~~f~~E~~~l~~l~---------H~niv~l~  310 (399)
                      ++|...+.||+|+||+||+|+. +++.||||+++....       ......+.+|+.+++.++         ||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4567789999999999999987 689999999965432       122357889999888775         66666665


Q ss_pred             eee-----------------ec-------------CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHH
Q 015852          311 GFC-----------------TT-------------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG  360 (399)
Q Consensus       311 g~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~g  360 (399)
                      +.+                 ..             .+..++||||+++|++.+.+.+     ..+++..+..++.|++.|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHH
Confidence            543                 32             6789999999999987777643     237899999999999999


Q ss_pred             HHHHh-cCCCCCceecCCCCCceeeCCCC--------------------ceeecccc
Q 015852          361 LSYLH-EHCDPKIIHRDVKAANILLDEDA--------------------DQSSKTIL  396 (399)
Q Consensus       361 L~yLH-~~~~~~ivHrDlK~~NILld~~~--------------------~~~i~df~  396 (399)
                      |+||| +.   +|+||||||+|||++.++                    .+||+||+
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG  227 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT  227 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCT
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeecc
Confidence            99999 88   999999999999999987                    89999994

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.92  E-value=2.8e-25  Score=229.02  Aligned_cols=136  Identities=24%  Similarity=0.353  Sum_probs=121.7

Q ss_pred             eeeccCCceEEEEEeC---CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCC
Q 015852          254 ILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  330 (399)
Q Consensus       254 ~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  330 (399)
                      .||+|+||.||+|.+.   ++..||||+++.........+|.+|+.+++.++|||||+++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999763   4567999999766444456689999999999999999999999976 56899999999999


Q ss_pred             hhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          331 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       331 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |.+++....   ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       422 L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          422 LHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             HHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             HHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence            999997543   2589999999999999999999999   99999999999999999999999994

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.92  E-value=3.3e-25  Score=210.87  Aligned_cols=147  Identities=29%  Similarity=0.489  Sum_probs=125.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCE--EEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKL--VAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~--vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...+.||+|+||.||+|+.. ++..  +|+|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            46777899999999999999864 5554  4999987544444455799999999999 899999999999999999999


Q ss_pred             EecCCCCChhhHhhhcC------------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCce
Q 015852          323 YPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  390 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~  390 (399)
                      |||+++|+|.+++....            .....+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997653            1223589999999999999999999999   99999999999999999999


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      ||+||+
T Consensus       182 kL~Dfg  187 (327)
T 1fvr_A          182 KIADFG  187 (327)
T ss_dssp             EECCTT
T ss_pred             EEcccC
Confidence            999994

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.92  E-value=3.3e-25  Score=216.77  Aligned_cols=146  Identities=23%  Similarity=0.322  Sum_probs=127.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC--ceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~  323 (399)
                      +.|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+++++.++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            35677899999999999999875 589999999976554455567899999999999999999999988755  679999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee----CCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl----d~~~~~~i~df~  396 (399)
                      ||+++|+|.+++...... ..+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+||+
T Consensus        89 e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             ecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            999999999999764322 2389999999999999999999999   99999999999999    788889999994

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.92  E-value=1.4e-25  Score=227.88  Aligned_cols=147  Identities=27%  Similarity=0.421  Sum_probs=128.9

Q ss_pred             HHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          242 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       242 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +++..++|...+.||+|+||.||+|++.++..||||+++...  .....|.+|+.+|+.++|+||+++++++.. +..++
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            344456677789999999999999999888889999997543  234579999999999999999999999876 67899


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.++++....  ..+++.++..++.||++||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus       339 v~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             eeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            9999999999999975321  2478999999999999999999999   99999999999999999999999994

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.92  E-value=3.7e-25  Score=205.63  Aligned_cols=144  Identities=32%  Similarity=0.474  Sum_probs=127.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .++|...+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            356777899999999999999864 577999999854321  22345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||+
T Consensus        88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg  154 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG  154 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCC
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecc
Confidence            99999999999997653    388999999999999999999998   99999999999999999999999995

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.92  E-value=2.6e-25  Score=207.44  Aligned_cols=143  Identities=26%  Similarity=0.385  Sum_probs=125.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CC-------CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCc
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DG-------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~-------~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  318 (399)
                      ++|...+.||+|+||.||+|+.. ++       ..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            45677799999999999999754 23       479999986532 3344579999999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc--------e
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--------Q  390 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~--------~  390 (399)
                      .++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999986432   378999999999999999999999   9999999999999999987        9


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      ||+||+
T Consensus       161 kl~Dfg  166 (289)
T 4fvq_A          161 KLSDPG  166 (289)
T ss_dssp             EECCCC
T ss_pred             eeccCc
Confidence            999994

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.92  E-value=1.8e-25  Score=212.63  Aligned_cols=143  Identities=25%  Similarity=0.416  Sum_probs=122.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|...+.||+|+||.||+|+.. +++    .||+|.+...........+.+|+.+++.++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            45677789999999999999864 444    378888754433333446889999999999999999999986 456889


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCC
Confidence            999999999999997642   2478899999999999999999999   99999999999999999999999994

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.92  E-value=1e-25  Score=212.86  Aligned_cols=157  Identities=28%  Similarity=0.397  Sum_probs=132.6

Q ss_pred             ccHHHHHHHhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccce
Q 015852          237 FSLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRL  309 (399)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l  309 (399)
                      +...++....++|...+.||+|+||.||+|+.      .+++.||||.++..........+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34455556677899999999999999999974      356789999997654433445799999999999 69999999


Q ss_pred             eeeeecCC-ceEEEEecCCCCChhhHhhhcCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 015852          310 YGFCTTVT-EKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  376 (399)
Q Consensus       310 ~g~~~~~~-~~~lv~e~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  376 (399)
                      ++++...+ ..++||||+++|+|.+++......            ...+++..+..++.|+++||+|||+.   +|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            99987755 489999999999999999865421            11278899999999999999999999   999999


Q ss_pred             CCCCceeeCCCCceeecccc
Q 015852          377 VKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       377 lK~~NILld~~~~~~i~df~  396 (399)
                      |||+||+++.++.+||+||+
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg  193 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFG  193 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCG
T ss_pred             CccceEEECCCCCEEECCCc
Confidence            99999999999999999994

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.92  E-value=5.8e-25  Score=204.06  Aligned_cols=144  Identities=28%  Similarity=0.464  Sum_probs=128.2

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||.+.....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            4677789999999999999986 5789999999864322  223457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++....   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg  157 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFG  157 (278)
T ss_dssp             ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeec
Confidence            9999999999997642   2588999999999999999999999   99999999999999999999999994

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.92  E-value=3.9e-25  Score=212.64  Aligned_cols=141  Identities=28%  Similarity=0.359  Sum_probs=120.1

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .+.|...+.||+|+||.||+|+.. +++.||||+++...   ....+.+|+.++..++||||+++++++...+..++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            356777899999999999999975 58899999986432   23468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC---CCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~---~~~~~i~df~  396 (399)
                      |+++|+|.+++....    .+++.+...++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||+
T Consensus       129 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             CCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCc
Confidence            999999999997542    488999999999999999999999   9999999999999976   8899999995

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.92  E-value=6.4e-25  Score=208.22  Aligned_cols=140  Identities=29%  Similarity=0.431  Sum_probs=123.9

Q ss_pred             CCCCceeeccCCceEEEEEeC-----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC--CceEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  321 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  321 (399)
                      |...+.||+|+||.||++.+.     +++.||||+++..........+.+|+++++.++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            366789999999999998652     57899999997654334455799999999999999999999999874  56789


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcc
Confidence            99999999999999764     278999999999999999999999   99999999999999999999999994

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.9e-25  Score=215.40  Aligned_cols=143  Identities=27%  Similarity=0.331  Sum_probs=126.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe----CCCCEEEEEEcccccc---cccHHHHHHHHHHHhcC-CCCCccceeeeeecCCc
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~  318 (399)
                      ++|...+.||+|+||.||+++.    .+++.||||+++....   ......+.+|+.++..+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4677789999999999999986    3689999999865431   12234577899999998 69999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||+++|+|.+++....    .+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             EEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence            999999999999999998653    488999999999999999999999   99999999999999999999999994

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.92  E-value=5.3e-25  Score=206.39  Aligned_cols=143  Identities=33%  Similarity=0.467  Sum_probs=122.8

Q ss_pred             CCCCCceeeccCCceEEEEEeCC----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeee-cCCceEEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT-TVTEKLLV  322 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv  322 (399)
                      .|...+.||+|+||.||+|+..+    ...+|+|.++..........+.+|+.+++.++||||+++++++. ..+..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            46667899999999999998642    23689999875444344457999999999999999999999865 45577899


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.++++...   ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       106 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             EECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             EeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccc
Confidence            99999999999997543   2478999999999999999999999   99999999999999999999999994

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.92  E-value=3.9e-25  Score=219.27  Aligned_cols=144  Identities=19%  Similarity=0.269  Sum_probs=125.3

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+|.. .+++.+|+|.+...... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            45678889999999999999985 47899999998654322 22346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC---CCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld---~~~~~~i~df~  396 (399)
                      ||+++|+|.+.+....    .+++.....++.|++.||+|||+.   +|+||||||+|||++   .++.+||+||+
T Consensus        90 E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           90 DLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             CCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            9999999999998653    488999999999999999999999   999999999999999   45789999994

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.92  E-value=2.6e-25  Score=206.55  Aligned_cols=144  Identities=28%  Similarity=0.419  Sum_probs=126.2

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..++|...+.||+|+||.||+|+..++..||||.++...  .....+.+|+++++.++||||+++++++. .+..++|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence            345677789999999999999998888899999986542  23457999999999999999999999986 456899999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+||+
T Consensus        88 ~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             CCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCc
Confidence            9999999999975321  1478999999999999999999999   99999999999999999999999994

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.92  E-value=3.8e-25  Score=213.31  Aligned_cols=144  Identities=26%  Similarity=0.349  Sum_probs=128.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|+++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56788899999999999999865 68999999997654333445799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++....    .+++.....++.+++.||+|||+.+  +|+||||||+|||++.++.+||+||+
T Consensus       113 ~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             CCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECC
Confidence            99999999998753    3789999999999999999999831  79999999999999999999999995

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.92  E-value=3.7e-25  Score=220.45  Aligned_cols=142  Identities=20%  Similarity=0.311  Sum_probs=114.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC-----Cce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  319 (399)
                      ++|...+.||+|+||+||+|+.. +++.||||++...... .....+.+|+.+++.++||||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            56788899999999999999854 7899999998653222 2234689999999999999999999998543     568


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+. |+|.++++...    .+++..+..++.||++||+|||+.   +||||||||+|||++.++.+||+||+
T Consensus       133 ~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence            99999985 79999987542    489999999999999999999999   99999999999999999999999994

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.92  E-value=1.2e-24  Score=205.83  Aligned_cols=141  Identities=24%  Similarity=0.329  Sum_probs=123.9

Q ss_pred             CCCC-CceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhc-CCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSN-KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~-~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .|.. .+.||+|+||.||+|+. .+++.||||+++... ......+.+|++++.+ .+||||+++++++...+..++|||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            4554 37899999999999985 478999999996542 3345578999999988 579999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc---eeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~---~~i~df~  396 (399)
                      |+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.   +||+||+
T Consensus        92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            999999999998753    488999999999999999999999   9999999999999998876   9999994

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=6.4e-25  Score=205.59  Aligned_cols=142  Identities=27%  Similarity=0.389  Sum_probs=122.6

Q ss_pred             CCCCceeeccCCceEEEEEeC-CC---CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce-EEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK-LLVY  323 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~-~~---~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lv~  323 (399)
                      |...+.||+|+||.||+|+.. ++   ..||+|.++..........|.+|+.+++.++||||+++++++...+.. +++|
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            444588999999999999853 33   379999986544334445799999999999999999999999876665 8999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+.+|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       103 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             CCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             ecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence            9999999999997633   2478999999999999999999999   99999999999999999999999994

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.92  E-value=4.3e-25  Score=208.88  Aligned_cols=147  Identities=26%  Similarity=0.370  Sum_probs=125.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeee----cCCceE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT----TVTEKL  320 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----~~~~~~  320 (399)
                      .++|...+.||+|+||.||+++. .+++.||||++... .......+.+|+.+++.++||||+++++++.    .....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            35677889999999999999986 57899999988543 2233457899999999999999999999987    334678


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+++|+|.+++.........+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence            99999999999999986433334689999999999999999999999   99999999999999999999999995

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.92  E-value=6.6e-25  Score=207.03  Aligned_cols=143  Identities=23%  Similarity=0.350  Sum_probs=126.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|++........ ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            46777899999999999999875 589999998865433222 3468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  147 (311)
T 4agu_A           83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG  147 (311)
T ss_dssp             CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence            999999999886543    488999999999999999999999   99999999999999999999999995

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.92  E-value=8.8e-25  Score=213.08  Aligned_cols=143  Identities=20%  Similarity=0.315  Sum_probs=125.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            56788899999999999999864 68899999986432 22334689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC--CCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~--~~~~~i~df~  396 (399)
                      +++|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+||+
T Consensus       130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence            99999999997542   2488999999999999999999999   9999999999999985  4679999994

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.92  E-value=2.3e-25  Score=211.97  Aligned_cols=143  Identities=26%  Similarity=0.440  Sum_probs=123.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|+++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            45777899999999999999865 78999999996544333333466899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++ |+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  145 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFG  145 (324)
T ss_dssp             CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSS
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCc
Confidence            98 599999876532   488999999999999999999999   99999999999999999999999994

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.92  E-value=9e-25  Score=210.73  Aligned_cols=152  Identities=22%  Similarity=0.345  Sum_probs=131.6

Q ss_pred             cHHHHHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccccc----------HHHHHHHHHHHhcCCCCCcc
Q 015852          238 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG----------ELQFQTEVKIISMAVHRNLL  307 (399)
Q Consensus       238 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~----------~~~f~~E~~~l~~l~H~niv  307 (399)
                      ...++....++|...+.||+|+||.||+|...+++.||||++........          ...+.+|+.+++.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            45677788899999999999999999999988899999999865432211          25689999999999999999


Q ss_pred             ceeeeeec-----CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCce
Q 015852          308 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  382 (399)
Q Consensus       308 ~l~g~~~~-----~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NI  382 (399)
                      ++++++..     ....++||||++ |+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            99999854     335799999998 68888887543   2589999999999999999999999   999999999999


Q ss_pred             eeCCCCceeecccc
Q 015852          383 LLDEDADQSSKTIL  396 (399)
Q Consensus       383 Lld~~~~~~i~df~  396 (399)
                      |++.++.+||+||+
T Consensus       166 l~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          166 LLADNNDITICDFN  179 (362)
T ss_dssp             EECTTCCEEECCTT
T ss_pred             EEcCCCCEEEEecC
Confidence            99999999999994

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.92  E-value=1.4e-25  Score=209.29  Aligned_cols=146  Identities=28%  Similarity=0.402  Sum_probs=129.7

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ...++|...+.||+|+||.||+|... ++..||+|.++..  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            34566778899999999999999875 5889999998643  23345799999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+||+
T Consensus        88 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             EECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence            999999999999986432  3588999999999999999999999   99999999999999999999999994

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.92  E-value=1.1e-24  Score=203.92  Aligned_cols=143  Identities=22%  Similarity=0.332  Sum_probs=127.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|.+......  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45677799999999999999875 5889999998654322  22346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++....    .+++.++..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        95 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  160 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG  160 (294)
T ss_dssp             ECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEecc
Confidence            9999999999987643    488999999999999999999999   99999999999999999999999994

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.92  E-value=4.5e-25  Score=212.16  Aligned_cols=142  Identities=31%  Similarity=0.441  Sum_probs=124.5

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .|...+.||+|+||.||+|+. .+++.||||++.......  ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            366778999999999999985 578999999986443222  23468999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+. |+|.+++....   ..+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||+
T Consensus       135 ~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          135 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             CCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             cCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence            997 68888886543   2489999999999999999999999   99999999999999999999999994

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.92  E-value=7.5e-25  Score=207.95  Aligned_cols=143  Identities=24%  Similarity=0.336  Sum_probs=127.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-----cHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      +.|...+.||+|+||.||+++.. +++.||+|.++......     ....+.+|+.+++.++||||+++++++......+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45777899999999999999865 68999999986543222     2457999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC----ceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~----~~~i~df~  396 (399)
                      +||||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++    .+||+||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999997542    478999999999999999999999   999999999999999988    79999994

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.92  E-value=1.5e-24  Score=202.29  Aligned_cols=142  Identities=31%  Similarity=0.589  Sum_probs=122.8

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccH------HHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE------LQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~------~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      ++|...+.||+|+||.||+|+. .+++.||+|++.........      ..+.+|+.+++.++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            4677779999999999999986 47899999998654332221      46899999999999999999999986654  


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceeeCCCCc-----eee
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDAD-----QSS  392 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlK~~NILld~~~~-----~~i  392 (399)
                      ++||||+++|+|.+.+....   ..+++..+..++.|++.||+|||+.   +  |+||||||+|||++.+++     +||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            79999999999999887543   2589999999999999999999998   7  999999999999998887     999


Q ss_pred             cccc
Q 015852          393 KTIL  396 (399)
Q Consensus       393 ~df~  396 (399)
                      +||+
T Consensus       171 ~Dfg  174 (287)
T 4f0f_A          171 ADFG  174 (287)
T ss_dssp             CCCT
T ss_pred             CCCC
Confidence            9994

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.92  E-value=1.2e-24  Score=201.88  Aligned_cols=142  Identities=23%  Similarity=0.327  Sum_probs=127.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+|+.. ++..+|+|++..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            45777899999999999999865 577999999865432 3455799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee---CCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl---d~~~~~~i~df~  396 (399)
                      +++++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+   +.++.++|+||+
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence            99999999987653    388999999999999999999999   99999999999999   888999999995

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.92  E-value=1.1e-24  Score=208.11  Aligned_cols=143  Identities=22%  Similarity=0.332  Sum_probs=126.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|.+......  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            34666789999999999999865 5789999998654322  22346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++....    .+++.++..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       121 e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  186 (335)
T 2owb_A          121 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG  186 (335)
T ss_dssp             CCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeecc
Confidence            9999999999987643    488999999999999999999999   99999999999999999999999994

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.92  E-value=4.3e-25  Score=207.15  Aligned_cols=151  Identities=28%  Similarity=0.371  Sum_probs=115.3

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ....++|...+.||+|+||.||+|.. .+++.||||.+..........++.+|+.+++.++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            34456788899999999999999985 46889999998654433444578999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhc----CCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRER----QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.+++...    ......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999998741    11123588999999999999999999999   99999999999999999999999994

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.92  E-value=1.2e-24  Score=202.21  Aligned_cols=143  Identities=27%  Similarity=0.357  Sum_probs=127.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-----cHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|.++......     ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45777899999999999999875 68999999986543221     2457999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC----ceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~----~~~i~df~  396 (399)
                      +||||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+||+
T Consensus        85 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999997643    489999999999999999999999   999999999999999887    79999994

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.92  E-value=1.2e-24  Score=204.57  Aligned_cols=142  Identities=31%  Similarity=0.462  Sum_probs=128.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.|...+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            3577779999999999999985 468899999997654445556799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++++|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus       102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg  164 (303)
T 3a7i_A          102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG  164 (303)
T ss_dssp             CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecc
Confidence            9999999998642     488999999999999999999999   99999999999999999999999994

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.92  E-value=4.6e-25  Score=204.75  Aligned_cols=147  Identities=24%  Similarity=0.342  Sum_probs=126.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeee--cCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCT--TVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lv  322 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...... .....+.+|+.+++.++||||+++++++.  .....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            46777899999999999999864 7899999998654322 23346999999999999999999999874  35678999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-----IIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++.........+++..+..++.|++.||+|||+.   +     |+||||||+||+++.++.+||+||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999986433334589999999999999999999998   6     9999999999999999999999994

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.92  E-value=1.1e-24  Score=201.98  Aligned_cols=143  Identities=24%  Similarity=0.405  Sum_probs=128.2

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+.. +++.||||.+....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            56777899999999999999875 78999999986432  1233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg  156 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG  156 (276)
T ss_dssp             ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecc
Confidence            9999999999997653    378999999999999999999999   99999999999999999999999994

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.92  E-value=3.2e-25  Score=212.10  Aligned_cols=144  Identities=26%  Similarity=0.309  Sum_probs=126.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc-------cHHHHHHHHHHHhcCCCCCccceeeeeecCC
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVT  317 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  317 (399)
                      .++|...+.||+|+||.||+|+. .+++.||||+++......       ....+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            45688889999999999999985 578899999986543211       2235788999999999999999999999999


Q ss_pred             ceEEEEecCCCC-ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 EKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 ~~~lv~e~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..++||||+.+| +|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999877 9999997643    489999999999999999999999   99999999999999999999999994

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.92  E-value=7.9e-25  Score=212.46  Aligned_cols=138  Identities=25%  Similarity=0.348  Sum_probs=117.3

Q ss_pred             CceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCCCC
Q 015852          252 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  330 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs  330 (399)
                      .+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            46799999999999986 4689999999865422 234579999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee--CCCCceeecccc
Q 015852          331 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL--DEDADQSSKTIL  396 (399)
Q Consensus       331 L~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl--d~~~~~~i~df~  396 (399)
                      |.+++....   ..+++..+..++.|+++||+|||+.   +|+||||||+|||+  ++++.+||+||+
T Consensus       173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG  234 (373)
T 2x4f_A          173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFG  234 (373)
T ss_dssp             EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCC
Confidence            999987542   2478999999999999999999999   99999999999999  677899999994

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=7.2e-25  Score=204.57  Aligned_cols=142  Identities=23%  Similarity=0.341  Sum_probs=123.1

Q ss_pred             CCCCCc-eeeccCCceEEEEEeC---CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          248 GFSNKN-ILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       248 ~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      +|...+ .||+|+||.||+|...   ++..||||.++..........+.+|+++++.++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            343444 8999999999999853   57789999997654334455799999999999999999999999 456689999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        89 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg  155 (287)
T 1u59_A           89 EMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG  155 (287)
T ss_dssp             ECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             EeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccc
Confidence            9999999999997542   2488999999999999999999999   99999999999999999999999994

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.92  E-value=1.3e-24  Score=205.18  Aligned_cols=144  Identities=23%  Similarity=0.305  Sum_probs=128.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .++|...+.||+|+||.||+++.. +++.||+|+++.......  ...+.+|+.+++.++||||+++++++...+..+++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            357888899999999999999864 688999999965433222  34689999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCc
Confidence            99999999999998653    488999999999999999999999   99999999999999999999999995

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.92  E-value=4.9e-25  Score=208.20  Aligned_cols=152  Identities=26%  Similarity=0.430  Sum_probs=123.3

Q ss_pred             HHHHhcCCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecC
Q 015852          242 LQVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV  316 (399)
Q Consensus       242 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~  316 (399)
                      +....++|...+.||+|+||.||+|+..    ++..||+|.++...... ....+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3444567888899999999999999753    34589999996543322 234699999999999999999999999875


Q ss_pred             Cc-----eEEEEecCCCCChhhHhhhcC--CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc
Q 015852          317 TE-----KLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  389 (399)
Q Consensus       317 ~~-----~~lv~e~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~  389 (399)
                      ..     .++||||+++|+|.+++....  .....+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence            53     499999999999999986432  2234589999999999999999999998   9999999999999999999


Q ss_pred             eeecccc
Q 015852          390 QSSKTIL  396 (399)
Q Consensus       390 ~~i~df~  396 (399)
                      +||+||+
T Consensus       186 ~kl~Dfg  192 (313)
T 3brb_A          186 VCVADFG  192 (313)
T ss_dssp             EEECSCS
T ss_pred             EEEeecC
Confidence            9999994

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.92  E-value=1.5e-24  Score=201.75  Aligned_cols=144  Identities=22%  Similarity=0.310  Sum_probs=126.9

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+|... +++.||+|++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            356788899999999999999864 6889999998654332 22346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc---eeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~---~~i~df~  396 (399)
                      ||+++|+|.+.+....    .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.   +||+||+
T Consensus        85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            9999999999987653    488999999999999999999999   9999999999999987766   9999994

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.92  E-value=2.1e-24  Score=205.50  Aligned_cols=134  Identities=20%  Similarity=0.324  Sum_probs=119.4

Q ss_pred             CceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEecCCCC
Q 015852          252 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      .+.||+|+||.||+|+.. +++.||||++...    ....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999874 6899999998532    3346889999999997 999999999999999999999999999


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeecccc
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  396 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~df~  396 (399)
                      +|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++   .+||+||+
T Consensus        92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccc
Confidence            9999998753    489999999999999999999999   999999999999998766   79999994

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.92  E-value=9.3e-25  Score=207.78  Aligned_cols=148  Identities=31%  Similarity=0.402  Sum_probs=125.0

Q ss_pred             hcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      .++|...+.||+|+||.||+|+.      .+++.||||.+..........++.+|+.+++.++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            35678889999999999999984      246789999996544444455799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCC---CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC---Cceeec
Q 015852          320 LLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSK  393 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~---~~~~i~  393 (399)
                      ++||||+++|+|.+++......   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   ..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999875421   13488999999999999999999999   99999999999999954   459999


Q ss_pred             ccc
Q 015852          394 TIL  396 (399)
Q Consensus       394 df~  396 (399)
                      ||+
T Consensus       186 Dfg  188 (327)
T 2yfx_A          186 DFG  188 (327)
T ss_dssp             CCH
T ss_pred             ccc
Confidence            994

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.91  E-value=1.2e-24  Score=205.29  Aligned_cols=147  Identities=20%  Similarity=0.302  Sum_probs=126.2

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|.. .+++.||+|+++.....  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4577789999999999999986 57899999998653222  22346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++.........+++.....++.|+++||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg  181 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  181 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecc
Confidence            99999999999975322234588999999999999999999999   99999999999999999999999994

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.91  E-value=1.1e-24  Score=214.71  Aligned_cols=144  Identities=24%  Similarity=0.336  Sum_probs=122.2

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-------ccHHHHHHHHHHHhcCCCCCccceeeeeecC
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-------GGELQFQTEVKIISMAVHRNLLRLYGFCTTV  316 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~  316 (399)
                      ..++|...+.||+|+||.||+|.. .+++.||||++......       .....+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            456788889999999999999986 46899999998643211       112248899999999999999999999754 


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeec
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSK  393 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~  393 (399)
                      +..++||||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++   .+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            45799999999999999987542    489999999999999999999999   999999999999997654   49999


Q ss_pred             ccc
Q 015852          394 TIL  396 (399)
Q Consensus       394 df~  396 (399)
                      ||+
T Consensus       285 DFG  287 (419)
T 3i6u_A          285 DFG  287 (419)
T ss_dssp             CSS
T ss_pred             ecc
Confidence            994

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=3.8e-25  Score=211.72  Aligned_cols=151  Identities=21%  Similarity=0.248  Sum_probs=125.6

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccc----ccccHHHHHHHHHHHhcCCCCCccceeeeeecCC
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  317 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  317 (399)
                      ....++|...+.||+|+||.||+|+. .+++.||+|++....    .......+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            34456788889999999999999986 468899999986432    1233457999999999999999999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCC------------------------------------CCCCChHHHHHHHHHHHHHH
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSS------------------------------------LPPLDWPTRKKIALGSARGL  361 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~gL  361 (399)
                      ..++||||+++|+|.+++......                                    ...+++.....++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998531100                                    01124567788999999999


Q ss_pred             HHHhcCCCCCceecCCCCCceeeCCCC--ceeecccc
Q 015852          362 SYLHEHCDPKIIHRDVKAANILLDEDA--DQSSKTIL  396 (399)
Q Consensus       362 ~yLH~~~~~~ivHrDlK~~NILld~~~--~~~i~df~  396 (399)
                      +|||+.   +|+||||||+|||++.++  .+||+||+
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg  215 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFG  215 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCT
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeecc
Confidence            999999   999999999999998777  89999994

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.91  E-value=1e-24  Score=207.76  Aligned_cols=143  Identities=27%  Similarity=0.473  Sum_probs=124.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|...+.||+|+||.||+|+.. +++    .||+|.++..........+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            46777899999999999999853 444    468887765544555668999999999999999999999998754 789


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        94 v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG  162 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCc
Confidence            9999999999999987533   488999999999999999999999   99999999999999999999999994

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.91  E-value=1.1e-24  Score=207.69  Aligned_cols=140  Identities=19%  Similarity=0.256  Sum_probs=124.0

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||.+.....   ...+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            4677889999999999999985 5789999999854322   23588999999999 89999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc-----eeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-----QSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~-----~~i~df~  396 (399)
                      |+ +|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.     +||+||+
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            99 999999998642   2589999999999999999999999   9999999999999999987     9999994

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.91  E-value=9e-25  Score=209.38  Aligned_cols=145  Identities=26%  Similarity=0.341  Sum_probs=127.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccccc----------------HHHHHHHHHHHhcCCCCCccce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG----------------ELQFQTEVKIISMAVHRNLLRL  309 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~----------------~~~f~~E~~~l~~l~H~niv~l  309 (399)
                      .++|...+.||+|+||.||+|+. +++.||||.+........                ...+.+|+.++..++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35688889999999999999998 899999999864432211                1679999999999999999999


Q ss_pred             eeeeecCCceEEEEecCCCCChhhH------hhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCce
Q 015852          310 YGFCTTVTEKLLVYPYMTNGSVASR------LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANI  382 (399)
Q Consensus       310 ~g~~~~~~~~~lv~e~~~~gsL~~~------L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NI  382 (399)
                      ++++...+..++||||+++|+|.++      +...  ....+++..+..++.|++.||+|||+ .   +|+||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            9999999999999999999999998      5432  12458999999999999999999998 7   999999999999


Q ss_pred             eeCCCCceeecccc
Q 015852          383 LLDEDADQSSKTIL  396 (399)
Q Consensus       383 Lld~~~~~~i~df~  396 (399)
                      +++.++.+||+||+
T Consensus       184 l~~~~~~~kl~dfg  197 (348)
T 2pml_X          184 LMDKNGRVKLSDFG  197 (348)
T ss_dssp             EECTTSCEEECCCT
T ss_pred             EEcCCCcEEEeccc
Confidence            99999999999994

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.91  E-value=1.2e-24  Score=202.71  Aligned_cols=143  Identities=29%  Similarity=0.448  Sum_probs=127.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+.....  ......+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46777899999999999999865 678999999854321  223457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|+++||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccc
Confidence            9999999999998653    378999999999999999999998   99999999999999999999999995

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.91  E-value=1e-24  Score=226.96  Aligned_cols=146  Identities=24%  Similarity=0.318  Sum_probs=128.0

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCce
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~  319 (399)
                      ...++|...++||+|+||+||+|+.. +++.||||+++...  .......+..|..++..+ +||||+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34567888899999999999999864 68899999996542  223344688899999887 799999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.++++...    .+++..+..++.||+.||+|||+.   +||||||||+|||||.++.+||+||+
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecc
Confidence            99999999999999998753    389999999999999999999999   99999999999999999999999995

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.91  E-value=1.2e-24  Score=215.34  Aligned_cols=143  Identities=25%  Similarity=0.336  Sum_probs=124.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC-----Cc
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TE  318 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~  318 (399)
                      .++|...+.||+|+||.||+|+.. +++.||||+++..... .....+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            357888899999999999999864 6889999999654322 2234789999999999999999999998765     56


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||+. |+|.++++...    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence            899999987 69999997542    489999999999999999999999   99999999999999999999999994

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.91  E-value=1.3e-24  Score=200.72  Aligned_cols=144  Identities=29%  Similarity=0.442  Sum_probs=120.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc---ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||.||+|+.. ++.||||+++.....   .....+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            46777899999999999999974 789999998654322   22357899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC--------CCceeeccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--------DADQSSKTI  395 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~--------~~~~~i~df  395 (399)
                      ||+++++|.+++...     .+++.....++.|+++||+|||+....+|+||||||+|||++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999998643     4889999999999999999999982223999999999999996        677999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       161 g  161 (271)
T 3dtc_A          161 G  161 (271)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.91  E-value=9.7e-25  Score=202.97  Aligned_cols=144  Identities=24%  Similarity=0.346  Sum_probs=124.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCC----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      .++|...+.||+|+||.||+|+...    +..||+|.++..........|.+|+.+++.++||||+++++++.. +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4567778999999999999998532    346999999765443445579999999999999999999999865 45689


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++++|.+++.....   .+++.....++.|+++||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        90 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccC
Confidence            9999999999999976532   478999999999999999999999   99999999999999999999999994

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.91  E-value=2e-24  Score=202.81  Aligned_cols=144  Identities=25%  Similarity=0.401  Sum_probs=126.1

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .+.|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            356777899999999999999975 58899999986542 3345579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECC
Confidence            9999999999876432   488999999999999999999999   99999999999999999999999995

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.91  E-value=1.4e-24  Score=224.48  Aligned_cols=136  Identities=26%  Similarity=0.361  Sum_probs=120.1

Q ss_pred             ceeeccCCceEEEEEeC---CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||.||+|.+.   .++.||||+++...... ...+|.+|+.++..++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999652   46789999997654332 34579999999999999999999999964 558899999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|.++++...    .+++..+..|+.||+.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus       454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFG  514 (635)
T 4fl3_A          454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  514 (635)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred             CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcC
Confidence            99999997643    488999999999999999999999   99999999999999999999999994

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.91  E-value=8e-25  Score=210.92  Aligned_cols=154  Identities=19%  Similarity=0.255  Sum_probs=132.4

Q ss_pred             ccccHHHHHHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-----CCCccc
Q 015852          235 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----HRNLLR  308 (399)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-----H~niv~  308 (399)
                      ..+++++.....++|...+.||+|+||.||+|+. .+++.||||+++..  ......+..|+.++..++     ||||++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            3455566666678899999999999999999986 47889999998642  222345788999998886     999999


Q ss_pred             eeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC--
Q 015852          309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--  386 (399)
Q Consensus       309 l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~--  386 (399)
                      +++++...+..++||||+ +++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++  
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence            999999999999999999 9999999986532  2488999999999999999999999   9999999999999986  


Q ss_pred             -----------------------CCceeecccc
Q 015852          387 -----------------------DADQSSKTIL  396 (399)
Q Consensus       387 -----------------------~~~~~i~df~  396 (399)
                                             ++.+||+||+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG  207 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG  207 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCT
T ss_pred             ccccccchhcccccccccccccCCCCEEEEecc
Confidence                                   7899999995

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.91  E-value=1.2e-24  Score=205.34  Aligned_cols=143  Identities=29%  Similarity=0.470  Sum_probs=121.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ++|...+.||+|+||.||+++.. ++.||||.+...   .....|.+|+.++++++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            35666789999999999999874 678999998532   23457999999999999999999999886  4578999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc-eeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-QSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~-~~i~df~  396 (399)
                      ++|+|.+++.... ....+++.....++.|+++||+|||+.+..+|+||||||+|||++.++. +||+||+
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence            9999999997643 2234788899999999999999999943238999999999999998887 7999995

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.91  E-value=1.2e-24  Score=207.08  Aligned_cols=143  Identities=26%  Similarity=0.394  Sum_probs=124.6

Q ss_pred             cCCCCCceeeccCCceEEEEEe-----CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec--CCce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~  319 (399)
                      ++|...+.||+|+||.||++++     .+++.||||++.... ......+.+|+++++.++||||+++++++..  ....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            4567779999999999999984     367899999986542 2234469999999999999999999998864  4568


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence            899999999999999986432   488999999999999999999998   99999999999999999999999995

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.91  E-value=2.9e-24  Score=216.67  Aligned_cols=144  Identities=22%  Similarity=0.361  Sum_probs=124.1

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc------------ccHHHHHHHHHHHhcCCCCCccceeee
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS------------GGELQFQTEVKIISMAVHRNLLRLYGF  312 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~------------~~~~~f~~E~~~l~~l~H~niv~l~g~  312 (399)
                      .++|...+.||+|+||+||+|+.. +++.||+|+++.....            .....+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            356778899999999999999864 6889999998654321            224568999999999999999999999


Q ss_pred             eecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---c
Q 015852          313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---D  389 (399)
Q Consensus       313 ~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~  389 (399)
                      +......++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999997653    389999999999999999999999   999999999999999876   6


Q ss_pred             eeecccc
Q 015852          390 QSSKTIL  396 (399)
Q Consensus       390 ~~i~df~  396 (399)
                      +||+||+
T Consensus       188 ~kl~Dfg  194 (504)
T 3q5i_A          188 IKIVDFG  194 (504)
T ss_dssp             EEECCCT
T ss_pred             EEEEECC
Confidence            8999994

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.9e-24  Score=207.40  Aligned_cols=145  Identities=28%  Similarity=0.419  Sum_probs=120.9

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc----cHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++......    ....+.+|+.+++.++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3467888999999999999999864 68999999996433221    123688999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++ +|.+++....   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecc
Confidence            999999986 8888887543   2478899999999999999999999   99999999999999999999999994

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=3.6e-24  Score=204.05  Aligned_cols=144  Identities=28%  Similarity=0.413  Sum_probs=122.2

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhc--CCCCCccceeeeeecC----
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTV----  316 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----  316 (399)
                      ....++|...+.||+|+||.||+|+.. ++.||||++...    ....+..|.+++..  ++||||+++++++...    
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            344567899999999999999999875 889999998532    22345556665554  4899999999999877    


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC-----CCCceecCCCCCceeeCCCCcee
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-----DPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      ...++||||+++|+|.++++..     .+++..+..++.|++.||+|||+.+     .++|+||||||+|||++.++.+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            6789999999999999999764     3889999999999999999999762     44899999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       183 l~Dfg  187 (337)
T 3mdy_A          183 IADLG  187 (337)
T ss_dssp             ECCCT
T ss_pred             EEeCC
Confidence            99995

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.91  E-value=5.5e-24  Score=198.95  Aligned_cols=144  Identities=23%  Similarity=0.347  Sum_probs=124.5

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      .+....+||+|+||.||+|+. .+++.||||.++... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            455567999999999999985 568899999986542 233457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-CCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-~~~~~i~df~  396 (399)
                      ++++|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+||+
T Consensus       102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A          102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecc
Confidence            99999999986532 22467888999999999999999999   9999999999999998 8999999994

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.91  E-value=3.1e-24  Score=207.64  Aligned_cols=147  Identities=23%  Similarity=0.311  Sum_probs=129.1

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-------cHHHHHHHHHHHhcC-CCCCccceeeee
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-------GELQFQTEVKIISMA-VHRNLLRLYGFC  313 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-------~~~~f~~E~~~l~~l-~H~niv~l~g~~  313 (399)
                      ....++|...+.||+|+||.||+|+.. +|+.||||+++......       ....+.+|+.++..+ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            344567888899999999999999975 79999999986543211       123588999999998 799999999999


Q ss_pred             ecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeec
Q 015852          314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  393 (399)
Q Consensus       314 ~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~  393 (399)
                      ......++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999998643    488999999999999999999999   99999999999999999999999


Q ss_pred             ccc
Q 015852          394 TIL  396 (399)
Q Consensus       394 df~  396 (399)
                      ||+
T Consensus       243 DfG  245 (365)
T 2y7j_A          243 DFG  245 (365)
T ss_dssp             CCT
T ss_pred             ecC
Confidence            995

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.91  E-value=7.9e-25  Score=204.71  Aligned_cols=142  Identities=25%  Similarity=0.353  Sum_probs=121.1

Q ss_pred             cCCCCCc-eeeccCCceEEEEEe---CCCCEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKN-ILGRGGFGKVYKGRL---ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~-~lG~G~fg~Vy~~~~---~~~~~vAvK~l~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|...+ .||+|+||.||+|..   .+++.||||+++....... ...+.+|+.+++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4455556 899999999999954   2467899999975433222 45799999999999999999999998 5567899


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        95 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             EEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence            999999999999998643    488999999999999999999999   99999999999999999999999994

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.91  E-value=1.5e-24  Score=206.69  Aligned_cols=144  Identities=22%  Similarity=0.350  Sum_probs=122.0

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ..++|...+.||+|+||.||+|+. .+++.||||+++...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            345688889999999999999985 478899999996543322 234688999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC-----CCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-----EDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld-----~~~~~~i~df~  396 (399)
                      |||++ |+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++     +++.+||+||+
T Consensus       112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99998 59999997653    388999999999999999999999   999999999999994     45559999995

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.91  E-value=1.8e-24  Score=206.26  Aligned_cols=143  Identities=25%  Similarity=0.422  Sum_probs=125.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||.||+|+.. +++.||||++....... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            45677789999999999999865 58999999985543322 23458899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++++|..++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  169 (331)
T 4aaa_A          105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  169 (331)
T ss_dssp             CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence            999999988875432    488999999999999999999999   99999999999999999999999994

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.91  E-value=2.7e-24  Score=215.72  Aligned_cols=143  Identities=27%  Similarity=0.438  Sum_probs=127.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      +.|...+.||+|+||.||+++.. +++.||||++.....  ......+.+|+.+++.++||||+++++++......++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            45777899999999999999865 789999999854432  234557999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee---CCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl---d~~~~~~i~df~  396 (399)
                      ||+.+|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+   +.++.+||+||+
T Consensus       106 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             CCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            9999999999997643    488999999999999999999999   99999999999999   567899999995

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.91  E-value=1.9e-24  Score=202.06  Aligned_cols=143  Identities=30%  Similarity=0.459  Sum_probs=122.2

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ..++|...+.||+|+||.||+|+...  .||||+++...... ....|.+|+.+++.++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            34568888999999999999998643  59999986543322 234699999999999999999999965 455689999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        99 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             EecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence            9999999999997543   2488999999999999999999999   99999999999999999999999994

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=2.6e-24  Score=209.75  Aligned_cols=143  Identities=23%  Similarity=0.387  Sum_probs=116.3

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCC-CCCccceeeeeecCC--ce
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT--EK  319 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~  319 (399)
                      ..++|...+.||+|+||.||+|.. .+++.||||++...... .....+.+|+.++..+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            346788889999999999999985 47899999998543222 23346889999999997 999999999997544  68


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||++ |+|..+++..     .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  154 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFG  154 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCc
Confidence            99999998 6899998763     378999999999999999999999   99999999999999999999999994

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.91  E-value=3.8e-24  Score=200.57  Aligned_cols=144  Identities=22%  Similarity=0.443  Sum_probs=124.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||.||+|+.. +++.||||.++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            46777899999999999999865 6899999998654322 223578899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+. |+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        83 ~~~-~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  148 (299)
T 2r3i_A           83 FLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  148 (299)
T ss_dssp             CCS-EEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTT
T ss_pred             ccc-CCHHHHHHhhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcch
Confidence            998 699999976532  3478899999999999999999999   99999999999999999999999995

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.91  E-value=2.6e-24  Score=204.68  Aligned_cols=143  Identities=26%  Similarity=0.447  Sum_probs=124.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-----CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC--ce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~  319 (399)
                      ++|...+.||+|+||.||++++     .+++.||||+++.. .......+.+|+.+++.++||||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            4567778999999999999984     36889999998653 2233457999999999999999999999987654  67


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence            899999999999999987532   488999999999999999999998   99999999999999999999999994

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.91  E-value=5.4e-24  Score=203.37  Aligned_cols=141  Identities=28%  Similarity=0.403  Sum_probs=124.5

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhc--CCCCCccceeeeeecCC---
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTVT---  317 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~---  317 (399)
                      ....++|...+.||+|+||.||+|+. +++.||||.++..    ....+.+|++++..  ++||||+++++++....   
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            44456789999999999999999988 5889999998532    23467888888876  78999999999998776   


Q ss_pred             -ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHh--------cCCCCCceecCCCCCceeeCCCC
Q 015852          318 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--------EHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       318 -~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlK~~NILld~~~  388 (399)
                       ..++||||+++|+|.+++...     .+++..+..++.|++.||+|||        +.   +|+||||||+|||++.++
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence             789999999999999999763     3789999999999999999999        66   999999999999999999


Q ss_pred             ceeecccc
Q 015852          389 DQSSKTIL  396 (399)
Q Consensus       389 ~~~i~df~  396 (399)
                      .+||+||+
T Consensus       185 ~~kL~Dfg  192 (342)
T 1b6c_B          185 TCCIADLG  192 (342)
T ss_dssp             CEEECCCT
T ss_pred             CEEEEECC
Confidence            99999994

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.91  E-value=2.7e-24  Score=216.38  Aligned_cols=143  Identities=24%  Similarity=0.385  Sum_probs=121.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      +.|...+.||+|+||.||+|+.. ++..||+|+++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34777799999999999999865 688999999865432 2334579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC---Cceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~---~~~~i~df~  396 (399)
                      |+++|+|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   +.+||+||+
T Consensus       117 ~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          117 CYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            999999999887653    388999999999999999999999   99999999999999874   459999995

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=1.7e-24  Score=210.69  Aligned_cols=145  Identities=21%  Similarity=0.294  Sum_probs=119.0

Q ss_pred             HHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC-----
Q 015852          243 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----  316 (399)
Q Consensus       243 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----  316 (399)
                      ....++|...+.||+|+||.||+|+. .+++.||||++.....     ...+|+.+++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34456788889999999999999985 5789999999854322     234799999999999999999998543     


Q ss_pred             ---------------------------------CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHH
Q 015852          317 ---------------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY  363 (399)
Q Consensus       317 ---------------------------------~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~y  363 (399)
                                                       ...++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             23789999998 58888876532223458999999999999999999


Q ss_pred             HhcCCCCCceecCCCCCceeeC-CCCceeecccc
Q 015852          364 LHEHCDPKIIHRDVKAANILLD-EDADQSSKTIL  396 (399)
Q Consensus       364 LH~~~~~~ivHrDlK~~NILld-~~~~~~i~df~  396 (399)
                      ||+.   +|+||||||+|||++ .++.+||+||+
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg  187 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFG  187 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCT
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECC
Confidence            9998   999999999999998 68899999994

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.9e-24  Score=209.37  Aligned_cols=141  Identities=23%  Similarity=0.350  Sum_probs=116.8

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC------c
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------E  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~  318 (399)
                      ++|...+.||+|+||.||+|.. .+++.||||++...... .....+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4577779999999999999986 47899999998543222 22346899999999999999999999987653      4


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||+ +++|.+++...     .+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence            59999999 88999999763     378999999999999999999999   99999999999999999999999994

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.91  E-value=4.3e-24  Score=199.48  Aligned_cols=141  Identities=25%  Similarity=0.380  Sum_probs=121.8

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeec----CCceEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLV  322 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv  322 (399)
                      |...+.||+|+||.||+|.. .++..||+|.+...... .....+.+|+.+++.++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            45567899999999999986 46889999998654332 234468999999999999999999998865    3457899


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceeeC-CCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLD-EDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlK~~NILld-~~~~~~i~df~  396 (399)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +  |+||||||+|||++ +++.+||+||+
T Consensus       108 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            99999999999998643    378999999999999999999998   6  99999999999998 78999999995

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.91  E-value=2.1e-24  Score=202.19  Aligned_cols=143  Identities=24%  Similarity=0.394  Sum_probs=124.2

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec---------
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT---------  315 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~---------  315 (399)
                      .++|...+.||+|+||.||+|+. .+++.||||.++..  ......+.+|+.+++.++||||+++++++..         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            34677889999999999999986 47899999998542  2234468999999999999999999998764         


Q ss_pred             ----CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          316 ----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       316 ----~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                          ....++||||+++|+|.+++....   ..+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                346789999999999999998643   2467889999999999999999999   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       157 l~dfg  161 (303)
T 1zy4_A          157 IGDFG  161 (303)
T ss_dssp             ECCCC
T ss_pred             EeeCc
Confidence            99995

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.91  E-value=5e-25  Score=214.04  Aligned_cols=146  Identities=16%  Similarity=0.183  Sum_probs=117.6

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc--cccHHHHHHHH---HHHhcCCCCCcccee-------eee
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEV---KIISMAVHRNLLRLY-------GFC  313 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~~~~~~f~~E~---~~l~~l~H~niv~l~-------g~~  313 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||+++....  ......|.+|+   ..++.++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            4577789999999999999996 5689999999964322  22345789999   556667899999998       555


Q ss_pred             ecCC-----------------ceEEEEecCCCCChhhHhhhcCCC---CCCCChHHHHHHHHHHHHHHHHHhcCCCCCce
Q 015852          314 TTVT-----------------EKLLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKII  373 (399)
Q Consensus       314 ~~~~-----------------~~~lv~e~~~~gsL~~~L~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  373 (399)
                      ...+                 ..+++|||+ +|+|.+++......   ...++|..+..|+.|++.||+|||++   +|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            4443                 278999999 68999999864210   11234688889999999999999999   999


Q ss_pred             ecCCCCCceeeCCCCceeecccc
Q 015852          374 HRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       374 HrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||||+|||++.++.+||+||+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG  251 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFE  251 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGG
T ss_pred             cCCCCHHHEEEcCCCCEEEEech
Confidence            99999999999999999999994

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.91  E-value=1.7e-24  Score=201.08  Aligned_cols=140  Identities=25%  Similarity=0.439  Sum_probs=123.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec----------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----------  315 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----------  315 (399)
                      .+|...+.||+|+||.||+|+.. +++.||+|.++...     ..+.+|+++++.++||||+++++++..          
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            45778899999999999999875 78999999986432     357789999999999999999998854          


Q ss_pred             ------CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc
Q 015852          316 ------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  389 (399)
Q Consensus       316 ------~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~  389 (399)
                            ....++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence                  3447899999999999999976432  2588999999999999999999999   9999999999999999999


Q ss_pred             eeecccc
Q 015852          390 QSSKTIL  396 (399)
Q Consensus       390 ~~i~df~  396 (399)
                      +||+||+
T Consensus       161 ~kl~Dfg  167 (284)
T 2a19_B          161 VKIGDFG  167 (284)
T ss_dssp             EEECCCT
T ss_pred             EEECcch
Confidence            9999995

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.91  E-value=4.7e-24  Score=201.06  Aligned_cols=146  Identities=29%  Similarity=0.440  Sum_probs=121.5

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc----ccHHHHHHHHHHHhcCC---CCCccceeeeeecC
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAV---HRNLLRLYGFCTTV  316 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~  316 (399)
                      ..++|...+.||+|+||+||+|+. .+++.||||+++.....    .....+.+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            456889999999999999999985 57899999998643211    12235777887776664   99999999999875


Q ss_pred             C-----ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          317 T-----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       317 ~-----~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      .     ..+++|||+. |+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            5     4789999997 699999986532  2489999999999999999999999   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       161 l~Dfg  165 (308)
T 3g33_A          161 LADFG  165 (308)
T ss_dssp             ECSCS
T ss_pred             EeeCc
Confidence            99994

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.91  E-value=2.2e-24  Score=206.79  Aligned_cols=141  Identities=22%  Similarity=0.282  Sum_probs=123.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCC--CCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~  323 (399)
                      +.|...+.||+|+||.||++...+++.||||++....... ....+.+|+.++..++|  +||+++++++......++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            3577789999999999999998889999999986543222 23468999999999986  99999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      | +.+|+|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+||+
T Consensus        89 e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             C-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             e-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecc
Confidence            9 56889999998753    488999999999999999999999   999999999999997 6789999994

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.91  E-value=2.3e-24  Score=201.05  Aligned_cols=148  Identities=22%  Similarity=0.262  Sum_probs=121.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHH-HHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~-f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+++. .+++.||+|+++.........+ +.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            45677889999999999999986 5789999999965533333333 455555688899999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||++ |+|.+++.........+++..+..++.|++.||+|||+.+  +|+||||||+|||++.++.+||+||+
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence            9998 5888887653223345899999999999999999999842  79999999999999999999999994

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.91  E-value=3.2e-24  Score=203.60  Aligned_cols=143  Identities=24%  Similarity=0.347  Sum_probs=120.8

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-------cccHHHHHHHHHHHhcCCCCCccceeeeeecCC
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-------SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  317 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  317 (399)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.....       ......+.+|+++++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            356788899999999999999864 688999999864321       112235889999999999999999999987654


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc---eeecc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKT  394 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~---~~i~d  394 (399)
                       .++||||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.+++   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             899999999999999987542    488999999999999999999999   9999999999999998765   99999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       161 fg  162 (322)
T 2ycf_A          161 FG  162 (322)
T ss_dssp             CT
T ss_pred             Cc
Confidence            94

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.91  E-value=3.8e-24  Score=200.47  Aligned_cols=144  Identities=28%  Similarity=0.313  Sum_probs=126.9

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--------ccHHHHHHHHHHHhcCC-CCCccceeeeeec
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--------GGELQFQTEVKIISMAV-HRNLLRLYGFCTT  315 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--------~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~  315 (399)
                      .++|...+.||+|+||.||+|... +++.||||.++.....        .....+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            356788899999999999999874 6889999998643211        11235889999999996 9999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ....++||||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999998653    488999999999999999999999   9999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       169 g  169 (298)
T 1phk_A          169 G  169 (298)
T ss_dssp             T
T ss_pred             c
Confidence            4

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.91  E-value=3.6e-24  Score=205.62  Aligned_cols=141  Identities=22%  Similarity=0.363  Sum_probs=124.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC-----CceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~  320 (399)
                      ++|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+.+++.++||||+++++++...     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            56778899999999999999865 68899999996543333345788999999999999999999988654     5789


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+. |+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        91 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             EEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence            9999998 6999998763     488999999999999999999999   99999999999999999999999994

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.91  E-value=2.5e-24  Score=214.80  Aligned_cols=141  Identities=22%  Similarity=0.286  Sum_probs=120.4

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC------
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  317 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------  317 (399)
                      .++|...+.||+|+||+||+|.. .+++.||||++...... .....+.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            35688889999999999999985 46889999999654222 23446889999999999999999999996543      


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ..++||||++++ |.+.+..      .+++.++..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence            469999999864 6666643      278999999999999999999999   99999999999999999999999994

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.91  E-value=4.3e-24  Score=201.01  Aligned_cols=142  Identities=25%  Similarity=0.395  Sum_probs=124.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||.||+++.. +++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            45777899999999999999864 789999999965322 2234689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee---CCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl---d~~~~~~i~df~  396 (399)
                      +++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++   ++++.++|+||+
T Consensus        88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg  154 (304)
T 2jam_A           88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFG  154 (304)
T ss_dssp             CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred             CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCC
Confidence            99999999997653    478999999999999999999999   99999999999999   788999999995

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.91  E-value=2.8e-24  Score=215.73  Aligned_cols=143  Identities=24%  Similarity=0.411  Sum_probs=126.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||+||+++.. +++.||||++..... ......+.+|+.+++.++||||+++++++......++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            45777899999999999999864 789999999864332 2345579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC---CCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld---~~~~~~i~df~  396 (399)
                      |+++|+|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++   .++.+||+||+
T Consensus       102 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A          102 LYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            999999999987653    488999999999999999999999   999999999999995   45679999995

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.91  E-value=2.9e-24  Score=210.36  Aligned_cols=138  Identities=22%  Similarity=0.294  Sum_probs=117.0

Q ss_pred             CCCCC-ceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHH-hcCCCCCccceeeeeec----CCceE
Q 015852          248 GFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTT----VTEKL  320 (399)
Q Consensus       248 ~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~  320 (399)
                      +|... ++||+|+||+||++... +++.||||+++..      ..+.+|+.++ +..+||||+++++++..    ....+
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            44443 68999999999999864 6889999998532      3577888876 55689999999998865    45689


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC---CCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~---~~~~~i~df~  396 (399)
                      +||||+++|+|.+++.....  ..+++..+..|+.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||+
T Consensus       136 lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            99999999999999986432  3489999999999999999999998   9999999999999998   7889999995

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.91  E-value=4.6e-24  Score=206.23  Aligned_cols=141  Identities=21%  Similarity=0.302  Sum_probs=123.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC-----CceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~  320 (399)
                      ++|...+.||+|+||.||+|+.. +++.||||++...........+.+|+.++..++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            46888899999999999999864 68899999996543333345789999999999999999999998764     3679


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+. |+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       107 iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             EEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence            9999998 5999998753     388999999999999999999999   99999999999999999999999994

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.91  E-value=1e-23  Score=198.22  Aligned_cols=145  Identities=23%  Similarity=0.330  Sum_probs=122.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccc---cccHHHHHHHHHHHhcCCCCCccceeeeee--cCCce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCT--TVTEK  319 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~  319 (399)
                      .++|...+.||+|+||.||++.. .+++.||+|.++....   ......+.+|+.+++.++||||+++++++.  .....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            35788999999999999999986 4688999999965421   233457999999999999999999999984  44578


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||++++ |.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccc
Confidence            9999999977 7777765432  3588999999999999999999999   99999999999999999999999994

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.91  E-value=4.8e-24  Score=204.84  Aligned_cols=143  Identities=29%  Similarity=0.467  Sum_probs=123.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC--------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  316 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------  316 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||++...... .....+.+|+.+++.++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            4677789999999999999987 57899999998654332 2244788999999999999999999998773        


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +..++||||+++ +|.+.+....   ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            457899999985 7877776543   2489999999999999999999999   99999999999999999999999995

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.90  E-value=2.4e-24  Score=206.55  Aligned_cols=139  Identities=19%  Similarity=0.296  Sum_probs=120.2

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+++.. +++.||||.++....     .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            456888899999999999999865 688999999864321     245678877776 7999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-C---ceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-A---DQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-~---~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+.++ +   .+||+||+
T Consensus        96 E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             CCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             eCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            9999999999997643    489999999999999999999999   99999999999998543 3   48999994

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.90  E-value=1.7e-24  Score=209.27  Aligned_cols=144  Identities=16%  Similarity=0.211  Sum_probs=118.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCC------CCEEEEEEcccccccc----------cHHHHHHHHHHHhcCCCCCccce
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSG----------GELQFQTEVKIISMAVHRNLLRL  309 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vAvK~l~~~~~~~----------~~~~f~~E~~~l~~l~H~niv~l  309 (399)
                      .++|...+.||+|+||.||+|....      ++.||||++.......          ....+.+|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3467788999999999999998754      4789999985432110          01134556677888999999999


Q ss_pred             eeeeecC----CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC
Q 015852          310 YGFCTTV----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  385 (399)
Q Consensus       310 ~g~~~~~----~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld  385 (399)
                      ++++...    ...++||||+ +|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998764    3479999999 999999998643   2489999999999999999999999   999999999999999


Q ss_pred             --CCCceeecccc
Q 015852          386 --EDADQSSKTIL  396 (399)
Q Consensus       386 --~~~~~~i~df~  396 (399)
                        .++.+||+||+
T Consensus       187 ~~~~~~~kl~DFG  199 (364)
T 3op5_A          187 YKNPDQVYLVDYG  199 (364)
T ss_dssp             SSCTTCEEECCCT
T ss_pred             cCCCCeEEEEECC
Confidence              88999999994

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.90  E-value=7.7e-24  Score=199.95  Aligned_cols=143  Identities=29%  Similarity=0.450  Sum_probs=122.6

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ..+.|...+.||+|+||.||+|... +++.||+|.+...   .....+.+|+.++..++||||+++++++...+..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3456888899999999999999865 5899999998643   23357899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....   ..+++.....++.|++.||.|||+.   +|+||||||+||+++.++.+||+||+
T Consensus       104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecc
Confidence            9999999999997432   2488999999999999999999999   99999999999999999999999994

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.90  E-value=4.6e-24  Score=208.28  Aligned_cols=141  Identities=22%  Similarity=0.275  Sum_probs=123.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCC--CCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ..|...+.||+|+||.||++...+++.||||++...... .....+.+|+.++..++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            347788999999999999999878999999998654322 22346999999999986  599999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      | +.+++|.+++....    .+++.++..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+||+
T Consensus       136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG  199 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG  199 (390)
T ss_dssp             E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred             e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecC
Confidence            9 67889999998653    478889999999999999999998   999999999999996 5899999994

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.90  E-value=4.4e-24  Score=203.54  Aligned_cols=141  Identities=33%  Similarity=0.514  Sum_probs=116.3

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHH--HhcCCCCCccceeeeeec-----CCc
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI--ISMAVHRNLLRLYGFCTT-----VTE  318 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~-----~~~  318 (399)
                      .++|...+.||+|+||.||+|+. +++.||||+++..    ....+..|.++  +..++||||+++++.+..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            35677889999999999999987 6789999998533    22344445544  456899999999985532     235


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC------CCCceecCCCCCceeeCCCCceee
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC------DPKIIHRDVKAANILLDEDADQSS  392 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDlK~~NILld~~~~~~i  392 (399)
                      .++||||+++|+|.+++....     .++..+..++.|+++||+|||+.+      .++|+||||||+|||++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            689999999999999997642     588999999999999999999873      338999999999999999999999


Q ss_pred             cccc
Q 015852          393 KTIL  396 (399)
Q Consensus       393 ~df~  396 (399)
                      +||+
T Consensus       162 ~DFG  165 (336)
T 3g2f_A          162 SDFG  165 (336)
T ss_dssp             CCCT
T ss_pred             eecc
Confidence            9994

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.90  E-value=2.3e-24  Score=223.65  Aligned_cols=146  Identities=23%  Similarity=0.311  Sum_probs=126.2

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      ...++|...+.||+|+||.||+|...    .+..||||.++..........|.+|+.+++.++||||+++++++. .+..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            33456777899999999999999864    245799999865443333457999999999999999999999985 4568


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.++++...   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence            99999999999999998643   2488999999999999999999999   99999999999999999999999994

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.90  E-value=2.3e-24  Score=200.07  Aligned_cols=142  Identities=28%  Similarity=0.438  Sum_probs=122.7

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC-CceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-TEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e  324 (399)
                      .++|...+.||+|+||.||+++.. ++.||||.++..   .....+.+|+.+++.++||||+++++++... +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            356777899999999999999874 789999998643   2345799999999999999999999987654 46899999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++.....  ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        96 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             cCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecc
Confidence            9999999999976421  1268889999999999999999999   99999999999999999999999994

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.90  E-value=1.5e-23  Score=196.22  Aligned_cols=140  Identities=18%  Similarity=0.222  Sum_probs=123.8

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||++....   ....+.+|+..+..+ +|+|++++++++......++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            4677889999999999999985 578999999985432   223588899999998 79999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc-----eeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-----QSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~-----~~i~df~  396 (399)
                      |+ +++|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.     +||+||+
T Consensus        87 ~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             ec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            99 9999999986432   489999999999999999999998   9999999999999988876     9999994

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=9.4e-24  Score=200.78  Aligned_cols=136  Identities=23%  Similarity=0.307  Sum_probs=121.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeec--CCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT--VTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv  322 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||+++.    .....+.+|+.+++.++ ||||+++++++..  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            4577789999999999999985 5789999999863    23457999999999997 9999999999987  5668999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      |||+++++|.+++..       +++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+||+
T Consensus       112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence            999999999999853       78889999999999999999999   999999999999999777 89999994

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.90  E-value=2.3e-24  Score=204.70  Aligned_cols=148  Identities=31%  Similarity=0.473  Sum_probs=128.2

Q ss_pred             HHHHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeec----
Q 015852          242 LQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT----  315 (399)
Q Consensus       242 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----  315 (399)
                      +....++|...+.||+|+||.||+|+. .+++.||||++....  .....+.+|+.++..+ +||||+++++++..    
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            334556788889999999999999986 478999999985432  2345789999999988 79999999999976    


Q ss_pred             --CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeec
Q 015852          316 --VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  393 (399)
Q Consensus       316 --~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~  393 (399)
                        .+..++||||+++|+|.+++.....  ..+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence              4578999999999999999986422  2478899999999999999999999   99999999999999999999999


Q ss_pred             ccc
Q 015852          394 TIL  396 (399)
Q Consensus       394 df~  396 (399)
                      ||+
T Consensus       172 Dfg  174 (326)
T 2x7f_A          172 DFG  174 (326)
T ss_dssp             CCT
T ss_pred             eCc
Confidence            995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.90  E-value=3e-24  Score=224.24  Aligned_cols=140  Identities=21%  Similarity=0.337  Sum_probs=120.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC--CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCc-----e
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----K  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~  319 (399)
                      ++|...+.||+|+||.||+|+..  +++.||||++...........|.+|+.++..++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            56778899999999999999864  6889999998654333334568999999999999999999999987665     6


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++++|.+++..      .++|.++..++.|+++||+|||++   +|+||||||+|||++++ .+||+||+
T Consensus       160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence            999999999999987753      489999999999999999999999   99999999999999986 89999995

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.90  E-value=9.9e-24  Score=200.86  Aligned_cols=148  Identities=22%  Similarity=0.274  Sum_probs=126.7

Q ss_pred             HHhcCCCCC-ceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCC-CCCccceeeeeecCCce
Q 015852          244 VATDGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       244 ~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~  319 (399)
                      ...+.|... +.||+|+||.||+|+.. +++.||+|+++..... .....+.+|+.++..+. ||||+++++++...+..
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            334445555 78999999999999865 6899999998654433 23457999999999885 69999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC---CCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~---~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||+
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             EEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            99999999999999986532  23589999999999999999999999   9999999999999998   7899999994

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.90  E-value=1.9e-23  Score=194.94  Aligned_cols=144  Identities=24%  Similarity=0.396  Sum_probs=127.4

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            456888899999999999999875 789999999865433 234557999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC---ceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~---~~~i~df~  396 (399)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   .+||+||+
T Consensus       101 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             EccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence            9999999999987653    388999999999999999999999   999999999999997654   69999995

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.90  E-value=1.2e-23  Score=197.53  Aligned_cols=139  Identities=23%  Similarity=0.303  Sum_probs=120.0

Q ss_pred             cCCCCC-ceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHH-hcCCCCCccceeeeeec----CCce
Q 015852          247 DGFSNK-NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTT----VTEK  319 (399)
Q Consensus       247 ~~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~  319 (399)
                      ++|... ++||+|+||.||++.. .+++.||+|+++.      ...+.+|+.++ +..+||||+++++++..    ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            345444 7899999999999986 5789999999853      23577888887 66799999999999876    5678


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC---CCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~---~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            999999999999999987532  2589999999999999999999999   9999999999999998   7889999994

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.90  E-value=1.1e-23  Score=204.16  Aligned_cols=140  Identities=22%  Similarity=0.293  Sum_probs=121.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC------c
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------E  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~  318 (399)
                      ++|...+.||+|+||.||+|... +++.||||++...... .....+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            56778899999999999999854 6889999998653322 22346889999999999999999999997654      6


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||++ |+|.+.+..      .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       105 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             EEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence            799999998 578888753      378999999999999999999999   99999999999999999999999994

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.90  E-value=6.2e-24  Score=205.70  Aligned_cols=141  Identities=25%  Similarity=0.354  Sum_probs=113.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC------Cc
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TE  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~  318 (399)
                      ++|...+.||+|+||.||+|.. .+++.||||++...... .....+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            5677889999999999999985 57889999998653222 2344688999999999999999999998654      55


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++++||+ +++|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       109 ~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             EEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence            79999999 68999988642     489999999999999999999999   99999999999999999999999994

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.90  E-value=2.5e-24  Score=203.66  Aligned_cols=148  Identities=24%  Similarity=0.444  Sum_probs=126.2

Q ss_pred             HHHHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCc
Q 015852          240 RELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       240 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  318 (399)
                      +++....++|...+.||+|+||.||+|+...  .+|+|.++..... .....|.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            3344456778889999999999999998754  4999998654322 223468899999999999999999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++|||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+||+
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             eEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence            999999999999999997643   2488999999999999999999999   999999999999998 6899999995

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.90  E-value=7.4e-24  Score=197.67  Aligned_cols=143  Identities=34%  Similarity=0.438  Sum_probs=115.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC--CCC--EEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA--DGK--LVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|...+.||+|+||.||+|++.  +++  .||||.++.....  .....+.+|+.+++.++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            45777899999999999999853  333  6899998654322  23457999999999999999999999988755 88


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|+||+++|+|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||+
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence            99999999999999986432   478999999999999999999999   99999999999999999999999994

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.90  E-value=1.4e-23  Score=198.15  Aligned_cols=140  Identities=26%  Similarity=0.377  Sum_probs=115.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeee-----------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT-----------  314 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-----------  314 (399)
                      ++|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            45777899999999999999875 58899999985432 223457899999999999999999998874           


Q ss_pred             ---cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC-CCCce
Q 015852          315 ---TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQ  390 (399)
Q Consensus       315 ---~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld-~~~~~  390 (399)
                         .....++||||++ |+|.+++...     .+++.....++.|++.||+|||+.   +|+||||||+|||++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               3457799999998 6999998642     478999999999999999999999   999999999999997 56799


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      ||+||+
T Consensus       161 kl~Dfg  166 (320)
T 2i6l_A          161 KIGDFG  166 (320)
T ss_dssp             EECCCT
T ss_pred             EEccCc
Confidence            999994

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.89  E-value=1.9e-23  Score=202.50  Aligned_cols=140  Identities=21%  Similarity=0.354  Sum_probs=121.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCce-----
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK-----  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-----  319 (399)
                      ++|...+.||+|+||.||+|... +++.||||+++...... ....+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            45777799999999999999864 68999999996543222 234689999999999999999999999877654     


Q ss_pred             -EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 -LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 -~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                       ++||||+. |+|.+++..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||+
T Consensus       122 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence             99999998 688888743      378999999999999999999999   99999999999999999999999994

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.89  E-value=1.7e-23  Score=198.51  Aligned_cols=145  Identities=28%  Similarity=0.488  Sum_probs=122.2

Q ss_pred             hcCCCCCceeeccCCceEEEEEe--CCCCEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeeee-----
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL--ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCT-----  314 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l---~H~niv~l~g~~~-----  314 (399)
                      .++|...+.||+|+||.||+|+.  .+++.||+|+++...... ....+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            45788889999999999999987  467899999986543222 223567787777655   8999999999987     


Q ss_pred             cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecc
Q 015852          315 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  394 (399)
Q Consensus       315 ~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~d  394 (399)
                      .....++||||+. |+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence            4567889999998 699999986532  2488999999999999999999999   999999999999999999999999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       164 fg  165 (326)
T 1blx_A          164 FG  165 (326)
T ss_dssp             CC
T ss_pred             Cc
Confidence            94

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.89  E-value=7.8e-24  Score=205.13  Aligned_cols=141  Identities=11%  Similarity=0.016  Sum_probs=104.7

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc--ccHHHHHHHH---HHHhcCCCCCcccee-------eeee
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEV---KIISMAVHRNLLRLY-------GFCT  314 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~f~~E~---~~l~~l~H~niv~l~-------g~~~  314 (399)
                      .|...+.||+|+||.||+|+.. +++.||||+++.....  .....+.+|+   ..++. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            3667799999999999999864 7899999999764322  2233577784   45555 799988754       3333


Q ss_pred             cC-----------------CceEEEEecCCCCChhhHhhhcCCCCCCCChHHH------HHHHHHHHHHHHHHhcCCCCC
Q 015852          315 TV-----------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR------KKIALGSARGLSYLHEHCDPK  371 (399)
Q Consensus       315 ~~-----------------~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~  371 (399)
                      ..                 ...++||||++ |+|.+++.....   .+.+..+      ..++.|+++||+|||++   +
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            22                 23799999999 899999986422   2455566      78889999999999999   9


Q ss_pred             ceecCCCCCceeeCCCCceeecccc
Q 015852          372 IIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       372 ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+||||||+|||++.++.+||+||+
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG  239 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVS  239 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGG
T ss_pred             CccCcCCHHHEEECCCCCEEEEecc
Confidence            9999999999999999999999994

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.89  E-value=1.4e-23  Score=206.77  Aligned_cols=140  Identities=29%  Similarity=0.427  Sum_probs=114.0

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC----C--ceE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV----T--EKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~  320 (399)
                      .|...+.||+|+||.||+|+.. +++.||||++....     ..+.+|+++++.++||||+++++++...    +  ..+
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            3566789999999999999975 68999999985432     1234799999999999999999988542    1  356


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-Cceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~~i~df~  396 (399)
                      +||||+++ ++.+.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++.+ +.+||+||+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            89999985 66666653212223589999999999999999999998   99999999999999966 568999994

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.89  E-value=2.2e-23  Score=200.43  Aligned_cols=140  Identities=21%  Similarity=0.349  Sum_probs=121.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCc------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE------  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------  318 (399)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....... ....+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            45777899999999999999864 68999999986543222 23468999999999999999999999987654      


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||+. |+|.+++..      .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus       104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence            499999998 688887743      378999999999999999999999   99999999999999999999999994

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.89  E-value=2.9e-23  Score=199.78  Aligned_cols=151  Identities=21%  Similarity=0.275  Sum_probs=113.0

Q ss_pred             HHHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCc
Q 015852          240 RELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  318 (399)
Q Consensus       240 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~  318 (399)
                      .+.....++|...+.||+|+||.||+|+.. +++.||||++....  .....+.+|+..+..++||||+++++++.....
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            344566788999999999999999999874 68999999885432  223357788888889999999999999865433


Q ss_pred             -------eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHh--cCCCCCceecCCCCCceeeCC-CC
Q 015852          319 -------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--EHCDPKIIHRDVKAANILLDE-DA  388 (399)
Q Consensus       319 -------~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDlK~~NILld~-~~  388 (399)
                             .++||||+++ +|...+.........+++.....++.|++.||+|||  +.   +|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                   7899999986 555554432222335788999999999999999999  66   9999999999999997 89


Q ss_pred             ceeecccc
Q 015852          389 DQSSKTIL  396 (399)
Q Consensus       389 ~~~i~df~  396 (399)
                      .+||+||+
T Consensus       170 ~~kl~Dfg  177 (360)
T 3e3p_A          170 TLKLCDFG  177 (360)
T ss_dssp             EEEECCCT
T ss_pred             cEEEeeCC
Confidence            99999994

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.89  E-value=1.2e-23  Score=200.05  Aligned_cols=144  Identities=26%  Similarity=0.367  Sum_probs=121.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeee--------cC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCT--------TV  316 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~--------~~  316 (399)
                      .+|...+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++..+. ||||+++++++.        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            4577789999999999999986 478999999985432 223446899999999996 999999999984        23


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCceeeCCCCceeecc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKT  394 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlK~~NILld~~~~~~i~d  394 (399)
                      ...+++|||+. |+|.+++..... ...+++..+..++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            34789999996 799999875322 23589999999999999999999998   6  99999999999999999999999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       182 fg  183 (337)
T 3ll6_A          182 FG  183 (337)
T ss_dssp             CT
T ss_pred             Cc
Confidence            94

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.89  E-value=7e-24  Score=203.42  Aligned_cols=142  Identities=18%  Similarity=0.181  Sum_probs=116.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC----CCCEEEEEEcccccccc----------cHHHHHHHHHHHhcCCCCCccceeee
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSG----------GELQFQTEVKIISMAVHRNLLRLYGF  312 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~~----------~~~~f~~E~~~l~~l~H~niv~l~g~  312 (399)
                      ++|...+.||+|+||.||+|+..    ++..+|||.+.......          ....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            45777899999999999999875    56789999986432110          11247788899999999999999999


Q ss_pred             eec----CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC
Q 015852          313 CTT----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       313 ~~~----~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~  388 (399)
                      +..    ....++||||+ +++|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            987    67789999999 999999997653    489999999999999999999999   999999999999999888


Q ss_pred             --ceeecccc
Q 015852          389 --DQSSKTIL  396 (399)
Q Consensus       389 --~~~i~df~  396 (399)
                        .+||+||+
T Consensus       189 ~~~~kL~Dfg  198 (345)
T 2v62_A          189 PDQVYLADYG  198 (345)
T ss_dssp             TTSEEECCCT
T ss_pred             CCcEEEEeCC
Confidence              99999994

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.89  E-value=7.9e-24  Score=199.81  Aligned_cols=146  Identities=23%  Similarity=0.353  Sum_probs=118.5

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc-----cHHHHHHHHHHHhcC----CCCCccceeeee
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMA----VHRNLLRLYGFC  313 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-----~~~~f~~E~~~l~~l----~H~niv~l~g~~  313 (399)
                      ...++|...+.||+|+||.||+|+. .+++.||||+++......     ....+.+|+.++..+    +|+||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3456788899999999999999986 468899999996543211     122466788888887    899999999999


Q ss_pred             ecCCceEEEEec-CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC-CCCcee
Q 015852          314 TTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQS  391 (399)
Q Consensus       314 ~~~~~~~lv~e~-~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld-~~~~~~  391 (399)
                      ...+..++|+|| +.+++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++ +++.+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            998999999999 78999999998753    489999999999999999999999   999999999999999 889999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       181 l~dfg  185 (312)
T 2iwi_A          181 LIDFG  185 (312)
T ss_dssp             ECCCS
T ss_pred             EEEcc
Confidence            99994

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.89  E-value=7e-24  Score=203.94  Aligned_cols=138  Identities=20%  Similarity=0.232  Sum_probs=118.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeCC---------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccc---------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLAD---------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR---------  308 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~---------  308 (399)
                      ++|...+.||+|+||.||+|+...         ++.||+|.+...      ..+.+|+.+++.++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            467778999999999999998653         789999998543      35889999999999999988         


Q ss_pred             ------eeeeeec-CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCc
Q 015852          309 ------LYGFCTT-VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  381 (399)
Q Consensus       309 ------l~g~~~~-~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~N  381 (399)
                            +++++.. ....++||||+ +|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  5667665 67789999999 999999998642  12489999999999999999999999   99999999999


Q ss_pred             eeeCCCC--ceeecccc
Q 015852          382 ILLDEDA--DQSSKTIL  396 (399)
Q Consensus       382 ILld~~~--~~~i~df~  396 (399)
                      ||++.++  .+||+||+
T Consensus       190 Il~~~~~~~~~kl~Dfg  206 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYG  206 (352)
T ss_dssp             EEEETTEEEEEEECCGG
T ss_pred             EEEcCCCCceEEEecCc
Confidence            9999998  89999994

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.89  E-value=2.2e-23  Score=203.75  Aligned_cols=140  Identities=24%  Similarity=0.383  Sum_probs=114.0

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCc------eEE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE------KLL  321 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l  321 (399)
                      +|...++||+|+||.||+|+...+..+|+|++.....     ...+|+.+++.++||||+++++++.....      .++
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            4677799999999999999987777799998854321     12469999999999999999999865433      789


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC-CCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld-~~~~~~i~df~  396 (399)
                      ||||++++.+ ..+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++ .++.+||+||+
T Consensus       116 v~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          116 VLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            9999987544 33332111223588999999999999999999999   999999999999999 79999999994

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.89  E-value=1.6e-23  Score=213.67  Aligned_cols=132  Identities=15%  Similarity=0.132  Sum_probs=104.0

Q ss_pred             eeccCCceEEEEE-eCCCCEEEEEEccccccc---------ccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEE
Q 015852          255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTS---------GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       255 lG~G~fg~Vy~~~-~~~~~~vAvK~l~~~~~~---------~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .+.|++|.+++++ .-.|+.+|||.+......         ...++|.+|+++|+++ .|+||+++++++.+....||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666555543 335788999998644211         1223699999999999 6999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||++||+|.++|....    +++.   .+|+.||+.||+|+|++   +||||||||+|||+++++.+||+||+
T Consensus       322 Eyv~G~~L~d~i~~~~----~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG  384 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE----EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG  384 (569)
T ss_dssp             ECCCSEEHHHHHHTTC----CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCcHHHHHHhCC----CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence            9999999999998643    3544   35899999999999999   99999999999999999999999995

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.89  E-value=3.8e-23  Score=204.28  Aligned_cols=142  Identities=21%  Similarity=0.298  Sum_probs=121.6

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcC------CCCCccceeeeeecCCce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA------VHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~~  319 (399)
                      .+|...+.||+|+||.||+|+.. +++.||||+++...  .....+.+|+.++..+      +|+||+++++++......
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            45777899999999999999864 68899999996432  2234577788777665      678999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc--eeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~--~~i~df~  396 (399)
                      ++||||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+||+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999996 699999986532  3489999999999999999999999   9999999999999999987  9999995

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.89  E-value=3.1e-23  Score=203.28  Aligned_cols=138  Identities=23%  Similarity=0.338  Sum_probs=110.5

Q ss_pred             CceeeccCCceEEEEEeC---CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec--CCceEEEEecC
Q 015852          252 KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM  326 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~  326 (399)
                      .++||+|+||.||+|+..   +++.||||++....   ....+.+|+.+++.++||||+++++++..  ....++||||+
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~  102 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA  102 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence            468999999999999865   57889999996432   23468899999999999999999999954  66789999999


Q ss_pred             CCCChhhHhhhcC-----CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee----CCCCceeecccc
Q 015852          327 TNGSVASRLRERQ-----SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl----d~~~~~~i~df~  396 (399)
                      . |+|.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+||+
T Consensus       103 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A          103 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             S-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             C-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            7 58888776321     1122488999999999999999999999   99999999999999    778899999994

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.88  E-value=1e-22  Score=190.17  Aligned_cols=141  Identities=22%  Similarity=0.271  Sum_probs=118.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeee-ecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC-TTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+|+. .+++.||||++.....   ...+.+|+.++..++|++++..+..+ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            46788899999999999999986 5788999998654322   22588899999999998888777666 5567789999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee---CCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl---d~~~~~~i~df~  396 (399)
                      ||+ +|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||+   ++++.+||+||+
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             Ecc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            999 9999999975432   489999999999999999999999   99999999999999   788999999994

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.88  E-value=4.4e-23  Score=196.08  Aligned_cols=148  Identities=23%  Similarity=0.324  Sum_probs=122.0

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHH-HHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+|... +++.||||+++.........++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            356777899999999999999874 788999999965433333345666665 778899999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcC-CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQ-SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++ +|.+++.... .....+++.....++.|++.||.|||+.  .+|+||||||+|||++.++.+||+||+
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            99985 8887776311 1123588999999999999999999984  279999999999999999999999994

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.88  E-value=2.3e-23  Score=197.68  Aligned_cols=145  Identities=22%  Similarity=0.345  Sum_probs=125.5

Q ss_pred             HhcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc-----cHHHHHHHHHHHhcCC--CCCccceeeeeecC
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAV--HRNLLRLYGFCTTV  316 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-----~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~  316 (399)
                      ..++|...+.||+|+||.||+|+. .+++.||||.++......     ....+.+|+.+++.++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            345678889999999999999985 578899999996543221     2235778999999886  59999999999999


Q ss_pred             CceEEEEecCCC-CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC-CCCceeecc
Q 015852          317 TEKLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKT  394 (399)
Q Consensus       317 ~~~~lv~e~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld-~~~~~~i~d  394 (399)
                      +..++|+||+.+ ++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||++ +++.+||+|
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence            999999999986 89999998653    488999999999999999999999   999999999999999 789999999


Q ss_pred             cc
Q 015852          395 IL  396 (399)
Q Consensus       395 f~  396 (399)
                      |+
T Consensus       194 fg  195 (320)
T 3a99_A          194 FG  195 (320)
T ss_dssp             CT
T ss_pred             Cc
Confidence            95

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.88  E-value=1.3e-22  Score=189.67  Aligned_cols=140  Identities=22%  Similarity=0.273  Sum_probs=120.5

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeee-ecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC-TTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||++....   ....+.+|+.++..++|++++..+.++ ......++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            5678889999999999999986 578999999985432   223689999999999998877776666 45667799999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee---CCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl---d~~~~~~i~df~  396 (399)
                      |+ +++|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||+   ++++.+||+||+
T Consensus        86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             ec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            99 9999999975432   489999999999999999999999   99999999999999   588899999994

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.88  E-value=6.1e-23  Score=193.86  Aligned_cols=143  Identities=21%  Similarity=0.263  Sum_probs=124.7

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCC--CCCccceeeeeecCCceEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~l  321 (399)
                      ..++|...+.||+|+||.||++...+++.||||.+...... .....+.+|+.++..++  |+||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34567788999999999999999888999999998654322 22346899999999997  5999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +|| +.+++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||+++ +.+||+||+
T Consensus       106 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             EEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence            999 67889999998653    478999999999999999999999   9999999999999974 899999994

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.88  E-value=3.2e-23  Score=213.01  Aligned_cols=146  Identities=25%  Similarity=0.355  Sum_probs=125.0

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec------CCce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT------VTEK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~  319 (399)
                      ++|...+.||+|+||.||+|.. .+++.||||+++..........+.+|+++++.++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6789999999999999999986 46889999998765444445579999999999999999999998765      5677


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc---eeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~---~~i~df~  396 (399)
                      ++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.   +||+||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            999999999999999986432 23588899999999999999999998   9999999999999998775   8999994

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.88  E-value=1.7e-22  Score=193.14  Aligned_cols=141  Identities=24%  Similarity=0.288  Sum_probs=114.6

Q ss_pred             hcCCCC-CceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec----CCce
Q 015852          246 TDGFSN-KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEK  319 (399)
Q Consensus       246 ~~~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~  319 (399)
                      .++|.. .++||+|+||.||+|+.. +++.||||++...     .....+....+..++||||+++++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            345666 357999999999999875 6899999998542     1122223334567899999999999876    3447


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC---Cceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~---~~~~i~df~  396 (399)
                      ++||||+++|+|.+++.....  ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.+   +.+||+||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            899999999999999986532  3589999999999999999999999   99999999999999874   459999994

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.88  E-value=1e-22  Score=193.67  Aligned_cols=142  Identities=22%  Similarity=0.314  Sum_probs=121.8

Q ss_pred             cCCCCCceeeccCCceEEEEEe--CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC------CccceeeeeecCCc
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL--ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR------NLLRLYGFCTTVTE  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~------niv~l~g~~~~~~~  318 (399)
                      ++|...+.||+|+||.||+|..  .+++.||||+++...  .....+.+|+.++..++|+      +++++++++...+.
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            4677889999999999999985  368899999986431  2234688899888877665      49999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC------------
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE------------  386 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~------------  386 (399)
                      .++||||+ +++|.+++.....  .++++..+..++.|++.||+|||+.   +|+||||||+|||++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 8999999976532  3578999999999999999999999   9999999999999998            


Q ss_pred             -------CCceeecccc
Q 015852          387 -------DADQSSKTIL  396 (399)
Q Consensus       387 -------~~~~~i~df~  396 (399)
                             ++.+||+||+
T Consensus       166 ~~~~~~~~~~~kl~Dfg  182 (339)
T 1z57_A          166 RDERTLINPDIKVVDFG  182 (339)
T ss_dssp             CEEEEESCCCEEECCCS
T ss_pred             cccccccCCCceEeeCc
Confidence                   6689999995

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.88  E-value=3.4e-22  Score=199.97  Aligned_cols=140  Identities=20%  Similarity=0.243  Sum_probs=119.6

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC-CccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||+++....   ..++.+|++++..++|+ ++..+..++...+..++|||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            5688889999999999999986 5789999998754322   22588999999999874 55556666677788899999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee---CCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl---d~~~~~~i~df~  396 (399)
                      |+ +++|.+++.....   .+++..+..|+.||+.||+|||+.   +||||||||+|||+   +.++.+||+||+
T Consensus        84 ~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             CC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCC
Confidence            99 9999999975432   489999999999999999999999   99999999999999   688999999994

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.88  E-value=1.4e-22  Score=191.31  Aligned_cols=144  Identities=24%  Similarity=0.368  Sum_probs=112.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHH-HHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~-f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      .++|...+.||+|+||.||+|+.. +++.||||++..........+ +.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356777789999999999999875 789999999965433322233 445556788899999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+ ++.+..+.....   ..+++..+..++.|+++||+|||+ +   +|+||||||+||+++.++.+||+||+
T Consensus       104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  170 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFG  170 (318)
T ss_dssp             CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECC
Confidence            999 445555544322   247899999999999999999998 5   79999999999999999999999994

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.88  E-value=8.2e-23  Score=202.20  Aligned_cols=139  Identities=25%  Similarity=0.222  Sum_probs=112.1

Q ss_pred             CCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEecCCC
Q 015852          250 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       250 ~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      ...++||+|+||+||.+...+|+.||||++...    ....+.+|+.++..+ +||||+++++++...+..++||||+. 
T Consensus        18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            345789999999998776668999999998543    234578899999875 89999999999999999999999996 


Q ss_pred             CChhhHhhhcCCCCCC---CChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-------------Cceee
Q 015852          329 GSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-------------ADQSS  392 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-------------~~~~i  392 (399)
                      |+|.+++.........   .++..+..++.|++.||+|||+.   +|+||||||+|||++.+             +.+||
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            6999999865322111   13345678999999999999999   99999999999999754             48999


Q ss_pred             cccc
Q 015852          393 KTIL  396 (399)
Q Consensus       393 ~df~  396 (399)
                      +||+
T Consensus       170 ~DFG  173 (434)
T 2rio_A          170 SDFG  173 (434)
T ss_dssp             CCCT
T ss_pred             cccc
Confidence            9994

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.87  E-value=9.4e-23  Score=198.49  Aligned_cols=135  Identities=25%  Similarity=0.359  Sum_probs=111.8

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC--------CCCccceeeeee---
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--------HRNLLRLYGFCT---  314 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~---  314 (399)
                      ++|...+.||+|+||+||+|+. .+++.||||+++..  ......+.+|+.+++.++        |+||+++++++.   
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            5688889999999999999985 46889999998643  222346889999998885        788999999987   


Q ss_pred             -cCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC
Q 015852          315 -TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  388 (399)
Q Consensus       315 -~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~  388 (399)
                       .....++||||+ +|++.+.+.....  ..+++..+..++.|++.||+|||+++  +|+||||||+|||++.++
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence             455789999999 5677776655321  34899999999999999999999853  799999999999999875

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=3.2e-22  Score=186.57  Aligned_cols=138  Identities=12%  Similarity=0.057  Sum_probs=109.6

Q ss_pred             HHHHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccc-----------------cHHHHHHHHHHHhcCC
Q 015852          240 RELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-----------------GELQFQTEVKIISMAV  302 (399)
Q Consensus       240 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-----------------~~~~f~~E~~~l~~l~  302 (399)
                      ..+......|...+.||+|+||.||+|+..+++.||+|.++......                 ....+.+|+.+++.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            33344444566679999999999999998779999999986432211                 2346899999999998


Q ss_pred             CCCccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCce
Q 015852          303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  382 (399)
Q Consensus       303 H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NI  382 (399)
                        | +++.+++.. +..++||||+++|+|.+ +..          .....++.|+++||+|||+.   +|+||||||+||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI  224 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  224 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence              5 677775543 55699999999999988 521          12457999999999999999   999999999999


Q ss_pred             eeCCCCceeecccc
Q 015852          383 LLDEDADQSSKTIL  396 (399)
Q Consensus       383 Lld~~~~~~i~df~  396 (399)
                      |++ ++.+||+||+
T Consensus       225 Ll~-~~~vkl~DFG  237 (282)
T 1zar_A          225 LVS-EEGIWIIDFP  237 (282)
T ss_dssp             EEE-TTEEEECCCT
T ss_pred             EEE-CCcEEEEECC
Confidence            999 9999999994

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.87  E-value=2.5e-22  Score=198.53  Aligned_cols=139  Identities=22%  Similarity=0.275  Sum_probs=114.7

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      .+|...++||+|+||+||.....+++.||||++.....    ..+.+|+.+++.+ +|||||++++++......++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            35677789999999997655556789999999854322    2356899999988 799999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-----CCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-----DADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-----~~~~~i~df~  396 (399)
                      +. |+|.+++.....   ...+.....++.|+++||+|||+.   +|+||||||+|||++.     +..+||+||+
T Consensus       100 ~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             CS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             CC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            97 699999986543   244456678999999999999999   9999999999999953     2357899994

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.86  E-value=8.7e-22  Score=191.51  Aligned_cols=146  Identities=23%  Similarity=0.298  Sum_probs=120.7

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CC-----CccceeeeeecCC
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HR-----NLLRLYGFCTTVT  317 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~~  317 (399)
                      ..++|...+.||+|+||+||+|+.. +++.||||+++...  ....++..|+.++..++ |+     +|+++.+++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3467888899999999999999864 68899999996432  22345777888887775 44     4999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC--CCCceeeccc
Q 015852          318 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDADQSSKTI  395 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld--~~~~~~i~df  395 (399)
                      ..++||||+. |+|.+++.....  ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++  .++.+||+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999996 599999987532  2488999999999999999999963 33899999999999995  4778999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       206 G  206 (382)
T 2vx3_A          206 G  206 (382)
T ss_dssp             T
T ss_pred             c
Confidence            5

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.86  E-value=6.4e-22  Score=189.55  Aligned_cols=142  Identities=19%  Similarity=0.305  Sum_probs=120.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CC-CEEEEEEcccccccccHHHHHHHHHHHhcCCCCC------ccceeeeeecCCc
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DG-KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN------LLRLYGFCTTVTE  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~-~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~  318 (399)
                      ++|...+.||+|+||.||+|... ++ +.||+|+++..  ......+.+|+.+++.++|++      ++.+.+++...+.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            56788899999999999999864 44 68999998643  123346888999998887766      8999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceee--------------
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL--------------  384 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILl--------------  384 (399)
                      .++||||+ ++++.+++.....  ..+++.++..++.|++.||+|||+.   +|+||||||+|||+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence            99999999 6777777766432  3588999999999999999999998   99999999999999              


Q ss_pred             -----CCCCceeecccc
Q 015852          385 -----DEDADQSSKTIL  396 (399)
Q Consensus       385 -----d~~~~~~i~df~  396 (399)
                           +.++.+||+||+
T Consensus       171 ~~~~~~~~~~~kl~Dfg  187 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFG  187 (355)
T ss_dssp             CCEEEESCCCEEECCCT
T ss_pred             ccccccCCCcEEEeecC
Confidence                 667899999995

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.85  E-value=9.5e-22  Score=199.50  Aligned_cols=128  Identities=15%  Similarity=0.239  Sum_probs=102.2

Q ss_pred             CCceeeccCCceEEEEEeCCCCEEEEEEcccccccc-------cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          251 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ..++||+|+||.||+|+. .++.+++|+........       ....|.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            357899999999999954 56788999764322111       1235899999999999999997777777778889999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++..            +..++.|+++||+|||++   +|+||||||+|||+++  .+||+||+
T Consensus       419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFG  474 (540)
T 3en9_A          419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFG  474 (540)
T ss_dssp             ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCT
T ss_pred             ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECc
Confidence            99999999999864            357899999999999999   9999999999999999  99999994

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.85  E-value=6.4e-22  Score=191.20  Aligned_cols=143  Identities=19%  Similarity=0.320  Sum_probs=119.6

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-----------CCCccceeeeee
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----------HRNLLRLYGFCT  314 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~  314 (399)
                      ++|...+.||+|+||.||+|+. .+++.||||+++...  .....+.+|+.++.+++           |+||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            4677789999999999999986 578899999986432  22346888999888776           899999999987


Q ss_pred             cCC----ceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC-----
Q 015852          315 TVT----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-----  385 (399)
Q Consensus       315 ~~~----~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld-----  385 (399)
                      ..+    ..+++|||+ +++|.+++.....  ..+++..+..++.|++.||+|||+++  +|+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence            654    678999999 8999999986432  24889999999999999999999853  799999999999994     


Q ss_pred             -CCCceeecccc
Q 015852          386 -EDADQSSKTIL  396 (399)
Q Consensus       386 -~~~~~~i~df~  396 (399)
                       .++.+||+||+
T Consensus       172 ~~~~~~kl~Dfg  183 (373)
T 1q8y_A          172 ENLIQIKIADLG  183 (373)
T ss_dssp             TTEEEEEECCCT
T ss_pred             cCcceEEEcccc
Confidence             44579999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.83  E-value=4e-21  Score=188.86  Aligned_cols=145  Identities=17%  Similarity=0.159  Sum_probs=107.5

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc--ccHHHHHHHHHHHhcCCC-CCccceeee-----------
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVH-RNLLRLYGF-----------  312 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~--~~~~~f~~E~~~l~~l~H-~niv~l~g~-----------  312 (399)
                      .|...++||+|+||+||+|+. .+++.||||+++.....  .....|.+|+.+++.++| +|......+           
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            355668999999999999995 57899999998633222  224579999999999987 322211111           


Q ss_pred             ----------eec-----CCceEEEEecCCCCChhhHhhhc---CCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 015852          313 ----------CTT-----VTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH  374 (399)
Q Consensus       313 ----------~~~-----~~~~~lv~e~~~~gsL~~~L~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  374 (399)
                                +..     ....+++|+++ +++|.+++...   ......++|..+..++.|+++||+|||++   +|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence                      111     12345666654 68999888521   11223477889999999999999999999   9999


Q ss_pred             cCCCCCceeeCCCCceeecccc
Q 015852          375 RDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       375 rDlK~~NILld~~~~~~i~df~  396 (399)
                      |||||+|||++.++.+||+||+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG  256 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFE  256 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGG
T ss_pred             CCcccceEEEecCCeEEEEecc
Confidence            9999999999999999999995

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=1e-19  Score=167.32  Aligned_cols=132  Identities=17%  Similarity=0.179  Sum_probs=100.7

Q ss_pred             CCCCceeeccCCceEEEEEe-CCCCE--EEEEEcccccccc-----------------------cHHHHHHHHHHHhcCC
Q 015852          249 FSNKNILGRGGFGKVYKGRL-ADGKL--VAVKRLKEERTSG-----------------------GELQFQTEVKIISMAV  302 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~-~~~~~--vAvK~l~~~~~~~-----------------------~~~~f~~E~~~l~~l~  302 (399)
                      |...+.||+|+||.||+|.. .+|+.  ||||+++......                       ....+.+|+..+..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45668899999999999987 67888  9999875431110                       0125889999999998


Q ss_pred             CCCc--cceeeeeecCCceEEEEecCCC-C----ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHh-cCCCCCcee
Q 015852          303 HRNL--LRLYGFCTTVTEKLLVYPYMTN-G----SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKIIH  374 (399)
Q Consensus       303 H~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH  374 (399)
                      |+++  ..++.+    ...++||||+.+ |    +|.+....       .++.....++.|++.||.||| +.   +|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8864  333332    356899999942 4    56555432       224467889999999999999 88   9999


Q ss_pred             cCCCCCceeeCCCCceeecccc
Q 015852          375 RDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       375 rDlK~~NILld~~~~~~i~df~  396 (399)
                      |||||+|||+++  .++|+||+
T Consensus       195 rDlkp~NILl~~--~~~liDFG  214 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMG  214 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCT
T ss_pred             CCCCHHHEEEcC--cEEEEECc
Confidence            999999999998  99999995

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.73  E-value=5.9e-18  Score=160.01  Aligned_cols=125  Identities=26%  Similarity=0.550  Sum_probs=111.4

Q ss_pred             CChhHHHHHHHHHhhcCCCCCCCCCCCCCCCCCCc--ceeeeeCCC---CCEEEEEeCCCCcee--ecChhhccCcCCCe
Q 015852           23 SANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCT--WFHITCNPE---GSVTRVDLGNAALSG--ELAPELGQLKNLEL   95 (399)
Q Consensus        23 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~--w~gv~c~~~---~~v~~l~l~~~~l~g--~ip~~l~~l~~L~~   95 (399)
                      +.++|.+||++||.++.+|. .+.+|+. +.+||.  |.||+|+..   ++|+.|+|++|+++|  .+|+.++++++|+.
T Consensus         3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~   80 (313)
T 1ogq_A            3 CNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence            56789999999999998886 7899965 468998  999999854   799999999999999  99999999999999


Q ss_pred             EeccC-CcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccccccc
Q 015852           96 LRLNN-NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus        96 l~l~~-n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      |+|++ |+++|.+|..+..+++|++|++++|+++|.+|. ...+.++..+++.+|.
T Consensus        81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~  136 (313)
T 1ogq_A           81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence            99995 999999999999999999999999999999996 3456677777777775

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.72  E-value=5.7e-18  Score=179.06  Aligned_cols=128  Identities=30%  Similarity=0.426  Sum_probs=107.9

Q ss_pred             hcccCChhHHHHHHHHHhhcCCCCCCCCCCCCCCCCCCcceeeeeCCCCCEEEEEeCCCCceee---cCh----------
Q 015852           19 LPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGE---LAP----------   85 (399)
Q Consensus        19 ~~~~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~v~~l~l~~~~l~g~---ip~----------   85 (399)
                      ++..+.++|.+||++||+++.||. .+++|+ .+.+||.|.||+|+ .++|+.|+|+++.++|.   +|+          
T Consensus         5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~-~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~   81 (768)
T 3rgz_A            5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWS-SNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES   81 (768)
T ss_dssp             ---CCHHHHHHHHHHHHTTCSCTT-SSTTCC-TTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred             ccccCCHHHHHHHHHHHhhCCCcc-cccCCC-CCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence            344567789999999999999998 899997 45689999999998 78999999999999998   654          


Q ss_pred             -------------hhccCcCCCeEeccCCcccccccc--cccCCCCCcEEecCCCcCcccCCCC--CCCCcccccccccc
Q 015852           86 -------------ELGQLKNLELLRLNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPDN--GSFSQFTPISFENN  148 (399)
Q Consensus        86 -------------~l~~l~~L~~l~l~~n~l~G~ip~--~~~~l~~L~~l~ls~N~l~G~iP~~--~~~~~~~~~~~~~n  148 (399)
                                   .++++++|++|+|++|.++|.+|.  .++++++|++||+++|.++|.+|..  ..+.++..+++++|
T Consensus        82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n  161 (768)
T 3rgz_A           82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN  161 (768)
T ss_dssp             EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred             cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence                         667788999999999999999998  9999999999999999999998864  35555666666555


Q ss_pred             c
Q 015852          149 L  149 (399)
Q Consensus       149 ~  149 (399)
                      .
T Consensus       162 ~  162 (768)
T 3rgz_A          162 S  162 (768)
T ss_dssp             C
T ss_pred             c
Confidence            3

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=2.2e-18  Score=165.82  Aligned_cols=134  Identities=16%  Similarity=0.114  Sum_probs=94.6

Q ss_pred             CCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc-------------ccHHHH--------HHHHHHHhcCCCCCc
Q 015852          248 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-------------GGELQF--------QTEVKIISMAVHRNL  306 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-------------~~~~~f--------~~E~~~l~~l~H~ni  306 (399)
                      -|...+.||+|+||.||+|...+|+.||||+++.....             ......        .+|...+.++.+..+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            37788999999999999999889999999987543211             001112        234555555544333


Q ss_pred             cceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC
Q 015852          307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  386 (399)
Q Consensus       307 v~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~  386 (399)
                      ....-+..  ...++||||+++++|..+...          .....+..|++.+|.|||+.   +||||||||.|||+++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence            22111111  234799999999888654321          22456789999999999998   9999999999999998


Q ss_pred             CCc----------eeecccc
Q 015852          387 DAD----------QSSKTIL  396 (399)
Q Consensus       387 ~~~----------~~i~df~  396 (399)
                      +++          +.|.||-
T Consensus       241 dgd~~d~~~~~~~~~iID~~  260 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFP  260 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCT
T ss_pred             CCCcccccccccceEEEEeC
Confidence            874          7899983

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.65  E-value=2.2e-16  Score=167.69  Aligned_cols=122  Identities=18%  Similarity=0.312  Sum_probs=106.4

Q ss_pred             CChhHHHHHHHHHhhcCCCCCCCCCCCCCC----CCC--Ccc------------eeeeeCCCCCEEEEEeCCCCceeecC
Q 015852           23 SANAEVDALYIFKSKLQDPNNSLQSWDNLP----GNL--CTW------------FHITCNPEGSVTRVDLGNAALSGELA   84 (399)
Q Consensus        23 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~----~~~--c~w------------~gv~c~~~~~v~~l~l~~~~l~g~ip   84 (399)
                      ....|.+||++||.++.+|     +|+...    .+|  |.|            .||+|+..++|+.|+|++++++|.+|
T Consensus       266 ~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip  340 (876)
T 4ecn_A          266 EYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP  340 (876)
T ss_dssp             HHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEEC
T ss_pred             cchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCc
Confidence            4557999999999999877     786543    466  999            99999987899999999999999999


Q ss_pred             hhhccCcCCCeEec-cCCccccc---------------------------------------------------------
Q 015852           85 PELGQLKNLELLRL-NNNSLSGL---------------------------------------------------------  106 (399)
Q Consensus        85 ~~l~~l~~L~~l~l-~~n~l~G~---------------------------------------------------------  106 (399)
                      +++++|+.|+.|+| ++|.++|.                                                         
T Consensus       341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~  420 (876)
T 4ecn_A          341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD  420 (876)
T ss_dssp             GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred             hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence            99999999999999 88877776                                                         


Q ss_pred             -------------------ccccccCCCCCcEEecCCCcCcc-----------------cCCCCC---CCCccccccccc
Q 015852          107 -------------------IPTSLTTITSLNILDLSNNRLSG-----------------PVPDNG---SFSQFTPISFEN  147 (399)
Q Consensus       107 -------------------ip~~~~~l~~L~~l~ls~N~l~G-----------------~iP~~~---~~~~~~~~~~~~  147 (399)
                                         ||..++++++|+.|+|++|+|+|                 .+|...   .+.++..+.+.+
T Consensus       421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~  500 (876)
T 4ecn_A          421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN  500 (876)
T ss_dssp             CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred             cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence                               89999999999999999999999                 488654   567777778877


Q ss_pred             cc
Q 015852          148 NL  149 (399)
Q Consensus       148 n~  149 (399)
                      |.
T Consensus       501 N~  502 (876)
T 4ecn_A          501 CP  502 (876)
T ss_dssp             CT
T ss_pred             CC
Confidence            75

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.60  E-value=1.5e-15  Score=157.13  Aligned_cols=125  Identities=21%  Similarity=0.307  Sum_probs=106.2

Q ss_pred             CChhHHHHHHHHHhhcCCCCC--------CCCCCCCCCCCCCcc---eeeeeCCCCCEEEEEeCCCCceeecChhhccCc
Q 015852           23 SANAEVDALYIFKSKLQDPNN--------SLQSWDNLPGNLCTW---FHITCNPEGSVTRVDLGNAALSGELAPELGQLK   91 (399)
Q Consensus        23 ~~~~~~~~l~~~k~~~~~~~~--------~l~~w~~~~~~~c~w---~gv~c~~~~~v~~l~l~~~~l~g~ip~~l~~l~   91 (399)
                      ....|++||.+++.+++++.-        ...+|+. +.++|.|   .||+|+..++|+.|+|++++++|.+|+++++|+
T Consensus        27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~  105 (636)
T 4eco_A           27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT  105 (636)
T ss_dssp             HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCT
T ss_pred             hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCc
Confidence            334699999999999875531        1337975 4789999   999999889999999999999999999999999


Q ss_pred             CCCeEeccCC----------------------------------------------------------------------
Q 015852           92 NLELLRLNNN----------------------------------------------------------------------  101 (399)
Q Consensus        92 ~L~~l~l~~n----------------------------------------------------------------------  101 (399)
                      +|+.|+|++|                                                                      
T Consensus       106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~  185 (636)
T 4eco_A          106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD  185 (636)
T ss_dssp             TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred             cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence            9999999988                                                                      


Q ss_pred             --------cccccccccccCCCCCcEEecCCCcCccc-----------------CCCC-C--CCCccccccccccc
Q 015852          102 --------SLSGLIPTSLTTITSLNILDLSNNRLSGP-----------------VPDN-G--SFSQFTPISFENNL  149 (399)
Q Consensus       102 --------~l~G~ip~~~~~l~~L~~l~ls~N~l~G~-----------------iP~~-~--~~~~~~~~~~~~n~  149 (399)
                              +++| ||++++++++|++|+|++|.|+|.                 +|.. .  .+.++..+.+.+|.
T Consensus       186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~  260 (636)
T 4eco_A          186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP  260 (636)
T ss_dssp             TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCT
T ss_pred             hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCc
Confidence                    4557 999999999999999999999996                 8865 3  47777788887775

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.50  E-value=1.5e-14  Score=152.93  Aligned_cols=95  Identities=41%  Similarity=0.761  Sum_probs=86.7

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+|++|+++|.||.+++++++|+.|||++|+|+|.||..++.+++|++||+++|+|+|+||..+.+..+...+|.|
T Consensus       657 ~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~g  736 (768)
T 3rgz_A          657 YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLN  736 (768)
T ss_dssp             TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCS
T ss_pred             cCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcC
Confidence            57889999999999999999999999999999999999999999999999999999999999999998999999999999


Q ss_pred             ccccCCCCCCCCCCCC
Q 015852          148 NLNLCGPNTKKPCSGS  163 (399)
Q Consensus       148 n~~lcg~~~~~~c~~~  163 (399)
                      |+++||.+.. +|...
T Consensus       737 N~~Lcg~~l~-~C~~~  751 (768)
T 3rgz_A          737 NPGLCGYPLP-RCDPS  751 (768)
T ss_dssp             CTEEESTTSC-CCCSC
T ss_pred             CchhcCCCCc-CCCCC
Confidence            9999998865 78543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.37  E-value=8.8e-14  Score=132.14  Aligned_cols=126  Identities=17%  Similarity=0.270  Sum_probs=107.2

Q ss_pred             CChhHHHHHHHHHhhc-CCCCCCCCCCC---CCCCCCCcceeeeeC---------CCCCEEEEEeCCCCceeecChhhcc
Q 015852           23 SANAEVDALYIFKSKL-QDPNNSLQSWD---NLPGNLCTWFHITCN---------PEGSVTRVDLGNAALSGELAPELGQ   89 (399)
Q Consensus        23 ~~~~~~~~l~~~k~~~-~~~~~~l~~w~---~~~~~~c~w~gv~c~---------~~~~v~~l~l~~~~l~g~ip~~l~~   89 (399)
                      +..+|.+||++||..+ .++.+.+.+|.   ....++|.|.|+.|+         ...+|+.|+|++|+++ .+|+.+++
T Consensus        24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~  102 (328)
T 4fcg_A           24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR  102 (328)
T ss_dssp             CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred             cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence            5567899999999988 57777778894   345789999999995         2368999999999998 99999999


Q ss_pred             CcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccccccccc
Q 015852           90 LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNLNL  151 (399)
Q Consensus        90 l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~~n~~l  151 (399)
                      +++|++|+|++|.++ .+|..++.+++|++|++++|+++ .+|. ...+.++..+++.+|..+
T Consensus       103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~  163 (328)
T 4fcg_A          103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL  163 (328)
T ss_dssp             GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTC
T ss_pred             CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCc
Confidence            999999999999999 99999999999999999999999 7884 345667777788776533

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=5.1e-12  Score=115.70  Aligned_cols=142  Identities=12%  Similarity=0.033  Sum_probs=108.9

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEE
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv  322 (399)
                      ...++|.....++.|+.+.||+.... ++.+++|....... .....+.+|+++++.+. |..+.++++++...+..++|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34456776777888888999999754 67899999864321 22235889999998874 67788999999888889999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC----------------------------------  368 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------  368 (399)
                      |||++|.+|.+.+..         ......++.+++++|+.||+..                                  
T Consensus        89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999998776421         1223578889999999999820                                  


Q ss_pred             ----------------------CCCceecCCCCCceeeCCCCceeecccc
Q 015852          369 ----------------------DPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       369 ----------------------~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                                            .+.++|+|+++.|||++++....|.||.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe  209 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG  209 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCT
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEch
Confidence                                  1358999999999999876556799983

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.17  E-value=3.8e-11  Score=109.24  Aligned_cols=125  Identities=14%  Similarity=0.036  Sum_probs=92.8

Q ss_pred             eccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCC--ccceeeeeecCCceEEEEecCCCCChhh
Q 015852          256 GRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKLLVYPYMTNGSVAS  333 (399)
Q Consensus       256 G~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~  333 (399)
                      +.|..+.||+....+|..+++|.....    ....+.+|+.+++.+.+.+  +.+++++....+..++||||+++.++. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            456669999998777888999987543    1235788999888876544  456888887777789999999998874 


Q ss_pred             HhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 015852          334 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC---------------------------------------------  368 (399)
Q Consensus       334 ~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------  368 (399)
                       ...       .+   ...++.++++.|+.||+..                                             
T Consensus       104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence             211       11   2356777888888888742                                             


Q ss_pred             ----------CCCceecCCCCCceeeCCCCceeecccc
Q 015852          369 ----------DPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       369 ----------~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                                .+.++|+|++|+|||++++....|.||.
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~  210 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCG  210 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCT
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcch
Confidence                      1129999999999999887667799993

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.14  E-value=3.7e-11  Score=113.17  Aligned_cols=92  Identities=33%  Similarity=0.590  Sum_probs=79.6

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..++.|+|++|.+++.+|. +..+++|+.|+|++|.++|.+|..+..+++|+.|++++|+++|.+|....+.++..+++.
T Consensus       221 ~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~  299 (313)
T 1ogq_A          221 KNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA  299 (313)
T ss_dssp             SCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTC
T ss_pred             CCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhc
Confidence            3567777777777766655 777888999999999999999999999999999999999999999998888999999999


Q ss_pred             cccccCCCCCCCCC
Q 015852          147 NNLNLCGPNTKKPC  160 (399)
Q Consensus       147 ~n~~lcg~~~~~~c  160 (399)
                      +|+.+||.+.. .|
T Consensus       300 ~N~~lc~~p~~-~C  312 (313)
T 1ogq_A          300 NNKCLCGSPLP-AC  312 (313)
T ss_dssp             SSSEEESTTSS-CC
T ss_pred             CCCCccCCCCC-CC
Confidence            99999997653 45

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=1.8e-10  Score=110.39  Aligned_cols=137  Identities=11%  Similarity=0.184  Sum_probs=100.8

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcc--cccccccHHHHHHHHHHHhcCC--CCCccceeeeeecC---CceEEEEe
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAV--HRNLLRLYGFCTTV---TEKLLVYP  324 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~--~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~e  324 (399)
                      .+.++.|.++.||+....+ ..+++|+..  ..........+.+|..+++.+.  +..+.+++.++...   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678999999999988754 578888765  3321122335788999998887  45678888888765   34799999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC------------------------------------  368 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------  368 (399)
                      |+++..+.+..      ...++..++..++.++++.|+.||+..                                    
T Consensus       122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99998774321      123677888899999999999999731                                    


Q ss_pred             -------------------CCCceecCCCCCceeeCCCCc--eeeccc
Q 015852          369 -------------------DPKIIHRDVKAANILLDEDAD--QSSKTI  395 (399)
Q Consensus       369 -------------------~~~ivHrDlK~~NILld~~~~--~~i~df  395 (399)
                                         .+.++|+|+++.|||+++++.  ..|.||
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDw  243 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDW  243 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCC
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECc
Confidence                               246999999999999998764  589998

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.11  E-value=1.6e-10  Score=98.86  Aligned_cols=100  Identities=22%  Similarity=0.270  Sum_probs=85.2

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecC
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLS  123 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls  123 (399)
                      ..|.|..|.|+.+          ..++.|+|++|++++-.|..+.++++|+.|+|++|++++..|..+..+++|+.|+|+
T Consensus         7 C~C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A            7 CSCSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             CEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            4467889999742          368899999999998888899999999999999999997766678999999999999


Q ss_pred             CCcCcccCCC-CCCCCcccccccccccccCC
Q 015852          124 NNRLSGPVPD-NGSFSQFTPISFENNLNLCG  153 (399)
Q Consensus       124 ~N~l~G~iP~-~~~~~~~~~~~~~~n~~lcg  153 (399)
                      +|++++..|. ...+.++..+++.+|+..|.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            9999986664 45677888899999987664

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.04  E-value=4.2e-10  Score=107.21  Aligned_cols=99  Identities=18%  Similarity=0.163  Sum_probs=83.1

Q ss_pred             CCcceeeeeCCC------------CCEEEEEeCC-CCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEe
Q 015852           55 LCTWFHITCNPE------------GSVTRVDLGN-AALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILD  121 (399)
Q Consensus        55 ~c~w~gv~c~~~------------~~v~~l~l~~-~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~  121 (399)
                      .|.|..|.|+..            .+++.|+|++ |.|++-.|..+++|++|+.|+|++|+|+|..|..|..+++|+.||
T Consensus         7 ~C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~   86 (347)
T 2ifg_A            7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (347)
T ss_dssp             CSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             cccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEe
Confidence            589999999854            2488999996 999988778899999999999999999999999999999999999


Q ss_pred             cCCCcCcccCCCCCCCCcccccccccccccCC
Q 015852          122 LSNNRLSGPVPDNGSFSQFTPISFENNLNLCG  153 (399)
Q Consensus       122 ls~N~l~G~iP~~~~~~~~~~~~~~~n~~lcg  153 (399)
                      |++|+|++-.|.......+..+.+.+|+.-|.
T Consensus        87 l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           87 LSFNALESLSWKTVQGLSLQELVLSGNPLHCS  118 (347)
T ss_dssp             CCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             CCCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence            99999997555433333377788888886664

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.97  E-value=1.1e-09  Score=98.25  Aligned_cols=98  Identities=19%  Similarity=0.246  Sum_probs=82.5

Q ss_pred             CCCCCcceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEe
Q 015852           52 PGNLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILD  121 (399)
Q Consensus        52 ~~~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~  121 (399)
                      ....|+|.+|.|...          ..++.|+|++|++++..|..+.++++|+.|+|++|.+++..+..+..+++|+.|+
T Consensus        15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~   94 (229)
T 3e6j_A           15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD   94 (229)
T ss_dssp             TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEE
Confidence            368999999999742          3689999999999998898999999999999999999755556678999999999


Q ss_pred             cCCCcCcccCCCC-CCCCccccccccccc
Q 015852          122 LSNNRLSGPVPDN-GSFSQFTPISFENNL  149 (399)
Q Consensus       122 ls~N~l~G~iP~~-~~~~~~~~~~~~~n~  149 (399)
                      |++|++++..|.. ..+.++..+.+.+|.
T Consensus        95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~  123 (229)
T 3e6j_A           95 LGTNQLTVLPSAVFDRLVHLKELFMCCNK  123 (229)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCcCCccChhHhCcchhhCeEeccCCc
Confidence            9999999765543 567777788887775

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.95  E-value=1.7e-09  Score=92.69  Aligned_cols=86  Identities=26%  Similarity=0.295  Sum_probs=71.2

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~  146 (399)
                      .++.|+|++|++++-.|..++++++|+.|+|++|+|++..+..+..+++|+.|+|++|++++-.|. ...+.++..+.+.
T Consensus        34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~  113 (174)
T 2r9u_A           34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLY  113 (174)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred             CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeC
Confidence            678999999999988888899999999999999999985555678899999999999999865554 4567778888888


Q ss_pred             cccccCC
Q 015852          147 NNLNLCG  153 (399)
Q Consensus       147 ~n~~lcg  153 (399)
                      +|+.-|.
T Consensus       114 ~N~~~c~  120 (174)
T 2r9u_A          114 NNPWDCE  120 (174)
T ss_dssp             SSCBCTT
T ss_pred             CCCcccc
Confidence            8876553

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=98.95  E-value=1.2e-09  Score=95.11  Aligned_cols=96  Identities=20%  Similarity=0.304  Sum_probs=79.0

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecCh-hhccCcCCCeEeccCCcccccccccccCCCCCcEEec
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAP-ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL  122 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~-~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~l  122 (399)
                      ..|.|..|.|+..          ..++.|+|++|++++..+. .++.+++|+.|+|++|++++.+|..+..+++|+.|+|
T Consensus         6 C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   85 (192)
T 1w8a_A            6 CHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             SEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEEC
Confidence            4578888988742          2688999999999765554 3889999999999999999998999999999999999


Q ss_pred             CCCcCcccCCC-CCCCCccccccccccc
Q 015852          123 SNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       123 s~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      ++|++++..|. ...+.++..+++++|.
T Consensus        86 s~N~l~~~~~~~~~~l~~L~~L~L~~N~  113 (192)
T 1w8a_A           86 GENKIKEISNKMFLGLHQLKTLNLYDNQ  113 (192)
T ss_dssp             CSCCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred             CCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence            99999988775 3556777788887775

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.91  E-value=2.6e-09  Score=91.57  Aligned_cols=96  Identities=25%  Similarity=0.376  Sum_probs=79.8

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecC
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLS  123 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls  123 (399)
                      ..|.|.+|.|+..          ..++.|+|++|++++-.+..++.+++|+.|++++|.+++..+..+..+++|+.|+++
T Consensus         5 C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   84 (177)
T 2o6r_A            5 CSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH   84 (177)
T ss_dssp             CEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence            4578999999742          368999999999996555567999999999999999997766778999999999999


Q ss_pred             CCcCcccCCCC-CCCCccccccccccc
Q 015852          124 NNRLSGPVPDN-GSFSQFTPISFENNL  149 (399)
Q Consensus       124 ~N~l~G~iP~~-~~~~~~~~~~~~~n~  149 (399)
                      +|++++..|.. ..+.++..+++.+|.
T Consensus        85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~  111 (177)
T 2o6r_A           85 ENKLQSLPNGVFDKLTQLKELALDTNQ  111 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCccccCHHHhhCCcccCEEECcCCc
Confidence            99999766543 566778888888775

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=98.89  E-value=2.4e-09  Score=93.21  Aligned_cols=86  Identities=17%  Similarity=0.341  Sum_probs=77.3

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++..|..+.++++|+.|+|++|.+++..|..+..+++|+.|+|++|++++.+|.. ..+.++..+.+
T Consensus        54 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  133 (192)
T 1w8a_A           54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL  133 (192)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEe
Confidence            47899999999999998999999999999999999999999988999999999999999999988853 45667788888


Q ss_pred             ccccccC
Q 015852          146 ENNLNLC  152 (399)
Q Consensus       146 ~~n~~lc  152 (399)
                      .+|+..|
T Consensus       134 ~~N~l~c  140 (192)
T 1w8a_A          134 ASNPFNC  140 (192)
T ss_dssp             TTCCBCC
T ss_pred             CCCCccC
Confidence            8887655

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.84  E-value=5.8e-09  Score=91.75  Aligned_cols=97  Identities=24%  Similarity=0.331  Sum_probs=79.2

Q ss_pred             CCCCcceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEec
Q 015852           53 GNLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL  122 (399)
Q Consensus        53 ~~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~l  122 (399)
                      ...|.|.+|.|+..          ..++.|+|++|++++..+..++++++|+.|++++|++++..+..+..+++|++|++
T Consensus         4 ~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L   83 (208)
T 2o6s_A            4 RCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL   83 (208)
T ss_dssp             TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEEC
Confidence            35678999999742          25899999999999655556889999999999999999766667889999999999


Q ss_pred             CCCcCcccCCC-CCCCCccccccccccc
Q 015852          123 SNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       123 s~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      ++|++++..+. ...+.++..+++.+|.
T Consensus        84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~  111 (208)
T 2o6s_A           84 STNQLQSLPNGVFDKLTQLKELALNTNQ  111 (208)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCcCCccCHhHhcCccCCCEEEcCCCc
Confidence            99999965554 2566777888887775

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.82  E-value=8.6e-09  Score=89.86  Aligned_cols=95  Identities=28%  Similarity=0.360  Sum_probs=80.7

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecC
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLS  123 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls  123 (399)
                      ..|.|..|.|+..          ..++.|+|++|+++ .+|..+.++++|+.|+|++|.+++..|..+..+++|+.|+|+
T Consensus         8 C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls   86 (193)
T 2wfh_A            8 CTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS   86 (193)
T ss_dssp             CEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC
Confidence            4567888888632          36899999999998 889999999999999999999998888889999999999999


Q ss_pred             CCcCcccCCC-CCCCCccccccccccc
Q 015852          124 NNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       124 ~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      +|.+++..|. ...+.++..+++.+|.
T Consensus        87 ~N~l~~i~~~~f~~l~~L~~L~L~~N~  113 (193)
T 2wfh_A           87 YNRLRCIPPRTFDGLKSLRLLSLHGND  113 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCccCEeCHHHhCCCCCCCEEECCCCC
Confidence            9999987764 4556777788888775

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.77  E-value=1.3e-08  Score=90.51  Aligned_cols=96  Identities=21%  Similarity=0.343  Sum_probs=80.6

Q ss_pred             CCCCcceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEec
Q 015852           53 GNLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL  122 (399)
Q Consensus        53 ~~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~l  122 (399)
                      ...|.|..|.|...          ..++.|+|++|++++-.+..+..+++|+.|+|++|.+++..|..+..+++|+.|+|
T Consensus         8 ~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L   87 (220)
T 2v9t_B            8 ACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVL   87 (220)
T ss_dssp             TSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEEC
T ss_pred             CCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEEC
Confidence            34578999999742          26899999999999776678999999999999999999999999999999999999


Q ss_pred             CCCcCcccCCC--CCCCCccccccccccc
Q 015852          123 SNNRLSGPVPD--NGSFSQFTPISFENNL  149 (399)
Q Consensus       123 s~N~l~G~iP~--~~~~~~~~~~~~~~n~  149 (399)
                      ++|++++ +|.  ...+.++..+.+.+|.
T Consensus        88 s~N~l~~-l~~~~f~~l~~L~~L~L~~N~  115 (220)
T 2v9t_B           88 YGNKITE-LPKSLFEGLFSLQLLLLNANK  115 (220)
T ss_dssp             CSSCCCC-CCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCcCCc-cCHhHccCCCCCCEEECCCCC
Confidence            9999984 454  2456777788888775

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.75  E-value=1.4e-08  Score=90.30  Aligned_cols=83  Identities=17%  Similarity=0.206  Sum_probs=63.9

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++-.|..+.++++|+.|+|++|.+++..|..+..+++|++|+|++|++++..|. ...+.++..+++
T Consensus        57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  136 (220)
T 2v70_A           57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL  136 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred             CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence            3678888888888876666788888888888888888877777788888888888888888877664 244566666777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       137 ~~N~  140 (220)
T 2v70_A          137 YDNQ  140 (220)
T ss_dssp             TTSC
T ss_pred             CCCc
Confidence            6664

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.73  E-value=1.9e-08  Score=87.58  Aligned_cols=87  Identities=23%  Similarity=0.315  Sum_probs=76.0

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|.+++-.|..+.++++|+.|+|++|.+++..|..+..+++|+.|+|++|++++-.+. ...+.++..+.+
T Consensus        54 ~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  133 (193)
T 2wfh_A           54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAI  133 (193)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEe
Confidence            4789999999999987777899999999999999999998888999999999999999999965443 345677888889


Q ss_pred             ccccccCC
Q 015852          146 ENNLNLCG  153 (399)
Q Consensus       146 ~~n~~lcg  153 (399)
                      .+|+..|.
T Consensus       134 ~~N~~~C~  141 (193)
T 2wfh_A          134 GANPLYCD  141 (193)
T ss_dssp             CSSCEECS
T ss_pred             CCCCeecC
Confidence            99987764

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.71  E-value=1.4e-08  Score=92.16  Aligned_cols=82  Identities=23%  Similarity=0.315  Sum_probs=67.7

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~  146 (399)
                      .++.|+|++|++++..|..+.++++|+.|+|++|.+++..|..+..+++|+.|++++|++++..|.. ..+.++..+.+.
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            5788999999998877778899999999999999999888888889999999999999998655432 456677777777


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       116 ~N~  118 (251)
T 3m19_A          116 GNQ  118 (251)
T ss_dssp             SSC
T ss_pred             CCc
Confidence            774

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.70  E-value=2.2e-08  Score=89.13  Aligned_cols=97  Identities=15%  Similarity=0.245  Sum_probs=81.4

Q ss_pred             CCCCcceeeeeCCC----------CCEEEEEeCCCCceeecCh-hhccCcCCCeEeccCCcccccccccccCCCCCcEEe
Q 015852           53 GNLCTWFHITCNPE----------GSVTRVDLGNAALSGELAP-ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILD  121 (399)
Q Consensus        53 ~~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~-~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~  121 (399)
                      ...|.|..+.|+.+          ..++.|+|++|++++..|. .+..+++|+.|+|++|.+++..|..+..+++|+.|+
T Consensus         8 ~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~   87 (220)
T 2v70_A            8 KCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL   87 (220)
T ss_dssp             TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEE
Confidence            34578999999742          2578999999999988664 478999999999999999998888999999999999


Q ss_pred             cCCCcCcccCCC-CCCCCccccccccccc
Q 015852          122 LSNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       122 ls~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      |++|++++..|. ...+.++..+.+++|.
T Consensus        88 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  116 (220)
T 2v70_A           88 LTSNRLENVQHKMFKGLESLKTLMLRSNR  116 (220)
T ss_dssp             CCSSCCCCCCGGGGTTCSSCCEEECTTSC
T ss_pred             CCCCccCccCHhHhcCCcCCCEEECCCCc
Confidence            999999987664 4566777888888775

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.68  E-value=1.2e-08  Score=103.17  Aligned_cols=94  Identities=22%  Similarity=0.321  Sum_probs=72.5

Q ss_pred             CCcceeeeeCCC------------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEec
Q 015852           55 LCTWFHITCNPE------------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL  122 (399)
Q Consensus        55 ~c~w~gv~c~~~------------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~l  122 (399)
                      .|.|.|+ |+..            ..++.|+|++|++++..|..++++++|++|+|++|.+++..|..+..+++|++|++
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L   81 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL   81 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence            5888887 7521            26888888888888877888888888888888888888877778888888888888


Q ss_pred             CCCcCcccCCC-CCCCCccccccccccc
Q 015852          123 SNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       123 s~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      ++|.+++..|. ...+.++..+++++|.
T Consensus        82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~  109 (549)
T 2z81_A           82 SDNHLSSLSSSWFGPLSSLKYLNLMGNP  109 (549)
T ss_dssp             TTSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred             CCCccCccCHHHhccCCCCcEEECCCCc
Confidence            88888876664 4556666666666664

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.63  E-value=3.9e-08  Score=100.61  Aligned_cols=108  Identities=14%  Similarity=0.140  Sum_probs=72.8

Q ss_pred             CCCCCCCCC---CCCCCCcce----eeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCccc
Q 015852           42 NNSLQSWDN---LPGNLCTWF----HITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLS  104 (399)
Q Consensus        42 ~~~l~~w~~---~~~~~c~w~----gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~  104 (399)
                      ...++.|+.   ....||.+.    .|.|...          ..++.|+|++|++++-.|..+.++++|++|+|++|+++
T Consensus        10 ~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~   89 (635)
T 4g8a_A           10 DDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ   89 (635)
T ss_dssp             ---------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             cchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC
Confidence            334555542   223577653    4778632          26889999999998666678999999999999999998


Q ss_pred             ccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccccccc
Q 015852          105 GLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       105 G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      +..|..|..+++|++|+|++|++++-.|. ...+.++..+.+.+|.
T Consensus        90 ~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~  135 (635)
T 4g8a_A           90 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN  135 (635)
T ss_dssp             EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSC
T ss_pred             CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCc
Confidence            87777888899999999999988865443 2445566666666654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.63  E-value=6.4e-08  Score=82.74  Aligned_cols=86  Identities=21%  Similarity=0.285  Sum_probs=71.9

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++-.+..++.+++|+.|+|++|.+++..|..+..+++|+.|++++|++++-.+.. ..+.++..+.+
T Consensus        52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  131 (177)
T 2o6r_A           52 TQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL  131 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             ccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEe
Confidence            47899999999998655556799999999999999999877777899999999999999999654432 45677888888


Q ss_pred             ccccccC
Q 015852          146 ENNLNLC  152 (399)
Q Consensus       146 ~~n~~lc  152 (399)
                      .+|+..|
T Consensus       132 ~~N~~~~  138 (177)
T 2o6r_A          132 HTNPWDC  138 (177)
T ss_dssp             CSSCBCC
T ss_pred             cCCCeec
Confidence            8887555

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.63  E-value=5.4e-08  Score=99.56  Aligned_cols=87  Identities=22%  Similarity=0.321  Sum_probs=69.7

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCC-Ccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSF-SQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~-~~~~~~~  144 (399)
                      ..++.|+|++|++++-.|..++++++|+.|+|++|++++..|..+..+++|+.|||++|++++..|.. ..+ .++..++
T Consensus       494 ~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~  573 (635)
T 4g8a_A          494 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN  573 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEE
T ss_pred             cccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEE
Confidence            36788888888888888888888888888888888888888888888888888888888888887753 223 4567778


Q ss_pred             cccccccCC
Q 015852          145 FENNLNLCG  153 (399)
Q Consensus       145 ~~~n~~lcg  153 (399)
                      +++|+..|.
T Consensus       574 L~~Np~~C~  582 (635)
T 4g8a_A          574 LTQNDFACT  582 (635)
T ss_dssp             CTTCCBCCS
T ss_pred             eeCCCCccc
Confidence            888887774

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.60  E-value=7.1e-08  Score=85.78  Aligned_cols=83  Identities=23%  Similarity=0.296  Sum_probs=66.4

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++-.|..+.++++|+.|+|++|.+++..+..+..+++|+.|+|++|.+++..|. ...+.++..+++
T Consensus        56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  135 (220)
T 2v9t_B           56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL  135 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence            4788999999999888888899999999999999999854444567889999999999999887664 245566777777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       136 ~~N~  139 (220)
T 2v9t_B          136 YDNK  139 (220)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            7775

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.59  E-value=3.5e-08  Score=94.10  Aligned_cols=96  Identities=27%  Similarity=0.328  Sum_probs=79.0

Q ss_pred             CCCCcceeeeeCC------------CCCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEE
Q 015852           53 GNLCTWFHITCNP------------EGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNIL  120 (399)
Q Consensus        53 ~~~c~w~gv~c~~------------~~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l  120 (399)
                      ..+|.|.|+ |+-            ...++.|+|++|++++-.+..+.++++|+.|+|++|.+++..|..+..+++|++|
T Consensus        27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            578999987 651            1368999999999997656689999999999999999999888889999999999


Q ss_pred             ecCCCcCcccCCC-CCCCCccccccccccc
Q 015852          121 DLSNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       121 ~ls~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      ++++|++++-.+. ...+.++..+++.+|.
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  135 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNP  135 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCC
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCC
Confidence            9999999864332 3556777788887775

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.58  E-value=9.4e-08  Score=85.48  Aligned_cols=82  Identities=21%  Similarity=0.330  Sum_probs=55.2

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++-.+..+..+++|+.|+|++|.+++..+..+..+++|+.|+|++|+++ .+|.. ..+.++..+++
T Consensus        64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L  142 (229)
T 3e6j_A           64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL  142 (229)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred             cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence            36777888888775333334577778888888888887665556677777888888888777 56532 34455666666


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       143 ~~N~  146 (229)
T 3e6j_A          143 DQNQ  146 (229)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            6664

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.58  E-value=9.6e-08  Score=87.52  Aligned_cols=96  Identities=22%  Similarity=0.322  Sum_probs=47.7

Q ss_pred             CCCCcceeeeeCCCCC---------------------EEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccc
Q 015852           53 GNLCTWFHITCNPEGS---------------------VTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSL  111 (399)
Q Consensus        53 ~~~c~w~gv~c~~~~~---------------------v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~  111 (399)
                      .+.|.|.|+.|.-.+.                     ++.|+|++|++++-.+..+.++++|+.|+|++|.++...+..+
T Consensus         2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~   81 (270)
T 2o6q_A            2 EALCKKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF   81 (270)
T ss_dssp             CCCBGGGTCSBEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTT
T ss_pred             CccCCCCCCCCEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhh
Confidence            3678888777742223                     4455555555543333345555555555555555553222333


Q ss_pred             cCCCCCcEEecCCCcCcccCCCC-CCCCcccccccccc
Q 015852          112 TTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN  148 (399)
Q Consensus       112 ~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~~n  148 (399)
                      ..+++|++|++++|.+++..+.. ..+.++..+.+.+|
T Consensus        82 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  119 (270)
T 2o6q_A           82 KELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN  119 (270)
T ss_dssp             SSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSS
T ss_pred             cCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCC
Confidence            45555555555555555432221 23344444444444

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.57  E-value=8.2e-08  Score=90.78  Aligned_cols=82  Identities=20%  Similarity=0.317  Sum_probs=63.1

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      ..++.|+|++|+++ .+|..++++++|+.|+|++|.+++ +|+.+..+++|+.|++++|++.|.+|.. ..+.++..+++
T Consensus       183 ~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L  260 (328)
T 4fcg_A          183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL  260 (328)
T ss_dssp             TTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred             CCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence            46778888888887 788888888888888888888885 6667888888888888888888888753 45666667777


Q ss_pred             ccccc
Q 015852          146 ENNLN  150 (399)
Q Consensus       146 ~~n~~  150 (399)
                      .+|..
T Consensus       261 ~~n~~  265 (328)
T 4fcg_A          261 KDCSN  265 (328)
T ss_dssp             TTCTT
T ss_pred             CCCCc
Confidence            76653

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.56  E-value=1.1e-07  Score=93.73  Aligned_cols=96  Identities=17%  Similarity=0.284  Sum_probs=74.2

Q ss_pred             CCCccee--eeeCCC---------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccc-cccCCCCCcEEe
Q 015852           54 NLCTWFH--ITCNPE---------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPT-SLTTITSLNILD  121 (399)
Q Consensus        54 ~~c~w~g--v~c~~~---------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~-~~~~l~~L~~l~  121 (399)
                      ..|.|.+  |.|...         .+++.|+|++|.+++..|..++++++|++|+|++|.+.+.+|+ .+..+++|++|+
T Consensus         6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~   85 (455)
T 3v47_A            6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK   85 (455)
T ss_dssp             -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred             ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence            5666665  888742         3688999999999988888899999999999999988888854 688888899999


Q ss_pred             cCCCcCcccCCC-CCCCCccccccccccc
Q 015852          122 LSNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       122 ls~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      +++|.+++..|. ...+.++..+.+.+|.
T Consensus        86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  114 (455)
T 3v47_A           86 LDYNQFLQLETGAFNGLANLEVLTLTQCN  114 (455)
T ss_dssp             CTTCTTCEECTTTTTTCTTCCEEECTTSC
T ss_pred             CCCCccCccChhhccCcccCCEEeCCCCC
Confidence            998888887774 3455666666666654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.55  E-value=2.2e-08  Score=106.79  Aligned_cols=83  Identities=29%  Similarity=0.419  Sum_probs=67.8

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      .+++.|+|++|++++..|..+.++++|+.|+|++|+|++..|..+.  ++|+.|||++|+++|.+|..  +..+..+++.
T Consensus       480 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~  555 (844)
T 3j0a_A          480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDIT  555 (844)
T ss_dssp             CCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEE
T ss_pred             ccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEec
Confidence            4788888888888877777788888999999999999876665555  78899999999999888853  5677888999


Q ss_pred             cccccCC
Q 015852          147 NNLNLCG  153 (399)
Q Consensus       147 ~n~~lcg  153 (399)
                      +|+..|.
T Consensus       556 ~Np~~C~  562 (844)
T 3j0a_A          556 HNKFICE  562 (844)
T ss_dssp             EECCCCS
T ss_pred             CCCcccc
Confidence            9998884

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.54  E-value=1.8e-07  Score=82.07  Aligned_cols=81  Identities=25%  Similarity=0.321  Sum_probs=44.9

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~  146 (399)
                      .++.|+|++|++++-.+..+..+++|+.|+|++|.+++..+..+..+++|+.|++++|++++..|. ...+.++..+++.
T Consensus        53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  132 (208)
T 2o6s_A           53 SLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLY  132 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             cCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECC
Confidence            456666666666533333345666666666666666654444456666666666666666544332 2334445555555


Q ss_pred             cc
Q 015852          147 NN  148 (399)
Q Consensus       147 ~n  148 (399)
                      +|
T Consensus       133 ~N  134 (208)
T 2o6s_A          133 QN  134 (208)
T ss_dssp             SS
T ss_pred             CC
Confidence            54

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.53  E-value=4e-08  Score=102.94  Aligned_cols=79  Identities=32%  Similarity=0.493  Sum_probs=54.7

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~  146 (399)
                      .+..|+|++|.+. .||..++++++|+.|+|++|.|+ .||..+..+++|++|+|++|.|+ .+|.. ..+.++..+.+.
T Consensus       225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~  301 (727)
T 4b8c_D          225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF  301 (727)
T ss_dssp             CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred             CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence            3556777777776 67777777777777777777777 77777777777777777777777 66643 344455555555


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       302 ~N~  304 (727)
T 4b8c_D          302 DNM  304 (727)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            553

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.53  E-value=2e-07  Score=87.01  Aligned_cols=131  Identities=20%  Similarity=0.159  Sum_probs=91.0

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCC--ccceeeeeecCC---ceEEEEec
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRN--LLRLYGFCTTVT---EKLLVYPY  325 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lv~e~  325 (399)
                      .+.++.|....||+..    ..+++|.....   .....+.+|.++++.+. +..  +.+++......+   ..|+||||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4668999999999853    45788875422   22346889999998763 333  334444433332   34889999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH--------------------------------------  367 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------  367 (399)
                      ++|.++......      .++..++..++.++++.|+.||+.                                      
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999888654322      255667777888888888888751                                      


Q ss_pred             -----------------CCCCceecCCCCCceeeCCC--Cceeeccc
Q 015852          368 -----------------CDPKIIHRDVKAANILLDED--ADQSSKTI  395 (399)
Q Consensus       368 -----------------~~~~ivHrDlK~~NILld~~--~~~~i~df  395 (399)
                                       ..+.++|+|+++.||+++++  ....|.||
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~  218 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDF  218 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCC
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeC
Confidence                             12458999999999999984  55789998

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.52  E-value=1.9e-07  Score=84.62  Aligned_cols=83  Identities=22%  Similarity=0.285  Sum_probs=62.4

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++..+..+..+++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..|. ...+.++..+++
T Consensus        83 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  162 (251)
T 3m19_A           83 TELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSL  162 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEEC
Confidence            4678888888888865556678888888888888888866666677888888888888888865552 345666777777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       163 ~~N~  166 (251)
T 3m19_A          163 STNQ  166 (251)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            7775

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.51  E-value=1e-07  Score=95.11  Aligned_cols=94  Identities=15%  Similarity=0.189  Sum_probs=75.8

Q ss_pred             CCcceeeeeCCCCCEEEEEeCCCCceeecChhhccCcCCCeEeccCCccccccccccc-CCCCCcEEecCCCcCcccCCC
Q 015852           55 LCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLT-TITSLNILDLSNNRLSGPVPD  133 (399)
Q Consensus        55 ~c~w~gv~c~~~~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~-~l~~L~~l~ls~N~l~G~iP~  133 (399)
                      .|.+.++.|..-..+..|+|++|.+++..|..++++++|+.|+|++|.++|.+|..+. .+++|+.|+|++|.+++. |.
T Consensus       108 ~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~  186 (487)
T 3oja_A          108 NNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG  186 (487)
T ss_dssp             SSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC
T ss_pred             CCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc
Confidence            3456666666556789999999999988888899999999999999999998888876 789999999999998876 44


Q ss_pred             CCCCCccccccccccc
Q 015852          134 NGSFSQFTPISFENNL  149 (399)
Q Consensus       134 ~~~~~~~~~~~~~~n~  149 (399)
                      ...+..+..+++++|.
T Consensus       187 ~~~l~~L~~L~Ls~N~  202 (487)
T 3oja_A          187 QVVFAKLKTLDLSSNK  202 (487)
T ss_dssp             CCCCTTCCEEECCSSC
T ss_pred             cccCCCCCEEECCCCC
Confidence            4456677777777765

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.51  E-value=2.1e-07  Score=85.36  Aligned_cols=83  Identities=24%  Similarity=0.279  Sum_probs=64.6

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++..|..++++++|+.|++++|.+++..|..+..+++|+.|++++|++++..|.. ..+.++..+.+
T Consensus       109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  188 (272)
T 3rfs_A          109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRL  188 (272)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEEC
Confidence            46888888888888666666788888888888888888777767788888888888888888665543 45667777777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       189 ~~N~  192 (272)
T 3rfs_A          189 YQNQ  192 (272)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            7765

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.51  E-value=7e-08  Score=84.13  Aligned_cols=81  Identities=19%  Similarity=0.331  Sum_probs=40.8

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+|++|++++..|..++.+++|+.|++++|.+++..|..+..+++|+.|++++|.+.+.+|....+.++..+++.+
T Consensus        89 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~  168 (197)
T 4ezg_A           89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQF  168 (197)
T ss_dssp             TCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTT
T ss_pred             CCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCC
Confidence            44555555555555445555555555555555555555555555555555555555555333444333344444444444


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      |
T Consensus       169 n  169 (197)
T 4ezg_A          169 D  169 (197)
T ss_dssp             B
T ss_pred             C
Confidence            3

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.51  E-value=4.3e-08  Score=81.25  Aligned_cols=60  Identities=25%  Similarity=0.342  Sum_probs=30.3

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  129 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G  129 (399)
                      .++.|+|++|.+++.  ..++.+++|+.|+|++|.+++.+|..+..+++|+.|++++|.+++
T Consensus        43 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~  102 (149)
T 2je0_A           43 ELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD  102 (149)
T ss_dssp             TCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCS
T ss_pred             CCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCC
Confidence            445555555555433  344455555555555555555455444445555555555555544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.49  E-value=1.1e-07  Score=96.61  Aligned_cols=80  Identities=29%  Similarity=0.407  Sum_probs=64.7

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccC-CC-CCCCCcccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV-PD-NGSFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~i-P~-~~~~~~~~~~~  144 (399)
                      ..++.|+|++|.++ .+|..++++++|+.|+|++|.+++ || .++.+++|+.|+|++|++++.+ |. ...+.++..++
T Consensus       463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~  539 (567)
T 1dce_A          463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN  539 (567)
T ss_dssp             TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred             ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence            36788888888888 888888888888888888888887 77 7888888888888888888875 53 35566777777


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +++|.
T Consensus       540 L~~N~  544 (567)
T 1dce_A          540 LQGNS  544 (567)
T ss_dssp             CTTSG
T ss_pred             ecCCc
Confidence            77775

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.49  E-value=2.4e-07  Score=94.68  Aligned_cols=97  Identities=15%  Similarity=0.194  Sum_probs=74.8

Q ss_pred             CCCCcce----eeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCc
Q 015852           53 GNLCTWF----HITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLN  118 (399)
Q Consensus        53 ~~~c~w~----gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~  118 (399)
                      .+||.|.    .|.|...          .+++.|+|++|++++-.|..++++++|+.|+|++|.+++..|..+..+++|+
T Consensus         4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~   83 (606)
T 3vq2_A            4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS   83 (606)
T ss_dssp             --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred             CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence            4677663    5778631          3688999999999888777889999999999999999888888888899999


Q ss_pred             EEecCCCcCcccCCC-CCCCCccccccccccc
Q 015852          119 ILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       119 ~l~ls~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      +|++++|.+++..|. ...+.++..+++.+|.
T Consensus        84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~  115 (606)
T 3vq2_A           84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETK  115 (606)
T ss_dssp             EEECTTCCCCCCCTTSSTTCTTCCEEECTTSC
T ss_pred             EeECCCCcccccChhhcCCcccCCEEEccCCc
Confidence            999999998887774 3455666666666664

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.48  E-value=2.5e-07  Score=87.34  Aligned_cols=94  Identities=24%  Similarity=0.335  Sum_probs=79.4

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecC
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLS  123 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls  123 (399)
                      ..|.|..+.|...          ..++.|+|++|.+++-.|..+.++++|+.|+|++|.+++..|..+..+++|+.|+++
T Consensus        31 c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           31 CHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             CcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            3478999999732          368999999999998777889999999999999999999999999999999999999


Q ss_pred             CCcCcccCCCCCCCCccccccccccc
Q 015852          124 NNRLSGPVPDNGSFSQFTPISFENNL  149 (399)
Q Consensus       124 ~N~l~G~iP~~~~~~~~~~~~~~~n~  149 (399)
                      +|.++ .+|.... .++..+.+.+|.
T Consensus       111 ~n~l~-~l~~~~~-~~L~~L~l~~n~  134 (332)
T 2ft3_A          111 KNHLV-EIPPNLP-SSLVELRIHDNR  134 (332)
T ss_dssp             SSCCC-SCCSSCC-TTCCEEECCSSC
T ss_pred             CCcCC-ccCcccc-ccCCEEECCCCc
Confidence            99998 6775432 566677776664

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.47  E-value=1.2e-07  Score=96.42  Aligned_cols=78  Identities=27%  Similarity=0.390  Sum_probs=71.3

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+|++|++++ +|. ++.+++|+.|+|++|.|+ .||..++.+++|+.|+|++|++++ +|....+.++..+++++
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~  517 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCN  517 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCS
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCC
Confidence            47889999999997 776 999999999999999999 999999999999999999999998 78777788888888888


Q ss_pred             cc
Q 015852          148 NL  149 (399)
Q Consensus       148 n~  149 (399)
                      |.
T Consensus       518 N~  519 (567)
T 1dce_A          518 NR  519 (567)
T ss_dssp             SC
T ss_pred             CC
Confidence            75

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.45  E-value=3.4e-07  Score=90.04  Aligned_cols=83  Identities=17%  Similarity=0.229  Sum_probs=60.8

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++..|..++++++|+.|+|++|.+++..|..+..+++|+.|++++|++++..|. ...+.++..+++
T Consensus       299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  378 (455)
T 3v47_A          299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL  378 (455)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence            3677788888888777777777788888888888888777777777778888888888877777663 244556666666


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       379 ~~N~  382 (455)
T 3v47_A          379 DTNQ  382 (455)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            6664

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.45  E-value=7.1e-08  Score=81.66  Aligned_cols=79  Identities=27%  Similarity=0.400  Sum_probs=47.3

Q ss_pred             CEEEEEeCCCCce-eecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCC-CCccccccc
Q 015852           68 SVTRVDLGNAALS-GELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGS-FSQFTPISF  145 (399)
Q Consensus        68 ~v~~l~l~~~~l~-g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~-~~~~~~~~~  145 (399)
                      .++.|+|++|+++ |.+|..+..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++.+|.... +.++..+++
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            4566666666665 56666666666666666666666654  5566666666666666666665553321 444555555


Q ss_pred             ccc
Q 015852          146 ENN  148 (399)
Q Consensus       146 ~~n  148 (399)
                      .+|
T Consensus       103 s~N  105 (168)
T 2ell_A          103 SGN  105 (168)
T ss_dssp             BSS
T ss_pred             cCC
Confidence            554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.43  E-value=3.2e-07  Score=78.43  Aligned_cols=77  Identities=23%  Similarity=0.353  Sum_probs=66.3

Q ss_pred             EEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCcccccccccc
Q 015852           70 TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN  148 (399)
Q Consensus        70 ~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~~n  148 (399)
                      +.+++++|++ +.+|..+.  +.|+.|+|++|++++..|..+..+++|+.|+|++|+|++-.+.. ..+.++..+++++|
T Consensus        15 ~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            6789999998 48888775  89999999999999999999999999999999999999854432 56778888888888


Q ss_pred             c
Q 015852          149 L  149 (399)
Q Consensus       149 ~  149 (399)
                      .
T Consensus        92 ~   92 (174)
T 2r9u_A           92 H   92 (174)
T ss_dssp             C
T ss_pred             c
Confidence            5

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.42  E-value=4.6e-07  Score=89.39  Aligned_cols=92  Identities=22%  Similarity=0.304  Sum_probs=78.0

Q ss_pred             ceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcC
Q 015852           58 WFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  127 (399)
Q Consensus        58 w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l  127 (399)
                      |..|.|...          ..++.|+|++|++++..|..+.++++|+.|+|++|.+++..|..+..+++|+.|+|++|++
T Consensus        56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l  135 (452)
T 3zyi_A           56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL  135 (452)
T ss_dssp             SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence            578889732          3689999999999998899999999999999999999998889999999999999999999


Q ss_pred             cccCCC-CCCCCccccccccccc
Q 015852          128 SGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       128 ~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      ++..+. ...+.++..+.+++|.
T Consensus       136 ~~~~~~~~~~l~~L~~L~L~~N~  158 (452)
T 3zyi_A          136 TVIPSGAFEYLSKLRELWLRNNP  158 (452)
T ss_dssp             SBCCTTTSSSCTTCCEEECCSCC
T ss_pred             CccChhhhcccCCCCEEECCCCC
Confidence            865554 3456677777777775

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.40  E-value=3e-07  Score=94.79  Aligned_cols=81  Identities=23%  Similarity=0.279  Sum_probs=67.2

Q ss_pred             CEEEEEeCCCCceeecChhhc--cCcCCCeEeccCCcccccccccccCCCCCcEEec------CCCcCcccCCCC-CCCC
Q 015852           68 SVTRVDLGNAALSGELAPELG--QLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL------SNNRLSGPVPDN-GSFS  138 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~--~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~l------s~N~l~G~iP~~-~~~~  138 (399)
                      .++.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|++      ++|++.|.+|.. ..+.
T Consensus       489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~  566 (636)
T 4eco_A          489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP  566 (636)
T ss_dssp             GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred             CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence            7888999999988 7888887  89999999999999998 8888889999999988      567888888853 4566


Q ss_pred             cccccccccccc
Q 015852          139 QFTPISFENNLN  150 (399)
Q Consensus       139 ~~~~~~~~~n~~  150 (399)
                      ++..+++++|..
T Consensus       567 ~L~~L~Ls~N~l  578 (636)
T 4eco_A          567 SLTQLQIGSNDI  578 (636)
T ss_dssp             SCCEEECCSSCC
T ss_pred             CCCEEECCCCcC
Confidence            777778877763

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.40  E-value=4.2e-07  Score=86.97  Aligned_cols=96  Identities=25%  Similarity=0.280  Sum_probs=75.1

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecChhhc-cCcCCCeEeccCCcccccccccccCCCCCcEEec
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELG-QLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL  122 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~-~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~l  122 (399)
                      ..|.|..|.|...          ..++.|+|++|++++-.+..+. ++++|+.|+|++|++++..|..+..+++|+.|+|
T Consensus        16 C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L   95 (361)
T 2xot_A           16 CLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL   95 (361)
T ss_dssp             CEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence            4467888899632          2477899999999877666676 8999999999999999877778899999999999


Q ss_pred             CCCcCcccCCC-CCCCCccccccccccc
Q 015852          123 SNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       123 s~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      ++|++++..|. ...+.++..+.+.+|.
T Consensus        96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~  123 (361)
T 2xot_A           96 SSNHLHTLDEFLFSDLQALEVLLLYNNH  123 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCcCCcCCHHHhCCCcCCCEEECCCCc
Confidence            99999876553 3456667777777765

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.40  E-value=1.3e-07  Score=78.42  Aligned_cols=80  Identities=26%  Similarity=0.395  Sum_probs=59.1

Q ss_pred             CEEEEEeCCCCce-eecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCC-CCCccccccc
Q 015852           68 SVTRVDLGNAALS-GELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG-SFSQFTPISF  145 (399)
Q Consensus        68 ~v~~l~l~~~~l~-g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~-~~~~~~~~~~  145 (399)
                      +++.+++++|+++ |.+|..+..+++|+.|++++|.+++.  ..+..+++|+.|++++|.+++.+|... .+.++..+++
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            5777888888887 77887778888888888888888765  667778888888888888887666432 2555666666


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      ++|.
T Consensus        96 s~N~   99 (149)
T 2je0_A           96 SGNK   99 (149)
T ss_dssp             TTSC
T ss_pred             CCCc
Confidence            6664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.39  E-value=5.3e-07  Score=84.95  Aligned_cols=94  Identities=24%  Similarity=0.354  Sum_probs=78.2

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecC
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLS  123 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls  123 (399)
                      ..|.|..+.|...          ..++.|+|++|++++..+..++++++|++|+|++|.+++..|..+..+++|+.|+++
T Consensus        29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            4568999999732          368899999999998777789999999999999999999889999999999999999


Q ss_pred             CCcCcccCCCCCCCCccccccccccc
Q 015852          124 NNRLSGPVPDNGSFSQFTPISFENNL  149 (399)
Q Consensus       124 ~N~l~G~iP~~~~~~~~~~~~~~~n~  149 (399)
                      +|.++ .+|... +.++..+.+.+|.
T Consensus       109 ~n~l~-~l~~~~-~~~L~~L~l~~n~  132 (330)
T 1xku_A          109 KNQLK-ELPEKM-PKTLQELRVHENE  132 (330)
T ss_dssp             SSCCS-BCCSSC-CTTCCEEECCSSC
T ss_pred             CCcCC-ccChhh-cccccEEECCCCc
Confidence            99998 566532 2556666666664

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.38  E-value=2.9e-07  Score=77.83  Aligned_cols=80  Identities=21%  Similarity=0.238  Sum_probs=53.0

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccC--CCCCCCCccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV--PDNGSFSQFTPISF  145 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~i--P~~~~~~~~~~~~~  145 (399)
                      .++.|+|++|.+++.  ..++.+++|+.|+|++|.+++.+|..+..+++|+.|++++|++++.-  +....+.++..+++
T Consensus        50 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l  127 (168)
T 2ell_A           50 NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDL  127 (168)
T ss_dssp             GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEEC
T ss_pred             CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEe
Confidence            567777777777654  55677777777777777777776666666777777777777776621  33344555666666


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       128 ~~N~  131 (168)
T 2ell_A          128 FNCE  131 (168)
T ss_dssp             CSSG
T ss_pred             eCCc
Confidence            6664

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.37  E-value=8.1e-08  Score=97.53  Aligned_cols=92  Identities=24%  Similarity=0.411  Sum_probs=61.6

Q ss_pred             CCCCCCCCCCCC-----cceee-eeCCCCCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCc
Q 015852           45 LQSWDNLPGNLC-----TWFHI-TCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLN  118 (399)
Q Consensus        45 l~~w~~~~~~~c-----~w~gv-~c~~~~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~  118 (399)
                      +.+|.. +.+||     .|.|+ .|. .++++.|+|++|++++ ||..+.  ++|+.|+|++|+|+ .||   ..+++|+
T Consensus        33 l~~W~~-~~~~~~~~~~~~~~l~~C~-~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~  103 (571)
T 3cvr_A           33 WDKWEK-QALPGENRNEAVSLLKECL-INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLE  103 (571)
T ss_dssp             HHHHHT-TCCTTCCHHHHHHHHHHHH-HTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred             HHHHhc-cCCccccccchhhhccccc-cCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCC
Confidence            446744 46788     79999 786 3578888888888886 777663  66777777777777 566   3456677


Q ss_pred             EEecCCCcCcccCCCCCCCCcccccccccc
Q 015852          119 ILDLSNNRLSGPVPDNGSFSQFTPISFENN  148 (399)
Q Consensus       119 ~l~ls~N~l~G~iP~~~~~~~~~~~~~~~n  148 (399)
                      .|++++|+|++ ||...  .++..+.+++|
T Consensus       104 ~L~Ls~N~l~~-ip~l~--~~L~~L~Ls~N  130 (571)
T 3cvr_A          104 YLDACDNRLST-LPELP--ASLKHLDVDNN  130 (571)
T ss_dssp             EEECCSSCCSC-CCCCC--TTCCEEECCSS
T ss_pred             EEEccCCCCCC-cchhh--cCCCEEECCCC
Confidence            77777777766 56521  14444455444

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.37  E-value=7.3e-07  Score=82.99  Aligned_cols=83  Identities=20%  Similarity=0.354  Sum_probs=65.2

Q ss_pred             CCEEEEEeCCCCcee-ecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCC-CCCCCCcccccc
Q 015852           67 GSVTRVDLGNAALSG-ELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP-DNGSFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g-~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP-~~~~~~~~~~~~  144 (399)
                      ..++.|+|++|.+++ .+|..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|.+++..+ ....+.++..++
T Consensus       150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  229 (306)
T 2z66_A          150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD  229 (306)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred             cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence            468888888888887 577788888888888888888888888888888888888888888877544 234456677777


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +++|.
T Consensus       230 L~~N~  234 (306)
T 2z66_A          230 YSLNH  234 (306)
T ss_dssp             CTTSC
T ss_pred             CCCCC
Confidence            77775

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.37  E-value=3.2e-07  Score=84.61  Aligned_cols=83  Identities=22%  Similarity=0.259  Sum_probs=57.6

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++..+..++.+++|+.|+|++|.+++..+..+..+++|+.|++++|.+++..|.. ..+.++..+++
T Consensus       129 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  208 (285)
T 1ozn_A          129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL  208 (285)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeC
Confidence            36777888888777555555777778888888888777655556777777888888888777766642 34555666666


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       209 ~~n~  212 (285)
T 1ozn_A          209 FANN  212 (285)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            6664

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.36  E-value=5.3e-07  Score=88.58  Aligned_cols=86  Identities=19%  Similarity=0.244  Sum_probs=67.5

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~  146 (399)
                      .++.|+|++|++++..|..+.++++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..+.. ..+.++..+++.
T Consensus       208 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  287 (440)
T 3zyj_A          208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH  287 (440)
T ss_dssp             SCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECC
T ss_pred             ccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcC
Confidence            5677778888888777778888888888888888888888888888888888888888888654432 456677788888


Q ss_pred             cccccCC
Q 015852          147 NNLNLCG  153 (399)
Q Consensus       147 ~n~~lcg  153 (399)
                      +|+..|.
T Consensus       288 ~Np~~Cd  294 (440)
T 3zyj_A          288 HNPWNCN  294 (440)
T ss_dssp             SSCEECS
T ss_pred             CCCccCC
Confidence            8987774

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.36  E-value=5.5e-07  Score=88.77  Aligned_cols=86  Identities=17%  Similarity=0.230  Sum_probs=66.0

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~  146 (399)
                      .++.|+|++|.+++..|..+.++++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..+.. ..+.++..+++.
T Consensus       219 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  298 (452)
T 3zyi_A          219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLH  298 (452)
T ss_dssp             TCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECC
T ss_pred             cccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEcc
Confidence            5667777777777777777888888888888888888887888888888888888888888554432 446677778888


Q ss_pred             cccccCC
Q 015852          147 NNLNLCG  153 (399)
Q Consensus       147 ~n~~lcg  153 (399)
                      +|+..|.
T Consensus       299 ~Np~~Cd  305 (452)
T 3zyi_A          299 HNPWNCD  305 (452)
T ss_dssp             SSCEECS
T ss_pred             CCCcCCC
Confidence            8887664

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.36  E-value=7e-07  Score=75.89  Aligned_cols=78  Identities=27%  Similarity=0.385  Sum_probs=67.0

Q ss_pred             EEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccccc
Q 015852           69 VTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFEN  147 (399)
Q Consensus        69 v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~~  147 (399)
                      .+.+++++|+++ .+|..+.  +.|+.|+|++|++++..|..+..+++|+.|+|++|++++-.|.. ..+.++..+++++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            368999999998 4887664  88999999999999999999999999999999999999665543 5677888888888


Q ss_pred             cc
Q 015852          148 NL  149 (399)
Q Consensus       148 n~  149 (399)
                      |.
T Consensus        88 N~   89 (170)
T 3g39_A           88 NQ   89 (170)
T ss_dssp             SC
T ss_pred             Cc
Confidence            85

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.35  E-value=2e-07  Score=86.82  Aligned_cols=95  Identities=31%  Similarity=0.383  Sum_probs=72.3

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecChh-hccCcCCCeEeccCCccc--ccccccccCCCCCcEE
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPE-LGQLKNLELLRLNNNSLS--GLIPTSLTTITSLNIL  120 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~-l~~l~~L~~l~l~~n~l~--G~ip~~~~~l~~L~~l  120 (399)
                      ..|.|.+|.|+..          ..++.|+|++|+++ .+|+. +.++++|+.|+|++|.++  |.+|..+..+++|+.|
T Consensus         5 C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L   83 (306)
T 2z66_A            5 CSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL   83 (306)
T ss_dssp             CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEE
T ss_pred             CeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEE
Confidence            4578999999842          36899999999998 67765 689999999999999987  4457777788888888


Q ss_pred             ecCCCcCcccCCCCCCCCccccccccccc
Q 015852          121 DLSNNRLSGPVPDNGSFSQFTPISFENNL  149 (399)
Q Consensus       121 ~ls~N~l~G~iP~~~~~~~~~~~~~~~n~  149 (399)
                      ++++|.+++-.+....+.++..+.+.+|.
T Consensus        84 ~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~  112 (306)
T 2z66_A           84 DLSFNGVITMSSNFLGLEQLEHLDFQHSN  112 (306)
T ss_dssp             ECCSCSEEEEEEEEETCTTCCEEECTTSE
T ss_pred             ECCCCccccChhhcCCCCCCCEEECCCCc
Confidence            88888887532223445566666666664

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.35  E-value=9.3e-07  Score=87.63  Aligned_cols=93  Identities=24%  Similarity=0.307  Sum_probs=72.3

Q ss_pred             cceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCc
Q 015852           57 TWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR  126 (399)
Q Consensus        57 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~  126 (399)
                      .|..|.|...          ..++.|+|++|++++-.|..+.++++|+.|+|++|.+++..|..+..+++|++|+|++|+
T Consensus        12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            3678888632          357889999999988878888999999999999999998888888899999999999998


Q ss_pred             CcccCCC-CCCCCccccccccccc
Q 015852          127 LSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       127 l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      +++-.+. ...+.++..+++++|.
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~  115 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENK  115 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSC
T ss_pred             CCccCcccccCCCCCCEEECCCCc
Confidence            8754332 2455666666666664

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.34  E-value=4e-07  Score=79.23  Aligned_cols=81  Identities=16%  Similarity=0.226  Sum_probs=70.6

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..++.|+|++|++++..|..++.+++|+.|++++|.+.+.+| .+..+++|+.|++++|.+++ +|....+.++..+++.
T Consensus       112 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~  189 (197)
T 4ezg_A          112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAF  189 (197)
T ss_dssp             TTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEEC
T ss_pred             CCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEee
Confidence            478999999999999899999999999999999999667787 68999999999999999987 4555667777888888


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       190 ~N~  192 (197)
T 4ezg_A          190 SQT  192 (197)
T ss_dssp             BC-
T ss_pred             Ccc
Confidence            875

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.34  E-value=1.2e-06  Score=80.33  Aligned_cols=82  Identities=15%  Similarity=0.151  Sum_probs=69.2

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~  146 (399)
                      .++.|+|++|++++..+..+.++++|+.|+|++|.+++..+..+..+++|+.|++++|.+++..|. ...+.++..+.+.
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            589999999999977777899999999999999999987777899999999999999999887654 3456667777777


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       109 ~n~  111 (276)
T 2z62_A          109 ETN  111 (276)
T ss_dssp             TSC
T ss_pred             CCC
Confidence            664

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.34  E-value=3.1e-07  Score=96.14  Aligned_cols=80  Identities=28%  Similarity=0.429  Sum_probs=71.1

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|.|+ .||..+++|++|+.|+|++|.|+ .||..++.+++|++|+|++|.|+ .||. ...+.++..+.+
T Consensus       247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L  323 (727)
T 4b8c_D          247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV  323 (727)
T ss_dssp             CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred             CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence            46889999999999 99999999999999999999999 89999999999999999999996 7785 456677788888


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      ++|.
T Consensus       324 ~~N~  327 (727)
T 4b8c_D          324 EGNP  327 (727)
T ss_dssp             TTSC
T ss_pred             CCCc
Confidence            8876

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.33  E-value=6e-07  Score=90.84  Aligned_cols=82  Identities=23%  Similarity=0.406  Sum_probs=53.2

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCccc-ccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLS-GLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~-G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      +++.|+|++|.+.+.+|..+.++++|+.|++++|.++ |.+|..+..+++|+.|++++|++++..|.. ..+.++..+.+
T Consensus       422 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  501 (570)
T 2z63_A          422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM  501 (570)
T ss_dssp             TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeC
Confidence            5666777777776666666666777777777777766 566666666777777777777776665532 34455555566


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       502 ~~n~  505 (570)
T 2z63_A          502 ASNQ  505 (570)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            5553

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.33  E-value=9e-07  Score=90.51  Aligned_cols=81  Identities=20%  Similarity=0.225  Sum_probs=47.0

Q ss_pred             EEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccccc
Q 015852           69 VTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFEN  147 (399)
Q Consensus        69 v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~~  147 (399)
                      ++.|+|++|.+++..|..++.+++|+.|+|++|.+++..|..++.+++|++|+|++|.+++-.|.. ..+.++..+.+.+
T Consensus        77 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~  156 (597)
T 3oja_B           77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSN  156 (597)
T ss_dssp             CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeC
Confidence            455666666666555556666666666666666666655555666666666666666666333221 3444555555555


Q ss_pred             cc
Q 015852          148 NL  149 (399)
Q Consensus       148 n~  149 (399)
                      |.
T Consensus       157 N~  158 (597)
T 3oja_B          157 NN  158 (597)
T ss_dssp             SC
T ss_pred             Cc
Confidence            53

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.33  E-value=4.9e-07  Score=85.78  Aligned_cols=77  Identities=22%  Similarity=0.221  Sum_probs=68.3

Q ss_pred             EEEeCCC-CceeecChhhccCcCCCeEeccC-CcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccccc
Q 015852           71 RVDLGNA-ALSGELAPELGQLKNLELLRLNN-NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFEN  147 (399)
Q Consensus        71 ~l~l~~~-~l~g~ip~~l~~l~~L~~l~l~~-n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~~  147 (399)
                      .++++++ +|+ .||. +..+++|+.|+|++ |.|++..|..|..+++|+.|+|++|+|+|..|.. ..+.++..+++++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4689988 888 4999 99999999999996 9999988889999999999999999999988754 6677888888888


Q ss_pred             cc
Q 015852          148 NL  149 (399)
Q Consensus       148 n~  149 (399)
                      |.
T Consensus        90 N~   91 (347)
T 2ifg_A           90 NA   91 (347)
T ss_dssp             SC
T ss_pred             Cc
Confidence            86

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.32  E-value=3.1e-06  Score=77.23  Aligned_cols=131  Identities=18%  Similarity=0.114  Sum_probs=90.8

Q ss_pred             ceeeccCCc-eEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceEEEEecCCCC
Q 015852          253 NILGRGGFG-KVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       253 ~~lG~G~fg-~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g  329 (399)
                      +.+..|..| .||+.... ++..+.+|+-...    ....+.+|...++.+. +--+.++++++...+..++|||++++.
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            345556665 58987754 4567888875432    2346788998887664 334667888888888999999999998


Q ss_pred             ChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 015852          330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-----------------------------------------  368 (399)
Q Consensus       330 sL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------------  368 (399)
                      ++.+.....        ......++.++++.|+-||+..                                         
T Consensus       106 ~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          106 TAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             EHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             cccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            877654321        1223345555666666666420                                         


Q ss_pred             --------------CCCceecCCCCCceeeCCCCceeeccc
Q 015852          369 --------------DPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       369 --------------~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                                    .+.++|+|+.+.|||+++++..-|.||
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDw  218 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDV  218 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEEC
Confidence                          123799999999999998777778897

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.32  E-value=9.4e-07  Score=80.98  Aligned_cols=83  Identities=23%  Similarity=0.271  Sum_probs=72.2

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      ..++.|+|++|.+++..|..++++++|+.|+|++|.+++..|..+..+++|+.|++++|++++..|.. ..+.++..+.+
T Consensus        85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  164 (272)
T 3rfs_A           85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL  164 (272)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence            47999999999999776667899999999999999999888888999999999999999999766643 56777888888


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       165 ~~n~  168 (272)
T 3rfs_A          165 SYNQ  168 (272)
T ss_dssp             CSSC
T ss_pred             CCCC
Confidence            8875

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.31  E-value=6.9e-07  Score=91.27  Aligned_cols=65  Identities=20%  Similarity=0.288  Sum_probs=33.0

Q ss_pred             CEEEEEeCCCCceee-cChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCC
Q 015852           68 SVTRVDLGNAALSGE-LAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  132 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~-ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP  132 (399)
                      +++.|+|++|++++. +|..++.+++|+.|+|++|.+++.+|..+..+++|+.|++++|++++.+|
T Consensus       449 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  514 (606)
T 3vq2_A          449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS  514 (606)
T ss_dssp             TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEG
T ss_pred             CCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCH
Confidence            445555555555542 44445555555555555555555545455555555555555555554444

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.30  E-value=1.3e-06  Score=79.85  Aligned_cols=83  Identities=23%  Similarity=0.290  Sum_probs=63.5

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++..|..++.+++|+.|+|++|.+++..+..+..+++|+.|++++|.+++..|. ...+.++..+++
T Consensus       109 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  188 (270)
T 2o6q_A          109 VNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL  188 (270)
T ss_dssp             SSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEEC
Confidence            3688888888888876666778888888888888888876556678888888888888888775443 344566777777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       189 ~~N~  192 (270)
T 2o6q_A          189 DNNQ  192 (270)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            7764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.29  E-value=4.2e-06  Score=78.11  Aligned_cols=131  Identities=15%  Similarity=0.135  Sum_probs=85.1

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC---Cccceeeeee-cCCceEEEEecCC
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---NLLRLYGFCT-TVTEKLLVYPYMT  327 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~e~~~  327 (399)
                      .+.++.|....||+.    +..+++|.-..   ......+.+|.+++..+.+.   .+.+.+.++. ..+..+++|||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356888888899987    45678887421   12234688999999988753   2455666664 3456789999999


Q ss_pred             CCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 015852          328 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH----------------------------------------  367 (399)
Q Consensus       328 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  367 (399)
                      |..+......      .++..++..++.++++.|+.||+.                                        
T Consensus        97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9887653211      122333344444444444444432                                        


Q ss_pred             -----------------CCCCceecCCCCCceeeCC---CCce-eeccc
Q 015852          368 -----------------CDPKIIHRDVKAANILLDE---DADQ-SSKTI  395 (399)
Q Consensus       368 -----------------~~~~ivHrDlK~~NILld~---~~~~-~i~df  395 (399)
                                       ..+.++|+|+++.|||+++   ++.. .|.||
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~  219 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDF  219 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCC
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEeh
Confidence                             2345799999999999998   4554 78998

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.29  E-value=8.4e-07  Score=89.98  Aligned_cols=81  Identities=22%  Similarity=0.305  Sum_probs=62.7

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..++.|+|++|.+++-.|..+.++++|+.|+|++|.+++..|..+..+++|++||+++|+++ .+|.. .+.++..++++
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~l~~L~~L~Ls  129 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC-PMASLRHLDLS  129 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC-CCTTCSEEECC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc-ccccCCEEECC
Confidence            46788888888888766677888888888888888888877778888888888888888887 57765 66666666666


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       130 ~N~  132 (562)
T 3a79_B          130 FND  132 (562)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            665

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.28  E-value=6.4e-07  Score=83.72  Aligned_cols=81  Identities=21%  Similarity=0.255  Sum_probs=62.3

Q ss_pred             CCEEEEEeCCCCce--eecChh-hccCcCCCeEeccCCcccccccccccCC---CCCcEEecCCCcCcccCCCCCCCCcc
Q 015852           67 GSVTRVDLGNAALS--GELAPE-LGQLKNLELLRLNNNSLSGLIPTSLTTI---TSLNILDLSNNRLSGPVPDNGSFSQF  140 (399)
Q Consensus        67 ~~v~~l~l~~~~l~--g~ip~~-l~~l~~L~~l~l~~n~l~G~ip~~~~~l---~~L~~l~ls~N~l~G~iP~~~~~~~~  140 (399)
                      ..++.|+|++|+++  +.++.. ++++++|+.|+|++|.+++.+|+.+..+   ++|+.|++++|+++ .+|... ..++
T Consensus       197 ~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~-~~~L  274 (310)
T 4glp_A          197 PAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL-PAKL  274 (310)
T ss_dssp             CCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC-CSCC
T ss_pred             CCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh-cCCC
Confidence            46888899999886  223333 4778899999999999998888887776   58999999999998 777643 3667


Q ss_pred             ccccccccc
Q 015852          141 TPISFENNL  149 (399)
Q Consensus       141 ~~~~~~~n~  149 (399)
                      ..+++++|.
T Consensus       275 ~~L~Ls~N~  283 (310)
T 4glp_A          275 RVLDLSSNR  283 (310)
T ss_dssp             SCEECCSCC
T ss_pred             CEEECCCCc
Confidence            777777775

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.28  E-value=5.6e-07  Score=90.19  Aligned_cols=78  Identities=22%  Similarity=0.254  Sum_probs=37.0

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcc-cCCC-CCCCCccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG-PVPD-NGSFSQFTPISF  145 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G-~iP~-~~~~~~~~~~~~  145 (399)
                      +++.|+|++|++++..|..++++++|++|+|++|+++ .||..  .+++|++|++++|.+++ .+|. ...+.++..+++
T Consensus        46 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L  122 (520)
T 2z7x_B           46 KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL  122 (520)
T ss_dssp             TCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEE
T ss_pred             cccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEe
Confidence            4445555555555444445555555555555555554 34443  45555555555555544 3432 223334444444


Q ss_pred             ccc
Q 015852          146 ENN  148 (399)
Q Consensus       146 ~~n  148 (399)
                      .+|
T Consensus       123 ~~n  125 (520)
T 2z7x_B          123 STT  125 (520)
T ss_dssp             EES
T ss_pred             cCc
Confidence            444

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.28  E-value=4.9e-07  Score=77.17  Aligned_cols=79  Identities=22%  Similarity=0.249  Sum_probs=52.9

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC---CCCCCcccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD---NGSFSQFTPIS  144 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~---~~~~~~~~~~~  144 (399)
                      .++.|+|++|.+++-  +.++.+++|+.|+|++|.+++..|..+..+++|+.|++++|.++ .+|.   ...+.++..++
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            677788888887764  56777778888888888887543334477778888888888773 4443   23444555566


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +.+|+
T Consensus       120 l~~N~  124 (176)
T 1a9n_A          120 ILRNP  124 (176)
T ss_dssp             CCSSG
T ss_pred             ecCCC
Confidence            66664

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.27  E-value=1.2e-06  Score=89.50  Aligned_cols=82  Identities=16%  Similarity=0.121  Sum_probs=67.6

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~  146 (399)
                      .++.|+|++|.+++-.|..++++++|++|+|++|.+++..|..|..+++|++|++++|++++..|. ...+.++..+.+.
T Consensus        34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  113 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI  113 (606)
T ss_dssp             TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred             cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence            688999999999988888899999999999999999988888899999999999999999887774 3445556666666


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       114 ~n~  116 (606)
T 3t6q_A          114 QTG  116 (606)
T ss_dssp             TSC
T ss_pred             ccC
Confidence            554

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.26  E-value=7.6e-07  Score=89.24  Aligned_cols=83  Identities=25%  Similarity=0.324  Sum_probs=71.9

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccc--cccccccCCCCCcEEecCCCcCcccCCCC--CCCCcccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSG--LIPTSLTTITSLNILDLSNNRLSGPVPDN--GSFSQFTP  142 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G--~ip~~~~~l~~L~~l~ls~N~l~G~iP~~--~~~~~~~~  142 (399)
                      ..++.|+|++|++++.+|..++.+++|+.|+|++|++++  .+|..+..+++|+.|++++|.+++.+|..  ..+.++..
T Consensus       324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~  403 (520)
T 2z7x_B          324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS  403 (520)
T ss_dssp             CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred             CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence            578999999999999999999999999999999999998  78888999999999999999999988853  44566777


Q ss_pred             ccccccc
Q 015852          143 ISFENNL  149 (399)
Q Consensus       143 ~~~~~n~  149 (399)
                      +.+++|.
T Consensus       404 L~Ls~N~  410 (520)
T 2z7x_B          404 LNMSSNI  410 (520)
T ss_dssp             EECCSSC
T ss_pred             EECcCCC
Confidence            7777764

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.26  E-value=1e-06  Score=93.69  Aligned_cols=81  Identities=20%  Similarity=0.299  Sum_probs=68.4

Q ss_pred             CEEEEEeCCCCceeecChhhc--cCcCCCeEeccCCcccccccccccCCCCCcEEecCC------CcCcccCCCC-CCCC
Q 015852           68 SVTRVDLGNAALSGELAPELG--QLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSN------NRLSGPVPDN-GSFS  138 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~--~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~------N~l~G~iP~~-~~~~  138 (399)
                      .++.|+|++|+++ .+|..+.  .+++|+.|+|++|.++| +|..+..+++|+.|+|++      |++.|.+|.. ..+.
T Consensus       729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~  806 (876)
T 4ecn_A          729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP  806 (876)
T ss_dssp             GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCS
T ss_pred             CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCC
Confidence            7889999999998 8898887  89999999999999998 898999999999999976      8888888853 4566


Q ss_pred             cccccccccccc
Q 015852          139 QFTPISFENNLN  150 (399)
Q Consensus       139 ~~~~~~~~~n~~  150 (399)
                      ++..+++++|..
T Consensus       807 ~L~~L~Ls~N~L  818 (876)
T 4ecn_A          807 SLIQLQIGSNDI  818 (876)
T ss_dssp             SCCEEECCSSCC
T ss_pred             CCCEEECCCCCC
Confidence            777788887763

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.26  E-value=5.9e-07  Score=84.09  Aligned_cols=82  Identities=24%  Similarity=0.255  Sum_probs=65.5

Q ss_pred             CCCEEEEEeCCCCcee--ecChhh-ccCcCCCeEeccCCccccccc-ccccCCCCCcEEecCCCcCcccCCCCCCCCccc
Q 015852           66 EGSVTRVDLGNAALSG--ELAPEL-GQLKNLELLRLNNNSLSGLIP-TSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT  141 (399)
Q Consensus        66 ~~~v~~l~l~~~~l~g--~ip~~l-~~l~~L~~l~l~~n~l~G~ip-~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~  141 (399)
                      -.+++.|+|++|++++  .++..+ .++++|+.|+|++|.+++.+| +.+..+++|+.|++++|+++ .+|.... .++.
T Consensus       200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~L~  277 (312)
T 1wwl_A          200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AKLS  277 (312)
T ss_dssp             CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SEEE
T ss_pred             CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CCce
Confidence            3578999999999983  455443 578999999999999999886 45677899999999999998 8886543 6677


Q ss_pred             cccccccc
Q 015852          142 PISFENNL  149 (399)
Q Consensus       142 ~~~~~~n~  149 (399)
                      .+++++|.
T Consensus       278 ~L~Ls~N~  285 (312)
T 1wwl_A          278 VLDLSYNR  285 (312)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCC
Confidence            78887775

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.24  E-value=4.1e-07  Score=85.13  Aligned_cols=80  Identities=19%  Similarity=0.318  Sum_probs=38.4

Q ss_pred             CEEEEEeCCCCceeecChhh--ccCcCCCeEeccCCcccccccccccCC-----CCCcEEecCCCcCcccCCC-CCCCCc
Q 015852           68 SVTRVDLGNAALSGELAPEL--GQLKNLELLRLNNNSLSGLIPTSLTTI-----TSLNILDLSNNRLSGPVPD-NGSFSQ  139 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l--~~l~~L~~l~l~~n~l~G~ip~~~~~l-----~~L~~l~ls~N~l~G~iP~-~~~~~~  139 (399)
                      +++.|+|++|+++|.+|..+  +.+++|+.|+|++|.+++. |..+..+     ++|++|++++|++++..|. ...+.+
T Consensus        96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A           96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            34455555555555555444  4555555555555555544 4444443     4555555555555444332 233444


Q ss_pred             ccccccccc
Q 015852          140 FTPISFENN  148 (399)
Q Consensus       140 ~~~~~~~~n  148 (399)
                      +..+++++|
T Consensus       175 L~~L~Ls~N  183 (312)
T 1wwl_A          175 LSTLDLSDN  183 (312)
T ss_dssp             CCEEECCSC
T ss_pred             CCEEECCCC
Confidence            444444444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.24  E-value=5.3e-07  Score=92.09  Aligned_cols=65  Identities=26%  Similarity=0.387  Sum_probs=39.4

Q ss_pred             CEEEEEeCCCCceee-c--ChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCC
Q 015852           68 SVTRVDLGNAALSGE-L--APELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  132 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~-i--p~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP  132 (399)
                      +++.|+|++|++++. +  +..+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++.+|
T Consensus       450 ~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  517 (606)
T 3t6q_A          450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI  517 (606)
T ss_dssp             TCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGG
T ss_pred             CCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCCh
Confidence            566666666666542 2  2345666666666666666666666666666666666666666666555

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.23  E-value=2.2e-06  Score=79.42  Aligned_cols=82  Identities=27%  Similarity=0.355  Sum_probs=66.9

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC--CCCCcccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN--GSFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~--~~~~~~~~~~  144 (399)
                      ..++.|+|++|++++-.|..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|++++ +|..  ..+.++..+.
T Consensus       100 ~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~  178 (290)
T 1p9a_G          100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLL  178 (290)
T ss_dssp             TTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC-CCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc-cCHHHhcCcCCCCEEE
Confidence            478899999999986666778999999999999999997766678889999999999999985 4432  4466777777


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +.+|.
T Consensus       179 L~~N~  183 (290)
T 1p9a_G          179 LQENS  183 (290)
T ss_dssp             CCSSC
T ss_pred             CCCCc
Confidence            87775

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.23  E-value=2.7e-06  Score=83.47  Aligned_cols=92  Identities=20%  Similarity=0.297  Sum_probs=75.7

Q ss_pred             ceeeeeCCC----------CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcC
Q 015852           58 WFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  127 (399)
Q Consensus        58 w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l  127 (399)
                      |..|.|...          ..++.|+|++|++++-.+..+.++++|+.|+|++|.+++..|..+..+++|+.|+|++|++
T Consensus        45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l  124 (440)
T 3zyj_A           45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL  124 (440)
T ss_dssp             SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred             CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence            678999732          3578999999999988888999999999999999999988888899999999999999999


Q ss_pred             cccCCC-CCCCCccccccccccc
Q 015852          128 SGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       128 ~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      ++-.+. ...+.++..+.+.+|.
T Consensus       125 ~~~~~~~~~~l~~L~~L~L~~N~  147 (440)
T 3zyj_A          125 TTIPNGAFVYLSKLKELWLRNNP  147 (440)
T ss_dssp             SSCCTTTSCSCSSCCEEECCSCC
T ss_pred             CeeCHhHhhccccCceeeCCCCc
Confidence            855442 3456667777777765

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.21  E-value=1.7e-06  Score=92.24  Aligned_cols=82  Identities=21%  Similarity=0.248  Sum_probs=58.3

Q ss_pred             CEEEEEeCCCCceeec-ChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC---CCCCCccccc
Q 015852           68 SVTRVDLGNAALSGEL-APELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD---NGSFSQFTPI  143 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~i-p~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~---~~~~~~~~~~  143 (399)
                      .++.|+|++|...+.| |..++++++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++.+|.   ...+.++..+
T Consensus        49 ~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L  128 (844)
T 3j0a_A           49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL  128 (844)
T ss_dssp             SCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEE
T ss_pred             cCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEE
Confidence            4566666666666666 45677777788888888888777777788888888888888888877665   3445566666


Q ss_pred             cccccc
Q 015852          144 SFENNL  149 (399)
Q Consensus       144 ~~~~n~  149 (399)
                      ++++|.
T Consensus       129 ~Ls~N~  134 (844)
T 3j0a_A          129 DLSKNQ  134 (844)
T ss_dssp             EEESCC
T ss_pred             ECCCCc
Confidence            666664

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.21  E-value=1.9e-06  Score=82.33  Aligned_cols=83  Identities=19%  Similarity=0.195  Sum_probs=68.7

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      .+++.|+|++|++++-.|..+.++++|+.|+|++|.|++..+..+..+++|+.|+|++|++++..|. ...+.++..+.+
T Consensus        64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  143 (361)
T 2xot_A           64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL  143 (361)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence            4788999999999877777899999999999999999887777888999999999999999877663 345666777777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      ++|.
T Consensus       144 ~~N~  147 (361)
T 2xot_A          144 SQNQ  147 (361)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            7775

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.19  E-value=2.7e-06  Score=78.83  Aligned_cols=82  Identities=24%  Similarity=0.247  Sum_probs=71.3

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      ..++.|+|++|+++ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|.. ..+.++..+++
T Consensus        77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  155 (290)
T 1p9a_G           77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL  155 (290)
T ss_dssp             TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence            47899999999998 88999999999999999999999887788999999999999999999654432 45677788888


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       156 ~~N~  159 (290)
T 1p9a_G          156 ANNN  159 (290)
T ss_dssp             TTSC
T ss_pred             CCCc
Confidence            8875

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.18  E-value=3.1e-06  Score=77.47  Aligned_cols=83  Identities=18%  Similarity=0.238  Sum_probs=71.2

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCC-CCCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP-DNGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP-~~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++..+..+.++++|+.|+|++|.+++..|..+..+++|+.|++++|++++..+ ....+.++..+.+
T Consensus        52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  131 (276)
T 2z62_A           52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV  131 (276)
T ss_dssp             TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred             cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence            478999999999997777789999999999999999999888899999999999999999988655 3455667777777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       132 ~~n~  135 (276)
T 2z62_A          132 AHNL  135 (276)
T ss_dssp             CSSC
T ss_pred             cCCc
Confidence            7765

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.17  E-value=2e-06  Score=87.11  Aligned_cols=84  Identities=21%  Similarity=0.279  Sum_probs=71.3

Q ss_pred             CCCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccc--cccccccCCCCCcEEecCCCcCcccCCCC--CCCCccc
Q 015852           66 EGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSG--LIPTSLTTITSLNILDLSNNRLSGPVPDN--GSFSQFT  141 (399)
Q Consensus        66 ~~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G--~ip~~~~~l~~L~~l~ls~N~l~G~iP~~--~~~~~~~  141 (399)
                      -..++.++|++|++++.+|..++++++|+.|+|++|++++  .+|..+..+++|+.|++++|++++.+|..  ..+.++.
T Consensus       352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~  431 (562)
T 3a79_B          352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL  431 (562)
T ss_dssp             CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred             CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence            3578999999999999899999999999999999999997  66778899999999999999999988853  4456667


Q ss_pred             cccccccc
Q 015852          142 PISFENNL  149 (399)
Q Consensus       142 ~~~~~~n~  149 (399)
                      .+.+++|.
T Consensus       432 ~L~l~~n~  439 (562)
T 3a79_B          432 VLNLSSNM  439 (562)
T ss_dssp             EEECCSSC
T ss_pred             EEECCCCC
Confidence            77777765

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.17  E-value=1.7e-06  Score=86.22  Aligned_cols=81  Identities=30%  Similarity=0.273  Sum_probs=69.4

Q ss_pred             CCEEEEEeCCCCceeecChhhc-cCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELG-QLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~-~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|.++|.+|..+. .+++|+.|+|++|.+++. | .+..+++|+.|+|++|.++|..|....+.++..+++
T Consensus       144 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L  221 (487)
T 3oja_A          144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISL  221 (487)
T ss_dssp             SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEEC
T ss_pred             CCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEe
Confidence            4799999999999999998887 799999999999999987 3 344699999999999999997776666777788888


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      ++|.
T Consensus       222 s~N~  225 (487)
T 3oja_A          222 RNNK  225 (487)
T ss_dssp             TTSC
T ss_pred             cCCc
Confidence            8775

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.17  E-value=1.8e-06  Score=85.53  Aligned_cols=86  Identities=19%  Similarity=0.265  Sum_probs=59.8

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~  146 (399)
                      .++.|+|++|.+++..+..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+.. ..+.++..+.+.
T Consensus       249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  328 (477)
T 2id5_A          249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD  328 (477)
T ss_dssp             TCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECC
T ss_pred             ccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEcc
Confidence            5667777777777666666777777777777777777777777777777777777777777643321 345566677777


Q ss_pred             cccccCC
Q 015852          147 NNLNLCG  153 (399)
Q Consensus       147 ~n~~lcg  153 (399)
                      +|+..|.
T Consensus       329 ~N~l~c~  335 (477)
T 2id5_A          329 SNPLACD  335 (477)
T ss_dssp             SSCEECS
T ss_pred             CCCccCc
Confidence            7776653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.16  E-value=3.7e-06  Score=80.05  Aligned_cols=80  Identities=8%  Similarity=-0.010  Sum_probs=53.2

Q ss_pred             cee-eccCCceEEEEEeC-------CCCEEEEEEcccccc--cccHHHHHHHHHHHhcCCC---CCccceeeeeecC---
Q 015852          253 NIL-GRGGFGKVYKGRLA-------DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVH---RNLLRLYGFCTTV---  316 (399)
Q Consensus       253 ~~l-G~G~fg~Vy~~~~~-------~~~~vAvK~l~~~~~--~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~---  316 (399)
                      +.| +.|....+|+....       +++.+++|.-.....  ......+.+|..+++.+..   -.+.+++.++...   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            556 78888999988754       256788887643320  1012357788888877642   3566777777554   


Q ss_pred             CceEEEEecCCCCChh
Q 015852          317 TEKLLVYPYMTNGSVA  332 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~  332 (399)
                      +..++||||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999987654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.16  E-value=3.1e-06  Score=77.83  Aligned_cols=83  Identities=23%  Similarity=0.284  Sum_probs=67.9

Q ss_pred             CCEEEEEeCCCC-ceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCcccccc
Q 015852           67 GSVTRVDLGNAA-LSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~-l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~  144 (399)
                      ..++.|+|++|+ ++.-.|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..+. ...+.++..+.
T Consensus        80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  159 (285)
T 1ozn_A           80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF  159 (285)
T ss_dssp             TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence            478899999997 6555577889999999999999999988888899999999999999999866554 34566777777


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +.+|.
T Consensus       160 l~~n~  164 (285)
T 1ozn_A          160 LHGNR  164 (285)
T ss_dssp             CCSSC
T ss_pred             CCCCc
Confidence            77774

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.14  E-value=2.7e-06  Score=85.67  Aligned_cols=83  Identities=20%  Similarity=0.221  Sum_probs=69.2

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcc-cCC-CCCCCCcccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG-PVP-DNGSFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G-~iP-~~~~~~~~~~~~  144 (399)
                      ..++.|+|++|++++..|..++++++|+.|+|++|.+++..|..++.+++|++|++++|.+++ .+| ....+.++..++
T Consensus        50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  129 (549)
T 2z81_A           50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR  129 (549)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred             CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence            478999999999998888889999999999999999998888889999999999999999986 444 345566677777


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +.+|.
T Consensus       130 L~~n~  134 (549)
T 2z81_A          130 IGNVE  134 (549)
T ss_dssp             EEESS
T ss_pred             CCCCc
Confidence            77665

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.13  E-value=4e-06  Score=78.83  Aligned_cols=82  Identities=30%  Similarity=0.331  Sum_probs=64.5

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|++++..|..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|.++ .+|. ...+.++..+++
T Consensus       192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l  270 (330)
T 1xku_A          192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL  270 (330)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred             ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence            36778888888888877888888888888888888888877778888888888888888887 6664 345566667777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       271 ~~N~  274 (330)
T 1xku_A          271 HNNN  274 (330)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            7765

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.12  E-value=3.4e-06  Score=87.40  Aligned_cols=81  Identities=22%  Similarity=0.289  Sum_probs=49.0

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~  146 (399)
                      +++.|+|++|.+++-.+..++++++|+.|+|++|.+++..|..+..+++|++|++++|++++-.+. ...+.++..+++.
T Consensus        26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~  105 (680)
T 1ziw_A           26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM  105 (680)
T ss_dssp             TCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred             CCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECC
Confidence            566677777776655555566666677777766666666666666666666666666666643221 2344444555554


Q ss_pred             cc
Q 015852          147 NN  148 (399)
Q Consensus       147 ~n  148 (399)
                      +|
T Consensus       106 ~n  107 (680)
T 1ziw_A          106 SN  107 (680)
T ss_dssp             SS
T ss_pred             CC
Confidence            44

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.10  E-value=2.3e-06  Score=72.89  Aligned_cols=80  Identities=21%  Similarity=0.233  Sum_probs=63.3

Q ss_pred             CCEEEEEeCCCCceeecChhh-ccCcCCCeEeccCCcccccccc--cccCCCCCcEEecCCCcCcccCCC-----CCCCC
Q 015852           67 GSVTRVDLGNAALSGELAPEL-GQLKNLELLRLNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPD-----NGSFS  138 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l-~~l~~L~~l~l~~n~l~G~ip~--~~~~l~~L~~l~ls~N~l~G~iP~-----~~~~~  138 (399)
                      ..+..|+|++|++++ +|+.+ ..+++|+.|+|++|.+ +.+|.  .+..+++|+.|++++|.++ .+|.     ...+.
T Consensus        64 ~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i-~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~  140 (176)
T 1a9n_A           64 RRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSL-VELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVP  140 (176)
T ss_dssp             SSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCC-CCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCT
T ss_pred             CCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcC-CcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCC
Confidence            478999999999995 55554 9999999999999999 46787  8899999999999999997 4554     23445


Q ss_pred             ccccccccccc
Q 015852          139 QFTPISFENNL  149 (399)
Q Consensus       139 ~~~~~~~~~n~  149 (399)
                      ++..+++.+|.
T Consensus       141 ~L~~Ld~~~n~  151 (176)
T 1a9n_A          141 QVRVLDFQKVK  151 (176)
T ss_dssp             TCSEETTEECC
T ss_pred             ccceeCCCcCC
Confidence            55555555553

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.07  E-value=5.1e-06  Score=84.89  Aligned_cols=83  Identities=20%  Similarity=0.229  Sum_probs=66.2

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|.+++..|..++++++|+.|+|++|.+++..|..+..+++|++|+|++|.+++..|. ...+.++..+.+
T Consensus        99 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  178 (597)
T 3oja_B           99 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL  178 (597)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEEC
Confidence            3688999999999887777789999999999999999854445568899999999999999887774 455666777777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|.
T Consensus       179 ~~N~  182 (597)
T 3oja_B          179 SSNR  182 (597)
T ss_dssp             TTSC
T ss_pred             cCCC
Confidence            6664

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.07  E-value=4.3e-06  Score=74.84  Aligned_cols=83  Identities=16%  Similarity=0.170  Sum_probs=67.2

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCc-ccccccccccCCCCCcEEecCC-CcCcccCCC-CCCCCccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNS-LSGLIPTSLTTITSLNILDLSN-NRLSGPVPD-NGSFSQFTPI  143 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~-l~G~ip~~~~~l~~L~~l~ls~-N~l~G~iP~-~~~~~~~~~~  143 (399)
                      ..++.|+|++|++++-.+..++++++|+.|++++|. +++..+..+..+++|+.|++++ |++++-.|. ...+.++..+
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            368999999999997666689999999999999997 7755555889999999999998 999865443 2356677777


Q ss_pred             cccccc
Q 015852          144 SFENNL  149 (399)
Q Consensus       144 ~~~~n~  149 (399)
                      .+.+|.
T Consensus       111 ~l~~n~  116 (239)
T 2xwt_C          111 GIFNTG  116 (239)
T ss_dssp             EEEEEC
T ss_pred             eCCCCC
Confidence            887775

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.05  E-value=3.2e-06  Score=75.72  Aligned_cols=84  Identities=17%  Similarity=0.237  Sum_probs=69.5

Q ss_pred             CCEEEEEeCCCC-ceeecChhhccCcCCCeEeccC-CcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccc---
Q 015852           67 GSVTRVDLGNAA-LSGELAPELGQLKNLELLRLNN-NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT---  141 (399)
Q Consensus        67 ~~v~~l~l~~~~-l~g~ip~~l~~l~~L~~l~l~~-n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~---  141 (399)
                      .+++.|+|++|+ +++-.+..+.++++|+.|++++ |.+++..|..+..+++|+.|++++|.+++ +|....+..+.   
T Consensus        55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~  133 (239)
T 2xwt_C           55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFF  133 (239)
T ss_dssp             TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEE
T ss_pred             CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-cccccccccccccc
Confidence            478999999997 7654455789999999999998 99997767789999999999999999998 78766666666   


Q ss_pred             cccccccccc
Q 015852          142 PISFENNLNL  151 (399)
Q Consensus       142 ~~~~~~n~~l  151 (399)
                      .+.+.+|..+
T Consensus       134 ~L~l~~N~~l  143 (239)
T 2xwt_C          134 ILEITDNPYM  143 (239)
T ss_dssp             EEEEESCTTC
T ss_pred             EEECCCCcch
Confidence            7777777333

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.05  E-value=5e-06  Score=77.84  Aligned_cols=80  Identities=16%  Similarity=0.206  Sum_probs=39.3

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCccccccccccc-CCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLT-TITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~-~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      .++.|+|++|++++..|..++.+++|+.|+|++|.+++..|..+. .+++|+.|++++|.+++. |....+.++..++++
T Consensus       121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls  199 (317)
T 3o53_A          121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLS  199 (317)
T ss_dssp             SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECC
T ss_pred             CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECC
Confidence            344555555555544444455555555555555555555444442 455555555555555443 322234444444444


Q ss_pred             cc
Q 015852          147 NN  148 (399)
Q Consensus       147 ~n  148 (399)
                      +|
T Consensus       200 ~N  201 (317)
T 3o53_A          200 SN  201 (317)
T ss_dssp             SS
T ss_pred             CC
Confidence            44

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.04  E-value=6.2e-06  Score=78.33  Aligned_cols=82  Identities=20%  Similarity=0.227  Sum_probs=70.0

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC---CCCCCccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD---NGSFSQFTPI  143 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~---~~~~~~~~~~  143 (399)
                      ..++.|+|++|++++..|..++++++|+.|+|++|.+++..+..+..+++|++|++++|++++ +|.   ...+.++..+
T Consensus        76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L  154 (353)
T 2z80_A           76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQIL  154 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEE
T ss_pred             CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEE
Confidence            479999999999998888889999999999999999997555558999999999999999984 554   3556777788


Q ss_pred             cccccc
Q 015852          144 SFENNL  149 (399)
Q Consensus       144 ~~~~n~  149 (399)
                      ++.+|.
T Consensus       155 ~l~~n~  160 (353)
T 2z80_A          155 RVGNMD  160 (353)
T ss_dssp             EEEESS
T ss_pred             ECCCCc
Confidence            888774

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.03  E-value=5.5e-06  Score=83.69  Aligned_cols=83  Identities=16%  Similarity=0.249  Sum_probs=63.8

Q ss_pred             CCEEEEEeCCCCceeecC-hhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCc-ccCCC-CCCCCccccc
Q 015852           67 GSVTRVDLGNAALSGELA-PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS-GPVPD-NGSFSQFTPI  143 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip-~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~-G~iP~-~~~~~~~~~~  143 (399)
                      ..++.|++++|.+.+..| ..+.++++|+.|++++|.+++.+|..+..+++|+.|++++|.++ |.+|. ...+.++..+
T Consensus       396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L  475 (570)
T 2z63_A          396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL  475 (570)
T ss_dssp             TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence            467788888888887666 45778888888888888888888888888888888888888887 56774 2445666677


Q ss_pred             cccccc
Q 015852          144 SFENNL  149 (399)
Q Consensus       144 ~~~~n~  149 (399)
                      ++.+|.
T Consensus       476 ~l~~n~  481 (570)
T 2z63_A          476 DLSQCQ  481 (570)
T ss_dssp             ECTTSC
T ss_pred             ECCCCc
Confidence            777664

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.02  E-value=9.1e-06  Score=78.23  Aligned_cols=60  Identities=20%  Similarity=0.259  Sum_probs=28.1

Q ss_pred             EEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCc
Q 015852           69 VTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  128 (399)
Q Consensus        69 v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~  128 (399)
                      ++.|+|++|.+++..|..++.+++|+.|+|++|.+++..|..+..+++|+.|++++|.++
T Consensus        71 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  130 (390)
T 3o6n_A           71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS  130 (390)
T ss_dssp             CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC
Confidence            334444444444333334444444444444444444444444444444555555544444

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.02  E-value=4.2e-06  Score=79.14  Aligned_cols=78  Identities=28%  Similarity=0.366  Sum_probs=41.5

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.++|++|++++-  +.+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..| ...+.++..+++.+
T Consensus       266 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~  342 (347)
T 4fmz_A          266 KLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFAN  342 (347)
T ss_dssp             TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSC
T ss_pred             CcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhh
Confidence            445555555555432  235555555555555555555555555555556666666555555444 33444444555544


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      |
T Consensus       343 N  343 (347)
T 4fmz_A          343 Q  343 (347)
T ss_dssp             C
T ss_pred             h
Confidence            4

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.02  E-value=4.4e-06  Score=76.23  Aligned_cols=65  Identities=26%  Similarity=0.356  Sum_probs=45.5

Q ss_pred             CCEEEEEeCCCCcee--ecChhhccCcCCCeEeccCCcccccccccccCCC--CCcEEecCCCcCcccCCC
Q 015852           67 GSVTRVDLGNAALSG--ELAPELGQLKNLELLRLNNNSLSGLIPTSLTTIT--SLNILDLSNNRLSGPVPD  133 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g--~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~--~L~~l~ls~N~l~G~iP~  133 (399)
                      ..+..|+|++|++++  .+|..+..+++|+.|+|++|++++.  ..+..+.  +|+.|+|++|.+++.+|.
T Consensus       170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred             CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence            367777788887777  6666677777788888888777764  2333333  777777877777777663

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.02  E-value=4e-06  Score=78.26  Aligned_cols=82  Identities=17%  Similarity=0.208  Sum_probs=69.2

Q ss_pred             CEEEEEeCCCCceeecChhh--ccCcCCCeEeccCCccccccc----ccccCCCCCcEEecCCCcCcccCCC-CCCCCcc
Q 015852           68 SVTRVDLGNAALSGELAPEL--GQLKNLELLRLNNNSLSGLIP----TSLTTITSLNILDLSNNRLSGPVPD-NGSFSQF  140 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l--~~l~~L~~l~l~~n~l~G~ip----~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~  140 (399)
                      +++.|+|++|.++|.+|..+  +.+++|+.|+|++|.+++.+|    ..+..+++|+.|++++|.+++..|. ...+.++
T Consensus        92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L  171 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL  171 (310)
T ss_dssp             CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred             ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence            48899999999999999888  899999999999999998766    3456789999999999999877664 3467778


Q ss_pred             ccccccccc
Q 015852          141 TPISFENNL  149 (399)
Q Consensus       141 ~~~~~~~n~  149 (399)
                      ..+++++|.
T Consensus       172 ~~L~Ls~N~  180 (310)
T 4glp_A          172 TSLDLSDNP  180 (310)
T ss_dssp             CEEECCSCT
T ss_pred             CEEECCCCC
Confidence            888888885

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.01  E-value=2.6e-06  Score=80.20  Aligned_cols=81  Identities=22%  Similarity=0.286  Sum_probs=62.0

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~~  146 (399)
                      .++.|+|++|.+++..|..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|+++ .+|. ...+.++..+++.
T Consensus       194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~  272 (332)
T 2ft3_A          194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH  272 (332)
T ss_dssp             SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECC
T ss_pred             CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECC
Confidence            5677788888887777777888888888888888888877777888888888888888887 6665 3445566667777


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       273 ~N~  275 (332)
T 2ft3_A          273 TNN  275 (332)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            665

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.00  E-value=2.5e-05  Score=73.40  Aligned_cols=137  Identities=16%  Similarity=0.232  Sum_probs=75.0

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-----CCCcccee-e--eeecCCceEEEEe
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----HRNLLRLY-G--FCTTVTEKLLVYP  324 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lv~e  324 (399)
                      +.|+.|..+.||+....++ .+++|+....     ......|..++..+.     .|.++.-. |  +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            4466677889999987655 4889987542     122334444444332     24333311 1  1123556789999


Q ss_pred             cCCCCChh--------------hHhhhcCCCC----------CCCChHHHH-----------------------------
Q 015852          325 YMTNGSVA--------------SRLRERQSSL----------PPLDWPTRK-----------------------------  351 (399)
Q Consensus       325 ~~~~gsL~--------------~~L~~~~~~~----------~~l~~~~~~-----------------------------  351 (399)
                      |++|..+.              ..+|......          ..-.|....                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              1122211100          012343211                             


Q ss_pred             --HHHHHHHHHHHHHhc----------CCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          352 --KIALGSARGLSYLHE----------HCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       352 --~i~~~ia~gL~yLH~----------~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                        .+...+.+++++|+.          ...+.++|+|+++.|||++.++.+.|.||
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDf  247 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDL  247 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCC
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEeh
Confidence              011123445667763          12457999999999999988889999999

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=97.97  E-value=7.3e-06  Score=75.86  Aligned_cols=78  Identities=27%  Similarity=0.446  Sum_probs=59.6

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..++.|+|++|++++ + +.+..+++|+.|++++|.+++.  +.+..+++|+.|++++|.+++..| ...+.++..+.++
T Consensus       112 ~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~  186 (291)
T 1h6t_A          112 KKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLS  186 (291)
T ss_dssp             TTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECC
T ss_pred             CCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECC
Confidence            468888888888876 3 5688888888888888888875  567888888888888888887655 5556666777776


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       187 ~N~  189 (291)
T 1h6t_A          187 KNH  189 (291)
T ss_dssp             SSC
T ss_pred             CCc
Confidence            664

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=97.97  E-value=1.1e-05  Score=73.41  Aligned_cols=75  Identities=25%  Similarity=0.358  Sum_probs=36.0

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+|++|++++ +|. +.. ++|+.|+|++|.+++ +| .+..+++|+.|++++|++++. |....+.++..+++++
T Consensus        86 ~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~  159 (263)
T 1xeu_A           86 KLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHG  159 (263)
T ss_dssp             SCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTT
T ss_pred             CCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCC
Confidence            45666666666654 332 122 555555555555554 22 355555555555555555442 3333334444444444


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      |
T Consensus       160 N  160 (263)
T 1xeu_A          160 N  160 (263)
T ss_dssp             S
T ss_pred             C
Confidence            4

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.95  E-value=5e-05  Score=69.96  Aligned_cols=78  Identities=17%  Similarity=0.221  Sum_probs=54.4

Q ss_pred             CCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC---CccceeeeeecCCceEEEEec
Q 015852          249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---NLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +...+.+|.|..+.||+.++.+|+.+.+|+-.... ......|..|.+.|+.+.-.   -+.+.++.    +..+++|||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            33456789999999999999999999999864332 22233588899988876422   23444443    234789999


Q ss_pred             CCCCCh
Q 015852          326 MTNGSV  331 (399)
Q Consensus       326 ~~~gsL  331 (399)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=97.95  E-value=1.4e-05  Score=76.96  Aligned_cols=82  Identities=21%  Similarity=0.274  Sum_probs=66.3

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCccccccccc-ccCCCCCcEEecCCCcCcccCCC-CCCCCcccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTS-LTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~-~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~  144 (399)
                      ..++.|+|++|.+++..|..++++++|+.|+|++|.++ .+|.. +..+++|+.|++++|.+++..|. ...+.++..+.
T Consensus        93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  171 (390)
T 3o6n_A           93 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ  171 (390)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEE
T ss_pred             CCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEE
Confidence            47889999999998877777899999999999999998 45554 58899999999999999877664 34566677777


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +.+|.
T Consensus       172 l~~n~  176 (390)
T 3o6n_A          172 LSSNR  176 (390)
T ss_dssp             CCSSC
T ss_pred             CCCCc
Confidence            77765

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=97.94  E-value=8.2e-06  Score=83.46  Aligned_cols=76  Identities=28%  Similarity=0.471  Sum_probs=45.9

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .+..|+|++|.+++ + +.+..|++|+.|+|++|.+++.  +.+..+++|+.|+|++|.+++..| ...+.++..+.+++
T Consensus       110 ~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~  184 (605)
T 1m9s_A          110 KLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSK  184 (605)
T ss_dssp             TCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCS
T ss_pred             CCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcC
Confidence            56677777777664 2 3466666666666666666654  456666666666666666665544 44444455555544


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      |
T Consensus       185 N  185 (605)
T 1m9s_A          185 N  185 (605)
T ss_dssp             S
T ss_pred             C
Confidence            4

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=97.94  E-value=9.8e-06  Score=82.18  Aligned_cols=70  Identities=33%  Similarity=0.448  Sum_probs=33.7

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+|++|.++ .||   ..+++|+.|+|++|+|++ ||. +..  +|+.|++++|++++ +|.  .+.++..+.+++
T Consensus        81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~  149 (571)
T 3cvr_A           81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE--LPALLEYINADN  149 (571)
T ss_dssp             TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC--CCTTCCEEECCS
T ss_pred             CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC--cCccccEEeCCC
Confidence            3555555555555 444   334555555555555554 444 333  45555555555544 443  233344444443


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      |
T Consensus       150 N  150 (571)
T 3cvr_A          150 N  150 (571)
T ss_dssp             S
T ss_pred             C
Confidence            3

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=97.93  E-value=1.7e-05  Score=72.27  Aligned_cols=58  Identities=33%  Similarity=0.488  Sum_probs=29.0

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  129 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G  129 (399)
                      .++.|++++|+++ .+| .+..+++|+.|+|++|++++..|  +..+++|+.|++++|++++
T Consensus        42 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~   99 (263)
T 1xeu_A           42 GVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN   99 (263)
T ss_dssp             TCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC
T ss_pred             cCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC
Confidence            4445555555544 233 34555555555555555554322  5555555555555555544

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.88  E-value=5.5e-05  Score=73.05  Aligned_cols=76  Identities=9%  Similarity=0.022  Sum_probs=48.4

Q ss_pred             CceeeccCCceEEEEEeC-CCCEEEEEEcccccc------cccHHHHHHHHHHHhcCCC--CC-ccceeeeeecCCceEE
Q 015852          252 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT------SGGELQFQTEVKIISMAVH--RN-LLRLYGFCTTVTEKLL  321 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~------~~~~~~f~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l  321 (399)
                      .+.+|.|.++.||++... +++.++||.......      ......+..|.+++..+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            367899999999999754 467899997643211      1122356778888876632  33 3345543  3455689


Q ss_pred             EEecCCCC
Q 015852          322 VYPYMTNG  329 (399)
Q Consensus       322 v~e~~~~g  329 (399)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=97.86  E-value=1.7e-05  Score=78.19  Aligned_cols=74  Identities=28%  Similarity=0.425  Sum_probs=38.3

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.++|++|++++ +| +++++++|+.|++++|++++ +|..+   .+|+.|++++|++++ +|....+.++..+.+.+
T Consensus       132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~~  204 (454)
T 1jl5_A          132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADN  204 (454)
T ss_dssp             TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCS
T ss_pred             CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECCC
Confidence            45555555555554 55 35555556666666555554 44332   345555555555554 44444444444444444


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      |
T Consensus       205 N  205 (454)
T 1jl5_A          205 N  205 (454)
T ss_dssp             S
T ss_pred             C
Confidence            4

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.86  E-value=1.1e-05  Score=76.76  Aligned_cols=95  Identities=13%  Similarity=0.178  Sum_probs=73.3

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecCh-hhccCcCCCeEeccCCcccccccc-cccCCCCCcE-E
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAP-ELGQLKNLELLRLNNNSLSGLIPT-SLTTITSLNI-L  120 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~-~l~~l~~L~~l~l~~n~l~G~ip~-~~~~l~~L~~-l  120 (399)
                      .-|+|..|.|+..          ..++.|+|++|+++ .||+ .+.++++|+.|+|++|++.+.||. .+..+++|.. +
T Consensus         7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l   85 (350)
T 4ay9_X            7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   85 (350)
T ss_dssp             SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred             cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence            3478999999732          25889999999998 5665 589999999999999999988886 5677888765 6


Q ss_pred             ecCCCcCcccCCCC-CCCCccccccccccc
Q 015852          121 DLSNNRLSGPVPDN-GSFSQFTPISFENNL  149 (399)
Q Consensus       121 ~ls~N~l~G~iP~~-~~~~~~~~~~~~~n~  149 (399)
                      .+++|++++-.|.. ..+.++..+.+.+|.
T Consensus        86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~  115 (350)
T 4ay9_X           86 IEKANNLLYINPEAFQNLPNLQYLLISNTG  115 (350)
T ss_dssp             EEEETTCCEECTTSBCCCTTCCEEEEEEEC
T ss_pred             cccCCcccccCchhhhhccccccccccccc
Confidence            66778888765543 456667777777775

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=97.85  E-value=1.5e-07  Score=81.98  Aligned_cols=79  Identities=18%  Similarity=0.272  Sum_probs=59.8

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..++.|+|++|++++ +| .+.++++|+.|++++|.++ .+|..+..+++|+.|++++|++++ +|....+.++..+++.
T Consensus        48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~  123 (198)
T 1ds9_A           48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMS  123 (198)
T ss_dssp             TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEES
T ss_pred             CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CCccccCCCCCEEECC
Confidence            467888888888876 77 7888888888888888887 678777777888888888888876 4544444556666666


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       124 ~N~  126 (198)
T 1ds9_A          124 NNK  126 (198)
T ss_dssp             EEE
T ss_pred             CCc
Confidence            664

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=97.85  E-value=1.7e-05  Score=74.18  Aligned_cols=81  Identities=30%  Similarity=0.273  Sum_probs=63.5

Q ss_pred             CCEEEEEeCCCCceeecChhhc-cCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELG-QLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~-~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~  145 (399)
                      ..++.|+|++|.+++..|..+. .+++|+.|+|++|.+++. | ....+++|+.|++++|++++-.|....+.++..+++
T Consensus       144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L  221 (317)
T 3o53_A          144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISL  221 (317)
T ss_dssp             SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEEC
T ss_pred             CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEEC
Confidence            4789999999999988777774 789999999999998865 3 334588899999999998876555555666777777


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      ++|.
T Consensus       222 ~~N~  225 (317)
T 3o53_A          222 RNNK  225 (317)
T ss_dssp             TTSC
T ss_pred             cCCc
Confidence            7775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.84  E-value=7.6e-05  Score=69.75  Aligned_cols=140  Identities=16%  Similarity=0.168  Sum_probs=91.4

Q ss_pred             CCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC---CCCccceeeeeecCCceEEEEecCC
Q 015852          251 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVYPYMT  327 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~  327 (399)
                      ..+.|+.|.+..+|+... ++..+.+|.....    ....|..|.+.++.+.   ...+.+++.++...+..++||||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            346789999999999876 4667888876432    2346888988887764   3567788888877788999999999


Q ss_pred             CCChh-----------hHhhhcCC-C-C----------------CCCChHHHH---HHHH----------------HHHH
Q 015852          328 NGSVA-----------SRLRERQS-S-L----------------PPLDWPTRK---KIAL----------------GSAR  359 (399)
Q Consensus       328 ~gsL~-----------~~L~~~~~-~-~----------------~~l~~~~~~---~i~~----------------~ia~  359 (399)
                      +..+.           ..||.... . .                -.-+|....   ++..                .+.+
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87642           12333211 0 0                012454322   1111                1111


Q ss_pred             H-HHHHhc-CCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          360 G-LSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       360 g-L~yLH~-~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      . ...|.. ...|.+||+|+.+.|++++.++ +.|.|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 223432 2357899999999999999887 8899874

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.84  E-value=1.6e-06  Score=88.87  Aligned_cols=77  Identities=18%  Similarity=0.289  Sum_probs=40.9

Q ss_pred             CCCCCCCCCCCCCcceeeeeC-------CCCCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCC
Q 015852           44 SLQSWDNLPGNLCTWFHITCN-------PEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITS  116 (399)
Q Consensus        44 ~l~~w~~~~~~~c~w~gv~c~-------~~~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~  116 (399)
                      .+.+|.. ..++|.|.|..|.       ....++.+++++|+++ .+|..+.  ++|+.|+|++|+++ .||.   .+++
T Consensus        11 ~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~   82 (622)
T 3g06_A           11 VWSAWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE   82 (622)
T ss_dssp             HHHHHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred             HHHHHHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence            3445643 3567888664321       0123566666666665 5555444  45555555555555 3444   3455


Q ss_pred             CcEEecCCCcCc
Q 015852          117 LNILDLSNNRLS  128 (399)
Q Consensus       117 L~~l~ls~N~l~  128 (399)
                      |++|+|++|+++
T Consensus        83 L~~L~Ls~N~l~   94 (622)
T 3g06_A           83 LRTLEVSGNQLT   94 (622)
T ss_dssp             CCEEEECSCCCS
T ss_pred             CCEEEcCCCcCC
Confidence            555555555554

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=97.84  E-value=2.5e-05  Score=77.12  Aligned_cols=74  Identities=24%  Similarity=0.328  Sum_probs=47.3

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+|++|++++ +|  ++.+++|+.|++++|.+++. |  ++.+++|+.|++++|++++ +| ...+.++..+.+.+
T Consensus        65 ~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~-~~~l~~L~~L~l~~  136 (457)
T 3bz5_A           65 GLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD-VSQNPLLTYLNCAR  136 (457)
T ss_dssp             TCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC-CTTCTTCCEEECTT
T ss_pred             CCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec-CCCCCcCCEEECCC
Confidence            56667777776665 33  66667777777777777663 3  6667777777777777766 44 44555556666655


Q ss_pred             cc
Q 015852          148 NL  149 (399)
Q Consensus       148 n~  149 (399)
                      |.
T Consensus       137 N~  138 (457)
T 3bz5_A          137 NT  138 (457)
T ss_dssp             SC
T ss_pred             Cc
Confidence            54

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=97.83  E-value=2.6e-05  Score=80.70  Aligned_cols=64  Identities=28%  Similarity=0.307  Sum_probs=32.5

Q ss_pred             CEEEEEeCCCCceeecCh-hhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCC
Q 015852           68 SVTRVDLGNAALSGELAP-ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  132 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~-~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP  132 (399)
                      .++.|+|++|++++ +|+ .++++++|++|+|++|.+++..|..+..+++|++|++++|.+++..|
T Consensus        74 ~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  138 (680)
T 1ziw_A           74 MLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL  138 (680)
T ss_dssp             TCCEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCC
T ss_pred             CcCEEECCCCccCc-cChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCc
Confidence            34555555555542 332 35555555555555555554444455555555555555555555444

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=97.82  E-value=2.4e-05  Score=72.40  Aligned_cols=78  Identities=24%  Similarity=0.382  Sum_probs=66.3

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..++.|+|++|.+++ + +.+..+++|+.|+|++|.+++.  +.+..+++|+.|++++|++++. +....+.++..++++
T Consensus        90 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~  164 (291)
T 1h6t_A           90 KNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLE  164 (291)
T ss_dssp             TTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECC
T ss_pred             CCCCEEECCCCcCCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEcc
Confidence            578999999999986 4 4599999999999999999973  5788999999999999999875 655667777888888


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       165 ~N~  167 (291)
T 1h6t_A          165 DNQ  167 (291)
T ss_dssp             SSC
T ss_pred             CCc
Confidence            775

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=97.82  E-value=2.3e-05  Score=80.17  Aligned_cols=77  Identities=26%  Similarity=0.401  Sum_probs=46.0

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .+..|+|++|.+++ + +.+..+++|+.|+|++|.+++ + +.+..+++|+.|+|++|.+++. +....+.++..+.+++
T Consensus        88 ~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~  162 (605)
T 1m9s_A           88 NLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLED  162 (605)
T ss_dssp             TCCEEECCSSCCCC-C-TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCS
T ss_pred             CCCEEECcCCCCCC-C-hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcC
Confidence            56666666666654 2 356666666666666666665 2 3466666666666666666654 4444455555555555


Q ss_pred             cc
Q 015852          148 NL  149 (399)
Q Consensus       148 n~  149 (399)
                      |.
T Consensus       163 N~  164 (605)
T 1m9s_A          163 NQ  164 (605)
T ss_dssp             SC
T ss_pred             Cc
Confidence            53

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=97.80  E-value=4.4e-07  Score=79.03  Aligned_cols=80  Identities=25%  Similarity=0.363  Sum_probs=65.6

Q ss_pred             CCEEEEEeCCCCceeecCh------hhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCC-CCCc
Q 015852           67 GSVTRVDLGNAALSGELAP------ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG-SFSQ  139 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~------~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~-~~~~  139 (399)
                      .+++.++|+.+.++|.+|+      .++.+++|+.|+|++|.+++ +| .+..+++|+.|++++|.++ .+|... .+.+
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            4667777888888888887      89999999999999999998 88 8999999999999999998 677531 2345


Q ss_pred             cccccccccc
Q 015852          140 FTPISFENNL  149 (399)
Q Consensus       140 ~~~~~~~~n~  149 (399)
                      +..+++++|.
T Consensus        95 L~~L~L~~N~  104 (198)
T 1ds9_A           95 LEELWISYNQ  104 (198)
T ss_dssp             CSEEEEEEEE
T ss_pred             CCEEECcCCc
Confidence            6666776664

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=97.76  E-value=2.6e-05  Score=77.07  Aligned_cols=78  Identities=26%  Similarity=0.361  Sum_probs=48.3

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..++.|+|++|++++..|  ++.+++|+.|+|++|++++..|  +..+++|+.|++++|.+++. |....+.++..+++.
T Consensus       287 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~  361 (466)
T 1o6v_A          287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAG  361 (466)
T ss_dssp             TTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECC
T ss_pred             CccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCC
Confidence            356777777777765332  6667777777777777776655  55666666666666666654 444445555555555


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       362 ~n~  364 (466)
T 1o6v_A          362 HNQ  364 (466)
T ss_dssp             SSC
T ss_pred             CCc
Confidence            553

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=97.75  E-value=3.2e-05  Score=76.38  Aligned_cols=59  Identities=25%  Similarity=0.313  Sum_probs=47.4

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccC
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  131 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~i  131 (399)
                      ..++.+++++|++++.   +++.+++|+.|++++|+++| +|  +..+++|+.|++++|+++|..
T Consensus       191 ~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~  249 (457)
T 3bz5_A          191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD  249 (457)
T ss_dssp             TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC
T ss_pred             CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC
Confidence            4678888888888764   37888888888888888888 66  778888888888888888753

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=97.74  E-value=3.7e-05  Score=71.67  Aligned_cols=78  Identities=22%  Similarity=0.440  Sum_probs=52.8

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..++.|+|++|.+++ +++ +..+++|+.|+|++|.+++ +| .+..+++|+.|++++|++++ +|....+.++..+.+.
T Consensus        63 ~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~  137 (308)
T 1h6u_A           63 NNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTPLAGLSNLQVLYLD  137 (308)
T ss_dssp             TTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGGGTTCTTCCEEECC
T ss_pred             CCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chhhcCCCCCCEEECC
Confidence            467777888777764 344 7777777788887777776 33 57777777777777777765 3444555556666666


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       138 ~n~  140 (308)
T 1h6u_A          138 LNQ  140 (308)
T ss_dssp             SSC
T ss_pred             CCc
Confidence            553

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=97.73  E-value=1.2e-05  Score=75.62  Aligned_cols=82  Identities=17%  Similarity=0.161  Sum_probs=57.7

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCccccc-ccccccCCCCCcEEecCCCcCcccCCC-CCCCCcccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGL-IPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~-ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~  144 (399)
                      ..++.+++++|.+++.++. +..+++|+.|+|++|.+++. +|..+..+++|+.|++++|.+++.+|. ...+.++..+.
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            4567777777777766554 56778888888888888776 777778888888888888887766553 13345566666


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +.+|.
T Consensus       149 L~~~~  153 (336)
T 2ast_B          149 LSGCS  153 (336)
T ss_dssp             CTTCB
T ss_pred             CCCCC
Confidence            66653

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=97.72  E-value=2.9e-05  Score=72.39  Aligned_cols=78  Identities=24%  Similarity=0.421  Sum_probs=57.2

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      .+++.|+|++|.+++- ++ ++.+++|+.|++++|.+++. |. +..+++|+.|++++|++++..| ...+.++..++++
T Consensus       129 ~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~  203 (308)
T 1h6u_A          129 SNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLK  203 (308)
T ss_dssp             TTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECT
T ss_pred             CCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEcc
Confidence            4678888888888754 33 78888888888888888863 33 7888888888888888876433 4455666666776


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       204 ~N~  206 (308)
T 1h6u_A          204 NNQ  206 (308)
T ss_dssp             TSC
T ss_pred             CCc
Confidence            664

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=97.66  E-value=5.2e-06  Score=78.05  Aligned_cols=82  Identities=26%  Similarity=0.229  Sum_probs=68.5

Q ss_pred             CCEEEEEeCCCCceee-cChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCC-cCccc-CCC-CCCCCcccc
Q 015852           67 GSVTRVDLGNAALSGE-LAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNN-RLSGP-VPD-NGSFSQFTP  142 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~-ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N-~l~G~-iP~-~~~~~~~~~  142 (399)
                      .+++.|+|++|.+++. +|..+..+++|+.|+|++|.+++.+|..++.+++|+.|++++| .+++. +|. ...+.++..
T Consensus        93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~  172 (336)
T 2ast_B           93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  172 (336)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence            4789999999999876 8888999999999999999999999999999999999999999 68763 443 233455666


Q ss_pred             cccccc
Q 015852          143 ISFENN  148 (399)
Q Consensus       143 ~~~~~n  148 (399)
                      +.+.+|
T Consensus       173 L~l~~~  178 (336)
T 2ast_B          173 LNLSWC  178 (336)
T ss_dssp             EECCCC
T ss_pred             EcCCCC
Confidence            666666

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=97.62  E-value=8.9e-06  Score=74.19  Aligned_cols=64  Identities=25%  Similarity=0.393  Sum_probs=51.9

Q ss_pred             ccCcCCCeEeccCCcccc--cccccccCCCCCcEEecCCCcCcccCCCCCCCC--cccccccccccccCC
Q 015852           88 GQLKNLELLRLNNNSLSG--LIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS--QFTPISFENNLNLCG  153 (399)
Q Consensus        88 ~~l~~L~~l~l~~n~l~G--~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~--~~~~~~~~~n~~lcg  153 (399)
                      .+++.|+.|+|++|.|++  .+|..+..+++|+.|+|++|++++. .....+.  .+..+.+.+|+ +|+
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Np-l~~  234 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNS-LCD  234 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTST-TGG
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCc-Ccc
Confidence            568899999999999999  7888888999999999999999974 2222233  67778888887 564

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=97.60  E-value=7.7e-05  Score=73.50  Aligned_cols=56  Identities=27%  Similarity=0.380  Sum_probs=35.4

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  129 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G  129 (399)
                      .++.+++++|++++ +|..+   .+|+.|++++|.+++ +| .+..+++|+.|++++|++++
T Consensus       154 ~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~  209 (454)
T 1jl5_A          154 FLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK  209 (454)
T ss_dssp             TCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS
T ss_pred             CCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc
Confidence            56677777777764 55432   366666666666665 55 46666666666666666665

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=97.59  E-value=5.9e-05  Score=74.45  Aligned_cols=78  Identities=31%  Similarity=0.472  Sum_probs=65.9

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..++.|+|++|.+++. |+ +..+++|+.|++++|.+++..|  +..+++|+.|++++|++++..| ...+.++..+.+.
T Consensus       265 ~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~  339 (466)
T 1o6v_A          265 TKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFY  339 (466)
T ss_dssp             TTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECC
T ss_pred             CCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECC
Confidence            4789999999999864 33 8899999999999999998655  7889999999999999998776 4567777888888


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       340 ~n~  342 (466)
T 1o6v_A          340 NNK  342 (466)
T ss_dssp             SSC
T ss_pred             CCc
Confidence            775

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.58  E-value=8.5e-06  Score=78.40  Aligned_cols=83  Identities=20%  Similarity=0.269  Sum_probs=55.0

Q ss_pred             CCEEEEEeCCCCce--e---ecChhhccCcCCCeEeccCCccc----ccccccccCCCCCcEEecCCCcCccc----CCC
Q 015852           67 GSVTRVDLGNAALS--G---ELAPELGQLKNLELLRLNNNSLS----GLIPTSLTTITSLNILDLSNNRLSGP----VPD  133 (399)
Q Consensus        67 ~~v~~l~l~~~~l~--g---~ip~~l~~l~~L~~l~l~~n~l~----G~ip~~~~~l~~L~~l~ls~N~l~G~----iP~  133 (399)
                      ..++.|+|++|+++  |   -+|..+..+++|+.|+|++|.++    +.+|..+..+++|+.|+|++|.+++.    +|.
T Consensus       187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~  266 (386)
T 2ca6_A          187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD  266 (386)
T ss_dssp             TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred             CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence            36777778877776  3   23336777777888888887776    66777777777788888887777665    332


Q ss_pred             C---CCCCccccccccccc
Q 015852          134 N---GSFSQFTPISFENNL  149 (399)
Q Consensus       134 ~---~~~~~~~~~~~~~n~  149 (399)
                      .   +.+.++..+.+.+|.
T Consensus       267 ~l~~~~~~~L~~L~L~~n~  285 (386)
T 2ca6_A          267 AFSKLENIGLQTLRLQYNE  285 (386)
T ss_dssp             HHHTCSSCCCCEEECCSSC
T ss_pred             HHhhccCCCeEEEECcCCc
Confidence            1   224455556665554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.54  E-value=1.8e-05  Score=76.12  Aligned_cols=83  Identities=18%  Similarity=0.367  Sum_probs=62.8

Q ss_pred             CCEEEEEeCCCCce-eecC---hhhccCcCCCeEeccCCccc--c---cccccccCCCCCcEEecCCCcCc----ccCCC
Q 015852           67 GSVTRVDLGNAALS-GELA---PELGQLKNLELLRLNNNSLS--G---LIPTSLTTITSLNILDLSNNRLS----GPVPD  133 (399)
Q Consensus        67 ~~v~~l~l~~~~l~-g~ip---~~l~~l~~L~~l~l~~n~l~--G---~ip~~~~~l~~L~~l~ls~N~l~----G~iP~  133 (399)
                      ..++.|+|++|+++ +.+|   ..+..+++|+.|+|++|.++  |   .+|..+..+++|+.|+|++|.++    +.+|.
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~  238 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  238 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence            68899999999987 5566   46778889999999999988  4   45558888999999999999986    55553


Q ss_pred             C-CCCCccccccccccc
Q 015852          134 N-GSFSQFTPISFENNL  149 (399)
Q Consensus       134 ~-~~~~~~~~~~~~~n~  149 (399)
                      . ..+.++..+.+++|.
T Consensus       239 ~l~~~~~L~~L~L~~n~  255 (386)
T 2ca6_A          239 ALKSWPNLRELGLNDCL  255 (386)
T ss_dssp             HGGGCTTCCEEECTTCC
T ss_pred             HHccCCCcCEEECCCCC
Confidence            1 334456666676664

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.46  E-value=6.1e-05  Score=77.19  Aligned_cols=74  Identities=22%  Similarity=0.282  Sum_probs=43.8

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      ..+..|+|++|++++ +|   ..+++|+.|+|++|.++ .||.   .+++|+.|+|++|+++ .+|. ...+.++..+++
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            356677777777664 55   34566666677766666 4554   4566666666666666 5553 233444455555


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|+
T Consensus       292 ~~N~  295 (622)
T 3g06_A          292 EGNP  295 (622)
T ss_dssp             CSCC
T ss_pred             cCCC
Confidence            5554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.46  E-value=2.8e-05  Score=74.18  Aligned_cols=82  Identities=28%  Similarity=0.319  Sum_probs=54.5

Q ss_pred             CEEEEEeCCCCceeecChhhccC-----cCCCeEeccCCcccccccccccC----C-CCCcEEecCCCcCcccCCCC---
Q 015852           68 SVTRVDLGNAALSGELAPELGQL-----KNLELLRLNNNSLSGLIPTSLTT----I-TSLNILDLSNNRLSGPVPDN---  134 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l-----~~L~~l~l~~n~l~G~ip~~~~~----l-~~L~~l~ls~N~l~G~iP~~---  134 (399)
                      .++.|+|++|++++..+..+..+     ++|+.|+|++|.+++..+..+..    + ++|+.|++++|.+++..+..   
T Consensus        52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  131 (362)
T 3goz_A           52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ  131 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence            67788888888777666666664     77888888888887776664433    3 77888888888876654421   


Q ss_pred             --CC-CCccccccccccc
Q 015852          135 --GS-FSQFTPISFENNL  149 (399)
Q Consensus       135 --~~-~~~~~~~~~~~n~  149 (399)
                        .. ...+..+++++|.
T Consensus       132 ~l~~~~~~L~~L~Ls~N~  149 (362)
T 3goz_A          132 AFSNLPASITSLNLRGND  149 (362)
T ss_dssp             HHTTSCTTCCEEECTTSC
T ss_pred             HHHhCCCceeEEEccCCc
Confidence              11 1355666666664

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=97.46  E-value=6.7e-05  Score=70.71  Aligned_cols=60  Identities=25%  Similarity=0.423  Sum_probs=53.7

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  128 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~  128 (399)
                      .+++.|+|++|++++..|..++.+++|+.|++++|.+++..|  +..+++|+.|++++|.++
T Consensus       287 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             TTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            478999999999999888999999999999999999998777  889999999999999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.45  E-value=0.00059  Score=66.34  Aligned_cols=74  Identities=14%  Similarity=0.097  Sum_probs=45.1

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccc---c-----ccHHHHHHHHHHHh-cCCCCCccceeeeeecCCceEEE
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERT---S-----GGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~-----~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .+.+|.|..+.||+... +++.++||.......   .     .....+..|+..+. ...+..+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            46789999999999864 467899994322110   0     12223444544332 22234566666654  4667899


Q ss_pred             EecC-CC
Q 015852          323 YPYM-TN  328 (399)
Q Consensus       323 ~e~~-~~  328 (399)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.11  E-value=0.00012  Score=69.76  Aligned_cols=83  Identities=25%  Similarity=0.205  Sum_probs=67.3

Q ss_pred             CCEEEEEeCCCCceeecC----hhhccCc-CCCeEeccCCcccccccccccCC-----CCCcEEecCCCcCcccCCC---
Q 015852           67 GSVTRVDLGNAALSGELA----PELGQLK-NLELLRLNNNSLSGLIPTSLTTI-----TSLNILDLSNNRLSGPVPD---  133 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip----~~l~~l~-~L~~l~l~~n~l~G~ip~~~~~l-----~~L~~l~ls~N~l~G~iP~---  133 (399)
                      ..++.|+|++|.+++.-+    ..+..++ +|+.|+|++|.+++..+..+..+     ++|+.|+|++|.+++..+.   
T Consensus        22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~  101 (362)
T 3goz_A           22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV  101 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred             CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence            359999999999987666    6678888 89999999999999888877765     9999999999999987664   


Q ss_pred             --CCCC-Cccccccccccc
Q 015852          134 --NGSF-SQFTPISFENNL  149 (399)
Q Consensus       134 --~~~~-~~~~~~~~~~n~  149 (399)
                        ...+ .++..+++++|.
T Consensus       102 ~~l~~~~~~L~~L~Ls~N~  120 (362)
T 3goz_A          102 KTLAAIPFTITVLDLGWND  120 (362)
T ss_dssp             HHHHTSCTTCCEEECCSSC
T ss_pred             HHHHhCCCCccEEECcCCc
Confidence              1222 567777887776

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.06  E-value=0.00069  Score=64.06  Aligned_cols=79  Identities=16%  Similarity=0.233  Sum_probs=58.8

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccc-cccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPT-SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~-~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      .++.|+|++|+++ .||+......+|+.|++++|+.-+.||. .+..+++|+.||+++|+++ .+|. ..+..+..+...
T Consensus       155 ~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~-~~~~~L~~L~~l  231 (350)
T 4ay9_X          155 ESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS-YGLENLKKLRAR  231 (350)
T ss_dssp             SCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCS-SSCTTCCEEECT
T ss_pred             hhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccCh-hhhccchHhhhc
Confidence            4678888999887 6777777788899999987777777886 4688899999999999887 4564 335555555554


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      ++.
T Consensus       232 ~~~  234 (350)
T 4ay9_X          232 STY  234 (350)
T ss_dssp             TCT
T ss_pred             cCC
Confidence            443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.93  E-value=0.0026  Score=59.55  Aligned_cols=27  Identities=30%  Similarity=0.372  Sum_probs=23.6

Q ss_pred             CCCceecCCCCCceeeCCC----Cceeeccc
Q 015852          369 DPKIIHRDVKAANILLDED----ADQSSKTI  395 (399)
Q Consensus       369 ~~~ivHrDlK~~NILld~~----~~~~i~df  395 (399)
                      .+.++|+|+.+.|||++.+    ..+.|.||
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf  212 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDF  212 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCC
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeC
Confidence            3479999999999999875    67899998

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.91  E-value=0.0027  Score=58.52  Aligned_cols=71  Identities=8%  Similarity=0.028  Sum_probs=42.1

Q ss_pred             CceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeeeecCCceEEEEecC-CCC
Q 015852          252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYM-TNG  329 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~-~~g  329 (399)
                      .+.|+.|....+|+.     ..+.+|.-......  .....+|..+++.+....+ .+++++  ..+..++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            577889999999998     45778876432111  1123457766665543233 345543  344457899999 554


Q ss_pred             Ch
Q 015852          330 SV  331 (399)
Q Consensus       330 sL  331 (399)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.82  E-value=0.0076  Score=56.02  Aligned_cols=75  Identities=19%  Similarity=0.119  Sum_probs=46.7

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCC--Cccceeee-----eecCCceEEEEec
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGF-----CTTVTEKLLVYPY  325 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lv~e~  325 (399)
                      ..++ |....||+....+|+.+++|.......  ....+..|..++..+...  .+.+++..     ....+..+++|||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4566 778899998776777799998753311  233566677776655422  23444442     1123456789999


Q ss_pred             CCCCC
Q 015852          326 MTNGS  330 (399)
Q Consensus       326 ~~~gs  330 (399)
                      +++..
T Consensus       109 i~G~~  113 (328)
T 1zyl_A          109 VGGRQ  113 (328)
T ss_dssp             CCCEE
T ss_pred             cCCCC
Confidence            98754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.82  E-value=0.0087  Score=55.47  Aligned_cols=139  Identities=7%  Similarity=0.042  Sum_probs=74.6

Q ss_pred             ceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCC--ccceeee------eecCCceEEEEe
Q 015852          253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGF------CTTVTEKLLVYP  324 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e  324 (399)
                      +.|+.|....+|+....++ .+++|......   ....+..|..++..+....  +.+++..      ....+..++++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            4466788889999887666 57788875421   1124556666665553212  2333321      112345689999


Q ss_pred             cCCCCChhh--------------HhhhcCCCC--C---C---CChHHHHH------------HHHHHHHHHHHHhcC---
Q 015852          325 YMTNGSVAS--------------RLRERQSSL--P---P---LDWPTRKK------------IALGSARGLSYLHEH---  367 (399)
Q Consensus       325 ~~~~gsL~~--------------~L~~~~~~~--~---~---l~~~~~~~------------i~~~ia~gL~yLH~~---  367 (399)
                      |++|..+..              .+|......  .   .   ..|.....            +...+.+.+++++..   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            999865321              122211110  0   0   12432111            111244455555532   


Q ss_pred             -CCCCceecCCCCCceeeCCCCceeeccc
Q 015852          368 -CDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       368 -~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                       ....++|+|+.+.|||++++....|.||
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf  212 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDF  212 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCC
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecc
Confidence             1346999999999999998765689998

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=96.78  E-value=0.00015  Score=71.11  Aligned_cols=64  Identities=28%  Similarity=0.281  Sum_probs=43.3

Q ss_pred             CCEEEEEeCCCCceeecChhhccC-----cCCCeEeccCCccccc----ccccccCCCCCcEEecCCCcCccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQL-----KNLELLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSGP  130 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l-----~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~G~  130 (399)
                      ..++.|+|++|.+++.-+..+...     ++|+.|++++|.+++.    +|..+..+++|+.|++++|.+++.
T Consensus       284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  356 (461)
T 1z7x_W          284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA  356 (461)
T ss_dssp             TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred             CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence            467788888887765444444332     5777777777777765    566666777777777777777654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.76  E-value=0.0035  Score=61.11  Aligned_cols=71  Identities=18%  Similarity=0.260  Sum_probs=46.6

Q ss_pred             ceeeccCCceEEEEEeCC--------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeeeecCCceEEEE
Q 015852          253 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~  323 (399)
                      +.|+.|....+|+....+        +..+.+|+-...   .....+..|..++..+...++ .++++.+.  +  .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            567788889999998753        467888876321   111356678888877753334 56666543  2  3899


Q ss_pred             ecCCCCC
Q 015852          324 PYMTNGS  330 (399)
Q Consensus       324 e~~~~gs  330 (399)
                      ||+++.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998644

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=96.66  E-value=0.00042  Score=67.83  Aligned_cols=83  Identities=17%  Similarity=0.182  Sum_probs=63.5

Q ss_pred             CCEEEEEeCCCCceee----cChhhccCcCCCeEeccCCcccccccccccC-----CCCCcEEecCCCcCcc----cCCC
Q 015852           67 GSVTRVDLGNAALSGE----LAPELGQLKNLELLRLNNNSLSGLIPTSLTT-----ITSLNILDLSNNRLSG----PVPD  133 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~----ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~-----l~~L~~l~ls~N~l~G----~iP~  133 (399)
                      .+++.|+|++|.+++.    +|..+..+++|+.|+|++|.+++..+..+..     .++|+.|++++|.+++    .+|.
T Consensus       313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~  392 (461)
T 1z7x_W          313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  392 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence            4789999999998865    6777888899999999999998876655543     6789999999999886    5553


Q ss_pred             C-CCCCccccccccccc
Q 015852          134 N-GSFSQFTPISFENNL  149 (399)
Q Consensus       134 ~-~~~~~~~~~~~~~n~  149 (399)
                      . ..+.++..+++.+|.
T Consensus       393 ~l~~~~~L~~L~l~~N~  409 (461)
T 1z7x_W          393 TLLANHSLRELDLSNNC  409 (461)
T ss_dssp             HHHHCCCCCEEECCSSS
T ss_pred             HHHhCCCccEEECCCCC
Confidence            2 234556667777775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.53  E-value=0.0085  Score=57.30  Aligned_cols=137  Identities=13%  Similarity=0.152  Sum_probs=75.8

Q ss_pred             ceeeccCCceEEEEEeC--------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCC-ccceeeeeecCCceEEEE
Q 015852          253 NILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~  323 (399)
                      +.+..|-...+|+....        +++.+.+|+-...  ........+|..+++.+.-.. ..++++++..    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            45666778889998864        2467888875321  223345678888887765322 3456665543    2899


Q ss_pred             ecCCCCChhh--------------H---hhhcCCC-CCCCC--hHHHHHHHHHHH-------------------HHHHHH
Q 015852          324 PYMTNGSVAS--------------R---LRERQSS-LPPLD--WPTRKKIALGSA-------------------RGLSYL  364 (399)
Q Consensus       324 e~~~~gsL~~--------------~---L~~~~~~-~~~l~--~~~~~~i~~~ia-------------------~gL~yL  364 (399)
                      ||+++..+..              .   ||..... .....  |.+..++..++.                   ..+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9999755431              1   1211110 11122  334444433321                   122333


Q ss_pred             ----hcC-CCCCceecCCCCCceeeCCC----Cceeeccc
Q 015852          365 ----HEH-CDPKIIHRDVKAANILLDED----ADQSSKTI  395 (399)
Q Consensus       365 ----H~~-~~~~ivHrDlK~~NILld~~----~~~~i~df  395 (399)
                          ... ....++|+|+.+.|||++++    +.+.+.||
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDw  249 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDF  249 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCC
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEec
Confidence                221 23468999999999999987    68899998

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.41  E-value=0.0037  Score=50.17  Aligned_cols=56  Identities=27%  Similarity=0.356  Sum_probs=42.5

Q ss_pred             EEEeCCCCce-eecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCc
Q 015852           71 RVDLGNAALS-GELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  128 (399)
Q Consensus        71 ~l~l~~~~l~-g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~  128 (399)
                      .++.++++|+ ..+|..+.  .+|+.|+|++|+|+.--+..+..+++|+.|+|++|.|.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5667777776 46665332  46899999999999654556788999999999999664

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.40  E-value=0.02  Score=56.20  Aligned_cols=73  Identities=15%  Similarity=0.172  Sum_probs=45.0

Q ss_pred             ceeeccCCceEEEEEeCC-CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeeeecCCceEEEEecCCCCC
Q 015852          253 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMTNGS  330 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~gs  330 (399)
                      +.|+.|-...+|+....+ +..+.+|+......  ....-.+|..++..+...++ .++++.+.  +  .+||||+++.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            567778889999998765 46788887633211  11112578888877765444 45666652  2  25999998744


Q ss_pred             h
Q 015852          331 V  331 (399)
Q Consensus       331 L  331 (399)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.28  E-value=0.0073  Score=57.36  Aligned_cols=72  Identities=7%  Similarity=0.015  Sum_probs=41.1

Q ss_pred             ceeeccCCceEEEEEeCC---------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCC-ccceeeeeecCCceEEE
Q 015852          253 NILGRGGFGKVYKGRLAD---------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~---------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv  322 (399)
                      +.++.|....+|+....+         +..+.+|+.......  ......|..++..+...+ +.++++..  .  -+++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            456778888999988654         267888876432211  112356777776664333 34566543  2  3689


Q ss_pred             EecCCCCC
Q 015852          323 YPYMTNGS  330 (399)
Q Consensus       323 ~e~~~~gs  330 (399)
                      |||+++..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=96.24  E-value=0.0014  Score=62.75  Aligned_cols=84  Identities=17%  Similarity=0.187  Sum_probs=62.2

Q ss_pred             CCCEEEEEeCCCCcee----ecChhhccCcCCCeEeccCCccccc----ccccccCCCCCcEEecCCCcCcccCC----C
Q 015852           66 EGSVTRVDLGNAALSG----ELAPELGQLKNLELLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSGPVP----D  133 (399)
Q Consensus        66 ~~~v~~l~l~~~~l~g----~ip~~l~~l~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~G~iP----~  133 (399)
                      ...++.|+|++|.++.    .++..+..+++|+.|+|++|.++..    ++..+...++|+.|+|++|.++..-.    .
T Consensus       154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~  233 (372)
T 3un9_A          154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR  233 (372)
T ss_dssp             TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHH
Confidence            3579999999999864    3566678889999999999999753    46677788899999999999875321    1


Q ss_pred             -CCCCCccccccccccc
Q 015852          134 -NGSFSQFTPISFENNL  149 (399)
Q Consensus       134 -~~~~~~~~~~~~~~n~  149 (399)
                       ......+..+++++|.
T Consensus       234 ~L~~~~~L~~L~Ls~N~  250 (372)
T 3un9_A          234 AAREHPSLELLHLYFNE  250 (372)
T ss_dssp             HHHHCSSCCEEECTTSS
T ss_pred             HHHhCCCCCEEeccCCC
Confidence             0112345667777775

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.19  E-value=0.0013  Score=66.59  Aligned_cols=82  Identities=12%  Similarity=0.034  Sum_probs=46.4

Q ss_pred             CEEEEEeCCC--CceeecChhhcc-CcCCCeEeccCCcccc-cccccccCCCCCcEEecCCCcCcccCC-CC-CCCCccc
Q 015852           68 SVTRVDLGNA--ALSGELAPELGQ-LKNLELLRLNNNSLSG-LIPTSLTTITSLNILDLSNNRLSGPVP-DN-GSFSQFT  141 (399)
Q Consensus        68 ~v~~l~l~~~--~l~g~ip~~l~~-l~~L~~l~l~~n~l~G-~ip~~~~~l~~L~~l~ls~N~l~G~iP-~~-~~~~~~~  141 (399)
                      .++.|+|+.+  .+++..+..++. +++|+.|+|++|.+++ .++..+..+++|+.|++++|.+++..+ .. ..+.++.
T Consensus       437 ~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~  516 (592)
T 3ogk_B          437 KLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLR  516 (592)
T ss_dssp             TCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCC
T ss_pred             CCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccC
Confidence            5666666532  355554444443 6667777777777766 344555666777777777776654322 11 1234455


Q ss_pred             cccccccc
Q 015852          142 PISFENNL  149 (399)
Q Consensus       142 ~~~~~~n~  149 (399)
                      .+.+++|.
T Consensus       517 ~L~ls~n~  524 (592)
T 3ogk_B          517 YLWVQGYR  524 (592)
T ss_dssp             EEEEESCB
T ss_pred             eeECcCCc
Confidence            55555554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=96.14  E-value=0.0019  Score=61.73  Aligned_cols=82  Identities=22%  Similarity=0.234  Sum_probs=59.5

Q ss_pred             CEEEEEeCCCCceeecChhh-----ccCcCCCeEeccCCcccc----cccccccCCCCCcEEecCCCcCcccC----CC-
Q 015852           68 SVTRVDLGNAALSGELAPEL-----GQLKNLELLRLNNNSLSG----LIPTSLTTITSLNILDLSNNRLSGPV----PD-  133 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l-----~~l~~L~~l~l~~n~l~G----~ip~~~~~l~~L~~l~ls~N~l~G~i----P~-  133 (399)
                      +++.|+|++|.++..-...+     ...+.|+.|+|++|.++.    .++..+..+++|++|||++|.++..-    +. 
T Consensus       127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~  206 (372)
T 3un9_A          127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ  206 (372)
T ss_dssp             TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred             hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence            68999999999975443444     246789999999999975    36666788999999999999987532    10 


Q ss_pred             CCCCCccccccccccc
Q 015852          134 NGSFSQFTPISFENNL  149 (399)
Q Consensus       134 ~~~~~~~~~~~~~~n~  149 (399)
                      ......+..+++++|.
T Consensus       207 L~~~~~L~~L~Ls~N~  222 (372)
T 3un9_A          207 LDRNRQLQELNVAYNG  222 (372)
T ss_dssp             GGGCSCCCEEECCSSC
T ss_pred             HhcCCCcCeEECCCCC
Confidence            1122346666776664

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.75  E-value=0.064  Score=50.26  Aligned_cols=26  Identities=19%  Similarity=0.276  Sum_probs=24.0

Q ss_pred             CCceecCCCCCceeeCCCCceeeccc
Q 015852          370 PKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       370 ~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ..++|+|+.+.||++++++.+.+.||
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~  231 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDW  231 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEEC
Confidence            46999999999999998888999998

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=95.39  E-value=0.0075  Score=51.40  Aligned_cols=63  Identities=17%  Similarity=0.223  Sum_probs=34.1

Q ss_pred             CCEEEEEeCCC-Cceee----cChhhccCcCCCeEeccCCccccc----ccccccCCCCCcEEecCCCcCcc
Q 015852           67 GSVTRVDLGNA-ALSGE----LAPELGQLKNLELLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  129 (399)
Q Consensus        67 ~~v~~l~l~~~-~l~g~----ip~~l~~l~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~G  129 (399)
                      ..++.|+|++| .++..    +...+...++|+.|+|++|.++..    +...+...+.|+.|+|++|.++.
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            35666666666 55421    333445556666666666666432    33334445556666666666553

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=94.93  E-value=0.0054  Score=58.36  Aligned_cols=83  Identities=14%  Similarity=0.254  Sum_probs=54.7

Q ss_pred             CCEEEEEeCC--CCceee--c---Chhh--ccCcCCCeEeccCCccccccccccc---CCCCCcEEecCCCcCccc----
Q 015852           67 GSVTRVDLGN--AALSGE--L---APEL--GQLKNLELLRLNNNSLSGLIPTSLT---TITSLNILDLSNNRLSGP----  130 (399)
Q Consensus        67 ~~v~~l~l~~--~~l~g~--i---p~~l--~~l~~L~~l~l~~n~l~G~ip~~~~---~l~~L~~l~ls~N~l~G~----  130 (399)
                      +.++.|+|+.  |...|.  +   .+.+  ..+++|+.|+|++|.+++..+..+.   .+++|+.|||+.|.+++.    
T Consensus       219 p~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~  298 (362)
T 2ra8_A          219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL  298 (362)
T ss_dssp             TTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHH
T ss_pred             CCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHH
Confidence            6788898853  322222  1   1222  3578999999999999876655554   578999999999999874    


Q ss_pred             CCCC-CCCCccccccccccc
Q 015852          131 VPDN-GSFSQFTPISFENNL  149 (399)
Q Consensus       131 iP~~-~~~~~~~~~~~~~n~  149 (399)
                      ++.. ..+.++..+.+.+|.
T Consensus       299 L~~~L~~l~~L~~L~L~~n~  318 (362)
T 2ra8_A          299 LLDHVDKIKHLKFINMKYNY  318 (362)
T ss_dssp             HHTTHHHHTTCSEEECCSBB
T ss_pred             HHhhcccCCcceEEECCCCc
Confidence            3322 234556666666553

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=94.78  E-value=0.0099  Score=50.63  Aligned_cols=65  Identities=23%  Similarity=0.247  Sum_probs=52.3

Q ss_pred             CCCEEEEEeCCCCcee----ecChhhccCcCCCeEeccCCccccc----ccccccCCCCCcEEec--CCCcCccc
Q 015852           66 EGSVTRVDLGNAALSG----ELAPELGQLKNLELLRLNNNSLSGL----IPTSLTTITSLNILDL--SNNRLSGP  130 (399)
Q Consensus        66 ~~~v~~l~l~~~~l~g----~ip~~l~~l~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~l--s~N~l~G~  130 (399)
                      ...++.|+|++|.++.    .+...+...+.|+.|+|++|.++..    +...+...++|+.|+|  ++|.++..
T Consensus        64 ~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~  138 (185)
T 1io0_A           64 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN  138 (185)
T ss_dssp             CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred             CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence            3578999999999864    2455566778899999999999865    5667788889999999  88988753

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=94.77  E-value=0.0038  Score=62.96  Aligned_cols=59  Identities=20%  Similarity=0.287  Sum_probs=26.3

Q ss_pred             EEEEEeCCCCceeecChhhcc-CcCCCeEeccCCcccccccccc-cCCCCCcEEecCCCcCc
Q 015852           69 VTRVDLGNAALSGELAPELGQ-LKNLELLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLS  128 (399)
Q Consensus        69 v~~l~l~~~~l~g~ip~~l~~-l~~L~~l~l~~n~l~G~ip~~~-~~l~~L~~l~ls~N~l~  128 (399)
                      ++.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.++
T Consensus       434 L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~  494 (594)
T 2p1m_B          434 LRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG  494 (594)
T ss_dssp             CCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred             ccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence            34444433 333333333333 4445555555555544433333 33455555555555543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=94.67  E-value=0.0096  Score=60.00  Aligned_cols=40  Identities=18%  Similarity=0.274  Sum_probs=19.0

Q ss_pred             cCcCCCeEeccCCccccc----ccccccCCCCCcEEecCCCcCc
Q 015852           89 QLKNLELLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLS  128 (399)
Q Consensus        89 ~l~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~  128 (399)
                      ++++|+.|+|++|.+++.    ++..+..+++|+.|++++|.++
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~  205 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFA  205 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCS
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCC
Confidence            445555555555554443    3333344444555555555443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=94.64  E-value=0.0072  Score=60.90  Aligned_cols=65  Identities=17%  Similarity=0.234  Sum_probs=49.6

Q ss_pred             CCEEEEEeCCCCceeecChhhc-cCcCCCeEeccCC-ccccc-ccccccCCCCCcEEecCCCcCcccC
Q 015852           67 GSVTRVDLGNAALSGELAPELG-QLKNLELLRLNNN-SLSGL-IPTSLTTITSLNILDLSNNRLSGPV  131 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~-~l~~L~~l~l~~n-~l~G~-ip~~~~~l~~L~~l~ls~N~l~G~i  131 (399)
                      .+++.|+|+++.+++..+..+. .+++|+.|+|++| .++.. ++..+..+++|+.|++++|.+++..
T Consensus       105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~  172 (594)
T 2p1m_B          105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVS  172 (594)
T ss_dssp             TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCC
T ss_pred             CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcc
Confidence            4788899999888887777776 6888999999888 45443 5555557888888888888877643

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=92.84  E-value=0.14  Score=40.69  Aligned_cols=57  Identities=19%  Similarity=0.358  Sum_probs=43.1

Q ss_pred             CeEeccCCccc-ccccccccCCCCCcEEecCCCcCcccCCCC--CCCCcccccccccccccCC
Q 015852           94 ELLRLNNNSLS-GLIPTSLTTITSLNILDLSNNRLSGPVPDN--GSFSQFTPISFENNLNLCG  153 (399)
Q Consensus        94 ~~l~l~~n~l~-G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~--~~~~~~~~~~~~~n~~lcg  153 (399)
                      ..++.+++.|+ -.||..+.  ++|+.|+|++|+|+. ||..  ..+.++..+.+.+|+-.|.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~~Cd   70 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPWRCD   70 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCeecc
Confidence            47899999997 57886543  469999999999985 5542  3455677788899988774

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.60  E-value=0.67  Score=44.75  Aligned_cols=73  Identities=5%  Similarity=0.052  Sum_probs=44.3

Q ss_pred             ceeeccCCceEEEEEeCC--------CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCC-ccceeeeeecCCceEEEE
Q 015852          253 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~  323 (399)
                      +.+..|-...+|+....+        ++.+.+|+-....  .....-.+|..+++.+.-.. ..++++.+.    -++||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            456667788899988653        5778888754321  11112356777776664223 345555332    37899


Q ss_pred             ecCCCCCh
Q 015852          324 PYMTNGSV  331 (399)
Q Consensus       324 e~~~~gsL  331 (399)
                      ||+++..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.09  E-value=0.072  Score=33.56  Aligned_cols=30  Identities=23%  Similarity=0.215  Sum_probs=16.1

Q ss_pred             ceeeeeeehhHHHHhhHhhhheeeeeccCC
Q 015852          185 AAIPVGVALGAALLFAVPVIGFAYWRRTRP  214 (399)
Q Consensus       185 ~~i~~~v~~~~~~~~~~~~~~~~~~~~~r~  214 (399)
                      ..|..+++.|.++++++.+..++++|||+.
T Consensus        11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           11 PSIATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             SSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             ceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            345555555555555555555566665554

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.16  E-value=0.037  Score=54.39  Aligned_cols=62  Identities=6%  Similarity=-0.007  Sum_probs=18.0

Q ss_pred             CCceeeccCCceEEEEEeCC-CCEEEE------EEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeec
Q 015852          251 NKNILGRGGFGKVYKGRLAD-GKLVAV------KRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT  315 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~~-~~~vAv------K~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~  315 (399)
                      ..+.+|   ||.||+|.+.. ..+|||      |..+..... .....|.+|..++...+|+|+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            345566   99999998754 467888      776543322 223468899999999999999999887643

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=89.32  E-value=0.15  Score=43.76  Aligned_cols=64  Identities=23%  Similarity=0.336  Sum_probs=45.5

Q ss_pred             CCCEEEEEeCCC-Ccee----ecChhhccCcCCCeEeccCCccccc----ccccccCCCCCcEEecCCCcCcc
Q 015852           66 EGSVTRVDLGNA-ALSG----ELAPELGQLKNLELLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  129 (399)
Q Consensus        66 ~~~v~~l~l~~~-~l~g----~ip~~l~~l~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~G  129 (399)
                      +..++.|+|++| ++..    .|-..+..-+.|+.|+|++|++...    |-..+..-+.|+.|+|++|+++.
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            457888899875 6642    2444566677889999999988633    33445556789999999998864

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=89.01  E-value=0.2  Score=46.35  Aligned_cols=41  Identities=15%  Similarity=0.240  Sum_probs=30.6

Q ss_pred             CcCCCeEeccCCccccccc-ccccCCCCCcEEecCCCcCcccCCC
Q 015852           90 LKNLELLRLNNNSLSGLIP-TSLTTITSLNILDLSNNRLSGPVPD  133 (399)
Q Consensus        90 l~~L~~l~l~~n~l~G~ip-~~~~~l~~L~~l~ls~N~l~G~iP~  133 (399)
                      +++|+.++|.+ +++- |+ ..|..|++|+.++++.|.++ .|++
T Consensus       100 ~~~L~~l~L~~-~i~~-I~~~aF~~~~~L~~l~l~~n~i~-~i~~  141 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKN-IEDAAFKGCDNLKICQIRKKTAP-NLLP  141 (329)
T ss_dssp             CTTCCC-CBCT-TCCE-ECTTTTTTCTTCCEEEBCCSSCC-EECT
T ss_pred             cCCCcEEECCc-cccc-hhHHHhhcCcccceEEcCCCCcc-ccch
Confidence            88899999888 7763 44 46788899999999988876 4443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=88.92  E-value=0.089  Score=33.05  Aligned_cols=30  Identities=30%  Similarity=0.279  Sum_probs=16.1

Q ss_pred             ceeeeeeehhHHHHhhHhhhheeeeeccCC
Q 015852          185 AAIPVGVALGAALLFAVPVIGFAYWRRTRP  214 (399)
Q Consensus       185 ~~i~~~v~~~~~~~~~~~~~~~~~~~~~r~  214 (399)
                      ..|..+++.+.++++++.+..++++|||+.
T Consensus        10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A           10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             ceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            345555555555555555555566665554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=88.81  E-value=0.72  Score=42.48  Aligned_cols=55  Identities=20%  Similarity=0.314  Sum_probs=40.4

Q ss_pred             CCEEEEEeCCCCceeecCh-hhccCcCCCeEeccCCcccccccc-cccCCCCCc-EEecCC
Q 015852           67 GSVTRVDLGNAALSGELAP-ELGQLKNLELLRLNNNSLSGLIPT-SLTTITSLN-ILDLSN  124 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~-~l~~l~~L~~l~l~~n~l~G~ip~-~~~~l~~L~-~l~ls~  124 (399)
                      ..++.++|++|+++ .||. .+.++.+|+.++|.+| +. .|+. .|..+++|+ .+++++
T Consensus       226 ~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~  283 (329)
T 3sb4_A          226 PNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA  283 (329)
T ss_dssp             TTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT
T ss_pred             CCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc
Confidence            36788888888776 5554 5777888888888887 44 3553 677788888 888877

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=87.29  E-value=0.086  Score=49.96  Aligned_cols=82  Identities=13%  Similarity=0.207  Sum_probs=48.3

Q ss_pred             CEEEEEeCCCCceeecChhhc--cCcCCCeEeccC--Cccccc--c---cccc--cCCCCCcEEecCCCcCcccCCC---
Q 015852           68 SVTRVDLGNAALSGELAPELG--QLKNLELLRLNN--NSLSGL--I---PTSL--TTITSLNILDLSNNRLSGPVPD---  133 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~--~l~~L~~l~l~~--n~l~G~--i---p~~~--~~l~~L~~l~ls~N~l~G~iP~---  133 (399)
                      +++.|+|..+.++......++  .+++|+.|+|+.  |+..|.  +   -+.+  ..+++|+.|+|++|.+++..+.   
T Consensus       194 ~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la  273 (362)
T 2ra8_A          194 NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL  273 (362)
T ss_dssp             TCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHH
T ss_pred             CCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHH
Confidence            455555555554433223344  799999999863  332222  1   1222  3578999999999998754321   


Q ss_pred             -CCCCCccccccccccc
Q 015852          134 -NGSFSQFTPISFENNL  149 (399)
Q Consensus       134 -~~~~~~~~~~~~~~n~  149 (399)
                       ...+.++..++++.|.
T Consensus       274 ~a~~~~~L~~LdLs~n~  290 (362)
T 2ra8_A          274 ESDILPQLETMDISAGV  290 (362)
T ss_dssp             HCSSGGGCSEEECCSSC
T ss_pred             hCccCCCCCEEECCCCC
Confidence             1234566666666553

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=85.64  E-value=0.35  Score=40.65  Aligned_cols=62  Identities=11%  Similarity=0.150  Sum_probs=46.0

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCc-ccccccccccCC----CCCcEEecCCCc-Cc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNS-LSGLIPTSLTTI----TSLNILDLSNNR-LS  128 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~-l~G~ip~~~~~l----~~L~~l~ls~N~-l~  128 (399)
                      -.++.|||+++.++..=-..+..+++|+.|+|+++. ++..--..++.+    ++|+.|||++.. +|
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT  128 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT  128 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence            379999999998764322457889999999999985 776544456654    479999998863 54

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=84.06  E-value=0.56  Score=40.14  Aligned_cols=60  Identities=20%  Similarity=0.245  Sum_probs=46.5

Q ss_pred             CCCEEEEEeCCCCceee----cChhhccCcCCCeEeccCCccccc----ccccccCCCCCcEEecCCC
Q 015852           66 EGSVTRVDLGNAALSGE----LAPELGQLKNLELLRLNNNSLSGL----IPTSLTTITSLNILDLSNN  125 (399)
Q Consensus        66 ~~~v~~l~l~~~~l~g~----ip~~l~~l~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~ls~N  125 (399)
                      +..++.|+|++|+++..    |...|..-+.|+.|+|++|+++..    |-..+..-+.|+.|+|++|
T Consensus        69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            45799999999999732    344556678899999999999755    3345666678999999865

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.88  E-value=4.3  Score=35.15  Aligned_cols=80  Identities=10%  Similarity=0.016  Sum_probs=56.1

Q ss_pred             CCCCccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHH-HHhcCCCCCceecCCCCC
Q 015852          302 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS-YLHEHCDPKIIHRDVKAA  380 (399)
Q Consensus       302 ~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivHrDlK~~  380 (399)
                      .||++  -...-.+.+...+.|+.-+++.-...++.       ++...+++++..++.-.. +++.     -+|=-+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            57777  33334556666676766545443444432       577889999988887766 5654     367788999


Q ss_pred             ceeeCCCCceeeccc
Q 015852          381 NILLDEDADQSSKTI  395 (399)
Q Consensus       381 NILld~~~~~~i~df  395 (399)
                      |+++|.++.|++.-.
T Consensus       114 NL~f~~~~~p~i~hR  128 (219)
T 4ano_A          114 NLMFNRALEPFFLHV  128 (219)
T ss_dssp             GEEECTTCCEEESCC
T ss_pred             eEEEeCCCcEEEEEc
Confidence            999999999998754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.48  E-value=3.1  Score=35.95  Aligned_cols=82  Identities=7%  Similarity=0.002  Sum_probs=56.7

Q ss_pred             CCCCCccceeeeeecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 015852          301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA  380 (399)
Q Consensus       301 l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~  380 (399)
                      ..||+.+.. ..-...+...+.|+.-+.+-=...++.       ++...+++++..|+.--++++..     +|=-+.|+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~  108 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD  108 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence            358888765 344455555555554443322222332       57788999999998888777754     67788999


Q ss_pred             ceeeCCCCceeeccc
Q 015852          381 NILLDEDADQSSKTI  395 (399)
Q Consensus       381 NILld~~~~~~i~df  395 (399)
                      |+++|.++.|++.--
T Consensus       109 NL~f~~~~~p~i~~R  123 (215)
T 4ann_A          109 ELFFTRDGLPIAKTR  123 (215)
T ss_dssp             GEEECTTSCEEESCC
T ss_pred             eEEEcCCCCEEEEEc
Confidence            999999999998754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	399
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-37
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-36
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-36
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-35
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-35
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-35
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-35
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-35
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-34
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-34
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-34
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-34
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-33
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-31
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-31
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-31
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-30
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-30
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-29
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-29
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-27
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-25
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-23
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-23
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-22
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.003

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 4e-40
 Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 7/147 (4%)

Query: 242 LQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM 300
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
                ++  YG   +  E  +   +M  GS+   L++       +      K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDED 387
           L+YL E    KI+HRDVK +NIL++  
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSR 141

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (341), Expect = 1e-37
 Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 19/164 (11%)

Query: 237 FSLRELQVATDGFSNK---------NILGRGGFGKVYKGRLA----DGKLVAVKRLKEER 283
           F+  +   A   F+ +          ++G G FG+V  G L         VA+K LK   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 284 TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP 343
           T      F +E  I+    H N++ L G  T  T  +++  +M NGS+ S LR+      
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---G 123

Query: 344 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                    +  G A G+ YL +      +HRD+ A NIL++ +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSN 164

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-37
 Identities = 42/140 (30%), Positives = 63/140 (45%), Gaps = 8/140 (5%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
           +       LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRL 70

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           +RLY   T      ++  YM NGS+   L+        L       +A   A G++++ E
Sbjct: 71  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 367 HCDPKIIHRDVKAANILLDE 386
                 IHRD++AANIL+ +
Sbjct: 128 RN---YIHRDLRAANILVSD 144

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 7e-37
 Identities = 37/152 (24%), Positives = 62/152 (40%), Gaps = 11/152 (7%)

Query: 240 RELQVATDGFSNKNI-LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEV 295
           ++L +  D     +I LG G FG V +G          VA+K LK+        +   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 296 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 355
           +I+    +  ++RL G C      +LV      G +   L  ++  +P        ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIP---VSNVAELLH 116

Query: 356 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
             + G+ YL E      +HRD+ A N+LL   
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNR 145

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 2e-36
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIIS- 299
           +  S    LG G FGKV +              VAVK LK            +E+K++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--------------PL 345
           +  H N++ L G CT     L++  Y   G + + LR ++ S                 L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 346 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           D       +   A+G+++L        IHRD+ A NILL   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-36
 Identities = 44/140 (31%), Positives = 66/140 (47%), Gaps = 10/140 (7%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLL 307
            +    +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
              G+ T   +  +V  +    S+   L   ++     +      IA  +A+G+ YLH  
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123

Query: 368 CDPKIIHRDVKAANILLDED 387
               IIHRD+K+ NI L ED
Sbjct: 124 S---IIHRDLKSNNIFLHED 140

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-36
 Identities = 43/140 (30%), Positives = 62/140 (44%), Gaps = 10/140 (7%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
                 +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQ 64

Query: 309 LYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
           L G        L +V  YM  GS+   LR R  S   L      K +L     + YL  +
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 368 CDPKIIHRDVKAANILLDED 387
                +HRD+ A N+L+ ED
Sbjct: 123 ---NFVHRDLAARNVLVSED 139

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-35
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 6/147 (4%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHR 304
           + +     +G G +G+  K R  +DGK++  K L     +  E Q   +EV ++    H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 305 NLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           N++R Y      T   L  V  Y   G +AS + +       LD     ++       L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 363 YLHEH--CDPKIIHRDVKAANILLDED 387
             H        ++HRD+K AN+ LD  
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK 150

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 36/142 (25%), Positives = 58/142 (40%), Gaps = 8/142 (5%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           + +     LG G +G+V         + VAVK +  +R        + E+ I  M  H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           +++ YG       + L   Y + G +  R+         +  P  ++       G+ YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLH 120

Query: 366 EHCDPKIIHRDVKAANILLDED 387
                 I HRD+K  N+LLDE 
Sbjct: 121 GIG---ITHRDIKPENLLLDER 139

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (327), Expect = 2e-35
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 29/176 (16%)

Query: 238 SLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQF 291
            L  L+   +       +G G FG+V++ R           +VAVK LKEE ++  +  F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 292 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL--------- 342
           Q E  +++   + N+++L G C       L++ YM  G +   LR               
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 343 -----------PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                      PPL    +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 176

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 3e-35
 Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 29/160 (18%)

Query: 254 ILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNL 306
           +LG G FGKV                VAVK LKE+  S       +E+K+++    H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP-------------------PLDW 347
           + L G CT      L++ Y   G + + LR ++                        L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 348 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                 A   A+G+ +L        +HRD+ A N+L+   
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG 200

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 3e-35
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 10/145 (6%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV 302
              FS+   +G G FG VY  R + + ++VA+K++        E       EV+ +    
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H N ++  G         LV  Y    +       ++    PL       +  G+ +GL+
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 129

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           YLH H    +IHRDVKA NILL E 
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEP 151

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 5e-35
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 8/139 (5%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
            +    +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQ 64

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG C       LV+ +M +G ++  LR ++         T   + L    G++YL E C
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 369 DPKIIHRDVKAANILLDED 387
              +IHRD+ A N L+ E+
Sbjct: 122 ---VIHRDLAARNCLVGEN 137

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 7e-35
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 17/145 (11%)

Query: 252 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 311
           +  +G+G FG+V++G+   G+ VAVK              + E+    M  H N+L    
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIA 64

Query: 312 FCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
                  T T+  LV  Y  +GS+   L         +      K+AL +A GL++LH  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHME 119

Query: 368 C-----DPKIIHRDVKAANILLDED 387
                  P I HRD+K+ NIL+ ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKN 144

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-34
 Identities = 39/139 (28%), Positives = 61/139 (43%), Gaps = 8/139 (5%)

Query: 249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 308
            +    LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQ 63

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG CT      ++  YM NG + + LRE +            ++       + YL    
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 369 DPKIIHRDVKAANILLDED 387
               +HRD+ A N L+++ 
Sbjct: 121 ---FLHRDLAARNCLVNDQ 136

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 8/154 (5%)

Query: 235 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT 293
              +  + ++     + K+ LG G +G+VY+G        VAVK LKE+     E  F  
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62

Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 353
           E  ++    H NL++L G CT      ++  +MT G++   LRE       +       +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYM 120

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A   +  + YL +      IHRD+ A N L+ E+
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGEN 151

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 5e-34
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 8/143 (5%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 304
            D +     LG G FGKVYK +      L A K +  +     E  +  E+ I++   H 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L           ++  +   G+V + + E +    PL     + +   +   L+YL
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYL 126

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H++   KIIHRD+KA NIL   D
Sbjct: 127 HDN---KIIHRDLKAGNILFTLD 146

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 6e-34
 Identities = 38/142 (26%), Positives = 65/142 (45%), Gaps = 11/142 (7%)

Query: 252 KNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 309
              +GRG F  VYKG   +    VA   L++ + +  E Q F+ E +++    H N++R 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 310 YGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           Y    +  +     +LV   MT+G++ + L+  +     +     +       +GL +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH 129

Query: 366 EHCDPKIIHRDVKAANILLDED 387
               P IIHRD+K  NI +   
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGP 150

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 6e-34
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 17/156 (10%)

Query: 235 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQF 291
           ++++L + ++          LG+G FG VY  R      ++A+K L + +   +G E Q 
Sbjct: 1   RQWALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53

Query: 292 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 351
           + EV+I S   H N+LRLYG+    T   L+  Y   G+V   L++        D     
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTA 109

Query: 352 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                 A  LSY H     ++IHRD+K  N+LL   
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSA 142

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 1e-33
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAV 302
           +    ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTR 350
           H N++ L G C       L   Y  +G++   LR+ +            S+   L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 351 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              A   ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 4e-33
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 11/150 (7%)

Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLADG-----KLVAVKRLKEERTSGGELQFQTEVKI 297
           ++     + + ++G G FG+VYKG L          VA+K LK   T    + F  E  I
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 298 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 357
           +    H N++RL G  +     +++  YM NG++   LRE+              +  G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGI 119

Query: 358 ARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A G+ YL        +HRD+ A NIL++ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSN 146

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-32
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 8/141 (5%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 306
           +    +  LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 74

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
           ++LY   +      +V  YM+ GS+   L+        L  P    +A   A G++Y+  
Sbjct: 75  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER 131

Query: 367 HCDPKIIHRDVKAANILLDED 387
                 +HRD++AANIL+ E+
Sbjct: 132 MN---YVHRDLRAANILVGEN 149

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 35/139 (25%), Positives = 55/139 (39%), Gaps = 12/139 (8%)

Query: 253 NILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLR 308
             LG G FG V KG        K VAVK LK E        +   E  ++    +  ++R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           + G C      +LV      G +   L++ +     +      ++    + G+ YL E  
Sbjct: 73  MIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126

Query: 369 DPKIIHRDVKAANILLDED 387
               +HRD+ A N+LL   
Sbjct: 127 --NFVHRDLAARNVLLVTQ 143

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 45/141 (31%), Positives = 59/141 (41%), Gaps = 11/141 (7%)

Query: 252 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
             ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 308 RLYGFCTTV-TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 366
            L G C       L+V PYM +G + + +R                  L  A+G   +  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKG---MKF 145

Query: 367 HCDPKIIHRDVKAANILLDED 387
               K +HRD+ A N +LDE 
Sbjct: 146 LASKKFVHRDLAARNCMLDEK 166

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-31
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 15/159 (9%)

Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTE 294
           E +VA +  +    LG+G FG VY+G             VA+K + E  +    ++F  E
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 295 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 348
             ++      +++RL G  +     L++   MT G + S LR           L P    
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 349 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
              ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  120 bits (302), Expect = 2e-31
 Identities = 33/150 (22%), Positives = 60/150 (40%), Gaps = 8/150 (5%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           D +     LG G FG V++    A G++   K +            + E+ I++   H  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPK 87

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           L+ L+       E +L+  +++ G +  R+         +           +  GL ++H
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH 144

Query: 366 EHCDPKIIHRDVKAANILLDEDADQSSKTI 395
           EH    I+H D+K  NI+ +     S K I
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKII 171

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  120 bits (302), Expect = 2e-31
 Identities = 31/144 (21%), Positives = 61/144 (42%), Gaps = 8/144 (5%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 305
           D +     LG G FG V++    A G   A K +     S  E   + E++ +S+  H  
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           L+ L+       E +++Y +M+ G +  ++ +  +    +      +      +GL ++H
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141

Query: 366 EHCDPKIIHRDVKAANILLDEDAD 389
           E+     +H D+K  NI+      
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRS 162

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 6e-31
 Identities = 32/143 (22%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 304
              ++    +G+G  G VY    +A G+ VA++++  ++    E     E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N++          E  +V  Y+  GS+   + E       +D      +     + L +L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFL 132

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H +   ++IHRD+K+ NILL  D
Sbjct: 133 HSN---QVIHRDIKSDNILLGMD 152

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-30
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 247 DGFSNKNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKII 298
           D       LG G FG+V                  VAVK LK + T        +E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 299 SMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPL 345
            M   H+N++ L G CT      ++  Y + G++   L+ R             +    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 346 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                   A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 171

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  117 bits (295), Expect = 2e-30
 Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 13/146 (8%)

Query: 247 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGE-----LQFQTEVKIISM 300
           + FS   I+GRGGFG+VY  R AD GK+ A+K L ++R    +     L  +  + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
                ++ +     T  +   +   M  G +   L +             +  A     G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDE 386
           L ++H      +++RD+K ANILLDE
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDE 142

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 3e-30
 Identities = 33/137 (24%), Positives = 57/137 (41%), Gaps = 11/137 (8%)

Query: 254 ILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 309
            +G G FG V++G           VA+K  K   +     +F  E   +    H ++++L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 310 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 369
            G  T      ++    T G + S L+ R+     LD  +    A   +  L+YL     
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK-- 127

Query: 370 PKIIHRDVKAANILLDE 386
            + +HRD+ A N+L+  
Sbjct: 128 -RFVHRDIAARNVLVSS 143

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  114 bits (286), Expect = 8e-30
 Identities = 42/151 (27%), Positives = 61/151 (40%), Gaps = 17/151 (11%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--------EERTSGGELQFQTEVKI 297
           + +  K ILGRG    V +       K  AVK +          E           EV I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 298 IS-MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 356
           +  ++ H N+++L     T T   LV+  M  G +   L E+      L     +KI   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 118

Query: 357 SARGLSYLHEHCDPKIIHRDVKAANILLDED 387
               +  LH+     I+HRD+K  NILLD+D
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDD 146

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 9e-30
 Identities = 48/139 (34%), Positives = 60/139 (43%), Gaps = 13/139 (9%)

Query: 255 LGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 308
           LG G FG V +G           VAVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 309 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 368
           LYG   T     +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR 131

Query: 369 DPKIIHRDVKAANILLDED 387
               IHRD+ A N+LL   
Sbjct: 132 ---FIHRDLAARNLLLATR 147

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 1e-29
 Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 5/143 (3%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 304
              ++N + +G G +G V       +   VA+K++          +   E+KI+    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N++ +       T + +   Y+    + + L +   +   L             RGL Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYI 125

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H      ++HRD+K +N+LL+  
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTT 145

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (285), Expect = 1e-29
 Identities = 39/144 (27%), Positives = 54/144 (37%), Gaps = 10/144 (6%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVH 303
           + F    ILG G F  V   R LA  +  A+K L++              E  ++S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
              ++LY       +      Y  NG     L +    +   D    +         L Y
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 364 LHEHCDPKIIHRDVKAANILLDED 387
           LH      IIHRD+K  NILL+ED
Sbjct: 124 LHGKG---IIHRDLKPENILLNED 144

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (285), Expect = 2e-29
 Identities = 33/142 (23%), Positives = 64/142 (45%), Gaps = 9/142 (6%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           LGRG FG V++    +  K    K +K + T   ++  + E+ I+++A HRN+L L+   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESF 70

Query: 314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 373
            ++ E ++++ +++   +  R+         L+              L +LH H    I 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIG 124

Query: 374 HRDVKAANILLDEDADQSSKTI 395
           H D++  NI+       + K I
Sbjct: 125 HFDIRPENIIYQTRRSSTIKII 146

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-29
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 23/161 (14%)

Query: 247 DGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISM 300
           D       LGRG FG+V +         A  + VAVK LKE  T        +E+KI+  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 301 AVHR-NLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPP------------LD 346
             H  N++ L G CT     L ++  +   G++++ LR +++   P            L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 347 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                  +   A+G+ +L      K IHRD+ A NILL E 
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 170

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (282), Expect = 4e-29
 Identities = 31/151 (20%), Positives = 64/151 (42%), Gaps = 8/151 (5%)

Query: 240 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII 298
           ++ +   D +  +++LG G F +V         KLVA+K + ++   G E   + E+ ++
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 299 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
               H N++ L     +     L+   ++ G +  R+ E+             ++     
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 389
             + YLH+     I+HRD+K  N+L     +
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDE 145

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 6e-29
 Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 13/148 (8%)

Query: 245 ATDGFSNKNILGRGGFGKVYKGR-LADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 299
            T+ F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++
Sbjct: 8   ETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
              + ++ RL G C T +   L+   M  G +   +RE +     +         +  A+
Sbjct: 67  SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAK 122

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDED 387
           G++YL +    +++HRD+ A N+L+   
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTP 147

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 16/146 (10%)

Query: 249 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 307
           +++  ++G G FG VY+ +L D G+LVA+K++ +++          E++I+    H N++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76

Query: 308 RLYGFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
           RL  F  +  EK       LV  Y+         R    +   L     K       R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
           +Y+H      I HRD+K  N+LLD D
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPD 158

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-28
 Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 11/143 (7%)

Query: 253 NILGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV---HRNL 306
             +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 307 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYL 364
           +RL+  CT           +    V   L     +   P +   T K +     RGL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H H   +++HRD+K  NIL+   
Sbjct: 133 HSH---RVVHRDLKPQNILVTSS 152

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  107 bits (268), Expect = 2e-27
 Identities = 33/136 (24%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYG 311
             +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 312 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 371
              T    +LV+ ++                  L+  T K   L    G++Y H+    +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---R 120

Query: 372 IIHRDVKAANILLDED 387
           ++HRD+K  N+L++ +
Sbjct: 121 VLHRDLKPQNLLINRE 136

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 5e-27
 Identities = 31/144 (21%), Positives = 56/144 (38%), Gaps = 17/144 (11%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYG 311
           +LG G  GKV +       +  A+K L++        + + EV++   A    +++R+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72

Query: 312 FCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
               +       L+V   +  G + SR+++R             +I       + YLH  
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI 130

Query: 368 CDPKIIHRDVKAANILLDEDADQS 391
               I HRDVK  N+L       +
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNA 151

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (267), Expect = 6e-27
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 17/154 (11%)

Query: 237 FSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQT 293
           +SL++ Q+          LG G FG+V+  R   +G+  A+K LK+E     +       
Sbjct: 1   YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53

Query: 294 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 353
           E  ++S+  H  ++R++G      +  ++  Y+        L            P  K  
Sbjct: 54  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY 109

Query: 354 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           A      L YLH      II+RD+K  NILLD++
Sbjct: 110 AAEVCLALEYLHSKD---IIYRDLKPENILLDKN 140

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  105 bits (263), Expect = 1e-26
 Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 14/148 (9%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAV 302
           +D +    ILG GG  +V+  R L   + VAVK L+ +  R     L+F+ E +  +   
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 303 HRNLLRLYGFCTTVTEKL----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           H  ++ +Y      T       +V  Y+   +    LR+   +  P+      ++   + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 121

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDE 386
           + L++ H++    IIHRDVK ANI++  
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISA 146

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 1e-26
 Identities = 35/143 (24%), Positives = 68/143 (47%), Gaps = 8/143 (5%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 304
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 305 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 364
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 365 HEHCDPKIIHRDVKAANILLDED 387
           H H    ++HRD+K  N+L++ +
Sbjct: 119 HSHR---VLHRDLKPQNLLINTE 138

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-26
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 11/145 (7%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV- 302
           + F    +LG+G FGKV+        +  A+K LK++     +       E +++S+A  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 303 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           H  L  ++    T      V  Y+  G +   ++         D       A     GL 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           +LH      I++RD+K  NILLD+D
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKD 139

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (264), Expect = 3e-26
 Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 11/168 (6%)

Query: 224 EDDSELQLGQLKRFSLRELQVAT-DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE 281
           E  ++ +   LK++       A  D F     LG G FG+V   +    G   A+K L +
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76

Query: 282 ERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 339
           ++    +       E +I+       L++L       +   +V  Y+  G + S LR   
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136

Query: 340 SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                   P  +  A        YLH      +I+RD+K  N+L+D+ 
Sbjct: 137 ----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ 177

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 7e-26
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 12/140 (8%)

Query: 253 NILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLL 307
           + LG G F  VYK R     ++VA+K++K     E   G       E+K++    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 308 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 367
            L       +   LV+ +M            + +   L     K   L + +GL YLH+H
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 368 CDPKIIHRDVKAANILLDED 387
               I+HRD+K  N+LLDE+
Sbjct: 120 W---ILHRDLKPNNLLLDEN 136

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 3e-25
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 21/163 (12%)

Query: 237 FSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-Q 290
           F  +E+                +G G +G V        G  VA+K+L     S     +
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 291 FQTEVKIISMAVHRNLLRLYGFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPP 344
              E++++    H N++ L    T        T+  LV P+M  G+   +L + +     
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----K 117

Query: 345 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
           L     + +     +GL Y+H      IIHRD+K  N+ ++ED
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED 157

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (252), Expect = 6e-25
 Identities = 33/148 (22%), Positives = 53/148 (35%), Gaps = 11/148 (7%)

Query: 241 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 299
           EL+V  + +     +G G FG +Y G  +A G+ VA+K    +       Q   E KI  
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYK 57

Query: 300 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 359
           M      +    +C    +  ++   +   S+                 T   +A     
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114

Query: 360 GLSYLHEHCDPKIIHRDVKAANILLDED 387
            + Y+H       IHRDVK  N L+   
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLG 139

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 5e-24
 Identities = 36/153 (23%), Positives = 57/153 (37%), Gaps = 13/153 (8%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-----QFQTEVKIISM 300
           D +     LG G F  V K R  + G   A K +K+ RT            + EV I+  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
             H N++ L+      T+ +L+   +  G     L +  +    L      +       G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 393
           + YLH      I H D+K  NI+L +      +
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 155

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 97.2 bits (241), Expect = 2e-23
 Identities = 26/143 (18%), Positives = 51/143 (35%), Gaps = 12/143 (8%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL-RLYGF 312
           +G G FG +++G  L + + VA+K       +    Q + E +   +      +  +Y F
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 313 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 372
                  +LV   +      S               T    A      +  +HE     +
Sbjct: 70  GQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SL 122

Query: 373 IHRDVKAANILLDEDADQSSKTI 395
           ++RD+K  N L+     +++  I
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMI 145

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.3 bits (239), Expect = 2e-23
 Identities = 30/142 (21%), Positives = 56/142 (39%), Gaps = 14/142 (9%)

Query: 254 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-----LQFQTEVKIISM--AVHRN 305
           +LG GGFG VY G  ++D   VA+K ++++R S         +   EV ++    +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 306 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 365
           ++RL  +       +L+                +     L     +         + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCH 127

Query: 366 EHCDPKIIHRDVKAANILLDED 387
                 ++HRD+K  NIL+D +
Sbjct: 128 NC---GVLHRDIKDENILIDLN 146

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 2e-23
 Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 10/147 (6%)

Query: 244 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISM 300
           V  + F    +LG+G FGKV   R  A G+  A+K L++E     +      TE +++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 301 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 360
             H  L  L     T      V  Y   G +   L   +           +      A  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYG---AEI 114

Query: 361 LSYLHEHCDPKIIHRDVKAANILLDED 387
           +S L       +++RD+K  N++LD+D
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKD 141

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 96.4 bits (239), Expect = 6e-23
 Identities = 31/145 (21%), Positives = 59/145 (40%), Gaps = 18/145 (12%)

Query: 247 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHR 304
           D +     LGRG + +V++   + + + V VK LK  +      + + E+KI+  +    
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGP 90

Query: 305 NLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 362
           N++ L         +   LV+ ++ N       +        L     +       + L 
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143

Query: 363 YLHEHCDPKIIHRDVKAANILLDED 387
           Y H      I+HRDVK  N+++D +
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHE 165

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 7e-23
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 17/149 (11%)

Query: 249 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNL 306
           +     +G+G FG+V+K R    G+ VA+K++  E    G  +    E+KI+ +  H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 307 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 358
           + L   C T             LV+ +  +           + L        K++     
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL----AGLLSNVLVKFTLSEIKRVM---Q 124

Query: 359 RGLSYLHEHCDPKIIHRDVKAANILLDED 387
             L+ L+     KI+HRD+KAAN+L+  D
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRD 153

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 5e-22
 Identities = 24/143 (16%), Positives = 41/143 (28%), Gaps = 19/143 (13%)

Query: 253 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---------GGELQFQTEVKIISMAVH 303
            ++G G    V+           VK  K   TS          G+L F       +    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
           R L +L G             Y   G+           L  +      ++       ++ 
Sbjct: 66  RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118

Query: 364 LHEHCDPKIIHRDVKAANILLDE 386
            +      I+H D+   N+L+ E
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE 138

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.9 bits (227), Expect = 1e-21
 Identities = 29/137 (21%), Positives = 60/137 (43%), Gaps = 9/137 (6%)

Query: 253 NILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLY 310
             +G G +G V+K +     ++VA+KR++ ++   G       E+ ++    H+N++RL+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 311 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 370
               +  +  LV+ +          +   S    LD    K       + L  L      
Sbjct: 68  DVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHSR 120

Query: 371 KIIHRDVKAANILLDED 387
            ++HRD+K  N+L++ +
Sbjct: 121 NVLHRDLKPQNLLINRN 137

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.4 bits (226), Expect = 2e-21
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 15/153 (9%)

Query: 243 QVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGEL---QFQTEV 295
           +V  + F    +LG G +GKV+  R       GKL A+K LK+             +TE 
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 296 KIISMAVHR-NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 354
           +++        L+ L+    T T+  L+  Y+  G + + L +R+            +I 
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138

Query: 355 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                 +  L       II+RD+K  NILLD +
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSN 165

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 3e-20
 Identities = 31/143 (21%), Positives = 53/143 (37%), Gaps = 5/143 (3%)

Query: 246 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVH 303
            + + N + +G G +G V        G  VAVK+L     S     +   E++++    H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 304 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 363
            N++ L    T                +             L     + +     RGL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 364 LHEHCDPKIIHRDVKAANILLDE 386
           +H      IIHRD+K +N+ ++E
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNE 156

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.0 bits (209), Expect = 7e-19
 Identities = 35/178 (19%), Positives = 60/178 (33%), Gaps = 33/178 (18%)

Query: 218 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAV 276
           F+ V   +  +     LKR+   +             +G G  G V         + VA+
Sbjct: 3   FYSV---EVGDSTFTVLKRYQNLKP------------IGSGAQGIVCAAYDAVLDRNVAI 47

Query: 277 KRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYGFCTT------VTEKLLVYPYMTNG 329
           K+L     +     +   E+ ++    H+N++ L    T         +  LV   M   
Sbjct: 48  KKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN 107

Query: 330 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 387
                  E        D      +      G+ +LH      IIHRD+K +NI++  D
Sbjct: 108 LCQVIQMEL-------DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 155

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 81.2 bits (199), Expect = 1e-17
 Identities = 27/146 (18%), Positives = 53/146 (36%), Gaps = 17/146 (11%)

Query: 255 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 313
           LG G F  V+  + + +   VA+K ++ ++        + E+K++      +  +     
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 314 TTVTEKLLVYPY------------MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 361
                KLL +                          ++     +     K+I+     GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 362 SYLHEHCDPKIIHRDVKAANILLDED 387
            Y+H  C   IIH D+K  N+L++  
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIV 162

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 77.5 bits (189), Expect = 2e-16
 Identities = 26/71 (36%), Positives = 38/71 (53%), Gaps = 1/71 (1%)

Query: 91  KNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 150
           KNL  L L NN + G +P  LT +  L+ L++S N L G +P  G+  +F   ++ NN  
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303

Query: 151 LCGPNTKKPCS 161
           LCG      C+
Sbjct: 304 LCGS-PLPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 65.2 bits (157), Expect = 2e-12
 Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 10/107 (9%)

Query: 27  EVDALYIFKSKLQDPNNSLQSWDNLPGNLC--TWFHITCNPEGSVTRV---DLGNAALSG 81
           +  AL   K  L +P   L SW     + C  TW  + C+ +    RV   DL    L  
Sbjct: 7   DKQALLQIKKDLGNPTT-LSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 82  --ELAPELGQLKNLELLRL-NNNSLSGLIPTSLTTITSLNILDLSNN 125
              +   L  L  L  L +   N+L G IP ++  +T L+ L +++ 
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.3 bits (147), Expect = 4e-11
 Identities = 20/79 (25%), Positives = 34/79 (43%), Gaps = 3/79 (3%)

Query: 56  CTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTIT 115
             +         ++  +DL N  + G L   L QLK L  L ++ N+L G IP     + 
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQ 291

Query: 116 SLNILDLSNNRL--SGPVP 132
             ++   +NN+     P+P
Sbjct: 292 RFDVSAYANNKCLCGSPLP 310

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.5 bits (140), Expect = 5e-10
 Identities = 27/136 (19%), Positives = 57/136 (41%), Gaps = 8/136 (5%)

Query: 16  LVALPMISANAEVDALYIFKSKLQD--PNNSLQSWDNLPGNLCTWFHITCNPE-GSVTRV 72
           +  L  +S   ++  L +  +++ +  P   L +  NL  N      I+      ++T +
Sbjct: 253 ISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYL 312

Query: 73  DLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
            L    +S      +  L  L+ L   NN +S    +SL  +T++N L   +N++S   P
Sbjct: 313 TLYFNNISDI--SPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368

Query: 133 DNGSFSQFTPISFENN 148
              + ++ T +   + 
Sbjct: 369 L-ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 7e-05
 Identities = 10/64 (15%), Positives = 27/64 (42%), Gaps = 4/64 (6%)

Query: 69  VTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             +  LG   ++  ++     L  +  L+ +   +  +    +  + +L  ++ SNN+L+
Sbjct: 24  KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT 79

Query: 129 GPVP 132
              P
Sbjct: 80  DITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 24/88 (27%), Positives = 33/88 (37%), Gaps = 4/88 (4%)

Query: 61  ITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNIL 120
                  ++  + L    L       L  L NL  L L NN +S L P  L+ +T L  L
Sbjct: 213 TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268

Query: 121 DLSNNRLSGPVPDNGSFSQFTPISFENN 148
            L  N++S   P  G  +       EN 
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQ 296

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 7e-08
 Identities = 20/98 (20%), Positives = 36/98 (36%), Gaps = 5/98 (5%)

Query: 68  SVTRVDLGNAALSGELAPEL-GQLKNLELLRLNNNSLSG----LIPTSLTTITSLNILDL 122
            +  +D+    LS     EL   L+  +++RL++  L+      I ++L    +L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 123 SNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPC 160
            +N L             TP      L+L         
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 3e-06
 Identities = 18/87 (20%), Positives = 26/87 (29%), Gaps = 9/87 (10%)

Query: 56  CTWFHITCNPEGSVTRVDLGNAALSGE----LAPELGQLKNLELLRLNNNSLSGLIPTSL 111
                    P   +  + L +  +S      LA  L    +L  L L+NN L       L
Sbjct: 358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417

Query: 112 TTI-----TSLNILDLSNNRLSGPVPD 133
                     L  L L +   S  + D
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEMED 444

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 9e-07
 Identities = 14/40 (35%), Positives = 21/40 (52%), Gaps = 2/40 (5%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSN 124
             L  L NL  + L NN +S + P  L   ++L I+ L+N
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 5e-04
 Identities = 14/48 (29%), Positives = 25/48 (52%), Gaps = 2/48 (4%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 132
             L  L  L  L+ ++N +S + P  L ++ +L  + L NN++S   P
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (110), Expect = 1e-06
 Identities = 16/65 (24%), Positives = 25/65 (38%), Gaps = 3/65 (4%)

Query: 62  TCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILD 121
             +   S   V+     L+  L P+L   K+  +L L+ N L      +L   T L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 122 LSNNR 126
           L    
Sbjct: 62  LDRAE 66

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 47.0 bits (110), Expect = 2e-06
 Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 11/105 (10%)

Query: 56  CTWFHITCN-------PEG---SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSG 105
           C    + C+       P+        +DL N  ++     +   LKNL  L L NN +S 
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 106 LIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 150
           + P +   +  L  L LS N+L   +P+    +       EN + 
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEIT 113

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 1e-05
 Identities = 5/40 (12%), Positives = 11/40 (27%)

Query: 87  LGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 126
                   +L ++   +  L    L  +  L      N +
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 4e-05
 Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 9/86 (10%)

Query: 48  WDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLI 107
                          C+   S+  +++ N  L  EL     +L+ L     + N L+ + 
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAEVP 320

Query: 108 PTSLTTITSLNILDLSNNRLSGPVPD 133
                   +L  L +  N L    PD
Sbjct: 321 EL----PQNLKQLHVEYNPLRE-FPD 341

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 15/73 (20%), Positives = 23/73 (31%), Gaps = 4/73 (5%)

Query: 56  CTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTIT 115
                   +    +        A S E+        +LE L ++NN L   +P       
Sbjct: 249 LDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PP 304

Query: 116 SLNILDLSNNRLS 128
            L  L  S N L+
Sbjct: 305 RLERLIASFNHLA 317

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 36.3 bits (82), Expect = 0.004
 Identities = 13/38 (34%), Positives = 15/38 (39%), Gaps = 4/38 (10%)

Query: 91  KNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
           +    L LNN  LS L P        L  L  S N L+
Sbjct: 38  RQAHELELNNLGLSSL-PEL---PPHLESLVASCNSLT 71

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 5e-05
 Identities = 7/75 (9%), Positives = 25/75 (33%), Gaps = 4/75 (5%)

Query: 82  ELAPELGQLKNLELLRLNNNSLSG----LIPTSLTTITSLNILDLSNNRLSGPVPDNGSF 137
            +   L +  +++ + L+ N++       +  ++ +   L I + S+        +    
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 138 SQFTPISFENNLNLC 152
            +    +      L 
Sbjct: 82  LRLLLQALLKCPKLH 96

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.2 bits (84), Expect = 0.002
 Identities = 18/84 (21%), Positives = 30/84 (35%), Gaps = 11/84 (13%)

Query: 56  CTWFHITCNPEGSVTRVDLGNAALSGELAPELGQ------LKNLELLRLNNNSLSGLIPT 109
            +   I      ++  + L +  LS   A  +           L+ LRL  N +      
Sbjct: 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 291

Query: 110 SLTTI-----TSLNILDLSNNRLS 128
           +L T+       L  L+L+ NR S
Sbjct: 292 TLKTVIDEKMPDLLFLELNGNRFS 315

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 2e-04
 Identities = 12/40 (30%), Positives = 22/40 (55%), Gaps = 2/40 (5%)

Query: 85  PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSN 124
             L  L  L+ L L+ N +S L   +L  + +L++L+L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.5 bits (83), Expect = 0.002
 Identities = 8/61 (13%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 69  VTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 128
             + +L   +++  +     +L +++ +  NN+ +  +    +  + ++  L L+ N+L+
Sbjct: 26  TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81

Query: 129 G 129
            
Sbjct: 82  D 82

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 5e-04
 Identities = 9/60 (15%), Positives = 21/60 (35%), Gaps = 2/60 (3%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 129
             +DL    L  ++   L     +   R   + +   +    +    +  +DLSN+ +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEV 60

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.001
 Identities = 12/52 (23%), Positives = 20/52 (38%), Gaps = 4/52 (7%)

Query: 79  LSGELAPELGQLKNLELLR---LNNNSLSGLIPTSLTTITSLNILDLSNNRL 127
           L+ EL  +  Q  N    R   L    +   I     T+   + +D S+N +
Sbjct: 3   LTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI 53

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (83), Expect = 0.003
 Identities = 12/82 (14%), Positives = 26/82 (31%), Gaps = 4/82 (4%)

Query: 48  WDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLI 107
                 NL         P  ++  + L +     +          L+  R +++ +   +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSL 264

Query: 108 PTSLTTITSLNILDLSNNRLSG 129
           P  L      ++  L+ N L G
Sbjct: 265 PQRLA---GRDLKRLAANDLQG 283

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	399
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.98
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.98
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.98
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.98
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.96
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.96
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.96
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.96
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.96
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.96
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.95
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.95
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.94
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.94
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.94
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.94
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.94
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.94
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.93
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.93
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.92
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.92
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.91
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.82
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.8
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.32
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.73
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.57
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.54
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.49
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.3
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.27
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.24
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.21
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.06
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.03
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	97.98
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	97.92
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.9
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	97.8
d2ifga3	156	High affinity nerve growth factor receptor, N-term	97.76
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	97.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.71
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.56
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.49
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	97.34
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.33
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.27
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.25
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.16
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.03
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.01
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	96.91
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	96.9
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	96.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.61
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	96.45
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	96.36
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	95.68
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.31
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.23
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	95.23
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	94.88
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	94.82
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.66
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	93.18
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	92.69
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	91.26
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	90.95

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-33  Score=262.33  Aligned_cols=149  Identities=28%  Similarity=0.395  Sum_probs=132.1

Q ss_pred             HHHHHhcCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCce
Q 015852          241 ELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  319 (399)
Q Consensus       241 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~  319 (399)
                      ++++..++|...+.||+|+||+||+|+.. +++.||||+++...  ....+|.+|+.+++.++|||||+++|+|.+.+..
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            33444567778899999999999999875 58899999996542  3445799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++.....  ..++|..+..|+.||++||+|||++   +|+||||||+|||+|+++.+||+||+
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccc
Confidence            999999999999999976432  3589999999999999999999998   99999999999999999999999994

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.98  E-value=4.6e-33  Score=260.05  Aligned_cols=144  Identities=29%  Similarity=0.443  Sum_probs=126.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CC---CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...++||+|+||+||+|+.. ++   ..||||.+.........++|.+|++++++++|||||+++|+|...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            34556689999999999999874 23   368999987654444456799999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++.....   .++|.++..++.|||+||+|||++   +|+||||||+|||||.++.+||+||+
T Consensus       106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcc
Confidence            999999999999876432   489999999999999999999998   99999999999999999999999994

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=7.6e-33  Score=253.92  Aligned_cols=142  Identities=27%  Similarity=0.436  Sum_probs=129.0

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ++|+..+.||+|+||+||+|++.+++.||||+++..  .....+|.+|++++++++|||||+++|+|...+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            456777899999999999999988889999999653  234457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.+++....   ..++|..+..++.|+|+||+|||+.   +|+||||||+|||+|+++.+||+||+
T Consensus        83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG  146 (263)
T d1sm2a_          83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  146 (263)
T ss_dssp             TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred             CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccc
Confidence            9999999987643   2488999999999999999999999   99999999999999999999999994

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=4.6e-33  Score=256.19  Aligned_cols=143  Identities=25%  Similarity=0.380  Sum_probs=126.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++..........+.+|+++++.++|||||++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            4677889999999999999986 478999999986544333344699999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus        85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG  148 (271)
T d1nvra_          85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  148 (271)
T ss_dssp             CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccch
Confidence            99999999997542    489999999999999999999999   99999999999999999999999994

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=7.4e-33  Score=255.61  Aligned_cols=143  Identities=29%  Similarity=0.439  Sum_probs=125.5

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ..++|...+.||+|+||+||+|++..  .||||+++..... .....|.+|+.++++++|||||+++|++.. +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            35678889999999999999998643  5999999654332 334579999999999999999999998765 5689999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.++++....   .++|.++..|+.|||+||+|||++   +||||||||+|||+|+++.+||+||+
T Consensus        83 Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             ecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence            99999999999976432   489999999999999999999998   99999999999999999999999994

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.4e-33  Score=256.77  Aligned_cols=144  Identities=28%  Similarity=0.422  Sum_probs=126.6

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..++|...+.||+|+||+||+|++++++.||||+++...  ...+.|.+|+.++++++|||||+++|++.. +..++|||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            345677788999999999999999888899999996532  334579999999999999999999998754 56799999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++.....  ..++|.+++.|+.||++||+|||++   +|+||||||+|||||+++.+||+||+
T Consensus        88 y~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          88 YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             CCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecccc
Confidence            9999999998765322  2489999999999999999999998   99999999999999999999999994

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-32  Score=258.54  Aligned_cols=144  Identities=26%  Similarity=0.366  Sum_probs=130.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .++|+..+.||+|+||+||+|+. .+|+.||+|+++..........+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46788889999999999999986 47899999999765444445679999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|.+++.+..    .+++..+..++.|+++||+|||+ +   +|+||||||+|||+++++.+||+||+
T Consensus        85 y~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             CCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence            999999999998653    38999999999999999999996 5   79999999999999999999999995

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.6e-32  Score=245.65  Aligned_cols=142  Identities=27%  Similarity=0.423  Sum_probs=129.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      ++|+..+.||+|+||+||+|++++++.||||+++...  ....+|.+|+.++++++||||++++|+|.+.+..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            5788899999999999999999888899999997543  33457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|..++.....   .+++..+.+++.|+++||+|||+.   +|+||||||+|||+|+++.+||+||+
T Consensus        82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG  145 (258)
T d1k2pa_          82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG  145 (258)
T ss_dssp             TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred             CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcch
Confidence            99999999775432   478999999999999999999998   99999999999999999999999994

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.9e-32  Score=247.25  Aligned_cols=143  Identities=32%  Similarity=0.484  Sum_probs=128.9

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||+||+|+.. +++.||+|++....  .......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46788899999999999999874 68999999986432  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|+++||+|||++   +||||||||+|||++.++.+||+||+
T Consensus        86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence            9999999999998653    489999999999999999999999   99999999999999999999999995

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.8e-32  Score=249.79  Aligned_cols=144  Identities=29%  Similarity=0.469  Sum_probs=127.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCC-----CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADG-----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      +.|+..++||+|+||+||+|.+++.     ..||||+++.........+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4566779999999999999986532     37999999765444445579999999999999999999999999999999


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+.+|++.+++.....   .++|.++..++.|++.||+|||+.   +|+||||||+|||||.++.+||+||+
T Consensus        87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccc
Confidence            9999999999998876532   589999999999999999999998   99999999999999999999999994

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.2e-31  Score=247.49  Aligned_cols=141  Identities=22%  Similarity=0.353  Sum_probs=128.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4688899999999999999985 579999999986543 23345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++.+.     .+++.+...++.|++.||+|||++   +||||||||+|||++.++.+||+||+
T Consensus        99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG  161 (293)
T d1yhwa1          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (293)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccch
Confidence            9999999988753     388999999999999999999999   99999999999999999999999994

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.9e-32  Score=250.60  Aligned_cols=143  Identities=24%  Similarity=0.368  Sum_probs=123.5

Q ss_pred             cCCCCCce-eeccCCceEEEEEeC---CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNI-LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~-lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...++ ||+|+||+||+|.++   ++..||||+++.........+|.+|++++++++|||||+++|+|.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            34445564 999999999999764   3557999999765444445679999999999999999999999865 568999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++.....   .+++.++..++.|+|+||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus        87 mE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG  154 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG  154 (285)
T ss_dssp             EECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             EEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccch
Confidence            999999999999865432   589999999999999999999998   99999999999999999999999994

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.3e-32  Score=249.96  Aligned_cols=143  Identities=28%  Similarity=0.412  Sum_probs=128.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.|+..+.||+|+||+||+|+. .+++.||||+++... ......|.+|+++++.++|||||++++++.+.+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            4567778999999999999986 478999999986542 33345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.+++.+...   .+++.++..++.|++.||+|||++   +|+||||||+|||++.++++||+||+
T Consensus        91 ~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          91 CAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEech
Confidence            999999999876432   489999999999999999999999   99999999999999999999999995

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.4e-32  Score=250.17  Aligned_cols=150  Identities=23%  Similarity=0.328  Sum_probs=120.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeec--CCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  322 (399)
                      ++|+..+.||+|+||+||+|+. .+|+.||||.++...... ....|.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5688889999999999999986 478999999986543322 23468999999999999999999999865  4567899


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++.+.......+++..+..++.|++.||+|||+..  ..+||||||||+|||+++++.+||+||+
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            9999999999999754322345899999999999999999999862  1259999999999999999999999994

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.6e-32  Score=250.70  Aligned_cols=144  Identities=27%  Similarity=0.416  Sum_probs=127.7

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ..++|...+.||+|+||+||+|+.++++.||||+++...  .....|.+|+.++++++|||||+++|+|. .+..++|||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E   91 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE   91 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence            346688889999999999999999888889999996542  33457999999999999999999999985 456899999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+++|+|..++.....  ..++|.+++.|+.||+.||+|||+.   +|+||||||+|||+|+++++||+||+
T Consensus        92 y~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfG  158 (285)
T d1fmka3          92 YMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  158 (285)
T ss_dssp             CCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccc
Confidence            9999999999876422  2489999999999999999999999   99999999999999999999999995

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.6e-31  Score=249.92  Aligned_cols=154  Identities=29%  Similarity=0.468  Sum_probs=134.3

Q ss_pred             HHHHHHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeee
Q 015852          240 RELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC  313 (399)
Q Consensus       240 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~  313 (399)
                      .+++..+++|+..+.||+|+||+||+|+..      +++.||||+++.........+|.+|+++++.++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            445556788999999999999999999853      35789999997655444456799999999999999999999999


Q ss_pred             ecCCceEEEEecCCCCChhhHhhhcCC--------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCce
Q 015852          314 TTVTEKLLVYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKII  373 (399)
Q Consensus       314 ~~~~~~~lv~e~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  373 (399)
                      ...+..+++|||+++|+|.++++....                    ....++|..++.|+.|++.||+|||++   +||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence            999999999999999999999975321                    123488999999999999999999998   999


Q ss_pred             ecCCCCCceeeCCCCceeecccc
Q 015852          374 HRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       374 HrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||||+|||+|.++++||+||+
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFG  185 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFG  185 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCS
T ss_pred             eeEEcccceEECCCCcEEEccch
Confidence            99999999999999999999995

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-31  Score=245.86  Aligned_cols=143  Identities=27%  Similarity=0.345  Sum_probs=128.9

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++...  .......+.+|++++++++|||||++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4688889999999999999986 478999999986432  2233457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +||||||||+|||+++++.+||+||+
T Consensus        88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence            9999999999988654    489999999999999999999999   99999999999999999999999994

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-31  Score=250.37  Aligned_cols=150  Identities=27%  Similarity=0.414  Sum_probs=126.0

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeCC-C-----CEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLAD-G-----KLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  316 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-----~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  316 (399)
                      +..++|...++||+|+||+||+|+... +     ..||||.+...........|.+|+.++.++ +|||||++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            344678888999999999999998532 2     369999986654444555799999999887 899999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCC-------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCC
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSS-------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  377 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  377 (399)
                      +..++||||+++|+|.++|+.....                   ...++|..++.|+.||++||+|||++   +||||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            9999999999999999999865321                   13489999999999999999999999   9999999


Q ss_pred             CCCceeeCCCCceeecccc
Q 015852          378 KAANILLDEDADQSSKTIL  396 (399)
Q Consensus       378 K~~NILld~~~~~~i~df~  396 (399)
                      ||+|||+|.++.+||+||+
T Consensus       191 Kp~Nill~~~~~~Kl~DFG  209 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFG  209 (325)
T ss_dssp             SGGGEEEETTTEEEECCCG
T ss_pred             chhccccccCCeEEEeecc
Confidence            9999999999999999994

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=3e-31  Score=248.51  Aligned_cols=142  Identities=29%  Similarity=0.403  Sum_probs=125.9

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      .|+..+.||+|+||+||+|+. .+++.||||+++......  ....|.+|+.++++++|||||++++++.+.+..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            377788999999999999985 578899999986543222  23468999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||++|+|..++....    .+++.++..++.||+.||+|||++   +||||||||+|||+++++.+||+||+
T Consensus        96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence            999999987765542    489999999999999999999999   99999999999999999999999995

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.3e-31  Score=242.78  Aligned_cols=136  Identities=26%  Similarity=0.361  Sum_probs=117.8

Q ss_pred             ceeeccCCceEEEEEeC---CCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecCCC
Q 015852          253 NILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  328 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~  328 (399)
                      +.||+|+||+||+|.++   .++.||||+++...... ...+|.+|+.++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999864   34689999996543332 23479999999999999999999999865 457899999999


Q ss_pred             CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          329 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       329 gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+|.++++...    .++|.++..++.||+.||+|||+.   +||||||||+|||++.++.+|++||+
T Consensus        92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFG  152 (277)
T d1xbba_          92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  152 (277)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchh
Confidence            99999998653    489999999999999999999998   99999999999999999999999994

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=7.9e-31  Score=245.54  Aligned_cols=143  Identities=23%  Similarity=0.371  Sum_probs=122.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      +.|+..+.||+|+||+||+|+.. +++.||||++...........+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56788899999999999999864 68999999997554444445688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC---CCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld---~~~~~~i~df~  396 (399)
                      +++|+|.+++....    .+++.+...++.|++.||+|||++   +|+||||||+|||++   +++.+||+||+
T Consensus        89 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          89 VSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             CCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             cCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccc
Confidence            99999999997643    489999999999999999999999   999999999999995   57899999994

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-30  Score=238.92  Aligned_cols=141  Identities=26%  Similarity=0.393  Sum_probs=120.4

Q ss_pred             CCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeec----CCceEEEEe
Q 015852          251 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYP  324 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e  324 (399)
                      ..+.||+|+||+||+|+.. +++.||+|.+...... .....|.+|++++++++|||||++++++..    ....++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            3467999999999999864 6889999998654332 234469999999999999999999999864    345789999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC-CCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld-~~~~~~i~df~  396 (399)
                      |+++|+|.+++.+..    .+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+||+
T Consensus        93 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          93 LMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence            999999999998653    488999999999999999999998 22399999999999997 57899999994

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.9e-30  Score=240.30  Aligned_cols=143  Identities=26%  Similarity=0.319  Sum_probs=127.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-----ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      +.|...+.||+|+||+||+|+. .+|+.||||+++.....     .....|.+|+.++++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5678889999999999999986 47899999998643321     12457999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCc----eeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD----QSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~----~~i~df~  396 (399)
                      +|||||++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.    +|++||+
T Consensus        90 iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999998753    489999999999999999999999   9999999999999998874    8999994

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.1e-30  Score=245.42  Aligned_cols=144  Identities=25%  Similarity=0.332  Sum_probs=129.6

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      .++|...+.||+|+||+||+|+. .+++.||||+++...  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            35688889999999999999986 579999999996542  223445789999999999999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||++   +||||||||+|||+|+++.+||+||+
T Consensus        84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG  150 (337)
T d1o6la_          84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecc
Confidence            99999999999998754    378889999999999999999999   99999999999999999999999994

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=2.6e-30  Score=242.91  Aligned_cols=143  Identities=29%  Similarity=0.421  Sum_probs=128.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++...  .......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4677889999999999999986 468999999996442  2233457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+++|+|..++....    .+++.....++.|++.||+|||++   +||||||||+|||+|.++.+||+||+
T Consensus        84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence            9999999999988654    378888899999999999999999   99999999999999999999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.96  E-value=2.3e-30  Score=238.85  Aligned_cols=143  Identities=29%  Similarity=0.324  Sum_probs=127.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc--------cHHHHHHHHHHHhcCC-CCCccceeeeeecC
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--------GELQFQTEVKIISMAV-HRNLLRLYGFCTTV  316 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~--------~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~  316 (399)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++......        ....+.+|+.++++++ |||||++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5678889999999999999986 578999999986543221        1225889999999997 99999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +..++||||+++|+|.++++...    .+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999998653    489999999999999999999999   99999999999999999999999994

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.4e-31  Score=245.33  Aligned_cols=150  Identities=27%  Similarity=0.424  Sum_probs=130.0

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  317 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~  317 (399)
                      +..++|...+.||+|+||.||+|.+.      +++.||||+++..........|.+|+.++++++|||||+++|+|...+
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            34466777899999999999999753      356899999975544444457999999999999999999999999999


Q ss_pred             ceEEEEecCCCCChhhHhhhcC------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCcee
Q 015852          318 EKLLVYPYMTNGSVASRLRERQ------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  391 (399)
Q Consensus       318 ~~~lv~e~~~~gsL~~~L~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~  391 (399)
                      ..++||||+++|+|.+++....      .....++|..+..++.|+|+||.|||+.   +|+||||||+|||+|+++.+|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEE
Confidence            9999999999999999987432      2223578999999999999999999998   999999999999999999999


Q ss_pred             ecccc
Q 015852          392 SKTIL  396 (399)
Q Consensus       392 i~df~  396 (399)
                      |+||+
T Consensus       174 l~DFG  178 (308)
T d1p4oa_         174 IGDFG  178 (308)
T ss_dssp             ECCTT
T ss_pred             Eeecc
Confidence            99994

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-30  Score=242.51  Aligned_cols=147  Identities=29%  Similarity=0.485  Sum_probs=125.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC--EEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|+..++||+|+||+||+|++. ++.  .||||+++........+.|.+|+++++++ +|||||+++|+|...+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            46777799999999999999865 443  57888886554444555799999999998 799999999999999999999


Q ss_pred             EecCCCCChhhHhhhcC------------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCce
Q 015852          323 YPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  390 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~  390 (399)
                      |||+++|+|.++++...            .....++|.++..++.|||+||.|+|+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            99999999999997541            2234689999999999999999999999   99999999999999999999


Q ss_pred             eecccc
Q 015852          391 SSKTIL  396 (399)
Q Consensus       391 ~i~df~  396 (399)
                      ||+||+
T Consensus       167 kl~DfG  172 (309)
T d1fvra_         167 KIADFG  172 (309)
T ss_dssp             EECCTT
T ss_pred             EEcccc
Confidence            999994

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.8e-31  Score=241.09  Aligned_cols=144  Identities=23%  Similarity=0.315  Sum_probs=124.5

Q ss_pred             hcCCCCCceeeccCCceEEEEEeCC----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      .++|...+.||+|+||+||+|+...    +..||||.++..........|.+|+.++++++|||||+++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4567788999999999999998642    35799999865544444557999999999999999999999985 467899


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||||+++|+|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+||++++++.+||+||+
T Consensus        85 v~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccch
Confidence            9999999999998876432   489999999999999999999999   99999999999999999999999994

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.96  E-value=4.7e-30  Score=244.55  Aligned_cols=143  Identities=21%  Similarity=0.324  Sum_probs=126.9

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+.++++++|||||++++++.+.+..++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4688889999999999999986 579999999986532 22344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeC--CCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld--~~~~~~i~df~  396 (399)
                      +++|+|.+++....   ..+++.+...|+.||+.||+|||++   +||||||||+|||++  .++.+||+||+
T Consensus       108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_         108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence            99999999886543   2489999999999999999999999   999999999999998  57899999995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.96  E-value=4.3e-30  Score=244.65  Aligned_cols=143  Identities=20%  Similarity=0.335  Sum_probs=126.9

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5788889999999999999986 478999999986542 22344689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC--CCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~--~~~~~i~df~  396 (399)
                      |++|+|.+++....   ..+++..+..|+.||+.||+|||++   +||||||||+|||++.  ++.+||+||+
T Consensus       105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2         105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence            99999999996543   2489999999999999999999999   9999999999999964  5789999995

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.5e-30  Score=238.63  Aligned_cols=139  Identities=33%  Similarity=0.491  Sum_probs=121.1

Q ss_pred             CceeeccCCceEEEEEeCC----CCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec-CCceEEEEecC
Q 015852          252 KNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPYM  326 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~~~----~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~  326 (399)
                      .++||+|+||+||+|++.+    ...||||+++.........+|.+|++++++++|||||+++|++.. +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4789999999999998643    236999999754444444579999999999999999999999875 45789999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++|+|.++++....   ..++..++.++.|+++||.|||+.   +|+||||||+|||+|+++.+||+||+
T Consensus       112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEeccc
Confidence            99999999876432   467889999999999999999998   99999999999999999999999994

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.9e-30  Score=240.39  Aligned_cols=143  Identities=26%  Similarity=0.467  Sum_probs=122.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCC----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  321 (399)
                      ++|+..++||+|+||+||+|+.. +|+    .||+|+++........++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35778899999999999999864 443    68999987655555566899999999999999999999999864 5678


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||+.+|+|.+++.....   .++|..+..++.|||+||+|||++   +||||||||+|||+|.++.+||+||+
T Consensus        88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccc
Confidence            8999999999998876532   589999999999999999999998   99999999999999999999999994

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.9e-30  Score=239.56  Aligned_cols=142  Identities=21%  Similarity=0.317  Sum_probs=125.8

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||+||+|... +++.||||.++...  .....+.+|+++++.++|||||++++++.+.+..++||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            56778899999999999999864 68899999996542  2234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC--Cceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED--ADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~--~~~~i~df~  396 (399)
                      |++|+|.+++....   ..+++.+...|+.|++.||+|||++   +|+||||||+|||++.+  ..+|++||+
T Consensus        83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence            99999999997643   2489999999999999999999999   99999999999999855  478999994

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.2e-30  Score=242.09  Aligned_cols=150  Identities=28%  Similarity=0.383  Sum_probs=130.4

Q ss_pred             HHhcCCCCCceeeccCCceEEEEEe------CCCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeecC
Q 015852          244 VATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  316 (399)
Q Consensus       244 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~  316 (399)
                      ...++|+..+.||+|+||.||+|++      .+++.||||+++..........|.+|+.++..+ +|||||+++|+|.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            3446677789999999999999975      245689999997655444555799999999998 699999999999999


Q ss_pred             CceEEEEecCCCCChhhHhhhcCC--------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCce
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQS--------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  382 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NI  382 (399)
                      ...+++|||+++|+|.++++....              ....+++..+..++.||++||+|||++   +||||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence            999999999999999999986532              123588999999999999999999999   999999999999


Q ss_pred             eeCCCCceeecccc
Q 015852          383 LLDEDADQSSKTIL  396 (399)
Q Consensus       383 Lld~~~~~~i~df~  396 (399)
                      |+|.++.+|++||+
T Consensus       177 l~~~~~~~ki~DfG  190 (311)
T d1t46a_         177 LLTHGRITKICDFG  190 (311)
T ss_dssp             EEETTTEEEECCCG
T ss_pred             cccccCcccccccc
Confidence            99999999999994

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.7e-30  Score=235.50  Aligned_cols=141  Identities=28%  Similarity=0.443  Sum_probs=122.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeec-CCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~  325 (399)
                      ++|+..+.||+|+||.||+|++. |+.||||+++..   ...+.|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            45666789999999999999984 778999999643   234579999999999999999999999865 4567999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +++|+|.++++++..  ..++|..+++|+.||+.||+|||+.   +|+||||||+|||++.++.+|++||+
T Consensus        83 ~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  148 (262)
T d1byga_          83 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  148 (262)
T ss_dssp             CTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             cCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccc
Confidence            999999999976421  2479999999999999999999998   99999999999999999999999994

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.7e-30  Score=240.32  Aligned_cols=154  Identities=28%  Similarity=0.380  Sum_probs=123.5

Q ss_pred             HHHHHHhcCCCCCceeeccCCceEEEEEeC------CCCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeee
Q 015852          240 RELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGF  312 (399)
Q Consensus       240 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~  312 (399)
                      .++++..++|...+.||+|+||+||+|+..      +++.||||+++..........+.+|+..+.++ +|+||++++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            444455677888899999999999999852      34689999997655444455788888877665 69999999999


Q ss_pred             eecCC-ceEEEEecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 015852          313 CTTVT-EKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKA  379 (399)
Q Consensus       313 ~~~~~-~~~lv~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~  379 (399)
                      +...+ ..++||||+++|+|.++++....            ....++|.++..++.||++||+|||++   +||||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence            87654 57899999999999999976432            123488999999999999999999999   999999999


Q ss_pred             CceeeCCCCceeecccc
Q 015852          380 ANILLDEDADQSSKTIL  396 (399)
Q Consensus       380 ~NILld~~~~~~i~df~  396 (399)
                      +|||+|+++.+||+||+
T Consensus       163 ~NILl~~~~~~Kl~DFG  179 (299)
T d1ywna1         163 RNILLSEKNVVKICDFG  179 (299)
T ss_dssp             GGEEECGGGCEEECC--
T ss_pred             cceeECCCCcEEEccCc
Confidence            99999999999999994

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=1.7e-29  Score=240.57  Aligned_cols=143  Identities=24%  Similarity=0.311  Sum_probs=128.9

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  323 (399)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++...  .......+.+|+.+++.++|||||++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5688889999999999999986 479999999986432  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          324 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       324 e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ||+.+|+|..++....    .+++.....++.|++.||.|||++   +||||||||+|||++.++.+||+||+
T Consensus       121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence            9999999999998753    489999999999999999999999   99999999999999999999999994

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.96  E-value=1.3e-29  Score=235.07  Aligned_cols=143  Identities=23%  Similarity=0.391  Sum_probs=127.4

Q ss_pred             cCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEec
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  325 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~  325 (399)
                      ++|...+.||+|+||+||+|+..+++.||||+++.... ......+.+|+.+++.++|||||++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            56778899999999999999998999999999965432 22345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          326 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       326 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +.++.+..+.+..    ..+++.....++.||+.||+|||+.   +||||||||+|||++.++.+|++||+
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG  145 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFG  145 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccc
Confidence            9987777666543    2489999999999999999999998   99999999999999999999999995

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.9e-29  Score=235.35  Aligned_cols=144  Identities=22%  Similarity=0.445  Sum_probs=122.6

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      |+|+..+.||+|+||+||+|+. .+++.||||+++..... ....++.+|++++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788889999999999999986 57899999999654322 234579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+.++ +.+++.....  ..+++..+..++.|++.||+|||++   +||||||||+|||++.++..|++||+
T Consensus        82 ~~~~~-~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG  147 (298)
T d1gz8a_          82 FLHQD-LKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  147 (298)
T ss_dssp             CCSEE-HHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ecCCc-hhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCC
Confidence            99754 4445443322  3489999999999999999999999   99999999999999999999999995

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.96  E-value=1.7e-29  Score=233.18  Aligned_cols=143  Identities=24%  Similarity=0.332  Sum_probs=126.3

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeeeecCC----ce
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EK  319 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~  319 (399)
                      ++|...+.||+|+||+||+|+. .+++.||||+++.....+.  ...|.+|+.+++.++|||||++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5688889999999999999986 5799999999975543322  346999999999999999999999987654    37


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||||+++|+|.+++....    .+++.+...++.|++.||+|||++   +|+||||||+|||++.++..+++||+
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred             EEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence            89999999999999987653    489999999999999999999998   99999999999999999999999994

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.8e-29  Score=236.27  Aligned_cols=143  Identities=25%  Similarity=0.394  Sum_probs=125.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccc--ccccHHHHHHHHHHHh-cCCCCCccceeeeeecCCceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv  322 (399)
                      ++|...+.||+|+||+||+|+.. +++.||||+++...  .......+..|+.++. .++|||||++++++.+.+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            56888899999999999999864 78999999996432  2233445677777654 78999999999999999999999


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.++++...    .+++.+...++.||+.||+|||++   +|+||||||+|||+++++.+|++||+
T Consensus        82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG  148 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG  148 (320)
T ss_dssp             EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccc
Confidence            99999999999998754    378899999999999999999999   99999999999999999999999994

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=2.6e-29  Score=240.55  Aligned_cols=143  Identities=28%  Similarity=0.377  Sum_probs=124.1

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccc--cccHHHHHH---HHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQT---EVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~f~~---E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|...++||+|+||+||+|+.. +|+.||||++.....  ......+.+   |+.+++.++|||||++++++...+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57888899999999999999864 799999999854321  122223444   467788889999999999999999999


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+++|+|.+++....    .+++..+..++.||+.||+|||++   +||||||||+|||+++++.+||+||+
T Consensus        84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeec
Confidence            9999999999999998753    378899999999999999999999   99999999999999999999999995

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.6e-29  Score=234.89  Aligned_cols=138  Identities=29%  Similarity=0.429  Sum_probs=116.9

Q ss_pred             CCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHH--HHHHHHHhcCCCCCccceeeeeecCC----ceEEE
Q 015852          249 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF--QTEVKIISMAVHRNLLRLYGFCTTVT----EKLLV  322 (399)
Q Consensus       249 ~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f--~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv  322 (399)
                      |...+.||+|+||.||+|++ +|+.||||+++..    ...++  ..|+..+..++|||||+++++|.+.+    ..++|
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            45568899999999999997 5789999998543    22334  44555567789999999999998654    47899


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcC-----CCCCceecCCCCCceeeCCCCceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-----CDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |||+++|+|.+++++.     .++|.++.+++.|+|.||+|+|+.     ..++||||||||+|||||+++.+||+||+
T Consensus        80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            9999999999999864     389999999999999999999974     24589999999999999999999999995

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-29  Score=235.28  Aligned_cols=149  Identities=29%  Similarity=0.409  Sum_probs=123.4

Q ss_pred             HhcCCCCCceeeccCCceEEEEEeCC--------CCEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeeeec
Q 015852          245 ATDGFSNKNILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  315 (399)
Q Consensus       245 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~  315 (399)
                      ..++|...+.||+|+||.||+|+...        +..||||+++.........++.+|+..+.++ +|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34567778999999999999997521        2479999997665444456788998888777 79999999999999


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCcee
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  383 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NIL  383 (399)
                      .+..++||||+++|+|.++++.+..            ....+++.+++.++.|++.||+|||+.   +||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence            9999999999999999999986532            123589999999999999999999999   9999999999999


Q ss_pred             eCCCCceeecccc
Q 015852          384 LDEDADQSSKTIL  396 (399)
Q Consensus       384 ld~~~~~~i~df~  396 (399)
                      ++.++.+||+||+
T Consensus       168 l~~~~~~kl~dfg  180 (299)
T d1fgka_         168 VTEDNVMKIADFG  180 (299)
T ss_dssp             ECTTCCEEECSTT
T ss_pred             ecCCCCeEeccch
Confidence            9999999999994

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-29  Score=233.19  Aligned_cols=143  Identities=34%  Similarity=0.424  Sum_probs=115.3

Q ss_pred             cCCCCCceeeccCCceEEEEEeC--CC--CEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeeeecCCceE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA--DG--KLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vAvK~l~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~  320 (399)
                      ++|+..+.||+|+||.||+|++.  ++  ..||||+++.......  ..+|.+|+.++++++|||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45777789999999999999853  23  3789999865543222  3479999999999999999999999976 4678


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      +||||+++|++.+.+.....   .+++..++.++.|+|+||+|||++   +|+||||||+|||++.++++||+||+
T Consensus        87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccch
Confidence            99999999999998876532   489999999999999999999998   99999999999999999999999994

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.7e-29  Score=233.41  Aligned_cols=138  Identities=29%  Similarity=0.385  Sum_probs=117.9

Q ss_pred             CceeeccCCceEEEEEe-CCCCEEEEEEcccccccc----cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEecC
Q 015852          252 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  326 (399)
Q Consensus       252 ~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~  326 (399)
                      .++||+|+||+||+|+. .+|+.||||+++......    ....+.+|+.+++.++|||||++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            47899999999999996 468999999996543221    1236899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          327 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       327 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++++..+....    ..+++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+||+
T Consensus        83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG  145 (299)
T d1ua2a_          83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  145 (299)
T ss_dssp             SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCc
Confidence            988777665432    2478889999999999999999999   99999999999999999999999995

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.8e-28  Score=224.21  Aligned_cols=143  Identities=20%  Similarity=0.335  Sum_probs=127.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||+||+|+. .+++.||||+++...... ...++.+|+.+++.++||||+++++++......++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4677789999999999999986 578999999996554332 34579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      |+.++++..+++...    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++++|++||+
T Consensus        82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecc
Confidence            999999988876543    478899999999999999999999   99999999999999999999999995

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.1e-28  Score=231.74  Aligned_cols=142  Identities=20%  Similarity=0.300  Sum_probs=119.9

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecCC----ceEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLL  321 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l  321 (399)
                      ++|...+.||+|+||+||+|+. .+++.||||+++..........+.+|+++|+.++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4577789999999999999985 5799999999965443333457899999999999999999999987643    2355


Q ss_pred             EEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          322 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       322 v~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ++||+.+|+|.+++...     .+++.....++.|+++||+|||++   +||||||||+|||++.++.+||+||+
T Consensus        88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG  154 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  154 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccC
Confidence            66777899999999754     389999999999999999999999   99999999999999999999999994

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.6e-28  Score=223.76  Aligned_cols=143  Identities=22%  Similarity=0.350  Sum_probs=122.7

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccc-----cHHHHHHHHHHHhcCC--CCCccceeeeeecCCc
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAV--HRNLLRLYGFCTTVTE  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~-----~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~  318 (399)
                      ++|...+.||+|+||+||+|+. .+++.||||+++......     ...++.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            4577789999999999999986 578999999986543221     1234778999999886  9999999999999999


Q ss_pred             eEEEEecCCC-CChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCC-Cceeecccc
Q 015852          319 KLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~-~~~~i~df~  396 (399)
                      .++||||+.+ +++.+++....    .+++.++..++.|+++||+|||+.   +|+||||||+|||++.+ +.+||+||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            9999999986 67888887653    489999999999999999999999   99999999999999955 789999995

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=9.2e-28  Score=227.23  Aligned_cols=139  Identities=23%  Similarity=0.295  Sum_probs=118.2

Q ss_pred             cCCCCC-ceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHh-cCCCCCccceeeeeec----CCce
Q 015852          247 DGFSNK-NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTT----VTEK  319 (399)
Q Consensus       247 ~~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~----~~~~  319 (399)
                      ++|... ++||+|+||+||+|+. .+++.||||+++.      ...+.+|++++. ..+|||||++++++.+    ....
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            467654 5799999999999986 5789999999853      235788998865 5589999999999865    3567


Q ss_pred             EEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC---CCceeecccc
Q 015852          320 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  396 (399)
Q Consensus       320 ~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~---~~~~~i~df~  396 (399)
                      ++|||||++|+|.+++..+..  ..+++.+...|+.|++.||+|||+.   +|+||||||+|||+++   ++.+||+||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            999999999999999986432  3589999999999999999999999   9999999999999986   4569999994

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.6e-27  Score=227.15  Aligned_cols=140  Identities=27%  Similarity=0.398  Sum_probs=114.4

Q ss_pred             CCCCCceeeccCCceEEEEEeC-CCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeeeecC------CceE
Q 015852          248 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEKL  320 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  320 (399)
                      +|+..++||+|+||+||+|+.. +++.||||+++....     .+.+|++++++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            3566789999999999999964 689999999965422     234799999999999999999998543      2468


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      +||||++++.+..+.+.. .....+++.++..++.|++.||+|||++   +|+||||||+|||++.++ .+||+||+
T Consensus        96 lv~Ey~~~~~~~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             EEEECCSEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             EEEeccCCccHHHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEeccc
Confidence            999999876444433221 1223589999999999999999999998   999999999999999875 89999995

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.4e-27  Score=224.54  Aligned_cols=141  Identities=23%  Similarity=0.350  Sum_probs=116.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecCC------c
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------E  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~  318 (399)
                      +.|...+.||+|+||+||+|+. .+|+.||||+++..... .....+.+|+.+|+.++|||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            5677789999999999999986 47999999999754322 22346899999999999999999999997654      4


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||+ +.+|..+.+..     .+++.....++.|++.||+|||++   +|+||||||+|||++.++..|++||+
T Consensus        98 ~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence            69999999 56777776543     389999999999999999999999   99999999999999999999999994

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.94  E-value=5.3e-27  Score=221.55  Aligned_cols=136  Identities=23%  Similarity=0.309  Sum_probs=119.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecC--CceEEE
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV--TEKLLV  322 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv  322 (399)
                      ++|...+.||+|+||+||+|+. .+++.||||+++..    ...++.+|+.+|+.++ ||||+++++++...  ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            5688889999999999999986 57899999998642    3457899999999985 99999999998754  458899


Q ss_pred             EecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCC-ceeecccc
Q 015852          323 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  396 (399)
Q Consensus       323 ~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~-~~~i~df~  396 (399)
                      |||+.+|+|..+.+       .+++..+..++.||+.||+|||++   +||||||||+|||++.++ .+|++||+
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccc
Confidence            99999999877642       378999999999999999999999   999999999999999765 58999995

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.3e-27  Score=223.31  Aligned_cols=143  Identities=22%  Similarity=0.330  Sum_probs=123.1

Q ss_pred             hcCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC-----Cc
Q 015852          246 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TE  318 (399)
Q Consensus       246 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~  318 (399)
                      .++|...+.||+|+||+||+|+. .+|+.||||+++..... .....+.+|+.+++.++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            35688889999999999999985 57999999999754332 2234688999999999999999999998643     34


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++++||+.+|+|.++++..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++..|++||+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence            56778888999999999643     389999999999999999999999   99999999999999999999999994

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.4e-27  Score=222.13  Aligned_cols=143  Identities=27%  Similarity=0.333  Sum_probs=125.5

Q ss_pred             cCCCCCceeeccCCceEEEEEe----CCCCEEEEEEcccccc---cccHHHHHHHHHHHhcCCC-CCccceeeeeecCCc
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTE  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vAvK~l~~~~~---~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~  318 (399)
                      ++|...+.||+|+||+||+|+.    .+|+.||||.++....   ......+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5688889999999999999974    2578999999865432   2234468899999999976 899999999999999


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .+++|||+.+|+|.+++....    .+.......++.|++.||+|+|+.   +|+||||||+|||+|.++.+||+||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeecc
Confidence            999999999999999998764    256788889999999999999999   99999999999999999999999994

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1e-26  Score=218.56  Aligned_cols=143  Identities=27%  Similarity=0.431  Sum_probs=119.1

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC--------
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  316 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------  316 (399)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++...... ....++.+|+.+++.++||||+++++.+...        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5677889999999999999986 57999999998654332 3345789999999999999999999988653        


Q ss_pred             CceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          317 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       317 ~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      ...+++|||+.++.+.......    ..++......++.|++.||.|||+.   +|+||||||+|||++.++.+|++||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            3578999999988776554432    2478888999999999999999999   99999999999999999999999994

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=9.9e-27  Score=217.34  Aligned_cols=144  Identities=28%  Similarity=0.469  Sum_probs=117.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CC-CCEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeeeec-----
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-AD-GKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTT-----  315 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~-~~~vAvK~l~~~~~~~-~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----  315 (399)
                      ++|+..+.||+|+||+||+|+. .+ ++.||||+++...... ....+.+|+.+++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            5788889999999999999986 34 6679999996543322 233567787776654   89999999999853     


Q ss_pred             CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeeccc
Q 015852          316 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       316 ~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ....+++|||+.+|++........   ..+++.....++.|++.||+|||++   +||||||||+|||+++++.+||+||
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence            245789999999887765544332   2478999999999999999999999   9999999999999999999999999


Q ss_pred             c
Q 015852          396 L  396 (399)
Q Consensus       396 ~  396 (399)
                      +
T Consensus       161 g  161 (305)
T d1blxa_         161 G  161 (305)
T ss_dssp             C
T ss_pred             h
Confidence            4

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=8.8e-26  Score=215.41  Aligned_cols=140  Identities=23%  Similarity=0.287  Sum_probs=117.5

Q ss_pred             cCCCCCceeeccCCceEEEEEeC-CCCEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeeeecC------Cc
Q 015852          247 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TE  318 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~  318 (399)
                      ++|...+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|+.+++.++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            45777899999999999999864 7999999999654332 2234689999999999999999999998643      57


Q ss_pred             eEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeecccc
Q 015852          319 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  396 (399)
Q Consensus       319 ~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~df~  396 (399)
                      .++||||+.++. .+.+..      .+++.....++.|++.||+|||+.   +|+||||||+|||++.++..|++||.
T Consensus        97 ~~iv~Ey~~~~l-~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDANL-CQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSEEH-HHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccchHH-HHhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            799999997654 444432      378999999999999999999999   99999999999999999999999995

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.92  E-value=4e-25  Score=205.24  Aligned_cols=140  Identities=18%  Similarity=0.223  Sum_probs=120.4

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCC-CCccceeeeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e  324 (399)
                      ++|...+.||+|+||+||+|+. .+++.||||++.....   ...+.+|++.+..+.| +|++.+++++......++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            4577889999999999999986 4689999998854322   2247788888888875 899999999999999999999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC-----CCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-----DADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~-----~~~~~i~df~  396 (399)
                      |+ +|+|.++++....   .+++.+...++.|++.||+|||+.   +|+||||||+|||++.     ++.+|++||+
T Consensus        82 ~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             ec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccc
Confidence            98 6899999876432   488999999999999999999999   9999999999999975     5679999994

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=1.7e-24  Score=201.51  Aligned_cols=140  Identities=21%  Similarity=0.212  Sum_probs=113.8

Q ss_pred             cCCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCcccee-eeeecCCceEEEEe
Q 015852          247 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY-GFCTTVTEKLLVYP  324 (399)
Q Consensus       247 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~-g~~~~~~~~~lv~e  324 (399)
                      ++|+..+.||+|+||+||+|+. .+++.||||++.....   ..++..|+++++.++|+|++..+ ++....+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            3577889999999999999986 5689999998764322   23578999999999887766554 44566778889999


Q ss_pred             cCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCC---CCceeecccc
Q 015852          325 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  396 (399)
Q Consensus       325 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~---~~~~~i~df~  396 (399)
                      |+. |++...+.....   .+++..+..++.|++.||+|||++   +||||||||+|||++.   +..+|++||+
T Consensus        84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          84 LLG-PSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             CCC-CBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EcC-CchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence            994 566666654332   489999999999999999999999   9999999999998764   4579999994

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=6.2e-22  Score=171.80  Aligned_cols=127  Identities=13%  Similarity=0.108  Sum_probs=99.7

Q ss_pred             CCceeeccCCceEEEEEeCCCCEEEEEEccccccc----c-------------cHHHHHHHHHHHhcCCCCCccceeeee
Q 015852          251 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS----G-------------GELQFQTEVKIISMAVHRNLLRLYGFC  313 (399)
Q Consensus       251 ~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~-------------~~~~f~~E~~~l~~l~H~niv~l~g~~  313 (399)
                      ..+.||+|+||.||+|+..+|+.||||+++.....    .             .......|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            45889999999999999888999999987532211    0             012355688889999999999887653


Q ss_pred             ecCCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCceeeCCCCceeec
Q 015852          314 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  393 (399)
Q Consensus       314 ~~~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK~~NILld~~~~~~i~  393 (399)
                          ..+++|||++++.+.+           ++......++.|++++|+|||++   +|+||||||+|||++++ .+++.
T Consensus        84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence                2479999999865432           23344567899999999999999   99999999999999965 58999


Q ss_pred             ccc
Q 015852          394 TIL  396 (399)
Q Consensus       394 df~  396 (399)
                      ||+
T Consensus       145 DFG  147 (191)
T d1zara2         145 DFP  147 (191)
T ss_dssp             CCT
T ss_pred             ECC
Confidence            996

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.82  E-value=4.8e-21  Score=182.45  Aligned_cols=143  Identities=20%  Similarity=0.254  Sum_probs=110.5

Q ss_pred             CCCCCceeeccCCceEEEEEe-CCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-----------CCCccceeeeeec
Q 015852          248 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----------HRNLLRLYGFCTT  315 (399)
Q Consensus       248 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~  315 (399)
                      +|...+.||+|+||+||+|+. .+|+.||||+++....  ....+.+|+.+++.++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            377789999999999999986 5799999999965321  2235778888887665           5789999988764


Q ss_pred             --CCceEEEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhc-CCCCCceecCCCCCceeeCCCCc---
Q 015852          316 --VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDAD---  389 (399)
Q Consensus       316 --~~~~~lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlK~~NILld~~~~---  389 (399)
                        ....+++++++..+.......... ....+++.....++.|++.||+|||+ .   +|+||||||+|||++.++.   
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence              345667777776655433333221 22357888999999999999999998 5   8999999999999987664   


Q ss_pred             ---eeecccc
Q 015852          390 ---QSSKTIL  396 (399)
Q Consensus       390 ---~~i~df~  396 (399)
                         ++++||+
T Consensus       168 ~~~~kl~dfg  177 (362)
T d1q8ya_         168 LIQIKIADLG  177 (362)
T ss_dssp             EEEEEECCCT
T ss_pred             cceeeEeecc
Confidence               8999995

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.80  E-value=2.5e-20  Score=173.91  Aligned_cols=126  Identities=27%  Similarity=0.566  Sum_probs=107.1

Q ss_pred             cCChhHHHHHHHHHhhcCCCCCCCCCCCCCCCCCC--cceeeeeCCCC---CEEEEEeCCCCcee--ecChhhccCcCCC
Q 015852           22 ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLC--TWFHITCNPEG---SVTRVDLGNAALSG--ELAPELGQLKNLE   94 (399)
Q Consensus        22 ~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c--~w~gv~c~~~~---~v~~l~l~~~~l~g--~ip~~l~~l~~L~   94 (399)
                      .+.++|.+||++||+++.+|. .+++|.. ..|||  .|.||+|+..+   ||+.|+|++++++|  .||+++++|++|+
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~   79 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHHCCCCC-cCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence            367889999999999999885 6899974 46999  59999998543   79999999999998  6899999999999


Q ss_pred             eEeccC-CcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccccccc
Q 015852           95 LLRLNN-NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  149 (399)
Q Consensus        95 ~l~l~~-n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~~n~  149 (399)
                      +|+|++ |+++|+||++|+++++|++|+|++|+++|..|.. ..+..+..+....|.
T Consensus        80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~  136 (313)
T d1ogqa_          80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccc
Confidence            999996 8999999999999999999999999999987752 333444555555554

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.32  E-value=4.8e-13  Score=123.67  Aligned_cols=92  Identities=33%  Similarity=0.596  Sum_probs=83.7

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..+..++++++.+.|.+| +++.+++|+.|+|++|+|+|.||.+++++++|++|||++|+|+|+||..+.++++..+++.
T Consensus       221 ~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~  299 (313)
T d1ogqa_         221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA  299 (313)
T ss_dssp             SCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTC
T ss_pred             cccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhC
Confidence            367889999999988765 6899999999999999999999999999999999999999999999998889999999999


Q ss_pred             cccccCCCCCCCCC
Q 015852          147 NNLNLCGPNTKKPC  160 (399)
Q Consensus       147 ~n~~lcg~~~~~~c  160 (399)
                      ||+.+||.|.+ +|
T Consensus       300 ~N~~l~g~plp-~c  312 (313)
T d1ogqa_         300 NNKCLCGSPLP-AC  312 (313)
T ss_dssp             SSSEEESTTSS-CC
T ss_pred             CCccccCCCCC-CC
Confidence            99999997653 45

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.74  E-value=1.9e-08  Score=82.51  Aligned_cols=99  Identities=18%  Similarity=0.176  Sum_probs=76.9

Q ss_pred             CCCcceeeeeCCC------------CCEEEEEeCCCC-ceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEE
Q 015852           54 NLCTWFHITCNPE------------GSVTRVDLGNAA-LSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNIL  120 (399)
Q Consensus        54 ~~c~w~gv~c~~~------------~~v~~l~l~~~~-l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l  120 (399)
                      .++.+.+|+|...            .+++.|++++|+ ++.--+..+.++++|+.|+|++|.++.--|..|..+++|+.|
T Consensus         6 ~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             CCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred             CcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence            3445778888631            368899998775 664444568999999999999999998778889999999999


Q ss_pred             ecCCCcCcccCCCC-CCCCcccccccccccccCC
Q 015852          121 DLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCG  153 (399)
Q Consensus       121 ~ls~N~l~G~iP~~-~~~~~~~~~~~~~n~~lcg  153 (399)
                      +|++|+++ .+|.. .....+..+.+++|+.-|.
T Consensus        86 ~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~  118 (156)
T d2ifga3          86 NLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS  118 (156)
T ss_dssp             ECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             eccCCCCc-ccChhhhccccccccccCCCcccCC
Confidence            99999998 55543 2233567788889987663

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.73  E-value=8.3e-09  Score=87.71  Aligned_cols=96  Identities=20%  Similarity=0.301  Sum_probs=80.7

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecC-hhhccCcCCCeEeccCCcccccccccccCCCCCcEEec
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELA-PELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL  122 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip-~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~l  122 (399)
                      .-|.|..|.|+..          ..++.|+|++|++++.++ ..+.++++|+.|+|++|.+.+..+..+..+++|+.|+|
T Consensus         6 C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L   85 (192)
T d1w8aa_           6 CHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             SEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence            4577999999742          268999999999988775 45789999999999999999999999999999999999


Q ss_pred             CCCcCcccCCC-CCCCCccccccccccc
Q 015852          123 SNNRLSGPVPD-NGSFSQFTPISFENNL  149 (399)
Q Consensus       123 s~N~l~G~iP~-~~~~~~~~~~~~~~n~  149 (399)
                      ++|++++-.|. ...+.++..+.+++|.
T Consensus        86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~  113 (192)
T d1w8aa_          86 GENKIKEISNKMFLGLHQLKTLNLYDNQ  113 (192)
T ss_dssp             CSCCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred             ccccccccCHHHHhCCCcccccccCCcc
Confidence            99999965554 3557777888888886

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.57  E-value=3.5e-08  Score=77.61  Aligned_cols=79  Identities=29%  Similarity=0.434  Sum_probs=50.4

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccC--CCCCCCCccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV--PDNGSFSQFTPISF  145 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~i--P~~~~~~~~~~~~~  145 (399)
                      .++.|+|++|+++ .+|+.++.+++|+.|++++|.+++ +| .+..+++|+.|++++|+++.--  .....+.++..+++
T Consensus        21 ~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l   97 (124)
T d1dcea3          21 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL   97 (124)
T ss_dssp             TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEEC
T ss_pred             CCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEEC
Confidence            5677777777776 567677777777777777777764 44 4677777777777777766321  11233445555666


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      .+|+
T Consensus        98 ~~N~  101 (124)
T d1dcea3          98 QGNS  101 (124)
T ss_dssp             TTSG
T ss_pred             CCCc
Confidence            6665

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.54  E-value=6.3e-08  Score=82.10  Aligned_cols=86  Identities=17%  Similarity=0.341  Sum_probs=74.7

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      .+++.|+|++|.+.+..+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++-.|.. ..+.++..+.+
T Consensus        54 ~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L  133 (192)
T d1w8aa_          54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL  133 (192)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEEC
T ss_pred             ceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccc
Confidence            47899999999999888899999999999999999999877778999999999999999999866542 45667777888


Q ss_pred             ccccccC
Q 015852          146 ENNLNLC  152 (399)
Q Consensus       146 ~~n~~lc  152 (399)
                      .+|+..|
T Consensus       134 ~~N~~~~  140 (192)
T d1w8aa_         134 ASNPFNC  140 (192)
T ss_dssp             TTCCBCC
T ss_pred             ccccccc
Confidence            8887555

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.49  E-value=8.1e-08  Score=75.44  Aligned_cols=75  Identities=27%  Similarity=0.402  Sum_probs=65.6

Q ss_pred             EEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccccc
Q 015852           71 RVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  149 (399)
Q Consensus        71 ~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~n~  149 (399)
                      .|+|++|+++ .+| .+..++.|++|++++|.++ .+|+.++.+++|+.|++++|.+++ +|....+.++..+++.+|.
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCccccccccCeEECCCCc
Confidence            5899999997 555 5899999999999999998 689899999999999999999985 5766777788888888876

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.30  E-value=1.7e-06  Score=76.28  Aligned_cols=143  Identities=13%  Similarity=0.073  Sum_probs=90.3

Q ss_pred             HHHHhcCCCCCceeeccCCceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeeeecCCceE
Q 015852          242 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKL  320 (399)
Q Consensus       242 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  320 (399)
                      +....+.|...+..+-++.+.||+... +++.+.+|+...... .....+.+|...+..+. +--+.+++.+....+..+
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            333344444333333334468998865 455677887644322 12224677888776553 444667788888888899


Q ss_pred             EEEecCCCCChhhHhhhcCCCCCCCChHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 015852          321 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--------------------------------  368 (399)
Q Consensus       321 lv~e~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------  368 (399)
                      +||+++++.++.+.....         .....++.++++.++.||+..                                
T Consensus        87 lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            999999998876544211         112334555556666666421                                


Q ss_pred             ------------------------CCCceecCCCCCceeeCCCCceeeccc
Q 015852          369 ------------------------DPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       369 ------------------------~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                                              .+.++|+|+.|.|||++++...-|.||
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDw  208 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL  208 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeec
Confidence                                    123799999999999998766779998

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.27  E-value=7.4e-07  Score=79.24  Aligned_cols=86  Identities=26%  Similarity=0.266  Sum_probs=71.4

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~  145 (399)
                      .++..+++++|.+++-.+..+..++.|+.+++++|++++..|..+..+++|+.|||++|+|+ .||.. ..+..+..+.+
T Consensus       124 ~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L  202 (266)
T d1p9ag_         124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL  202 (266)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEEC
T ss_pred             cccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEe
Confidence            46788899999888555556677899999999999999888888999999999999999999 88853 44566788889


Q ss_pred             ccccccCC
Q 015852          146 ENNLNLCG  153 (399)
Q Consensus       146 ~~n~~lcg  153 (399)
                      .||+-.|.
T Consensus       203 ~~Np~~Cd  210 (266)
T d1p9ag_         203 HGNPWLCN  210 (266)
T ss_dssp             CSCCBCCS
T ss_pred             cCCCCCCC
Confidence            99987774

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.24  E-value=9.8e-07  Score=78.42  Aligned_cols=80  Identities=23%  Similarity=0.197  Sum_probs=62.9

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+|++|++++-.+..+.++++|+.|+|++|+++ .+|. ++.+++|+.|+|++|++++..+....+.++..+.+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~  109 (266)
T d1p9ag_          32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSF  109 (266)
T ss_dssp             TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCS
T ss_pred             CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccccccccccccccccccccccccccccc
Confidence            5888999999998655567889999999999999987 4653 5788999999999999987665555666666666666


Q ss_pred             cc
Q 015852          148 NL  149 (399)
Q Consensus       148 n~  149 (399)
                      |.
T Consensus       110 ~~  111 (266)
T d1p9ag_         110 NR  111 (266)
T ss_dssp             SC
T ss_pred             cc
Confidence            54

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.21  E-value=5.5e-07  Score=80.83  Aligned_cols=81  Identities=22%  Similarity=0.275  Sum_probs=42.9

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~  146 (399)
                      .+..+++++|.+++-.+..+..++.|+.|++++|++++..|..+..+++|+.+++++|++++..|.. ..+.++..++++
T Consensus       130 ~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~  209 (284)
T d1ozna_         130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF  209 (284)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             ccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccc
Confidence            4555666666665333344555556666666666665555555555666666666666665544432 223334444444


Q ss_pred             cc
Q 015852          147 NN  148 (399)
Q Consensus       147 ~n  148 (399)
                      +|
T Consensus       210 ~N  211 (284)
T d1ozna_         210 AN  211 (284)
T ss_dssp             SS
T ss_pred             cc
Confidence            44

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.06  E-value=3.5e-06  Score=76.04  Aligned_cols=92  Identities=26%  Similarity=0.424  Sum_probs=71.6

Q ss_pred             CCCcceeeeeCCC----------CCEEEEEeCCCCceeecCh-hhccCcCCCeEeccCCcccccccccccCCCCCcEEec
Q 015852           54 NLCTWFHITCNPE----------GSVTRVDLGNAALSGELAP-ELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDL  122 (399)
Q Consensus        54 ~~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~-~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~l  122 (399)
                      .-|.|.+|.|+..          ..++.|+|++|+++ .+|+ .+.++++|+.|++++|.+....|..+..++.|+.|++
T Consensus         8 c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_           8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence            4478999999742          35889999999997 5554 7899999999999999999877888999999999999


Q ss_pred             CCCcCcccCCCCCCCCcccccccccc
Q 015852          123 SNNRLSGPVPDNGSFSQFTPISFENN  148 (399)
Q Consensus       123 s~N~l~G~iP~~~~~~~~~~~~~~~n  148 (399)
                      ++|+++. +|.. ....+..+....|
T Consensus        87 ~~n~l~~-l~~~-~~~~l~~L~~~~n  110 (305)
T d1xkua_          87 SKNQLKE-LPEK-MPKTLQELRVHEN  110 (305)
T ss_dssp             CSSCCSB-CCSS-CCTTCCEEECCSS
T ss_pred             cCCccCc-Cccc-hhhhhhhhhcccc
Confidence            9999984 5542 2233344444443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.03  E-value=1.4e-06  Score=71.46  Aligned_cols=59  Identities=15%  Similarity=0.276  Sum_probs=28.6

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  129 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G  129 (399)
                      ++..|+|++|+++ .||.-...++.|+.|+|++|.++ .++ .+..+++|+.|++++|.++.
T Consensus        19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~   77 (162)
T d1a9na_          19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR   77 (162)
T ss_dssp             SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCE
T ss_pred             cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccC
Confidence            3445555555544 33433344555555555555554 232 34455555555555555543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.98  E-value=3.1e-06  Score=69.34  Aligned_cols=81  Identities=21%  Similarity=0.260  Sum_probs=62.9

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcc--cCCCCCCCCcccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG--PVPDNGSFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G--~iP~~~~~~~~~~~~  144 (399)
                      ..++.|+|++|+++ .++ .+..+++|+.|++++|.++.--+..+..+++|+.|++++|+++.  .+.....+.++..++
T Consensus        41 ~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~  118 (162)
T d1a9na_          41 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC  118 (162)
T ss_dssp             TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEE
T ss_pred             ccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhh
Confidence            47899999999998 564 48899999999999999986545556789999999999999874  222233455666677


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +.+|+
T Consensus       119 l~~N~  123 (162)
T d1a9na_         119 ILRNP  123 (162)
T ss_dssp             CCSSG
T ss_pred             cCCCc
Confidence            77775

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.92  E-value=4.4e-06  Score=77.45  Aligned_cols=77  Identities=23%  Similarity=0.376  Sum_probs=60.5

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..+..++|++|++++- + .+..+++|+.|++++|++++ +| .+..+++|+.|++++|++++-.| ...+.++..+.++
T Consensus       307 ~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~  381 (384)
T d2omza2         307 KNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLN  381 (384)
T ss_dssp             TTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECC
T ss_pred             cccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCC
Confidence            4678889999988864 3 37888999999999999885 44 68889999999999999987654 5566677777776


Q ss_pred             cc
Q 015852          147 NN  148 (399)
Q Consensus       147 ~n  148 (399)
                      +|
T Consensus       382 ~N  383 (384)
T d2omza2         382 DQ  383 (384)
T ss_dssp             CE
T ss_pred             CC
Confidence            65

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.90  E-value=1.6e-05  Score=69.48  Aligned_cols=74  Identities=12%  Similarity=0.022  Sum_probs=50.8

Q ss_pred             eeeccCC-ceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCC--CCCccceeeeeecCCceEEEEecCCCCC
Q 015852          254 ILGRGGF-GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVYPYMTNGS  330 (399)
Q Consensus       254 ~lG~G~f-g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~gs  330 (399)
                      .+..|.. +.||+....++..+.+|.-....    ...+..|...++.+.  .-.+.+++.+..+.+..++||||+++.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3445543 57899988777778888764332    223667777776554  3335667888788888999999998765


Q ss_pred             h
Q 015852          331 V  331 (399)
Q Consensus       331 L  331 (399)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.80  E-value=1.8e-05  Score=71.09  Aligned_cols=82  Identities=30%  Similarity=0.331  Sum_probs=67.7

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC-CCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~~~~~~  145 (399)
                      .+++.+++++|...+..+..+.+++.++.|++++|.+++..|..+..+++|++|+|++|+++ .||. ...+.++..+++
T Consensus       171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L  249 (305)
T d1xkua_         171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL  249 (305)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred             CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence            36788889998888888888888999999999999998888888888999999999999887 5664 345677777888


Q ss_pred             cccc
Q 015852          146 ENNL  149 (399)
Q Consensus       146 ~~n~  149 (399)
                      ++|.
T Consensus       250 s~N~  253 (305)
T d1xkua_         250 HNNN  253 (305)
T ss_dssp             CSSC
T ss_pred             CCCc
Confidence            7775

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.76  E-value=1.9e-05  Score=63.98  Aligned_cols=61  Identities=23%  Similarity=0.168  Sum_probs=53.4

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  128 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~  128 (399)
                      .+++.|+|++|+++.--|..+..+++|+.|+|++|.|+ .+|..+....+|+.|+|++|.|.
T Consensus        56 ~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             cccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence            57899999999999766777999999999999999999 67776666668999999999885

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.76  E-value=1.8e-05  Score=70.53  Aligned_cols=82  Identities=20%  Similarity=0.238  Sum_probs=50.2

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCC-CCCCcccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFE  146 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~~~~~~~  146 (399)
                      +++.++|++|.+....+..+..+..|+.+++++|++++..+..+..+++|+.|++++|++++-.|.. ..+..+..+...
T Consensus       106 ~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~  185 (284)
T d1ozna_         106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH  185 (284)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             cCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhh
Confidence            5667777777766555555666677777777777777555556666777777777777776544322 233444444444


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       186 ~N~  188 (284)
T d1ozna_         186 QNR  188 (284)
T ss_dssp             SSC
T ss_pred             hcc
Confidence            443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.71  E-value=1.5e-05  Score=68.55  Aligned_cols=74  Identities=26%  Similarity=0.399  Sum_probs=48.1

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISF  145 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~  145 (399)
                      .+++.+++++|.+.+..  .++++++|+.|+|++|.+++ +| .+..+++|+.|++++|++++ +|+...+.++..+++
T Consensus       151 ~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~~l~~l~~L~~L~l  224 (227)
T d1h6ua2         151 TNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTL  224 (227)
T ss_dssp             TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CGGGTTCTTCCEEEE
T ss_pred             cccccccccccccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC-CcccccCCCCCEEEe
Confidence            35677777777765432  36777778888888887775 44 36777788888888887774 444444444444444

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.56  E-value=0.00014  Score=67.85  Aligned_cols=76  Identities=9%  Similarity=0.010  Sum_probs=46.0

Q ss_pred             ceeeccCCceEEEEEeCC-CCEEEEEEccccc------ccccHHHHHHHHHHHhcCC---CCCccceeeeeecCCceEEE
Q 015852          253 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEER------TSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLV  322 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~-~~~vAvK~l~~~~------~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv  322 (399)
                      +.||.|....||+....+ ++.+.||.-....      ......+...|.+.++.+.   ...+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            568999999999998654 6788999653211      1111223456777665442   2334555544  45566899


Q ss_pred             EecCCCCC
Q 015852          323 YPYMTNGS  330 (399)
Q Consensus       323 ~e~~~~gs  330 (399)
                      |||+.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.49  E-value=6.6e-05  Score=63.71  Aligned_cols=76  Identities=24%  Similarity=0.391  Sum_probs=50.0

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.++++++.+.. ++ .+..+++|+.|+|++|.+++ ++ .++.+++|+.|++++|++++ +|....+.++..+.+.+
T Consensus        47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~  121 (210)
T d1h6ta2          47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEH  121 (210)
T ss_dssp             TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTT
T ss_pred             CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-ccccccccccccccccc
Confidence            56677777777663 32 36777778888888887776 33 35677778888888877764 45444455555555554


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      |
T Consensus       122 ~  122 (210)
T d1h6ta2         122 N  122 (210)
T ss_dssp             S
T ss_pred             c
Confidence            4

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.34  E-value=0.00012  Score=67.44  Aligned_cols=76  Identities=21%  Similarity=0.354  Sum_probs=49.6

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|++++++++ .+ ..+..|++|++|+|++|++++. | .+.++++|++|++++|.+++. +....+.++..+...+
T Consensus        45 ~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i-~~l~~l~~L~~L~~~~  119 (384)
T d2omza2          45 QVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFN  119 (384)
T ss_dssp             TCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCS
T ss_pred             CCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccc-cccccccccccccccc
Confidence            5677777777765 24 3467777778888888777753 3 277777788888877777653 3344555555555544


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      |
T Consensus       120 ~  120 (384)
T d2omza2         120 N  120 (384)
T ss_dssp             S
T ss_pred             c
Confidence            4

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.33  E-value=0.00013  Score=61.69  Aligned_cols=78  Identities=24%  Similarity=0.401  Sum_probs=52.1

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      .++..+++++|.+. .+ +.+..++.|+.++++.|.+++  +..+..+++|+.+++++|++++ +++...+.++..++++
T Consensus       112 ~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~l~~l~~L~~L~Ls  186 (210)
T d1h6ta2         112 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLS  186 (210)
T ss_dssp             TTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECC
T ss_pred             cccccccccccccc-cc-ccccccccccccccccccccc--cccccccccccccccccccccc-cccccCCCCCCEEECC
Confidence            36778888888764 23 346777777777777777765  2345667777777777777765 4444556666666666


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       187 ~N~  189 (210)
T d1h6ta2         187 KNH  189 (210)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            664

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.27  E-value=0.00013  Score=62.84  Aligned_cols=93  Identities=13%  Similarity=0.255  Sum_probs=58.8

Q ss_pred             CCcceeeeeCCC----------CCEEEEEeCCCCceeecCh-hhccCcCCCeEeccCCcccccccc-cccCCCCCcEEec
Q 015852           55 LCTWFHITCNPE----------GSVTRVDLGNAALSGELAP-ELGQLKNLELLRLNNNSLSGLIPT-SLTTITSLNILDL  122 (399)
Q Consensus        55 ~c~w~gv~c~~~----------~~v~~l~l~~~~l~g~ip~-~l~~l~~L~~l~l~~n~l~G~ip~-~~~~l~~L~~l~l  122 (399)
                      -|.+..|.|...          ..++.|+|++|.++ .+|+ .+.++++|++|++++|.+...+|. .+..++.+..+++
T Consensus         7 ~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~   85 (242)
T d1xwdc1           7 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   85 (242)
T ss_dssp             EECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred             CCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence            356777778521          24677888888776 4444 567788888888888877776654 4667777777776


Q ss_pred             C-CCcCcccCCCC-CCCCcccccccccc
Q 015852          123 S-NNRLSGPVPDN-GSFSQFTPISFENN  148 (399)
Q Consensus       123 s-~N~l~G~iP~~-~~~~~~~~~~~~~n  148 (399)
                      . .|++....|.. ..+.++..+.+.+|
T Consensus        86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~  113 (242)
T d1xwdc1          86 EKANNLLYINPEAFQNLPNLQYLLISNT  113 (242)
T ss_dssp             ECCTTCCEECTTSEECCTTCCEEEEESC
T ss_pred             cccccccccccccccccccccccccchh
Confidence            5 35555444432 33445555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.25  E-value=0.00024  Score=59.52  Aligned_cols=76  Identities=22%  Similarity=0.409  Sum_probs=42.5

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+++++++. .++ .+..+++|+.|++++|++++..|  +.++++|+.|++++|.+.. +|....+..+..+.+.+
T Consensus        41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~  115 (199)
T d2omxa2          41 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFN  115 (199)
T ss_dssp             TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECCS
T ss_pred             CCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-ccccccccccccccccc
Confidence            4566666666654 232 35666666677777666665332  6666666666666666542 33333444444444444


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      |
T Consensus       116 ~  116 (199)
T d2omxa2         116 N  116 (199)
T ss_dssp             S
T ss_pred             c
Confidence            3

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.16  E-value=0.00031  Score=63.43  Aligned_cols=73  Identities=27%  Similarity=0.342  Sum_probs=43.8

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.|+|++|+++ .+|..   +.+|+.|++++|+++ .|+. +  .+.|++|++++|.++ .+|....+..+..+.+.+
T Consensus        59 ~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~~~~l~~L~~L~l~~  129 (353)
T d1jl5a_          59 HLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPELQNSSFLKIIDVDN  129 (353)
T ss_dssp             TCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCS
T ss_pred             CCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccchhhhccceeecccc
Confidence            4667777777776 66643   345666666666665 2331 1  135777777777776 456655556666665555


Q ss_pred             cc
Q 015852          148 NL  149 (399)
Q Consensus       148 n~  149 (399)
                      |.
T Consensus       130 ~~  131 (353)
T d1jl5a_         130 NS  131 (353)
T ss_dssp             SC
T ss_pred             cc
Confidence            43

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.03  E-value=4.7e-06  Score=70.56  Aligned_cols=79  Identities=18%  Similarity=0.281  Sum_probs=55.2

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      ..+..|+|++|+++ .++ .+..+++|+.|+|++|.++ .+|.....+++|+.|++++|+++. ++....+.++..++++
T Consensus        48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~L~  123 (198)
T d1m9la_          48 KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMS  123 (198)
T ss_dssp             TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHHHHHHHHSSEEEES
T ss_pred             cccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cccccccccccccccc
Confidence            36788888888877 565 4888888888888888886 566555556678888888888764 3333344455666666


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       124 ~N~  126 (198)
T d1m9la_         124 NNK  126 (198)
T ss_dssp             EEE
T ss_pred             cch
Confidence            654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.01  E-value=0.00046  Score=57.63  Aligned_cols=78  Identities=24%  Similarity=0.414  Sum_probs=62.3

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCcccccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFE  146 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~  146 (399)
                      .+++.|+|++|++++- ++ ++++++|+.|++++|.+.. +| .+..++.|+.|++++|.+... +....+.++..+.++
T Consensus        62 ~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~-~~~~~l~~L~~L~l~  136 (199)
T d2omxa2          62 NNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI-DPLKNLTNLNRLELS  136 (199)
T ss_dssp             TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECC
T ss_pred             CCcCcCccccccccCc-cc-ccCCccccccccccccccc-cc-ccccccccccccccccccccc-cccchhhhhHHhhhh
Confidence            4799999999999864 43 8999999999999999874 44 488999999999999988754 334556667777777


Q ss_pred             ccc
Q 015852          147 NNL  149 (399)
Q Consensus       147 ~n~  149 (399)
                      +|.
T Consensus       137 ~n~  139 (199)
T d2omxa2         137 SNT  139 (199)
T ss_dssp             SSC
T ss_pred             hhh
Confidence            664

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=96.91  E-value=0.00063  Score=57.91  Aligned_cols=76  Identities=22%  Similarity=0.376  Sum_probs=57.8

Q ss_pred             CEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccc
Q 015852           68 SVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN  147 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~  147 (399)
                      .++.+++.+++++ .++ .+..+++|+.|++++|.+++..|  +..+++|+.+++++|.++ .++....+..+..+.+.+
T Consensus        42 ~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l~~  116 (227)
T d1h6ua2          42 GITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTS  116 (227)
T ss_dssp             TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEECTT
T ss_pred             CcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-cccccccccccccccccc
Confidence            6789999999887 464 58899999999999999987554  888999999999999876 455444444454445444


Q ss_pred             c
Q 015852          148 N  148 (399)
Q Consensus       148 n  148 (399)
                      +
T Consensus       117 ~  117 (227)
T d1h6ua2         117 T  117 (227)
T ss_dssp             S
T ss_pred             c
Confidence            3

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=96.90  E-value=1e-05  Score=68.44  Aligned_cols=80  Identities=15%  Similarity=0.301  Sum_probs=63.9

Q ss_pred             CCEEEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCccc--CCCCCCCCcccccc
Q 015852           67 GSVTRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP--VPDNGSFSQFTPIS  144 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~--iP~~~~~~~~~~~~  144 (399)
                      .++..|+|++|+++ .+|.....+++|+.|++++|+++. ++ .+..+++|+.|++++|+++.-  +.....+.++..+.
T Consensus        70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~  146 (198)
T d1m9la_          70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL  146 (198)
T ss_dssp             TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred             ccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhccccccccccCCCccceee
Confidence            37899999999986 677666667789999999999985 44 578899999999999998742  22345667788888


Q ss_pred             ccccc
Q 015852          145 FENNL  149 (399)
Q Consensus       145 ~~~n~  149 (399)
                      +.+|+
T Consensus       147 L~~N~  151 (198)
T d1m9la_         147 LAGNP  151 (198)
T ss_dssp             ECSSH
T ss_pred             cCCCc
Confidence            88886

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=96.74  E-value=0.00081  Score=60.47  Aligned_cols=53  Identities=30%  Similarity=0.308  Sum_probs=37.8

Q ss_pred             CcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCCCCCCCccccccccccc
Q 015852           90 LKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  149 (399)
Q Consensus        90 l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~~~~~~~~n~  149 (399)
                      +++|++|+|++|+++ .||+.   +++|+.|++++|+++ .+|..  +.++..+++++|+
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~--~~~L~~L~L~~N~  335 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNP  335 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSC
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc--cCCCCEEECcCCc
Confidence            567888888888887 57753   567888888888887 67653  3456667777776

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.61  E-value=0.0029  Score=56.96  Aligned_cols=67  Identities=18%  Similarity=0.134  Sum_probs=42.6

Q ss_pred             ceEEEEEeCCCCEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc--ccee-----eeeecCCceEEEEecCCCC
Q 015852          261 GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL--LRLY-----GFCTTVTEKLLVYPYMTNG  329 (399)
Q Consensus       261 g~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~lv~e~~~~g  329 (399)
                      -.||+.+..+|+.+++|.-+....  ...++..|...+..+....+  +..+     ......+..+.+++|++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            479999999999999998765432  23457778777765542222  1111     1123345678899999864

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.45  E-value=0.00039  Score=56.21  Aligned_cols=61  Identities=25%  Similarity=0.292  Sum_probs=33.3

Q ss_pred             ccCcCCCeEeccCCccccc--ccccccCCCCCcEEecCCCcCcccCCCC--CCCCccccccccccc
Q 015852           88 GQLKNLELLRLNNNSLSGL--IPTSLTTITSLNILDLSNNRLSGPVPDN--GSFSQFTPISFENNL  149 (399)
Q Consensus        88 ~~l~~L~~l~l~~n~l~G~--ip~~~~~l~~L~~l~ls~N~l~G~iP~~--~~~~~~~~~~~~~n~  149 (399)
                      ..++.|+.|+|++|.++.-  ++..+..+++|+.||+++|.++. ++..  .....+..+.+.||+
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Np  126 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNS  126 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTST
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCC
Confidence            4566677777777776642  33445566667777777776653 2211  111234555566665

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.36  E-value=0.0018  Score=55.29  Aligned_cols=61  Identities=15%  Similarity=0.193  Sum_probs=49.7

Q ss_pred             EEEEeCCCCceeecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCCC
Q 015852           70 TRVDLGNAALSGELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  133 (399)
Q Consensus        70 ~~l~l~~~~l~g~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP~  133 (399)
                      ..++.++++++ .+|..+.  +++++|+|++|+++.--+..|..+++|++|++++|.+...+|.
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~   71 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA   71 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec
Confidence            35777888887 8887664  5899999999999853344689999999999999999887764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.68  E-value=0.0011  Score=53.45  Aligned_cols=66  Identities=23%  Similarity=0.236  Sum_probs=51.4

Q ss_pred             CCEEEEEeCCCCcee--ecChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCCCcCcccCC
Q 015852           67 GSVTRVDLGNAALSG--ELAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  132 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g--~ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~N~l~G~iP  132 (399)
                      +.++.|+|++|+++.  .++..+..+++|+.|+|++|.++.--+-.......|+.+++++|.++....
T Consensus        65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence            478999999999984  345567889999999999999985322233345579999999999987654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.31  E-value=0.047  Score=50.01  Aligned_cols=72  Identities=18%  Similarity=0.261  Sum_probs=45.2

Q ss_pred             ceeeccCCceEEEEEeCCC--------CEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeeeecCCceEEEE
Q 015852          253 NILGRGGFGKVYKGRLADG--------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVY  323 (399)
Q Consensus       253 ~~lG~G~fg~Vy~~~~~~~--------~~vAvK~l~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~  323 (399)
                      +.|+-|-.-.+|+....++        +.|.+++.. .  ........+|..+++.+.-.++ .++++++..    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            5677788889999876532        345555542 2  2223345678888877653344 467776642    6899


Q ss_pred             ecCCCCCh
Q 015852          324 PYMTNGSV  331 (399)
Q Consensus       324 e~~~~gsL  331 (399)
                      ||+++..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.23  E-value=0.0029  Score=58.77  Aligned_cols=61  Identities=20%  Similarity=0.230  Sum_probs=27.0

Q ss_pred             CEEEEEeCCCCceeecChh----hccCcCCCeEeccCCccccc----cccccc-CCCCCcEEecCCCcCc
Q 015852           68 SVTRVDLGNAALSGELAPE----LGQLKNLELLRLNNNSLSGL----IPTSLT-TITSLNILDLSNNRLS  128 (399)
Q Consensus        68 ~v~~l~l~~~~l~g~ip~~----l~~l~~L~~l~l~~n~l~G~----ip~~~~-~l~~L~~l~ls~N~l~  128 (399)
                      .+..++++++.++..-...    +....+|+.|+|++|+++..    ++..+. ..+.|+.|+|++|+++
T Consensus       313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~  382 (460)
T d1z7xw1         313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS  382 (460)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence            4455555555544321111    22334455555555555432    222232 2344555555555554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.23  E-value=0.0034  Score=55.23  Aligned_cols=62  Identities=31%  Similarity=0.308  Sum_probs=53.1

Q ss_pred             CCEEEEEeCCCCceee-cChhhccCcCCCeEeccCCcccccccccccCCCCCcEEecCC-CcCc
Q 015852           67 GSVTRVDLGNAALSGE-LAPELGQLKNLELLRLNNNSLSGLIPTSLTTITSLNILDLSN-NRLS  128 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~-ip~~l~~l~~L~~l~l~~n~l~G~ip~~~~~l~~L~~l~ls~-N~l~  128 (399)
                      .+++.+||+++.++.. ++.-+..+++|++|+|+++.+++..+..++++++|+.|++++ +.++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it  109 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS  109 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence            4789999999988754 445578899999999999999999999999999999999998 4554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.88  E-value=0.014  Score=51.18  Aligned_cols=62  Identities=21%  Similarity=0.248  Sum_probs=36.1

Q ss_pred             CEEEEEeCCC--Ccee-ecChhhccCcCCCeEeccCC-cccccccccccCCCCCcEEecCC-CcCcc
Q 015852           68 SVTRVDLGNA--ALSG-ELAPELGQLKNLELLRLNNN-SLSGLIPTSLTTITSLNILDLSN-NRLSG  129 (399)
Q Consensus        68 ~v~~l~l~~~--~l~g-~ip~~l~~l~~L~~l~l~~n-~l~G~ip~~~~~l~~L~~l~ls~-N~l~G  129 (399)
                      .++.+++++.  .++. .+..-..++++|+.|++++| .+++..+..+.++++|++|++++ +++++
T Consensus       149 ~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~  215 (284)
T d2astb2         149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP  215 (284)
T ss_dssp             TCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCCh
Confidence            5666666643  2332 12222345667777777664 46666666677777777777776 44544

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.82  E-value=0.0036  Score=58.05  Aligned_cols=62  Identities=24%  Similarity=0.345  Sum_probs=33.4

Q ss_pred             CEEEEEeCCCCcee----ecChhhccCcCCCeEeccCCccccc----cccccc-CCCCCcEEecCCCcCcc
Q 015852           68 SVTRVDLGNAALSG----ELAPELGQLKNLELLRLNNNSLSGL----IPTSLT-TITSLNILDLSNNRLSG  129 (399)
Q Consensus        68 ~v~~l~l~~~~l~g----~ip~~l~~l~~L~~l~l~~n~l~G~----ip~~~~-~l~~L~~l~ls~N~l~G  129 (399)
                      .+++|+|++|+++-    .|+..+..+++|+.|||++|.++..    +...+. ...+|+.|++++|+++.
T Consensus        28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~   98 (460)
T d1z7xw1          28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG   98 (460)
T ss_dssp             TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBG
T ss_pred             CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccc
Confidence            34556666666541    3344455666677777777666421    112221 12356777777776654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.66  E-value=0.39  Score=41.75  Aligned_cols=27  Identities=19%  Similarity=0.223  Sum_probs=24.0

Q ss_pred             CCCceecCCCCCceeeCCCCceeeccc
Q 015852          369 DPKIIHRDVKAANILLDEDADQSSKTI  395 (399)
Q Consensus       369 ~~~ivHrDlK~~NILld~~~~~~i~df  395 (399)
                      ..++||+|+.++||+++.+...-|.||
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF  208 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDF  208 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCC
T ss_pred             ccccccCCcchhhhhcccccceeEecc
Confidence            347999999999999998877789999

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=93.18  E-value=0.018  Score=51.66  Aligned_cols=61  Identities=20%  Similarity=0.317  Sum_probs=27.7

Q ss_pred             CEEEEEeCCCCcee----ecChhhccCcCCCeEeccCCccccc-----ccccccCCCCCcEEecCCCcCc
Q 015852           68 SVTRVDLGNAALSG----ELAPELGQLKNLELLRLNNNSLSGL-----IPTSLTTITSLNILDLSNNRLS  128 (399)
Q Consensus        68 ~v~~l~l~~~~l~g----~ip~~l~~l~~L~~l~l~~n~l~G~-----ip~~~~~l~~L~~l~ls~N~l~  128 (399)
                      .+..++++.|.++-    .+...+.....|+.|+|++|.++..     +...+..+++|+.|+|++|.++
T Consensus       159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence            44455555554431    1222334445555555555555421     2223444555555555555543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=92.69  E-value=0.025  Score=50.63  Aligned_cols=64  Identities=23%  Similarity=0.336  Sum_probs=49.2

Q ss_pred             CCEEEEEeCCCCceee-----cChhhccCcCCCeEeccCCccccc----ccccccCCCCCcEEecCCCcCccc
Q 015852           67 GSVTRVDLGNAALSGE-----LAPELGQLKNLELLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSGP  130 (399)
Q Consensus        67 ~~v~~l~l~~~~l~g~-----ip~~l~~l~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~G~  130 (399)
                      ..+..++|+.|+++..     +...+..+++|+.|+|++|.++..    +...+..++.|+.|++++|.+++.
T Consensus       186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~  258 (344)
T d2ca6a1         186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR  258 (344)
T ss_dssp             TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred             hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence            4688899999987632     334467788899999999998643    555677888999999999988753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=91.26  E-value=0.058  Score=42.92  Aligned_cols=42  Identities=26%  Similarity=0.353  Sum_probs=18.8

Q ss_pred             hccCcCCCeEeccCCccccc----ccccccCCCCCcEEecCCCcCc
Q 015852           87 LGQLKNLELLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLS  128 (399)
Q Consensus        87 l~~l~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~  128 (399)
                      +...+.|+.|+|++|.+...    +-..+...+.|+.|+|++|.++
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            34444455555555555422    1122333444555555555544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=90.95  E-value=0.043  Score=43.71  Aligned_cols=63  Identities=22%  Similarity=0.261  Sum_probs=47.7

Q ss_pred             CCCEEEEEeCCCCceee----cChhhccCcCCCeEeccCCccccc----ccccccCCCCCcEEecCCCcCc
Q 015852           66 EGSVTRVDLGNAALSGE----LAPELGQLKNLELLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLS  128 (399)
Q Consensus        66 ~~~v~~l~l~~~~l~g~----ip~~l~~l~~L~~l~l~~n~l~G~----ip~~~~~l~~L~~l~ls~N~l~  128 (399)
                      ...+..|+|++|.++..    +...+...+.|+.|+|++|.++..    +-..+...++|+.|++++|.+.
T Consensus        43 n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          43 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             CCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            45789999999998632    233456678899999999999765    2235667788999999988643